Citrus Sinensis ID: 047195
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 559 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LZM4 | 657 | Wall-associated receptor | yes | no | 0.994 | 0.846 | 0.546 | 0.0 | |
| Q9M342 | 639 | Wall-associated receptor | no | no | 0.996 | 0.871 | 0.505 | 1e-167 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.676 | 0.491 | 0.359 | 1e-65 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.554 | 0.412 | 0.423 | 7e-65 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.624 | 0.478 | 0.377 | 9e-64 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.561 | 0.396 | 0.401 | 7e-63 | |
| Q8GYF5 | 622 | Wall-associated receptor | no | no | 0.491 | 0.442 | 0.427 | 1e-61 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.595 | 0.437 | 0.373 | 2e-61 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.964 | 0.736 | 0.302 | 2e-61 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.595 | 0.445 | 0.375 | 2e-61 |
| >sp|Q9LZM4|WAKLQ_ARATH Wall-associated receptor kinase-like 20 OS=Arabidopsis thaliana GN=WAKL20 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 646 bits (1666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/607 (54%), Positives = 423/607 (69%), Gaps = 51/607 (8%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C NCG + VPYPLSTGP CGDQ+Y++ C G L+F L+GSSY+ITSIN ++Q +++RPP
Sbjct: 43 CPNCGPMVVPYPLSTGPTCGDQAYRINCVGGKLYFGALHGSSYVITSINSVTQRIVLRPP 102
Query: 62 GLIKN-KCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYI 120
GL + CI+AD QGL+LD +L F+I+SSNT++++NCS MLQ P +CS TS+C+SYI
Sbjct: 103 GLASSVSCISADVSKQGLELDPHLPFSITSSNTILLLNCSQAMLQAPIDCSPTSLCYSYI 162
Query: 121 RDN--PVAK-------RTGGSINEYRIRVRAERCAAYQSFVDL----DLSLPVSKWPEPG 167
++N P +K RT GS Y IR+ C AYQSFV L ++ P KWP+ G
Sbjct: 163 KNNASPCSKAPLCCTFRTDGSQTAYTIRINGGGCLAYQSFVGLNPNKEVPPPGKKWPDTG 222
Query: 168 VKIEWALPREPTCKLPVDCQDLL-NSMCLQDAESAGQKRCLYKAGFQWDPISGICKSLKC 226
++++WALP+EP CK VDC LL S CL D S G KRC K G +WDP++ IC KC
Sbjct: 223 LELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWDPVNAICG--KC 280
Query: 227 SHGKGCKHKKPKTA-----------VIGVLATIKFYKHFHQSNRE---VSLTKVQKDISG 272
HGK CK KK + + + KH HQ ++ ++ K ++++
Sbjct: 281 RHGKHCKKKKKTVVFAGAAVAVVGVTLAIAVAVIGTKHSHQKVKKDIHKNIVKEREEMLS 340
Query: 273 ANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG 332
AN++G+ +RIF+ REIT+ATNNFS NL+G+GGFGEVFKA+L+D TITA+KRAKL NTKG
Sbjct: 341 ANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKG 400
Query: 333 IDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGNWPPLK 377
D ILNEVRILCQ+NHRSL + PNGTLF+ LH W PL
Sbjct: 401 TDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWKPLT 460
Query: 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL-----A 432
W RL IA QTA+ +AYLH A PPIYHRD+KSSNILLDEKL+AK+SDFGLSRL
Sbjct: 461 WRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTET 520
Query: 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV 492
N SH+ T AQGTLGYLDPEYY NFQLTDKSDVYSFGVVL+E++TSKKA+DF REEEDV
Sbjct: 521 ANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDV 580
Query: 493 NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552
NLV+Y ++ QERL + IDP+LK+ A++I++ +++ G L +ACL+ERRQNRPS+KEVA
Sbjct: 581 NLVMYINKMMDQERLTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMKEVA 640
Query: 553 DEIERII 559
DEIE II
Sbjct: 641 DEIEYII 647
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9M342|WAKLP_ARATH Wall-associated receptor kinase-like 15 OS=Arabidopsis thaliana GN=WAKL15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 590 bits (1520), Expect = e-167, Method: Compositional matrix adjust.
Identities = 308/609 (50%), Positives = 401/609 (65%), Gaps = 52/609 (8%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRC-NAGMLWFDGLNGSSYMITSINPLSQSLIIRP 60
C NCG VPYPLSTG CGD Y++RC N G LWFD LNGS+ I +I+P Q ++RP
Sbjct: 29 CPNCGSTRVPYPLSTGLDCGDPGYRIRCDNYGSLWFDTLNGSTNPIKTIDPSGQRFVLRP 88
Query: 61 PGLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEML----QKPFNCSSTSIC 116
PG +NKC++ D G+QLD NL FN+S SNTV++MNC+ + L + FNCS S+C
Sbjct: 89 PGFEQNKCVSVDIKYHGIQLDLNLPFNVSCSNTVIIMNCTKDGLDAYSSQGFNCSDNSLC 148
Query: 117 HSYIRDNPVAK------------RTGGSINEYRI-RVRAERCAAYQSFVDLDLSLPVSKW 163
H ++ N A+ +TG S+N Y++ R R + C+AYQSF++LDL++PVSKW
Sbjct: 149 HKFLNANLEARGNCRGVTSCCWYKTGASVNTYKVYRARPDMCSAYQSFMNLDLTIPVSKW 208
Query: 164 PEPGVKIEWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGICKS 223
EP V+I W PREP CK DC+DLLNS+C D+ + GQKRC K GFQWD ++ +C+
Sbjct: 209 GEPAVEILWEAPREPVCKSQGDCRDLLNSVCSNDSTNLGQKRCFCKKGFQWDSVNAVCEV 268
Query: 224 LKCSHGKGCKHKKPKTAVIG--------VLATIKFYKHFHQSNREV-------SLTKVQK 268
+CS K CK + G ++A + NR + S+ K+ +
Sbjct: 269 NRCSKRKSCKRWSNLPLLGGLAGGVGAILIAGFITKTIVSKQNRRIAGNQSWASVRKLHR 328
Query: 269 DISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLG 328
++ N++G L RIF+ +EI +AT+NF+ NLLG GGFGEVFK LDD T AVKRAKLG
Sbjct: 329 NLLSINSTG-LDRIFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLG 387
Query: 329 NTKGIDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGN- 372
N K I I+NEV+ILCQ++H++L + PNGTLF+ ++ G
Sbjct: 388 NEKSIYQIVNEVQILCQVSHKNLVKLLGCCIELEMPVLVYEFVPNGTLFEHIYGGGGGGG 447
Query: 373 --WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
+ L RL IA QTAQ + YLH ++PPIYHRD+KSSNILLDE LD K++DFGLSR
Sbjct: 448 GLYDHLPLRRRLMIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSR 507
Query: 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
L ++ SHVTT AQGTLGYLDPEYY+NFQLTDKSDVYSFGVVL ELLT KKA+DFNREEE
Sbjct: 508 LGVSDVSHVTTCAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEE 567
Query: 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
DVNLVV+ LK+ RL+D IDP++ GA+E E++SMKA G+L C+ E RQ RP+++
Sbjct: 568 DVNLVVFVRKALKEGRLMDVIDPVIGIGATEKEIESMKALGVLAELCVKETRQCRPTMQV 627
Query: 551 VADEIERII 559
A EIE I+
Sbjct: 628 AAKEIENIL 636
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 159/442 (35%), Positives = 233/442 (52%), Gaps = 64/442 (14%)
Query: 171 EWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDP-ISGICKSLK---- 225
E+ + R + + C +C ++ + G C +GF+ +P I G CK +
Sbjct: 276 EYTILRRDNREYGIGC------LCDYNSTTTGYATCSCASGFEGNPYIPGECKDINECVR 329
Query: 226 -------CSHGK--------GCKHKKPKTAVIGV---LATIKF-------YKHFHQSNRE 260
C+ GK C++ + VIG+ +T+ F YK + R
Sbjct: 330 GIDGNPVCTAGKCVNLLGGYTCEYTNHRPLVIGLSTSFSTLVFIGGIYWLYKFIRRQRRL 389
Query: 261 VSLTKVQKDISGANNSGRL---------ARIFSSREITEATNNFSTGNLLGSGGFGEVFK 311
K K G +L R+F+SRE+ +AT NFS +LG GG G V+K
Sbjct: 390 NQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTVYK 449
Query: 312 AILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMS 356
+L D I AVK++K+ + ++ +NEV IL Q+NHR+ L
Sbjct: 450 GMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFI 509
Query: 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD 416
PNG LF+ LH S ++ W RL IA A A++YLH A+ PIYHRDIKS+NI+LD
Sbjct: 510 PNGNLFEHLHD-DSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLD 568
Query: 417 EKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVEL 476
EK AK+SDFG SR +H+TT GT+GY+DPEY+ + Q TDKSDVYSFGVVL EL
Sbjct: 569 EKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAEL 628
Query: 477 LTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAA 536
+T +K+V F R +E L YF +K+ RL D ID +++G +L+ + A +
Sbjct: 629 ITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGC---KLNQVTAAAKIARK 685
Query: 537 CLDERRQNRPSIKEVADEIERI 558
CL+ + + RPS+++V+ E+E+I
Sbjct: 686 CLNMKGRKRPSMRQVSMELEKI 707
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 7e-65, Method: Compositional matrix adjust.
Identities = 145/342 (42%), Positives = 203/342 (59%), Gaps = 32/342 (9%)
Query: 241 VIGVLATIKFYKH---------FHQSNREVSLTKVQKDISGANNSGRLARIFSSREITEA 291
V+G+ IKF K F + N + L K Q G N ++IFSS+E+ +A
Sbjct: 361 VLGIWGLIKFVKKRRKIIRKRMFFKRNGGL-LLKQQLTTRGGNVQS--SKIFSSKELEKA 417
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL 351
T+NF+ +LG GG G V+K +L D I AVKR+K+ + ++ +NEV +L Q+NHR++
Sbjct: 418 TDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNI 477
Query: 352 FMSMS---------------PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
M PNG LF RLH S ++ + W RL I+ + A A+AYLH
Sbjct: 478 VKLMGCCLETEVPILVYEHIPNGDLFKRLHH-DSDDYT-MTWDVRLRISVEIAGALAYLH 535
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
A+ P+YHRD+K++NILLDEK AK+SDFG SR +H+TT GT GYLDPEY+
Sbjct: 536 SAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQ 595
Query: 457 NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516
Q TDKSDVYSFGVVLVEL+T +K R EE+ LV +F +KQ R++D +D +K
Sbjct: 596 TSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIK 655
Query: 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
EG + L+ + A L CL + + RP+++EV+ E+ERI
Sbjct: 656 EGCT---LEQVLAVAKLARRCLSLKGKKRPNMREVSVELERI 694
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 244 bits (624), Expect = 9e-64, Method: Compositional matrix adjust.
Identities = 144/381 (37%), Positives = 214/381 (56%), Gaps = 32/381 (8%)
Query: 202 GQKRCLYKAGFQWDPISGICKSLKCSHGKGCKHKKPKTA---VIGVLATIKFYKHFHQSN 258
G+ C+ AG ++ + I K K +H VIG+ KF + +
Sbjct: 327 GEDTCVNMAG-RYSCVPKITKPAKLAHVLRGVLIGLLGLLFFVIGIFGLYKFIRKRRRII 385
Query: 259 REVSLTK------VQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKA 312
R + K +++ ++ + S +++IFSSRE+ +AT+NFS +LG GG G V+K
Sbjct: 386 RSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKR 445
Query: 313 ILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSP 357
+L D +I AVKR+K+ + ++ +NE+ +L Q+NHR+ L P
Sbjct: 446 MLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIP 505
Query: 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE 417
NG LF RLH + W RL IA + A A++Y+H A+ PI+HRDIK++NILLDE
Sbjct: 506 NGDLFKRLHDEYDDYM--MTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDE 563
Query: 418 KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
K AKISDFG SR +H+TT GT GY+DPEY+++ Q T KSDVYSFGVVLVEL+
Sbjct: 564 KYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELI 623
Query: 478 TSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAAC 537
T +K + R EE + L YF +K+ R VD ID +K+ + ++ A L C
Sbjct: 624 TGEKPMSRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKDESKQV-----MAVAKLARRC 678
Query: 538 LDERRQNRPSIKEVADEIERI 558
L+ + RP+++EV+ ++ERI
Sbjct: 679 LNRKGNKRPNMREVSIKLERI 699
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (617), Expect = 7e-63, Method: Compositional matrix adjust.
Identities = 136/339 (40%), Positives = 197/339 (58%), Gaps = 25/339 (7%)
Query: 241 VIGVLATIKFYKHFHQSNREVSLTK------VQKDISGANNSGRLARIFSSREITEATNN 294
V+G+ KF K + N++ K +Q+ + +FSSRE+ +AT N
Sbjct: 387 VVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATEN 446
Query: 295 FSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---- 350
FS+ +LG GG G V+K +L D I AVK++K+ + ++ +NEV IL Q+NHR+
Sbjct: 447 FSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKL 506
Query: 351 -----------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
L PNG LF+ LH N W+ RL IA A A++YLH A
Sbjct: 507 LGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMA-TWNIRLRIAIDIAGALSYLHSSA 565
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
+ PIYHRD+KS+NI+LDEK AK+SDFG SR +H+TT GT+GY+DPEY+ + Q
Sbjct: 566 SSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQ 625
Query: 460 LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGA 519
TDKSDVYSFGVVLVEL+T +K++ F R +E+ L YF +K+ +L D ID +++G
Sbjct: 626 FTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDGC 685
Query: 520 SEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
L + A + CL+ + + RPS++EV+ E++ I
Sbjct: 686 M---LSQVTATAKVARKCLNLKGRKRPSMREVSMELDSI 721
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYF5|WAKLR_ARATH Wall-associated receptor kinase-like 21 OS=Arabidopsis thaliana GN=WAKL21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 238 bits (606), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 126/295 (42%), Positives = 180/295 (61%), Gaps = 20/295 (6%)
Query: 282 IFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVR 341
++ +EI +AT++FS N+LG+G +G V+ + + A+KR K +T ID ++NE++
Sbjct: 301 FYTYKEIEKATDSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIK 360
Query: 342 ILCQLNHRSLF---------------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
+L ++H +L PNGTL+ L + PPL W RL IA
Sbjct: 361 LLSSVSHPNLVRLLGCCFADGEPFLVYEFMPNGTLYQHLQHERG--QPPLSWQLRLAIAC 418
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG---ASHVTTFA 443
QTA AIA+LH PPIYHRDIKSSNILLD + ++KISDFGLSRL ++ ASH++T
Sbjct: 419 QTANAIAHLHSSVNPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHISTAP 478
Query: 444 QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503
QGT GYLDP+Y+ +FQL+DKSDVYSFGVVLVE+++ K +DF R +VNL + +
Sbjct: 479 QGTPGYLDPQYHQDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVDRIG 538
Query: 504 QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+ R+VD IDP L + + S+ L CL R RP++ E+ +++ RI
Sbjct: 539 RGRVVDIIDPCLNKEINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHRI 593
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 237 bits (604), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 141/378 (37%), Positives = 207/378 (54%), Gaps = 45/378 (11%)
Query: 221 CKSLKCSHGKG---CKHKKPKTA----------------VIGVLATIKFYKHFHQSNREV 261
CK C + G C+ KKP G+ KF K +S+R
Sbjct: 325 CKDQSCVNKPGWFTCEPKKPGQIKPVFQGVLIGSALLLFAFGIFGLYKFIKKQRRSSRMR 384
Query: 262 SLTK------VQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILD 315
+ +++ ++ + +++IFSS E+ +AT+NF+T +LG GG G V+K +L
Sbjct: 385 VFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLV 444
Query: 316 DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSPNGT 360
D I AVKR+K + ++ +NEV +L Q+NHR+ L PNG
Sbjct: 445 DGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGD 504
Query: 361 LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420
L RL R + ++ + W RLHIA + A A++YLH A+ PIYHRDIK++NILLDEK
Sbjct: 505 LCKRL-RDECDDYI-MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQ 562
Query: 421 AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
K+SDFG SR +H+TT GT GY+DPEY+ + + TDKSDVYSFGVVLVEL+T K
Sbjct: 563 VKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGK 622
Query: 481 KAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDE 540
+ EE+ +F +K+ R +D +D +K+ E LD + A L CL+
Sbjct: 623 NPSSRVQSEENRGFAAHFVAAVKENRFLDIVDERIKD---ECNLDQVMAVAKLAKRCLNR 679
Query: 541 RRQNRPSIKEVADEIERI 558
+ + RP+++EV+ E+ERI
Sbjct: 680 KGKKRPNMREVSVELERI 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 237 bits (604), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 201/664 (30%), Positives = 300/664 (45%), Gaps = 125/664 (18%)
Query: 3 TNCGHIPVPYPLSTGPGC---GDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIR 59
T CG++ V YP T PGC GD+S+ + CN F G + S++ + ++R
Sbjct: 31 TRCGNVAVEYPFGTSPGCYYPGDESFNLTCNEQEKLFFG--NMPVINMSLSGQLRVRLVR 88
Query: 60 PPGLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNC-SIEMLQ------------- 105
++ DY Q L N F +S N V+ C S L+
Sbjct: 89 SRVCYDSQGKQTDYIAQRTTLGN---FTLSELNRFTVVGCNSYAFLRTSGVEKYSTGCIS 145
Query: 106 -------KPFNCSSTSIC-------HSYIRDNPVAKRTGGSINEYRIRVRA----ERCAA 147
K +CS C +S++R P + +++ + A +
Sbjct: 146 ICDSATTKNGSCSGEGCCQIPVPRGYSFVRVKPHSFHNHPTVHLFNPCTYAFLVEDGMFD 205
Query: 148 YQSFVDLDLSLPVSKWPEPGVKIEWALPREPTCKLPVDCQDLL--NSMCLQDAESAGQK- 204
+ + DL+ V+ +P V ++W++ + TCK V+ + + NS C G
Sbjct: 206 FHALEDLNNLRNVTTFP---VVLDWSIG-DKTCK-QVEYRGVCGGNSTCFDSTGGTGYNC 260
Query: 205 RCLYKAGFQWDP-ISGICKSLK--------CSHGKGCKHKKP------------------ 237
+CL GF+ +P + C+ + CS C++ K
Sbjct: 261 KCL--EGFEGNPYLPNGCQDINECISSRHNCSEHSTCENTKGSFNCNCPSGYRKDSLNSC 318
Query: 238 ---------KTAVIGVLATIKF-----------YKHFHQSNREVSLTKVQKD-------- 269
+ I + TI F K H+ N E+ +++
Sbjct: 319 TRKVRPEYFRWTQIFLGTTIGFSVIMLGISCLQQKIKHRKNTELRQKFFEQNGGGMLIQR 378
Query: 270 ISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGN 329
+SGA S +IF+ + + EATN + +LG GG G V+K IL D +I A+K+A+LGN
Sbjct: 379 VSGAGPSNVDVKIFTEKGMKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGN 438
Query: 330 TKGIDPILNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWP 374
++ +NEV +L Q+NHR+ L +GTLFD LH S
Sbjct: 439 RSQVEQFINEVLVLSQINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLH--GSLYDS 496
Query: 375 PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434
L W HRL IA + A ++AYLH A+ PI HRDIK++NILLD+ L AK++DFG SRL
Sbjct: 497 SLTWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPM 556
Query: 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNL 494
+TT QGTLGYLDPEYY L +KSDVYSFGVVL+ELL+ +KA+ F R NL
Sbjct: 557 DKEQLTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPHCPKNL 616
Query: 495 VVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554
V F + K R + ID + ++ E+ + A C + RP +KEVA E
Sbjct: 617 VSCFASATKNNRFHEIIDGQVMNEDNQREIQEAAR---IAAECTRLMGEERPRMKEVAAE 673
Query: 555 IERI 558
+E +
Sbjct: 674 LEAL 677
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (603), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 142/378 (37%), Positives = 212/378 (56%), Gaps = 45/378 (11%)
Query: 221 CKSLKCSHGKG---CKHKKP---KTAVIGVL----------ATIKFYKHFHQSNREVSLT 264
CK C + G C+ KKP K + GVL YK + + + +
Sbjct: 317 CKDQSCVNLPGWFDCQPKKPEQLKRVIQGVLIGSALLLFAFGIFGLYKFVQKRRKLIRMR 376
Query: 265 K---------VQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILD 315
K +++ ++ + ++RIFSS E+ +AT+NF+ +LG GG G V+K +L
Sbjct: 377 KFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLV 436
Query: 316 DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSPNGT 360
D I AVKR+K + ++ +NEV +L Q+NHR+ L PNG
Sbjct: 437 DGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGD 496
Query: 361 LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420
L RLH +S ++ + W RLHIA + A A++YLH A+ PIYHRDIK++NILLDE+
Sbjct: 497 LCKRLHD-ESDDYT-MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNR 554
Query: 421 AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
AK+SDFG SR +H+TT GT GY+DPEY+ + + T+KSDVYSFGVVLVELLT +
Sbjct: 555 AKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGE 614
Query: 481 KAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDE 540
K R EE+ L +F +K+ R++D +D +K+ E +D + + L CL+
Sbjct: 615 KPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKD---ECNMDQVMSVANLARRCLNR 671
Query: 541 RRQNRPSIKEVADEIERI 558
+ + RP+++EV+ E+E I
Sbjct: 672 KGKKRPNMREVSIELEMI 689
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 559 | ||||||
| 255578007 | 641 | kinase, putative [Ricinus communis] gi|2 | 0.998 | 0.870 | 0.587 | 0.0 | |
| 225440470 | 636 | PREDICTED: wall-associated receptor kina | 0.985 | 0.866 | 0.606 | 0.0 | |
| 147790445 | 636 | hypothetical protein VITISV_001450 [Viti | 0.985 | 0.866 | 0.604 | 0.0 | |
| 449448886 | 639 | PREDICTED: wall-associated receptor kina | 0.996 | 0.871 | 0.554 | 0.0 | |
| 15241674 | 657 | wall-associated receptor kinase-like 20 | 0.994 | 0.846 | 0.546 | 0.0 | |
| 297810305 | 657 | hypothetical protein ARALYDRAFT_486985 [ | 0.994 | 0.846 | 0.545 | 0.0 | |
| 356523191 | 648 | PREDICTED: wall-associated receptor kina | 0.994 | 0.858 | 0.548 | 1e-180 | |
| 255578009 | 566 | ATP binding protein, putative [Ricinus c | 0.890 | 0.879 | 0.543 | 1e-176 | |
| 225449384 | 629 | PREDICTED: wall-associated receptor kina | 0.996 | 0.885 | 0.515 | 1e-174 | |
| 296086176 | 690 | unnamed protein product [Vitis vinifera] | 0.996 | 0.807 | 0.515 | 1e-173 |
| >gi|255578007|ref|XP_002529875.1| kinase, putative [Ricinus communis] gi|223530651|gb|EEF32525.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 715 bits (1845), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/604 (58%), Positives = 442/604 (73%), Gaps = 46/604 (7%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C NCG + VPYPLST P CGDQ YK+RC AG LWFDG+NGSSY I +INPL + LII+PP
Sbjct: 28 CGNCGRLLVPYPLSTRPDCGDQHYKLRCTAGTLWFDGVNGSSYTIKTINPLIRRLIIQPP 87
Query: 62 GLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEM----LQKPFNCSSTSICH 117
L N CI++D+H QG+QLD+NL FNISSSNT++++NC+ + L P +CS SICH
Sbjct: 88 NLANNSCISSDFHSQGIQLDHNLPFNISSSNTILLLNCTDSVSHLKLNPPMDCSPASICH 147
Query: 118 SYIRDNPVA---------KRTGGSINEYRIRVRAERCAAYQSFVDLDLS--LPVSKWPEP 166
+YI+++ A RTGG N ++V C+AYQSFV+LDL L ++KWPEP
Sbjct: 148 NYIKEHAAACIIAPLCCTFRTGGLQNVDALKVYVGECSAYQSFVNLDLKTVLALNKWPEP 207
Query: 167 GVKIEWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGICKSLKC 226
V+IEW LP+EP C+ PVDC++LL S CL D GQKRC AGF+WDPI+G+C+++KC
Sbjct: 208 EVEIEWMLPQEPVCRTPVDCRELLYSKCLADPIIFGQKRCFCNAGFKWDPINGLCQNVKC 267
Query: 227 SHGKGCKHKKPKTAVIGVLAT------------IKFYKHFHQSNR-EVSLTKVQKDISGA 273
GK C+ +K KTA+ +A I FY H+S + + +L K +K++ A
Sbjct: 268 RTGKACRKRKKKTALFAGVALAGGAILLVAVTGILFYNQHHRSRQAQKNLIKERKEMLNA 327
Query: 274 NNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGI 333
+SG+ ARIF+ +EI +ATNNFS NL+GSGGFGEVFK ILDD TITA+KRAKLGNTKG
Sbjct: 328 KHSGKSARIFTGKEIIKATNNFSKDNLIGSGGFGEVFKGILDDGTITAIKRAKLGNTKGT 387
Query: 334 DPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGNWPPLKW 378
D +LNEVRILCQ+NHRSL + PNGTLF+ LH QS W PL W
Sbjct: 388 DQVLNEVRILCQVNHRSLVRLLGCCVELELPIMIYEYIPNGTLFEHLHCNQSSKWTPLPW 447
Query: 379 HHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL---ALNG 435
RL IA QTA+ +AYLH A PPIYHRD+KSSNILLDE+L+AK+SDFGLSRL + N
Sbjct: 448 QRRLRIAHQTAEGLAYLHSAALPPIYHRDVKSSNILLDERLNAKVSDFGLSRLVETSENN 507
Query: 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
SH+ T AQGTLGYLDPEYY NFQLTDKSDVYSFGVVL+E+LTSKKA+DFNREEEDVNLV
Sbjct: 508 DSHIFTCAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLMEILTSKKAIDFNREEEDVNLV 567
Query: 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555
VY +++++R++DAIDP+LKE AS++EL++MKA G L A CLDE+RQNRPS+KEVADEI
Sbjct: 568 VYMKKMIEEDRILDAIDPVLKESASKLELETMKALGSLAATCLDEKRQNRPSMKEVADEI 627
Query: 556 ERII 559
+ II
Sbjct: 628 QYII 631
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440470|ref|XP_002271602.1| PREDICTED: wall-associated receptor kinase-like 20 [Vitis vinifera] gi|297740320|emb|CBI30502.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/594 (60%), Positives = 428/594 (72%), Gaps = 43/594 (7%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C +CG IPVPYPLSTGPGCGDQSYKVRCNAG LWFD L+ SSY+ITSINP ++ +I++P
Sbjct: 28 CGDCGRIPVPYPLSTGPGCGDQSYKVRCNAGTLWFDALSQSSYVITSINPGTRRMIVKPA 87
Query: 62 GLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYIR 121
L+ N CI D GLQLD +NI SSNT+M+MNCS +L NCS SICH+YIR
Sbjct: 88 SLLANTCITTDIQVGGLQLDRISPYNIPSSNTIMLMNCSNAVLNSSVNCSPNSICHAYIR 147
Query: 122 DNPVAK-----------RTGGSINEYRIRVRAERCAAYQSFVDLDLSLPVSKWPEPGVKI 170
+N VA + GG +N Y+I VR E C AYQSFV+L SLPV +WPEPG++I
Sbjct: 148 ENVVAAACRSTAKCCWFKAGGPVNAYKIGVRDEGCMAYQSFVNLATSLPVKRWPEPGLEI 207
Query: 171 EWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGICKSLKCSHGK 230
EWALP+EP CK+P DC LLNSMCL D GQ+RC KAGF W PI+G+C++LKC K
Sbjct: 208 EWALPQEPICKIPKDCSTLLNSMCLPDGAILGQRRCFCKAGFHWGPINGLCQNLKCEKAK 267
Query: 231 GCK----HKKPKTAVIGVLATIKFY--------KHFHQSNREV--SLTKVQKDISGANNS 276
CK + P + V+A I +H RE SL K ++D+ ANNS
Sbjct: 268 SCKHKKKSRTPLLGGVAVVAAILILVPVGILVCRHRQNLKREAQGSLIKKREDMLNANNS 327
Query: 277 GRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPI 336
G++A+IFS +EI ATNNFS N +GSGGF EVFK ILDD T+TAVKRAKLGNTKG D +
Sbjct: 328 GKMAKIFSGKEIKRATNNFSKDNFIGSGGFSEVFKGILDDGTVTAVKRAKLGNTKGTDQV 387
Query: 337 LNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGNWPPLKWHHR 381
LNEVRILCQ+NHR L + PNGTLFD LH S WP L W R
Sbjct: 388 LNEVRILCQVNHRCLVRLLGCCVELEQPIMIYEYIPNGTLFDHLHGHHSRKWPALTWRRR 447
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL---NGASH 438
L IA QTA+ +AYLH A PPIYHRD+KSSNILLDEKLDAK+SDFGLSRLA+ ASH
Sbjct: 448 LSIALQTAEGLAYLHSSAVPPIYHRDVKSSNILLDEKLDAKVSDFGLSRLAVVSEANASH 507
Query: 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF 498
+TT AQGTLGYLDPEYY NFQLTDKSDVYSFGVVL+ELLTSKKA+DFNREEEDVNLV+Y
Sbjct: 508 ITTCAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEDVNLVLYI 567
Query: 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552
I+K+E+L+D IDP+LK+GAS+++++S+KA GLL AACLDERRQ+RPS+KE A
Sbjct: 568 KKIMKEEKLMDVIDPVLKDGASKVDMESVKALGLLAAACLDERRQSRPSMKEAA 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147790445|emb|CAN69970.1| hypothetical protein VITISV_001450 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 693 bits (1788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/594 (60%), Positives = 427/594 (71%), Gaps = 43/594 (7%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C +CG PVPYPLSTGPGCGDQSYKVRCNAG LWFD L+ SSY+ITSINP ++ +I++P
Sbjct: 28 CGDCGRXPVPYPLSTGPGCGDQSYKVRCNAGTLWFDALSQSSYVITSINPGTRRMIVKPA 87
Query: 62 GLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYIR 121
L+ N CI D GLQLD +NI SSNT+M+MNCS +L NCS SICH+YIR
Sbjct: 88 SLLANTCITTDIQVGGLQLDRISPYNIPSSNTIMLMNCSNAVLNSSVNCSPNSICHAYIR 147
Query: 122 DNPVAK-----------RTGGSINEYRIRVRAERCAAYQSFVDLDLSLPVSKWPEPGVKI 170
+N A +TGG +N Y+I VR E C AYQSFV+L SLPV +WPEPG++I
Sbjct: 148 ENVAAAACRSTXKCCWFKTGGPVNAYKIGVRDEGCMAYQSFVNLATSLPVKRWPEPGLEI 207
Query: 171 EWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGICKSLKCSHGK 230
EWALP+EP CK+P DC LLNSMCL D GQ+RC KAGF W PI+G+C++LKC K
Sbjct: 208 EWALPQEPICKIPKDCSTLLNSMCLPDGAILGQRRCFCKAGFHWGPINGLCQNLKCEKAK 267
Query: 231 GCK----HKKPKTAVIGVLATIKFY--------KHFHQSNREV--SLTKVQKDISGANNS 276
CK + P + V+A I +H RE SL K ++D+ ANNS
Sbjct: 268 SCKHKKKSRTPLLGGVAVVAAILILVPVGILVCRHRQNLKREAQGSLIKKREDMLNANNS 327
Query: 277 GRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPI 336
G++A+IFS +EI ATNNFS N +GSGGF EVFK ILDD T+TAVKRAKLGNTKG D +
Sbjct: 328 GKMAKIFSGKEIKRATNNFSKDNFIGSGGFSEVFKGILDDGTVTAVKRAKLGNTKGTDQV 387
Query: 337 LNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGNWPPLKWHHR 381
LNEVRILCQ+NHR L + PNGTLFD LH S WP L W R
Sbjct: 388 LNEVRILCQVNHRCLVRLLGCCVELEQPIMIYEYIPNGTLFDHLHGHHSRKWPALTWRRR 447
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL---NGASH 438
L IA QTA+ +AYLH A PPIYHRD+KSSNILLDEKLDAK+SDFGLSRLA+ ASH
Sbjct: 448 LSIALQTAEGLAYLHSSAVPPIYHRDVKSSNILLDEKLDAKVSDFGLSRLAVVSEANASH 507
Query: 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF 498
+TT AQGTLGYLDPEYY NFQLTDKSDVYSFGVVL+ELLTSKKA+DFNREEEDVNLV+Y
Sbjct: 508 ITTCAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEDVNLVLYI 567
Query: 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552
I+K+E+L+D IDP+LK+GAS+++++S+KA GLL AACLDERRQ+RPS+KE A
Sbjct: 568 KKIMKEEKLMDVIDPVLKDGASKVDMESVKALGLLAAACLDERRQSRPSMKEAA 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448886|ref|XP_004142196.1| PREDICTED: wall-associated receptor kinase-like 20-like [Cucumis sativus] gi|449519080|ref|XP_004166563.1| PREDICTED: wall-associated receptor kinase-like 20-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/604 (55%), Positives = 425/604 (70%), Gaps = 47/604 (7%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C +CG PVPYPLST P CGD Y+VRC A LWF+ NGSSY+ITS+N +++ LIIRPP
Sbjct: 26 CPDCGRTPVPYPLSTRPDCGDPLYRVRCAAAELWFESANGSSYLITSVNSVARKLIIRPP 85
Query: 62 GLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYIR 121
GL KN C+++D+ G LD L F IS NTV++ NCSIE+L+ +NCS S+CH +I+
Sbjct: 86 GLAKNTCVSSDFRTDGFWLDTRLPFTISDRNTVLLYNCSIEVLENNWNCSHNSVCHDFIK 145
Query: 122 DNPVAK------------RTGGSINEYRIRVRAERCAAYQSFVDLDLSLPVSKWPEPGVK 169
NPVA +GGS+ YRIRVR ERC+AY+ FV+L S P KWPEPGV+
Sbjct: 146 QNPVAMAACKTAPTCCWYTSGGSLTSYRIRVRKERCSAYECFVNLGGSAPAKKWPEPGVE 205
Query: 170 IEWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGICK--SLKCS 227
I+WA PREP C++ +DC++ NS CL D + QKRCL K +WDP++G+C +LK
Sbjct: 206 IQWAPPREPPCRVAMDCRNWENSACLPDHTNPKQKRCLCKVPSKWDPVNGLCNGNNLKIQ 265
Query: 228 HGKGCKHKKPKTAVI--GVLATI--------------KFYKHFHQSNREVSLTKVQKDIS 271
+ K K K VI GV+A + K + + N E+S +V++ I
Sbjct: 266 NKTIHKKKHKKVPVILGGVMAGVFLMVIGGSIIFVISKRREQLPKRN-ELSSKQVREVIL 324
Query: 272 GANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK 331
AN+SG+ AR+F+++EI +ATNNFS NLLGSGG+GEVFK L+D T+ AVKRAKLG+ K
Sbjct: 325 TANSSGKSARMFTTKEIAKATNNFSKENLLGSGGYGEVFKGNLEDGTLVAVKRAKLGSMK 384
Query: 332 GIDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLH-RVQSGNWPP 375
GID ILNEVRILCQ+NHR L + NG LFD LH S WPP
Sbjct: 385 GIDQILNEVRILCQVNHRYLVRLLGCCLELEQPLLIYEYISNGNLFDHLHGNTSSSKWPP 444
Query: 376 LKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435
L HRL+IARQTA +AYLH A P IYHRDIKSSNILLDEKL+AK++DFGLSRLA+
Sbjct: 445 LTLSHRLYIARQTADGLAYLHTSAMPRIYHRDIKSSNILLDEKLNAKVADFGLSRLAITE 504
Query: 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
+SH+TT AQGTLGYLDPEYY+NFQLTDKSDVYSFGVV++ELLTS+KA+DFNREEEDVNLV
Sbjct: 505 SSHITTGAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVMLELLTSEKAIDFNREEEDVNLV 564
Query: 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555
VY I++++RL++ +DP++K AS +E++ +KA G L AACLDE+RQNRP++KEVADE+
Sbjct: 565 VYIKKIIQEDRLMEVVDPVIKHRASRVEVEIIKALGSLAAACLDEKRQNRPTMKEVADEL 624
Query: 556 ERII 559
II
Sbjct: 625 ANII 628
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15241674|ref|NP_195827.1| wall-associated receptor kinase-like 20 [Arabidopsis thaliana] gi|75335716|sp|Q9LZM4.1|WAKLQ_ARATH RecName: Full=Wall-associated receptor kinase-like 20; Flags: Precursor gi|7340681|emb|CAB82980.1| putative protein kinase [Arabidopsis thaliana] gi|332003045|gb|AED90428.1| wall-associated receptor kinase-like 20 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/607 (54%), Positives = 423/607 (69%), Gaps = 51/607 (8%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C NCG + VPYPLSTGP CGDQ+Y++ C G L+F L+GSSY+ITSIN ++Q +++RPP
Sbjct: 43 CPNCGPMVVPYPLSTGPTCGDQAYRINCVGGKLYFGALHGSSYVITSINSVTQRIVLRPP 102
Query: 62 GLIKN-KCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYI 120
GL + CI+AD QGL+LD +L F+I+SSNT++++NCS MLQ P +CS TS+C+SYI
Sbjct: 103 GLASSVSCISADVSKQGLELDPHLPFSITSSNTILLLNCSQAMLQAPIDCSPTSLCYSYI 162
Query: 121 RDN--PVAK-------RTGGSINEYRIRVRAERCAAYQSFVDL----DLSLPVSKWPEPG 167
++N P +K RT GS Y IR+ C AYQSFV L ++ P KWP+ G
Sbjct: 163 KNNASPCSKAPLCCTFRTDGSQTAYTIRINGGGCLAYQSFVGLNPNKEVPPPGKKWPDTG 222
Query: 168 VKIEWALPREPTCKLPVDCQDLL-NSMCLQDAESAGQKRCLYKAGFQWDPISGICKSLKC 226
++++WALP+EP CK VDC LL S CL D S G KRC K G +WDP++ IC KC
Sbjct: 223 LELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWDPVNAICG--KC 280
Query: 227 SHGKGCKHKKPKTA-----------VIGVLATIKFYKHFHQSNRE---VSLTKVQKDISG 272
HGK CK KK + + + KH HQ ++ ++ K ++++
Sbjct: 281 RHGKHCKKKKKTVVFAGAAVAVVGVTLAIAVAVIGTKHSHQKVKKDIHKNIVKEREEMLS 340
Query: 273 ANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG 332
AN++G+ +RIF+ REIT+ATNNFS NL+G+GGFGEVFKA+L+D TITA+KRAKL NTKG
Sbjct: 341 ANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKG 400
Query: 333 IDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGNWPPLK 377
D ILNEVRILCQ+NHRSL + PNGTLF+ LH W PL
Sbjct: 401 TDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWKPLT 460
Query: 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL-----A 432
W RL IA QTA+ +AYLH A PPIYHRD+KSSNILLDEKL+AK+SDFGLSRL
Sbjct: 461 WRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTET 520
Query: 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV 492
N SH+ T AQGTLGYLDPEYY NFQLTDKSDVYSFGVVL+E++TSKKA+DF REEEDV
Sbjct: 521 ANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDV 580
Query: 493 NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552
NLV+Y ++ QERL + IDP+LK+ A++I++ +++ G L +ACL+ERRQNRPS+KEVA
Sbjct: 581 NLVMYINKMMDQERLTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMKEVA 640
Query: 553 DEIERII 559
DEIE II
Sbjct: 641 DEIEYII 647
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297810305|ref|XP_002873036.1| hypothetical protein ARALYDRAFT_486985 [Arabidopsis lyrata subsp. lyrata] gi|297318873|gb|EFH49295.1| hypothetical protein ARALYDRAFT_486985 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/607 (54%), Positives = 425/607 (70%), Gaps = 51/607 (8%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C NCG + VPYPLSTGP CGDQ+Y++ C G L+F L+GSSY+ITSIN ++Q +++ PP
Sbjct: 43 CPNCGPMVVPYPLSTGPNCGDQAYRINCVGGKLYFGALHGSSYVITSINSVTQRIVLSPP 102
Query: 62 GLIKN-KCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYI 120
GL + CI+AD QGL+LD +L F+I+SSNT++++NCS MLQ P +CS TS+C+SYI
Sbjct: 103 GLASSVSCISADVSKQGLELDPHLPFSITSSNTILLLNCSQAMLQAPIDCSPTSLCYSYI 162
Query: 121 RDN--PVAK-------RTGGSINEYRIRVRAERCAAYQSFVDL----DLSLPVSKWPEPG 167
++N P +K RT GS Y IR+ + C AYQSFV L ++ P KWP+ G
Sbjct: 163 KNNASPCSKAPLCCTFRTDGSQTAYTIRINSGGCLAYQSFVGLNPNKEVPPPGIKWPDTG 222
Query: 168 VKIEWALPREPTCKLPVDCQDLL-NSMCLQDAESAGQKRCLYKAGFQWDPISGICKSLKC 226
++++WALP+EP CK VDC LL S CL D S G KRC K G +WDP++ IC KC
Sbjct: 223 LELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKRGLEWDPVNAICG--KC 280
Query: 227 SHGKGCKHKKPKTA-----------VIGVLATIKFYKHFHQSNRE---VSLTKVQKDISG 272
HGK CK KK + + + KH HQ ++ ++ K ++++
Sbjct: 281 RHGKHCKKKKKTVVFAGVAVAVVGATLAIAVAVIATKHSHQKVKKDLHKNIVKEREEMLS 340
Query: 273 ANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG 332
AN++G+ +RIF+ REIT+ATNNFS NL+G+GGFGEVFKA+L+D TITA+KRAKL NTKG
Sbjct: 341 ANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKG 400
Query: 333 IDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGNWPPLK 377
D ILNEVRILCQ+NHRSL + PNGTLF+ LH W PL
Sbjct: 401 TDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGNPDHTWKPLT 460
Query: 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL-----A 432
W RL IA QTA+ +AYLH A PPIYHRD+KSSNILLD+KL+AK+SDFGLSRL
Sbjct: 461 WRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDDKLNAKVSDFGLSRLVDLTET 520
Query: 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV 492
N SH+ T AQGTLGYLDPEYY NFQLTDKSDVYSFGVVL+E++TSKKA+DF+REEEDV
Sbjct: 521 ANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFSREEEDV 580
Query: 493 NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552
NLV+Y ++ QERL++ IDP+LK+ AS++++ +M+ G L +ACL+ERRQNRPS+KEVA
Sbjct: 581 NLVMYINKMMDQERLIECIDPLLKKTASKLDMQTMQQLGNLASACLNERRQNRPSMKEVA 640
Query: 553 DEIERII 559
DEIE II
Sbjct: 641 DEIEYII 647
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523191|ref|XP_003530225.1| PREDICTED: wall-associated receptor kinase-like 15-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1649), Expect = e-180, Method: Compositional matrix adjust.
Identities = 334/609 (54%), Positives = 424/609 (69%), Gaps = 53/609 (8%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C CG VPYPLST P CGD SYK+RC G L+FD +NG SY IT+INP +Q I+ P
Sbjct: 29 CPTCGQTRVPYPLSTAPNCGDPSYKIRCTGGTLFFDSINGFSYAITAINPTTQRFILHPS 88
Query: 62 GLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYIR 121
G + N C++ D+ +G+ LD N FNI+SSNTV+++NCS + P NCS +SICH Y++
Sbjct: 89 GFLNNTCMSTDFPNKGIWLDTNSPFNITSSNTVVLLNCSNNVFTTPRNCSLSSICHKYVK 148
Query: 122 DNPVAKR----------------TGGSINEYRIRVRAERCAAYQSFVDLDLSLPVSKWPE 165
+N VA + TGGS+ YRIRVR ERC+AY SF +LD SLPVS W
Sbjct: 149 ENDVAAKICGPRSHAPQTCCHIKTGGSVTAYRIRVRKERCSAYFSFPNLDPSLPVSMW-R 207
Query: 166 PGVKIEWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGICKSLK 225
PGV++EW LP EP+C++ DC DL NS+C + G ++C+ K G++W ++GIC+++K
Sbjct: 208 PGVELEWELPEEPSCRVNEDCLDLENSVCSPNPMIGGSRKCMCKRGYEWYSVNGICQNIK 267
Query: 226 CSHGKGCKHKKPKTAVIG-------------VLATIKFY--KHFHQSNREVSLTKVQKDI 270
C HG+GCK + KT++IG ++ T+ Y + + E SL++ +DI
Sbjct: 268 CEHGRGCKRRNKKTSLIGGTTLFAIATLTTAMITTLVLYLRRQRIKGETEQSLSRA-RDI 326
Query: 271 SGANNSG-RLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGN 329
ANNSG R A+IF+ +E+T+AT+NFS NLLG GGFGEVFK LDD TITA+KRAK GN
Sbjct: 327 LNANNSGGRSAKIFTMKELTKATSNFSKANLLGFGGFGEVFKGTLDDGTITAIKRAKPGN 386
Query: 330 TKGIDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQ----S 370
+GID ILNEV+ILCQ+NHRSL + PNGTLF+ LH S
Sbjct: 387 IRGIDQILNEVKILCQVNHRSLVRLLGCCVELPEPLLVYEYVPNGTLFEHLHHHHHNNNS 446
Query: 371 GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
L WH RL IA QTA+ IAYLH A P IYHRDIKSSNILLD+ LDAK+SDFGLSR
Sbjct: 447 SKGIRLGWHSRLRIAHQTAEGIAYLHNAAVPRIYHRDIKSSNILLDDNLDAKVSDFGLSR 506
Query: 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
L ++ A+H+TT A+GTLGYLDPEYY+NFQLTDKSDVYSFGVVL+ELLTSKKA+DFNREEE
Sbjct: 507 LVVSDATHITTCAKGTLGYLDPEYYVNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 566
Query: 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
DVNLVV L++ RL+D +DPMLK G S +EL++MKAFG L ACLD+RR+NRP++K+
Sbjct: 567 DVNLVVLIKRALREGRLMDNVDPMLKSGDSRLELETMKAFGALAIACLDDRRKNRPTMKD 626
Query: 551 VADEIERII 559
+ADEIE II
Sbjct: 627 IADEIECII 635
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578009|ref|XP_002529876.1| ATP binding protein, putative [Ricinus communis] gi|223530652|gb|EEF32526.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1614), Expect = e-176, Method: Compositional matrix adjust.
Identities = 327/602 (54%), Positives = 392/602 (65%), Gaps = 104/602 (17%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C NCG IPVPYPLST PGCGD YK+ C G LW D +N SSY+ITSI P+ + P
Sbjct: 17 CRNCGRIPVPYPLSTAPGCGDPLYKLSCRGGTLWLDAVNSSSYIITSIYPVDPTANNPAP 76
Query: 62 GLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYIR 121
NCSS S CH Y+R
Sbjct: 77 ------------------------------------------XXPSMNCSSASRCHEYLR 94
Query: 122 DNPVAK---------------RTGGSINEYRIRVRAERCAAYQSFVDLDLSLPVSKWPEP 166
+N +AK +TGGS+NE+RIRVR+ERC+AYQSFV+LD+ LPVSKWPEP
Sbjct: 95 ENAIAKSACEATADKQRCCWFKTGGSLNEFRIRVRSERCSAYQSFVNLDMDLPVSKWPEP 154
Query: 167 GVKIEWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGICKSLK- 225
GV++EW LP EP D S GQKRC + GFQWDPI+G+C+ +
Sbjct: 155 GVELEWMLPFEP------------------DPVSVGQKRCFCRDGFQWDPINGVCQMGRN 196
Query: 226 CSHGKGCKHKKPKTAVIGVLAT----------IKFYKHFHQSNRE---VSLTKVQKDISG 272
C HG C + KT++IG LA + Y+ + QS RE VSL+KV++ I
Sbjct: 197 CKHGGYCNKQTRKTSLIGALAVGAMFLGITTMVVVYRKYSQSRRELAHVSLSKVRERILS 256
Query: 273 ANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG 332
+ SG + RIF+S+EIT ATNNFS+ NLLGSGGFGEVFK I+DD T A+KRAK GNTKG
Sbjct: 257 VSTSGIVGRIFTSKEITRATNNFSSENLLGSGGFGEVFKGIIDDGTTIAIKRAKTGNTKG 316
Query: 333 IDPILNEVRILCQLNHRSLF---------------MSMSPNGTLFDRLHRVQSGNWPPLK 377
ID ILNEVRILCQ+NHR L PNGTLFD LH++ S PL
Sbjct: 317 IDQILNEVRILCQVNHRCLVKLHGCCVELEHPLLVYEYIPNGTLFDHLHKICSSKREPLT 376
Query: 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
W RL IA QTA+ +AYLH ATPPIYHRDIKSSNILLD +L+AK+SDFGLSRLA+ S
Sbjct: 377 WLRRLVIAHQTAEGLAYLHSSATPPIYHRDIKSSNILLDNELNAKVSDFGLSRLAVTDTS 436
Query: 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497
H+TT AQGTLGYLDPEYY+NFQLTDKSDVYSFGVVL+ELLTSKKA+DFNR +E+VNLV+Y
Sbjct: 437 HITTCAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLLELLTSKKAIDFNRVDEEVNLVIY 496
Query: 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557
LK E+L+DA+DP +KEGAS++EL++MKA G L AACLDE+RQNRP++KE ADEIE
Sbjct: 497 GRKFLKGEKLLDAVDPFVKEGASKLELETMKALGSLAAACLDEKRQNRPTMKEAADEIEY 556
Query: 558 II 559
II
Sbjct: 557 II 558
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225449384|ref|XP_002282445.1| PREDICTED: wall-associated receptor kinase-like 20 isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1590), Expect = e-174, Method: Compositional matrix adjust.
Identities = 308/597 (51%), Positives = 392/597 (65%), Gaps = 40/597 (6%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C +CG+ VPYPLSTG CGDQ YK+RC+AG L FD LN SSY I+SI P Q +IRP
Sbjct: 24 CPDCGNTSVPYPLSTGADCGDQEYKIRCDAGTLRFDTLN-SSYSISSITPQIQRFVIRPA 82
Query: 62 GLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYI- 120
N C+ D QG+QL+ +L FN++SSNT++ +NC+ +L+ P NCSS S+CH+YI
Sbjct: 83 SFAGNTCVTTDLPNQGIQLNESLPFNVTSSNTILYLNCTDTLLRSPLNCSSISLCHTYIN 142
Query: 121 --------RDNPV--AKRTGGSINEYRIRVRAERCAAYQSFVDLDLSLPVSKWPEPGVKI 170
D P+ + GGS + IRVR C AY+SFV+LD S PV++WPEPGV+I
Sbjct: 143 GTRDAAACEDAPICCTFKAGGSTTSHSIRVRDAGCRAYRSFVNLDASTPVNRWPEPGVEI 202
Query: 171 EWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGIC-KSLKCSHG 229
+W PREP C DC D +NS C D +AG RC K+G WDP+ G+C +++ C
Sbjct: 203 QWVSPREPVCTSQSDCTDGMNSTCGPDPATAGVSRCFCKSGLWWDPVGGLCAQNVTCQDP 262
Query: 230 KGCKHKKPKTAVIGVLATI------------KFYKHFHQSNREVSLTKVQKDISGANNSG 277
GC + G+ I + +H + L + +++I AN G
Sbjct: 263 DGCGSTNKTPLIAGLTVGIGAALIAAVIAILVYRRHRRIKEAQDRLAREREEILNANGGG 322
Query: 278 RLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPIL 337
+ A+ F+ +EI ATN+FS LLG+GG+GEV+K ILDD TI A+K AKLGN KG D +L
Sbjct: 323 KFAKNFTGKEIKRATNSFSHDRLLGAGGYGEVYKGILDDGTIVAIKCAKLGNAKGTDQVL 382
Query: 338 NEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGNWPPLKWHHRL 382
NEV ILCQ+NHRSL + PNGTL + L + G L W HRL
Sbjct: 383 NEVGILCQVNHRSLVRLLGCCVELEQPIMVYEFIPNGTLLEHLQGQRPGGRGSLTWSHRL 442
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
IA TA+ +AYLH A PPIYHRD+KSSNILLDEK++AK++DFGLSRLA SHV+T
Sbjct: 443 RIAHDTAEGLAYLHSSAVPPIYHRDVKSSNILLDEKMNAKVADFGLSRLAHTDMSHVSTC 502
Query: 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502
AQGTLGYLDPEYY N+QLTDKSDVYSFGVVL+ELLTS+KA+DFNR +DVNL VY +
Sbjct: 503 AQGTLGYLDPEYYRNYQLTDKSDVYSFGVVLLELLTSQKAIDFNRPADDVNLAVYVQRTV 562
Query: 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
++ERL+DAIDP+LKE AS +EL++MKA G L CL+ERRQNRPS+KEV +EI II
Sbjct: 563 EEERLMDAIDPLLKEQASSLELETMKAMGFLAVGCLEERRQNRPSMKEVTEEIGYII 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296086176|emb|CBI31617.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1588), Expect = e-173, Method: Compositional matrix adjust.
Identities = 308/597 (51%), Positives = 392/597 (65%), Gaps = 40/597 (6%)
Query: 2 CTNCGHIPVPYPLSTGPGCGDQSYKVRCNAGMLWFDGLNGSSYMITSINPLSQSLIIRPP 61
C +CG+ VPYPLSTG CGDQ YK+RC+AG L FD LN SSY I+SI P Q +IRP
Sbjct: 24 CPDCGNTSVPYPLSTGADCGDQEYKIRCDAGTLRFDTLN-SSYSISSITPQIQRFVIRPA 82
Query: 62 GLIKNKCIAADYHGQGLQLDNNLRFNISSSNTVMVMNCSIEMLQKPFNCSSTSICHSYI- 120
N C+ D QG+QL+ +L FN++SSNT++ +NC+ +L+ P NCSS S+CH+YI
Sbjct: 83 SFAGNTCVTTDLPNQGIQLNESLPFNVTSSNTILYLNCTDTLLRSPLNCSSISLCHTYIN 142
Query: 121 --------RDNPV--AKRTGGSINEYRIRVRAERCAAYQSFVDLDLSLPVSKWPEPGVKI 170
D P+ + GGS + IRVR C AY+SFV+LD S PV++WPEPGV+I
Sbjct: 143 GTRDAAACEDAPICCTFKAGGSTTSHSIRVRDAGCRAYRSFVNLDASTPVNRWPEPGVEI 202
Query: 171 EWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGIC-KSLKCSHG 229
+W PREP C DC D +NS C D +AG RC K+G WDP+ G+C +++ C
Sbjct: 203 QWVSPREPVCTSQSDCTDGMNSTCGPDPATAGVSRCFCKSGLWWDPVGGLCAQNVTCQDP 262
Query: 230 KGCKHKKPKTAVIGVLATI------------KFYKHFHQSNREVSLTKVQKDISGANNSG 277
GC + G+ I + +H + L + +++I AN G
Sbjct: 263 DGCGSTNKTPLIAGLTVGIGAALIAAVIAILVYRRHRRIKEAQDRLAREREEILNANGGG 322
Query: 278 RLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPIL 337
+ A+ F+ +EI ATN+FS LLG+GG+GEV+K ILDD TI A+K AKLGN KG D +L
Sbjct: 323 KFAKNFTGKEIKRATNSFSHDRLLGAGGYGEVYKGILDDGTIVAIKCAKLGNAKGTDQVL 382
Query: 338 NEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGNWPPLKWHHRL 382
NEV ILCQ+NHRSL + PNGTL + L + G L W HRL
Sbjct: 383 NEVGILCQVNHRSLVRLLGCCVELEQPIMVYEFIPNGTLLEHLQGQRPGGRGSLTWSHRL 442
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
IA TA+ +AYLH A PPIYHRD+KSSNILLDEK++AK++DFGLSRLA SHV+T
Sbjct: 443 RIAHDTAEGLAYLHSSAVPPIYHRDVKSSNILLDEKMNAKVADFGLSRLAHTDMSHVSTC 502
Query: 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502
AQGTLGYLDPEYY N+QLTDKSDVYSFGVVL+ELLTS+KA+DFNR +DVNL VY +
Sbjct: 503 AQGTLGYLDPEYYRNYQLTDKSDVYSFGVVLLELLTSQKAIDFNRPADDVNLAVYVQRTV 562
Query: 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
++ERL+DAIDP+LKE AS +EL++MKA G L CL+ERRQNRPS+KEV +EI II
Sbjct: 563 EEERLMDAIDPLLKEQASSLELETMKAMGFLAVGCLEERRQNRPSMKEVTEEIGYII 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 559 | ||||||
| TAIR|locus:2185118 | 657 | AT5G02070 [Arabidopsis thalian | 0.488 | 0.415 | 0.514 | 6.5e-74 | |
| TAIR|locus:2084425 | 639 | AT3G53840 [Arabidopsis thalian | 0.397 | 0.347 | 0.592 | 5.1e-121 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.516 | 0.375 | 0.422 | 5.4e-71 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.488 | 0.344 | 0.434 | 3.9e-66 | |
| TAIR|locus:2014912 | 732 | WAK2 "wall-associated kinase 2 | 0.513 | 0.392 | 0.422 | 7.7e-64 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.516 | 0.384 | 0.440 | 9.9e-64 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.515 | 0.394 | 0.418 | 1.4e-62 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.513 | 0.391 | 0.418 | 1.4e-62 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.508 | 0.384 | 0.417 | 1.6e-61 | |
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.540 | 0.407 | 0.412 | 8.8e-61 |
| TAIR|locus:2185118 AT5G02070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 6.5e-74, P = 6.5e-74
Identities = 155/301 (51%), Positives = 193/301 (64%)
Query: 159 PVSKWPEPGVKIEWALPREPTCKLPVDCQDLLN-SMCLQDAESAGQKRCLYKAGFQWDPI 217
P KWP+ G++++WALP+EP CK VDC LL S CL D S G KRC K G +WDP+
Sbjct: 214 PGKKWPDTGLELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWDPV 273
Query: 218 SGICKSLXXXXX-----XXXXXXXXXTAVIGVLATIKFY----KHFHQS-NREV--SLTK 265
+ IC AV+GV I KH HQ +++ ++ K
Sbjct: 274 NAICGKCRHGKHCKKKKKTVVFAGAAVAVVGVTLAIAVAVIGTKHSHQKVKKDIHKNIVK 333
Query: 266 VQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA 325
++++ AN++G+ +RIF+ REIT+ATNNFS NL+G+GGFGEVFKA+L+D TITA+KRA
Sbjct: 334 EREEMLSANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRA 393
Query: 326 KLGNTKGIDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQS 370
KL NTKG D ILNEVRILCQ+NHRSL + PNGTLF+ LH
Sbjct: 394 KLNNTKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSD 453
Query: 371 GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
W PL W RL IA QTA+ +AYLH A PPIYHRD+KSSNILLDEKL+AK+SDFGLSR
Sbjct: 454 RTWKPLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 513
Query: 431 L 431
L
Sbjct: 514 L 514
|
|
| TAIR|locus:2084425 AT3G53840 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 5.1e-121, Sum P(2) = 5.1e-121
Identities = 135/228 (59%), Positives = 166/228 (72%)
Query: 338 NEVRIL--C-QLNHRSLFMSMSPNGTLFDRLHRVQSGN---WPPLKWHHRLHIARQTAQA 391
N V++L C +L L PNGTLF+ ++ G + L RL IA QTAQ
Sbjct: 409 NLVKLLGCCIELEMPVLVYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRRLMIAHQTAQG 468
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLD 451
+ YLH ++PPIYHRD+KSSNILLDE LD K++DFGLSRL ++ SHVTT AQGTLGYLD
Sbjct: 469 LDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSDVSHVTTCAQGTLGYLD 528
Query: 452 PEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511
PEYY+NFQLTDKSDVYSFGVVL ELLT KKA+DFNREEEDVNLVV+ LK+ RL+D I
Sbjct: 529 PEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKALKEGRLMDVI 588
Query: 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
DP++ GA+E E++SMKA G+L C+ E RQ RP+++ A EIE I+
Sbjct: 589 DPVIGIGATEKEIESMKALGVLAELCVKETRQCRPTMQVAAKEIENIL 636
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 5.4e-71, Sum P(4) = 5.4e-71
Identities = 130/308 (42%), Positives = 190/308 (61%)
Query: 266 VQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA 325
+Q+ ++ + R+F+SRE+ +AT NFS +LG GG G V+K +L D I AVK++
Sbjct: 404 LQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKS 463
Query: 326 KLGNTKGIDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQS 370
K+ + ++ +NEV IL Q+NHR++ + PNG LF+ LH S
Sbjct: 464 KVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHD-DS 522
Query: 371 GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
++ W RL IA A A++YLH A+ PIYHRDIKS+NI+LDEK AK+SDFG SR
Sbjct: 523 DDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSR 582
Query: 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
+H+TT GT+GY+DPEY+ + Q TDKSDVYSFGVVL EL+T +K+V F R +E
Sbjct: 583 TVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQE 642
Query: 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
L YF +K+ RL D ID +++G +L+ + A + CL+ + + RPS+++
Sbjct: 643 YRTLATYFTLAMKENRLSDIIDARIRDGC---KLNQVTAAAKIARKCLNMKGRKRPSMRQ 699
Query: 551 VADEIERI 558
V+ E+E+I
Sbjct: 700 VSMELEKI 707
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 589 (212.4 bits), Expect = 3.9e-66, Sum P(3) = 3.9e-66
Identities = 127/292 (43%), Positives = 182/292 (62%)
Query: 282 IFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVR 341
+FSSRE+ +AT NFS+ +LG GG G V+K +L D I AVK++K+ + ++ +NEV
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493
Query: 342 ILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
IL Q+NHR++ + PNG LF+ LH N W+ RL IA
Sbjct: 494 ILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMAT-WNIRLRIAI 552
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
A A++YLH A+ PIYHRD+KS+NI+LDEK AK+SDFG SR +H+TT GT
Sbjct: 553 DIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGT 612
Query: 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506
+GY+DPEY+ + Q TDKSDVYSFGVVLVEL+T +K++ F R +E+ L YF +K+ +
Sbjct: 613 VGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENK 672
Query: 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
L D ID +++G L + A + CL+ + + RPS++EV+ E++ I
Sbjct: 673 LFDIIDARIRDGCM---LSQVTATAKVARKCLNLKGRKRPSMREVSMELDSI 721
|
|
| TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 7.7e-64, Sum P(2) = 7.7e-64
Identities = 130/308 (42%), Positives = 180/308 (58%)
Query: 266 VQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA 325
+Q+ +SGA S +IF+ + + EATN + +LG GG G V+K IL D +I A+K+A
Sbjct: 376 IQR-VSGAGPSNVDVKIFTEKGMKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKA 434
Query: 326 KLGNTKGIDPILNEVRILCQLNHRSLFMSMS-------P--------NGTLFDRLHRVQS 370
+LGN ++ +NEV +L Q+NHR++ + P +GTLFD LH
Sbjct: 435 RLGNRSQVEQFINEVLVLSQINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLY 494
Query: 371 GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
+ L W HRL IA + A ++AYLH A+ PI HRDIK++NILLD+ L AK++DFG SR
Sbjct: 495 DS--SLTWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASR 552
Query: 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
L +TT QGTLGYLDPEYY L +KSDVYSFGVVL+ELL+ +KA+ F R
Sbjct: 553 LIPMDKEQLTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPHC 612
Query: 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
NLV F + K R + ID + ++ E+ + A C + RP +KE
Sbjct: 613 PKNLVSCFASATKNNRFHEIIDGQVMNEDNQREIQEAAR---IAAECTRLMGEERPRMKE 669
Query: 551 VADEIERI 558
VA E+E +
Sbjct: 670 VAAELEAL 677
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 615 (221.5 bits), Expect = 9.9e-64, Sum P(2) = 9.9e-64
Identities = 137/311 (44%), Positives = 191/311 (61%)
Query: 263 LTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAV 322
L K Q G N ++IFSS+E+ +AT+NF+ +LG GG G V+K +L D I AV
Sbjct: 391 LLKQQLTTRGGNVQS--SKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAV 448
Query: 323 KRAKLGNTKGIDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHR 367
KR+K+ + ++ +NEV +L Q+NHR++ M PNG LF RLH
Sbjct: 449 KRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHH 508
Query: 368 VQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427
S ++ + W RL I+ + A A+AYLH A+ P+YHRD+K++NILLDEK AK+SDFG
Sbjct: 509 -DSDDYT-MTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFG 566
Query: 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNR 487
SR +H+TT GT GYLDPEY+ Q TDKSDVYSFGVVLVEL+T +K R
Sbjct: 567 TSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMR 626
Query: 488 EEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS 547
EE+ LV +F +KQ R++D +D +KEG + L+ + A L CL + + RP+
Sbjct: 627 PEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCT---LEQVLAVAKLARRCLSLKGKKRPN 683
Query: 548 IKEVADEIERI 558
++EV+ E+ERI
Sbjct: 684 MREVSVELERI 694
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 1.4e-62, Sum P(2) = 1.4e-62
Identities = 129/308 (41%), Positives = 198/308 (64%)
Query: 266 VQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA 325
+++ ++ + + +++IFSS+E+ +AT+NFS +LG GG G V+K +L D +I AVKR+
Sbjct: 400 LKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRS 459
Query: 326 KLGNTKGIDPILNEVRILCQLNHRSLFMSMS---------------PNGTLFDRLHRVQS 370
K+ + ++ +NE+ +L Q+NHR++ + PNG LF RLH +S
Sbjct: 460 KVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHD-ES 518
Query: 371 GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
++ + W RL IA + A A+ Y+H A+ PI+HRDIK++NILLDEK AK+SDFG SR
Sbjct: 519 DDYT-MTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSR 577
Query: 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
+H+TT GT GY+DPEY+++ Q T KSDVYSFGVVLVEL+T +K + R EE
Sbjct: 578 SVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEE 637
Query: 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
L +F +K+ R++D ID +K+ E +L+ + A L CL+ + +NRP++KE
Sbjct: 638 GRGLATHFLEAMKENRVIDIIDIRIKD---ESKLEQVMAVAKLARKCLNRKGKNRPNMKE 694
Query: 551 VADEIERI 558
V++E+ERI
Sbjct: 695 VSNELERI 702
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 1.4e-62, Sum P(2) = 1.4e-62
Identities = 129/308 (41%), Positives = 184/308 (59%)
Query: 266 VQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA 325
+Q+ +SGA S +IF+ + EAT+ ++ +LG GG G V+K IL D +I A+K+A
Sbjct: 380 IQR-LSGAGPSNVDVKIFTEEGMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKA 438
Query: 326 KLGNTKGIDPILNEVRILCQLNHRSLFMSMS-------P--------NGTLFDRLHRVQS 370
+LG+ ++ +NEV +L Q+NHR++ + P +GTLFD LH
Sbjct: 439 RLGDRSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMF 498
Query: 371 GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
+ L W HRL IA + A +AYLH A+ PI HRD+K++NILLDE L AK++DFG SR
Sbjct: 499 DS--SLTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASR 556
Query: 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
L +TT QGTLGYLDPEYY L +KSDVYSFGVVL+ELL+ +KA+ F R +
Sbjct: 557 LIPMDQEQLTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQS 616
Query: 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
+LV YF + +K+ RL + ID + ++ E+ + C + RPS+KE
Sbjct: 617 SKHLVSYFVSAMKENRLHEIIDGQVMNEYNQREIQESAR---IAVECTRIMGEERPSMKE 673
Query: 551 VADEIERI 558
VA E+E +
Sbjct: 674 VAAELEAL 681
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 1.6e-61, Sum P(2) = 1.6e-61
Identities = 127/304 (41%), Positives = 179/304 (58%)
Query: 270 ISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGN 329
+SGA S +IF+ + EAT+ + +LG GG G V+K IL D +I A+K+A+LG+
Sbjct: 385 LSGAGPSNVDVKIFTEEGMKEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGD 444
Query: 330 TKGIDPILNEVRILCQLNHRSLFMSMS-------P--------NGTLFDRLHRVQSGNWP 374
++ +NEV +L Q+NHR++ + P +GTLFD LH +
Sbjct: 445 NSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDS-- 502
Query: 375 PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434
L W HRL +A + A +AYLH A+ PI HRDIK++NILLDE L AK++DFG SRL
Sbjct: 503 SLTWEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPM 562
Query: 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNL 494
+ T QGTLGYLDPEYY L +KSDVYSFGVVL+ELL+ +KA+ F R + ++
Sbjct: 563 DKEDLATMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHI 622
Query: 495 VVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554
V YF + K+ RL + ID + ++ E+ KA + C + RP +KEVA E
Sbjct: 623 VSYFASATKENRLHEIIDGQVMNENNQREIQ--KA-ARIAVECTRLTGEERPGMKEVAAE 679
Query: 555 IERI 558
+E +
Sbjct: 680 LEAL 683
|
|
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 570 (205.7 bits), Expect = 8.8e-61, Sum P(2) = 8.8e-61
Identities = 134/325 (41%), Positives = 190/325 (58%)
Query: 249 KFYKHFHQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGE 308
K + F + N L +Q+ +SGA S +IF+ + EATN + +LG GG G
Sbjct: 372 KLRRQFFEQNGGGML--IQR-LSGAGLSNIDFKIFTEEGMKEATNGYDESRILGQGGQGT 428
Query: 309 VFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLFMSMS-------P---- 357
V+K IL D TI A+K+A+L +++ +D ++EV +L Q+NHR++ + P
Sbjct: 429 VYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNVVKILGCCLETEVPLLVY 488
Query: 358 ----NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNI 413
NGTLFD LH + L W HRL IA + A +AYLH A+ PI HRDIK++NI
Sbjct: 489 EFITNGTLFDHLHGSIFDS--SLTWEHRLRIAIEVAGTLAYLHSSASIPIIHRDIKTANI 546
Query: 414 LLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVL 473
LLDE L AK++DFG S+L +TT QGTLGYLDPEYY L +KSDVYSFGVVL
Sbjct: 547 LLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVL 606
Query: 474 VELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLL 533
+ELL+ +KA+ F R + +LV YF + ++ RL + ID + +E L ++ +
Sbjct: 607 MELLSGQKALCFERPQASKHLVSYFVSATEENRLHEIIDDQV---LNEDNLKEIQEAARI 663
Query: 534 GAACLDERRQNRPSIKEVADEIERI 558
A C + RP +KEVA ++E +
Sbjct: 664 AAECTRLMGEERPRMKEVAAKLEAL 688
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LZM4 | WAKLQ_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5469 | 0.9946 | 0.8462 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00021376001 | SubName- Full=Chromosome chr8 scaffold_23, whole genome shotgun sequence; (636 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 559 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-11 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 5e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 90/281 (32%), Positives = 116/281 (41%), Gaps = 51/281 (18%)
Query: 295 FSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPI--LNEVRILCQLNH--- 348
+ LGSG FG V+KA I AVK K + K E+RIL +L+H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 349 ------------RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
L M G LFD L + G PL IA Q + + YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGG---PLSEDEAKKIALQILRGLEYLH 115
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE--- 453
I HRD+K NILLDE KI+DFGL++ L +S +TTF GT Y+ PE
Sbjct: 116 SNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLL 171
Query: 454 ---YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510
Y K DV+S GV+L ELLT K NIL Q +L+
Sbjct: 172 GGNGY-----GPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRR 213
Query: 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
I E + L CL++ RP+ +E+
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 65/195 (33%), Positives = 90/195 (46%), Gaps = 27/195 (13%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGI-DPILNEVRILCQLNH---------- 348
LG GGFG V+ A A+K K ++ + + +L E+ IL +LNH
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 349 -----RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403
L M G+L D L N L L I Q + + YLH I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE----NEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 404 YHRDIKSSNILLDEKLD-AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLT 461
HRD+K NILLD K++DFGLS+L + S + T GT Y+ PE + +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYS 172
Query: 462 DKSDVYSFGVVLVEL 476
+KSD++S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 68/203 (33%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 295 FSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP-ILNEVRILCQLNHR--- 349
+ LG G FG+V+ A + A+K K K IL E++IL +L H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 350 ------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
L M G LFD L + L RQ A+ YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLHS 115
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
I HRD+K NILLDE K++DFGL+R L+ +TTF GT Y+ PE +
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 458 FQLTDKSDVYSFGVVLVELLTSK 480
D++S GV+L ELLT K
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 298 GNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNH------ 348
G LLG G FG V+ A+ D + AVK +L + + ++ + E+RIL L H
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 349 -----------RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
++F+ G+L L + P ++ RQ + +AYLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR-----KYTRQILEGLAYLHS 119
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSR-LALNGASHVTTFAQGTLGYLDPEYYI 456
I HRDIK +NIL+D K++DFG ++ L T +GT ++ PE
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 457 NFQLTDKSDVYSFGVVLVELLTSK 480
+ +D++S G ++E+ T K
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 65/205 (31%), Positives = 89/205 (43%), Gaps = 33/205 (16%)
Query: 298 GNLLGSGGFGEVFKAILDD-----ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL 351
G LG G FGEV+K L ET AVK K G + + + L E I+ +L+H ++
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 352 ---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
P G L D L + L L +A Q A+ + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG----EKLTLKDLLQMALQIAKGMEYLE 119
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG---YLDPE 453
HRD+ + N L+ E L KISDFGLSR + G ++ PE
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPE 174
Query: 454 YYINFQLTDKSDVYSFGVVLVELLT 478
+ + T KSDV+SFGV+L E+ T
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 63/202 (31%), Positives = 90/202 (44%), Gaps = 28/202 (13%)
Query: 298 GNLLGSGGFGEVFKAILDDETIT-----AVKRAKLG-NTKGIDPILNEVRILCQLNHRSL 351
G LG G FGEV+K L + AVK K + + I+ L E RI+ +L+H ++
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 352 F---------------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
M G L L + + P L L A Q A+ + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR----PKLSLSDLLSFALQIARGMEYLE 119
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
HRD+ + N L+ E L KISDFGLSR + + + + ++ PE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 457 NFQLTDKSDVYSFGVVLVELLT 478
+ T KSDV+SFGV+L E+ T
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 65/202 (32%), Positives = 91/202 (45%), Gaps = 27/202 (13%)
Query: 298 GNLLGSGGFGEVFKAILDD-----ETITAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL 351
G LG G FGEV+K L E AVK K + + I+ L E RI+ +L+H ++
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 352 F---------------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
M P G L D L + + L L A Q A+ + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE 120
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
HRD+ + N L+ E L KISDFGLSR + + + + ++ PE
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 457 NFQLTDKSDVYSFGVVLVELLT 478
+ T KSDV+SFGV+L E+ T
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 64/209 (30%), Positives = 89/209 (42%), Gaps = 36/209 (17%)
Query: 299 NLLGSGGFGEVFKAILDD----ETITAVKRAKLGNTKG-IDPILNEVRILCQLNHR---- 349
LG G FGEV+K L T AVK K ++ L E R++ +L H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 350 ---------SLFMSMS--PNGTLFDRLHRVQ----SGNWPPLKWHHRLHIARQTAQAIAY 394
L++ + G L D L + + S L L A Q A+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG-----Y 449
L + HRD+ + N L+ E L KISDFGLSR + + T G +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173
Query: 450 LDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ PE + T KSDV+SFGV+L E+ T
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 63/202 (31%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 299 NLLGSGGFGEVFKA-ILDDETITAVKRAKLGN--TKGIDPILNEVRILCQLNH------- 348
+G G FG+V+ D + +K L N K + LNEV+IL +LNH
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 349 ------RSLF--MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
L M + G L ++ + + P L Q A+ YLH +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLH---S 121
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL 460
I HRDIK NI L K+ DFG+S++ L+ + GT YL PE N
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 461 TDKSDVYSFGVVLVELLTSKKA 482
KSD++S G VL EL T K
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 27/203 (13%)
Query: 295 FSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH----- 348
F +G GGFGEV+KA A+K KL + + + I+NE++IL + H
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 349 --------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
L++ M G+L D L L ++ ++ + + YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLK----STNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLS-RLALNGASHVTTFAQGTLGYLDPEYYIN 457
I HRDIK++NILL + K+ DFGLS +L+ A + GT ++ PE
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING 171
Query: 458 FQLTDKSDVYSFGVVLVELLTSK 480
K+D++S G+ +EL K
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 62/197 (31%), Positives = 91/197 (46%), Gaps = 28/197 (14%)
Query: 301 LGSGGFGEVFKA-ILDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH-------- 348
LG G FG+V D + A+K + K+ K ++ L E IL ++NH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 349 -----RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
L++ + +P G LF L + G + R + A + A+ YLH L
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSE--ERARFYAA-EIVLALEYLHSLG-- 113
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
I +RD+K NILLD K++DFGL++ + S TF GT YL PE +
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 462 DKSDVYSFGVVLVELLT 478
D +S GV+L E+LT
Sbjct: 172 KAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKG--IDPILNEVRILCQLNHRS 350
N+ G+L+G G FG V+K + L+ A+K+ L K + I+ E+ +L L H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 351 L---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR---QTAQAI 392
+ + + NG+L + + G +P +A Q Q +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFP------ESLVAVYVYQVLQGL 112
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
AYLH + HRDIK++NIL + K++DFG++ LN S GT ++ P
Sbjct: 113 AYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAP 168
Query: 453 EYYINFQLTDKSDVYSFGVVLVELLTSK 480
E + SD++S G ++ELLT
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHR- 349
+F N +G G FG VFK + D+ + A+K+ L N + + ++E R+L +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 350 --------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
++ M + NG L L Q G P R I Q +A+L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFI--QILLGLAHL 117
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG---YLDP 452
H + I HRDIKS N+ LD + KI D G+++L S T FA +G YL P
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL----LSDNTNFANTIVGTPYYLSP 170
Query: 453 EYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNRE 488
E + +KSDV++ GVVL E T K D N +
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 99.0 bits (245), Expect = 2e-22
Identities = 80/285 (28%), Positives = 111/285 (38%), Gaps = 42/285 (14%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGID---PILNEVRILCQLNHRS 350
++ LG G FGEV+ A D + A+K L E++IL LNH
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 351 ----------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
L M G+L D L + G PL L I Q A+ Y
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEY 116
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLD-AKISDFGLSRLALNGASHVTTFAQ-----GTLG 448
LH + I HRDIK NILLD K+ DFGL++L + S + A GT G
Sbjct: 117 LH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 449 YLDPEYYINFQL---TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505
Y+ PE + L + SD++S G+ L ELLT + + + + L
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
L + P E S+ D +K L + +NR S
Sbjct: 234 SLASPLSPSNPELISKAASDLLK-------KLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 45/215 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETIT-AVKRAKL-GNTKGIDPILNEVRILCQLNHRS 350
++ +LG G G V+K A+K+ + G+ + +L E++ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 351 L------------------FMSMSPNGTLFDRLHRVQSGNWPP--LKWHHRLHIARQTAQ 390
+ +M G+L D L +V G P L +IARQ +
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDG---GSLADLLKKV--GKIPEPVLA-----YIARQILK 110
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGY- 449
+ YLH I HRDIK SN+L++ K + KI+DFG+S++ N TF GT+ Y
Sbjct: 111 GLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYM 167
Query: 450 ----LDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
+ E Y + +D++S G+ L+E K
Sbjct: 168 SPERIQGESY-----SYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 22/193 (11%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLFM------- 353
LG+G FGEV++ + ++ T AVK K G T L E +I+ +L H L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 354 --------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYH 405
+ G+L + L LK + +A Q A +AYL H
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 406 RDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSD 465
RD+ + N+L+ E K++DFGL+R+ A+ + + PE + + + KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 466 VYSFGVVLVELLT 478
V+SFG++L E++T
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 46/215 (21%)
Query: 298 GNLLGSGGFGEVFKAI-LDDETITAVKRAKL--GNTKGIDPILNEVRILCQLNHRSL--- 351
GN +G G FG+V+ A+ LD + AVK ++ + K I I +E+++L L H +L
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 352 ------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLH----IARQTAQ---AI 392
FM GTL + L H R+ I T Q +
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLE------------HGRILDEHVIRVYTLQLLEGL 112
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS-RLALNGASHVTTFA--QGTLGY 449
AYLH + I HRDIK +NI LD K+ DFG + +L N + GT Y
Sbjct: 113 AYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169
Query: 450 LDPEYYINFQLTDK---SDVYSFGVVLVELLTSKK 481
+ PE + +D++S G V++E+ T K+
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 47/227 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
++F G ++G G F V A + A+K + +L K + + E +L +LN
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 349 --------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
+L+ + PNG L + + S + ++ A + A+
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-----YAAEILLAL 115
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ-------- 444
YLH I HRD+K NILLD+ + KI+DFG +++ +S +
Sbjct: 116 EYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 445 -----------GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
GT Y+ PE SD+++ G ++ ++LT K
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 79/274 (28%), Positives = 118/274 (43%), Gaps = 50/274 (18%)
Query: 301 LGSGGFGEVFKAIL----DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNH------ 348
LG G FGE A L +D+++ K L + K LNE+ IL L H
Sbjct: 8 LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 349 -------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
+L + M + GTL+D++ R + + L Q A++Y+H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE---EMVLWYLFQIVSAVSYIH--- 118
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I HRDIK+ NI L + K+ DFG+S++ + S T GT Y+ PE +
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVK 177
Query: 460 LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGA 519
KSD+++ G VL ELLT K+ D +NLVV ++V +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV---------KIVQGNYTPVVSVY 225
Query: 520 SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553
S EL S+ + L + + RP+ EV D
Sbjct: 226 SS-ELISLV------HSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 34/199 (17%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------- 351
LG+G FGEV+ + T AVK K G L E +I+ +L H L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL---HLLA 399
+MS G+L D L +SG L+ + +A Q A+ +AYL + +
Sbjct: 73 EEPIYIVTEYMS---KGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI- 125
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
HRD+ + NIL+ E L KI+DFGL+RL + A+ + + PE +
Sbjct: 126 -----HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR 180
Query: 460 LTDKSDVYSFGVVLVELLT 478
T KSDV+SFG++L E++T
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNHR 349
+F ++G G FG+V D + + A+K + K + +LNE RIL +LNH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 350 ---SLFMSMSPNGTLFDRLHRVQSGNWPPLKWH--HRLHIARQTAQ--------AIAYLH 396
+L+ S ++ + + G+ L++H ++ + + + A+ YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGD---LRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
+ I HRDIK NILLDE+ I+DF ++ + + T+ + GT GY+ PE
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTS-GTPGYMAPEVLC 172
Query: 457 NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE 489
+ D +S GV E L K+ +
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 65/195 (33%), Positives = 98/195 (50%), Gaps = 27/195 (13%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------- 351
LG+G FGEV+ + T AVK K G T + L E +I+ +L H L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403
+MS G+L D L + G LK + + +A Q A +AY+ +
Sbjct: 73 EPIYIVTEYMS---KGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERMN---Y 123
Query: 404 YHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDK 463
HRD++S+NIL+ + L KI+DFGL+RL + A+ + + PE + + T K
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 464 SDVYSFGVVLVELLT 478
SDV+SFG++L EL+T
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 62/193 (32%), Positives = 98/193 (50%), Gaps = 23/193 (11%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF-----MSM 355
LG+G FGEV+ + T A+K K G + + L E ++ QL H L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 356 SP---------NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHR 406
P NG+L D L + G L + + +A Q A+ +A++ HR
Sbjct: 73 EPIYIITEYMENGSLVDFL-KTPEGI--KLTINKLIDMAAQIAEGMAFIERKNY---IHR 126
Query: 407 DIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSD 465
D++++NIL+ E L KI+DFGL+RL + A+ + + PE IN+ T KSD
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSD 185
Query: 466 VYSFGVVLVELLT 478
V+SFG++L E++T
Sbjct: 186 VWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 301 LGSGGFGEVFKAILDDETIT----AVKRAKLGNTKGIDPILNEVRILCQLNHR------- 349
+G G GEV+KA + T A+K+ +L + + I+NE+ I+ H
Sbjct: 27 IGEGASGEVYKAT---DRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYD 82
Query: 350 ------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
L++ M G+L D + + N+ + ++ R+ Q + YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTD----IITQNFVRMNEPQIAYVCREVLQGLEYLHSQ--- 135
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFG----LSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
+ HRDIKS NILL + K++DFG L++ S V GT ++ PE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-----GTPYWMAPEVIKR 190
Query: 458 FQLTDKSDVYSFGVVLVELL 477
K D++S G++ +E+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 4e-18
Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 21/195 (10%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF-----MSM 355
LG G FGEV+ + T A+K K G T + L E +I+ +L H L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 356 SP---------NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHR 406
P G+L D L + G+ LK + +A Q A +AY+ + HR
Sbjct: 73 EPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHR 126
Query: 407 DIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDV 466
D++++NIL+ + L KI+DFGL+RL + A+ + + PE + + T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 467 YSFGVVLVELLTSKK 481
+SFG++L EL+T +
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 31/202 (15%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPI--LNEVRILCQLNHRSL-----F 352
+G G +G+V+KA + A+K+ ++ N K PI + E+++L +L H ++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 353 MSMSPNGTLF--------DR---LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
++ G+++ D L + +Q + + YLH +
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES----QIKCYMKQLLEGLQYLH---SN 119
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
I HRDIK SNIL++ K++DFGL+R S T TL Y PE + T
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE--LLLGAT 177
Query: 462 D---KSDVYSFGVVLVELLTSK 480
+ D++S G +L EL K
Sbjct: 178 RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 40/229 (17%)
Query: 301 LGSGGFGEVF----KAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH-------- 348
+ G +G VF K+ D I +K+A + +D +L E IL Q
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 349 -----RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
++L++ M P G L L V G+ + R++IA + A+ YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENV--GSLD--EDVARIYIA-EIVLALEYLHSNG-- 113
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ-------GTLGYLDPEY 454
I HRD+K NIL+D K++DFGLS++ L + GT Y+ PE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 455 YINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503
+ + D +S G +L E L F+ E + F NIL
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG--IPPFHGETPE----EIFQNILN 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF-----MSM 355
LG G FGEV+ + T A+K K G T + L E +++ +L H L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 356 SP---------NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHR 406
P G+L D L + + G + L+ + +A Q A +AY+ + HR
Sbjct: 73 EPIYIVTEYMSKGSLLDFL-KGEMGKY--LRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 407 DIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDV 466
D++++NIL+ E L K++DFGL+RL + A+ + + PE + + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 467 YSFGVVLVELLTSKKAVDF----NREEED 491
+SFG++L E LT+K V + NRE D
Sbjct: 187 WSFGILLTE-LTTKGRVPYPGMVNREVLD 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 59/201 (29%), Positives = 79/201 (39%), Gaps = 29/201 (14%)
Query: 300 LLGSGGFGEVFKAILDDETIT----AVKRAKLGN-TKGIDPILNEVRILCQLNHRSLF-- 352
LG G FG V + AVK K + +D L E I+ L+H +L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 353 --------MSM----SPNGTLFDRLHRVQSGNWPPLKWHHRLH-IARQTAQAIAYLHLLA 399
+ M +P G+L DRL + G++ L A Q A + YL
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLI----STLCDYAVQIANGMRYLES-- 115
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSR-LALNGASHVTTFAQGT-LGYLDPEYYIN 457
HRD+ + NILL KI DFGL R L N +V + PE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 458 FQLTDKSDVYSFGVVLVELLT 478
+ SDV+ FGV L E+ T
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 54/196 (27%), Positives = 83/196 (42%), Gaps = 27/196 (13%)
Query: 301 LGSGGFGEVFKAILDDET--ITAVKRAKLGN-TKGI-DPILNEVRILCQLNHRSL--FMS 354
+G G G VFKA D ET A+K+ L GI + L E++ L H + +
Sbjct: 8 IGEGAHGIVFKAK-DRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 355 MSPNGT------------LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
+ P+G+ L + L + PL R + +AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHANG--- 119
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I HRD+K +N+L+ KI+DFGL+RL + + T Y PE + D
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 463 KS-DVYSFGVVLVELL 477
D+++ G + ELL
Sbjct: 180 PGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 63/215 (29%), Positives = 91/215 (42%), Gaps = 39/215 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN-----TKGIDPILNEVRILCQL 346
N+ G LLG G FG V+ +D AVK+ K ++ + E+++L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 347 NHR---------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQA 391
H S+FM P G++ D+L + L RQ +
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEG 116
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS------RLALNGASHVTTFAQG 445
+ YLH + I HRDIK +NIL D + K+ DFG S + G VT G
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT----G 169
Query: 446 TLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
T ++ PE K+DV+S G +VE+LT K
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 295 FSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR---SL 351
F+ LGSG FGEV++ + + A+K K + EV+ L +L H+ SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 352 FMSMSPNGTLF---------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
F S ++ L ++S L + +A Q A+ +AYL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
HRD+ + NIL+ E L K++DFGL+RL + ++++ + + PE + +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARL-IKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 463 KSDVYSFGVVLVELLT 478
KSDV+SFG++L E+ T
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 62/202 (30%), Positives = 81/202 (40%), Gaps = 35/202 (17%)
Query: 301 LGSGGFGEVFKAIL----DDETITAVKRAKLG-NTKGIDPILNEVRILCQLNHRS----- 350
LG G FG V K + E AVK K G L E ++ QL+H
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 351 ---------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
L M ++P G L L + +A Q A +AYL
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLK-----KRREIPVSDLKELAHQVAMGMAYLESKH-- 115
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG---TLGYLDPE--YYI 456
HRD+ + N+LL + AKISDFG+SR AL S L + PE Y
Sbjct: 116 -FVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 457 NFQLTDKSDVYSFGVVLVELLT 478
F + KSDV+S+GV L E +
Sbjct: 174 KF--SSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 24/200 (12%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRS------- 350
+G G FG V K D I K GN K +++EV IL +L H +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 351 ----------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH--LL 398
+ M G L + + + ++ I Q A+ H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ HRD+K +NI LD + K+ DFGL+++ + +S T+ GT Y+ PE +
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHM 185
Query: 459 QLTDKSDVYSFGVVLVELLT 478
+KSD++S G ++ EL
Sbjct: 186 SYDEKSDIWSLGCLIYELCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 29/196 (14%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS--------- 350
+GSG +G+V+KA + + A+K KL + I E+ +L + H +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 351 ----LFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIY 404
L++ M G+L D + PL ++ R+T + +AYLH T I
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLH--ETGKI- 123
Query: 405 HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD-- 462
HRDIK +NILL E D K++DFG+S + +F GT ++ PE +
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPE-VAAVERKGGY 181
Query: 463 --KSDVYSFGVVLVEL 476
K D+++ G+ +EL
Sbjct: 182 DGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 51/193 (26%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPI--LNEVRILCQLNHRSLFM---S 354
+G G +G V+KA I A+K+ KL P L E+++L +LNH ++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 355 MSPNGTL---FDRLH----RVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRD 407
G L F+ + ++ L Q Q +A+ H + I HRD
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRD 123
Query: 408 IKSSNILLDEKLDAKISDFGLSRLALNGASHVT-TFAQGTLGYLDPEYYIN-FQLTDKSD 465
+K N+L++ + K++DFGL+R G+ T T Y PE + + D
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVD 181
Query: 466 VYSFGVVLVELLT 478
++S G + ELL+
Sbjct: 182 IWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 28/222 (12%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNH-- 348
+F LG G +G V+K L D A+K LG + K + +NE+RIL +NH
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 349 -----------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
L + M +P G L + + + + I Q + + L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQAL 119
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYY 455
H I HRD+KS+NILL KI D G+S++ + GT Y+ PE +
Sbjct: 120 HEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVW 173
Query: 456 INFQLTDKSDVYSFGVVLVELLTSKKAVDFN-REEEDVNLVV 496
+ KSD++S G +L E+ T A F R +D+ V
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATF--APPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 40/214 (18%)
Query: 298 GNLLGSGGFGEVFKAILDDET--ITAVKRAKL--GNTKG-------IDPILNEVRILCQL 346
G L+GSG FG V+ ++ + + AVK+ +L + +D + E+ +L +L
Sbjct: 5 GALIGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 347 ---------------NHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQA 391
+H ++F+ P G++ L+ + ++ + RQ +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKG 118
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS-RLALNGASHVTTFA----QGT 446
+ YLH I HRDIK +NIL+D K KISDFG+S +L N S T A QG+
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
+ ++ PE T K+D++S G ++VE+LT K
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 23/193 (11%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF-----MSM 355
LG+G FGEV+ A + T AVK K G + ++ L E ++ L H L ++
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 356 SP---------NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHR 406
P G+L D L + G+ PL + + Q A+ +A++ HR
Sbjct: 73 EPIYIITEFMAKGSLLDFL-KSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNYIHR 126
Query: 407 DIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSD 465
D++++NIL+ L KI+DFGL+R+ + A+ + + PE INF T KSD
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA-INFGSFTIKSD 185
Query: 466 VYSFGVVLVELLT 478
V+SFG++L+E++T
Sbjct: 186 VWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 43/209 (20%)
Query: 300 LLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------- 351
+LG G +G V+ A L + A+K +++ + P+ E+ + L HR++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHI--ARQTAQAIAYLHLLATP 401
FM P G+L L W PLK + + I +Q + + YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLR----SKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ-- 128
Query: 402 PIYHRDIKSSNILLDEKLDA-KISDFGLS-RLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I HRDIK N+L++ KISDFG S RLA G + T GTL Y+ PE
Sbjct: 129 -IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPE------ 179
Query: 460 LTDK--------SDVYSFGVVLVELLTSK 480
+ DK +D++S G +VE+ T K
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 34/202 (16%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTK-GIDPI--LNEVRILCQLNH-------- 348
LG G +G V+KA I A+K+ +L N + GI P L E+ +L +L H
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI-PSTALREISLLKELKHPNIVKLLD 65
Query: 349 -----RSLFMSMSPNGTLFDR-LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
R L++ D L + PL + I Q + +AY H +
Sbjct: 66 VIHTERKLYLVFE----YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHR 118
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSR---LALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I HRD+K NIL++ K++DFGL+R + L +H TL Y PE + +
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAPEILLGSK 174
Query: 460 LTDKS-DVYSFGVVLVELLTSK 480
+ D++S G + E++T K
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------ 351
G +G G FG+V + + AVK K ++ L E ++ L H +L
Sbjct: 11 GATIGKGEFGDVMLGDYRGQKV-AVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 352 ------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
+M+ G+L D L +S + +L A + + YL
Sbjct: 69 VLQGNPLYIVTEYMA---KGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE--- 119
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
HRD+ + N+L+ E L AK+SDFGL++ AS + + + PE +
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKK 175
Query: 460 LTDKSDVYSFGVVLVEL 476
+ KSDV+SFG++L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------- 351
LG+G FGEV+ ++ T AVK K G T + L E ++ L H L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
+M+ G+L D L + G + + + Q A+ +AY+
Sbjct: 73 EEPIYIITEYMA---KGSLLDFLKSDEGGK---VLLPKLIDFSAQIAEGMAYIE---RKN 123
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLT 461
HRD++++N+L+ E L KI+DFGL+R+ + A+ + + PE INF T
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE-AINFGSFT 182
Query: 462 DKSDVYSFGVVLVELLTSKK 481
KSDV+SFG++L E++T K
Sbjct: 183 IKSDVWSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 70/237 (29%), Positives = 103/237 (43%), Gaps = 51/237 (21%)
Query: 295 FSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPI--LNEVRILCQLNHRS 350
F +G G +G+V+KA D +T + A+K+ +L N K PI + E++IL QLNHR+
Sbjct: 9 FDIIGQIGEGTYGQVYKAR-DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 351 LFMSMSPNGTLFDRLHRVQSGNWPPLKWH--------------HRL-------------- 382
+ L + + L + H L
Sbjct: 68 IV-----------NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED 116
Query: 383 HIA---RQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439
HI +Q + + Y H HRDIK SNILL+ K K++DFGL+RL + S
Sbjct: 117 HIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 440 TTFAQGTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
T TL Y PE + + + DV+S G +L EL T K N+E + L+
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 62/198 (31%), Positives = 88/198 (44%), Gaps = 28/198 (14%)
Query: 301 LGSGGFGEVFKA-ILDDETITAVKRAKLG-NTKGIDPILNEVRIL--CQ----------- 345
LG+G G V K I AVK +L N IL E+ IL C
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 346 LNHRSLFMSMS-PNGTLFDRLHRVQSGNWP--PLKWHHRLHIARQTAQAIAYLHLLATPP 402
N+ + + M +G D++ + G P L IA + + YLH
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--EKHK 121
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I HRD+K SNIL++ + K+ DFG+S +N S TF GT Y+ PE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN--SLAKTFV-GTSSYMAPERIQGNDYSV 178
Query: 463 KSDVYSFGVVLVELLTSK 480
KSD++S G+ L+EL T +
Sbjct: 179 KSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 23/195 (11%)
Query: 300 LLGSGGFGEVFKAILDDETITAVKRAKLGNTKGID-PILNEVRILCQLNHRSL------- 351
LLG G FGEVFK L D+T AVK K + + L+E RIL Q +H ++
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403
M + P G L + + LK + A A +AYL
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKD----ELKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 404 YHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDK 463
HRD+ + N L+ E KISDFG+SR +G + Q + + PE + + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 464 SDVYSFGVVLVELLT 478
SDV+S+G++L E +
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 300 LLGSGGFGEVFKAILD----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--- 351
++G+G FGEVF+ IL E A+K K G T K L+E I+ Q +H ++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 352 ------FMSMS------PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
F NG L D+ R G + + + + R A + YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQL---VGMLRGIAAGMKYL---S 124
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG--ASHVTTFAQGTLGYLDPEYYIN 457
HRD+ + NIL++ L+ K+SDFGLSR+ + ++ T+ + + + PE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 458 FQLTDKSDVYSFGVVLVELLT 478
+ T SDV+SFG+V+ E+++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 35/208 (16%)
Query: 299 NLLGSGGFGEVFKAI-LDDETITAVKRAKLGNT--KGIDP--ILNEVRILCQLNH----- 348
+GSG +G V A+ A+K K+ N ID IL E+++L L H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 349 -RSLFMSMSPNGTLFDR-----------LHRV-QSGNWPPLKWHHRLHIARQTAQAIAYL 395
+ SP F+ LH+V +S PL H + Q + + YL
Sbjct: 64 LLDILRPPSPED--FNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYL 119
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG--TLGYLDPE 453
H + + HRD+K SNIL++ D KI DFGL+R + T Y PE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 454 YYINFQLTDKS-DVYSFGVVLVELLTSK 480
++ K+ D++S G + ELLT K
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 50/214 (23%)
Query: 298 GNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKG-----IDPILNEVRILCQLNHR-- 349
G LLGSG FG V++ + LDD AVK L + + + E+ +L +L H
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 350 -------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
+F+ + P G+L L + S P ++ + RQ + YLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY-----TRQILLGLEYLH 119
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA-----QGTLGYLD 451
HRDIK +NIL+D K++DFG+++ V F+ +G+ ++
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMA 169
Query: 452 PEYYI-----NFQLTDKSDVYSFGVVLVELLTSK 480
PE +D++S G ++E+ T K
Sbjct: 170 PEVIAQQGGYGLA----ADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 37/213 (17%)
Query: 298 GNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNT---------KGI-DPILNEVRILCQL 346
G L+G G +G V+ A+ + + AVK+ +L T K + + +E+ L L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 347 NHR---------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQA 391
+H S+F+ P G++ R L Q +
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLV----RFFTEQVLEG 120
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA-QGTLGYL 450
+AYLH + I HRD+K+ N+L+D KISDFG+S+ + + + + QG++ ++
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 451 DPEYYINFQ--LTDKSDVYSFGVVLVELLTSKK 481
PE ++ + K D++S G V++E+ ++
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 36/198 (18%)
Query: 300 LLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR---SLFMSM 355
LG G +G V+KAI + + A+K + + + I+ E+ IL Q + + S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 356 SPNGTLF------------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403
N L+ D + L I QT + + YLH
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNK----TLTEEEIAAILYQTLKGLEYLHSNK---K 120
Query: 404 YHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ-----GTLGYLDPEYYINF 458
HRDIK+ NILL+E+ AK++DFG+S T A+ GT ++ PE
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 459 QLTDKSDVYSFGVVLVEL 476
+K+D++S G+ +E+
Sbjct: 175 GYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG-----NTKGIDPILNEVRILCQLN 347
N+ G LLG G FG V+ D AVK+ + +K ++ + E+++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 348 HR-----------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
H S+FM P G++ D+L ++ L + RQ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILE 117
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR------LALNGASHVTTFAQ 444
++YLH + I HRDIK +NIL D + K+ DFG S+ L+ G VT
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---- 170
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
GT ++ PE K+D++S G +VE+LT K
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 9e-15
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 26/197 (13%)
Query: 300 LLGSGGFGEVFKAILDDETITAVKRAKLGNTKGI-DPILNEVRILCQLNHRSL------- 351
+G G FG+V+K +L T AVK + + L E IL Q +H ++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403
M + P G+L L + ++ L L ++ A + YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 404 YHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT-FAQGTLGYLDPEYYINF-QLT 461
HRD+ + N L+ E KISDFG+SR G V+ Q + + PE +N+ + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE-ALNYGRYT 173
Query: 462 DKSDVYSFGVVLVELLT 478
+SDV+S+G++L E +
Sbjct: 174 SESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 76/294 (25%), Positives = 115/294 (39%), Gaps = 54/294 (18%)
Query: 299 NLLGSGGFGEVFKA---ILDDET--ITAVKRAK-LGNTKGIDPILNEVRILCQLNH---- 348
LG G FG+V L D T AVK G + E+ IL L+H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 349 -----------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
RSL + M P+G+L D L R + L + Q + + YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR----LLLFSSQICKGMDYL 125
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG--YLDPE 453
+ HRD+ + NIL++ + KISDFGL+++ + G + PE
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 454 YYINFQLTDKSDVYSFGVVLVELLT--------SKKAVDFNREEEDVNLVVYFGNILKQ- 504
+ + SDV+SFGV L EL T + + + +V +LK+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242
Query: 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
ERL P E+ D MK C + Q+RPS ++ ++R+
Sbjct: 243 ERL-----PRPPSCPDEV-YDLMK-------LCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 301 LGSGGFGEVFKAILDDETIT----AVKRAKLGNTKGIDPILNEVRILCQLNH-------- 348
LG GGFG V + + T VK+ + T + I +E IL + NH
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 349 -----RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
+ ++M M G L+ L G + ++ R +IA A YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR--GLFD--EYTARFYIA-CVVLAFEYLHNRG-- 113
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
I +RD+K N+LLD K+ DFG ++ +G TF GT Y+ PE +N
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QKTWTFC-GTPEYVAPEIILNKGYD 170
Query: 462 DKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503
D +S G++L ELLT + F ++ED + +Y +ILK
Sbjct: 171 FSVDYWSLGILLYELLTGR--PPFGEDDED-PMEIY-NDILK 208
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 64/207 (30%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGI--DPILNEVRILCQLNH 348
N + ++G G +G V K + T I A+K+ K L EV++L QL H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKC-RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH 59
Query: 349 -------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L++ TL + L G PP R +I Q QAIA
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG-LPPDAV--RSYIW-QLLQAIA 114
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR-LALNGASHVTTFAQGTLGYLDP 452
Y H I HRDIK NIL+ E K+ DFG +R L AS +T + T Y P
Sbjct: 115 YCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAP 170
Query: 453 EYYINFQLTDKS-DVYSFGVVLVELLT 478
E + K DV++ G ++ ELL
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 35/214 (16%)
Query: 300 LLGSGGFGEVFKAILDDET----ITAVKRAKLGNTKGIDPILNEVRILCQ------LNHR 349
+LG G FG+V A L I A+K+ + ++ + E R+L L H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH- 60
Query: 350 SLFMSMSPNGTLF---------DRLHRVQSGNWPPLKWHHRLHIARQT---AQAIAYLHL 397
LF + LF D + +QS R AR A+ I L
Sbjct: 61 -LFCTFQTKEHLFFVMEYLNGGDLMFHIQSS--------GRFDEARARFYAAEIICGLQF 111
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
L I +RD+K N+LLD+ KI+DFG+ + +NG +TF GT Y+ PE
Sbjct: 112 LHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKG 170
Query: 458 FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEED 491
+ + D +SFGV+L E+L + F+ E+ED
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSP--FHGEDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 29/199 (14%)
Query: 299 NLLGSGGFGEVFKAILDDETIT-AVKRAKLGNTKGIDPILNEVRILCQLNHRSL------ 351
+ LG G +GEV++ + ++T AVK K +T ++ L E ++ ++ H +L
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 352 ------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
FM G L D L + L++A Q + A+ YL
Sbjct: 71 CTREPPFYIITEFM---TYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE--- 121
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
HRD+ + N L+ E K++DFGLSRL A+ + + PE +
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 460 LTDKSDVYSFGVVLVELLT 478
+ KSDV++FGV+L E+ T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 300 LLGSGGFGEVFKAILDDE----TITAVKRAKLGNTKGIDPILNEVRILCQ------LNHR 349
+LG G FG+VF A L I A+K+ + ++ + E R+L L H
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH- 60
Query: 350 SLFMSMSPNGTLFDRLHRVQSGNWPPLKWH----HRLHIARQT---AQAIAYLHLLATPP 402
L+ + LF + + G+ L +H H+ + R T A+ I L L +
Sbjct: 61 -LYCTFQTKENLFFVMEYLNGGD---LMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I +RD+K NILLD KI+DFG+ + + G + TF GT Y+ PE + +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNT 175
Query: 463 KSDVYSFGVVLVELLTSKKAVDFNREEE 490
D +SFGV+L E+L + + EEE
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 38/207 (18%)
Query: 298 GNLLGSGGFGEVFKA--ILDDETI---TAVKRAKLGNT-KGIDPILNEVRILCQLNH--- 348
+LGSG FG V+K I + E + A+K + + K IL+E ++ ++H
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71
Query: 349 -RSLFMSMS----------PNGTLFD--RLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
R L + +S P G L D R H+ G+ L W Q A+ ++YL
Sbjct: 72 VRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 396 ---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLD 451
L+ HRD+ + N+L+ KI+DFGL++L + + ++
Sbjct: 126 EEKRLV------HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 452 PEYYINFQLTDKSDVYSFGVVLVELLT 478
E ++ T KSDV+S+GV + EL+T
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPI--LNEVRILCQLNHR 349
F N +G G +G V++A D + I A+K+ ++ N + PI L E+ +L L H
Sbjct: 8 EFEKLNRIGEGTYGIVYRA-RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 350 ---------------SLFMSMS----PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
S+F+ M +L D + P + Q +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT-------PFSESQVKCLMLQLLR 119
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL 450
+ YLH I HRD+K SN+LL +K KI+DFGL+R A +T TL Y
Sbjct: 120 GLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175
Query: 451 DPEYYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496
PE + + D+++ G +L ELL K + E E ++L++
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 76/295 (25%), Positives = 125/295 (42%), Gaps = 61/295 (20%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDD--ETITAVKRAKLGN----------TKGIDPILNEVR 341
++ LGSG FG V+K + + + A+K + N K I I++EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 342 ILC-QLNHRS-------------LFMSM-----SPNGTLFDRLHRVQSGNWPPLK-WHHR 381
I+ QL H + L++ M +P G F+ L + + + + W+
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWN-- 117
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
I Q A+ YLH I HRD+ +NI+L E I+DFGL++ T
Sbjct: 118 --IFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLT 171
Query: 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501
GT+ Y PE N +K+DV++FG +L ++ T + Y N+
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-------------LQPPFYSTNM 218
Query: 502 LK-QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555
L ++V+A+ L EG + S ++ +CL + RP I +V+ I
Sbjct: 219 LSLATKIVEAVYEPLPEG-----MYSEDVTDVIT-SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKA-ILDDETITAVKR---AKLGNTKGIDPILNEVRILCQLNH 348
++F LG+G FG V A+K AK+ K ++ +LNE RIL + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 349 -------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+L++ M P G LF L + P R + A Q A+
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR---FPEP-VARFYAA-QVVLALE 115
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YLH L I +RD+K N+LLD KI+DFG ++ + GT YL PE
Sbjct: 116 YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPE 168
Query: 454 YYINFQLTDKS-DVYSFGVVLVELL 477
I + K+ D ++ G+++ E+L
Sbjct: 169 -IILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 59/289 (20%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKL-GNTKG-----IDPILNEVRILCQL 346
+ G LG+G F ++A + T+ AVK+ NT ++ + E+R++ +L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 347 NHR---------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQA 391
NH +LF+ G++ L + K ++ Q +
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRG 115
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGLS-RLA--LNGASHVTTFAQGTL 447
++YLH I HRD+K +N+L+D +I+DFG + RLA GA GT+
Sbjct: 116 LSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507
++ PE Q DV+S G V++E+ T+K +N E+ +L + F ++
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP--WNAEKHSNHLALIF-------KI 223
Query: 508 VDAIDP-----MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
A L G ++ L CL+ + ++RP +E+
Sbjct: 224 ASATTAPSIPEHLSPGLRDVTL-----------RCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 34/215 (15%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQL-N 347
+ T F ++G G +G+V+KA + A+K + + + I E IL + N
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 348 HRS---------------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
H + L M + G++ D + ++ LK +I R
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILR 120
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
+T + +AYLH + HRDIK NILL + + K+ DFG+S + TF GT
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GT 176
Query: 447 LGYLDPE-----YYINFQLTDKSDVYSFGVVLVEL 476
++ PE + +SDV+S G+ +EL
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 51/165 (30%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 336 ILNEVRILCQLNHRSLF---------------MSMSPNGTLFDRLHRVQSGNWPPLKWHH 380
NE ++L L+H ++ M +P GTL + + + +
Sbjct: 46 AQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE---DT 102
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFGLSRLALNGASHV 439
LH Q A+ ++H T I HRD+K+ NILLD+ K+ KI DFG+S++ L+ S
Sbjct: 103 ILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI-LSSKSKA 158
Query: 440 TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVD 484
T GT Y+ PE KSD+++ G VL EL + K+A +
Sbjct: 159 YTVV-GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 45/210 (21%)
Query: 300 LLGSGGFGEVFKA-ILDDETITAVKR-AKLGNTKGIDPILNEVRILCQLN---------- 347
+GSG G+V+K + AVK+ + GN + IL ++ ++ + +
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 348 ----HRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI--AYLHLLATP 401
+F+ M T D+L + G P I + AI A +L
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPE-------DILGKMTVAIVKALHYLKEKH 134
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLS-RLALNGASHVTTFAQGTLGYLDPE------- 453
+ HRD+K SNILLD + K+ DFG+S RL S T + G Y+ PE
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 454 ---YYINFQLTDKSDVYSFGVVLVELLTSK 480
Y I ++DV+S G+ LVEL T +
Sbjct: 192 NPKYDI------RADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 66/239 (27%), Positives = 96/239 (40%), Gaps = 37/239 (15%)
Query: 301 LGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGI-DPILNEVRILCQLNHRSL-- 351
LG G FG+VF +D+ + AVK K + E +L H ++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 352 --------------FMSMSPNGTL--FDRLH----RVQSGNWPP---LKWHHRLHIARQT 388
F M +G L F R H P L L IA Q
Sbjct: 73 FYGVCTEGDPPIMVFEYM-EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR-LALNGASHVTTFAQGTL 447
A + YL A+ HRD+ + N L+ L KI DFG+SR + V +
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506
++ PE + + T +SDV+SFGVVL E+ T K + E+V + G +L++ R
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 68/237 (28%), Positives = 99/237 (41%), Gaps = 35/237 (14%)
Query: 301 LGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--F 352
LG G FG+VF A D+ + AVK K + E +L L H + F
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 353 MSMSPNG---------------TLFDRLH-----RVQSGNWPP--LKWHHRLHIARQTAQ 390
+ G F R H + GN P L LHIA+Q A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN-RPAELTQSQMLHIAQQIAA 131
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGY 449
+ YL A+ HRD+ + N L+ E L KI DFG+SR + + V + +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 450 LDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506
+ PE + + T +SDV+S GVVL E+ T K + +V + G +L++ R
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 61/216 (28%), Positives = 85/216 (39%), Gaps = 41/216 (18%)
Query: 301 LGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGIDPILNEVRILCQLNH------ 348
LG G FG+VF A D+ + AVK K + E +L L H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 349 -------RSLFM---------------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
R L M S P+ + V G L L IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG---QLTLGQMLAIAS 129
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR-LALNGASHVTTFAQG 445
Q A + YL A+ HRD+ + N L+ + L KI DFG+SR + V
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 446 TLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK 481
+ ++ PE + + T +SD++SFGVVL E+ T K
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 52/234 (22%)
Query: 339 EVRILCQLNHRSLF----------------MSMSPNGTLFDRLHRVQSGNWPP----LKW 378
E ++L QL H ++ M G L+ +L + Q G P ++W
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEW 107
Query: 379 HHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438
Q A A+ YLH I HRD+K+ N+ L K+ D G++R+ N
Sbjct: 108 F------VQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158
Query: 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF 498
+T GT Y+ PE + N KSDV++ G + E+ T K A FN +D+N +VY
Sbjct: 159 ASTLI-GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA--FN--AKDMNSLVY- 212
Query: 499 GNILKQERLVDA-IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
R+++ + PM K D G L A L +R + RPS+K +
Sbjct: 213 -------RIIEGKLPPMPK--------DYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
+ARQ IAYLH I HRDIK SN+L++ + KI+DFG+SR+ L
Sbjct: 172 DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPCNS 227
Query: 443 AQGTLGYLDPEYYINFQLTD------KSDVYSFGVVLVE 475
+ GT+ Y+ PE IN L D++S GV ++E
Sbjct: 228 SVGTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 41/216 (18%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG-----NTKGIDPILNEVRILCQLN 347
N+ G LLG G FGEV+ D AVK+ +K ++ + E+++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 348 HR-----------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
H S+F+ P G++ D+L + L + RQ Q
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQ 117
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR------LALNGASHVTTFAQ 444
++YLH + I HRDIK +NIL D + K+ DFG S+ ++ G VT
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT---- 170
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
GT ++ PE K+DV+S +VE+LT K
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 44/209 (21%)
Query: 299 NLLGSGGFGEVFKAIL----DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL-- 351
++G G FGEV + L E A+K K G++ K L E I+ Q +H ++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 352 ----------------FMSMSPNGTL--FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+M NG+L F R + + + + R A +
Sbjct: 70 LEGVVTKSRPVMIITEYME---NGSLDKFLRENDGK------FTVGQLVGMLRGIASGMK 120
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG---TLGYL 450
YL + HRD+ + NIL++ L K+SDFGLSR + + TT +G + +
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT--KGGKIPIRWT 175
Query: 451 DPEYYINFQ-LTDKSDVYSFGVVLVELLT 478
PE I ++ T SDV+SFG+V+ E+++
Sbjct: 176 APE-AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 30/200 (15%)
Query: 300 LLGSGGFGEVF--KAIL--DDETITAVKRAKLGNTKGIDPI--LNEVRILCQLNHR---- 349
+LG G FG+VF + I D + A+K K K D + E IL ++NH
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 350 -----------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
L + G LF RL + +K++ + A A+ +LH L
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY-----LAELALALDHLHSL 117
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
I +RD+K NILLDE+ K++DFGLS+ +++ +F GT+ Y+ PE
Sbjct: 118 G---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRR 173
Query: 459 QLTDKSDVYSFGVVLVELLT 478
T +D +SFGV++ E+LT
Sbjct: 174 GHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 59/289 (20%)
Query: 300 LLGSGGFGEVFKAILD----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--- 351
++G+G FGEV + L E A+K K G T K L+E I+ Q +H ++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 352 ---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
FM NG L D R G + ++ + + R A + YL
Sbjct: 71 EGVVTKSRPVMIITEFME---NGAL-DSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL- 122
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG------YL 450
+ HRD+ + NIL++ L K+SDFGLSR + S T +LG +
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TSSLGGKIPIRWT 178
Query: 451 DPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510
PE + T SDV+S+G+V+ E+++ + ++ +DV N ++Q+ +
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI------NAIEQDYRLPP 232
Query: 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
PM D A L C + R RP ++ ++++I
Sbjct: 233 --PM----------DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 40/109 (36%), Positives = 59/109 (54%), Gaps = 5/109 (4%)
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
IA + + YL+ + I HRDIK SNIL++ + K+ DFG+S +N S TF
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--SIADTF 162
Query: 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEED 491
GT Y+ PE + T KSDV+S G+ ++EL K F+ ++D
Sbjct: 163 V-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 77/296 (26%), Positives = 117/296 (39%), Gaps = 60/296 (20%)
Query: 300 LLGSGGFGEVFKAILD---DET--ITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---- 350
LG G FG V D D T + AVK+ + + + E+ IL L H +
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 351 -------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHR--LHIARQTAQAIAYL 395
L M P G+L D L + + + HR L A Q + + YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE------RLDHRKLLLYASQICKGMEYL 124
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH--VTTFAQGTLGYLDPE 453
+ HRD+ + NIL++ + KI DFGL+++ + V + + + PE
Sbjct: 125 ---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 454 YYINFQLTDKSDVYSFGVVLVELLT------SKKAVDFNR---EEEDVNLVVYFGNILKQ 504
+ + SDV+SFGVVL EL T S A +++ +V + +LK
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 505 ERLVDAID--PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+ A P EI MK C + RPS E+A ++E I
Sbjct: 242 NGRLPAPPGCPA------EIY-AIMK-------ECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 41/262 (15%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF------MS 354
+GSG FG V+ ++ A+K + G D + E +++ +L+H L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED-FIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 355 MSP---------NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYH 405
SP +G L D L R Q G L + + +AYL + + H
Sbjct: 71 RSPICLVFEFMEHGCLSDYL-RAQRGK---FSQETLLGMCLDVCEGMAYLE---SSNVIH 123
Query: 406 RDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSD 465
RD+ + N L+ E K+SDFG++R L+ +T + + + PE + + + KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 466 VYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELD 525
V+SFGV++ E+ + K NR +V + G L + RL AS+ +
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL-----------ASQSVYE 232
Query: 526 SMKAFGLLGAACLDERRQNRPS 547
M+ C ER ++RPS
Sbjct: 233 LMQ-------HCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 33/207 (15%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK----GIDP-ILNEVRILCQL 346
+ G LG G + V+KA D ET I A+K+ KLG K GI+ L E+++L +L
Sbjct: 1 RYEKGKKLGEGTYAVVYKAR-DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL 59
Query: 347 NH------RSLFMSMSPNGTLFDRLH----RVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
H +F S +F+ + +V L T + + YLH
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE--- 453
I HRD+K +N+L+ K++DFGL+R + +T T Y PE
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF 175
Query: 454 ---YYINFQLTDKSDVYSFGVVLVELL 477
+Y D++S G + ELL
Sbjct: 176 GARHY-----GVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 47/228 (20%)
Query: 294 NFSTGNLLGSGGFGEVFKAI------LDDETITAVKRAKLG-NTKGIDPILNEVRILCQL 346
N G LG G FG+V KA T AVK K ++ + +L+E +L Q+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 347 NHRS---LFMSMSPNGTL--------------FDRLHR------VQSGNWP--------- 374
NH L+ + S +G L F R R + S
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 375 --PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432
L + A Q ++ + YL A + HRD+ + N+L+ E KISDFGLSR
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 433 LNGASHVTTFAQGTL--GYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
S+V ++G + ++ E + T +SDV+SFGV+L E++T
Sbjct: 178 YEEDSYVKR-SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 29/199 (14%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------- 351
LG+G FG V + A+K K G+ D + E +++ +L+H L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
+MS NG L + L P L + + + +AYL +
Sbjct: 71 QRPIYIVTEYMS---NGCLLNYLREHGKRFQP----SQLLEMCKDVCEGMAYLE---SKQ 120
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
HRD+ + N L+D++ K+SDFGLSR L+ + ++ + + PE + + +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 463 KSDVYSFGVVLVELLTSKK 481
KSDV++FGV++ E+ + K
Sbjct: 181 KSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 45/225 (20%)
Query: 288 ITEATNNFSTGNLLGSGGFGEVFKAILDDETITA-----VKRAKLGNTK-GIDPILNEVR 341
I + + + +LL G FG +F IL DE VK K ++ + +L E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 342 ILCQLNHRSL-------------------FMSMSPNGTLFDRLHRVQSGNWP-PLKWHHR 381
+L L+H+++ +M+ N LF + R+ N P L
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWG-NLKLFLQQCRLGEANNPQALSTQQL 119
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
+H+A Q A ++YLH + H+DI + N ++DE+L KI+D LSR H
Sbjct: 120 VHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH--- 173
Query: 442 FAQGTLG--------YLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
LG ++ E +N + + SDV+SFGV+L EL+T
Sbjct: 174 ----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 46/222 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETI---TAVKRAK-LGNTKGIDPILNEVRILCQLNH 348
N+ +++G G FG+V KA + + + A+KR K + E+ +LC+L H
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 349 RS----------------LFMSMSPNGTLFDRLHRVQSGNWPP-----------LKWHHR 381
L + +P+G L D L + + P L
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
LH A A+ + YL + HRD+ + NIL+ E AKI+DFGLSR
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEV 176
Query: 442 FAQGTLGYLDPEYY----INFQL-TDKSDVYSFGVVLVELLT 478
+ + T+G L + +N+ + T SDV+S+GV+L E+++
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 41/216 (18%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG-----NTKGIDPILNEVRILCQLN 347
N+ G LLG G FG V+ +D A K+ + +K + + E+++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 348 HR-----------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
H ++FM P G++ D+L + L RQ +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILE 117
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR------LALNGASHVTTFAQ 444
++YLH + I HRDIK +NIL D + K+ DFG S+ ++ G VT
Sbjct: 118 GMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT---- 170
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
GT ++ PE K+DV+S G +VE+LT K
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 294 NFSTGNLLGSGGFGEVF--KAILDDE--TITAVKRAKLGNTKGIDPILNEVRILCQLNHR 349
+ +G G FG+++ KA D E I + K+ K + EV +L ++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHP 59
Query: 350 SL---FMSMSPNGTLF---------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
++ F S NG LF D + R+ L Q + + ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH- 118
Query: 398 LATPPIYHRDIKSSNILLDEK-LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
I HRDIKS NI L + + AK+ DFG++R LN + + GT YL PE
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 457 NFQLTDKSDVYSFGVVLVELLTSKKAVDFN 486
N +K+D++S G VL EL T K + N
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 69/285 (24%), Positives = 116/285 (40%), Gaps = 51/285 (17%)
Query: 295 FSTGNLLGSGGFGEVFKAILDDETITAVKRA------KLGNTKGIDPILNEVRILCQLNH 348
++ G +LG G +G V+ + + + AVK+ L K + + EV +L L H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 349 R---------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
S+FM P G++ L+R G P + +Q +A
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF--GPLPEPVF---CKYTKQILDGVA 116
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR----LALNGA-SHVTTFAQGTLG 448
YLH + HRDIK +N++L K+ DFG +R + L+G S++ GT
Sbjct: 117 YLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 449 YLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508
++ PE KSD++S G + E+ T K + + + + Y G L+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA---SMDRLAAMFYIGA---HRGLM 227
Query: 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553
P L + S +D + +CL + RPS ++
Sbjct: 228 ----PRLPDSFSAAAIDFVT-------SCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 29/199 (14%)
Query: 301 LGSGGFGEVFKAI--LDDETI-TAVKRAKLGNTKGI-DPILNEVRI-------------- 342
LGSG FG V K + + + I A+K K N K + D ++ E I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 343 LCQLNHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
+C+ L M M+ G L ++ SG + + + + Q + + YL
Sbjct: 63 VCEAEALMLVMEMASGGPL----NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKN 115
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT--TFAQGTLGYLDPEYYINF-Q 459
HRD+ + N+LL + AKISDFGLS+ S+ + + L + PE INF +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE-CINFRK 174
Query: 460 LTDKSDVYSFGVVLVELLT 478
+ +SDV+S+G+ + E +
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 58/189 (30%), Positives = 86/189 (45%), Gaps = 17/189 (8%)
Query: 301 LGSGGFGEVFKAILD-DETITAVKRAKLGNTKGI-DPILNEVRILCQLNHRS---LFMSM 355
+G G FGEVF L D T AVK + + L E RIL Q +H + L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 356 SPNGTLFDRLHRVQSGNW--------PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRD 407
+ ++ + VQ G++ P LK + + A + YL + HRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 408 IKSSNILLDEKLDAKISDFGLSRLALNGASHVT-TFAQGTLGYLDPEYYINFQLTDKSDV 466
+ + N L+ EK KISDFG+SR +G T Q + + PE + + +SDV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 467 YSFGVVLVE 475
+SFG++L E
Sbjct: 180 WSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 36/212 (16%)
Query: 299 NLLGSGGFGEVFKAILDD-------ETITAVKRAKLGNT-KGIDPILNEVRILCQLNH-- 348
N LGSG FGEV++ D AVK + G T + L E ++ NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 349 -------------RSLFMSMSPNGTL--FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+ + M + G L + R RV+ P L L I A+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDA-----KISDFGLSRLALNGASHVTTFAQGTLG 448
YL + HRD+ + N L+ EK KI DFGL+R + + + +G L
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLP 176
Query: 449 --YLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
++ PE ++ + T +SDV+SFGV++ E+LT
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 46/216 (21%)
Query: 299 NLLGSGGFGEVFKAILDDETI---TAVKRAK-LGNTKGIDPILNEVRILCQLNHRSLFMS 354
+++G G FG+V KA + + + A+KR K + E+ +LC+L H ++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 355 M----------------SPNGTLFD--RLHRV---------QSGNWPPLKWHHRLHIARQ 387
+ +P+G L D R RV + L LH A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
A+ + YL + HRD+ + NIL+ E AKI+DFGLSR + + T+
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTM 170
Query: 448 GYLDPEYY----INFQL-TDKSDVYSFGVVLVELLT 478
G L + +N+ + T SDV+S+GV+L E+++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 38/93 (40%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
IA + ++YLH + I HRDIK SNILL K K+ DFG+S +N S TF
Sbjct: 110 IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN--SLAGTFT 164
Query: 444 QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVEL 476
GT Y+ PE + SDV+S G+ L+E+
Sbjct: 165 -GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKA-----ILDDETIT-AVKRAK-LGNTKGIDPILNEVRILCQ 345
NN S G LG+G FG+V +A D + AVK K ++ + +++E++I+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 346 L-NHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTA 389
L NH + + G L + L R + L L + Q A
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF---LTLEDLLSFSYQVA 151
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT-FAQGTLG 448
+ +A+L A+ HRD+ + N+LL KI DFGL+R +N +++V A+ +
Sbjct: 152 KGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 449 YLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
++ PE N T +SDV+S+G++L E+ +
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 24/199 (12%)
Query: 301 LGSGGFGEVF----KAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR------- 349
LG GGFGEV +A + + +L KG + + E RIL +++ R
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 350 --------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
L M++ G L ++ V N P Q + +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-PGFPEPRACFYTAQIISGLEHLH---QR 116
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
I +RD+K N+LLD + +ISD GL+ +G S +A GT G++ PE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYD 175
Query: 462 DKSDVYSFGVVLVELLTSK 480
D ++ GV L E++ ++
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 31/198 (15%)
Query: 301 LGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPILNEVRILCQLNHR--------- 349
LG G FG+V+KA + ET + A K + + + ++ + E+ IL NH
Sbjct: 20 LGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 350 ------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403
+ + P G + + + G L I RQ +A+ YLH + I
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLH---SMKI 131
Query: 404 YHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD- 462
HRD+K+ N+LL D K++DFG+S + +F GT ++ PE + + D
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDT 190
Query: 463 ----KSDVYSFGVVLVEL 476
K+D++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPIL-----NEVRILC 344
E TN + +G G FG V A D T V K+ P+L E+++L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSA-RDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLK 64
Query: 345 QLNHRSLF----MSMSPNGTLF-------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L H ++ + +SP ++ LHR+ + PL+ + Q + +
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR--PLEKQFIQYFLYQILRGLK 122
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
Y+H + + HRD+K SNIL++E D KI DFGL+R+ +T + T Y PE
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYVS-TRYYRAPE 175
Query: 454 YYINFQLTD-KSDVYSFGVVLVELLTSK 480
+ +Q D + D++S G + E+L K
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 8e-12
Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 33/199 (16%)
Query: 300 LLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKG-IDPILNEVRILCQLNHRSLF---- 352
+G G FGEV+KAI D T + A+K L + I+ I E++ L Q RS +
Sbjct: 8 CIGKGSFGEVYKAI-DKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC--RSPYITKY 64
Query: 353 -------------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
M G+ D L + G L + I R+ + YLH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLL---KPG---KLDETYIAFILREVLLGLEYLH--- 115
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
HRDIK++NILL E+ D K++DFG+S + S TF GT ++ PE
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSG 174
Query: 460 LTDKSDVYSFGVVLVELLT 478
+K+D++S G+ +EL
Sbjct: 175 YDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 294 NFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGIDPILNEVR----IL 343
N LG G FGEVF A ET+ VK + + +E R +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL---QKTKDENLQSEFRRELDMF 62
Query: 344 CQLNHRS------LFMSMSPN---------GTLFDRLHRVQSGNW----PPLKWHHRLHI 384
+L+H++ L P+ G L L +S + PPL ++ +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ 444
Q A + +L + HRD+ + N L+ + + K+S LS+ N + A
Sbjct: 123 CTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK 481
L +L PE + KSDV+SFGV++ E+ T +
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 65/248 (26%), Positives = 104/248 (41%), Gaps = 55/248 (22%)
Query: 301 LGSGGFGEVFKA----ILDDE--TITAVKRAKLGNTKGIDP-ILNEVRILCQLNHRS--- 350
+G G FG VF+A +L E T+ AVK K + + E ++ + +H +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 351 -------------LFMSMSPNGTLFDRLH-----------------RVQSGNWPPLKWHH 380
LF M+ G L + L R N PL
Sbjct: 73 LLGVCAVGKPMCLLFEYMAY-GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT 440
+L IA+Q A +AYL + HRD+ + N L+ E + KI+DFGLSR +
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSA 183
Query: 441 TFAQGT------LGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNL 494
+ + + + ++ PE + T +SDV+++GVVL E+ + + E+V
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
Query: 495 VVYFGNIL 502
V GN+L
Sbjct: 244 YVRDGNVL 251
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 46/216 (21%)
Query: 299 NLLGSGGFGEVFKAILDDETI---TAVKRAK-LGNTKGIDPILNEVRILCQLNHRS---- 350
+++G G FG+V +A++ + + A+K K + E+ +LC+L H
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 351 ----------LFMSM--SPNGTLFD--RLHRV---------QSGNWPPLKWHHRLHIARQ 387
L++++ +P G L D R RV + G L L A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
A + L+ HRD+ + N+L+ E L +KI+DFGLSR + + T+
Sbjct: 128 VATG---MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKTM 177
Query: 448 GYLDPEYY----INFQL-TDKSDVYSFGVVLVELLT 478
G L + +N+ + T KSDV+SFGV+L E+++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 32/78 (41%), Positives = 46/78 (58%), Gaps = 1/78 (1%)
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
+ HRDIKS NI L + K+ DFG +RL + ++ T+ GT Y+ PE + N +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNN 179
Query: 463 KSDVYSFGVVLVELLTSK 480
KSD++S G +L EL T K
Sbjct: 180 KSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 62/207 (29%), Positives = 85/207 (41%), Gaps = 45/207 (21%)
Query: 301 LGSGGFGEVFKA--ILDDETITAVKR----AKLGNTKGIDPILNEVRILCQLNHRSLFMS 354
+G G FG V+ A + +E + A+K+ K N K D I+ EVR L QL H
Sbjct: 23 IGHGSFGAVYFARDVRTNEVV-AIKKMSYSGKQSNEKWQD-IIKEVRFLQQLRH------ 74
Query: 355 MSPNGTLFDRLHRVQSGNW------------------PPLKWHHRLHIARQTAQAIAYLH 396
PN + + + W PL+ I Q +AYLH
Sbjct: 75 --PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
HRDIK+ NILL E K++DFG + L S V GT ++ PE +
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVIL 184
Query: 457 NF---QLTDKSDVYSFGVVLVELLTSK 480
Q K DV+S G+ +EL K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 64/211 (30%), Positives = 86/211 (40%), Gaps = 50/211 (23%)
Query: 301 LGSGGFGEVFKAILD---DET--ITAVKRAKLGNTKGIDP-ILNEVRILCQLNHRS---- 350
LG G FG+V D D T + AVK K + E+ IL L H +
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 351 -------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
L M P G+L D L + + L L A+Q + +AYLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLH- 124
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLS----------RLALNGASHVTTFAQGTL 447
+ HRD+ + N+LLD KI DFGL+ R+ +G S V +A
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA---- 178
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
E + + SDV+SFGV L ELLT
Sbjct: 179 ----VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 28/163 (17%)
Query: 291 ATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPI--LNEVRILCQLN 347
++ LG G FGEV+KA + + A+K+ + N K PI L E++IL +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 348 HRSLF----MSMS-PNGTLFDRL----------HRVQSG--NWPPLKWHHRLHIA---RQ 387
H ++ M++ P+ + R H + SG P +K I Q
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDL-SGLLENPSVKLTES-QIKCYMLQ 123
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
+ I YLH I HRDIK++NIL+D + KI+DFGL+R
Sbjct: 124 LLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 65/240 (27%), Positives = 100/240 (41%), Gaps = 36/240 (15%)
Query: 301 LGSGGFGEVFKA------ILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--F 352
LG G FG+VF A D+ + AVK K E +L L H + F
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 353 MSMSPNG----TLFD-----RLHRVQSGNWP---------------PLKWHHRLHIARQT 388
+ +G +F+ L++ + P L LHIA Q
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTL 447
A + YL A+ HRD+ + N L+ L KI DFG+SR + + V +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507
++ PE + + T +SDV+SFGV+L E+ T K F +V + G +L++ R+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/206 (28%), Positives = 82/206 (39%), Gaps = 33/206 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKA-ILDDETITAVKRAK---LGNTKGIDPILNEVRILCQLNH 348
+F +G GG+G+VF A D I A+KR K L + +L E IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 349 R-------------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHH-RLHIARQTAQAI 392
L+++M P G R N L H R ++A A+
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDF-----RTLLNNLGVLSEDHARFYMAEMFE-AV 114
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
LH L HRD+K N L+D K++DFGLS+ + A+ V G+ Y+ P
Sbjct: 115 DALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAP 167
Query: 453 EYYINFQLTDKSDVYSFGVVLVELLT 478
E D +S G +L E L
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 33/230 (14%)
Query: 298 GNLLGSGGFGEVFKAIL----DDETITAVKRAKLGNTKGI-DPILNEVRILCQLNHRS-- 350
G +G G FG+V++ + +++ AVK K + + + L E I+ Q +H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 351 ------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
+ M ++P G L R + + L + + Q + A+AYL
Sbjct: 71 KLIGVITENPVWIVMELAPLGEL--RSYLQVNKYSLDLA--SLILYSYQLSTALAYLE-- 124
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ HRDI + N+L+ K+ DFGLSR + + + + + + ++ PE INF
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE-SINF 182
Query: 459 -QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507
+ T SDV+ FGV + E+L + DV G I ERL
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-----IGRIENGERL 227
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 61/210 (29%), Positives = 88/210 (41%), Gaps = 37/210 (17%)
Query: 301 LGSGGFGEVFKAIL------DDETITAVKRAK-LGNTKGIDPILNEVRILCQLNHRSLF- 352
LG G FG+V+K L T A+K K K E ++ L H ++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 353 -----MSMSPNGTLFD-----RLHRVQSGNWP---------------PLKWHHRLHIARQ 387
P LF+ LH N P L LHIA Q
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGT 446
A + YL ++ HRD+ + N L+ E L KISDFGLSR + + V + +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVEL 476
+ ++ PE + + T +SD++SFGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 32/202 (15%)
Query: 300 LLGSGGFGEVFKAIL--DDETI---TAVKRAKLGNT-KGIDPILNEVRIL---------- 343
+LGSG FG V+K I D E + A+K + + K IL+E ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 344 ----CQLNHRSLFMSMSPNGTLFD--RLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
C + L + P G L D R ++ + G+ L W Q A+ ++YL
Sbjct: 74 LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE 127
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA-LNGASHVTTFAQGTLGYLDPEYYI 456
+ + HRD+ + N+L+ KI+DFGL+RL ++ + + + ++ E +
Sbjct: 128 VR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 457 NFQLTDKSDVYSFGVVLVELLT 478
+ + T +SDV+S+GV + EL+T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 300 LLGSGGFGEVFKAILDDE----TITAVKRAKLGNTKGIDPILNEVRILCQ------LNHR 349
+LG G FG+V A L + + A+K+ + ++ + E R+L L H
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH- 60
Query: 350 SLFMSMSPNGTLFDRLHRVQSGNWPPLKWH----HRLHIARQT---AQAIAYLHLLATPP 402
L+ + LF + + G+ L +H R + R T A+ + L L +
Sbjct: 61 -LYCTFQTKEHLFFVMEFLNGGD---LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I +RD+K N++LD KI+DFG+ + + G + +TF GT Y+ PE + T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTF 175
Query: 463 KSDVYSFGVVLVELLTSKKAVDFNREEED 491
D +SFGV+L E+L + F+ ++ED
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP--FHGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 63/270 (23%), Positives = 114/270 (42%), Gaps = 41/270 (15%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH------------ 348
LGSG FG V + A+K + G D + E +++ +L+H
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 349 -RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYH 405
R +F+ NG L + L R + G L L + +A+ YL + H
Sbjct: 71 QRPIFIVTEYMANGCLLNYL-RERKGK---LGTEWLLDMCSDVCEAMEYLE---SNGFIH 123
Query: 406 RDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSD 465
RD+ + N L+ E K+SDFGL+R L+ + + + + PE + + + KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 466 VYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELD 525
V+SFGV++ E+ + K +V V G L + +L
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLA----------------- 226
Query: 526 SMKAFGLLGAACLDERRQNRPSIKEVADEI 555
+ + ++ +C E+ ++RP+ K++ ++
Sbjct: 227 PTEVYTIMY-SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ-- 444
Q + + Y+H + + HRD+K SN+LL+ D KI DFGL+R+A H +
Sbjct: 114 QILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 445 GTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
T Y PE +N + K+ D++S G +L E+L+++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 53/285 (18%)
Query: 300 LLGSGGFGEV----FKAILDDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--- 351
++G+G FGEV K E A+K K G T K L+E I+ Q +H ++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 352 ---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
+M NG+L D R G + ++ + + R A + YL
Sbjct: 71 EGVVTKSKPVMIVTEYME---NGSL-DAFLRKHDGQFTVIQL---VGMLRGIASGMKYLS 123
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG--ASHVTTFAQGTLGYLDPEY 454
+ HRD+ + NIL++ L K+SDFGLSR+ + A++ T + + + PE
Sbjct: 124 DMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 455 YINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514
+ T SDV+S+G+V+ E+++ + + +DV + G L PM
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA--------PM 232
Query: 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
D A L C + R RP +++ ++++I
Sbjct: 233 ----------DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 40/212 (18%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAK---LGNTKGIDPILNEVRILCQLN 347
NF +G G F V+KAI L D + A+K+ + + + K L E+ +L QL+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 348 HRSL---FMSMSPNGTLFDRLHRVQSGNWPPLKWH----HRLHIAR-------QTAQAIA 393
H ++ S N L L +G+ + H RL R Q A+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ---GTLGYL 450
++H + I HRDIK +N+ + K+ D GL R S TT A GT Y+
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYM 173
Query: 451 DPE------YYINFQLTDKSDVYSFGVVLVEL 476
PE Y NF KSD++S G +L E+
Sbjct: 174 SPERIHENGY--NF----KSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 33/175 (18%)
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
I R+ A+ Y+H + HRDIK++NIL+ + K+ DFG++ L +S +TF
Sbjct: 106 IIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 444 QGTLGYLDPEYYINFQLTD-KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN-I 501
GT ++ PE + D K+D++S G+ + E+ T GN
Sbjct: 163 -GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT--------------------GNPP 201
Query: 502 LKQERLVDAIDPMLKEGASEIELDS----MKAFGLLGAACLDERRQNRPSIKEVA 552
A+ + K +E + ++ F AACLDE + R S +E+
Sbjct: 202 YSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF---VAACLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 21/196 (10%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--FMSM 355
G ++G G FG V + + + AVK K T L E ++ +L+H++L + +
Sbjct: 11 GEIIGEGEFGAVLQGEYTGQKV-AVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 356 SPNGTLFDRLHRVQSGNWPP-LKWHHR--------LHIARQTAQAIAYLHLLATPPIYHR 406
+ L+ + + GN L+ R L + A+ + YL + + HR
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124
Query: 407 DIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDV 466
D+ + NIL+ E AK+SDFGL+R+ G + + T PE + + + KSDV
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSSKSDV 180
Query: 467 YSFGVVLVELLTSKKA 482
+S+GV+L E+ + +A
Sbjct: 181 WSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 27/199 (13%)
Query: 295 FSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKG-IDPILNEVRILCQ------- 345
F+ +G G FGEV+K I + + + A+K L + I+ I E+ +L Q
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 346 ------LNHRSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
L L++ M G+ D L + G PL+ + I R+ + + YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL---KPG---PLEETYIATILREILKGLDYLH- 118
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
+ HRDIK++N+LL E+ D K++DFG++ + TF GT ++ PE
Sbjct: 119 --SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 175
Query: 458 FQLTDKSDVYSFGVVLVEL 476
K+D++S G+ +EL
Sbjct: 176 SAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 5e-11
Identities = 29/109 (26%), Positives = 47/109 (43%), Gaps = 13/109 (11%)
Query: 1 SC-TNCGHIPVPYPLSTGPGCG-DQSYKVRCNAG----MLWFDGLNGSSYMITSINPLSQ 54
C CG++ +PYP GPGC D +++ CN L L +Y + SI+ +
Sbjct: 3 GCPDRCGNVSIPYPFGIGPGCARDPGFELTCNNTTSPPRLL---LGNGNYEVLSISLANG 59
Query: 55 SLIIRPPGLIKNKCIAAD-YHGQGLQLDNNLRFNISSS-NTVMVMNCSI 101
++ + P I + C + L F SSS N +V+ C+
Sbjct: 60 TVRVLDP--ISSNCYNSSGKRTDNGSLSLGGPFFFSSSRNKFVVVGCNT 106
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 34/80 (42%), Positives = 45/80 (56%), Gaps = 1/80 (1%)
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I HRDIKS NI L + K+ DFG++R+ LN + GT YL PE N +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENRPYNN 180
Query: 463 KSDVYSFGVVLVELLTSKKA 482
KSD+++ G VL E+ T K A
Sbjct: 181 KSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 61/210 (29%), Positives = 88/210 (41%), Gaps = 48/210 (22%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTK-GIDPILNEVRILCQLNH---------- 348
+G G V+ AI L + A+KR L + +D + EV+ + Q NH
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 349 ---RSLFMSMS--PNGTLFDRL-HRVQSGNWPPLKWHHRLHIA---RQTAQAIAYLHLLA 399
L++ M G+L D + G IA ++ + + YLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD------EAIIATVLKEVLKGLEYLHSNG 122
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSR-LALNGASHV---TTFAQGTLGYLDPE-- 453
HRDIK+ NILL E KI+DFG+S LA G TF GT ++ PE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVM 178
Query: 454 -----YYINFQLTDKSDVYSFGVVLVELLT 478
Y K+D++SFG+ +EL T
Sbjct: 179 EQVHGY------DFKADIWSFGITAIELAT 202
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 40/228 (17%)
Query: 301 LGSGGFGEVFKAILDD-ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-------LF 352
LG G G VF A+ D + AVK+ L + + + L E++I+ +L+H + L
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 353 MSMSPNG------TLFDRLHRVQSG---------NWPPLKWHHRLHIARQTAQAIAYLHL 397
S S T + ++ VQ PL H Q + + Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH- 131
Query: 398 LATPPIYHRDIKSSNILLD-EKLDAKISDFGLSRLALNGASH--------VTTFAQGTLG 448
+ + HRD+K +N+ ++ E L KI DFGL+R+ SH VT + +
Sbjct: 132 --SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL 189
Query: 449 YLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496
L P Y T D+++ G + E+LT K E E + L++
Sbjct: 190 LLSPNNY-----TKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 57/224 (25%), Positives = 83/224 (37%), Gaps = 50/224 (22%)
Query: 296 STGNLLGSGGFGEVFKAIL------DDETITAVKRAK----------------------- 326
+ G LG G FG+V KA ++ + AVK K
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 327 -------LGNTKGIDPILNEVRILCQLNHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWH 379
LG P+ V N R + P G L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE--ETLTQK 132
Query: 380 HRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439
+ A Q A+ + +L A+ HRD+ + N+L+ E KI+DFGL+R H+
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHI 185
Query: 440 TTFAQGTLGYLD-----PEYYINFQLTDKSDVYSFGVVLVELLT 478
+ + T G L PE + T +SDV+SFGV+L E+ T
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 301 LGSGGFGEVFKA--ILDDETITAVKRAKLGNTKGIDPI--LNEVRILCQLNHRS---LFM 353
+G G FGEVFKA + I A+K+ + N K PI L E++IL L H + L
Sbjct: 20 IGQGTFGEVFKARHKKTKQ-IVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 354 SMSPNGTLFDR---------------LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
T ++R L + S + + + Y+H
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH-- 136
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSR---LALNGASHVTTFAQGTLGYLDPEYY 455
I HRD+K++NIL+ + K++DFGL+R L+ N + T TL Y PE
Sbjct: 137 -RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL 195
Query: 456 IN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
+ D++ G ++ E+ T + N E+ + L+
Sbjct: 196 LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 29/200 (14%)
Query: 295 FSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKG-IDPILNEVRILCQ------ 345
F+ +G G FGEVFK I D+ T + A+K L + I+ I E+ +L Q
Sbjct: 6 FTKLERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 346 -------LNHRSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
L L++ M G+ D L ++G P + ++ + + YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLL---RAG---PFDEFQIATMLKEILKGLDYLH 118
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
+ HRDIK++N+LL E+ D K++DFG++ + TF GT ++ PE
Sbjct: 119 ---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174
Query: 457 NFQLTDKSDVYSFGVVLVEL 476
K+D++S G+ +EL
Sbjct: 175 QSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 21/219 (9%)
Query: 300 LLGSGGFGEVFKAILD--DE--TITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLFMSM 355
+LG G FG+V A L DE + +K+ + ++ + E R+L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 356 SPNGTLFDRLHRV-QSGNWPPLKWH----HRLHIARQT---AQAIAYLHLLATPPIYHRD 407
DRL V + N L +H R R A+ + L L I +RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 408 IKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKS-DV 466
+K N+LLD + KI+DFG+ + + G +TF GT Y+ PE +++Q + D
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPE-ILSYQPYGPAVDW 179
Query: 467 YSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505
++ GV+L E+L + + + E+E F +IL+ E
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDE------LFQSILEDE 212
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 294 NFSTGNLLGSGGFGEVFKAIL--DDE--TITAVKRAKLGNTKGIDPILNEVRILCQLNHR 349
+F+ +LG G FG+V A DE I +K+ + ++ + E R+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 350 SLFMSMSPNGTLFDRLHRV-QSGNWPPLKWH----------HRLHIARQTAQAIAYLHLL 398
+ DRL+ V + N L +H H + A + A + +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH-- 118
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ I +RD+K N++LD + KI+DFG+ + + G TF GT Y+ PE I +
Sbjct: 119 -SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPE-IIAY 175
Query: 459 QLTDKS-DVYSFGVVLVELLTSKKAVDFNREEE 490
Q KS D ++FGV+L E+L + D E+E
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 299 NLLGSGGFGEVFKAILDDETITAVKRAKLG-------NTKGIDPILNEVRILCQLNHR-- 349
+ +GSG +G+V A D +T V KL + K E+R+L ++H
Sbjct: 21 SPVGSGAYGQVCSAF-DTKTGRKVAIKKLSRPFQSAIHAKRT---YRELRLLKHMDHENV 76
Query: 350 -SLFMSMSPNGTLFD----------------RLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
L +P +L D + + Q L H + Q + +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ-----KLSDDHIQFLVYQILRGL 131
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
Y+H + I HRD+K SNI ++E + KI DFGL+R +T + T Y P
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVA-TRWYRAP 184
Query: 453 EYYINF-QLTDKSDVYSFGVVLVELLTSK 480
E +N+ D++S G ++ ELLT K
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 35/200 (17%)
Query: 301 LGSGGFGEVFKA------------ILDDETITAVKRAK---------LGNTKGIDPILNE 339
+G G FG+V A +L + I K K L N K P L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK--HPFLVG 60
Query: 340 VRILCQLNHRSLFMSMSPNG-TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
+ Q + F+ NG LF L R +S P +++ A + A A+ YLH L
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY-----AAEIASALGYLHSL 115
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
I +RD+K NILLD + ++DFGL + + + +TF GT YL PE +
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPE-VLRK 170
Query: 459 QLTDKS-DVYSFGVVLVELL 477
Q D++ D + G VL E+L
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 42/212 (19%)
Query: 295 FSTGNLLGSGGFGEVFKA--ILDDETI---TAVKRAKLGNT-KGIDPILNEVRILCQLNH 348
F +LGSG FG V+K I + E + A+K + + K IL+E ++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 349 R--------------SLFMSMSPNGTLFD--RLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
L + P G L D R H+ G+ L W Q A+ +
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 122
Query: 393 AYL---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG---T 446
YL L+ HRD+ + N+L+ KI+DFGL++L GA A+G
Sbjct: 123 NYLEERRLV------HRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVP 174
Query: 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ ++ E ++ T +SDV+S+GV + EL+T
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT--TFAQGTL 447
Q + +H + + + HRDIKS+NILL K+ DFG S++ S TF GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTP 209
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVD 484
Y+ PE + + K+D++S GV+L ELLT K+ D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 35/200 (17%)
Query: 301 LGSGGFGEVFKAILDDET-ITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL-------- 351
LG G FG+V+KA + A K ++ + + ++ + E+ IL + H ++
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 352 ----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
F ++ L R L ++ RQ +A+ +LH +
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER-------GLTEPQIRYVCRQMLEALNFLH---SH 122
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
+ HRD+K+ NILL D K++DFG+S + TF GT ++ PE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFK 181
Query: 462 D-----KSDVYSFGVVLVEL 476
D K+D++S G+ L+EL
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 3e-10
Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 29/200 (14%)
Query: 295 FSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKG-IDPILNEVRILCQ------ 345
F+ +G G FGEVFK I D+ T + A+K L + I+ I E+ +L Q
Sbjct: 6 FTKLEKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 346 -------LNHRSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
L L++ M G+ D L + G PL I R+ + + YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPG---PLDETQIATILREILKGLDYLH 118
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
+ HRDIK++N+LL E + K++DFG++ + TF GT ++ PE
Sbjct: 119 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 174
Query: 457 NFQLTDKSDVYSFGVVLVEL 476
K+D++S G+ +EL
Sbjct: 175 QSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 37/204 (18%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRA--KLGNTKGIDPI----LNEVRILCQLNH------ 348
+GSG +G V AI +T + K A K+ + + + L E++IL H
Sbjct: 13 IGSGAYGVVCSAI---DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 349 RSLFMSMSPNGTLFDR-----------LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
R + P G F LH + + PL H + Q + + Y+H
Sbjct: 70 RDILR---PPGADFKDVYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH- 124
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ---GTLGYLDPEY 454
+ + HRD+K SN+L++E + +I DFG++R + + F T Y PE
Sbjct: 125 --SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 455 YINF-QLTDKSDVYSFGVVLVELL 477
++ + T D++S G + E+L
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 33/214 (15%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDP-------ILNEVRILCQL 346
+ + LG G FGEV++ + AV+ T L E I+ +
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 347 NH---------------RSLFMSMSPNGTL--FDRLHRVQSGNWPPLKWHHRLHIARQTA 389
NH R + + + G L F R +R + L L AR A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLD---AKISDFGLSRLALNGASHVTTFAQGT 446
+ YL HRDI + N LL K AKI+DFG++R + AS+ +
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-DIYRASYYRKGGRAM 182
Query: 447 L--GYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
L ++ PE +++ T K+DV+SFGV+L E+ +
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 38/204 (18%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILN--EVRILCQLNH--------- 348
LG G FG V+ A + + A+K+ K + +N EV+ L +LN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 349 -----RSLFMSMSP-NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
L+ G L+ L + + G P I Q Q +A++H
Sbjct: 66 VFRENDELYFVFEYMEGNLYQ-LMKDRKG--KPFSESVIRSIIYQILQGLAHIHKHG--- 119
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE------YYI 456
+HRD+K N+L+ KI+DFGL+R + + T + T Y PE Y
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRSTSY- 176
Query: 457 NFQLTDKSDVYSFGVVLVELLTSK 480
+ + D+++ G ++ EL T +
Sbjct: 177 SSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 20/193 (10%)
Query: 301 LGSGGFGEVFKAILDDET----ITAVKRAKLGNTKGIDPILNEVRILCQLNHR---SLFM 353
+G G FG+V + D + +++A + + + L E +L Q+N L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 354 SMSPNGTLFDRLHRVQSGNWPPLKWHH-----RLHIARQ---TAQAIAYLHLLATPPIYH 405
S L+ L + G +HH R ++R TA+ + L L + +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIY 116
Query: 406 RDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSD 465
RD+K NILLD + + DFGL +L + TF GT YL PE + T D
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKAVD 175
Query: 466 VYSFGVVLVELLT 478
++ GV+L E+LT
Sbjct: 176 WWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 50/208 (24%)
Query: 304 GGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPI--LNEVRILCQLNHRSL-------- 351
G +G V++A D +T I A+K+ K+ K PI L E+ IL +L H ++
Sbjct: 16 GTYGVVYRA-RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74
Query: 352 -------FMSMS----PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
+M M +L + + P + Q +A+LH
Sbjct: 75 GSNLDKIYMVMEYVEHDLKSLMETMK-------QPFLQSEVKCLMLQLLSGVAHLHDNW- 126
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG--TLGYLDPE----- 453
I HRD+K+SN+LL+ + KI DFGL+R S + + Q TL Y PE
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 454 -YYINFQLTDKSDVYSFGVVLVELLTSK 480
Y + D++S G + ELLT K
Sbjct: 182 KEY-----STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 27/196 (13%)
Query: 301 LGSGGFGEVFKA-ILDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNHR------- 349
LG GGFGEV + + A K + +L KG LNE +IL +++ R
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 350 --------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
L M++ G L + H G P + A Q + +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDL--KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR-- 115
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
I +RD+K N+LLD+ + +ISD GL+ + L G + A GT GY+ PE
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEVYD 172
Query: 462 DKSDVYSFGVVLVELL 477
D ++ G L E++
Sbjct: 173 FSVDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 39/102 (38%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
IA T +A+ YL I HRD+K SNILLD + K+ DFG+S ++ S T
Sbjct: 111 KIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTR 166
Query: 443 AQGTLGYLDPEYYINFQLTD----KSDVYSFGVVLVELLTSK 480
G Y+ PE I+ D +SDV+S G+ L E+ T K
Sbjct: 167 DAGCRPYMAPE-RIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 33/207 (15%)
Query: 301 LGSGGFGEVF----KAILDDETITAVKRAKLGNTKGIDPI---LNEVRILCQLN------ 347
LG G FG V+ K ++ E T V + + LNE ++ + N
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 348 ---------HRSLFMSMSPNGTLFD--RLHR---VQSGNWPPLKWHHRLHIARQTAQAIA 393
+ M + G L R R + P + +A + A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG--YLD 451
YL HRD+ + N ++ E L KI DFG++R + + +G L ++
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMA 189
Query: 452 PEYYINFQLTDKSDVYSFGVVLVELLT 478
PE + T KSDV+SFGVVL E+ T
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 28/204 (13%)
Query: 300 LLGSGGFGEVFKAILDDETITAVKRAKLGNT----KGIDPILNEVRILCQLNH------R 349
++G G +G V AI D T V K+ + IL E+++L L H +
Sbjct: 7 VIGKGSYGVVCSAI-DTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 350 SLFMSMSPNG-----TLFD----RLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
+ + S +F+ LH+V N HH+ + Q +A+ Y+H T
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY-QLLRALKYIH---T 121
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT--TFAQGTLGYLDPEYYINF 458
++HRD+K NIL + KI DFGL+R+A N T T Y PE +F
Sbjct: 122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 181
Query: 459 --QLTDKSDVYSFGVVLVELLTSK 480
+ T D++S G + E+LT K
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 37/105 (35%), Positives = 49/105 (46%), Gaps = 12/105 (11%)
Query: 375 PLKWHHRLHIARQ-TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433
P W A+Q A+ + + L I HRDIK N+L+D+ K++DFGLSR L
Sbjct: 95 PEDW------AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148
Query: 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
V GT YL PE + SD +S G V+ E L
Sbjct: 149 ENKKFV-----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 29/76 (38%), Positives = 45/76 (59%), Gaps = 3/76 (3%)
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I HRD+K SNIL++ + + K+ DFG+S ++ S +F GT Y+ PE T
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYTV 177
Query: 463 KSDVYSFGVVLVELLT 478
+SD++S G+ LVE+
Sbjct: 178 QSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 71/301 (23%)
Query: 298 GNLLGSGGFGEVFKAILD-DETI--TAVKRAKLG--NTKGIDPILNEVRILCQLNHRSLF 352
G LG G FG V + L+ D++I AVK K+ ++ L+E + + +H ++
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV- 62
Query: 353 MSMSPNGTLFDRLHRVQSGNWP------PLKWHHRLH--------------IARQT---- 388
M G V+S +P P H LH + Q
Sbjct: 63 --MRLIGVCL---QTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 389 ----AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ 444
A + YL ++ HRD+ + N +L+E ++ ++DFGLS+ NG + Q
Sbjct: 118 MTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG----DYYRQ 170
Query: 445 GTLGYLDPEYYINFQ------LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF 498
G + + P +I + T KSDV+SFGV + E+ T + E ++ +
Sbjct: 171 GRIAKM-PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229
Query: 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
GN LKQ D +D + L ++C ++RPS + + E+E+
Sbjct: 230 GNRLKQP--PDCLDGLYS----------------LMSSCWLLNPKDRPSFETLRCELEKA 271
Query: 559 I 559
+
Sbjct: 272 L 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 294 NFSTGNLLGSGGFGEVFKA-------------------ILDDETITAVKRAKLGNTKGID 334
+F+ +LG G FG+V A I DD+ + ++ G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 335 PILNEVRILCQLNHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
P L ++ Q R F+ NG D ++++Q K H + A + A + +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGG--DLMYQIQQVG--RFKEPHAVFYAAEIAIGLFF 116
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
LH + I +RD+K N++LD + KI+DFG+ + + TF GT Y+ PE
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPE- 171
Query: 455 YINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEED 491
I +Q KS D ++FGV+L E+L + F E+ED
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 295 FSTGNLLGSGGFGEV----FKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR- 349
F +LG GGFGEV +A +++ ++ KG LNE +IL ++N R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 350 --SLFMSMSPNGTLFDRLHRVQSGNWPPLKWH--HRLHIARQTAQAIAY-------LHLL 398
SL + L L + G+ LK+H H + +A+ Y L L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGD---LKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
I +RD+K NILLD+ +ISD GL+ G + GT+GY+ PE N
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNE 176
Query: 459 QLTDKSDVYSFGVVLVELLTSK 480
+ T D ++ G +L E++ +
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 35/105 (33%), Positives = 60/105 (57%), Gaps = 4/105 (3%)
Query: 375 PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434
PL L + Q AQ + +L A+ HRD+ + N+LL + AKI DFGL+R +N
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 435 GASHVTT-FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+++V A+ + ++ PE + T +SDV+S+G++L E+ +
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 33/198 (16%)
Query: 301 LGSGGFGEVFKAILD---DETITAVKRAKLGNTKGI--DPILNEVRILCQLNHR------ 349
LGSG FG V K + E AVK K N D +L E ++ QL++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 350 --------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
L M ++ G L L + + + + + Q + + YL
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKNKH-----VTEKNITELVHQVSMGMKYLE---ET 114
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT----LGYLDPEYYIN 457
HRD+ + N+LL + AKISDFGLS+ AL GA A+ + + PE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSK-AL-GADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 458 FQLTDKSDVYSFGVVLVE 475
++ + KSDV+SFGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 76/277 (27%), Positives = 111/277 (40%), Gaps = 61/277 (22%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKR----AKLGNTKGIDPILNEVRILCQLNHRSLFMSM 355
+G G FG V+ A + AVK+ K N K D I+ EV+ L QL H
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKH------- 80
Query: 356 SPNGTLFDRLHRVQSGNW------------------PPLKWHHRLHIARQTAQAIAYLHL 397
PN + + + W PL+ I Q +AYLH
Sbjct: 81 -PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH- 138
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
+ + HRDIK+ NILL E K++DFG + + S V GT ++ PE +
Sbjct: 139 --SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILA 191
Query: 458 F---QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514
Q K DV+S G+ +EL K + FN +N + +I + + P
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPL-FN-----MNAMSALYHIAQND------SPT 239
Query: 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
L+ S DS + F CL + Q RP+ E+
Sbjct: 240 LQ---SNEWTDSFRGF---VDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 31/199 (15%)
Query: 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418
G LF L R +S P +++ A + A A+ YLH + I +RD+K NILLD +
Sbjct: 81 GELFFHLQRERSFPEPRARFY-----AAEIASALGYLHSIN---IVYRDLKPENILLDSQ 132
Query: 419 LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELL 477
++DFGL + + + TTF GT YL PE I Q D + D + G VL E+L
Sbjct: 133 GHVVLTDFGLCKEGIAQSDTTTTFC-GTPEYLAPE-VIRKQPYDNTVDWWCLGAVLYEML 190
Query: 478 TSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAAC 537
+ R+ ++ + NIL + +L+ GA S+ A+ +L
Sbjct: 191 YGLPPF-YCRDVAEM-----YDNILHKPL-------VLRPGA------SLTAWSIL-EEL 230
Query: 538 LDERRQNRPSIKEVADEIE 556
L++ RQ R KE EI+
Sbjct: 231 LEKDRQRRLGAKEDFLEIQ 249
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG---ASHVTTFA 443
Q A+ + YL A+ HRD+ + N +LDE K++DFGL+R + + H T A
Sbjct: 106 QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 444 QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ + ++ E + T KSDV+SFGV+L EL+T
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 22/201 (10%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAK---LGNTKGIDPILNEVRILCQLNHR 349
NF +G G F EV++A L D A+K+ + L + K + E+ +L QLNH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 350 SL---FMSMSPNGTLFDRLHRVQSGNWPPLKWH---HRLHIARQTA-----QAIAYLHLL 398
++ + S + L L +G+ + H + I +T Q + L +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG---YLDPEYY 455
+ + HRDIK +N+ + K+ D GL R S TT A +G Y+ PE
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSPERI 178
Query: 456 INFQLTDKSDVYSFGVVLVEL 476
KSD++S G +L E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPI---LNEVRILCQLNHRSL------ 351
LG G FG+V+KA + + A AK+ +TK + + + E+ IL +H ++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 352 ------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
F + + L R PL + +QT +A+ YLH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELER-------PLTEPQIRVVCKQTLEALNYLH--- 120
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I HRD+K+ NIL D K++DFG+S +F GT ++ PE +
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCET 179
Query: 460 LTD-----KSDVYSFGVVLVEL 476
D K+DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 32/199 (16%)
Query: 300 LLGSGGFGEVF----KA--------ILDDETI--------TAVKRAKLGNTKGIDPILNE 339
LLG G FG+V KA IL E I T + L NT+ P L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR--HPFLTA 59
Query: 340 VRILCQLNHRSLF-MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
++ Q + R F M + G LF L R + + +++ + A+ YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----GAEIVSALGYLH-- 112
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ + +RD+K N++LD+ KI+DFGL + ++ + + TF GT YL PE +
Sbjct: 113 -SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 170
Query: 459 QLTDKSDVYSFGVVLVELL 477
D + GVV+ E++
Sbjct: 171 DYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH-VT 440
LHIA Q A + YL ++ H+D+ + NIL+ E+L KISD GLSR + + V
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 441 TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ + ++ PE + + + SD++SFGVVL E+ +
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 294 NFSTGNLLGSGGFGEVF----KAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR 349
+F+ +LG G FG+V K + I +K+ + ++ + E R+L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 350 SLFMSMSPNGTLFDRLHRV-QSGNWPPLKWHHRLHIARQTAQAIAY-------LHLLATP 401
+ DRL+ V + N L +H + + QA+ Y L L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
I +RD+K N++LD + KI+DFG+ + + TF GT Y+ PE I +Q
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPE-IIAYQPY 178
Query: 462 DKS-DVYSFGVVLVELLTSKKAVDFNREEE 490
KS D +++GV+L E+L + D E+E
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 28/195 (14%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF------- 352
+GSG +G+V+KA L + AVK KL I E+ ++ + H ++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 353 --------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIY 404
M G+L D H PL ++ R+T Q +AYLH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLH---SKGKM 128
Query: 405 HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI---NFQLT 461
HRDIK +NILL + D K++DFG++ + +F GT ++ PE N
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 462 DKSDVYSFGVVLVEL 476
D+++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 32/74 (43%), Positives = 42/74 (56%), Gaps = 2/74 (2%)
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I HRD+K+ NI L L KI DFG+SRL + TTF GT Y+ PE +
Sbjct: 127 ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT-GTPYYMSPEALKHQGYDS 184
Query: 463 KSDVYSFGVVLVEL 476
KSD++S G +L E+
Sbjct: 185 KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
IA + + YL L I HRD+K SN+L++ + K+ DFG+S +N S T+
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN--SIAKTYV 154
Query: 444 QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVEL 476
GT Y+ PE Q SDV+S G+ +EL
Sbjct: 155 -GTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 36/212 (16%)
Query: 294 NFSTGNLLGSGGFGEVF---KAILDDE----------TITAVKRAK-LGNTKGIDPILNE 339
NF +LG+G +G+VF K D T V++AK +T+ +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 340 VR---ILCQLNHR-------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTA 389
VR L L++ L + G LF L+ Q ++ + R++IA +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY--QREHFT--ESEVRVYIA-EIV 115
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGY 449
A+ +LH L I +RDIK NILLD + ++DFGLS+ L GT+ Y
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172
Query: 450 LDPEYYINFQLTDKSDV---YSFGVVLVELLT 478
+ PE I +S GV+ ELLT
Sbjct: 173 MAPE-VIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 64/221 (28%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 300 LLGSGGFGEVFKAIL-DDETITAVKRAK---LGNTKGIDPILNEVRILC-QLNH---RSL 351
+LG G FG+V A L + + AVK K + ++ + E RIL NH L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWH----HRLHIARQ---TAQAIAYLHLLATPPIY 404
+ LF + V G+ L +H R AR A+ + L L I
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGD---LMFHIQKSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 405 HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKS 464
+RD+K N+LLD + K++DFG+ + + +TF GT Y+ PE
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGPSV 177
Query: 465 DVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505
D ++ GV+L E+L F E ED F IL E
Sbjct: 178 DWWAMGVLLYEMLCGHAP--FEAENED----DLFEAILNDE 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 300 LLGSGGFGEVF----KA--------ILDDETITA--------VKRAKLGNTKGIDPILNE 339
LLG G FG+V KA IL E I A + L NT+ P L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR--HPFLTS 59
Query: 340 VRILCQLNHRSLF-MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
++ Q R F M G LF L R + + +++ + A+ YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFY-----GAEIVSALDYLH-- 112
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ I +RD+K N++LD+ KI+DFGL + + A+ + TF GT YL PE +
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDN 170
Query: 459 QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV 492
D + GVV+ E++ + +N++ E +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 10/102 (9%)
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
IA +A+ YLH + + HRD+K SN+L++ K+ DFG+S ++ S T
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTID 163
Query: 444 QGTLGYLDPEYYINFQLTD-----KSDVYSFGVVLVELLTSK 480
G Y+ PE IN +L KSDV+S G+ ++EL T +
Sbjct: 164 AGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 38/205 (18%)
Query: 300 LLGSGGFGEVFKAIL--DDETITAVKRAKLGNT----KGIDPILNEVRILCQLNHR---- 349
+LGSG FG V+K I + ET+ K+ N K ++E I+ ++H
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 350 ----------SLFMSMSPNGTLFDRLHRVQS--GNWPPLKWHHRLHIARQTAQAIAYLHL 397
L + P+G L D +H + G+ L W Q A+ + YL
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE- 126
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGY----LDPE 453
+ HRD+ + N+L+ KI+DFGL+RL L G G + L+
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPIKWMALECI 183
Query: 454 YYINFQLTDKSDVYSFGVVLVELLT 478
+Y F T +SDV+S+GV + EL+T
Sbjct: 184 HYRKF--THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 32/202 (15%)
Query: 300 LLGSGGFGEVF----KA--------ILDDETI--------TAVKRAKLGNTKGIDPILNE 339
LLG G FG+V KA IL E I T + L NT+ P L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTA 59
Query: 340 VRILCQLNHRSLF-MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
++ Q + R F M + G LF L R + +++ + A+ YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALEYLH-- 112
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ + +RDIK N++LD+ KI+DFGL + ++ + + TF GT YL PE +
Sbjct: 113 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 170
Query: 459 QLTDKSDVYSFGVVLVELLTSK 480
D + GVV+ E++ +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 52/223 (23%)
Query: 295 FSTGNLLGSGGFGEVFKAIL--DDETI--TAVKRAKLGN--TKGIDPILNEVRILCQLNH 348
G +LG G FG V + L DD + AVK KL I+ L+E + +H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 349 RSL------------------------FMSMSPNGTLFDRLHRVQSGNWP---PLKWHHR 381
++ FM +G L L + G P PL+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFM---KHGDLHSFLLYSRLGGLPEKLPLQ--TL 115
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
L A + YL + HRD+ + N +L E + ++DFGLS+ +G
Sbjct: 116 LKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG----DY 168
Query: 442 FAQGTLGYLDPEYYINFQ------LTDKSDVYSFGVVLVELLT 478
+ QG + + P +I + T KSDV++FGV + E+ T
Sbjct: 169 YRQGRIAKM-PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 61/213 (28%), Positives = 89/213 (41%), Gaps = 45/213 (21%)
Query: 295 FSTGNLLGSGGFGEVFKAILDDET--ITAVKR----AKLGNTKGIDPILNEVRILCQLNH 348
F+ +G G FG V+ A D T + A+K+ K N K D I+ EV+ L ++ H
Sbjct: 27 FTDLREIGHGSFGAVYFA-RDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIKH 84
Query: 349 RSLFMSMSPNGTLFDRLHRVQSGNW------------------PPLKWHHRLHIARQTAQ 390
PN + + + W PL+ I Q
Sbjct: 85 --------PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL 450
+AYLH + + HRDIK+ NILL E K++DFG + +A S V GT ++
Sbjct: 137 GLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWM 188
Query: 451 DPEYYINF---QLTDKSDVYSFGVVLVELLTSK 480
PE + Q K DV+S G+ +EL K
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 58/203 (28%), Positives = 84/203 (41%), Gaps = 32/203 (15%)
Query: 301 LGSGGFGEVFKAILDDE-----TITAVKRAKLGNTKG-IDPILNEVRILCQLNHRS---- 350
LG G FG+V D E AVK K + I + E+ IL L H +
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 351 -------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
L M P+G+L + L R N + +L A Q + + YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF--AQGTLGYLDPEYY 455
+ HRD+ + N+L++ + KI DFGL++ + T + + PE
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 456 INFQLTDKSDVYSFGVVLVELLT 478
I + SDV+SFGV L ELLT
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 30/205 (14%)
Query: 294 NFSTGNLLGSGGFGEVFKA--ILDDETITAVKRAK---LGNTKGIDPILNEVRILCQLNH 348
NF +G G F EV++A +LD + + A+K+ + + + K + E+ +L QLNH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPV-ALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 349 RSLFM---SMSPNGTLFDRLHRVQSGNWPPL----KWHHRLHIAR-------QTAQAIAY 394
++ S + L L +G+ + K RL R Q A+ +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG---YLD 451
+H + + HRDIK +N+ + K+ D GL R S TT A +G Y+
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMS 174
Query: 452 PEYYINFQLTDKSDVYSFGVVLVEL 476
PE KSD++S G +L E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 300 LLGSGGFGEVF----KA--------ILDDETITA--------VKRAKLGNTKGIDPILNE 339
LLG G FG+V KA IL E I A + L N++ P L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTA 59
Query: 340 VRILCQLNHRSLF-MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
++ Q + R F M + G LF L R + + +++ + A+ YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----GAEIVSALDYLH-- 112
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ + +RD+K N++LD+ KI+DFGL + + + + TF GT YL PE +
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDN 171
Query: 459 QLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
D + GVV+ E++ + +N++ E
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 22/188 (11%)
Query: 376 LKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435
L W R IA A+A+ +LH +P + ++ I++D K + + RL+L G
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPG 830
Query: 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
T + Y+ PE +T+KSD+Y FG++L+ELLT K D E V+
Sbjct: 831 LLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA---EFGVH-- 885
Query: 496 VYFGNILKQER-------LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548
G+I++ R L IDP ++ S + + ++ L C RP
Sbjct: 886 ---GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMN-LALHCTATDPTARPCA 941
Query: 549 KEVADEIE 556
+V +E
Sbjct: 942 NDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 48/222 (21%)
Query: 298 GNLLGSGGFGEVFKAI---LDDE-----TITAVKRAKLGNT-KGIDPILNEVRILCQL-- 346
G LG G FG+V A LD E T AVK K T K + +++E+ ++ +
Sbjct: 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 347 --NHRSLFMSMSPNGTLFDRLHRVQSGNW--------PP---------------LKWHHR 381
N +L + + +G L+ + GN PP L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
+ A Q A+ + YL A+ HRD+ + N+L+ E KI+DFGL+R H+
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 195
Query: 442 FAQGTLG-----YLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ + T G ++ PE + T +SDV+SFGV+L E+ T
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 294 NFSTGNLLGSGGFGEV----FKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR 349
+F G LG+G FG V K + I +K+ ++ K + + E IL +L+H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 350 SLFMSMSP---------------NGTLFDRLHRVQSGNWPP--LKWHHRLHIARQTAQAI 392
+ M G LF L + +G +P K++H + A
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHA-----ELVLAF 131
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT--TFAQ-GTLGY 449
YLH + I +RD+K N+LLD K K++DFG A V TF GT Y
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGF-------AKKVPDRTFTLCGTPEY 181
Query: 450 LDPEYYINFQLTDKS-DVYSFGVVLVELL 477
L PE I + K+ D ++ GV+L E +
Sbjct: 182 LAPE-VIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKA----ILDD---ETIT-AVKRAKLGNT-KGIDPILNEVRIL 343
+ + G LG G FG+V A I D E +T AVK K T K + +++E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 344 CQL----NHRSLFMSMSPNGTLFDRLHRVQSGNWP-------PLKWHHRLHIARQTAQAI 392
+ N +L + + +G L+ + GN P + IAR + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 393 AY-------------LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439
+ + LA+ HRD+ + N+L+ E KI+DFGL+R +N +
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYY 193
Query: 440 TTFAQGTL--GYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
G L ++ PE + T +SDV+SFGV++ E+ T
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 42/217 (19%)
Query: 301 LGSGGFGEV----------FKAILDDE-----TITAVKRAKLGNTKGI-DPILNEVRILC 344
LG G FGEV F E + AVK + TK + L E++I+
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 345 QLNHRSLF------MSMSP---------NGTLFDRLHR-------VQSGNWPPLKWHHRL 382
+L + ++ +S P NG L L + + N P + + L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH-VTT 441
++A Q A + YL A+ HRD+ + N L+ KI+DFG+SR +G + +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
A + ++ E + + T SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 72/307 (23%), Positives = 118/307 (38%), Gaps = 78/307 (25%)
Query: 295 FSTGNLLGSGGFGEVFKAILDDETITAVK------RAKLGNTKGIDPILNEVRILCQLNH 348
F+ G +LG G FG V +A L E + K +A + ++ I+ L E + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 349 RSLFMSMSPNGT--LFDRLHRVQSGNWP------PLKWHHRLH--------------IAR 386
PN + L G P P H LH +
Sbjct: 61 --------PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL 112
Query: 387 QT--------AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438
QT A + YL ++ HRD+ + N +L+E + ++DFGLS+ +G
Sbjct: 113 QTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG--- 166
Query: 439 VTTFAQGTLGYLDPEYYINFQLTD-----KSDVYSFGVVLVELLTSKKAVDFNREEEDVN 493
+ QG L ++ L D SDV++FGV + E++T + E ++
Sbjct: 167 -DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225
Query: 494 LVVYFGNILKQ--ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+ GN LKQ + L D + M + C + RPS + +
Sbjct: 226 NYLIKGNRLKQPPDCLEDVYELMCQ--------------------CWSPEPKCRPSFQHL 265
Query: 552 ADEIERI 558
D++E I
Sbjct: 266 RDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 26/193 (13%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH----------- 348
+G G G V+ AI + A+K+ L + I+NE+ ++ + H
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 349 --RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIY 404
L++ M G+L D + + + R+ QA+ +LH + +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLH---SNQVI 137
Query: 405 HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKS 464
HRDIKS NILL K++DFG S +T GT ++ PE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 465 DVYSFGVVLVELL 477
D++S G++ +E++
Sbjct: 197 DIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 295 FSTGNLLGSGGFGEV----FKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR- 349
F +LG GGFGEV +A +++ ++ KG LNE +IL ++N +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 350 --------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
L +++ G L + H GN P + L A + + L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDL--KFHIYNMGN-PGFEEERALFYAAEILCGLEDL 118
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYY 455
H +RD+K NILLD+ +ISD GL+ G S GT+GY+ PE
Sbjct: 119 H---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVL 173
Query: 456 INFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE 489
N + T D + G ++ E++ + +E+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 35/195 (17%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------- 351
+G G FG+V +L D V + N L E ++ QL H +L
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 352 ----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
+M+ G+L D L +S L L + +A+ YL
Sbjct: 71 EKGGLYIVTEYMA---KGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---AN 121
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
HRD+ + N+L+ E AK+SDFGL++ AS + + + PE + +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 462 DKSDVYSFGVVLVEL 476
KSDV+SFG++L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 46/153 (30%), Positives = 62/153 (40%), Gaps = 28/153 (18%)
Query: 346 LNHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQTAQAIAYLHLLA 399
L L M +G LFD L + +L I RQ +A+ LH
Sbjct: 81 LKGHVLIMDYIKDGDLFDLLKK-----------EGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 400 TPPIYHRDIKSSNILLDEKLD-AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
I H DIK N+L D D + D+GL ++ + GTL Y PE I
Sbjct: 130 ---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYDGTLDYFSPE-KIKG 180
Query: 459 QLTDKS-DVYSFGVVLVELLTSKKAVDFNREEE 490
D S D ++ GV+ ELLT K + +EE
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 375 PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434
PL + + Q A+ + +L A+ HRD+ + NILL E KI DFGL+R
Sbjct: 169 PLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225
Query: 435 GASHVTTF-AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+V A+ L ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 300 LLGSGGFGEVFKAILD--DE--TITAVKRAKLGNTKGIDPILNEVRILC-QLNH---RSL 351
+LG G FG+V A L DE I +K+ + +D + E RIL H +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 352 FMSMSPNGTLFDRLHRVQSGNWP-PLKWHHRLHIARQ---TAQAIAYLHLLATPPIYHRD 407
LF + V G+ ++ + R A+ L L + +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 408 IKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVY 467
+K NILLD + K++DFG+ + + TTF GT Y+ PE + D +
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELEYGPSVDWW 180
Query: 468 SFGVVLVELLTSKKAVDFNREEE 490
+ GV++ E++ + + + E++
Sbjct: 181 ALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 29/212 (13%)
Query: 300 LLGSGGFGEV----FKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR------ 349
+LG GGFGEV +A +++ ++ KG LNE RIL ++N R
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 350 ---------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
L +++ G L + H GN P + A A+ L L
Sbjct: 67 YAYETKDALCLVLTIMNGGDL--KFHIYNMGN-PGFDEQRAIFYA---AELCCGLEDLQR 120
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL 460
I +RD+K NILLD++ +ISD GL+ G + GT+GY+ PE N +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKY 178
Query: 461 TDKSDVYSFGVVLVELLTSKKAVDFNREEEDV 492
T D + G ++ E++ + F + +E V
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSP--FRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 47/273 (17%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------- 351
LGSG FG V + A+K G D + E +++ +L+H L
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED-FIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
FM NG L + L R + G L + + + + YL
Sbjct: 71 QKPLYIVTEFME---NGCLLNYL-RQRQGKLSK---DMLLSMCQDVCEGMEYLE---RNS 120
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
HRD+ + N L+ K+SDFG++R L+ ++ A+ + + PE + + +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 463 KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEI 522
KSDV+SFGV++ E+ T K + +V ++ G L + +L AS
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL-----------ASMT 229
Query: 523 ELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555
+ M +C E+ + RP+ E+ I
Sbjct: 230 VYEVM-------YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDETI--TAVKR---AKLGNTKGIDPILNEVRILCQLNH 348
+F+ LG+G FG V A +E A+KR +K+ K +D + +E +IL +NH
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 349 R---SLFMSMSPNGTLFDRLHRVQSGNWPP-LKWHHRLHI---ARQTAQAIAYLHLLATP 401
+L+ S L+ L V G + L+ + R AQ + L +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
I +RD+K N+LLD+ K++DFG +++ + T GT Y+ PE +N
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLC-GTPEYIAPEILLNVGHG 206
Query: 462 DKSDVYSFGVVLVELL 477
+D ++ G+ + E+L
Sbjct: 207 KAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 37/209 (17%)
Query: 301 LGSGGFGEVF----KAILDDETITAVKRAKLGNTKGIDP---ILNEVRILCQLNHRSL-- 351
LG G FG V+ K ++ DE T V + + LNE ++ + N +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 352 -------------FMSMSPNGTLFDRLHRVQS---GN----WPPLKWHHRLHIARQTAQA 391
M + G L L ++ N P LK + +A + A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK--KMIQMAGEIADG 131
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG--Y 449
+AYL+ HRD+ + N ++ E KI DFG++R + + +G L +
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 187
Query: 450 LDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ PE + T SDV+SFGVVL E+ T
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 35/201 (17%)
Query: 300 LLGSGGFGEVF------------------KAIL---DDETITAVKRAKLGNTKGIDPILN 338
++G G FG+V KAIL +++ I + + L N K P L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--HPFLV 59
Query: 339 EVRILCQLNHRSLFMSMSPNG-TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
+ Q + F+ NG LF L R + P +++ A + A A+ YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-----AAEIASALGYLHS 114
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
L I +RD+K NILLD + ++DFGL + + +TF GT YL PE ++
Sbjct: 115 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPE-VLH 169
Query: 458 FQLTDKS-DVYSFGVVLVELL 477
Q D++ D + G VL E+L
Sbjct: 170 KQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 34/201 (16%)
Query: 301 LGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPI-----LNEVRILCQLNHRSLFM 353
+G G +G VFK + ET I A+K+ DP+ L E+R+L QL H +L
Sbjct: 9 IGEGSYGVVFKC-RNRETGQIVAIKKFVESED---DPVIKKIALREIRMLKQLKHPNLVN 64
Query: 354 SMSP--------------NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
+ + T+ + L + G + H I QT QA+ + H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI-NF 458
HRD+K NIL+ ++ K+ DFG +R+ L G T T Y PE + +
Sbjct: 121 ---CIHRDVKPENILITKQGQIKLCDFGFARI-LTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 459 QLTDKSDVYSFGVVLVELLTS 479
Q DV++ G V ELLT
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
Q + + Y+H + + HRD+K SN+LL+ D KI DFGL+R +T + T
Sbjct: 116 QLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-T 171
Query: 447 LGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSK 480
Y PE +N + T DV+S G + ELL K
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 45/207 (21%)
Query: 301 LGSGGFGEVFKA--ILDDETITAVKR----AKLGNTKGIDPILNEVRILCQLNHRSLFMS 354
+G G FG V+ A + + E + A+K+ K N K D I+ EVR L +L H
Sbjct: 23 IGHGSFGAVYFARDVRNSEVV-AIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRH------ 74
Query: 355 MSPNGTLFDRLHRVQSGNW------------------PPLKWHHRLHIARQTAQAIAYLH 396
PN + + + W PL+ + Q +AYLH
Sbjct: 75 --PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
+ + HRD+K+ NILL E K+ DFG + + V GT ++ PE +
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 457 NF---QLTDKSDVYSFGVVLVELLTSK 480
Q K DV+S G+ +EL K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 38/126 (30%), Positives = 62/126 (49%), Gaps = 5/126 (3%)
Query: 369 QSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428
+ P + + LH+A Q A + YL ++ HRD+ + N L+ E L KI+DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 429 SRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNR 487
SR G + + A + ++ E + + T SDV++FGV L E+L K +
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244
Query: 488 -EEEDV 492
+E V
Sbjct: 245 LTDEQV 250
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 45/225 (20%)
Query: 280 ARIFSSREITEATNNFSTGNLLGSGGFGEVFKA--ILDDETI---TAVK-----RAKLGN 329
ARI E+ + LLGSG FG V K I + ++I A+K +
Sbjct: 1 ARILKETELRK-------LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 330 TKGIDPILNE--------VRIL--CQLNHRSLFMSMSPNGTLFDRLHRVQSGNWPP---L 376
+ D +L VR+L C L +SP G+L D + R + P L
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLL 112
Query: 377 KWHHRLHIARQTAQAIAYL--HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL- 433
W Q A+ + YL H + HR++ + NILL +I+DFG++ L
Sbjct: 113 NW------CVQIAKGMYYLEEHRMV-----HRNLAARNILLKSDSIVQIADFGVADLLYP 161
Query: 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ + + + + ++ E + + T +SDV+S+GV + E+++
Sbjct: 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 4/105 (3%)
Query: 375 PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434
L + + Q A+ + +L A+ HRD+ + NILL E KI DFGL+R
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 435 GASHVTTF-AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+V A+ L ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 58/242 (23%), Positives = 91/242 (37%), Gaps = 40/242 (16%)
Query: 293 NNFSTGNLLGSGGFGEVF----KAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLN- 347
+F +L+G G FGEV KA D + +K++ L + + E IL N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 348 --------------HRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+ L M P G L L+R + + + ++A AI
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA---QFYLAELV-LAIH 116
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDP 452
+H + HRDIK N+L+D K++DFG S L V + GT Y+ P
Sbjct: 117 SVHQMG---YVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAP 172
Query: 453 EYYINFQLTDKS------DVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506
E K D +S GV+ E++ + E + NI+ +R
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF-----HEG-TSAKTYNNIMNFQR 226
Query: 507 LV 508
+
Sbjct: 227 FL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 301 LGSGGFGEV-----------------FKAILDDETITAVKRAKLGNTKGI-DPILNEVRI 342
LG G FGEV D + AVK + + + L EV+I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 343 LCQLNHRS-------------LFMSMS--PNGTLFDRLHRVQ------SGNWPPLKWHHR 381
L +L+ + L M M NG L L + + N L +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR-LALNGASHVT 440
L++A Q A + YL + HRD+ + N L+ + KI+DFG+SR L + V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 441 TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
A + ++ E + + T KSDV++FGV L E+LT
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 42/120 (35%), Positives = 61/120 (50%), Gaps = 11/120 (9%)
Query: 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418
G LF L R + P +++ A + A AI YLH L I +RD+K NILLD +
Sbjct: 81 GELFFHLQRERCFLEPRARFY-----AAEVASAIGYLHSLN---IIYRDLKPENILLDSQ 132
Query: 419 LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELL 477
++DFGL + + +TF GT YL PE + + D++ D + G VL E+L
Sbjct: 133 GHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
L + Q A+ +++L A+ HRD+ + NILL KI DFGL+R N +++V
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 442 -FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
A+ + ++ PE N T +SDV+S+G++L E+ +
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 18/139 (12%)
Query: 355 MSPNGT---LFDRLHRVQSGNWPPLK-----WHHRLHI------ARQTAQAIAYLHLLAT 400
G LF R SG+ P + W L + + Q A+ + +L A+
Sbjct: 136 RIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---AS 192
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT-FAQGTLGYLDPEYYINFQ 459
HRD+ + NILL E KI DFGL+R +V A+ L ++ PE +
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252
Query: 460 LTDKSDVYSFGVVLVELLT 478
T +SDV+SFGV+L E+ +
Sbjct: 253 YTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 405 HRDIKSSNILLDEKLDAKISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDK 463
HRD+KS+NI L K+ DFG S+ + S V + GT YL PE + + + K
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251
Query: 464 SDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497
+D++S GV+L ELLT + + E + V+Y
Sbjct: 252 ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285
|
Length = 478 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 4/95 (4%)
Query: 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH-VTTFA 443
A Q A+ + YL A+ HRD+ + N+L+ E KI+DFGL+R N + TT
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 444 QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ + ++ PE + T +SDV+SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 32/109 (29%), Positives = 56/109 (51%), Gaps = 12/109 (11%)
Query: 375 PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434
L + + A Q A+ + YL + HRD+ + N+L+ E KI+DFGL+R
Sbjct: 130 QLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR---- 182
Query: 435 GASHVTTFAQGTLG-----YLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
G + + + + G ++ PE + T +SDV+SFG+++ E+ T
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 60/218 (27%)
Query: 301 LGSGGFGEVFKAILDDET--ITAVKRA---------------------KLGNTKGIDPIL 337
LG G +G V+KAI D T + A+K+ +LG+ I +L
Sbjct: 15 LGKGAYGIVWKAI-DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLL 73
Query: 338 NEVRILCQLNHRSLFMSMSPNGTLFD----RLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
N ++ N + +++ +F+ LH V N L+ H+ +I Q +A+
Sbjct: 74 NVIK---AENDKDIYL-------VFEYMETDLHAVIRANI--LEDVHKRYIMYQLLKALK 121
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR----LALNGASHVTTFAQGTLGY 449
Y+H + + HRD+K SNILL+ K++DFGL+R L N + V T T Y
Sbjct: 122 YIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 450 LDPEYYINFQLTDKSDVYSFGV-------VLVELLTSK 480
PE + S Y+ GV +L E+L K
Sbjct: 179 RAPEILL------GSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 8/108 (7%)
Query: 374 PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433
P L + + + Q A + +L A+ HRD+ + N+L+ E KI DFGL+R +
Sbjct: 234 PALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 434 NGASHV---TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
++++ +TF L ++ PE N T SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 28/198 (14%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDETITAV-KRAKLGNTKGIDPILNEVRILCQLNHRSLF 352
++ L G G VF A + V K + G T L E +L +NH S+
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSV- 119
Query: 353 MSMSPNGTLFDR-------------LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
+ TL L+ + PL L I +Q + + YLH
Sbjct: 120 --IRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I HRD+K+ NI +++ I D G ++ + + + GT+ PE +
Sbjct: 178 ---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL--AGTVETNAPEVLARDK 232
Query: 460 LTDKSDVYSFGVVLVELL 477
K+D++S G+VL E+L
Sbjct: 233 YNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 25/200 (12%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNT----KGIDPILNEVRILCQLNHRSLFMSMS 356
+G G FG V+ ++ D V K+ N + E+++LC H ++ ++
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 357 ----PNGTLFDR-----------LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
P+ F+ LH++ PL H Q + + YLH +
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SA 122
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ-L 460
I HRDIK N+L++ KI DFGL+R+ S T T Y PE + +
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHY 182
Query: 461 TDKSDVYSFGVVLVELLTSK 480
T D++S G + ELL +
Sbjct: 183 TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
Q + + Y+H + I HRD+K SN+ ++E + KI DFGL+R + +T + T
Sbjct: 128 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-AT 180
Query: 447 LGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
Y PE +N+ +++ D++S G ++ ELLT +
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 29/74 (39%), Positives = 45/74 (60%), Gaps = 3/74 (4%)
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I HRD+K SNIL++ + + K+ DFG+S ++ S +F GT Y+ PE +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSV 181
Query: 463 KSDVYSFGVVLVEL 476
+SD++S G+ LVEL
Sbjct: 182 QSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF------- 352
+GSG +G+V+KA ++ + A+K KL + + E+ ++ H ++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 353 --------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIY 404
M G+L D H PL +++R+T Q + YLH +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLH---SKGKM 128
Query: 405 HRDIKSSNILLDEKLDAKISDFGLS 429
HRDIK +NILL + K++DFG+S
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 14/111 (12%)
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGASHV 439
+ Q A+A H I HRD+K NI++ + AK+ DFG+ L L G
Sbjct: 83 RLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL-LPGVRDA 138
Query: 440 -------TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAV 483
TT GT Y PE +T SD+Y++G++ +E LT ++ V
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 300 LLGSGGFGEV----FKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR---SLF 352
+LG GGFGEV +A +++ ++ KG LNE +IL ++N R SL
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 353 MSMSPNGTLFDRLHRVQSGNWPPLKWH--HRLHIARQTAQAIAY-------LHLLATPPI 403
+ L L + G+ LK+H + + +A+ Y L L I
Sbjct: 67 YAYETKDALCLVLTLMNGGD---LKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 404 YHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDK 463
+RD+K NILLD+ +ISD GL+ G GT+GY+ PE N + T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 464 SDVYSFGVVLVELLTSKKAVDFNREEEDV 492
D + G ++ E++ K F + +E V
Sbjct: 182 PDWWGLGCLIYEMIEGKSP--FRQRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 62/202 (30%), Positives = 82/202 (40%), Gaps = 39/202 (19%)
Query: 301 LGSGGFGEVFKAI-LDDETITA--VKRAKLGNTKGIDPILNEVRILCQLNHRSLF----- 352
L G GEVF DE VK G T G E+ IL ++HR++
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHA 154
Query: 353 --------MSMSPNGT--LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
M M P LF + R PL + I R+ +A+AYLH
Sbjct: 155 YRWKSTVCMVM-PKYKCDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLH---GRG 205
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA----QGTLGYLDPEYYINF 458
I HRD+K+ NI LDE +A + DFG A +H T GTL PE
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFG---AACKLDAHPDTPQCYGWSGTLETNSPELLALD 262
Query: 459 QLTDKSDVYSFGVVLVELLTSK 480
K+D++S G+VL E+
Sbjct: 263 PYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR----LALNGASHVTTF 442
Q + Y+H + + HRD+K N+L++ + KI DFGL+R A +T +
Sbjct: 113 QILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 443 AQGTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
T Y PE ++FQ K+ DV+S G +L ELL K
Sbjct: 170 V-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 42/202 (20%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGN-TKGI-DPILNEVRILCQLNHRSLFMSMSP 357
+G G +G VFKA + I A+KR +L + +G+ L E+ +L +L H+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR---- 63
Query: 358 NGTLFDRLHRVQSGNWPPLKWHH----------------RLHIAR----QTAQAIAYLHL 397
L+D LH S L + + I + Q + +A+ H
Sbjct: 64 ---LYDVLH---SDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH- 116
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG--TLGYLDPEYY 455
+ + HRD+K N+L+++ + K++DFGL+R V ++ TL Y P+
Sbjct: 117 --SHNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVRCYSAEVVTLWYRPPDVL 171
Query: 456 INFQLTDKS-DVYSFGVVLVEL 476
+L S D++S G + EL
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 21/172 (12%)
Query: 319 ITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---LFMSMSPNGTLFDRLHRVQSGNWPP 375
AVK+ L + + + NEV I+ H + ++ S L+ + ++ G
Sbjct: 46 QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105
Query: 376 LKWHHRLH------IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG-- 427
+ H R++ + +A+++LH + HRDIKS +ILL K+SDFG
Sbjct: 106 IVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162
Query: 428 --LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
+S+ S V GT ++ PE + D++S G++++E++
Sbjct: 163 AQVSKEVPRRKSLV-----GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPI----LNEVRILCQLNHRS---LFM 353
+GSG +G V A LD T V KL + E+R+L + H + L
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 354 SMSPNGTLFDRLHRV------QSGNWPPLKWHHRLHIAR------QTAQAIAYLHLLATP 401
+P+ +L DR H + L H +L R Q + + Y+H
Sbjct: 82 VFTPDLSL-DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AA 137
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QL 460
I HRD+K N+ ++E + KI DFGL+R S +T + T Y PE +N+
Sbjct: 138 GIIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVV-TRWYRAPEVILNWMHY 193
Query: 461 TDKSDVYSFGVVLVELLTSK 480
T D++S G ++ E+LT K
Sbjct: 194 TQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 301 LGSGGFGEVFKA-ILDDETITAVKR---AKLGNTKGIDPILNEVRILCQLN--------- 347
LG GGFGEV + + + A K+ +L G L E IL ++N
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 348 ------HRSLFMSMSPNGTLFDRLHRV-QSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
H L MS+ G L ++ V + G L+ +H + Q I +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSMD- 115
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL 460
I +RD+K N+LLD++ + ++SD GL+ +G + T GT GY+ PE
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPY 171
Query: 461 TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVN 493
+ D ++ G + E++ + F +E V
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR--TPFKDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 45/215 (20%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLG-NTKGI-DPILNEVRILCQLNH- 348
NF +G G +G V+KA + T + A+K+ +L T+G+ + E+ +L +LNH
Sbjct: 1 NFQKVEKIGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 59
Query: 349 ------------RSLFMSMSPNGTLFDRLHR-----VQSGNWPPLKWHHRLHIARQTAQA 391
L++ +F+ LH+ + + + Q Q
Sbjct: 60 NIVKLLDVIHTENKLYL-------VFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLD 451
+A+ H + + HRD+K N+L++ + K++DFGL+R A T TL Y
Sbjct: 113 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 168
Query: 452 PE------YYINFQLTDKSDVYSFGVVLVELLTSK 480
PE YY + D++S G + E++T +
Sbjct: 169 PEILLGCKYY-----STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 52/230 (22%), Positives = 79/230 (34%), Gaps = 51/230 (22%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAK---LGNTKGIDPILNEVRILCQLNH 348
++F ++G G FGEV+ D + A+K + + I + E IL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 349 R---SLFMSMSPNGTLFDRLHRVQSG---NWPPLKWHHRL--HIAR----QTAQAIAYLH 396
L+ S L+ + + G N L AR + A+ +H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNL--LIRKDVFPEETARFYIAELVLALDSVH 118
Query: 397 LLATPPIY-HRDIKSSNILLDEKLDAKISDFGLS-------------------------- 429
L + HRDIK NIL+D K++DFGL
Sbjct: 119 KLG----FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 430 --RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
R GT Y+ PE + D +S GV+L E+L
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 55/230 (23%), Positives = 81/230 (35%), Gaps = 59/230 (25%)
Query: 298 GNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTK-------------GID-PILNEVRI 342
G LG G +G+V KA I A+K+ K+ GI L E++I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 343 LCQLNHRSLFMSM------------------SPNGTLFDRLHRVQSGNWPPLKWHHRLHI 384
+ ++ H ++ M + S + DR R L I
Sbjct: 74 MNEIKHENI-MGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR--------LTESQVKCI 124
Query: 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ 444
Q + LH HRD+ +NI ++ K KI+DFGL+R T
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 445 G-------------TLGYLDPEYYINFQ-LTDKSDVYSFGVVLVELLTSK 480
TL Y PE + + D++S G + ELLT K
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 3/74 (4%)
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I HRD+K SNIL++ + + K+ DFG+S ++ S +F GT Y+ PE +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSV 181
Query: 463 KSDVYSFGVVLVEL 476
+SD++S G+ LVE+
Sbjct: 182 QSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 285 SREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEV---- 340
++ + E +++ +GSG +G V AI D T V KL P +E+
Sbjct: 7 NKTVWELPERYTSLKQVGSGAYGSVCSAI-DKRTGEKVAIKKLSR-----PFQSEIFAKR 60
Query: 341 -----RILCQLNH------RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTA 389
+L + H +F S + +G F + V L+ ++
Sbjct: 61 AYRELTLLKHMQHENVIGLLDVFTS-AVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV 119
Query: 390 QAIAY-----LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ 444
Q + Y L + + I HRD+K N+ ++E + KI DFGL+R A + +T +
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVV 176
Query: 445 GTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
T Y PE +N+ +++ D++S G ++ E+LT K
Sbjct: 177 -TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 51/224 (22%)
Query: 295 FSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPI--LNEV---RILCQLNH 348
+ +G G +G V+KA L+ A+K+ ++ ++ P+ L E+ + L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 349 RSLFMSMSPNGT-LFDRLHRVQSG---------------------NWPP--LKWHHRLHI 384
PN L D H ++ P L +
Sbjct: 61 --------PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ 444
RQ + + +LH + I HRD+K NIL+ KI+DFGL+R+ + +
Sbjct: 113 MRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV- 168
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNRE 488
TL Y PE + D++S G + EL F R
Sbjct: 169 -TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL--------FRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 32/202 (15%)
Query: 300 LLGSGGFGEVFKAILDDET-------ITAVKRAKL-------GNTKGIDPILNEVR--IL 343
+LG GG+G+VF+ + +K+A + +TK IL V+ +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 344 CQLNHR-------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
L + L + G LF L R G + ++ +++ + + A+ +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLER--EGIF--MEDTACFYLS-EISLALEHLH 117
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
I +RD+K NILLD + K++DFGL + +++ + TF GT+ Y+ PE +
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILM 173
Query: 457 NFQLTDKSDVYSFGVVLVELLT 478
D +S G ++ ++LT
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 6e-07
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 48/216 (22%)
Query: 295 FSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGID-------PILNEVRILCQLN 347
F L+G+G +G+V+K VK +L K +D I E+ +L + +
Sbjct: 8 FELVELVGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 348 HRS----------------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIA 385
H L M G++ D + + GN +W +I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEW--IAYIC 117
Query: 386 RQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG 445
R+ + +++LH + HRDIK N+LL E + K+ DFG+S TF G
Sbjct: 118 REILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 173
Query: 446 TLGYLDPEYYINFQLTD-----KSDVYSFGVVLVEL 476
T ++ PE + D KSD++S G+ +E+
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 9/192 (4%)
Query: 315 DDETITAVKRAK-LGNTKGIDPILNEVRILCQLNHRSLFMSMSPNGTLFDRLHRVQSGNW 373
DDE I V+ K + +P L + Q R + NG D + +Q
Sbjct: 35 DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG--DLMFHMQRQRK 92
Query: 374 PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433
P + H R + A + A+ +LH I +RD+K N+LLD K++D+G+ + L
Sbjct: 93 LP-EEHARFYAA-EICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147
Query: 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVN 493
+TF GT Y+ PE + D ++ GV++ E++ + D + D+N
Sbjct: 148 GPGDTTSTFC-GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
Query: 494 LVVYFGNILKQE 505
Y ++ ++
Sbjct: 207 TEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 38/204 (18%)
Query: 300 LLGSGGFGEV-------------FKAILDDETITAVKRAKLGNTKGIDPILNE---VRIL 343
++G G FGEV K + E I A + I N V++
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 344 CQL-NHRSLFMSMS--PNGTLFDRLHRVQSGNWP-PLKWHHRLHIARQTAQAIAYLHLLA 399
+ + L+M M P G L + + N+ P KW R + A + A+ +H +
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLM-----SNYDIPEKWA-RFYTA-EVVLALDAIHSMG 162
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLS-RLALNGASHVTTFAQGTLGYLDPEYYINF 458
HRD+K N+LLD+ K++DFG ++ NG T A GT Y+ PE +
Sbjct: 163 ---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKS- 217
Query: 459 QLTD-----KSDVYSFGVVLVELL 477
Q D + D +S GV L E+L
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 30/99 (30%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
+HI Q A + +L ++ + H+D+ + N+L+ +KL+ KISD GL R + A +
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR-EVYAADYYKL 182
Query: 442 FAQGTLG--YLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
L ++ PE + + + SD++S+GVVL E+ +
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 294 NFSTGNLLGSGGFGEVF---KAILDD----------ETITAVKRAKLG-NTKGIDPILNE 339
NF +LG+G +G+VF K D + V++AK +T+ +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 340 VR---ILCQLNHR-------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTA 389
VR L L++ L + G +F L++ + + ++++ + +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY-----SGEII 115
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGY 449
A+ +LH L I +RDIK NILLD + ++DFGLS+ L+ T GT+ Y
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 450 LDPEYYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEE 490
+ PE K+ D +S G+++ ELLT A F E E
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTG--ASPFTLEGE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 301 LGSGGFGEVFKAI---LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--FMSM 355
+G G G VF AI E A+K+ L + I+NE+ ++ +L + ++ F+
Sbjct: 27 IGQGASGTVFTAIDVATGQEV--AIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 356 SPNG-TLFDRLHRVQSGNWPPLKWHHRLH------IARQTAQAIAYLHLLATPPIYHRDI 408
G LF + + G+ + + + R+ QA+ +LH + HRDI
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 409 KSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYS 468
KS N+LL K++DFG S +T GT ++ PE K D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 469 FGVVLVELL 477
G++ +E++
Sbjct: 201 LGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 43/209 (20%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDETIT----AVKRAKLGNT---KGIDPILNEVRILCQL 346
+ +G+G FG V L + I+ A+K + K + NE R+L ++
Sbjct: 2 DLERIKTVGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 347 NH-------------RSLFMSMS--PNGTLFDRLH---RVQSGNWPPLKWHHRLHIARQT 388
+H R L+M M P G LF L R + L A +
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNST--------GLFYASEI 110
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG 448
A+ YLH I +RD+K NILLD++ K++DFG ++ + T GT
Sbjct: 111 VCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPE 163
Query: 449 YLDPEYYINFQLTDKSDVYSFGVVLVELL 477
YL PE + D ++ G+++ E+L
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 33/207 (15%)
Query: 301 LGSGGFGEVFKAILDD------ETITAVKRA-KLGNTKGIDPILNEVRIL----CQLNHR 349
LG G FG V++ D ET AVK + + + LNE ++ C R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 350 SL-----------FMSMSPNGTL--FDRLHRVQSGN---WPPLKWHHRLHIARQTAQAIA 393
L M + +G L + R R ++ N PP + +A + A +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL--GYLD 451
YL+ HRD+ + N ++ KI DFG++R + + +G L ++
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRWMA 189
Query: 452 PEYYINFQLTDKSDVYSFGVVLVELLT 478
PE + T SD++SFGVVL E+ +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT 440
+ +IA + A+ +LH I +RD+K NILLD + DFGLS+ L
Sbjct: 99 KFYIA-ELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154
Query: 441 TFAQGTLGYLDPEYYINFQ-LTDKSDVYSFGVVLVEL 476
TF GT YL PE ++ + T D +S GV++ E+
Sbjct: 155 TFC-GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
+ R+ QA+ +LH + + HRDIKS NILL K++DFG S +T
Sbjct: 120 VCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 444 QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
GT ++ PE K D++S G++ +E++
Sbjct: 177 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGID-PILNEVRILCQLNH------RS 350
G +G G +G V+KA D K GI E+ +L +L H +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 351 LFMSMSPNGT--LFD----------RLHRVQSGNWPPLKWHHRLHIARQTAQAIAY---- 394
+F+S S LFD + HR N P++ + R +++ Y
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ------LPRSMVKSLLYQILD 119
Query: 395 -LHLLATPPIYHRDIKSSNILL----DEKLDAKISDFGLSRLALNGASHVTTF--AQGTL 447
+H L + HRD+K +NIL+ E+ KI+D G +RL + + T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 448 GYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDV 492
Y PE + + K+ D+++ G + ELLTS+ F+ +ED+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI--FHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 4/100 (4%)
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL 450
+ YLH I +RD+K N+LLD + KI+DFGL + + +TF GT +L
Sbjct: 113 GLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFL 168
Query: 451 DPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
PE T D + GV++ E+L + + EEE
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 379 HHRL-HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
H R+ ++ Q I +LH + I HRD+K SNI++ KI DFGL+R A G S
Sbjct: 118 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTS 172
Query: 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
+ T T Y PE + + D++S G ++ E++ K
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 55/243 (22%), Positives = 87/243 (35%), Gaps = 82/243 (33%)
Query: 302 GSGGFGEVFKAILDDETIT---AVKRAKLGNTK--GID-PILNEVRILCQLNH------- 348
G G +G V+KA + A+K+ K + GI E+ +L +L H
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 349 --------RSLFMSMSPNGTLF-----DRLHRVQSGNWPPLKWHHRLHIAR--------- 386
+S+++ LF D ++ HR
Sbjct: 69 EVFLEHADKSVYL-------LFDYAEHDLWQIIK---------FHRQAKRVSIPPSMVKS 112
Query: 387 ---QTAQAIAYLHLLATPPIYHRDIKSSNILL----DEKLDAKISDFGLSRLALNGASHV 439
Q + YLH + + HRD+K +NIL+ E+ KI D GL+RL + +
Sbjct: 113 LLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAPL 166
Query: 440 TTFAQG-----TLGYLDPE------YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNRE 488
A T+ Y PE +Y T D+++ G + ELLT + F
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTLE--PIFKGR 219
Query: 489 EED 491
E
Sbjct: 220 EAK 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV---TTFAQ 444
T Q + LA+ HRD+ + N+LL + KI DFGL+R ++ +++V +TF
Sbjct: 243 TYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL- 301
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ ++ PE + T SDV+S+G++L E+ +
Sbjct: 302 -PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 31/137 (22%)
Query: 379 HHRLHIARQTAQAIAYLHLLATPP----IYHRDIKSSNILLDEKLD-------------- 420
H + I RQ A+AY H L P + HRD+K NI L +
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 421 ---AKISDFGLSR-LALNGASHVTTFAQGTLGYLDPEYYINFQLT--DKSDVYSFGVVLV 474
AKI DFGLS+ + + +H GT Y PE ++ + DKSD+++ G ++
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 475 ELLTSK----KAVDFNR 487
EL + K KA +F++
Sbjct: 235 ELCSGKTPFHKANNFSQ 251
|
Length = 1021 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
Q Q I + H + + HRD+K N+L+D K K++DFGL+R A V T T
Sbjct: 109 QILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVT 164
Query: 447 LGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSK 480
L Y PE + + D++S G + E+ T K
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 8/184 (4%)
Query: 301 LGSGGFGEVFKAILDDE-TITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---LFMSMS 356
+G G G V A + + AVK+ L + + + NEV I+ H + ++ S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 357 PNGTLFDRLHRVQSGNWPPLKWHHRLH---IARQTAQAIAYLHLLATPPIYHRDIKSSNI 413
L+ + ++ G + H R++ IA + L +L + HRDIKS +I
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI 147
Query: 414 LLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVL 473
LL K+SDFG + GT ++ PE + D++S G+++
Sbjct: 148 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIWSLGIMV 206
Query: 474 VELL 477
+E++
Sbjct: 207 IEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 379 HHRL-HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
H R+ ++ Q I +LH + I HRD+K SNI++ KI DFGL+R A G S
Sbjct: 125 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTS 179
Query: 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
+ T T Y PE + + D++S G ++ E++
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
Q + + Y+H + I HRD+K SN+ ++E + +I DFGL+R A +T + T
Sbjct: 126 QLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQA---DDEMTGYV-AT 178
Query: 447 LGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
Y PE +N+ +++ D++S G ++ ELL K
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 46/162 (28%), Positives = 64/162 (39%), Gaps = 39/162 (24%)
Query: 293 NNFSTGNLLGSGGFGEV-FKAILDDETITAVK---------RAKLGNTKGIDPILNE--- 339
+F T ++G G FGEV D I A+K + +L + K +L E
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 340 ---VRILCQL---NHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWH------HRLHIARQ 387
V + + L M P G L L +K+ R ++A +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML----------IKYDTFSEDVTRFYMA-E 109
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429
AI +H L HRDIK NIL+D K+SDFGLS
Sbjct: 110 CVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 36/204 (17%)
Query: 301 LGSGGFGEVFKAI--LDDETITAVKRAKLGNTKGIDP--ILNEVRILCQLNHRSLFMSMS 356
+G G +G V+KA + +ETI A+K+ +L P + E+ +L ++ H ++
Sbjct: 10 IGEGTYGVVYKARDRVTNETI-ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV---- 64
Query: 357 PNGTLFDRLH----------------RVQSGNWPPLKWHHRL--HIARQTAQAIAYLHLL 398
L D +H + + P + RL Q + IAY H
Sbjct: 65 ---RLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH-- 119
Query: 399 ATPPIYHRDIKSSNILLDEKLDA-KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI- 456
+ + HRD+K N+L+D + +A K++DFGL+R A T TL Y PE +
Sbjct: 120 -SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVVTLWYRAPEILLG 177
Query: 457 NFQLTDKSDVYSFGVVLVELLTSK 480
+ + D++S G + E++ K
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 36/217 (16%)
Query: 286 REITEATNNFSTGNLLGSGGFGEV-------------FKAILDDETITAVKRAKLGNTKG 332
R++ ++ ++G G FGEV K + E I A +
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 333 IDPILNE---VRILCQL-NHRSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
I N V++ C + + L+M M P G L + + P KW
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKWAKFY---- 147
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS-RLALNGASHVTTFAQG 445
TA+ + L + + + HRD+K N+LLD+ K++DFG ++ G T A G
Sbjct: 148 -TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVG 205
Query: 446 TLGYLDPEYYINFQLTD-----KSDVYSFGVVLVELL 477
T Y+ PE + Q D + D +S GV L E+L
Sbjct: 206 TPDYISPE-VLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 11/196 (5%)
Query: 315 DDETITAVKRAK-LGNTKGIDPILNEVRILCQLNHRSLFMSMSPNGTLFDRLHRVQSGNW 373
DDE I V+ K + P L + Q R F+ NG D + +Q
Sbjct: 35 DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRK 92
Query: 374 PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433
P + H R + A + + A+ YLH I +RD+K N+LLD + K++D+G+ + L
Sbjct: 93 LP-EEHARFYSA-EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147
Query: 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDF--NREEED 491
+TF GT Y+ PE D ++ GV++ E++ + D + + D
Sbjct: 148 RPGDTTSTFC-GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206
Query: 492 VNLVVYFGNILKQERL 507
N Y ++ ++++
Sbjct: 207 QNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
+I R+ + +A+LH + HRDIK N+LL E + K+ DFG+S TF
Sbjct: 125 YICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181
Query: 443 AQGTLGYLDPEYYINFQLTD-----KSDVYSFGVVLVEL 476
GT ++ PE + D +SD++S G+ +E+
Sbjct: 182 I-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 40/166 (24%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 321 AVKRAKLGNTKGIDPILNEVRILCQLNHRS---LFMSMSPNGTLFDRLHRVQSGNWPPLK 377
AVK+ L + + + NEV I+ +H + ++ S L+ + ++ G +
Sbjct: 51 AVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV 110
Query: 378 WHHRLH------IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431
H R++ + +A++YLH + HRDIKS +ILL K+SDFG
Sbjct: 111 THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167
Query: 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
+ GT ++ PE + D++S G++++E++
Sbjct: 168 VSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 6e-06
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
+ R+ QA+ +LH + + HRDIKS NILL K++DFG S +T
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 444 QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
GT ++ PE K D++S G++ +E++
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 301 LGSGGFGEV-----------------FKAILDDETITAVKRAKL-GNTKGIDPILNEVRI 342
LG G FGEV + + AVK + N + L E++I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 343 LCQLNHRSLFMSMS---------------PNGTLFDRLHRVQ------SGNWPPLKWHHR 381
+ +L ++ ++ NG L L R + + + +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH-VT 440
+ +A Q A + YL L HRD+ + N L+ + KI+DFG+SR +G + +
Sbjct: 133 IFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 441 TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
A + ++ E + + T SDV++FGV L E+LT
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 40/225 (17%)
Query: 294 NFSTGNLLGSGGFGEVF---------------KAILDDETITAVKRAKLG-NTKGIDPIL 337
NF +LG+G +G+VF +L TI V++AK +T+ +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI--VQKAKTTEHTRTERQVL 58
Query: 338 NEVR---ILCQLNHR-------SLFMSMSPNGTLFDRL-HRVQSGNWPPLKWHHRLHIAR 386
+R L L++ L + G LF L R + K +
Sbjct: 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER------FKEQEVQIYSG 112
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
+ A+ +LH L I +RDIK NILLD ++DFGLS+ GT
Sbjct: 113 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 447 LGYLDPEYYINFQLT-DKS-DVYSFGVVLVELLTSKKAVDFNREE 489
+ Y+ P+ DK+ D +S GV++ ELLT + E+
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 301 LGSGGFGEVFKAILD-DETITAVKRAKLGNTKGID-PILNEVRILCQLNHRSLFMSMSPN 358
LG G + VFK E + A+K +L + +G + EV +L L H ++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV------ 66
Query: 359 GTLFDRLHRVQS----------------GNWPPLKWHHRLHIAR-QTAQAIAYLHLLATP 401
TL D +H + N L H + I Q + ++Y H
Sbjct: 67 -TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KR 122
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG----TLGYLDPEYYI- 456
I HRD+K N+L++EK + K++DFGL+R A V T TL Y P+ +
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLAR-----AKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 457 NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
+ + + D++ G +L E+ T + + +E+++L+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 4/112 (3%)
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
L I R +AI YLH I HRDIK+ NI ++ D + DFG + ++ ++
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVN 493
GT+ PE D++S G+VL E+ T ++ F ++ D +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL-FEKDGLDGD 292
|
Length = 391 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 379 HHRL-HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
H R+ ++ Q I +LH I HRD+K SNI++ KI DFGL+R A G S
Sbjct: 117 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTS 171
Query: 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
+ T T Y PE + + D++S G ++ E++
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGID-PILNEVRILCQLNH------RS 350
G +G G +G V+KA D K GI E+ +L +L H +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65
Query: 351 LFMSMSPNGT--LFD----------RLHRVQSGNWPPLKWHHRLHIARQTAQAIAY---- 394
+F+S + LFD + HR N P++ + R +++ Y
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ------LPRGMVKSLLYQILD 119
Query: 395 -LHLLATPPIYHRDIKSSNILL----DEKLDAKISDFGLSRLALNGASHVTTF--AQGTL 447
+H L + HRD+K +NIL+ E+ KI+D G +RL + + T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 448 GYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDV 492
Y PE + + K+ D+++ G + ELLTS+ F+ +ED+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI--FHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 29/76 (38%), Positives = 40/76 (52%), Gaps = 4/76 (5%)
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
+ +RD+K +NILLDE +ISD GL+ H + GT GY+ PE D
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYD 174
Query: 463 KS-DVYSFGVVLVELL 477
S D +S G +L +LL
Sbjct: 175 SSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 41/209 (19%)
Query: 301 LGSGGFGEVFKAILDDET--ITAVKRAKL-GNTKGIDPI-LNEVRILCQLNHRS------ 350
+G G +G+V+KA D T + A+K+ +L + +GI P L E+ +L L+
Sbjct: 9 IGEGTYGKVYKA-RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 351 ----------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
+F + + F + G P K Q + +A+
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY--QLLKGVAH 125
Query: 395 LHLLATPPIYHRDIKSSNILLD-EKLDAKISDFGLSR---LALNGASHVTTFAQGTLGYL 450
H + HRD+K N+L+D +K KI+D GL R + + +H TL Y
Sbjct: 126 CHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLWYR 178
Query: 451 DPEYYI-NFQLTDKSDVYSFGVVLVELLT 478
PE + + + D++S G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
Q Q IAY H + + HRD+K N+L+D + K++DFGL+R A T T
Sbjct: 107 QLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRTYTHEVVT 162
Query: 447 LGYLDPEYYI-NFQLTDKSDVYSFGVVLVELLTSK 480
L Y PE + + Q + D++S G + E++ +
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 32/111 (28%), Positives = 52/111 (46%), Gaps = 18/111 (16%)
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS--- 437
R++ A +T A+ YLH I HRD+K N+L+ K++DFGLS++ L +
Sbjct: 104 RMYFA-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 438 ---HVTTFAQ--------GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
H+ + GT Y+ PE + D ++ G++L E L
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 15/138 (10%)
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
+ +RD+K +NILLDE +ISD GL+ H + GT GY+ PE D
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYD 174
Query: 463 KS-DVYSFGVVLVELLTSKKAVDFN--REEEDVNLVVYFGNILKQERLVDAIDPMLK--- 516
S D +S G +L +LL + +++ +++ + N+ L D+ P LK
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV----ELPDSFSPELKSLL 230
Query: 517 EGASEIELDSMKAFGLLG 534
EG ++ D K G LG
Sbjct: 231 EGL--LQRDVSKRLGCLG 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 13/166 (7%)
Query: 321 AVKRAKLGNTKGIDPILNEVRILCQLNHRS---LFMSMSPNGTLFDRLHRVQSGNWPPLK 377
AVK L + + + NEV I+ H++ ++ S L+ + +Q G +
Sbjct: 50 AVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 109
Query: 378 WHHRLH------IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431
RL+ + QA+ YLH + + HRDIKS +ILL K+SDFG
Sbjct: 110 SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166
Query: 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
+ GT ++ PE + D++S G++++E++
Sbjct: 167 ISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 34/95 (35%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
+ARQ AI Y+H I HRDIK+ N+L++ D + DFG + A S T F
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS--TPFH 319
Query: 444 QGTLGYLD---PEYYINFQLTDKSDVYSFGVVLVE 475
G G +D PE T D++S G+V+ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 5/97 (5%)
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
+ RQ + + +LH I HRD+K NIL+ K++DFGL+R+ T
Sbjct: 113 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPV 167
Query: 444 QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
TL Y PE + D++S G + E+ K
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 34/206 (16%)
Query: 301 LGSGGFGEVFKA--ILDDETITAVKRAKLGNTKGIDPI--LNEVRILCQL------NHRS 350
+G G +G+VFKA + + A+KR ++ + P+ + EV +L L N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 351 LFMSMSPNGT----------------LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
LF + + T L L +V P + Q + + +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF---QLLRGLDF 125
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
LH + + HRD+K NIL+ K++DFGL+R+ T TL Y PE
Sbjct: 126 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEV 180
Query: 455 YINFQLTDKSDVYSFGVVLVELLTSK 480
+ D++S G + E+ K
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 379 HHRL-HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
H R+ ++ Q I +LH + I HRD+K SNI++ KI DFGL+R A +
Sbjct: 122 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTN 176
Query: 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
+ T T Y PE + + D++S G ++ EL+
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 26/97 (26%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
+A+ L+ L I +RD+K N+LLD + K++D+G+ + + +TF GT
Sbjct: 102 SAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTP 160
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVD 484
Y+ PE D ++ GV++ E++ + D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 29/66 (43%), Positives = 35/66 (53%), Gaps = 10/66 (15%)
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG--ASH 438
R +IA +T AI +H L HRDIK N+LLD K K+SDFGL G SH
Sbjct: 104 RFYIA-ETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSH 155
Query: 439 VTTFAQ 444
T F +
Sbjct: 156 RTEFYR 161
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 51/217 (23%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 301 LGSGGFGEVFKAILD-DETITAVKRAKLGNTKGID-PILNEVRILCQLNHRSLFMSMSPN 358
LG G + VFK E + A+K +L + +G + EV +L L H ++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 359 GTLFDRLHRVQS-------------------GNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
TL D +H +S GN + H+ Q + +AY H
Sbjct: 68 -TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNI--MSMHNVKIFLYQILRGLAYCH--- 121
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI-NF 458
+ HRD+K N+L++E+ + K++DFGL+R A + + + TL Y P+ + +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 459 QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
+ + + D++ G + E+ + + + E++++L+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 73/257 (28%), Positives = 104/257 (40%), Gaps = 67/257 (26%)
Query: 300 LLGSGGFGEVFKAILDD-ETITAVK---RAKLGNTKGIDPILNEVRILCQLNHR---SLF 352
LLG G G VF L + A+K + ++ + +L E IL L+H +L+
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 353 ------------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
M P G LF RL + Q G + R + A A+ YLHLL
Sbjct: 68 ASFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLSEE-VARFYAAEVLL-ALEYLHLLG- 123
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLS-----------RLALNGASH-------VTTF 442
I +RD+K NILL E +SDF LS + G+ TF
Sbjct: 124 --IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 443 AQ----------GTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELL---TSKKAVDFNRE 488
++ GT Y+ PE I+ + D ++ G++L E+L T K NR+
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS--NRD 238
Query: 489 EEDVNLVVYFGNILKQE 505
E F NILK+E
Sbjct: 239 ET-------FSNILKKE 248
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 36/202 (17%)
Query: 300 LLGSGGFGEVFKAILDDET--ITAVKR-AKLGNTKGIDPI-LNEVRILCQLNHRSL---- 351
L+G G +G V K ET I A+K+ + + K + I + E+R+L QL H +L
Sbjct: 8 LVGEGSYGMVMKC-KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 352 --------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
F+ + T+ D L + +G L Q + I + H
Sbjct: 67 EVFRRKKRLYLVFEFV----DHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCHS 118
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
I HRDIK NIL+ + K+ DFG +R L V T T Y PE +
Sbjct: 119 ---HNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVG 174
Query: 458 FQLTDKS-DVYSFGVVLVELLT 478
++ D+++ G ++ E+LT
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 41/183 (22%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 376 LKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435
L + +L +A + + L+ P ++++ S + L+ E KI GL ++ +
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP 176
Query: 436 ASHVTTFAQGTLGYLDPEYYINF--QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVN 493
F + Y + + + T K D+YS GVVL E+ T K
Sbjct: 177 PFKNVNF----MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK------------- 219
Query: 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553
+ F N+ +E + D I + K + ++ LD + AC RP+IKE+
Sbjct: 220 --IPFENLTTKE-IYDLI--INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274
Query: 554 EIE 556
+
Sbjct: 275 NLS 277
|
Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 40/219 (18%)
Query: 286 REITEATNNFSTGNLLGSGGFGEV-------------FKAILDDETITAVKRAKLGNTKG 332
R++ ++ ++G G FGEV K + E I A +
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 333 IDPILNEVRILCQL-----NHRSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIA 385
I N ++ QL + R L+M M P G L + + P KW A
Sbjct: 96 IMAFANSPWVV-QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKW------A 144
Query: 386 R-QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS-RLALNGASHVTTFA 443
R TA+ + L + + HRD+K N+LLD+ K++DFG ++ G T A
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-A 203
Query: 444 QGTLGYLDPEYYINFQLTD-----KSDVYSFGVVLVELL 477
GT Y+ PE + Q D + D +S GV L E+L
Sbjct: 204 VGTPDYISPE-VLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 51/194 (26%), Positives = 77/194 (39%), Gaps = 10/194 (5%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAK--LGNTKGIDPILNEV---RILCQL 346
N F ++G G +G V K + + I A+K+ K N + + L E+ R L Q
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 347 NHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHR----LHIARQTAQAIAYLHLLATPP 402
N L + G L+ V+ L+ + Q I +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I HRDIK N+L+ K+ DFG +R G++ T T Y PE +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 463 KSDVYSFGVVLVEL 476
D++S G +L EL
Sbjct: 181 AVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 29/97 (29%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG- 445
Q + IA+ H + HRD+K N+L++++ + K++DFGL+R V TF+
Sbjct: 108 QLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAF---GIPVNTFSNEV 161
Query: 446 -TLGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
TL Y P+ + + S D++S G ++ E++T +
Sbjct: 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 28/115 (24%), Positives = 47/115 (40%), Gaps = 22/115 (19%)
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
L I + I Y+H + + HRD+K NILL + I D+G + +
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLL 171
Query: 442 FAQ------------------GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
GT Y+ PE + ++ +D+Y+ GV+L ++LT
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 63/239 (26%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVK---RAKLGNTKGIDPILNEVRILCQLN 347
++F + ++G G FGEV + + +T I A+K +A + + + I E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59
Query: 348 -------------HRSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
R+L++ M P G + L + + + + + +IA +T AI
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS----EEATQFYIA-ETVLAI 114
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL------------------------ 428
+H L HRDIK N+LLD K K+SDFGL
Sbjct: 115 DAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 429 SRLALNGASHVTTFAQ----------GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
S +N T+ + GT Y+ PE ++ D +S GV++ E+L
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 35/217 (16%)
Query: 301 LGSGGFGEVFKAILD-DETITAVKRAKLGNTKGID-PILNEVRILCQLNHRSLFMSMSPN 358
LG G + V+K + + A+K +L + +G + EV +L L H ++
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 359 GTLFDRLHRVQS-------------------GNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
TL D +H +S GN + H+ Q + + Y H
Sbjct: 68 -TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH--- 121
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI-NF 458
+ HRD+K N+L++E+ + K++DFGL+R A + + + TL Y P+ + +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 459 QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
+ + D++ G + E+ T + + EE ++ +
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 60/218 (27%), Positives = 88/218 (40%), Gaps = 37/218 (16%)
Query: 288 ITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILN-------EV 340
+ + T+ + +G G +G+V+K +T K L K +DPI + E
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYK-------VTNKKDGSLAAVKILDPISDVDEEIEAEY 69
Query: 341 RILCQL-NHRSL--FMSM------SPNGTLFDRLHRVQSGNWPPL-----KWHHRLH--- 383
IL L NH ++ F M G L+ L G+ L RL
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
I+ A+ L L I HRD+K +NILL + K+ DFG+S L +
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTS 188
Query: 444 QGTLGYLDPEYYINFQLTDKS-----DVYSFGVVLVEL 476
GT ++ PE Q D S DV+S G+ +EL
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 271 SGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRA---- 325
+ A ++ + ++ GN++G+G FG V++AI +D A+K+
Sbjct: 44 NNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP 103
Query: 326 KLGNTK-GIDPILNEVRIL----------CQLNHRSLF----MSMSPNGTLFDRLHRVQS 370
+ N + I LN + I+ + N +++F M P H ++
Sbjct: 104 QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163
Query: 371 GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA-KISDFGLS 429
+ PL + +L+ + Q +A+AY+H + I HRD+K N+L+D K+ DFG +
Sbjct: 164 NHALPL-FLVKLY-SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218
Query: 430 RLALNGASHVTTFAQGTLGYLDPEYYI-NFQLTDKSDVYSFGVVLVELL 477
+ L G V+ + Y PE + T D++S G ++ E++
Sbjct: 219 KNLLAGQRSVSYIC--SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 29/106 (27%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
Q + ++Y+H I HRD+K N+L+ + + K++DFGL+R A + SH + T
Sbjct: 111 QLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVT 166
Query: 447 LGYLDPEYYI-NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEED 491
L Y P+ + + + + D++ G + VE++ A ++ +D
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 52/209 (24%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILN--EVRILCQLNHRSLFMSMSP 357
+G G F EV KA A+K K + K ++ + N E++ L +L+ + +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 358 NGTLFDRLH--------------------RVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
LFDR R + PL Q +++ ++H
Sbjct: 66 --VLFDRKTGRLALVFELMDMNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHR 118
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ--GTLGYLDPE-- 453
I+HRDIK NIL+ + + K++DFG R G + + T Y PE
Sbjct: 119 NG---IFHRDIKPENILIKDDI-LKLADFGSCR----GIYSKPPYTEYISTRWYRAPECL 170
Query: 454 ----YYINFQLTDKSDVYSFGVVLVELLT 478
YY K D+++ G V E+L+
Sbjct: 171 LTDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 24/83 (28%), Positives = 43/83 (51%), Gaps = 15/83 (18%)
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG---YLDPEYYINFQ 459
I HRD+K +N+L++ K+ DFG+S + V + A+ +G Y+ PE +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 460 LTD------KSDVYSFGVVLVEL 476
+SDV+S G+ ++E+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 20/48 (41%), Positives = 30/48 (62%), Gaps = 3/48 (6%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434
+ A A+ YLH I HRD+K N+L+ + K++DFGLS++ LN
Sbjct: 112 EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 34/95 (35%), Positives = 47/95 (49%), Gaps = 14/95 (14%)
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGY 449
AI +H L HRDIK N+LLD+ +++DFG S L L V + A GT Y
Sbjct: 114 AIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDY 169
Query: 450 LDPEYYINFQLTD-------KSDVYSFGVVLVELL 477
+ PE I + D + D +S GV + E+L
Sbjct: 170 ISPE--ILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 9/99 (9%)
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
+I + + +LH+ T HRD+K +NILL + K+ DFG+S L
Sbjct: 128 YILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNT 183
Query: 443 AQGTLGYLDPEYYINFQLTDKS-----DVYSFGVVLVEL 476
+ GT ++ PE Q D + DV+S G+ +EL
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-TTFAQGTL 447
A+ + +H + HRDIK N+LLD +++DFG S L +N V ++ A GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTP 167
Query: 448 GYLDPEYYINFQ-----LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502
Y+ PE + + D +S GV + E+L + F E +LV +G I+
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP--FYAE----SLVETYGKIM 221
Query: 503 KQE 505
E
Sbjct: 222 NHE 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 59/236 (25%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDET-----ITAVKRAKLGNTKGIDPILNEVRILCQLNH 348
+F + ++G G FGEV + + +T + +++A + + + I E IL + +
Sbjct: 2 DFESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 349 R---SLFMSMSPNGTLFDRLHRVQSGNWPPL--------KWHHRLHIARQTAQAIAYLHL 397
+F S L+ + + G+ L + + +IA +T AI +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQ 119
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ------------- 444
L HRDIK N+LLD K K+SDFGL L A H T F +
Sbjct: 120 LG---FIHRDIKPDNLLLDSKGHVKLSDFGLCT-GLKKA-HRTEFYRNLNHSLPSDFTFQ 174
Query: 445 -----------------------GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
GT Y+ PE ++ D +S GV++ E+L
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 29/114 (25%), Positives = 47/114 (41%), Gaps = 24/114 (21%)
Query: 375 PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434
PL R I +Q A+ Y+H + HRDIK NI L+ + DFG
Sbjct: 264 PLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGT------ 313
Query: 435 GASHVTTFAQ----------GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
F + GT+ PE + +D++S G++L+++L+
Sbjct: 314 ----AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 54/210 (25%), Positives = 79/210 (37%), Gaps = 68/210 (32%)
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA-KISDFGLS---RLALNGASHV 439
I RQ A+ LH +T I HRD+K NI+ E + KI D G + R+ +N
Sbjct: 260 IMRQILFALDGLH--STG-IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----- 311
Query: 440 TTFAQGTLGY------LDPEY-----YI----------------------NFQLTDKSDV 466
Y LDP Y YI L D+ D+
Sbjct: 312 ---------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362
Query: 467 YSFGVVLVE-----LLTSKKAVDFNREEEDVNLVVYFGNILKQER-LVDA-IDPMLKEGA 519
YS G++ ++ L + + FNR+ + L R LV+ P L+ G
Sbjct: 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRN------DYDLVAWRKLVEPRASPDLRRGF 416
Query: 520 SEIELDSMKAFGLLGAACLDERRQNRPSIK 549
++LD + LL + + RQ R S K
Sbjct: 417 EVLDLDGGAGWELLKSMMRFKGRQ-RISAK 445
|
Length = 566 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
Q + +AY+H I HRD+K N+L+ + K++DFGL+R A + S + T
Sbjct: 111 QLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVT 166
Query: 447 LGYLDPEYYINFQLTDKS---DVYSFGVVLVELL 477
L Y P+ + TD S D++ G + +E+L
Sbjct: 167 LWYRPPDVLLG--ATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 5/78 (6%)
Query: 405 HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ----- 459
HRDIK NIL+D +++DFG + + ++ A GT Y+ PE +
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184
Query: 460 LTDKSDVYSFGVVLVELL 477
+ D +S GV + E+L
Sbjct: 185 YGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 21/48 (43%), Positives = 27/48 (56%), Gaps = 4/48 (8%)
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428
R +IA T AI +H + HRDIK NIL+D K++DFGL
Sbjct: 104 RFYIAELTC-AIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 559 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.58 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.87 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.79 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.78 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.78 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.32 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.21 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.06 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.94 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.69 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.56 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.35 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.23 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.18 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 97.12 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.04 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.0 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.94 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.81 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.76 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.73 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.64 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 96.59 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.43 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.39 | |
| PLN02236 | 344 | choline kinase | 96.1 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.0 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.97 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 95.16 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.96 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.1 | |
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 94.06 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.96 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 93.47 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.33 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.09 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 93.07 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.48 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 91.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.43 | |
| PTZ00384 | 383 | choline kinase; Provisional | 91.06 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 90.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.6 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=410.79 Aligned_cols=274 Identities=47% Similarity=0.746 Sum_probs=239.8
Q ss_pred cccccChHHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------
Q 047195 279 LARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------- 351 (559)
Q Consensus 279 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni------- 351 (559)
..+.|+++++.++|++|....+||+|+||.||+|.++++..||||++.........+|.+|++++.+++||||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 4677999999999999999999999999999999999999999998776554314569999999999999994
Q ss_pred ---------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEE
Q 047195 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAK 422 (559)
Q Consensus 352 ---------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~k 422 (559)
|+||+++|+|.++|+..... +++|..+++||.++|+||+|||.....+||||||||+|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 78999999999999875432 789999999999999999999988777899999999999999999999
Q ss_pred EeecccceeccC-CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 423 ISDFGLSRLALN-GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 423 l~DFG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
|+|||+|+.... ........ .||.+|+|||++.....+.|+||||||++|+||+||+++.+...+.....+..|.+..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999977654 32222221 6999999999999999999999999999999999999999876656666788999999
Q ss_pred hhcchhhhcccccccc-CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 502 LKQERLVDAIDPMLKE-GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+....+.+++|+.+.. .... .+.+..+..++.+|++.+|++||+|.||+++|+.+
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~--~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPD--EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHCcchhheeCCCccCCCCCh--HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 9999999999999874 3221 15777899999999999999999999999999765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=357.29 Aligned_cols=241 Identities=32% Similarity=0.443 Sum_probs=195.2
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCC--hhhHHHHHHHHHhcCCCce----------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG--IDPILNEVRILCQLNHRSL----------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni----------------v~~ 354 (559)
....+.+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||| |+|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3455566799999999999999887779999987654322 4589999999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC-eEECCCCCCCeeecCCC-CEEEeecccceec
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP-IYHRDIKSSNILLDEKL-DAKISDFGLSRLA 432 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-iiH~Dikp~Nill~~~~-~~kl~DFG~a~~~ 432 (559)
|+++|+|.++++.. ....+++..+++++.|||+|++||| +++ ||||||||+|||++.++ ++||+|||+++..
T Consensus 121 y~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 99999999999874 2246999999999999999999999 777 99999999999999997 9999999999876
Q ss_pred cCCCceeeeeccccCCccCccccc--cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYI--NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
.... ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... .. ..........
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~-----~~~~v~~~~~---- 263 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ-----VASAVVVGGL---- 263 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH-----HHHHHHhcCC----
Confidence 5432 2233356999999999999 56899999999999999999999999985543 11 1111111111
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.+ ..+......+..|+.+||+.||+.||++.+++.+|+.+
T Consensus 264 -Rp-------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 264 -RP-------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred -CC-------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 11 11122457888999999999999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=332.18 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=195.6
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce-----------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL-----------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni-----------------v 352 (559)
.+|++.++||+|.||+||++. +.++..+|.|.+... +.+..+++..|+.+|++|+|||| |
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 358889999999999999998 678999999998764 33445779999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC-CCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA-TPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||++..|+|..++...... ...+++..+++++.|++.||.++|+.- ..-|+||||||.||+|+.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 7999999999999876543 357899999999999999999999421 13499999999999999999999999999998
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
+...... ....+|||.||+||.+....|+.||||||+||++|||..-++||.+++-.+ + ...+..+....+-
T Consensus 178 l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~---L----~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 178 LSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS---L----CKKIEQGDYPPLP 249 (375)
T ss_pred hcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH---H----HHHHHcCCCCCCc
Confidence 8765433 344569999999999999999999999999999999999999998763211 1 1222222221111
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
+ .--+..+.+|+..|+..||+.||+...+++.+.
T Consensus 250 ~-----------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 D-----------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred H-----------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1 123366788999999999999999655555443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=340.33 Aligned_cols=236 Identities=29% Similarity=0.382 Sum_probs=190.6
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce----------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL----------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni----------------v~~~ 355 (559)
+.+..+.||+|..|+|||++++ +++.+|+|.+.... ....+++.+|++++...+||+| +|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4556688999999999999965 67899999996543 3445789999999999999985 5799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
|++|+|.+++.... .+++...-+|+.+|++||.|||. .++||||||||+|||++..|++||+|||.++...+.
T Consensus 160 MDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999998753 48999999999999999999994 378999999999999999999999999999887654
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
......||..|||||.+.+..|+.++||||||++++|+.+|+.|+........ .... .+..+++
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-~~~~---------Ll~~Iv~--- 296 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-DIFE---------LLCAIVD--- 296 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-CHHH---------HHHHHhc---
Confidence 33334599999999999999999999999999999999999999976521111 1111 1111221
Q ss_pred ccCCChhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIEL-DSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+..+..+. ....++..++..||+.||.+|||++|+++
T Consensus 297 -~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 297 -EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111122 35688999999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=336.77 Aligned_cols=238 Identities=26% Similarity=0.303 Sum_probs=188.4
Q ss_pred HhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCC-------CChhhHHHHHHHHHhcCCCce-----------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNT-------KGIDPILNEVRILCQLNHRSL----------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~-------~~~~~~~~E~~~l~~l~h~ni----------- 351 (559)
..+.|.+.+.||+|+||.|-+|. .++++.||||++..... .......+|++||++|+||||
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34578889999999999999998 67899999999865321 123346799999999999995
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC---CCEEEe
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK---LDAKIS 424 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~---~~~kl~ 424 (559)
|+||+.+|.|++.+-... .+.+..-+.+++|++.|+.||| ++||+||||||+|||++.+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence 679999999999987643 3777788999999999999999 8999999999999999766 679999
Q ss_pred ecccceeccCCCceeeeeccccCCccCccccccCC---CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 425 DFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ---LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 425 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
|||+|+... ....+...+|||.|.|||++.+.. +..|+|+||+||+||-+++|..||......... ...
T Consensus 322 DFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl--~eQ---- 393 (475)
T KOG0615|consen 322 DFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL--KEQ---- 393 (475)
T ss_pred ccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH--HHH----
Confidence 999999875 344556677999999999998654 334889999999999999999999755432211 111
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+..+++. .......+..++..+|+.+||..||++|||+.|+++
T Consensus 394 I~~G~y~---------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 394 ILKGRYA---------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HhcCccc---------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111110 011112456678889999999999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=347.06 Aligned_cols=232 Identities=28% Similarity=0.426 Sum_probs=192.9
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCceE---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSLF---------------M 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~niv---------------~ 353 (559)
..|...+.||+|||+.||+++. ..|..+|+|++... .....+.+.+||+|.++|+||||| .
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999996 88999999998763 344557799999999999999964 5
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
|++.+++|..++.+. .++++.+++.+.+||+.||.||| +++|||||||..|+|++++.++||+|||||..+.
T Consensus 98 ELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence 889999999998743 36999999999999999999999 8889999999999999999999999999999887
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.+..... ..+|||.|+|||++....++..+||||+|||||.|+.|++||+...-.+.. +.++...
T Consensus 170 ~~~Erk~-TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-------~~Ik~~~------- 234 (592)
T KOG0575|consen 170 YDGERKK-TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-------NKIKLNE------- 234 (592)
T ss_pred Ccccccc-eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-------HHHHhcC-------
Confidence 5543333 345999999999999989999999999999999999999999744322211 1111110
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
-..+.....+..+||.++|+.+|.+|||+.+|+.
T Consensus 235 ------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 ------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111234466788999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=330.26 Aligned_cols=227 Identities=26% Similarity=0.350 Sum_probs=185.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++++.||+|+||+||.++. +.++.+|+|+++.. .....+...+|..||.+++||.| |
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999999985 55799999998764 33456778999999999999985 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++|+.||.|+.+|++.. .+++..+..++.+|+.||.||| +++||||||||+|||||++|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 79999999999998754 4899999999999999999999 888999999999999999999999999999976
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
........+ .+||+.|||||++.+..|+..+|+||||+++|||++|.+||...+....... +..+++
T Consensus 176 ~~~~~~t~t-fcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~-------I~~~k~----- 242 (357)
T KOG0598|consen 176 LKDGDATRT-FCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK-------ILKGKL----- 242 (357)
T ss_pred ccCCCcccc-ccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH-------HhcCcC-----
Confidence 554333333 4699999999999999999999999999999999999999986653321111 111110
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCC
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRP 546 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 546 (559)
...+.-...+..++++.+|+.+|++|.
T Consensus 243 -------~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -------PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -------CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 000111235677889999999999995
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=345.80 Aligned_cols=239 Identities=31% Similarity=0.427 Sum_probs=198.3
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCCC
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSPN 358 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~ 358 (559)
.+...+.||+|-||.||+|.++....||+|.++..... .++|.+|+++|++|+|+|| |+||++.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 35566889999999999999999999999999876444 3789999999999999984 7899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|.++|.... ...+.....+.++.|||+|++||+ ++++|||||...||||+++..+||+|||||+...++...
T Consensus 286 GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 286 GSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred CcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99999998732 245888999999999999999999 889999999999999999999999999999976666665
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
......-+..|.|||.+....++.||||||||++||||+| |+.|+......+-. ..+..+ .+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-------~~le~G---------yR- 422 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-------ELLERG---------YR- 422 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-------HHHhcc---------Cc-
Confidence 5555667889999999999999999999999999999999 56666544332211 111111 01
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
-..+..++..+.+++..||+.+|++|||++.+...|+++
T Consensus 423 --lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 423 --LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred --CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 011234668899999999999999999999999999876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=315.25 Aligned_cols=252 Identities=23% Similarity=0.268 Sum_probs=192.4
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
+.|+.+.++|+|+||+||+.+. +.|+.||||++...... -.+-.++|+++|++|+|+|| |+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4588889999999999999995 56899999998765432 22447899999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|++..-|. -|+.... .++.+.+.+++.|+++|+.|+| ++++|||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~~dhTvL~-eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLH-ELERYPN----GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHH-HHHhccC----CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 98775444 4444332 3888999999999999999999 89999999999999999999999999999998764
Q ss_pred CCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHhhcc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG--------NILKQE 505 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 505 (559)
.....+..+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|++..+.++..++.... ..+...
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2333455668999999999987 689999999999999999999999999887666554443222 112111
Q ss_pred hh-hhccccccc--cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RL-VDAIDPMLK--EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~-~~~~d~~l~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ..+.-|... +.....-.....-+++++..||+.||++|++-++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 111111110 0000011234456889999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.73 Aligned_cols=187 Identities=32% Similarity=0.475 Sum_probs=164.9
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
..+|.+.+.||.|+||+||+|++ +++..||||.+... .++..+.+..|+++|+.++|||| ||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35789999999999999999995 56799999998776 55566778999999999999995 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC------CCEEEeecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK------LDAKISDFG 427 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~------~~~kl~DFG 427 (559)
||+.+|+|.++++... .+++..++.++.|+|.||++|| +++||||||||+||||+.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999998754 4899999999999999999999 8899999999999999764 468999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCc
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNRE 488 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~ 488 (559)
+|+....+. .....+|++-|||||++...+|+.|+|+||+|+|||++++|+.||+....
T Consensus 161 fAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 161 FARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 999876432 33445699999999999999999999999999999999999999985543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=331.23 Aligned_cols=249 Identities=25% Similarity=0.309 Sum_probs=194.6
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL-----------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni-----------------v 352 (559)
+.|+.+++||+|.||.||+|+ ..+++.||+|++..... ....-..+||.||++|+|||| |
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778999999999999999 67899999999988763 334557899999999999995 4
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+|||++ +|..++... .-.+++.+++.+++|++.||+|+| +++|+|||||.+|||||++|.+||+|||||+++
T Consensus 197 FeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 566654 444444332 235899999999999999999999 999999999999999999999999999999988
Q ss_pred cCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH-----HHhhcch
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG-----NILKQER 506 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 506 (559)
........+..+-|.+|.|||.+.+. .|+.++|+||.||||.||++|++.+.+..+.++...+...- ..|...+
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 87766667777899999999999886 69999999999999999999999999887666554432211 1111111
Q ss_pred h--hhcc------ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 L--VDAI------DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~--~~~~------d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+ ...+ ...+.+.+ ........+|+..+|..||++|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~----~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETF----KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHh----ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 1111 11222221 223356678899999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.36 Aligned_cols=234 Identities=26% Similarity=0.378 Sum_probs=197.8
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
..|...++||+|+.|.||.|. ..+++.||||++........+-+++|+.+|+..+|+|| ||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457778899999999999998 56788999999998887777889999999999999994 79999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.|++... .+++.++..|++++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999764 3899999999999999999999 8999999999999999999999999999998887666
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
....+. +|||.|||||++....|+.|.||||||++++||+-|.+||-..++.....+ ....+ -+.++
T Consensus 424 ~KR~Tm-VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL------Ia~ng------~P~lk 490 (550)
T KOG0578|consen 424 SKRSTM-VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPKLK 490 (550)
T ss_pred Cccccc-cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH------HhhcC------CCCcC
Confidence 544444 499999999999999999999999999999999999999975433221111 11111 11222
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ...+...+.+++.+||+.|+++||+++|+|+
T Consensus 491 ~-----~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 N-----PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred C-----ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1 1345678999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=338.44 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=199.4
Q ss_pred ChHHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce----------
Q 047195 284 SSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------- 351 (559)
Q Consensus 284 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------- 351 (559)
+.+++++..++..+.+.||+|.||+||+|+|.+ .||||.+..... +..+.|.+||.++++.+|.||
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 446777777888999999999999999999875 499999987654 456789999999999999995
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
|..++++.+||.+++.... .+.....++|++||++|+.||| .++|||||||..|||+.++++|||+|||
T Consensus 461 ~~AIiTqwCeGsSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 461 PLAIITQWCEGSSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ceeeeehhccCchhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccc
Confidence 4577899999999987653 5889999999999999999999 8999999999999999999999999999
Q ss_pred cceeccC--CCceeeeeccccCCccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 047195 428 LSRLALN--GASHVTTFAQGTLGYLDPEYYINF---QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502 (559)
Q Consensus 428 ~a~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 502 (559)
++..... +.... ....|...|||||++... +|+..+||||||+|+|||++|.-|+...+.+..+...
T Consensus 534 Latvk~~w~g~~q~-~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV------- 605 (678)
T KOG0193|consen 534 LATVKTRWSGEQQL-EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV------- 605 (678)
T ss_pred ceeeeeeecccccc-CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------
Confidence 9875432 11111 223388899999998743 6899999999999999999999999833332221110
Q ss_pred hcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 503 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..+- +.+ +.........+++.+|+..||..++++||++.+|+.+|+.++
T Consensus 606 GrG~----l~p----d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 606 GRGY----LMP----DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cccc----cCc----cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 0110 111 111112355678899999999999999999999999998864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=330.80 Aligned_cols=254 Identities=21% Similarity=0.246 Sum_probs=197.8
Q ss_pred HhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhh-HHHHHHHHHhcC-CCce----------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP-ILNEVRILCQLN-HRSL---------------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~-~~~E~~~l~~l~-h~ni---------------- 351 (559)
..++|.+.++||.|.||.||+|+ ...+..||||+++..-..+.+- =++|++.|++|+ ||||
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34679999999999999999999 5678899999998755443222 379999999999 9996
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+|||+ .+|++++... ...+++..+..|+.||++||+|+| .+|+.|||+||+|||+..+..+||+|||+|+.
T Consensus 88 VfE~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eHHhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccc
Confidence 456764 5889988764 247999999999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc------
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ------ 504 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 504 (559)
+.... ..+..+.|.+|+|||++.. .-|+.+.|+|++|||++|+.+-++.|.+.++-++...+-.+......
T Consensus 160 v~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 160 VRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 76433 3455568999999999865 56899999999999999999999999988776665544332221111
Q ss_pred chhhhcccccccc----CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 505 ERLVDAIDPMLKE----GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 505 ~~~~~~~d~~l~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
..+...++-.+.. ....+-.....+.++|+.+|+.+||.+|||+++.++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1122222211111 1111112356788999999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=299.23 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=193.5
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCC--hhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKG--IDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.+|...++||+|.||.||+|+ .+.++.||||+++..+.++ ....++|++.|+.++|+|| |.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999 5678999999998875542 2458999999999999994 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|++ .+|..++.... ..+...+++.++.++++||+||| .+.|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 875 36777775432 46889999999999999999999 88899999999999999999999999999998865
Q ss_pred CCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc--
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI-- 511 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 511 (559)
..... +..+-|.+|.|||.+.+. .|+..+||||.|||+.||+-|.+.|.+.++-++...+..+.....+..+.++.
T Consensus 154 p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 154 PNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 43332 223589999999999875 69999999999999999999999988777655544433322222222221110
Q ss_pred -ccc-cc----cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 512 -DPM-LK----EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 512 -d~~-l~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
|-. +. ......-........+|+..|+..||.+|+|++|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000 00 00000112334556899999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=320.56 Aligned_cols=239 Identities=33% Similarity=0.459 Sum_probs=189.6
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-----------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL-----------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----------------v~ 353 (559)
..+|...+.||+|+||.||++... ++...|||.+...+....+.+.+|+.+|.+++|||| +|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 346888899999999999999964 489999999887654446779999999999999985 46
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEeecccceec
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFGLSRLA 432 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~DFG~a~~~ 432 (559)
||+++|+|.+++..... .+++..++.+.+||++||+||| +++|+|+||||+|||++. ++.+||+|||+++..
T Consensus 96 Ey~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 89999999999987543 4999999999999999999999 899999999999999999 799999999999876
Q ss_pred cC--CCceeeeeccccCCccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 433 LN--GASHVTTFAQGTLGYLDPEYYINFQ-LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 433 ~~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
.. .........+||+.|||||++.+.. ...++|||||||+++||+||++||... .+ ...+.........
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~---~~~~~~~ig~~~~--- 240 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FE---EAEALLLIGREDS--- 240 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cc---hHHHHHHHhccCC---
Confidence 53 2222234456999999999998632 335999999999999999999999743 11 1111111111110
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.| .++...+....+++..|++.+|+.||||.++++.
T Consensus 241 --~P-------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 241 --LP-------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred --CC-------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 11 1222345677889999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=311.00 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=192.0
Q ss_pred HhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
..+.|++.+.||.|..++||+|+ ...+..||||++....-. ..+.+.+|+..|+.++|||| ||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 35689999999999999999999 566799999999876443 35889999999999999995 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
.||.+|++.+++...-.. .+.+..+..|++++++||.||| .+|.||||||+.||||+++|.|||+|||.+..+-
T Consensus 104 pfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred hhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999875543 3899999999999999999999 8999999999999999999999999999876543
Q ss_pred C-CCceee--eeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 434 N-GASHVT--TFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 434 ~-~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
. +..... ...+||+.|||||+++. ..|+.|+||||||++..||.+|+.||....+-. .+. ..+......
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl----~tLqn~pp~ 251 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLL----LTLQNDPPT 251 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHH----HHhcCCCCC
Confidence 2 222111 33469999999999654 369999999999999999999999997443221 011 111111000
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ......+........+.+++..||+.||++|||++++++
T Consensus 252 -~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 -LL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -cc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 001111112344468899999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=319.86 Aligned_cols=236 Identities=25% Similarity=0.359 Sum_probs=190.5
Q ss_pred HHhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecC---CCCChhhHHHHHHHHHhc-CCCce-------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG---NTKGIDPILNEVRILCQL-NHRSL------------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni------------- 351 (559)
.-.++|..++.||+|+|++|++|+ ...++.+|||++... ..+..+-+..|-.+|.+| +||-|
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345689999999999999999999 556899999997543 233445678899999999 78875
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
|++|.++|+|.++|.+.+ .+++...+.++.||+.||+||| ++|||||||||+|||||+++++||+|||.|
T Consensus 150 YFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccc
Confidence 568999999999999864 4999999999999999999999 899999999999999999999999999999
Q ss_pred eeccCCCce---------e-e--eeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 047195 430 RLALNGASH---------V-T--TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 430 ~~~~~~~~~---------~-~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~ 497 (559)
+.+...... . . ..-+||..|.+||++.+...+..+|+|+||||||+|+.|++||...++...
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------ 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------ 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------
Confidence 987532211 1 1 234599999999999999999999999999999999999999986653221
Q ss_pred HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 498 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+++.+. ++-.... ..++.+.+|+.+.|..||.+|+|.++|.+
T Consensus 296 FqkI~~-------l~y~fp~-------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 296 FQKIQA-------LDYEFPE-------GFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHH-------hcccCCC-------CCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 111111 1111122 22366788999999999999999988865
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=325.71 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=189.7
Q ss_pred hCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni------------ 351 (559)
.++|++.++||+|+||.||+|.. .++..||||++..... .....+.+|+.++.++ +||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45799999999999999999973 2346899999875432 2345689999999999 89984
Q ss_pred ----EEeeCCCCcHhHhHhhccCC--------------------------------------------------------
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSG-------------------------------------------------------- 371 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~-------------------------------------------------------- 371 (559)
+|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57999999999988753210
Q ss_pred -CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee-eeeccccCCc
Q 047195 372 -NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGY 449 (559)
Q Consensus 372 -~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y 449 (559)
...++++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++......... .....+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0134788889999999999999999 7899999999999999999999999999998654322211 1223367889
Q ss_pred cCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHH
Q 047195 450 LDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMK 528 (559)
Q Consensus 450 ~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 528 (559)
+|||++.+..++.++||||||+++|||++ |..||......+. .......+... ... .....
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~-----~~~-------~~~~~ 304 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRM-----RAP-------ENATP 304 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCC-----CCC-------CCCCH
Confidence 99999998899999999999999999997 9999875432211 11111111100 000 12235
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 529 AFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 529 ~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.+.+++.+||+.+|++|||+.||+++|++++
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=298.12 Aligned_cols=250 Identities=24% Similarity=0.237 Sum_probs=190.8
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCCh--hhHHHHHHHHHhcCCCce-----------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGI--DPILNEVRILCQLNHRSL-----------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~--~~~~~E~~~l~~l~h~ni-----------------v 352 (559)
++|+.+.+|++|+||.||+|+ .+++.+||+|+++....+.- -.-++||.+|.+.+|||| |
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 357888999999999999999 46789999999987654322 235899999999999996 4
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|+|++. +|..+++... +++...+++-+..|+++|++||| .+.|+||||||+|+|+++.|.+||+|||+|+.+
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 555543 4555555543 46899999999999999999999 888999999999999999999999999999988
Q ss_pred cCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc-
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA- 510 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 510 (559)
..... ..+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++.|.+....++.+.+........+.-+...
T Consensus 228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 76533 33455589999999999876 6999999999999999999999999988766655544332222111111111
Q ss_pred -------------cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 -------------IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 -------------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
--..++..+.... ..+.-.+|+..+|..||.+|-|+.|.++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~--lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALS--LSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccc--cchhHHHHHHHHhccCccccccHHHhhc
Confidence 1111222222111 3456678999999999999999999875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=310.63 Aligned_cols=233 Identities=30% Similarity=0.436 Sum_probs=190.5
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
..|...+.||+|.||.||+|.. +.++.||+|++.+... ...+++..|+.+|.+++++|| +|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3577789999999999999994 5678999999987644 446789999999999999984 6899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+.+|++.+.|+... .+.+..+..|.++++.|+.||| .++.+|||||+.|||+..+|.+||+|||.+-.....
T Consensus 93 ~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999997532 3577888889999999999999 889999999999999999999999999999887665
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
.....++ +|||.|||||++....|+.|+||||||++.+||.+|.+|+....+..-.. .+...--|.+
T Consensus 165 ~~rr~tf-vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L 231 (467)
T KOG0201|consen 165 VKRRKTF-VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRL 231 (467)
T ss_pred hhccccc-cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCcc
Confidence 5544444 49999999999998899999999999999999999999986443311100 0011111222
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+ .....+.+++..||..+|+.|||+.++++
T Consensus 232 ~~-------~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DG-------DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cc-------ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22 34467888999999999999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=304.62 Aligned_cols=255 Identities=24% Similarity=0.286 Sum_probs=194.2
Q ss_pred HHhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEee--cCCCCChhhHHHHHHHHHhcCCCceE--------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAK--LGNTKGIDPILNEVRILCQLNHRSLF-------------- 352 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~--~~~~~~~~~~~~E~~~l~~l~h~niv-------------- 352 (559)
.....|...+.||+|+||.|..+. ..++..||||++. ..+....++..+|+++|+.++|+||+
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344567778999999999999998 4578999999987 55666667899999999999999963
Q ss_pred ------EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 353 ------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 353 ------~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
+|+| ..+|..+++.. +.++...+..+.+|+++||.|+| +.+|+||||||+|+|++.+..+||+||
T Consensus 99 ~DvYiV~elM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccc
Confidence 3444 44566666543 24899999999999999999999 888999999999999999999999999
Q ss_pred ccceeccCC-CceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 047195 427 GLSRLALNG-ASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 427 G~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
|+|+..... .....+..+-|.+|.|||++.. ..|+...||||+|||+.||++|+..|.+.+...+..++........+
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 999987542 2223355668999999998865 57999999999999999999999999988776666655433322222
Q ss_pred chh--------hhccc---cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ERL--------VDAID---PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~~~--------~~~~d---~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+ ...+. +.-+..+...-........+|+.+||..||.+|+|++|.++
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 221 11111 11111111111223356678999999999999999999885
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=283.53 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=197.9
Q ss_pred hCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
.++|.+.++||+|||+-||+++ ..++..+|+|++...+.++.+..++|++..++++|||+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999998 67889999999999888888999999999999999993
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
+..|...|+|.+.++....+ ...+++.+.++|+.++++||++||... .++.||||||.|||+++.+.++|.|||.++
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 66888999999999875432 357999999999999999999999432 359999999999999999999999999987
Q ss_pred eccCC---Ccee-----eeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 047195 431 LALNG---ASHV-----TTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG 499 (559)
Q Consensus 431 ~~~~~---~~~~-----~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 499 (559)
...-. .... -.....|..|.|||.+. +...+.++|||||||+||+|+.|..||+..-.+...
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS------- 250 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS------- 250 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-------
Confidence 65321 1100 01123789999999875 346789999999999999999999999743222111
Q ss_pred HHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 500 NILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 500 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
....+....+....+ ..-++.+.+++++||+.||.+||++.+++..++.++
T Consensus 251 ------laLAv~n~q~s~P~~---~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 ------LALAVQNAQISIPNS---SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------EEEeeeccccccCCC---CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 001111222221111 114477899999999999999999999999998864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=302.21 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=186.5
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCceEE-------------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLFM------------------- 353 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 353 (559)
.|...+++|.|+||.||+|+.. .+..+|||++-....- -.+|+.+|+.+.|||||.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4666789999999999999954 5699999998654332 247999999999999753
Q ss_pred -eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC-CCEEEeeccccee
Q 047195 354 -SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGLSRL 431 (559)
Q Consensus 354 -~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~-~~~kl~DFG~a~~ 431 (559)
||++. +|++.+..... ....++...++-+..||++||+||| +.+|+||||||+|+|+|.+ |.+||+|||.|+.
T Consensus 101 leymP~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhchH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 44442 55666654211 1245777888899999999999999 7889999999999999965 8999999999999
Q ss_pred ccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh--
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV-- 508 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 508 (559)
...+..... ...|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+..++...+.........+.+.
T Consensus 176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 887665533 3478999999999886 69999999999999999999999999877665554444333222222211
Q ss_pred -----hccccccccCC-C-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 -----DAIDPMLKEGA-S-EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 -----~~~d~~l~~~~-~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+...+.++... . ........+..+|+.++|+.+|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11112222111 0 012334567889999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=289.97 Aligned_cols=221 Identities=26% Similarity=0.311 Sum_probs=182.3
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|+.++.||.|+||.|.+++. .++..+|+|++... ..+..+...+|..+|+.+.||.+ ||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4688999999999999999995 46789999998764 33556778999999999999974 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+|.++|.|+.++++.+ .+++..++.++.||+.||+||| +.+|++|||||+|||+|.+|.+||+|||.|+...
T Consensus 124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999998865 4999999999999999999999 7889999999999999999999999999999875
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.. +...+|||.|+|||+++...|..++|+||||+++|||+.|..||...++... ...+.++++
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-------Y~KI~~~~v------ 258 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-------YEKILEGKV------ 258 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-------HHHHHhCcc------
Confidence 43 4456799999999999999999999999999999999999999986654221 111111111
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCC
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNR 545 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 545 (559)
+ .+.-....+.+|+...|+.|-.+|
T Consensus 259 --~-----fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --K-----FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --c-----CCcccCHHHHHHHHHHHhhhhHhh
Confidence 0 011223556778888888888887
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=316.00 Aligned_cols=233 Identities=29% Similarity=0.362 Sum_probs=187.1
Q ss_pred HhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecC----CC-CChhhHHHHHHHHHhcC-CCce------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG----NT-KGIDPILNEVRILCQLN-HRSL------------ 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~----~~-~~~~~~~~E~~~l~~l~-h~ni------------ 351 (559)
....|.+.+.||+|+||+|++|. ..++..||+|.+... .. ...+.+.+|+.++++++ ||||
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 35689999999999999999997 456799999976553 11 23456778999999999 9994
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC-CCEEEeecc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFG 427 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~-~~~kl~DFG 427 (559)
||||..+|+|++.+... ..+.+..+..+++|++.|++|+| +++|+||||||+|||++.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 78999999999999872 24888999999999999999999 8899999999999999999 999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCC-CC-cccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQ-LT-DKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
++.... .........+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||+..+. ...... +..+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-i~~~ 238 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-IRKG 238 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-HhcC
Confidence 998774 2223344556999999999999877 86 689999999999999999999975221 111111 1111
Q ss_pred hhhhccccccccCCChhhHHH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDS-MKAFGLLGAACLDERRQNRPSIKEVA 552 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPt~~evl 552 (559)
.+ ..+... ...+..|+.+||..+|..|+|+.+++
T Consensus 239 ~~-------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EF-------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Cc-------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 10 011112 46788899999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=311.82 Aligned_cols=231 Identities=26% Similarity=0.370 Sum_probs=190.8
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. .++.+.+.+|++|++.++|||| |.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999954 56889999986643 3456679999999999999995 568
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|..+ +|+.+++... .++++.+..++.++..||.||| +++|+|||+||+|||++..+++|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 8776 9999998753 4999999999999999999999 88999999999999999999999999999998765
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
+ ....+.+.|||-|||||.+.+.+|+..+|.||+|||+||+++|++||.... ..........+
T Consensus 153 ~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d---------- 215 (808)
T KOG0597|consen 153 N-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD---------- 215 (808)
T ss_pred C-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC----------
Confidence 3 445566779999999999999999999999999999999999999996321 11111111111
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+.+....+..++...|..||..|.|..+++.
T Consensus 216 ----~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 ----PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11112355677888999999999999999998874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=310.49 Aligned_cols=231 Identities=27% Similarity=0.333 Sum_probs=185.0
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCc---------------eE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRS---------------LF 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~n---------------iv 352 (559)
.++|++++.||+|+||.||+++. ..|..+|+|+++..+. .....++.|-.+|....+++ ||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 47899999999999999999994 5689999999987643 44567899999999988876 47
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||.+||++..+|.... .|++..+..++.+++.||+-|| +.|+|||||||+|+|||..|++||+||||++-.
T Consensus 220 MEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchh
Confidence 89999999999998754 5999999999999999999999 888999999999999999999999999998532
Q ss_pred cC-----------------------CCc----e-------------------eeeeccccCCccCccccccCCCCcccch
Q 047195 433 LN-----------------------GAS----H-------------------VTTFAQGTLGYLDPEYYINFQLTDKSDV 466 (559)
Q Consensus 433 ~~-----------------------~~~----~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 466 (559)
.. +.. . .....+|||.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 000 0 0012349999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC
Q 047195 467 YSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP 546 (559)
Q Consensus 467 ~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 546 (559)
||||||+||||.|.+||....+.+....+......+..+. +.....+..+||.++|. ||++|.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~----------------~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE----------------EVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC----------------cCcccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999999988776654433332222111110 01222566788899999 999997
Q ss_pred C
Q 047195 547 S 547 (559)
Q Consensus 547 t 547 (559)
-
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 5
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.03 Aligned_cols=236 Identities=25% Similarity=0.345 Sum_probs=183.6
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++++++|+|+ |+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999985 578999999886532 2223457899999999999984 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.+.+..... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999888764322 25889999999999999999999 88899999999999999999999999999987543
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..........
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~-------- 221 (285)
T cd05631 155 GET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKEDQ-------- 221 (285)
T ss_pred CCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhccc--------
Confidence 221 223458999999999999899999999999999999999999997554322110 0111110000
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
..........+.+|+++||+.||++||+ ++++++
T Consensus 222 -----~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 -----EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -----ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0001123467888999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=306.54 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=185.3
Q ss_pred CCCCCCCccccCCccEEEEEEecC-----------------CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-----------------ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--- 351 (559)
++|.+.++||+|+||.||++.+++ +..+|+|.+..... ....++.+|++++.+++||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 34699998875432 234579999999999999984
Q ss_pred ------------EEeeCCCCcHhHhHhhccC--------------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEE
Q 047195 352 ------------FMSMSPNGTLFDRLHRVQS--------------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYH 405 (559)
Q Consensus 352 ------------v~~~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH 405 (559)
|+||+++++|.+++..... .....+++..+..++.|++.||.||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 6799999999998865321 11134788889999999999999999 788999
Q ss_pred CCCCCCCeeecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhC--CCC
Q 047195 406 RDIKSSNILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTS--KKA 482 (559)
Q Consensus 406 ~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg--~~p 482 (559)
|||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 12223467899999999888899999999999999999974 455
Q ss_pred CCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 483 VDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
+....... .............. .. ... .....+..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~-~~---~~~-----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGR-QV---YLF-----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhccc-cc---ccc-----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 54332211 11111111111000 00 000 001233678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=330.61 Aligned_cols=245 Identities=30% Similarity=0.406 Sum_probs=198.9
Q ss_pred hCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
..+....+.||+|+||+||+|+. ++...||||.++..... ..++|.+|+++|..|+||||
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 45567778999999999999984 35689999999887665 66789999999999999997
Q ss_pred --EEeeCCCCcHhHhHhhccCCC---------CCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGN---------WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~ 420 (559)
|.|||..|+|.++|....... ..+++..+.+.||.|||.|++||- ++.++||||..+|.||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence 459999999999997543221 234889999999999999999999 788999999999999999999
Q ss_pred EEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 047195 421 AKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYF 498 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 498 (559)
|||+||||++.......+ ......-..+||+||.++...+|.+||||||||+|||+++ |+.|+.+...++-
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------- 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------- 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------
Confidence 999999999865433222 2223335789999999999999999999999999999998 7888876654431
Q ss_pred HHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 499 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
......+++. ..+..++.++..|+..||+.+|++||+++||-.+|+.+
T Consensus 715 Ie~i~~g~lL------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 715 IECIRAGQLL------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HHHHHcCCcc------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 1222233221 11235668899999999999999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=294.40 Aligned_cols=256 Identities=21% Similarity=0.247 Sum_probs=185.9
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCC-C-hhhHHHHHHHHHhcCCCc-eEE---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTK-G-IDPILNEVRILCQLNHRS-LFM--------------- 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~-~-~~~~~~E~~~l~~l~h~n-iv~--------------- 353 (559)
..|+..++||+|+||+||+|+ ..+|+.||+|++...... . -...++|+.+|++|+|+| ||.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346667889999999999999 567899999999876552 2 245789999999999999 543
Q ss_pred ------eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 354 ------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 354 ------~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
||. ..+|..++....... ..++...+..+..||++||+||| +++|+||||||+||||+++|.+||+|||
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 332 235556665543211 24666889999999999999999 8999999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
+|+........ .+...+|.+|.|||++.+. .|+...||||+|||++||++++..|.+..+.++...+........+..
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99866533322 2334589999999999987 699999999999999999999999988776433322222111111111
Q ss_pred hhhcc-----cccccc-----CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 507 LVDAI-----DPMLKE-----GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 507 ~~~~~-----d~~l~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
+.... +..... ..............+++.+||+.+|.+|.|++.++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11110 100000 0000011122468889999999999999999999875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=304.84 Aligned_cols=253 Identities=21% Similarity=0.201 Sum_probs=185.8
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
++|++.+.||+|+||.||+++.+ +++.+|+|++.... ....+.+.+|++++++++|+|| |+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999965 57889999987543 2334568899999999999984 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|++++.+..+... . ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~~-~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-P----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-C----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9988766544332 1 25889999999999999999999 78899999999999999999999999999987644
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH---------hhcc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI---------LKQE 505 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---------~~~~ 505 (559)
..........|++.|+|||++.+..++.++||||||+++|||++|+.||......+........... ....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 3322223345899999999998888999999999999999999999999765432221111110000 0000
Q ss_pred hhhhccccccccCCC---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGAS---EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.......+....... .........+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000 000123467899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=314.83 Aligned_cols=247 Identities=27% Similarity=0.381 Sum_probs=188.1
Q ss_pred hCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhc-CCCce------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGN-TKGIDPILNEVRILCQL-NHRSL------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni------------ 351 (559)
.++|++.+.||+|+||.||+|++ ..+..+|||+++... ....+.+.+|+.+++.+ +||||
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44789999999999999999963 345689999986543 23345789999999999 89995
Q ss_pred ---EEeeCCCCcHhHhHhhccCC---------------------------------------------------------
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSG--------------------------------------------------------- 371 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~--------------------------------------------------------- 371 (559)
||||+++|+|.+++......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 57999999999988643210
Q ss_pred -------------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 372 -------------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 372 -------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
....+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0124788899999999999999999 788999999999999999999999999999866433221
Q ss_pred e-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 439 V-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 439 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
. .....++..|+|||++.+..++.++||||||+++|||++ |..||........ .......+.. ...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~~~-----~~~- 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEGYR-----MLS- 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhCcc-----CCC-
Confidence 1 122335678999999998899999999999999999998 7888764332111 1111111100 000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
+.....++.+|+.+||+.||++|||+.||+++|++.+
T Consensus 339 ------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~ 375 (375)
T cd05104 339 ------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375 (375)
T ss_pred ------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence 0012356889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=299.86 Aligned_cols=241 Identities=25% Similarity=0.387 Sum_probs=191.2
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.++|++.++||+|++|.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+|| ++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35789999999999999999998888889999876533 335789999999999999985 67889
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++..... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999875432 34788899999999999999999 7889999999999999999999999999998765433
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
........++..|+|||++....++.++||||||+++|||++ |+.||....... ...... .... .+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~~----~~~~ 226 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ----RGYR----MPRM 226 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCCC----CCCC
Confidence 222223346778999999988889999999999999999998 898986443221 111111 1000 0000
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 227 --------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 --------ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11235688899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.73 Aligned_cols=242 Identities=23% Similarity=0.349 Sum_probs=196.5
Q ss_pred hCCCCCCCccccCCccEEEEEEecCC-cEEEEEEeecCCCCChhhHHHHHHHHHhcC-CCce------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDE-TITAVKRAKLGNTKGIDPILNEVRILCQLN-HRSL------------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni------------------ 351 (559)
..++++.+.|.+|||+.||+|....+ ..+|+|++...+....+.+.+||.+|++|+ |+||
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 44678889999999999999997766 999999999988888899999999999997 9995
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
+|||+.+|.|.|+|...... .|++.++++|+.|+++|+++||.+ ..+|||||||-+||||+.+++.||||||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 46999999999999864432 399999999999999999999976 5789999999999999999999999999
Q ss_pred cceeccCCCcee--------eeeccccCCccCcccc---ccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 047195 428 LSRLALNGASHV--------TTFAQGTLGYLDPEYY---INFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496 (559)
Q Consensus 428 ~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~ 496 (559)
.|.-........ .....-|+-|+|||++ .+...++|+|||+|||+||-|.....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 986432211100 0112268999999986 4678999999999999999999999999744221
Q ss_pred HHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 497 YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 497 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.+++....- .. ...-...|..||+.||+.+|++||++-+|++.+.+|.
T Consensus 265 ------------aIlng~Y~~--P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 265 ------------AILNGNYSF--PP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ------------eEEeccccC--CC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 111111111 10 1245578999999999999999999999999988763
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=304.71 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=183.4
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.++||+|+||.||+|..+ ++..+|+|.++.... .....+.+|+.++++++|+|| |+||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46999999999999999999854 678999999875433 233568899999999999995 5677
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
++ ++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 76 48888776432 24788999999999999999999 889999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc---------
Q 047195 436 ASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE--------- 505 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 505 (559)
... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+...............
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 TKT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred Ccc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 221 122348999999998865 468899999999999999999999997654433222111111000000
Q ss_pred hhhhccccccccC-CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEG-ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.....+..... .............+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0111111100000 00000112356788999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.72 Aligned_cols=230 Identities=27% Similarity=0.372 Sum_probs=188.8
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCC---hhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKG---IDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.+|++.+.||+|.||+|-+|. ...|+.||||.++....++ +-.+.+|++||+.|+|||| ||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 358888999999999999998 5789999999987765444 3458899999999999994 79
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||..+|.|++++...+ .+++.++..+++||..|+.|+| .++++|||||.+|||+|+++++||+|||++.++.
T Consensus 133 EYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999998754 4999999999999999999999 8999999999999999999999999999998876
Q ss_pred CCCceeeeeccccCCccCccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLT-DKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.+. ..+..+|+|-|.+||++.+.+|. +.+|-||||++||.|+.|..||++.+... ++. .+..+
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvr----QIs~G------- 268 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVR----QISRG------- 268 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHH----Hhhcc-------
Confidence 543 33445699999999999998874 68999999999999999999998664221 111 11111
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...+ .+.+....-||++||..+|++|.|+.+|+.
T Consensus 269 -aYrE------P~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 269 -AYRE------PETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -cccC------CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 1111 112233456899999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.35 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=180.9
Q ss_pred CCCCCCCccccCCccEEEEEEe--cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhc---CCCceE-------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL--DDETITAVKRAKLGNT--KGIDPILNEVRILCQL---NHRSLF------------- 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv------------- 352 (559)
++|++.+.||+|+||.||+|+. .+++.+|+|.+..... .....+.+|+.+++++ +||||+
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4689999999999999999985 3468899998875432 2234577888888776 699863
Q ss_pred -------EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 353 -------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 353 -------~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
+||+. ++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 34554 577777765332 34889999999999999999999 78899999999999999999999999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...............
T Consensus 154 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 154 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred ccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 9999865433 12233458999999999988889999999999999999999999997654433221111110000000
Q ss_pred hhhhc---cccccc----cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDA---IDPMLK----EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~---~d~~l~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+... ....+. .............+.+|+.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000 0000111123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=314.63 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=187.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni------------ 351 (559)
.++|++.+.||+|+||.||+++. .++..||+|++..... .....+.+|+++++.+ +|+||
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34789999999999999999873 2335799999875432 2345688999999999 89985
Q ss_pred ---EEeeCCCCcHhHhHhhccC----------------------------------------------------------
Q 047195 352 ---FMSMSPNGTLFDRLHRVQS---------------------------------------------------------- 370 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~---------------------------------------------------------- 370 (559)
|+||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 5689999999998864221
Q ss_pred -------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee-eee
Q 047195 371 -------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-TTF 442 (559)
Q Consensus 371 -------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~ 442 (559)
....++++..+.+++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01124788889999999999999999 8899999999999999999999999999998654432211 122
Q ss_pred ccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 443 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
..++..|+|||++.+..++.++||||||+++|||++ |+.||........ ........ . .....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~-~----~~~~~----- 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRG-Y----QMSRP----- 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcc-c----CccCC-----
Confidence 235678999999988899999999999999999997 9999864432111 01111110 0 00000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
...+..+.+++.+||+.+|++|||+.+|+++|++++
T Consensus 338 --~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 --DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 012356888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=300.54 Aligned_cols=241 Identities=20% Similarity=0.299 Sum_probs=187.9
Q ss_pred CCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCc---------------eE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRS---------------LF 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~n---------------iv 352 (559)
++|++.+.||+|+||.||+|.++ .+..+|+|.++.... .....+.+|+.++++++||| +|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999753 356899999876533 23356899999999999999 47
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +++++||||||+|||++.++.+|++|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 89999999999886532 25889999999999999999999 888999999999999999999999999987654
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . ........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~----~~~~~~~~---- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---I----KAVEDGFR---- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H----HHHHCCCC----
Confidence 3222111112235678999999988899999999999999999875 9999875432211 1 11111100
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
... ....+..+.+++.+||+.+|++|||+.+|++.|++++
T Consensus 227 -~~~-------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~ 266 (266)
T cd05064 227 -LPA-------PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266 (266)
T ss_pred -CCC-------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence 000 1123467888999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.95 Aligned_cols=241 Identities=25% Similarity=0.358 Sum_probs=189.7
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc---------------eEEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~ 356 (559)
.+|++.+.||+|+||.||+|..+ .+..+|+|.+... ....+++.+|++++++++|+| +++||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35788899999999999999854 5788999987643 334567999999999999998 468999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++..... ..+++..+..++.|+++||+||| +++++||||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 85 TYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999998865322 35889999999999999999999 7889999999999999999999999999998765433
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
........++..|+|||.+.+..++.++||||||+++|||++ |..|+......+ .. ...... .....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~-~~~~~~-----~~~~~ 226 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VY-ELLEKG-----YRMER 226 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-HHHHCC-----CCCCC
Confidence 222222234678999999988889999999999999999998 888886443211 11 111110 00001
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
+...+..+.+++.+||+.+|++|||+.+++++|+.++
T Consensus 227 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 227 -------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred -------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 1123467888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.82 Aligned_cols=230 Identities=21% Similarity=0.287 Sum_probs=182.0
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCCCC---hhhHHHHHHHHHhcCCCce-------------------EEeeC
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG---IDPILNEVRILCQLNHRSL-------------------FMSMS 356 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni-------------------v~~~~ 356 (559)
..||+|+++.||+|.. +++.||||.++...... .+.+.+|+.+|++++|||| |+||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999987 57899999987654433 4667899999999999984 56889
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+++... ..+++.....++.|++.||.|||. ..+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999998753 248899999999999999999993 2478899999999999999999999999988654321
Q ss_pred ceeeeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ......... ...
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~------~~~i~~~~~-----~~~ 242 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI------YDLIINKNN-----SLK 242 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCC-----CCC
Confidence 12348899999999876 5789999999999999999999999975432211 111100100 000
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+ +......+.+++.+||+.||++|||++||++.|+.+
T Consensus 243 ~-------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 243 L-------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C-------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1 112346788999999999999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.01 Aligned_cols=237 Identities=24% Similarity=0.366 Sum_probs=186.7
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSP 357 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~ 357 (559)
++|++.+.||+|+||.||++.++++..+|+|.+.... ...+++.+|++++++++|||| |+||.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4588889999999999999998888889999876433 334679999999999999984 679999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+|+|.+.+.... ..+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999886532 24889999999999999999999 78899999999999999999999999999886543322
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ... ...... ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~----i~~~~~--~~~~~-- 224 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEM----ISRGFR--LYRPK-- 224 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHCCCC--CCCCC--
Confidence 22222235678999999988889999999999999999999 8888864432211 111 111100 00011
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.....+.+++.+||+.+|++|||+.+++++|.
T Consensus 225 --------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 --------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12256889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=304.81 Aligned_cols=229 Identities=24% Similarity=0.295 Sum_probs=183.3
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCc---------------eEE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRS---------------LFM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~n---------------iv~ 353 (559)
++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||| +|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999964 68899999986532 233456889999999999998 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 9999999999987532 4888999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .. .......
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~-~i~~~~~------ 215 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YE-KILAGKL------ 215 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHHhCCc------
Confidence 322 123489999999999988899999999999999999999999975432111 11 1111100
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
.+. ......+.+|+++||+.||.+||+ +.|+++
T Consensus 216 ~~~-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 EFP-------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCC-------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 011 112356788999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.37 Aligned_cols=236 Identities=24% Similarity=0.357 Sum_probs=195.3
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCc----------------eEE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRS----------------LFM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~n----------------iv~ 353 (559)
++|..++++|+|+||.+++.++ .+...+++|.+..... ...+...+|+.+++++.||| |||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5789999999999999999884 4567899999877543 33456899999999999999 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+|++||++.+.+..... ..++++.+.+++.|++.|+.||| ++.|+|||||++|||++.+..|||.|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999988663 35899999999999999999999 7889999999999999999999999999999876
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... ......||+.||.||.+.+.+|..|+|||||||++|||.+-+++|...+-... ...+- ...+
T Consensus 158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i~ki~--------~~~~-- 223 (426)
T KOG0589|consen 158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---ILKIN--------RGLY-- 223 (426)
T ss_pred Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---HHHHh--------hccC--
Confidence 6542 34445699999999999999999999999999999999999999975543221 11111 0111
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
...+.....++..++..||+.+|+.||++.+++.+
T Consensus 224 ------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 ------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12223345678899999999999999999999875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.11 Aligned_cols=243 Identities=28% Similarity=0.335 Sum_probs=190.2
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCc---------------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRS--------------- 350 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~n--------------- 350 (559)
....++|.+.+.||+|+||+||+++. .+++.+|||.+..... .....+.+|+.++..++|+|
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999984 5789999999876432 33456889999999998876
Q ss_pred --------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEE
Q 047195 351 --------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAK 422 (559)
Q Consensus 351 --------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~k 422 (559)
+|+||+++|+|.+.+..... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence 35688999999998875332 2246889999999999999999999 88999999999999999999999
Q ss_pred EeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 423 ISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 423 l~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
|+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~~~ 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHKT 257 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH
Confidence 999999987543221 12233459999999999999899999999999999999999999996443211 11111
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
. ... .++ .+......+.+++.+||+.+|++|||+.++++.
T Consensus 258 ~-~~~----~~~--------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 L-AGR----YDP--------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred h-cCC----CCC--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 110 011 111234678899999999999999999999863
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=295.82 Aligned_cols=240 Identities=28% Similarity=0.401 Sum_probs=190.0
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EEeeCC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FMSMSP 357 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~ 357 (559)
.++|++.++||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|+ +++|++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecC
Confidence 357899999999999999999988888899999875433 34679999999999999984 679999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++..... ..+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 84 KGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999875322 34889999999999999999999 78899999999999999999999999999987644322
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .... +... .....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----~~~~-----~~~~~- 224 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ----VERG-----YRMPC- 224 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcC-----CCCCC-
Confidence 22222235678999999988889999999999999999999 888886432211 1111 1100 00000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
+......+.+++.+||+.+|++|||+.++.+.|++
T Consensus 225 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 ------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11234678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=313.27 Aligned_cols=227 Identities=26% Similarity=0.352 Sum_probs=184.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcC-CCce---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLN-HRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~-h~ni--------------- 351 (559)
.++|.++++||+|.||+|+++.. .+++.+|||.++... ..+.+....|.+|+...+ ||.|
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46899999999999999999995 457899999998764 345667889999998876 8864
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||||..||++..+.+. ..+++..+..++..|+.||.||| .++||+||||.+|||||.+|++||+|||+++.
T Consensus 447 vmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccc
Confidence 8999999994444332 24899999999999999999999 89999999999999999999999999999997
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
...... .+....|||.|||||++.+..|+..+|+|||||+||||+.|+.||.++++++.-+. ...+
T Consensus 518 ~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds------I~~d------- 583 (694)
T KOG0694|consen 518 GMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS------IVND------- 583 (694)
T ss_pred cCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HhcC-------
Confidence 653333 33445699999999999999999999999999999999999999997765442111 1111
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
|+. .+..++.+...+++++|..+|++|.-+
T Consensus 584 ~~~-------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVR-------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCC-------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 011 122445778889999999999999866
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=296.15 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=191.2
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EEeeCC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FMSMSP 357 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~ 357 (559)
.++|++.++||+|+||.||+|+.++...+|+|++..... ..+.+.+|++++++++|+|| |++|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 356899999999999999999987777899999875333 34678999999999999984 678999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++..... ..+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 84 KGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999875322 24789999999999999999999 78899999999999999999999999999986654332
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||......+. . . ..... ....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~---~-~~~~~-----~~~~-- 223 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L---D-QVERG-----YRMP-- 223 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---H---H-HHhcC-----CCCC--
Confidence 22223346778999999988889999999999999999999 7778764432111 0 0 00000 0000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.....+..+.+++.+|++.+|++|||++++++.|++.+
T Consensus 224 -----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 -----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -----CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 01234467889999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=299.55 Aligned_cols=241 Identities=26% Similarity=0.364 Sum_probs=194.1
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc---------------eEEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~ 356 (559)
..+|++.++||.|+||.||+|...++..+++|.+..........+.+|+.+++.++|+| +|+||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45689999999999999999998889999999988776656678999999999999998 478999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++..... ..+++..+..++.|++.||+||| +++++|+||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 85 EKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999976432 35889999999999999999999 7889999999999999999999999999997654332
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
... ....++..|+|||.+....++.++||||||+++|+|++ |+.||......+. ..... .. . ....
T Consensus 159 ~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~----~~-~----~~~~ 225 (261)
T cd05148 159 YLS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQIT----AG-Y----RMPC 225 (261)
T ss_pred ccc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHH----hC-C----cCCC
Confidence 211 12336778999999988889999999999999999998 7888864432111 11111 10 0 0000
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 226 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 -------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 112336688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.73 Aligned_cols=244 Identities=27% Similarity=0.378 Sum_probs=189.8
Q ss_pred CCCCCCCccccCCccEEEEEEecCC------cEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDE------TITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
++|++.+.||+|+||.||+|..... ..+|+|.+..... ...+.+.+|+.++++++||||
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4688999999999999999985332 5789998865432 234568999999999999984
Q ss_pred -EEeeCCCCcHhHhHhhccCCCC-----------CCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNW-----------PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL 419 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~ 419 (559)
++||+++++|.+++........ ..+++..+..++.|++.||+||| .++++|+||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 6789999999999876432111 35788899999999999999999 78899999999999999999
Q ss_pred CEEEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 047195 420 DAKISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 420 ~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~ 497 (559)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------ 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 999999999986543221 12223346889999999988889999999999999999998 9999875433211
Q ss_pred HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 498 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
...+...... ......+.++.+|+.+||+.+|.+|||+.||+++|+++
T Consensus 236 -~~~i~~~~~~------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 -IEMIRSRQLL------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHHHcCCcC------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111111110 01123457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=296.23 Aligned_cols=241 Identities=26% Similarity=0.372 Sum_probs=190.0
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.++|++.+.||+|++|.||+|..+++..+|+|.++... ...+++.+|++++++++|+|+ ++||.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688999999999999999998788889999987543 334679999999999999984 57888
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++.... ...+++..+..++.|++.||.||| +++++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 84 KYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999987543 135899999999999999999999 7889999999999999999999999999998765332
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
.........+..|+|||++.+..++.++||||||+++|||++ |+.||....... ... ..... .. ...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~-~~----~~~ 225 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQG-YR----MPC 225 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcC-CC----CCC
Confidence 221121223467999999988889999999999999999999 888886433211 110 11010 00 000
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.......+.+++.+||+.+|++||++.+++++|+++
T Consensus 226 -------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 -------PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 112336788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=309.21 Aligned_cols=226 Identities=26% Similarity=0.331 Sum_probs=178.5
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g 359 (559)
+.||+|+||.||++.. .+++.+|+|+++... ......+.+|+.++++++|||| ||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 568899999987532 2334568899999999999984 78999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
+|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 151 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT- 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc-
Confidence 999888753 25889999999999999999999 888999999999999999999999999998754322211
Q ss_pred eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCC
Q 047195 440 TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGA 519 (559)
Q Consensus 440 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 519 (559)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .. ...... ..+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~-~~~~~~------~~~p--- 215 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FE-LILMEE------IRFP--- 215 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH------HH-HHHcCC------CCCC---
Confidence 2234599999999999988999999999999999999999999964332110 00 000000 0111
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 520 SEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 520 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 ----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12336678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.21 Aligned_cols=246 Identities=22% Similarity=0.226 Sum_probs=178.8
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCceE---------------EeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF---------------MSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~niv---------------~~~~ 356 (559)
.+|++.+.||+|+||.||++.. ..++.+|+|... .+.+.+|++++++++||||| +++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5799999999999999999985 567899999643 24578999999999999963 4554
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
.++|...+... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 166 -~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 166 -KTDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred -CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 46777776542 24889999999999999999999 7889999999999999999999999999997543322
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcccc----ccHHHHHHHHhhc--------
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEED----VNLVVYFGNILKQ-------- 504 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~-------- 504 (559)
........||+.|+|||++.+..++.++||||||+++|||++|+.|+........ .............
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 2222334599999999999888999999999999999999999988754321110 0111111110000
Q ss_pred --chhhhcc----ccccc--cCC--ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 --ERLVDAI----DPMLK--EGA--SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 --~~~~~~~----d~~l~--~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.... ..... ... ..........+.+|+.+||+.||++|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000 000 0011234567889999999999999999999985
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=295.29 Aligned_cols=241 Identities=27% Similarity=0.384 Sum_probs=192.1
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EEeeCC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FMSMSP 357 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~ 357 (559)
.++|++.++||+|+||.||+|..++++.+|+|.+..... ..+++.+|+.++++++|+|+ +++|+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 457899999999999999999988889999998875433 34679999999999999984 678899
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++..... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 84 NGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999998865332 35889999999999999999999 88899999999999999999999999999977653322
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.......++..|+|||++....++.++||||||+++|||++ |+.||......+. .. .+.... .....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~-----~~~~~ 225 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ----NLERGY-----RMPRP 225 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH----HHHcCC-----CCCCC
Confidence 22223346788999999988889999999999999999999 9999864432111 00 111100 00000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.....++.+++.+||+.+|++|||++++++.|+.+
T Consensus 226 -------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 226 -------DNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred -------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 12235789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=310.65 Aligned_cols=238 Identities=23% Similarity=0.308 Sum_probs=186.8
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++.+++|+|| |+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999965 57899999987542 2334568899999999999984 68
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++... ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999999653 24889999999999999999999 7889999999999999999999999999997654
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....... + ...+..
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~-----~~~~~~ 219 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY----W-----KETLQR 219 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh----c-----cccccC
Confidence 3 12234589999999999988999999999999999999999999975443221111100 0 000000
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.. ...........+.+++.+||+.+|++|||+.++++.
T Consensus 220 ~~---~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PV---YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CC---CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 000002334678889999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.41 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=180.4
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
+|++.+.||+|+||.||+|+. .++..+|||++... .......+.+|++++++++||||
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999985 46899999988643 22334568999999999999985
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|+||+. ++|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 456664 6777777542 24889999999999999999999 7889999999999999999999999999998
Q ss_pred eccCCCce--eeeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH-------
Q 047195 431 LALNGASH--VTTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG------- 499 (559)
Q Consensus 431 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~------- 499 (559)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||................
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 65322211 1123458999999999865 578899999999999999999999997554322111110000
Q ss_pred -HHhhcchhhhccccccc---cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 500 -NILKQERLVDAIDPMLK---EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 500 -~~~~~~~~~~~~d~~l~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...........++.... ......-......+.+++.+||+.+|++|||++|+++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000000000 0000000012356788999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=298.75 Aligned_cols=243 Identities=26% Similarity=0.357 Sum_probs=189.8
Q ss_pred CCCCCCCccccCCccEEEEEEecC------CcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce--------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD------ETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
++|.+.+.||+|+||.||+|...+ ...+|+|.++..... ..+.+.+|+++++.++|+|+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998633 478999998765443 34689999999999999983
Q ss_pred -EEeeCCCCcHhHhHhhccC---------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCE
Q 047195 352 -FMSMSPNGTLFDRLHRVQS---------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~ 421 (559)
++||+++++|.+++..... .....+++..+..++.|++.||.||| +++++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 6899999999999976421 12245788999999999999999999 8889999999999999999999
Q ss_pred EEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 047195 422 KISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFG 499 (559)
Q Consensus 422 kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 499 (559)
||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH-
Confidence 9999999976533221 11223336788999999999899999999999999999998 9999864433221 1111
Q ss_pred HHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 500 NILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 500 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
..+... .........+.+++++||+.+|++|||+.||+++|++
T Consensus 238 ---~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 ---TQGRLL------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---HcCCcC------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111100 0011233678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=297.78 Aligned_cols=238 Identities=24% Similarity=0.272 Sum_probs=181.1
Q ss_pred HHhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCC--------------CChhhHHHHHHHHHhcCCCce---
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNT--------------KGIDPILNEVRILCQLNHRSL--- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--- 351 (559)
+..++|++.+.||+|.||.|-+|. ..+++.+|||++..... ...+...+||.||+++.|+|+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 446789999999999999999999 46789999999864311 123578999999999999996
Q ss_pred --------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC
Q 047195 352 --------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE 417 (559)
Q Consensus 352 --------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~ 417 (559)
|.||+..|.+...-. ....+.+.+++++++++..||+||| .++||||||||+|+||++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcC
Confidence 446666665432111 1122889999999999999999999 899999999999999999
Q ss_pred CCCEEEeecccceeccCCCc----eeeeeccccCCccCccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCCcc
Q 047195 418 KLDAKISDFGLSRLALNGAS----HVTTFAQGTLGYLDPEYYINFQ----LTDKSDVYSFGVVLVELLTSKKAVDFNREE 489 (559)
Q Consensus 418 ~~~~kl~DFG~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~il~el~tg~~p~~~~~~~ 489 (559)
+|++||+|||.+.....+.. .......|||.|+|||...+.. .+.+.||||+|++||.|+.|+-||..+...
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 99999999999987632211 1112356999999999987632 356889999999999999999999744321
Q ss_pred ccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 490 EDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+ ....+++..|.-... .+..+.+.+|+++||..||+.|.+..+|..
T Consensus 326 ~---------------l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 326 E---------------LFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred H---------------HHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 1 112233333322111 144577889999999999999999999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=306.70 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=188.8
Q ss_pred hCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni------------ 351 (559)
.++|++.+.||+|+||.||+|... .++.||+|++..... ...+.+.+|+.++.++ +|+||
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 347999999999999999999632 247899998865432 2335688999999999 78874
Q ss_pred ----EEeeCCCCcHhHhHhhccCC--------------------------------------------------------
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSG-------------------------------------------------------- 371 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~-------------------------------------------------------- 371 (559)
+++|+++++|.+.+......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 57899999999888643210
Q ss_pred CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee-eeeccccCCcc
Q 047195 372 NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYL 450 (559)
Q Consensus 372 ~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~ 450 (559)
....+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0126789999999999999999999 8899999999999999999999999999998764332222 12234677899
Q ss_pred CccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHH
Q 047195 451 DPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKA 529 (559)
Q Consensus 451 aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 529 (559)
|||++.+..++.++|||||||++|||++ |+.||......+. .......... ... +.....+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~-----~~~-------~~~~~~~ 304 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTR-----MRA-------PEYATPE 304 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCC-----CCC-------CccCCHH
Confidence 9999999999999999999999999998 9999865332211 1111111100 000 0122356
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 530 FGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 530 l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
+.+++.+||+.+|++||++.||+++|++++
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=302.88 Aligned_cols=240 Identities=24% Similarity=0.385 Sum_probs=186.5
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCc----EEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DET----ITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
.+|++.+.||+|+||.||+|++. ++. .+|+|.++.... ...+++.+|+.+++.++|+|| +
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46999999999999999999853 333 389998865432 334679999999999999995 5
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++|+++|+|.+.+.... ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 87 TQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccc
Confidence 68889999999987532 24788899999999999999999 888999999999999999999999999999876
Q ss_pred cCCCceee-eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASHVT-TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
........ ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ . .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~--- 229 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGER--- 229 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHhCCCC---
Confidence 54333222 12224678999999998899999999999999999998 999986432211 0 111111100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+.. .......+.+++.+||+.+|++|||+.++++.|..+
T Consensus 230 ----~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 230 ----LPQ-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ----CCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 011225678899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=293.49 Aligned_cols=241 Identities=26% Similarity=0.406 Sum_probs=188.7
Q ss_pred CCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
++|++.+.||+|+||+||+|.+. +...+|||.+..... ....++.+|+.++++++|+|| +
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56899999999999999999864 245789998765433 234578999999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+|+||||+|||+++++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 79999999999986532 25889999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~----~~~~~~~---- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VI----KAVEDGY---- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HH----HHHHcCC----
Confidence 522222 1222335678999999988889999999999999999998 888885332111 11 1111100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..+. ....+..+.+++.+||+.+|++||++.||+++|++++
T Consensus 226 ~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 226 RLPP--------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCC--------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0000 1123366889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=298.55 Aligned_cols=244 Identities=28% Similarity=0.369 Sum_probs=189.7
Q ss_pred CCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
.+|.+.+.||+|+||+||++.. .++..+|+|.+........+.+.+|++++++++|+||
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4688899999999999999974 2345688998876555556679999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccC--------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 FMSMSPNGTLFDRLHRVQS--------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
++||+++++|.+++..... .....+++..+..++.|++.||+||| +++++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 6799999999998865321 12235899999999999999999999 888999999999999999999999
Q ss_pred eecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 047195 424 SDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-------~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------IEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH
Confidence 999999865432221 1122335778999999988889999999999999999998 8888864432211 111
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
...+.... ... .....+.+++.+||+.+|.+|||+.||++.|+++
T Consensus 235 i~~~~~~~-----~~~-------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 235 ITQGRVLQ-----RPR-------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHcCCcCC-----CCC-------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11111100 001 1235689999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=302.33 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=186.3
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.++|++.+.||+|+||.||+++.. ++..+|+|.+..... ...+.+.+|+++|++++|+|| |+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999964 578899998876432 234579999999999999984 689
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999987532 48889999999999999999993 23699999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc---------
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE--------- 505 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 505 (559)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...........
T Consensus 157 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred cc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccccCCccccC
Confidence 22 1233589999999999988899999999999999999999999964432111 00000000000
Q ss_pred ---------------------hhhhccccccccCCChh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 506 ---------------------RLVDAIDPMLKEGASEI-ELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 506 ---------------------~~~~~~d~~l~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
...+..+.......... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000000 01234678999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=299.66 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=181.0
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.++|++.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+.++++++|||| |+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999965 688999999875433 223467899999999999994 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+. ++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 875 67777775432 24788899999999999999999 88899999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch---hh--
Q 047195 435 GASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER---LV-- 508 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 508 (559)
... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .............. +.
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 156 PSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred CCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccch
Confidence 221 1223448999999999865 457889999999999999999999997543211 11111111100000 00
Q ss_pred ---hccccc-ccc-CCChhh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 ---DAIDPM-LKE-GASEIE-----LDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ---~~~d~~-l~~-~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...++. ... ...... ......+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 000 000000 011245778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=294.31 Aligned_cols=243 Identities=24% Similarity=0.375 Sum_probs=185.3
Q ss_pred CCCCCccccCCccEEEEEEecCC---cEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce------------------
Q 047195 295 FSTGNLLGSGGFGEVFKAILDDE---TITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~~~---~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
|.+.+.||+|+||.||+|...+. ..+|+|.++... ....+.+.+|+++++.++|+||
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 45678999999999999986543 258899876542 3335678999999999999884
Q ss_pred ---EEeeCCCCcHhHhHhhccC-CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQS-GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
+++|+++|+|.+.+..... .....+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 4578888999887754321 22235889999999999999999999 7899999999999999999999999999
Q ss_pred cceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 428 LSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 428 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... . .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I----YDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcC
Confidence 998765432211 122236778999999988889999999999999999999 788886432211 1 1111111
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.... . .......+.+++.+||+.+|++|||+.+|++.|++++
T Consensus 231 ~~~~-----~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 231 NRLK-----Q-------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCCC-----C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1000 0 1123356889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.50 Aligned_cols=231 Identities=29% Similarity=0.380 Sum_probs=188.9
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.-|++++-||.|+.|.|-+|+ ...|+.+|||++.... ......+.+|+.||+-+.|||+ |.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 348889999999999999999 4679999999987652 2224568899999999999994 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|.|++++-... ++++.++.++++||+.|+.|+| ..+|+||||||+|+|||..+++||+|||+|.+-.
T Consensus 92 Eyv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999997643 5999999999999999999999 6679999999999999999999999999998755
Q ss_pred CCCceeeeeccccCCccCccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLT-DKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.+. .....+|+|.|.|||++.+.+|+ .++||||.|+|||.|+||+-||+.++-. .+..... .+
T Consensus 164 ~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlKV~----~G------- 227 (786)
T KOG0588|consen 164 PGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLKVQ----RG------- 227 (786)
T ss_pred CCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHHHH----cC-------
Confidence 433 23445699999999999999885 6999999999999999999999844321 1111111 11
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+ +.+...+.+..+|+++||..||+.|.|++||++
T Consensus 228 -----~f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 228 -----VF-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -----cc-cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 11 112344567889999999999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.82 Aligned_cols=228 Identities=25% Similarity=0.299 Sum_probs=182.2
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||.||+++.+ +++.+|+|.+... .....+.+.+|+.++++++|||| |+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999964 5789999998653 22345678999999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999887532 4788899999999999999999 8889999999999999999999999999998664
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... ...||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........+
T Consensus 170 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~------ 232 (329)
T PTZ00263 170 DRTF----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGRL------ 232 (329)
T ss_pred CCcc----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCCc------
Confidence 3221 23589999999999988899999999999999999999999964432110 111111110
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVA 552 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl 552 (559)
.+. ......+.+|+.+||+.||++||+ +.+++
T Consensus 233 ~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 233 KFP-------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCC-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 000 112256788999999999999997 56665
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=272.64 Aligned_cols=233 Identities=27% Similarity=0.355 Sum_probs=189.0
Q ss_pred hCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++++.||+|-||.||+|+ .+++..||+|++.... ..-.+++.+|++|.+.|+|||| +
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3579999999999999999999 5678899999986542 2334679999999999999995 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||..+|+++..|..... ..+++.....+..|+|.|+.|+| .++||||||||+|+|++.++.+||+|||.+-..
T Consensus 101 lEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 799999999999985443 34788888999999999999999 889999999999999999999999999998654
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.. .......||..|.+||...+..++.++|+|++|++.||++.|.+||+.....+. .+.+.. .+..+
T Consensus 175 p~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-------YkrI~k---~~~~~ 241 (281)
T KOG0580|consen 175 PS---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-------YKRIRK---VDLKF 241 (281)
T ss_pred CC---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-------HHHHHH---ccccC
Confidence 32 222334599999999999999999999999999999999999999975442211 111111 11111
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
| ........+++.+|+..+|.+|.+..|+++
T Consensus 242 p----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 P----------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred C----------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1 233466788999999999999999999886
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.32 Aligned_cols=226 Identities=27% Similarity=0.329 Sum_probs=178.5
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCc---------------eEEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRS---------------LFMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~~~g 359 (559)
+.||+|+||.||++.. .+++.+|+|++... .......+.+|+++++.++||| |||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999998753 2334467889999999999998 478999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
+|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 151 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T 151 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-c
Confidence 998888653 24889999999999999999999 88899999999999999999999999999875432221 1
Q ss_pred eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCC
Q 047195 440 TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGA 519 (559)
Q Consensus 440 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 519 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..... .. +..+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~-~~------~~~~p--- 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELIL-ME------DIKFP--- 215 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhc-cC------CccCC---
Confidence 2234599999999999888899999999999999999999999964432111 00000 00 00111
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 520 SEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 520 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 216 ----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred ----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 12335678899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.86 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=187.2
Q ss_pred CCCCCccccCCccEEEEEEecC----CcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 295 FSTGNLLGSGGFGEVFKAILDD----ETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~~----~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
|++.+.||+|+||.||+|.... ...+|+|+++.... ...+.+.+|++.++.++|+|+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998642 36799999875432 334678999999999999985
Q ss_pred ----EEeeCCCCcHhHhHhhccCC-CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSG-NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
+++|+++++|...+...... ....+++..+..++.|++.||+||| +++++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 45788899999888654322 2246899999999999999999999 788999999999999999999999999
Q ss_pred ccceeccCCCceee-eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhc
Q 047195 427 GLSRLALNGASHVT-TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 427 G~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
|+++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~----~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYD----YLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHc
Confidence 99987653322211 11235678999999988889999999999999999999 888886433211 111 1111
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
... ...+......+.+++.+||+.+|++|||+.||++.|++++
T Consensus 231 ~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 231 GNR------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CCC------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 100 0011223467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.07 Aligned_cols=225 Identities=25% Similarity=0.343 Sum_probs=176.0
Q ss_pred cccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcH
Q 047195 301 LGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FMSMSPNGTL 361 (559)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L 361 (559)
||+|+||.||+++.. +++.+|+|.+... .......+.+|+.++++++|||| |+||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5788999998653 23345678899999999999985 6799999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeee
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 441 (559)
.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 151 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTN 151 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccc
Confidence 9988753 24889999999999999999999 88899999999999999999999999999976433222 223
Q ss_pred eccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 442 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....... ... .+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~-~~~------~~------ 212 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ-EPL------RF------ 212 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-CCC------CC------
Confidence 3459999999999999899999999999999999999999997443211 1111111 000 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
+......+.+++.+||+.||++||++..+.+.
T Consensus 213 -~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 213 -PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred -CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 11233567889999999999999865444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=297.37 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=188.4
Q ss_pred CCCCCCCccccCCccEEEEEEe-----cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce----------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-----DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
++|++.+.||+|+||.||++.. .++..+|+|++........+.+.+|++++++++|+|+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788899999999999999974 3578899999876665556789999999999999984
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|+||+++++|.+++.... ..+++..+..++.|++.||+||| .++|+||||||+|||+++++.+||+|||+++
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 678899999999986532 25889999999999999999999 8889999999999999999999999999998
Q ss_pred eccCCCceee--eeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh----hc
Q 047195 431 LALNGASHVT--TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL----KQ 504 (559)
Q Consensus 431 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~ 504 (559)
.......... ....++..|+|||++.+..++.++||||||+++|||++|..++...... . ........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~ 232 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-F---MRMMGNDKQGQMIV 232 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-h---hhhcccccccccch
Confidence 7654332211 1122345699999998888999999999999999999988765422110 0 00000000 00
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..+.+.+..... ..........+.+++.+||+.+|++||||.||+++|+.|
T Consensus 233 ~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGR---LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000011100000 000112346788999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=292.26 Aligned_cols=237 Identities=24% Similarity=0.375 Sum_probs=186.9
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSP 357 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~ 357 (559)
++|++.+.||+|+||.||++...++..+|+|.+.... ...+++.+|+.++++++|||| ++||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4588889999999999999998777789999877443 334679999999999999984 678889
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 83 NGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999886532 25899999999999999999999 88899999999999999999999999999886644332
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ... ...... ....
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~----~~~~~~-----~~~~ 223 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEK----VSQGLR-----LYRP 223 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH----HhcCCC-----CCCC
Confidence 22222235678999999988889999999999999999998 8888864432211 111 111100 0000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 224 -------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 -------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 012367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=307.21 Aligned_cols=223 Identities=29% Similarity=0.430 Sum_probs=180.4
Q ss_pred CCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcHh
Q 047195 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSPNGTLF 362 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L~ 362 (559)
++-||.|+.|.||+|++++ ..||||+++.. -..+|+-|++|+|+|| ||||+..|.|+
T Consensus 129 LeWlGSGaQGAVF~Grl~n-etVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHN-ETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeeccC-ceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 4669999999999999864 67899987643 2357889999999994 79999999999
Q ss_pred HhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeee
Q 047195 363 DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442 (559)
Q Consensus 363 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 442 (559)
.+|...+ ++.......+..+||.|+.||| .+.|||||||.-||||+.+..+||+|||.++...+. +..+.
T Consensus 201 ~VLka~~-----~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS- 270 (904)
T KOG4721|consen 201 EVLKAGR-----PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS- 270 (904)
T ss_pred HHHhccC-----ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh-
Confidence 9997643 5788889999999999999999 888999999999999999999999999999876543 33333
Q ss_pred ccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChh
Q 047195 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEI 522 (559)
Q Consensus 443 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 522 (559)
..||..|||||++.+.+.+.|+||||||||||||+||.-|+..-+..-. +|.. .... |.- ..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwGV-GsNs--------L~L---pv 332 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWGV-GSNS--------LHL---PV 332 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EEec-cCCc--------ccc---cC
Confidence 3499999999999999999999999999999999999999863322111 1100 0000 100 11
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 523 ELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 523 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
+..+++-+..|+++||+..|..||++.+++..|+
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 2355678889999999999999999999998875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=306.44 Aligned_cols=236 Identities=24% Similarity=0.305 Sum_probs=181.3
Q ss_pred CCCCCCccccCCccEEEEEEe----cCCcEEEEEEeecC----CCCChhhHHHHHHHHHhcC-CCc--------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLG----NTKGIDPILNEVRILCQLN-HRS-------------- 350 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~~avk~~~~~----~~~~~~~~~~E~~~l~~l~-h~n-------------- 350 (559)
+|++.+.||+|+||.||+++. .+++.+|+|++... .....+.+.+|+.++++++ |+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999874 35789999998643 2233456889999999995 776
Q ss_pred -eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 351 -LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 351 -iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
+|+||+++|+|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 478999999999988653 24889999999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
+..............||+.|+|||++.+. .++.++||||||+++|||++|+.||........... +......
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~---- 225 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE---VSRRILK---- 225 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH---HHHHHhc----
Confidence 86544333333344599999999998765 478899999999999999999999975432221111 1111100
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
.++.+.. .....+.+++.+||+.||++|| +++++++
T Consensus 226 --~~~~~~~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 --CDPPFPS-------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCCCCCC-------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111111 2235678899999999999999 6667664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=288.98 Aligned_cols=245 Identities=23% Similarity=0.343 Sum_probs=192.2
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|++|.||+|... +++.+|+|.++... ....+.+.+|++++++++|+|+ ++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999965 78999999876432 2335679999999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|..++..... ....+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999998875432 2245889999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
...... ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ ...... .+
T Consensus 158 ~~~~~~-~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~----~~ 227 (267)
T cd08224 158 SKTTAA-HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-IEKCDY----PP 227 (267)
T ss_pred CCCccc-ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh-hhcCCC----CC
Confidence 332221 223488999999999888899999999999999999999999864321 11111110 111100 00
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.. .......+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 228 ~~-------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LP-------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CC-------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00 113346788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.93 Aligned_cols=239 Identities=27% Similarity=0.383 Sum_probs=188.8
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc--------------eEEeeCCC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS--------------LFMSMSPN 358 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n--------------iv~~~~~~ 358 (559)
++|.+.+.||+|++|.||++..+++..+|+|.+.... ...+.+.+|++++++++|+| +++||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 4688889999999999999998777789999876543 23467899999999999998 46799999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||+++........
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 85 GSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999875322 34789999999999999999999 788999999999999999999999999999866433222
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... ...... ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~-----~~~--- 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLE----QVERGY-----RMP--- 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCC-----CCC---
Confidence 2222336778999999988889999999999999999999 888886433211 111 111100 000
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
.....+..+.+++.+||+.+|++||++.+|+++|++
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 ----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011234678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=291.50 Aligned_cols=237 Identities=24% Similarity=0.360 Sum_probs=185.5
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSP 357 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~ 357 (559)
.+|++.+.||+|+||.||++..+++..+|+|.+..... ..+.+.+|++++++++|+|| |+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35888899999999999999987778899998764332 33578999999999999985 678889
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++.... ..+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 83 NGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999887532 25889999999999999999999 78899999999999999999999999999976543322
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. ..... .....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----~~~~~-----~~~~~- 222 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VE----SVSAG-----YRLYR- 222 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HH----HHHcC-----CcCCC-
Confidence 21122224567999999988889999999999999999999 7888864432211 10 01000 00000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
....+.++.+++.+||+.+|++|||+.||++.|.
T Consensus 223 ------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 ------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred ------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0123467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.20 Aligned_cols=245 Identities=26% Similarity=0.379 Sum_probs=192.9
Q ss_pred CCCCCCCccccCCccEEEEEEecC--C----cEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce--------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD--E----TITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~--~----~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
...+..+.||+|+||.||+|...+ + ..||||.++... .....+|++|..+|+.++||||
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 455667889999999999998543 3 348888887653 4556789999999999999995
Q ss_pred -EEeeCCCCcHhHhHhhccCCC--CCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGN--WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
++|||++|+|..+|+..+... ...+...+.+.++.|||+|+.||+ ++++|||||..+|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence 569999999999998763221 246889999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCceeee-eccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 429 SRLALNGASHVTT-FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 429 a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
|+.+......... ...-...|||||.+.+..++.|+|||||||+|||++| |..|+...++.+- .......++
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhCCc
Confidence 9955443332222 2235678999999999999999999999999999999 5567654443221 111122221
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
+ ..+..++..+.+|+..||+.+|++||++..+++.++.|+
T Consensus 923 L-------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 923 L-------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred c-------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 1 112345578889999999999999999999999988763
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.57 Aligned_cols=237 Identities=23% Similarity=0.303 Sum_probs=185.9
Q ss_pred CCCCCCccccCCccEEEEEEec-C-CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-D-ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~-~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.|.+.+.||+|++|.||+|... + +..+|+|.+..........+.+|+.+|+.++|||| ||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999843 3 57788887766555545668899999999999995 68999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+.+..... ...++++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999998864322 2235889999999999999999999 8899999999999999999999999999998765432
Q ss_pred c-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 S-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ...... .+. .+
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~~~-~~~----~~--- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQVL-YGK----YD--- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCC----CC---
Confidence 2 12233459999999999988889999999999999999999999996443211 011100 000 00
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+......+.+++.+||+.+|++|||+.++++
T Consensus 290 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011123356888999999999999999999875
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=297.26 Aligned_cols=244 Identities=27% Similarity=0.353 Sum_probs=190.4
Q ss_pred CCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
.+|.+.+.||+|+||.||++... +...+++|.+........+.+.+|++++++++|+||
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35788899999999999999742 345688888876555555679999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC
Q 047195 352 FMSMSPNGTLFDRLHRVQS-----------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~ 420 (559)
|+||+++++|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 6799999999999865321 11134789999999999999999999 888999999999999999999
Q ss_pred EEEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 047195 421 AKISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYF 498 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 498 (559)
+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543221 11223346788999999988889999999999999999999 999986443221 1
Q ss_pred HHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 499 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
......+..... ....+..+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 235 ~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 IECITQGRVLER------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhCCCCCCC------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111111100 112235688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=303.57 Aligned_cols=226 Identities=27% Similarity=0.339 Sum_probs=177.8
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g 359 (559)
+.||+|+||.||+++. .++..+|+|.+... .......+.+|+++++.++|||| ||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999998753 22334567899999999999984 78999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
+|...+.... .+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 151 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc-
Confidence 9988886532 4889999999999999999999 788999999999999999999999999998754322211
Q ss_pred eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCC
Q 047195 440 TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGA 519 (559)
Q Consensus 440 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 519 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..... ... ..+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~-~~~------~~~p--- 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELIL-MEE------IRFP--- 215 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHh-cCC------CCCC---
Confidence 2234589999999999888899999999999999999999999964432111 00000 000 0011
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 520 SEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 520 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 ----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 12336678899999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=311.04 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=193.2
Q ss_pred HHHHHHhCCCCCCCccccCCccEEEEEEecC--C--cE-EEEEEeecC---CCCChhhHHHHHHHHHhcCCCce------
Q 047195 286 REITEATNNFSTGNLLGSGGFGEVFKAILDD--E--TI-TAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL------ 351 (559)
Q Consensus 286 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~--~--~~-~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni------ 351 (559)
..++...++-.+.++||+|+||.||+|.++. + .. ||||..+.. ......+|++|+++|++++||||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3444455666777999999999999999543 2 23 899998853 34556789999999999999995
Q ss_pred ---------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEE
Q 047195 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAK 422 (559)
Q Consensus 352 ---------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~k 422 (559)
|||++.||+|.++|..... .++..++..++.+.|.||+||| ++++|||||-.+|+|++.++.+|
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEE
Confidence 6799999999999987543 5899999999999999999999 88899999999999999999999
Q ss_pred EeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 047195 423 ISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 423 l~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
|+|||+++...... .......-...|+|||.+....++.++||||||+++||+++ |..|+.+....+- ...
T Consensus 303 ISDFGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v-------~~k 374 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV-------KAK 374 (474)
T ss_pred eCccccccCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-------HHH
Confidence 99999987654111 11112235789999999999999999999999999999999 7888875543321 111
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.......- .. +...+..+..++.+|+..+|++||||.++.+.|+.+
T Consensus 375 I~~~~~r~--------~~---~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 375 IVKNGYRM--------PI---PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred HHhcCccC--------CC---CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 10111000 00 113446778888899999999999999999999876
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.38 Aligned_cols=240 Identities=24% Similarity=0.366 Sum_probs=184.4
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCc----EEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DET----ITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
++|++.+.||+|+||+||+|.+. ++. .+++|.+..... ....++..|+.++++++|+|| +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 35788899999999999999863 343 467777654322 234568889999999999995 5
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++|+++|+|.+++.... ..+++..+..++.|++.||+||| +++++||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 68889999999997532 25899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||........ ......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcC--
Confidence 433222 1223346788999999988889999999999999999998 9989865432211 1111111100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..+. .....+.+++.+||..+|++|||+.|+++.|+.+
T Consensus 231 ~~~~----------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 231 AQPQ----------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred CCCC----------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0010 1124567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=296.22 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=186.8
Q ss_pred HhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------ 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------ 351 (559)
..++|++.+.||+|+||.||+|..+ .+..+|+|.+..... ....++.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 246799998754322 234568999999999999985
Q ss_pred ---EEeeCCCCcHhHhHhhccCC-----CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSG-----NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
|+||+++++|.+++...... ....+++..+..++.|++.||+||| +++++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 67999999999998753321 1234678889999999999999999 788999999999999999999999
Q ss_pred eecccceeccCCCceee-eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 047195 424 SDFGLSRLALNGASHVT-TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+|||+++.......... ....+++.|+|||++.+..++.++||||||+++|||++ |..||........ ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~-------~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV-------LRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHH
Confidence 99999876543222111 12235788999999988889999999999999999999 6788864432211 011
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
........ . +......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~~-----~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLD-----K-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCC-----C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111000 0 11223568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=289.23 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=190.8
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||.||+|+. .++..+|||.+.... ......+.+|+++++.++|||+ ++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4789999999999999999995 478899999876432 2333568899999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||.++++|.+++...... ...+++..+..++.|++.||+||| +++++|+||||+|||++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999888654322 235788999999999999999999 8899999999999999999999999999988754
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
..... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ...... .+
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~-~~~~~~-----~~ 226 (267)
T cd08228 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQ-KIEQCD-----YP 226 (267)
T ss_pred chhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHH-HHhcCC-----CC
Confidence 32221 12234888999999998888899999999999999999999998643211 111111 111100 00
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.+ ........+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 227 ~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PL------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CC------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00 0113346788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.22 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=186.9
Q ss_pred CCCCCccccCCccEEEEEE-----ecCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 295 FSTGNLLGSGGFGEVFKAI-----LDDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~-----~~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
|++.+.||+|+||+||++. ..++..+|+|.+..... .....+.+|++++++++|+||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 4888999999999998865 24577899999876433 234678899999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
++||+++++|.+++... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 56888999999888642 4899999999999999999999 78899999999999999999999999999987
Q ss_pred ccCCCcee--eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 432 ALNGASHV--TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 432 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ ..............+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIE 235 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhh
Confidence 65432211 1122356679999999888899999999999999999999999864322110 00000000000111111
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.++...... .+...+..+.+++.+||+.+|++|||+++|+++|+++
T Consensus 236 ~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111100 1122346789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=302.32 Aligned_cols=226 Identities=25% Similarity=0.347 Sum_probs=177.6
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCc----------------eEE
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRS----------------LFM 353 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~n----------------iv~ 353 (559)
+|++.+.||+|+||.||+|..+ +++.+|+|++... .....+.+..|++++..++|++ +||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999855 5688999998753 2334567889999999998765 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999998886532 4788999999999999999999 7889999999999999999999999999987533
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. . .. ..... .
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~---~~-i~~~~------~ 218 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F---QS-IMEHN------V 218 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H---HH-HHcCC------C
Confidence 2222 12234599999999999998899999999999999999999999975432211 1 10 11100 0
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
.+. ......+.+++.+||+.+|.+||+.
T Consensus 219 ~~~-------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYP-------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC-------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011 1223567889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=304.61 Aligned_cols=230 Identities=23% Similarity=0.295 Sum_probs=182.7
Q ss_pred hCCCCCCCccccCCccEEEEEEecC--CcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD--ETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
.++|++.+.||+|+||.||+|..++ +..+|+|++... .....+.+.+|+++++.++||||
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3469999999999999999998543 368999988643 23345678899999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 109 v~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 789999999999987532 4889999999999999999999 88899999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 181 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~---- 245 (340)
T PTZ00426 181 VDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGII---- 245 (340)
T ss_pred cCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC----
Confidence 54322 23359999999999988889999999999999999999999997543211 0111111100
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
.+. ......+.+++++||+.+|++|+ |++++++
T Consensus 246 --~~p-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 --YFP-------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --CCC-------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 001 11225577899999999999995 8888765
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.66 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=178.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
..+|++.+.||+|+||.||+|.. ..++.+|||++.... ....+|+.+|+.++|+||
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999986 467899999875432 335679999999999985
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeec
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDF 426 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DF 426 (559)
||||++ ++|.+.+..... ....+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 456665 466666654321 2246889999999999999999999 88899999999999999664 7999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
|+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+...............
T Consensus 216 Gla~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 999866543222 223489999999998764 68999999999999999999999997654433221111100000000
Q ss_pred hhh-------hcccccccc-CC-ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLV-------DAIDPMLKE-GA-SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~-------~~~d~~l~~-~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+. .+--+.+.. .. ...+...+.++.+|+.+||+.+|.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 000000000 00 0000112357889999999999999999999874
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.07 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=180.4
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
+|++.+.||+|+||.||++.. .+++.+|||++... .......+.+|+++++.++|+||
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999985 57899999988643 22334578999999999999985
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|+||+. ++|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 345554 4566655432 35899999999999999999999 8889999999999999999999999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh--
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL-- 507 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 507 (559)
..............+++.|+|||++.+. .++.++|||||||++|||++|+.||......+...... ........
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~~~g~~~~~~ 228 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT---DLLGTPSLEA 228 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH---HHcCCCCHHH
Confidence 6544333223334588999999998774 47899999999999999999999997654332221111 11000000
Q ss_pred --------hhcccccccc-----CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 --------VDAIDPMLKE-----GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 --------~~~~d~~l~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...+...... ............+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000000 000000112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.09 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=189.4
Q ss_pred HhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcC-CCce-----------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLN-HRSL----------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni----------- 351 (559)
..++|.++++||+|+||.||+|+.. ....||||++..... ...+.+.+|+++|+++. ||||
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568999999999999999999842 234699999865433 23457999999999996 9994
Q ss_pred ----EEeeCCCCcHhHhHhhccCC--------------------------------------------------------
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSG-------------------------------------------------------- 371 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~-------------------------------------------------------- 371 (559)
|+||+++|+|.+++......
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 68999999999988653210
Q ss_pred -----------------------------------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec
Q 047195 372 -----------------------------------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD 416 (559)
Q Consensus 372 -----------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~ 416 (559)
....+++..+..++.|++.||+||| +++|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence 0124778888999999999999999 78899999999999999
Q ss_pred CCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccH
Q 047195 417 EKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNL 494 (559)
Q Consensus 417 ~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~ 494 (559)
+++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--- 348 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--- 348 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---
Confidence 99999999999998654332221 122336788999999988889999999999999999997 8888864322111
Q ss_pred HHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 495 VVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 495 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.......+. ... ........+.+++.+||+.+|++|||+.+|+++|++++
T Consensus 349 ---~~~~~~~~~-----~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 ---FYNKIKSGY-----RMA-------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHHHHhcCC-----CCC-------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111110 000 01123467889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.80 Aligned_cols=236 Identities=22% Similarity=0.298 Sum_probs=185.8
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||+||+|+.. +++.+|||++.... ......+.+|++++..++|+|| |+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999964 68999999987542 2344678899999999999984 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999998764 25889999999999999999999 7899999999999999999999999999997654
Q ss_pred CCC----------------------------ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCC
Q 047195 434 NGA----------------------------SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDF 485 (559)
Q Consensus 434 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~ 485 (559)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 1112234599999999999998999999999999999999999999975
Q ss_pred CCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 047195 486 NREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-IKEVAD 553 (559)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~ 553 (559)
...... ........ ..+ .+.. . ......+.+++.+||+ +|++||+ +.++++
T Consensus 233 ~~~~~~------~~~i~~~~---~~~--~~p~-~----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 233 DTLQET------YNKIINWK---ESL--RFPP-D----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCHHHH------HHHHhccC---Ccc--cCCC-C----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 442211 11111000 000 0000 0 0134668889999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.81 Aligned_cols=232 Identities=26% Similarity=0.368 Sum_probs=174.2
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|+..+.||+|+||.||+++.. +++.||||.+..... .....+.+|+++++.++|+|| |+||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34667789999999999999854 689999999865432 224568999999999999995 5678
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+. ....+..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 154 ~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 154 MDGGSLEGT---------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 888877432 13566778899999999999999 788999999999999999999999999999876432
Q ss_pred CceeeeeccccCCccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYIN-----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
... .....||..|+|||++.. ...+.++|||||||++|||++|+.||......+........ . ..
T Consensus 222 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~-~~----- 291 (353)
T PLN00034 222 MDP-CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---C-MS----- 291 (353)
T ss_pred ccc-ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---h-cc-----
Confidence 211 123459999999998743 22346899999999999999999999733222111110000 0 00
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
............+.+|+.+||+.+|++|||+.||++
T Consensus 292 -------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 292 -------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000011123467889999999999999999999986
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=296.79 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=190.0
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCC-CCChhhHHHHHHHHHhc-CCCce----------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGN-TKGIDPILNEVRILCQL-NHRSL---------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni---------- 351 (559)
...++|++.+.||+|+||.||++... ....+|+|.+.... .....++.+|+.+++++ +|+||
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34457889999999999999999853 23678999887532 23345688999999999 79985
Q ss_pred -----EEeeCCCCcHhHhHhhccC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 352 -----FMSMSPNGTLFDRLHRVQS-----------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
++||.++|+|..++..... .....+++..++.++.|++.||+||| +++|+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence 6789999999999865321 12346889999999999999999999 7889999999999999
Q ss_pred cCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccccc
Q 047195 416 DEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVN 493 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~ 493 (559)
++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--
Confidence 999999999999998765432211 122235678999999988889999999999999999997 8888864332111
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.. ....... .. ........+.+|+.+||+.+|++||||.|+++.|++++
T Consensus 244 ----~~-~~~~~~~-------~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ----FK-LLKEGYR-------ME-----KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HH-HHHcCCc-------CC-----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 1111100 00 01122356889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=293.56 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=187.1
Q ss_pred CCCCCCccccCCccEEEEEEe-----cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce----------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-----DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
.|++.+.||+|+||.||+++. .++..+|+|.++... ......+.+|++++++++|+|+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478899999999999999973 357889999986543 3334679999999999999984
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|+||.++++|.+++.... ..+++..+..++.|++.||+||| +++++||||||+|||+++++.+||+|||+++
T Consensus 85 lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 678899999999886432 25899999999999999999999 8899999999999999999999999999998
Q ss_pred eccCCCce--eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcc---------ccccHHHHHH
Q 047195 431 LALNGASH--VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE---------EDVNLVVYFG 499 (559)
Q Consensus 431 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~---------~~~~~~~~~~ 499 (559)
........ ......++..|+|||++.+..++.++||||||+++|||++++.|....... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHH
Confidence 66433221 112234677899999998888999999999999999999987764321100 000000 000
Q ss_pred HHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 500 NILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 500 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
....... . .......+..+.+|+.+||+.+|++|||+.++++.|++|+
T Consensus 237 ~~~~~~~---------~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 237 RVLEEGK---------R---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHHHcCc---------c---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 0000000 0 0001123467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=291.89 Aligned_cols=240 Identities=25% Similarity=0.386 Sum_probs=185.9
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCc----EEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDET----ITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~----~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
++|++.+.||+|+||+||+|++ .++. .||+|.++.... ....++.+|+.+++.++|+|+ +
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 4688899999999999999985 3443 478998865432 334578999999999999985 5
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++|+++|+|.+.+.... ..+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..
T Consensus 87 ~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 87 TQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 68899999999886532 25889999999999999999999 888999999999999999999999999999876
Q ss_pred cCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~-- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPD----LLEKGERL-- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCCcC--
Confidence 5332221 112235678999999988889999999999999999998 888886432211 111 11111000
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.........+.+++.+||+.||++|||+.++++.|+++
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 231 ----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 00112335678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.12 Aligned_cols=255 Identities=24% Similarity=0.271 Sum_probs=180.0
Q ss_pred hHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc-------------
Q 047195 285 SREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------------- 350 (559)
Q Consensus 285 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n------------- 350 (559)
.+++....++|++.++||+|+||+||+|.. ..++.||||+++... .....+..|+.+++.++|.+
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344445568899999999999999999985 457889999986432 22345677888888876543
Q ss_pred ---------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCC-CCeEECCCCCCCeeecCCC-
Q 047195 351 ---------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT-PPIYHRDIKSSNILLDEKL- 419 (559)
Q Consensus 351 ---------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~Dikp~Nill~~~~- 419 (559)
||++++ +++|.+++... ..+++..+..|+.||+.||+||| + .+||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCc
Confidence 233433 67788877653 25899999999999999999999 5 4899999999999998765
Q ss_pred ---------------CEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 047195 420 ---------------DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVD 484 (559)
Q Consensus 420 ---------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~ 484 (559)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4999999987643221 223459999999999999999999999999999999999999998
Q ss_pred CCCccccccHHHHHHHH----hh----cchhhhccc------cccc--------cCCChhhHHHHHHHHHHHHHhcccCC
Q 047195 485 FNREEEDVNLVVYFGNI----LK----QERLVDAID------PMLK--------EGASEIELDSMKAFGLLGAACLDERR 542 (559)
Q Consensus 485 ~~~~~~~~~~~~~~~~~----~~----~~~~~~~~d------~~l~--------~~~~~~~~~~~~~l~~l~~~cl~~~p 542 (559)
.....+........... +. ........+ +... .............+.+|+.+||+.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 65543322221111000 00 000000000 0000 00000001113457899999999999
Q ss_pred CCCCCHHHHHH
Q 047195 543 QNRPSIKEVAD 553 (559)
Q Consensus 543 ~~RPt~~evl~ 553 (559)
++|||+.|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.86 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=183.6
Q ss_pred CCCCCCCccccCCccEEEEEEecC-C--cEEEEEEeecC-CCCChhhHHHHHHHHHhc-CCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-E--TITAVKRAKLG-NTKGIDPILNEVRILCQL-NHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-~--~~~avk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni---------------v 352 (559)
++|++.+.||+|+||.||+|..++ + ..+++|.++.. .....+.+.+|++++.++ +|||| +
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998643 3 34688877643 223346789999999999 79884 6
Q ss_pred EeeCCCCcHhHhHhhccC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCE
Q 047195 353 MSMSPNGTLFDRLHRVQS-----------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~ 421 (559)
+||.++++|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 789999999999865321 11135888999999999999999999 7899999999999999999999
Q ss_pred EEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 047195 422 KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGN 500 (559)
Q Consensus 422 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 500 (559)
||+|||++....... .......+..|+|||++....++.++||||||+++|||++ |+.||....... . ..
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~---~~- 229 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L---YE- 229 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HH-
Confidence 999999986432111 1111123567999999988889999999999999999997 999986443211 0 01
Q ss_pred HhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 501 ILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 501 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... ..... +......+.+++.+||+.+|.+|||+.+++++|++++
T Consensus 230 ~~~~~-----~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 230 KLPQG-----YRMEK-------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHhcC-----CCCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00000 00000 1123356889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.03 Aligned_cols=185 Identities=26% Similarity=0.368 Sum_probs=156.7
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++++++|+|| |+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999965 578889998775432 233568999999999999984 679
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||+++++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999987532 47888999999999999999993 24799999999999999999999999999875533
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFN 486 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~ 486 (559)
.. .....|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 21 12235899999999998888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.72 Aligned_cols=237 Identities=24% Similarity=0.299 Sum_probs=185.3
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCc---------------eEE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRS---------------LFM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~n---------------iv~ 353 (559)
++|++.+.||+|+||+||++.. .+++.+|+|+++... ....+.+.+|+.+++.++|+| ||+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688999999999999999985 468899999987542 233456889999999999998 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999987642 25899999999999999999999 8889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccc------cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYI------NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
...........||+.|+|||++. ...++.++||||||+++|||++|+.||........ ..........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~ 227 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRF 227 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCc
Confidence 44433334446999999999986 45678899999999999999999999975432211 1111111100
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... .. .......+.+|+..||+ +|++|||+.++++
T Consensus 228 ~~~-----~~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKF-----PE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCC-----CC-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 00 01233567889999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=289.12 Aligned_cols=242 Identities=28% Similarity=0.384 Sum_probs=190.7
Q ss_pred HhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
..++|.+.+.||+|+||.||+|..++++.+|||.+.... ...+++.+|+.++++++|+|+ ++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346799999999999999999998888889999887543 345779999999999999995 6789
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++..... ..+++..+..++.|++.||.||| +++++|+||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 83 MSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred cCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999876332 35899999999999999999999 788999999999999999999999999999866532
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
.........++..|+|||.+.+..++.++||||||++++||++ |+.||....... ...... .. ....
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~----~~-----~~~~ 224 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVE----RG-----YRMP 224 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC-----CCCC
Confidence 2211122225678999999988889999999999999999998 888886433211 111110 00 0000
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. +...+..+.+++.+||+.+|++||+++++.+.|+..
T Consensus 225 ~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 225 R-------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred C-------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 0 011235788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.43 Aligned_cols=226 Identities=27% Similarity=0.361 Sum_probs=177.0
Q ss_pred CccccCCccEEEEEEe----cCCcEEEEEEeecC----CCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 299 NLLGSGGFGEVFKAIL----DDETITAVKRAKLG----NTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~----~~~~~~avk~~~~~----~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+.||+|+||.||+++. ..++.+|+|.++.. .......+.+|+.+|++++|||| |+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999984 35789999998753 22334567899999999999984 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+.+.... .+.+..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999886532 4788888999999999999999 788999999999999999999999999998754332
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...... .... .+
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~-~~~~------~~ 219 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKIL-KGKL------NL 219 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHH-cCCC------CC
Confidence 22 1223458999999999988889999999999999999999999997543211 111111 1100 01
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
+......+.+++.+||+.+|++|| ++.++++
T Consensus 220 -------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 -------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112235678999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=301.96 Aligned_cols=226 Identities=25% Similarity=0.327 Sum_probs=177.6
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCc---------------eEEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRS---------------LFMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~~~g 359 (559)
+.||+|+||.||++.. .++..+|+|.+.... ......+.+|+++++.++|+| |||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 568899999987532 233456789999999999998 478999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCC-CCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT-PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
+|.+.+... ..+++..+..++.||+.||+||| + ++|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 998888653 24889999999999999999999 5 68999999999999999999999999998754322222
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. ...... ..+..
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~-~i~~~~------~~~p~- 217 (325)
T cd05594 153 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FE-LILMEE------IRFPR- 217 (325)
T ss_pred -cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HH-HHhcCC------CCCCC-
Confidence 2233599999999999888999999999999999999999999964432111 00 000000 01111
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
.....+.+++.+||+.||++|+ ++.++++
T Consensus 218 ------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 218 ------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1235678899999999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=291.00 Aligned_cols=232 Identities=24% Similarity=0.319 Sum_probs=178.0
Q ss_pred cccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcH
Q 047195 301 LGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FMSMSPNGTL 361 (559)
Q Consensus 301 lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L 361 (559)
||+|+||+||++.. .+++.+|+|.+..... ...+.+..|++++++++|+|| ||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 4678999999865322 233567899999999999984 6899999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeee
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 441 (559)
.+.+..... ....+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cc
Confidence 888754322 2246899999999999999999999 788999999999999999999999999999765443322 22
Q ss_pred eccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 442 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...... .+.... .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~---------~~~~~~-----~ 219 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR---------ILNDSV-----T 219 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHh---------hcccCC-----C
Confidence 335899999999999989999999999999999999999999754322110 000000 000000 0
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
.+......+.+++.+||+.+|++|| |+.++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0112346788999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=296.24 Aligned_cols=252 Identities=19% Similarity=0.262 Sum_probs=182.1
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|.+.+.||+|+||.||+|+.+ ++..+|+|.+...... ....+.+|++++++++|+|| |+||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46899999999999999999854 6788999998754332 23467899999999999984 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++ +|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 764 7777765432 24788899999999999999999 889999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc---
Q 047195 436 ASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI--- 511 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 511 (559)
... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+................+..+.
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 158 TKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred ccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 221 122347899999998865 468899999999999999999999997654433222211110000000000000
Q ss_pred ---ccccccC----CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 ---DPMLKEG----ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 ---d~~l~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+...... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 00000123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=285.49 Aligned_cols=231 Identities=26% Similarity=0.354 Sum_probs=180.9
Q ss_pred ccccCCccEEEEEEe---cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCc--------------eEEeeCCCCc
Q 047195 300 LLGSGGFGEVFKAIL---DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRS--------------LFMSMSPNGT 360 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~---~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~n--------------iv~~~~~~g~ 360 (559)
.||+|+||.||+|.+ .++..+|+|+++.... ...+++.+|+.+++.++|+| +|+||.++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 699999999999964 3578899998865432 23467899999999999998 4678999999
Q ss_pred HhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceee
Q 047195 361 LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT 440 (559)
Q Consensus 361 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 440 (559)
|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 82 LNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99988643 24889999999999999999999 88899999999999999999999999999987654332211
Q ss_pred --eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 441 --TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 441 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+ . .......... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~i~~~~~~-----~~-- 219 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V----TQMIESGERM-----EC-- 219 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHCCCCC-----CC--
Confidence 12234678999999888888999999999999999998 999986443221 1 1111111100 01
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
+......+.+++.+||+.+|++||++.+|+++|++
T Consensus 220 -----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11233668899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.86 Aligned_cols=187 Identities=27% Similarity=0.392 Sum_probs=157.9
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCc---------------eEE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRS---------------LFM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~n---------------iv~ 353 (559)
++|++.+.||+|+||+||++.. .+++.+|+|++.... ......+.+|+.++.+++|+| +||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999985 457899999986532 233456889999999999997 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999998753 25899999999999999999999 8899999999999999999999999999987543
Q ss_pred CCCc----------------------------------eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhC
Q 047195 434 NGAS----------------------------------HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTS 479 (559)
Q Consensus 434 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg 479 (559)
.... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 001223599999999999988999999999999999999999
Q ss_pred CCCCCCCC
Q 047195 480 KKAVDFNR 487 (559)
Q Consensus 480 ~~p~~~~~ 487 (559)
+.||....
T Consensus 233 ~~Pf~~~~ 240 (363)
T cd05628 233 YPPFCSET 240 (363)
T ss_pred CCCCCCCC
Confidence 99997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=291.73 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=178.6
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC--ChhhHHHHHHHHHhc---CCCceE---------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK--GIDPILNEVRILCQL---NHRSLF--------------- 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv--------------- 352 (559)
+|++.+.||+|+||+||+|... +++.+|+|.++..... ....+.+|+.+++++ +|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888899999999999999854 6889999988754322 224567888888766 699853
Q ss_pred -----EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 353 -----MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 353 -----~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
+|++. ++|.+.+..... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccC
Confidence 35554 467776654322 34899999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
+++....... .....+|..|+|||++.+..++.++||||||+++|||++|+.||......+................+
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 154 LARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 9986543221 12334899999999998888999999999999999999999998655432211111100000000000
Q ss_pred hh-------ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VD-------AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~-------~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ...+................+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000001111123466789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=286.49 Aligned_cols=234 Identities=24% Similarity=0.323 Sum_probs=184.4
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce----------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL----------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni----------------v~~~~ 356 (559)
++|++.+.||+|+||.||++... +..+|+|..+.. ...+.+.+|+.++++++|+|+ ++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999765 677899987643 234679999999999999884 67889
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+.+..... ..+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999998875332 35889999999999999999999 8899999999999999999999999999987543322
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+ .... ..... .+..
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------~~~~-~~~~~-----~~~~ 220 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPR-VEKGY-----KMDA 220 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HhcCC-----CCCC
Confidence 12235678999999988889999999999999999998 888876332111 1110 10000 0000
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
....+..+.+++.+||+.+|++|||+.++++.|++|
T Consensus 221 -------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 -------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 012336788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=306.27 Aligned_cols=236 Identities=22% Similarity=0.333 Sum_probs=181.4
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||+||+++.. +++.+|||++.... ......+.+|+.+++.++|+|| |+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999964 68899999987532 2334567899999999999984 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999998753 24899999999999999999999 7889999999999999999999999999987543
Q ss_pred CCCce-------------------------------------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHH
Q 047195 434 NGASH-------------------------------------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVEL 476 (559)
Q Consensus 434 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el 476 (559)
..... ......||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 00123489999999999888999999999999999999
Q ss_pred HhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 047195 477 LTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS---IKEVAD 553 (559)
Q Consensus 477 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~evl~ 553 (559)
++|+.||........ .......... + ..... ......+.+++.+|+. +|.+|++ +.|+++
T Consensus 233 ~~G~~Pf~~~~~~~~------~~~i~~~~~~---~--~~~~~-----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 233 LVGYPPFCSDNPQET------YRKIINWKET---L--QFPDE-----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCCCCCHHHH------HHHHHcCCCc---c--CCCCC-----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999975432211 1111100000 0 00000 0123567788888996 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=288.14 Aligned_cols=239 Identities=25% Similarity=0.361 Sum_probs=185.2
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
++|++.+.||+|+||.||+|+. .+++.+|+|++..........+.+|+.++++++|+|| |+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4799999999999999999995 5678999999876655555678899999999999984 67999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999988643 24789999999999999999999 7889999999999999999999999999998654322
Q ss_pred ceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.. .....+++.|+|||.+. ...++.++||||||+++|||++|+.|+........... +..... ..+
T Consensus 161 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~---~~~ 229 (267)
T cd06646 161 AK-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSNF---QPP 229 (267)
T ss_pred cc-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCCC---CCC
Confidence 11 12234889999999874 34577899999999999999999999853332111000 000000 001
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
.... .......+.+++.+||+.+|++|||++++++.|
T Consensus 230 ~~~~-----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD-----KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc-----ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1100 012346788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=293.79 Aligned_cols=234 Identities=36% Similarity=0.494 Sum_probs=177.2
Q ss_pred CCCccccCCccEEEEEEec-----CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 297 TGNLLGSGGFGEVFKAILD-----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-----~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+.+.||.|.||.||+|.+. .+..|+||.++.... ...+.+.+|++.+++++|||| |+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999976 357889999865433 236789999999999999994 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++|+|.+++.... ...+++..+..|+.|++.||.||| +++++|+||+++|||+++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999998752 235899999999999999999999 778999999999999999999999999999876332
Q ss_pred Cce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 436 ASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 436 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
... ..........|+|||.+.+..++.++||||||+++|||++ |+.|+......+ .... ..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~-~~~~~~~~---- 225 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEK-LKQGQRLP---- 225 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHH-HHTTEETT----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccc-ccccccce----
Confidence 222 2223347789999999988889999999999999999999 677775332211 1111 11111100
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
.. ......+..++.+||+.+|++|||+.+++++|
T Consensus 226 -~~-------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -IP-------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -SB-------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ec-------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 11236688899999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=285.30 Aligned_cols=233 Identities=25% Similarity=0.350 Sum_probs=181.0
Q ss_pred ccccCCccEEEEEEec---CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------EEeeCCCCcH
Q 047195 300 LLGSGGFGEVFKAILD---DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------FMSMSPNGTL 361 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~~---~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~~g~L 361 (559)
.||+|+||.||+|.+. ++..+|+|.+..... ...+.+.+|+.++++++|+|| |+||+++++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999753 455789998876543 234568999999999999985 6799999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceee-
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT- 440 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~- 440 (559)
.+++.... ..+++..+..++.|++.||+||| +++++||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 82 NKFLSGKK----DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99886432 35899999999999999999999 78899999999999999999999999999976543322211
Q ss_pred -eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 441 -TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 441 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+. ......... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~-----~----- 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-------MSFIEQGKR-----L----- 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCCCC-----C-----
Confidence 11224578999999888889999999999999999996 9999864432110 111111100 0
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..+.....++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 218 --~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 --DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00112346788899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=287.20 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=191.1
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.+|++.+.||+|++|.||++.. .++..++||.+.... ....+++.+|+.+++.++|+|| ++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999994 578999999876532 2234578999999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+|.++++|.+++..... ....+++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998875332 2245889999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
..... .....++..|+|||.+.+..++.++||||||+++|||++|..||....... ..... ... ....+
T Consensus 158 ~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~-~~~-----~~~~~ 226 (267)
T cd08229 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK-KIE-----QCDYP 226 (267)
T ss_pred cCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhh-hhh-----cCCCC
Confidence 33221 122348899999999988889999999999999999999999986432211 11111 000 00001
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.+. .......+.+++.+||+.+|++||||.+|+++++++
T Consensus 227 ~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PLP------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCC------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 010 112446788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=293.00 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=186.8
Q ss_pred HhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------ 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------ 351 (559)
..++|++.+.||+|+||.||+|..+ .+..+|+|.+..... .....+.+|+.+++.++|+|+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568999999999999999999753 245789998764432 223468899999999999984
Q ss_pred ---EEeeCCCCcHhHhHhhccCC-----CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSG-----NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
|+||+++|+|.+++...... ....+.+..+..++.|++.||.||| +++|+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 67999999999999764321 1234577788999999999999999 888999999999999999999999
Q ss_pred eecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 047195 424 SDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ . ...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~----~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---V----LKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHH
Confidence 9999987654322111 112235678999999988889999999999999999998 677875432211 0 011
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
....... .. .......+.+++.+||+.+|++|||+.++++.|++.
T Consensus 234 ~~~~~~~-----~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGYL-----DQ-------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCCC-----CC-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111000 00 012236789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=290.70 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=185.9
Q ss_pred CCCCCCCccccCCccEEEEEEe-----cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-----DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++|++.+.||+|+||+||+|.. .++..+++|.+..... .....+.+|++++++++|+||
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999984 3457899999875332 233578899999999999984
Q ss_pred EEeeCCCCcHhHhHhhccC------------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC
Q 047195 352 FMSMSPNGTLFDRLHRVQS------------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL 419 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~ 419 (559)
++||+++++|.+++..... .....+++..+..++.|++.||+||| +++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 6799999999998853221 01235788899999999999999999 78899999999999999999
Q ss_pred CEEEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 047195 420 DAKISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 420 ~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~ 497 (559)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||....... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~--- 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---V--- 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H---
Confidence 999999999986543322 11222335678999999988889999999999999999998 888886433211 1
Q ss_pred HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 498 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
........... . .......+.+++.+||+.+|++||++.+|+++|..
T Consensus 236 -~~~~~~~~~~~-----~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 -IEMVRKRQLLP-----C-------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcCCcCC-----C-------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111000 0 11223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=287.41 Aligned_cols=241 Identities=25% Similarity=0.408 Sum_probs=190.0
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EEeeCC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FMSMSP 357 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~ 357 (559)
.++|++.+.||+|+||.||++..+++..+|+|.+.... ...+.+.+|++++++++|+|+ ++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 45789999999999999999998888889999876532 234679999999999999884 678999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 84 KGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999876332 34788899999999999999999 78899999999999999999999999999976644332
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.......++..|+|||++....++.++||||||+++|++++ |+.||....... .. ......... + .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~----~-~- 224 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI----RALERGYRM----P-R- 224 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhCCCCC----C-C-
Confidence 22223346678999999988889999999999999999999 888886433211 11 111111000 0 0
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.......+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 225 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 225 ------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 012335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.19 Aligned_cols=244 Identities=28% Similarity=0.401 Sum_probs=184.1
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCc--EEEEEEeecCC-CCChhhHHHHHHHHHhc-CCCce---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DET--ITAVKRAKLGN-TKGIDPILNEVRILCQL-NHRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~~avk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni--------------- 351 (559)
.++|++.+.||+|+||.||+|.++ ++. .+++|.++... ......+.+|++++.++ +|+||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357889999999999999999864 343 45777765432 23345788999999999 89984
Q ss_pred EEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC
Q 047195 352 FMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~ 420 (559)
|+||+++++|.+++...... ....+++..++.++.|++.||+||| +++++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 67999999999998754311 1235789999999999999999999 889999999999999999999
Q ss_pred EEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 047195 421 AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFG 499 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 499 (559)
+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|||+| |..||......+. ..
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE 234 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------HH
Confidence 99999999864321111 111224678999999988889999999999999999998 9999864432211 11
Q ss_pred HHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 500 NILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 500 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
. .... ..... .......+.+++.+||+.+|++||++.+++++|++++
T Consensus 235 ~-~~~~---------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 235 K-LPQG---------YRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred H-HhcC---------CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 1000 00000 0112356788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=291.68 Aligned_cols=244 Identities=28% Similarity=0.382 Sum_probs=186.4
Q ss_pred CCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
+|++.+.||+|+||.||+|... ....+++|.+..... ...+.+.+|+.+++.++||||
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999843 225688887764432 234678999999999999995
Q ss_pred EEeeCCCCcHhHhHhhccC-------------------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCC
Q 047195 352 FMSMSPNGTLFDRLHRVQS-------------------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSN 412 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~N 412 (559)
++||+.+++|.+++..... .....+++..++.++.|++.||+||| +++++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 5789999999998865321 11235788999999999999999999 7889999999999
Q ss_pred eeecCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccc
Q 047195 413 ILLDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEE 490 (559)
Q Consensus 413 ill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~ 490 (559)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997654322211 122235778999999988889999999999999999998 888886443221
Q ss_pred cccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
......... .... .......+.+++.+||+.+|++||++.|+++.|++++
T Consensus 238 -------~~~~~~~~~-----~~~~-------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 -------LFNLLKTGY-----RMER-------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -------HHHHHhCCC-----CCCC-------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111111110 0000 0122357889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.05 Aligned_cols=236 Identities=24% Similarity=0.283 Sum_probs=177.5
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.|++++.||+|+||+||+|+. .+++.+|+|++.... ......+.+|++++++++|+|| |+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999985 567899999986532 2334578999999999999984 689
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 999999999987532 4888899999999999999999 78899999999999999999999999999754311
Q ss_pred CCc----------------------------------------------eeeeeccccCCccCccccccCCCCcccchhH
Q 047195 435 GAS----------------------------------------------HVTTFAQGTLGYLDPEYYINFQLTDKSDVYS 468 (559)
Q Consensus 435 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 468 (559)
... .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 0011235999999999998888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHh--cccCCCCCC
Q 047195 469 FGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAAC--LDERRQNRP 546 (559)
Q Consensus 469 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~c--l~~~p~~RP 546 (559)
|||++|||++|+.||......+... ......... .+.. . .....++.+|+.+| +..++..||
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~------~i~~~~~~~-----~~~~-~----~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQL------KVINWENTL-----HIPP-Q----VKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHH------HHHcccccc-----CCCC-C----CCCCHHHHHHHHHHccCcccccCCC
Confidence 9999999999999997544322110 000000000 0000 0 01224566677774 455666699
Q ss_pred CHHHHHH
Q 047195 547 SIKEVAD 553 (559)
Q Consensus 547 t~~evl~ 553 (559)
++.|+++
T Consensus 298 ~~~~~l~ 304 (381)
T cd05626 298 GADDIKA 304 (381)
T ss_pred CHHHHhc
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=291.08 Aligned_cols=245 Identities=27% Similarity=0.368 Sum_probs=190.4
Q ss_pred hCCCCCCCccccCCccEEEEEEecC-----CcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce--------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD-----ETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
.++|++.+.||+|+||.||+|...+ +..+++|.+.... ....+.+.+|+.++++++|+|+
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578899999999999999999765 6888999876432 2334668999999999999995
Q ss_pred --EEeeCCCCcHhHhHhhccCC---CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 --FMSMSPNGTLFDRLHRVQSG---NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
+++|.++++|.+++...... ....+++..+..++.|++.||+||| +++++||||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 45778889999988664321 1246899999999999999999999 788999999999999999999999999
Q ss_pred ccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhc
Q 047195 427 GLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 427 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...+..+ ... ....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA----YLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH----HHHc
Confidence 9998654333221 122336778999999988889999999999999999999 999986443211 111 1111
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.. .+.. ....+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 235 ~~-------~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GY-------RLAQ-----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CC-------CCCC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 10 0000 012235788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=297.48 Aligned_cols=222 Identities=24% Similarity=0.346 Sum_probs=173.9
Q ss_pred CccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhc-CCCc---------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQL-NHRS---------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l-~h~n---------------iv~~~~~~ 358 (559)
+.||+|+||+||+|+.+ +++.+|+|++... .....+.+..|+.++..+ +||| +||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5789999998753 233456678899999876 6888 47899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 99998886532 4889999999999999999999 888999999999999999999999999998764322221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ... ...... .+
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~-i~~~~~------~~--- 215 (320)
T cd05590 153 -TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEA-ILNDEV------VY--- 215 (320)
T ss_pred -ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHH-HhcCCC------CC---
Confidence 2234599999999999988899999999999999999999999975442211 111 111100 00
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
+......+.+++++||+.||++||++.
T Consensus 216 ----~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 216 ----PTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred ----CCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 011235678899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=302.92 Aligned_cols=237 Identities=22% Similarity=0.298 Sum_probs=182.9
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||+++.. ++..+|+|++... .....+.+.+|+.+++.++|||| |
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457999999999999999999854 6789999998643 22333557899999999999984 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++...
T Consensus 122 ~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 122 MEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 8999999999988642 3778888999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccC----CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINF----QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~ 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNSL 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCcC
Confidence 43322222334599999999998653 47889999999999999999999997543211 111111100000
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQN--RPSIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~ 553 (559)
.... .......+.+++.+||+.+|++ |||+.|+++
T Consensus 267 -----~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 -----TFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -----CCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 0000 0123467788999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=290.49 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=187.5
Q ss_pred CCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++|...++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999632 356788998876665666789999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCC----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCE
Q 047195 352 FMSMSPNGTLFDRLHRVQSG----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~ 421 (559)
++||+++++|.+++...... ....+++..+..++.|++.||+||| +++++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 67899999999998754210 1135789999999999999999999 8889999999999999999999
Q ss_pred EEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 047195 422 KISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFG 499 (559)
Q Consensus 422 kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 499 (559)
||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I---- 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H----
Confidence 999999997654322211 122235788999999988889999999999999999998 8888854332111 0
Q ss_pred HHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 500 NILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 500 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
........ ... ....+..+.+++.+||+.+|++||++.||+++|++
T Consensus 235 ~~~~~~~~-----~~~-------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRE-----LER-------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCcc-----CCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00000000 000 01223568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.41 Aligned_cols=232 Identities=21% Similarity=0.335 Sum_probs=176.9
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhc-CCCce---------------EEeeCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQL-NHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l-~h~ni---------------v~~~~~~ 358 (559)
+.||+|+||.||++.. .+++.+|+|.++... ....+.+.+|+.++.++ +|||| ||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999985 467899999987532 23345688999999998 69884 7899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 9998888643 25899999999999999999999 88899999999999999999999999999875322221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHhhcchhhhccccccc
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE--DVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
......||+.|+|||++.+..++.++||||||+++|||++|+.||+.....+ ......+.......... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p 225 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC
Confidence 1223458999999999999899999999999999999999999997432211 11111111111111110 011
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCC------HHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPS------IKEVA 552 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt------~~evl 552 (559)
......+.+++.+||+.||.+||| +.+++
T Consensus 226 -------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 226 -------RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 122356788999999999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=284.65 Aligned_cols=236 Identities=24% Similarity=0.372 Sum_probs=188.5
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.++|++.+.||+|+||.||++... ++.+|+|.+..... ..+++.+|+.++++++|+|+ |+||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 347889999999999999999865 78899999876544 45789999999999999984 67899
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+.+..... ..+++..+..++.|++.||.||| +++++|+||||+||++++++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999875432 25899999999999999999999 8889999999999999999999999999998663222
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
. ....+..|+|||++....++.++||||||++++||++ |+.||......+ .. ........ ...
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~-----~~~ 220 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PHVEKGYR-----MEA 220 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhcCCC-----CCC
Confidence 1 2235678999999988889999999999999999997 888886432211 11 11111000 000
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
....+..+.+++.+||..+|++|||+.||+++|+.|
T Consensus 221 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 -------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 112246788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=291.59 Aligned_cols=236 Identities=26% Similarity=0.338 Sum_probs=183.4
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
+|++.+.||+|+||+||++.. .+++.+|+|++..... .....+.+|+.++++++|+|| |+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999985 4688999999865322 223457889999999999984 679
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++++|.+++..... ..+++..+..++.|++.||.||| +++++||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999988865322 35899999999999999999999 78899999999999999999999999999987543
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||......... ...........
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~-------- 221 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ-------- 221 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc--------
Confidence 322 12235899999999998888999999999999999999999999754322111 00111010000
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
..........+.+|+.+||+.||++|| ++.++++
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 -----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 001112346688899999999999999 7878764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=298.18 Aligned_cols=228 Identities=23% Similarity=0.345 Sum_probs=173.6
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhc-CCCce---------------EEeeCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQL-NHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni---------------v~~~~~~ 358 (559)
+.||+|+||.||+++. .+++.+|+|.++.. .....+.+.+|+.++.++ +|||| |+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 45789999998754 223345678899998876 79884 7899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|...+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 9998887653 24899999999999999999999 788999999999999999999999999998754322211
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcccc--ccHHHHHHHHhhcchhhhccccccc
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEED--VNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .....+.......... .+
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~- 224 (329)
T cd05618 153 -TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI- 224 (329)
T ss_pred -cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC-
Confidence 2234589999999999998999999999999999999999999964321111 1111111111111110 01
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
+......+.+++.+||+.||++|||+
T Consensus 225 ------p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 ------PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ------CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11233567889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=293.74 Aligned_cols=246 Identities=25% Similarity=0.403 Sum_probs=188.4
Q ss_pred hCCCCCCCccccCCccEEEEEEe--------cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhc-CCCce----------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL--------DDETITAVKRAKLGN-TKGIDPILNEVRILCQL-NHRSL---------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni---------- 351 (559)
..+|.+.+.||+|+||.||+++. .++..+|+|.+.... ....+++.+|+.+++.+ +|+||
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688999999999999999973 134578999876432 33456799999999999 89984
Q ss_pred -----EEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
++||+++++|.+++...... ....+++..+..++.|++.||.||| +++++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 78999999999998764321 1235788899999999999999999 7889999999999999
Q ss_pred cCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccccc
Q 047195 416 DEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVN 493 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~ 493 (559)
++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..|+......+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 999999999999998764322221 222336678999999988889999999999999999998 777775432211
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
... ........ . ........+..++.+||+.+|++|||+.||++.|++|+
T Consensus 248 ---~~~-~~~~~~~~-------~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 248 ---LFK-LLKEGHRM-------D-----KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred ---HHH-HHHcCCcC-------C-----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 111 11111000 0 01123467888999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.55 Aligned_cols=226 Identities=23% Similarity=0.329 Sum_probs=176.0
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcC-CCc---------------eEE
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLN-HRS---------------LFM 353 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~-h~n---------------iv~ 353 (559)
+|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+..|..++..+. |++ +|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999855 56899999987532 223345778888888875 554 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999998886532 4889999999999999999999 7889999999999999999999999999997543
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . .. ......
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~---~~-i~~~~~------ 218 (323)
T cd05616 153 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F---QS-IMEHNV------ 218 (323)
T ss_pred CCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---H---HH-HHhCCC------
Confidence 2221 12234589999999999998999999999999999999999999975432211 1 11 111100
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
.+ +......+.+++.+||+.+|++|++.
T Consensus 219 ~~-------p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AY-------PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC-------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 11233567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=283.89 Aligned_cols=235 Identities=29% Similarity=0.425 Sum_probs=187.2
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|++.+.||+|++|.||++..+ ++..+++|.+... .....+++.+|++++++++|+|+ |+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999864 6789999988653 23445679999999999999984 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999876422 35889999999999999999999 788999999999999999999999999998866543
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
... .....+++.|+|||++.+..++.++||||||++++||++|+.||....... . .......
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~----~~~~~~~---------- 216 (256)
T cd08529 155 TNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---L----ILKIIRG---------- 216 (256)
T ss_pred cch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHcC----------
Confidence 222 223348899999999988889999999999999999999999997544211 0 0001111
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
............+.+++.+||+.+|++||++.++++.
T Consensus 217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 --VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0111111334678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.68 Aligned_cols=238 Identities=21% Similarity=0.295 Sum_probs=181.2
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++|||| |
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999964 5788999998642 22234568899999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||++...
T Consensus 122 ~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 122 MEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 7999999999988642 3788899999999999999999 888999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQ----LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
............||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ ...........
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~ 266 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHKNSL 266 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCccc
Confidence 433322223445999999999987543 78899999999999999999999975432211 11111100000
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQN--RPSIKEVADE 554 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~ 554 (559)
.+.. .......+.+++..||..++.+ |||+.|+++.
T Consensus 267 -----~~p~-----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 -----NFPE-----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----CCCC-----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000 1123456778888899855543 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=302.36 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=190.2
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcC-CCce---------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNTK-GIDPILNEVRILCQLN-HRSL--------- 351 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~-h~ni--------- 351 (559)
....++|.+.+.||+|+||.||+|++. .+..||+|+++..... ..+.+.+|+++|.++. ||||
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344457888999999999999999853 3467999998764332 2357899999999998 9985
Q ss_pred ------EEeeCCCCcHhHhHhhccC-------------------------------------------------------
Q 047195 352 ------FMSMSPNGTLFDRLHRVQS------------------------------------------------------- 370 (559)
Q Consensus 352 ------v~~~~~~g~L~~~l~~~~~------------------------------------------------------- 370 (559)
|+||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 6799999999999875321
Q ss_pred --------------------------------------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCC
Q 047195 371 --------------------------------------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSN 412 (559)
Q Consensus 371 --------------------------------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~N 412 (559)
.....+++..+..++.|++.||+||| +++++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcce
Confidence 01124677788999999999999999 8899999999999
Q ss_pred eeecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccc
Q 047195 413 ILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEE 490 (559)
Q Consensus 413 ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~ 490 (559)
||+++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 99999999999999999865432211 1112236788999999988889999999999999999998 888886443211
Q ss_pred cccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
. .......+. .... +......+.+++.+||+.+|++||+++||++.|++++
T Consensus 350 ~------~~~~~~~~~-----~~~~-------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q------FYNAIKRGY-----RMAK-------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------HHHHHHcCC-----CCCC-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 011111110 0000 1122367889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=296.65 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=186.5
Q ss_pred hCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni------------ 351 (559)
.++|++.+.||+|+||.||+|.. .+++.+|||+++.... ...+.+.+|+.++.++ +|+||
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999973 3467899999875432 2345688999999999 67773
Q ss_pred ----EEeeCCCCcHhHhHhhccCC--------------------------------------------------------
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSG-------------------------------------------------------- 371 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~-------------------------------------------------------- 371 (559)
++||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67999999999988653210
Q ss_pred ------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee-eeecc
Q 047195 372 ------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-TTFAQ 444 (559)
Q Consensus 372 ------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~ 444 (559)
....+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0123678888999999999999999 8899999999999999999999999999997653322111 11223
Q ss_pred ccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhh
Q 047195 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIE 523 (559)
Q Consensus 445 gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 523 (559)
++..|+|||.+.+..++.++||||||+++|||++ |..||........ .......+... ...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~-----~~~------- 304 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRM-----RAP------- 304 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCC-----CCC-------
Confidence 5678999999988889999999999999999997 8888864322111 11111111100 000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 524 LDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 524 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
......+.+++.+||+.+|++|||+.||++.|+.++
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 012246788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=330.68 Aligned_cols=248 Identities=23% Similarity=0.339 Sum_probs=196.9
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
....|...+.||+|+||.||+|+. .++..||||++...... ...|++++++++|||| |||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345677788999999999999986 57899999988643322 2357899999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.++++. ++|..+.+++.|+++||+|||..++++|+||||||+||+++.++.+++. ||.......
T Consensus 764 y~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 764 YIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 9999999999852 7899999999999999999997667799999999999999999888876 666543322
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
. ....+|+.|+|||++.+..++.++||||||+++|||+||+.|++.... .......|............++|+.
T Consensus 835 ~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 D-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred C-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcc
Confidence 1 112488999999999988999999999999999999999999854322 2233444554444444555666776
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+..... ...+...++.+++.+||+.+|++||||.||+++|+++
T Consensus 909 ~~~~~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 909 IRGDVS-VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred ccCCCC-ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 654322 2345667888999999999999999999999999986
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=286.86 Aligned_cols=241 Identities=26% Similarity=0.417 Sum_probs=187.0
Q ss_pred CCCCCCCccccCCccEEEEEEec-CC---cEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCc---------------eE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DE---TITAVKRAKLGN-TKGIDPILNEVRILCQLNHRS---------------LF 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~---~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~n---------------iv 352 (559)
++|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+.+|++++++++|+| +|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46888899999999999999864 23 378899886543 233467899999999999998 47
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 85 TEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 89999999999886532 25889999999999999999999 788999999999999999999999999999866
Q ss_pred cCCCceeee--eccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 433 LNGASHVTT--FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 433 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
......... ....+..|+|||++....++.++||||||+++|||++ |+.||......+ . ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~----~~~i~~~~--- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---V----MKAINDGF--- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H----HHHHhcCC---
Confidence 543222111 1123457999999988889999999999999999997 999986443211 1 11111110
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..+. .......+.+++.+||+.+|++||++.+|++.|++++
T Consensus 228 -~~~~--------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 -RLPA--------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -CCCC--------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0000 0123367889999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=300.92 Aligned_cols=250 Identities=23% Similarity=0.244 Sum_probs=178.7
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCceE---------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSLF--------------- 352 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~niv--------------- 352 (559)
..++|++.+.||+|+||.||++.. .++..+|+|++... .......+.+|+.+++.++||||+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999985 45889999998653 223346788999999999999864
Q ss_pred ------EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 353 ------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 353 ------~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
+||+. ++|.+.+.. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecC
Confidence 34443 334444321 3778888999999999999999 889999999999999999999999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH---------
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY--------- 497 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~--------- 497 (559)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+.......
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9997543221 12234589999999999998999999999999999999999999975543221100000
Q ss_pred -------HHHHhhcc------hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 498 -------FGNILKQE------RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 498 -------~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........ .+.+.....+..............+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 000000000000000001112356789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=287.18 Aligned_cols=240 Identities=24% Similarity=0.361 Sum_probs=188.3
Q ss_pred CCCCCCCccccCCccEEEEEEecC----CcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce--------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD----ETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL--------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni--------------v~ 353 (559)
++|.+.+.||+|+||.||+|...+ ...++||...... ....+.+.+|+.++++++|+|+ |+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 468888999999999999998543 2468889876554 3345679999999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 86 ELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 8999999999986532 24899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
...........++..|+|||.+....++.++||||||+++|||++ |+.||......+. ... .......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~----~~~~~~~---- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGR----IENGERL---- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HHcCCcC----
Confidence 443222223335678999999888889999999999999999996 9999864432211 111 1110000
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.. ....+..+.+++.+|+..+|++|||+.++++.|+++
T Consensus 228 -~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 -PM-------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 112336788899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=295.36 Aligned_cols=225 Identities=26% Similarity=0.375 Sum_probs=173.5
Q ss_pred CccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHh-cCCCce---------------EEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQ-LNHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~-l~h~ni---------------v~~~~~~ 358 (559)
+.||+|+||.||+|+.. +++.+|+|.++.. .....+.+..|..++.. .+|||| |+||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 5788999998753 22334556778777775 478884 7899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 9999888653 24888999999999999999999 7889999999999999999999999999998654322 2
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ..... .. .+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~------~~~i~-~~------~~~~~-- 216 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL------FDSIL-ND------RPHFP-- 216 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-cC------CCCCC--
Confidence 22334589999999999988899999999999999999999999975432111 11100 00 00111
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIK-EVA 552 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl 552 (559)
......+.+++.+||+.+|++||++. +++
T Consensus 217 -----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 -----RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11235678899999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.87 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=184.0
Q ss_pred CCCCCCCccccCCccEEEEEEecC---------------CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCc------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD---------------ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRS------ 350 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~---------------~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~n------ 350 (559)
++|++.+.||+|+||.||++...+ ...+|+|.+..... ...+.+.+|++++++++|+|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 479999999999999999987532 23588998865422 23456899999999999998
Q ss_pred ---------eEEeeCCCCcHhHhHhhccC-------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCee
Q 047195 351 ---------LFMSMSPNGTLFDRLHRVQS-------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNIL 414 (559)
Q Consensus 351 ---------iv~~~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nil 414 (559)
+|+||+++++|.+++..... .....+++..+..++.|++.||+||| +++++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 47899999999998865321 11124788899999999999999999 888999999999999
Q ss_pred ecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCCcccc
Q 047195 415 LDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT--SKKAVDFNREEED 491 (559)
Q Consensus 415 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t--g~~p~~~~~~~~~ 491 (559)
+++++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ +..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999999765432221 1122335778999999988889999999999999999998 4456553332211
Q ss_pred ccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 492 VNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
.......+.... ....... ....+..+.+++++||+.+|++|||+.+|++.|++
T Consensus 242 ---~~~~~~~~~~~~------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 ---IENTGEFFRNQG------RQIYLSQ---TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHhhhhcc------ccccCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111000 0000000 01123678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=294.80 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=187.6
Q ss_pred hCCCCCCCccccCCccEEEEEEec--------CCcEEEEEEeecCC-CCChhhHHHHHHHHHhc-CCCce----------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD--------DETITAVKRAKLGN-TKGIDPILNEVRILCQL-NHRSL---------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni---------- 351 (559)
.++|.+.+.||+|+||.||++... +...+|+|.+.... .....++.+|+++++.+ +|+||
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357999999999999999999742 23579999887542 23345788999999999 79884
Q ss_pred -----EEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
|+||+++++|.+++...... ....+++..++.++.|++.||+||| +++++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 67999999999999764321 1235889999999999999999999 7899999999999999
Q ss_pred cCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccccc
Q 047195 416 DEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVN 493 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~ 493 (559)
++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--- 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence 999999999999987654321111 112224578999999988889999999999999999998 788875433211
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.......... . .........+.+++.+||+.+|++|||+.+|++.|++|+
T Consensus 251 ----~~~~~~~~~~-------~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 251 ----LFKLLKEGHR-------M-----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ----HHHHHHcCCC-------C-----CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1111111100 0 001123367888999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=297.32 Aligned_cols=226 Identities=24% Similarity=0.385 Sum_probs=176.2
Q ss_pred CccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhc-CCCc---------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQL-NHRS---------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l-~h~n---------------iv~~~~~~ 358 (559)
+.||+|+||.||+|+.. +++.+|+|++... .....+.+..|++++..+ +||| +||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 5789999998753 233445678899999875 7887 47899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|...+.... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 99998886532 4888999999999999999999 788999999999999999999999999998764322221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ........ . ..
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~~~----~---~~--- 215 (321)
T cd05591 153 -TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILHDD----V---LY--- 215 (321)
T ss_pred -ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHcCC----C---CC---
Confidence 2234589999999999888999999999999999999999999975543221 11111100 0 00
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRP-------SIKEVAD 553 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------t~~evl~ 553 (559)
+......+.+++.+||+.+|++|| ++.++++
T Consensus 216 ----p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 ----PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 011235678899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=300.36 Aligned_cols=250 Identities=22% Similarity=0.222 Sum_probs=180.7
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce----------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
..++|++.+.||+|+||.||++.. ..++.+|||++... .......+.+|+.+++.++|+||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999985 45788999998653 23334678899999999999985
Q ss_pred -----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
|+||+.+ +|.+.+.. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeC
Confidence 4566543 55555532 3778889999999999999999 889999999999999999999999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH--------
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF-------- 498 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~-------- 498 (559)
|+++...... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...+..+........
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9997653321 122345899999999999989999999999999999999999999755432221111000
Q ss_pred HHHh--------hc-ch-----hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 499 GNIL--------KQ-ER-----LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 499 ~~~~--------~~-~~-----~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... .. .. ........+..............+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 00 00 00000000000000001112356789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=293.47 Aligned_cols=184 Identities=26% Similarity=0.343 Sum_probs=145.4
Q ss_pred CCccccCCccEEEEEEec---CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCceE-----------------EeeCC
Q 047195 298 GNLLGSGGFGEVFKAILD---DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF-----------------MSMSP 357 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~---~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~niv-----------------~~~~~ 357 (559)
.++||+|+||+||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+ ++|..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 45789999886432 235688999999999999963 45543
Q ss_pred CCcHhHhHhhccC----CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee----cCCCCEEEeecccc
Q 047195 358 NGTLFDRLHRVQS----GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL----DEKLDAKISDFGLS 429 (559)
Q Consensus 358 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill----~~~~~~kl~DFG~a 429 (559)
++|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 577777653221 11235888999999999999999999 8889999999999999 45678999999999
Q ss_pred eeccCCCce--eeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 047195 430 RLALNGASH--VTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNR 487 (559)
Q Consensus 430 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~ 487 (559)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876433221 12234589999999998764 58899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=288.73 Aligned_cols=244 Identities=24% Similarity=0.344 Sum_probs=185.2
Q ss_pred hCCCCCCCccccCCccEEEEEEecC------CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD------ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|++|.||+|...+ ...+++|....... .....+.+|+.++++++|+||
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568999999999999999998653 56788888764432 223568999999999999984
Q ss_pred --EEeeCCCCcHhHhHhhccCC--CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC---CEEEe
Q 047195 352 --FMSMSPNGTLFDRLHRVQSG--NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL---DAKIS 424 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~---~~kl~ 424 (559)
|+||+++++|.+++...... ....+++..+..++.||+.||+||| +++++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 67899999999998765321 1235889999999999999999999 78899999999999998654 59999
Q ss_pred ecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHh
Q 047195 425 DFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNIL 502 (559)
Q Consensus 425 DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 502 (559)
|||+++......... ......+..|+|||++.+..++.++||||||+++|||++ |+.||......+. .. ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~----~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME----FV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HH
Confidence 999998663222111 111123568999999988889999999999999999997 8888864432211 11 01
Q ss_pred hcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 503 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
.... ... .+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 235 ~~~~---------~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 235 TGGG---------RLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HcCC---------cCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 0000 000 011233678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=291.03 Aligned_cols=242 Identities=21% Similarity=0.301 Sum_probs=184.0
Q ss_pred CCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
+|.+.+.||+|+||.||+|... ++..+|+|.++..... ..+.+.+|+.++++++|+||
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677889999999999999853 2478999998754332 23568899999999999996
Q ss_pred EEeeCCCCcHhHhHhhccC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC
Q 047195 352 FMSMSPNGTLFDRLHRVQS-----------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~ 420 (559)
+++|..+++|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 4578889999988753211 11235788889999999999999999 888999999999999999999
Q ss_pred EEEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 047195 421 AKISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYF 498 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 498 (559)
+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+ .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~---- 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V---- 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----
Confidence 99999999886543222 11223336789999999988889999999999999999998 777776432211 1
Q ss_pred HHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 499 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
........... . .......+.+++.+||+.+|++||++++|++.|+.
T Consensus 236 ~~~i~~~~~~~-----~-------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQVLP-----C-------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCcCC-----C-------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111100 0 11234668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=287.12 Aligned_cols=232 Identities=25% Similarity=0.324 Sum_probs=177.2
Q ss_pred cccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcH
Q 047195 301 LGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FMSMSPNGTL 361 (559)
Q Consensus 301 lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L 361 (559)
||+|+||.||++.. .+++.+|+|.+..... .....+..|++++++++|||| |+||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 4689999998864321 223456779999999999994 6799999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeee
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 441 (559)
.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++........ ..
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 152 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--IT 152 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--ee
Confidence 888865322 34888999999999999999999 78899999999999999999999999999876644322 22
Q ss_pred eccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 442 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
...|+..|+|||++.+..++.++||||||+++|||++|+.||........ ......... ...+....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~---------~~~~~~~~-- 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL---------EDEVKFEH-- 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh---------cccccccc--
Confidence 34589999999999888899999999999999999999999864332111 111111100 00000000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
.....++.+|+.+||+.||++||+++|+++.+
T Consensus 220 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 --QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred --ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12235678999999999999999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=285.98 Aligned_cols=241 Identities=25% Similarity=0.399 Sum_probs=187.5
Q ss_pred CCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.+|++.+.||+|+||.||+|... ....+|+|.++.... ...+.+.+|+.++++++|||| |
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999853 234788998765432 234578999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... ..+++..+..++.|++.||+||| +++++||||||+|||++.++.+||+|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 79999999999987532 24788999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeee--ccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 433 LNGASHVTTF--AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 433 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
.......... ..++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ .... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~----~~~~~--- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKA----IEEGY--- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHH----HhCCC---
Confidence 5433222221 123568999999988889999999999999999886 999986443221 1111 11110
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.... ....+..+.+++.+||+.+|++||||.++++.|++++
T Consensus 227 --~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 227 --RLPA-------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred --cCCC-------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 0000 1123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.47 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=187.5
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-CC-----c---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLN-HR-----S--------------- 350 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-h~-----n--------------- 350 (559)
.+|++.+.||+|+||.|.++.. +.++.||||+++.. +....+...|+.+|..|+ |- |
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3799999999999999999984 56899999998753 444577889999999997 32 2
Q ss_pred eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC--CEEEeeccc
Q 047195 351 LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL--DAKISDFGL 428 (559)
Q Consensus 351 iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~--~~kl~DFG~ 428 (559)
||.|.+ ..+|++++.... ...++...++.++.||+.||..|| ..+|||.||||+||||.+.. .+||+|||+
T Consensus 265 iVfELL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeehhh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 344444 568999997643 356999999999999999999999 77899999999999997543 699999999
Q ss_pred ceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH-------
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI------- 501 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~------- 501 (559)
|......-. ....+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+.++.++...+......
T Consensus 338 Sc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 338 SCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred ccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 987543222 334788999999999999999999999999999999999999888776655444322111
Q ss_pred --------hhc-chhh------h----------------cccc-ccc---cCC-ChhhHHHHHHHHHHHHHhcccCCCCC
Q 047195 502 --------LKQ-ERLV------D----------------AIDP-MLK---EGA-SEIELDSMKAFGLLGAACLDERRQNR 545 (559)
Q Consensus 502 --------~~~-~~~~------~----------------~~d~-~l~---~~~-~~~~~~~~~~l~~l~~~cl~~~p~~R 545 (559)
+.. .... . ..+. ... .+. ..........+++++++||.+||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 000 0000 0 0000 000 000 11112345678999999999999999
Q ss_pred CCHHHHHH
Q 047195 546 PSIKEVAD 553 (559)
Q Consensus 546 Pt~~evl~ 553 (559)
+|+.++++
T Consensus 494 ~tp~qal~ 501 (586)
T KOG0667|consen 494 ITPAQALN 501 (586)
T ss_pred CCHHHHhc
Confidence 99999875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.48 Aligned_cols=229 Identities=22% Similarity=0.323 Sum_probs=175.9
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhc-CCCc---------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQL-NHRS---------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l-~h~n---------------iv~~~~~~ 358 (559)
+.||+|+||+||++.. .+++.+|+|+++... ....+.+.+|+.++.++ +|+| +|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 457899999987542 23345688999999888 5887 47899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|...+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 9999888653 24899999999999999999999 788999999999999999999999999998753322211
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........................ .+
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~--- 222 (327)
T cd05617 153 -TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI--- 222 (327)
T ss_pred -eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC---
Confidence 22345999999999999989999999999999999999999999754332222222222221111110 00
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
+......+.+++.+||+.||++||++.
T Consensus 223 ----p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 223 ----PRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ----CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 112235678899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=296.24 Aligned_cols=229 Identities=25% Similarity=0.338 Sum_probs=176.0
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHH---HhcCCCc---------------eE
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRIL---CQLNHRS---------------LF 352 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l---~~l~h~n---------------iv 352 (559)
|++.+.||+|+||.||++.. .+++.+|||+++... ....+.+.+|++++ +.++||| +|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 66788999999999999985 468899999987532 23345677777765 4567998 47
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|...+.. ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 899999999877753 25899999999999999999999 888999999999999999999999999998754
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ... .....
T Consensus 152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~-i~~~~------ 217 (324)
T cd05589 152 MGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDS-IVNDE------ 217 (324)
T ss_pred CCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhCC------
Confidence 32221 12234589999999999988899999999999999999999999975432211 010 10100
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
.... ......+.+++.+||+.||++||+ +.++++
T Consensus 218 ~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 VRYP-------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCC-------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0011 122356788999999999999994 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.82 Aligned_cols=232 Identities=29% Similarity=0.398 Sum_probs=181.5
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcHh
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL---------------FMSMSPNGTLF 362 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L~ 362 (559)
++||+|+||.||+|...++..+|+|.+...... ....+.+|++++++++|+|| |+||.++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 469999999999999888899999987654332 23468899999999999984 77999999999
Q ss_pred HhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeee
Q 047195 363 DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442 (559)
Q Consensus 363 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 442 (559)
+.+.... ..+.+..+..++.|++.+|.||| +++++||||||+||++++++.+||+|||++.............
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 9886432 24789999999999999999999 8899999999999999999999999999987644332222222
Q ss_pred ccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 443 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
..++..|+|||++.+..++.++||||||+++|||++ |..||........ ........ . ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-------~~~~~~~~-~----~~~------ 215 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-------REQVEKGY-R----MSC------ 215 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHHcCC-C----CCC------
Confidence 235678999999988889999999999999999998 8889864432111 01111110 0 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.......+.+++.+|++.+|++|||+.|++++|.
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 -PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0123367889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=284.00 Aligned_cols=237 Identities=24% Similarity=0.402 Sum_probs=185.0
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSP 357 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~ 357 (559)
.+|++.+.||+|+||.||++.+.++..+|+|.+..... ..+++.+|++++++++|||+ +++|++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46888899999999999999987788899998764433 34679999999999999984 678899
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++.... ..+++..+..++.|++.+|+||| +.+++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999998886532 24789999999999999999999 78899999999999999999999999999876543322
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.......++.+|+|||.+.+..++.++||||||+++|||++ |+.||....... . ... .... .....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~---~~~-~~~~--~~~~~~~-- 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---V---VET-INAG--FRLYKPR-- 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---H---HHH-HhCC--CCCCCCC--
Confidence 11112225678999999988889999999999999999998 888886433211 0 111 1000 0000111
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.....+.+|+.+||+.+|++|||+.|++++|.
T Consensus 225 --------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 --------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12367889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.22 Aligned_cols=236 Identities=26% Similarity=0.319 Sum_probs=192.7
Q ss_pred HhCCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCCC---ChhhHHHHHHHHHhcC-CCce--------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTK---GIDPILNEVRILCQLN-HRSL-------------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~-h~ni-------------- 351 (559)
....|++.+.||+|.||.||+++.+. ++.+|+|.+...... ..+.+.+|+.+|+++. ||||
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34578999999999999999999655 899999998765443 3468999999999999 9994
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC----CCEEEeec
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK----LDAKISDF 426 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~----~~~kl~DF 426 (559)
|||++.+|.|++.+... .+++..+..++.|++.++.||| +.+|+||||||+|+|+... +.+|++||
T Consensus 113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 78999999999999775 2899999999999999999999 7889999999999999643 47999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
|++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... ....+.
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~ 254 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD 254 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC
Confidence 99998766 334455679999999999999999999999999999999999999998665433211 111111
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+ ..-...+ ........++++.||..||.+|+|+.++++
T Consensus 255 ~-----~f~~~~w----~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 F-----DFTSEPW----DDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred C-----CCCCCCc----cccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1 0011111 133567888999999999999999999986
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=296.89 Aligned_cols=251 Identities=23% Similarity=0.265 Sum_probs=179.3
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCceEE------------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSLFM------------ 353 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~------------ 353 (559)
.+..++|++.+.||+|+||+||++.. .++..+|||++..... .....+.+|++++++++|+||+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34567899999999999999999985 5678999999865322 23456789999999999999642
Q ss_pred ---------eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEe
Q 047195 354 ---------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKIS 424 (559)
Q Consensus 354 ---------~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~ 424 (559)
++ .+++|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+
T Consensus 91 ~~~~~~~~~~~-~~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNL-MGADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeec-CCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEc
Confidence 22 25667666542 24889999999999999999999 8889999999999999999999999
Q ss_pred ecccceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH----
Q 047195 425 DFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG---- 499 (559)
Q Consensus 425 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~---- 499 (559)
|||+++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.........
T Consensus 161 Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 161 DFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred CCccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999998654322 22348999999999877 468899999999999999999999997543222111100000
Q ss_pred ----HHhhcchhhhccccc--cc-cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 500 ----NILKQERLVDAIDPM--LK-EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 500 ----~~~~~~~~~~~~d~~--l~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...........+... .. .............+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000 00 0000000011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=300.01 Aligned_cols=250 Identities=22% Similarity=0.211 Sum_probs=179.3
Q ss_pred HHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCceE--------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSLF-------------- 352 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~niv-------------- 352 (559)
...++|++.+.||+|+||.||++.. ..++.+|||++.... ......+.+|+.+++.++|+||+
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999985 467899999886532 23345688999999999999863
Q ss_pred -------EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 353 -------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 353 -------~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
+||++ +++.+.+.. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence 34443 234444321 3788888999999999999999 88999999999999999999999999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH-------
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF------- 498 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~------- 498 (559)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+........
T Consensus 163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99997653321 122345899999999999889999999999999999999999999755432211111000
Q ss_pred -HHHhhcchhhhcccc---------------ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 499 -GNILKQERLVDAIDP---------------MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 499 -~~~~~~~~~~~~~d~---------------~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ......++. .+..............+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 241 FMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00000 000000000 0000000011122356789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=284.94 Aligned_cols=236 Identities=25% Similarity=0.326 Sum_probs=179.8
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||+|+||.||+|.. .++..+|+|.+.... .....++.+|++++++++|||+ |+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999984 567899999886542 2334568999999999999984 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.... .+++..+..++.|++.||+||| +.+|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 8988885431 3678888999999999999999 888999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
. .....++..|+|||++.+..++.++||||||+++|+|++|+.||...................... ..+.+
T Consensus 149 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 220 (279)
T cd06619 149 I---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVL 220 (279)
T ss_pred c---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCC
Confidence 2 122358999999999998889999999999999999999999986433221111000000000000 00111
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.. .....++.+++.+||+.+|++||++.|+++.
T Consensus 221 ~~------~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PV------GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC------CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 1123567889999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.48 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=187.5
Q ss_pred hCCCCCCCccccCCccEEEEEEecC-----------------CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD-----------------ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL-- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni-- 351 (559)
.++|++.+.||+|+||.||++...+ ...+|+|.+..... ...+++.+|++++++++|+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3579999999999999999987542 24578998775432 345678999999999999995
Q ss_pred -------------EEeeCCCCcHhHhHhhccCC------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCC
Q 047195 352 -------------FMSMSPNGTLFDRLHRVQSG------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSN 412 (559)
Q Consensus 352 -------------v~~~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~N 412 (559)
++|+.++++|.+++...... ....+++..+..++.|++.||+||| +++|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 56888999999998765421 1236899999999999999999999 7889999999999
Q ss_pred eeecCCCCEEEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCCcc
Q 047195 413 ILLDEKLDAKISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT--SKKAVDFNREE 489 (559)
Q Consensus 413 ill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t--g~~p~~~~~~~ 489 (559)
|++++++.++|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ +..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876543221 22223446789999999988889999999999999999998 56666433211
Q ss_pred ccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 490 EDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
. ........+.......... . ....+.++.+++.+||+.+|++|||+.||++.|++
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~~------~---~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 Q---VIENAGHFFRDDGRQIYLP------R---PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H---HHHHHHhccccccccccCC------C---ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 1111111111111000000 0 01223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=293.44 Aligned_cols=225 Identities=25% Similarity=0.375 Sum_probs=174.7
Q ss_pred CccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHh-cCCCc---------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQ-LNHRS---------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~-l~h~n---------------iv~~~~~~ 358 (559)
+.||+|+||+||+|... +++.+|+|.++... ......+..|..++.. ++||| +|+||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987542 2334567788888876 58988 47899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 9999988653 24888999999999999999999 889999999999999999999999999998754322221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. . .. .... .+.+.
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~---~~-i~~~------~~~~~-- 216 (316)
T cd05619 153 -TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---F---QS-IRMD------NPCYP-- 216 (316)
T ss_pred -eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---H---HH-HHhC------CCCCC--
Confidence 2234589999999999988899999999999999999999999975432111 0 00 0000 01111
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIK-EVA 552 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl 552 (559)
......+.+++.+||+.+|++||++. ++.
T Consensus 217 -----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 -----RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -----ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11235678899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=288.87 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=185.0
Q ss_pred CCCCCCCccccCCccEEEEEEec-----------------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-----------------DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--- 351 (559)
++|++.+.||+|+||.||++... +...+|+|.+..... ...+++.+|+++++.++|+||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46999999999999999998532 234688998875432 334678999999999999984
Q ss_pred ------------EEeeCCCCcHhHhHhhccCCC------CCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCe
Q 047195 352 ------------FMSMSPNGTLFDRLHRVQSGN------WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNI 413 (559)
Q Consensus 352 ------------v~~~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Ni 413 (559)
++||+++++|.+++....... ...+++..+..++.|++.||+||| +.+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 679999999999987643211 124778889999999999999999 78899999999999
Q ss_pred eecCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCCccc
Q 047195 414 LLDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT--SKKAVDFNREEE 490 (559)
Q Consensus 414 ll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t--g~~p~~~~~~~~ 490 (559)
|+++++.+||+|||+++......... .....+++.|+|||......++.++||||||+++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999997654322211 122234678999999888889999999999999999998 666765433222
Q ss_pred cccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
.. ......+..... ....+ .....+..+.+++.+||+.+|++|||+.||++.|++
T Consensus 242 ~~---~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VI---ENTGEFFRDQGR-QVYLP--------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHhhccc-cccCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 111111111000 00000 011233678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.89 Aligned_cols=186 Identities=26% Similarity=0.343 Sum_probs=155.6
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCc---------------eEEe
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRS---------------LFMS 354 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~n---------------iv~~ 354 (559)
.|++.+.||+|+||+||+|+. .+++.+|+|++.... ....+.+.+|+.++++++|+| +|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999985 567899999986532 233457889999999999998 4789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 999999999887532 4788899999999999999999 78899999999999999999999999999753210
Q ss_pred CC----------------------------------------------ceeeeeccccCCccCccccccCCCCcccchhH
Q 047195 435 GA----------------------------------------------SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYS 468 (559)
Q Consensus 435 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 468 (559)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00011235899999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 047195 469 FGVVLVELLTSKKAVDFNR 487 (559)
Q Consensus 469 lG~il~el~tg~~p~~~~~ 487 (559)
|||++|||++|+.||....
T Consensus 234 lGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred chHHHHHHHhCCCCCCCCC
Confidence 9999999999999997544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.73 Aligned_cols=236 Identities=23% Similarity=0.317 Sum_probs=178.9
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||+||++.. .+++.+|||++.... ....+.+.+|++++++++|||| |+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688999999999999999985 568899999986532 2334668899999999999984 68
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999988653 24888999999999999999999 8889999999999999999999999999986432
Q ss_pred CCCce----------------------------------------------eeeeccccCCccCccccccCCCCcccchh
Q 047195 434 NGASH----------------------------------------------VTTFAQGTLGYLDPEYYINFQLTDKSDVY 467 (559)
Q Consensus 434 ~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 467 (559)
..... ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 10000 00123599999999999988999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCC--
Q 047195 468 SFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNR-- 545 (559)
Q Consensus 468 SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-- 545 (559)
||||++|||++|+.||......+. ......... .+ .+.. . ......+.+|+.+||+ +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~---~~--~~p~-~----~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHET------YRKIINWRE---TL--YFPD-D----IHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHH------HHHHHccCC---cc--CCCC-C----CCCCHHHHHHHHHHhc-CHhhcCC
Confidence 999999999999999975443211 111100000 00 0000 0 0123567789999997 66665
Q ss_pred -CCHHHHHH
Q 047195 546 -PSIKEVAD 553 (559)
Q Consensus 546 -Pt~~evl~ 553 (559)
||+.|+++
T Consensus 296 r~~~~~~l~ 304 (377)
T cd05629 296 RGGAHEIKS 304 (377)
T ss_pred CCCHHHHhc
Confidence 59988875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=284.93 Aligned_cols=237 Identities=28% Similarity=0.420 Sum_probs=178.8
Q ss_pred CccccCCccEEEEEEecC-Cc--EEEEEEeecCC-CCChhhHHHHHHHHHhc-CCCce---------------EEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILDD-ET--ITAVKRAKLGN-TKGIDPILNEVRILCQL-NHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-~~--~~avk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni---------------v~~~~~~ 358 (559)
+.||+|+||.||+|..++ +. .+++|.++... ....+.+.+|+++++++ +|||+ ++||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999654 33 46788776432 33446789999999999 79884 6799999
Q ss_pred CcHhHhHhhccC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 359 GTLFDRLHRVQS-----------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 359 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
++|.+++..... .....+++..+..++.|++.||+||| +++++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 11235789999999999999999999 7899999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
++........ ......+..|+|||++....++.++||||||+++|||++ |+.||......+ .... .....
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~-~~~~~ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK-LPQGY 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHH-HhCCC
Confidence 9863221111 111224567999999988889999999999999999997 999986432211 1111 10100
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.+. ........+.+++.+||+.+|.+|||+.+++++|++|+
T Consensus 229 -------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 -------RLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------CCC-----CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 01122356889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.05 Aligned_cols=243 Identities=27% Similarity=0.402 Sum_probs=188.0
Q ss_pred CCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce-------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni------------- 351 (559)
++|.+.+.||+|+||.||++.. ..+..+|+|.++.... ...+.+.+|+.+++++ +|+||
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4689999999999999999974 2345789998765432 2345689999999999 79984
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
++||+++++|.+++..... ..+++..+..++.|++.||+||| +++|+|+||||+|||++.++.+||+|||++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 6789999999999875332 23899999999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 430 RLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 430 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
+........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ +......+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~- 261 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGY- 261 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCC-
Confidence 865443221 1122336788999999988889999999999999999998 8988864432111 111111110
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.... .......+.+++.+||+.+|++|||+.||++.|++++
T Consensus 262 ----~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 262 ----RMAQ-------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred ----cCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 0000 0112357889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=281.26 Aligned_cols=240 Identities=24% Similarity=0.306 Sum_probs=176.1
Q ss_pred CccccCCccEEEEEEecC---CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAILDD---ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~---~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g 359 (559)
+.||+|+||.||+|...+ ...+|+|.++.... .....+.+|+.++++++|||+ |+||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998643 35788998765443 233478999999999999994 67999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
+|.+++..........+++..+..++.|++.||+||| +.+++|+||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997643322234677788899999999999999 7889999999999999999999999999987543322211
Q ss_pred -eeeccccCCccCccccccC-------CCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 440 -TTFAQGTLGYLDPEYYINF-------QLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 440 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. .... ........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT----VREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH----hhcccCCC
Confidence 1223467889999988542 35789999999999999996 9999864432211 1110 01111111
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.++.+.. .....+.+++..|+ .+|++|||+.||+..|+
T Consensus 231 ~~~~~~~-------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL-------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC-------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1122211 12245777888998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.12 Aligned_cols=236 Identities=22% Similarity=0.255 Sum_probs=178.1
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||.||+++. .+++.+|||.+.... ......+.+|+++|++++|+|| ||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4689999999999999999985 458899999986432 2334668899999999999984 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++..+.
T Consensus 81 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 999999999998753 24788889999999999999999 8889999999999999999999999999975321
Q ss_pred CCC------------------------------------------ceeeeeccccCCccCccccccCCCCcccchhHHHH
Q 047195 434 NGA------------------------------------------SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGV 471 (559)
Q Consensus 434 ~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ 471 (559)
... ........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 000 00011235999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC---CH
Q 047195 472 VLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP---SI 548 (559)
Q Consensus 472 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---t~ 548 (559)
++|||++|+.||......+.... .. .+.. . +. +.. . ......+.+++.+|+ .+|.+|+ |+
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~---i~-~~~~-~----~~--~~~-~----~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLK---VI-NWET-T----LH--IPS-Q----AKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHH---Hh-ccCc-c----cc--CCC-C----CCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 99999999999975543221100 00 0000 0 00 000 0 012345666777766 5999999 88
Q ss_pred HHHHH
Q 047195 549 KEVAD 553 (559)
Q Consensus 549 ~evl~ 553 (559)
.|+++
T Consensus 296 ~ell~ 300 (376)
T cd05598 296 DEIKA 300 (376)
T ss_pred HHHhC
Confidence 88874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.79 Aligned_cols=223 Identities=28% Similarity=0.346 Sum_probs=175.7
Q ss_pred CccccCCccEEEEEEe----cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEeeCC
Q 047195 299 NLLGSGGFGEVFKAIL----DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMSMSP 357 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~----~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~ 357 (559)
+.||+|+||.||+++. .+++.+|+|++..... .....+.+|++++++++|||| |+||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 3578999999875432 233567889999999999984 679999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 99999988653 24899999999999999999999 78899999999999999999999999999986543322
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... .... .+
T Consensus 154 ~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i~-~~~~------~~-- 217 (318)
T cd05582 154 K-AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMIL-KAKL------GM-- 217 (318)
T ss_pred c-eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHHH-cCCC------CC--
Confidence 2 2234589999999999888899999999999999999999999975432111 11100 1000 00
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e 550 (559)
+......+.+++++||+.||++|||+.+
T Consensus 218 -----p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 -----PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -----CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122356788999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=281.86 Aligned_cols=233 Identities=28% Similarity=0.420 Sum_probs=181.9
Q ss_pred CccccCCccEEEEEEecC----CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------EEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAILDD----ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------FMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~----~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~~g 359 (559)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++++.|+|+ |++|++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 479999999999997422 26899998875543 234678999999999999985 56888999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
+|.+.+.... .+++..+..++.|++.||+||| ..+++|+||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 81 PLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred cHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999987532 5889999999999999999999 7889999999999999999999999999998765433222
Q ss_pred ee--eccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 440 TT--FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 440 ~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.. ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..... .......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~----~~~~~~~------- 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML----ESGERLP------- 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----HcCCcCC-------
Confidence 11 1224568999999988889999999999999999998 899986443211 11111 1110000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.....+..+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 219 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -----RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0112236788999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=296.49 Aligned_cols=241 Identities=29% Similarity=0.413 Sum_probs=188.8
Q ss_pred cccccChHHHHHHhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCCc----
Q 047195 279 LARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTK---GIDPILNEVRILCQLNHRS---- 350 (559)
Q Consensus 279 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~n---- 350 (559)
++..|..++-++. |.-++.||.|+||.||.|+ ..+...||||++....+. ..++++.||+.|.+++|||
T Consensus 15 iA~LF~k~DPEkl---f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieY 91 (948)
T KOG0577|consen 15 IADLFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEY 91 (948)
T ss_pred HHHHHccCCHHHH---HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccc
Confidence 3444544444433 5667889999999999999 456789999999876443 3467999999999999999
Q ss_pred -----------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC
Q 047195 351 -----------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL 419 (559)
Q Consensus 351 -----------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~ 419 (559)
+||||+- |+-.|+++-.. .++.+.++..|..+.+.||+||| +.+.||||||.-|||+++.|
T Consensus 92 kgCyLre~TaWLVMEYCl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g 163 (948)
T KOG0577|consen 92 KGCYLREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPG 163 (948)
T ss_pred cceeeccchHHHHHHHHh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCC
Confidence 4788874 57777776543 36899999999999999999999 77899999999999999999
Q ss_pred CEEEeecccceeccCCCceeeeeccccCCccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 047195 420 DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN---FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496 (559)
Q Consensus 420 ~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~ 496 (559)
.|||+|||.|....... ..+|||.|||||++.. ++|+-|+||||||++..||.-+++|....+.......+
T Consensus 164 ~VKLaDFGSAsi~~PAn-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI- 237 (948)
T KOG0577|consen 164 LVKLADFGSASIMAPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI- 237 (948)
T ss_pred eeeeccccchhhcCchh-----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-
Confidence 99999999997654332 2349999999999864 57999999999999999999999998755432211110
Q ss_pred HHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 497 YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 497 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... .|.|. ..+....+..++..||+.-|.+|||..+++.
T Consensus 238 -----AQNe------sPtLq------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 238 -----AQNE------SPTLQ------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -----HhcC------CCCCC------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 0000 11111 2466788999999999999999999999875
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=287.73 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=187.8
Q ss_pred hCCCCCCCccccCCccEEEEEEecC------CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD------ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|+||.||+|..++ +..+|+|.+..... .....+.+|+.+++.++|+||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578899999999999999998542 36899999765432 334568899999999999984
Q ss_pred --EEeeCCCCcHhHhHhhccCC-----CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEe
Q 047195 352 --FMSMSPNGTLFDRLHRVQSG-----NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKIS 424 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~ 424 (559)
|+||+++++|.+++...... ....+++..+..++.|++.||.||| +++++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 67899999999998754321 1234788899999999999999999 8889999999999999999999999
Q ss_pred ecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHh
Q 047195 425 DFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNIL 502 (559)
Q Consensus 425 DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 502 (559)
|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-------LKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-------HHHH
Confidence 99998765432211 1222336789999999988889999999999999999998 8888864332211 1111
Q ss_pred hcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 503 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
....... +. ......+.+++.+||+.+|++|||+.++++.|++
T Consensus 235 ~~~~~~~-----~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLD-----LP-------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCC-----CC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111000 00 1124678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=293.74 Aligned_cols=225 Identities=24% Similarity=0.351 Sum_probs=174.0
Q ss_pred CccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhc-CCCc---------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQL-NHRS---------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l-~h~n---------------iv~~~~~~ 358 (559)
+.||+|+||.||+++.+ ++..+|+|.++... ......+..|..++..+ +|+| +||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 57899999987532 23345677888888764 7887 47899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|...+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence 9999888653 24788999999999999999999 88899999999999999999999999999875432222
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . .. ..... .+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~---~~-~~~~~------~~~~~-- 216 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L---FE-SIRVD------TPHYP-- 216 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HH-HHHhC------CCCCC--
Confidence 2233459999999999998899999999999999999999999997543211 1 01 00000 01111
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIK-EVA 552 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl 552 (559)
......+.+++.+||+.||++||++. +++
T Consensus 217 -----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 -----RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11235678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=283.22 Aligned_cols=235 Identities=24% Similarity=0.341 Sum_probs=176.9
Q ss_pred CccccCCccEEEEEEec----CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce----------------EEeeCC
Q 047195 299 NLLGSGGFGEVFKAILD----DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL----------------FMSMSP 357 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni----------------v~~~~~ 357 (559)
+.||+|+||.||+|... +...+|+|.+.... ....+.+.+|+.+++.++|||+ +++|+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46999999999999853 23578999875432 3345678899999999999984 568889
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++.... ..+.+..+..++.|++.||+||| +.+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999987532 23677788899999999999999 78899999999999999999999999999976543221
Q ss_pred ee---eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCC-CCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 438 HV---TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK-AVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 438 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+. |+...... ... ........ .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~---~~~~~~~~------~ 221 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DIT---VYLLQGRR------L 221 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HHHhcCCC------C
Confidence 11 112236778999999988889999999999999999999654 45422211 111 11110000 0
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.. +...+..+.+++.+||+.+|++||++.||++.|++++
T Consensus 222 ~~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQ-------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CC-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00 0112356889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=281.56 Aligned_cols=236 Identities=30% Similarity=0.394 Sum_probs=184.2
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-----CChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-----KGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++|++.+.||+|++|.||++.. .+++.+|+|.+..... ...+.+.+|++++++++||||
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999985 4688999998765422 223568899999999999985
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
++||+++++|.+.+.... .+++..+..++.|++.||.||| ..+++||||+|+||++++++.+||+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 568899999999887532 4788999999999999999999 88899999999999999999999999999976
Q ss_pred ccCCCceee--eeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 432 ALNGASHVT--TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 432 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
......... ....++..|+|||++.+..++.++||||||+++|||++|+.||........ ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~---- 223 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQP---- 223 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccC----
Confidence 543221111 223478899999999988899999999999999999999999863321110 01000000
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
....+ +......+.+++.+||..+|++|||+.++++.
T Consensus 224 -~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -TNPQL-------PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCC-------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00111 11233567889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=283.02 Aligned_cols=235 Identities=23% Similarity=0.352 Sum_probs=184.9
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
+|++.+.||+|+||.||++... ++..+|+|.++... ....+.+.+|+.++++++|+|+ +++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999854 67889999886532 3445678899999999999984 67999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+.+..... ..+++..+..++.|++.||.||| +++|+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999988865322 34788999999999999999999 8899999999999999999999999999997664332
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||....... ..... ...... +
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~----~--- 219 (255)
T cd08219 155 A-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKV-CQGSYK----P--- 219 (255)
T ss_pred c-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHH-hcCCCC----C---
Confidence 2 1223448899999999988889999999999999999999999996432211 01110 011100 0
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.+......+.+++.+||+.+|++|||+.|++.+
T Consensus 220 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -----LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011233567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=294.65 Aligned_cols=227 Identities=23% Similarity=0.345 Sum_probs=176.7
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCc----------------eEE
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRS----------------LFM 353 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~n----------------iv~ 353 (559)
+|+..+.||+|+||.||++.. .+++.+|+|++... .....+.+..|+.++..+.|++ +|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467789999999999999985 46889999998753 2233456888999998887643 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999998886532 4889999999999999999999 8889999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..... ....
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~-~~~~------ 218 (323)
T cd05615 153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL------FQSIM-EHNV------ 218 (323)
T ss_pred CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hCCC------
Confidence 2221 12234489999999999888899999999999999999999999975432111 11111 1000
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
.+. ......+.+++.+||+.+|.+|++..
T Consensus 219 ~~p-------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 SYP-------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCC-------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 000 12235678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.62 Aligned_cols=241 Identities=26% Similarity=0.409 Sum_probs=185.4
Q ss_pred CCCCCCCccccCCccEEEEEEecC-C---cEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-E---TITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-~---~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
++|++.+.||+|+||.||+|.... + ..+|||.+.... .....+|.+|+.++++++|||| |
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998643 2 369999886542 3334679999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... ..+++..+..++.|++.||+||| +++++|+||||+|||++.++.+||+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 84 TEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 79999999999886532 24789999999999999999999 788999999999999999999999999998765
Q ss_pred cCCCceee-e-ecc--ccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 433 LNGASHVT-T-FAQ--GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 433 ~~~~~~~~-~-~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
........ . ... .+..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----~~~-- 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----EQD-- 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcC--
Confidence 43222111 1 111 2457999999988889999999999999999886 999986443211 11111 000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.. +.. ..+.+..+.+++.+||+.+|++||++.+|+++|++++
T Consensus 228 ---~~--~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 228 ---YR--LPP-----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred ---Cc--CCC-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 00 000 0123356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=280.93 Aligned_cols=234 Identities=28% Similarity=0.424 Sum_probs=184.5
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce----------------EEe
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL----------------FMS 354 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni----------------v~~ 354 (559)
+|++.+.||+|++|.||++.. .+++.+|+|++.... ....+.+.+|++++++++|+|+ ++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488899999999999999985 457889999986543 2344578999999999999884 568
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++++|.+.+..... ..+++..+..++.|++.||++|| +++++||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 8889999988875322 35899999999999999999999 88899999999999999999999999999987643
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
... ......+++.|+|||++.+..++.++||||||+++++|++|+.||...+... ..... ..+.. +.
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~-~~~~~-----~~ 221 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRI-IEGKL-----PP 221 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHH-HhcCC-----CC
Confidence 322 2223348899999999998889999999999999999999999986433111 11111 11111 00
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+ .......+.+++.+||+.+|++|||+.++++
T Consensus 222 ~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 M-------PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred C-------ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1 1233467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.04 Aligned_cols=240 Identities=26% Similarity=0.407 Sum_probs=197.0
Q ss_pred CCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
...+.++||.|.||.|++|+++ ....||||-++.... +...+|+.|+.||.++.|||| |.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567789999999999999964 357899999998654 445689999999999999995 45
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
|||+||+|..+|+.... .+.+.+..-++++||.|+.||- +.+++||||...|||++.+...|++|||+++..+
T Consensus 710 EyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999987543 4899999999999999999999 8889999999999999999999999999999887
Q ss_pred CCCceeeeec--cccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 434 NGASHVTTFA--QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 434 ~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
++.....+.. .-..+|.|||.+....+|.+|||||||++|||.++ |.+|+-...+++- ...
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV----------------Ika 846 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV----------------IKA 846 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH----------------HHH
Confidence 6653333222 23578999999999999999999999999999886 8888764433321 111
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
++.-.+ -..+++++..|.+|+++||++|..+||++.+|+.+|.+++
T Consensus 847 Ie~gyR---LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 847 IEQGYR---LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHhccC---CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 111111 1224678899999999999999999999999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=293.13 Aligned_cols=226 Identities=25% Similarity=0.358 Sum_probs=176.9
Q ss_pred CccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhc-CCCce---------------EEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQL-NHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni---------------v~~~~~~ 358 (559)
+.||+|+||+||++..+ ++..+|+|+++.. .....+.+.+|+++++.+ +|||| |+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 5789999998753 233456678899999887 68884 7899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 99998886532 4899999999999999999999 888999999999999999999999999998753322221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... ...... ..+.
T Consensus 153 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~-~i~~~~------~~~~-- 216 (318)
T cd05570 153 -TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQ-SILEDE------VRYP-- 216 (318)
T ss_pred -ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHH-HHHcCC------CCCC--
Confidence 122348999999999999899999999999999999999999997443211 011 111110 0011
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSI-----KEVAD 553 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evl~ 553 (559)
......+.+++.+||+.||++|||+ .++++
T Consensus 217 -----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 -----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1223567899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=281.49 Aligned_cols=233 Identities=28% Similarity=0.380 Sum_probs=178.5
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcH
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSMSPNGTL 361 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L 361 (559)
+.||+|+||.||+|+. .+++.+|+|....... .....+.+|++++++++|+|| |+||.++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999986 4688899998764332 334679999999999999984 6799999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee-e
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-T 440 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~ 440 (559)
.+++.... ..+++..+..++.|++.||+||| +++++||||||+|||++.++.+||+|||++.......... .
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99886432 25789999999999999999999 8889999999999999999999999999987543221111 1
Q ss_pred eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCC
Q 047195 441 TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGA 519 (559)
Q Consensus 441 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 519 (559)
.....+..|+|||.+.+..++.++||||||+++|||++ |..|+........ ....... .....
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~---------~~~~~ 217 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQG---------VRLPC 217 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcC---------CCCCC
Confidence 11123567999999988889999999999999999998 8878753322110 0000000 00000
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 520 SEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 520 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
....+..+.+++.+||+.+|++|||+.+|+++|+.
T Consensus 218 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 218 ---PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 11224678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.80 Aligned_cols=239 Identities=22% Similarity=0.296 Sum_probs=179.2
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCc---------------eEE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRS---------------LFM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~n---------------iv~ 353 (559)
++|++.+.||+|+||.||+++. .+++.+|+|.+... .....+.+.+|+.++..++|+| +|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4689999999999999999995 45889999998642 2233456889999999999988 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999986532 24889999999999999999999 8889999999999999999999999999987655
Q ss_pred CCCceeeeeccccCCccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYIN-----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
...........||+.|+|||++.. ..++.++||||||+++|||++|+.||......+. ...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~ 227 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHF 227 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcc
Confidence 433322333459999999999863 3578899999999999999999999964432111 11111110000
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCC--CCCCHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQ--NRPSIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~--~RPt~~evl~ 553 (559)
. +.... ......+.+++++||..+++ .||++.++++
T Consensus 228 ~-----~~~~~----~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 228 Q-----FPPDV----TDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred c-----CCCcc----CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 0 00000 11335677788887765443 3789988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=296.44 Aligned_cols=222 Identities=29% Similarity=0.368 Sum_probs=171.5
Q ss_pred CccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHH-HHHhcCCCce---------------EEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVR-ILCQLNHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~-~l~~l~h~ni---------------v~~~~~~ 358 (559)
+.||+|+||+||+|+.. +++.+|+|++.... .....++.+|.. +++.++|||| |+||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986532 222345566655 4578999984 6899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|...+... ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK- 151 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence 9999888653 24888999999999999999999 88899999999999999999999999999875432221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+ ...... ... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~-~~~------~~~~-- 216 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNIL-NKP------LRLK-- 216 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHH-cCC------CCCC--
Confidence 2223458999999999998899999999999999999999999997543211 111111 000 0111
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
......+.+++.+||+.+|++||++.
T Consensus 217 -----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 -----PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11236688899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=293.46 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=202.7
Q ss_pred HHHHHHhCCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc--------------
Q 047195 286 REITEATNNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-------------- 350 (559)
Q Consensus 286 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n-------------- 350 (559)
++++....+..+..+||.|.||.||.|.|+. ...||||-++.. ....++|+.|+.+|+.++|||
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4555556677888999999999999999865 567899988764 455689999999999999999
Q ss_pred -eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 351 -LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 351 -iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
||.|||.+|+|.++|..... ..++....+.++.||+.|++||. .+++|||||...|.|+.++..+||+||||+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred EEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchh
Confidence 46799999999999987654 34777778899999999999999 888999999999999999999999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
+++..+....-......+.|.|||.+....++.|+|||+||++|||+.| |..|+.+.+ +.....
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~--------- 477 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYG--------- 477 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHH---------
Confidence 9988776555555557889999999988889999999999999999988 777876432 222111
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
+++.-.+-+. +..++..+.+|++.||++.|.+||++.|+-+.+|.|+
T Consensus 478 -LLEkgyRM~~---PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 478 -LLEKGYRMDG---PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -HHhccccccC---CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 1111111111 1245678999999999999999999999999999874
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.86 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=182.5
Q ss_pred HHHHHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce-----------
Q 047195 287 EITEATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL----------- 351 (559)
Q Consensus 287 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni----------- 351 (559)
++....++|++.+.||+|+||.||++..+ +++.+|+|.+... .....+.+.+|+.+++.++||||
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 33444578999999999999999999964 5788999998642 22233557899999999999984
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
|+||+++|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 78999999999988642 3788888999999999999999 8889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccC----CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINF----QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 503 (559)
+++..............||+.|+|||++... .++.++||||||+++|||++|+.||...+... .......
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence 9987654332222344599999999998754 37889999999999999999999997543211 1111111
Q ss_pred cchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047195 504 QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQN--RPSIKEVADE 554 (559)
Q Consensus 504 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~ 554 (559)
........+ .......+.+++.+||..++.+ ||++.|+++.
T Consensus 262 ~~~~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 HKNSLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCcccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 110000000 0123356778899999844433 7788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=287.03 Aligned_cols=234 Identities=23% Similarity=0.344 Sum_probs=186.5
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.+|++.+.||+|++|.||+|.. .+++.+++|.+........+.+.+|+.+++.+.|+|+ |+||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788999999999999999984 5678999999887666666789999999999999984 67999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999998854 24788999999999999999999 7889999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... .. ...... +.+.
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-----~~-~~~~~~------~~~~ 237 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YL-IATNGT------PELQ 237 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-----HH-HhcCCC------CCCC
Confidence 21 12234889999999998888899999999999999999999999654322110 00 000000 0000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........+.+++.+||..+|++|||+.|+++
T Consensus 238 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 -----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -----CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 01123356788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=270.72 Aligned_cols=237 Identities=24% Similarity=0.311 Sum_probs=182.6
Q ss_pred HhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
..++|++.+.||+|.|+.||+.. ...|+.+|+|.+... ...+.+++.+|++|-+.|+|||| |
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34678888999999999999987 456888888876543 34467889999999999999996 5
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC---CCEEEeecccc
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK---LDAKISDFGLS 429 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~---~~~kl~DFG~a 429 (559)
++++.++.|..-+-.. .-+++..+....+||++||.|+| .++|||||+||+|+|+-.. .-+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceE
Confidence 6889999986554332 23788889999999999999999 8999999999999999543 35899999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
..+..+ .......|||+|||||++...+|+..+|||+-|+|||-|+.|..||....... + +.+. ..+...
T Consensus 161 i~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l---ye~I-~~g~yd- 230 (355)
T KOG0033|consen 161 IEVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L---YEQI-KAGAYD- 230 (355)
T ss_pred EEeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H---HHHH-hccccC-
Confidence 987732 22333459999999999999999999999999999999999999997533211 1 1111 111100
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+++ .+.+ ...++...|+++||..||.+|.|+.|.+.
T Consensus 231 -~~~---~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 -YPS---PEWD----TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -CCC---cccC----cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 000 0111 22355678999999999999999999874
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=283.45 Aligned_cols=238 Identities=24% Similarity=0.384 Sum_probs=183.1
Q ss_pred HHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCc-----------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRS----------------- 350 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~n----------------- 350 (559)
.+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.+++++ +|+|
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3556788899999999999999985 457889999987543 3446789999999998 6876
Q ss_pred ----eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 351 ----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 351 ----iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
+++||+.+++|.+++..... ..+++..+..++.|++.||+||| +++|+|+||||+||++++++.+||+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccC
Confidence 36688899999998876322 35889999999999999999999 788999999999999999999999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
|++........ ......|++.|+|||++. +..++.++||||||+++|||++|+.||....... ....
T Consensus 156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~-- 227 (272)
T cd06637 156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL-- 227 (272)
T ss_pred CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH--
Confidence 99986543221 122344899999999986 3357889999999999999999999985332111 0000
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... .+.+.. ......+.+|+.+||+.+|.+|||+.|+++
T Consensus 228 ~~~~~-----~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IPRNP-----APRLKS------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HhcCC-----CCCCCC------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 001100 122356889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=286.39 Aligned_cols=244 Identities=26% Similarity=0.351 Sum_probs=186.6
Q ss_pred hCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|+||.||++... ++..+|+|.+..... ....++.+|+.++++++|+|+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457899999999999999999853 467899998875432 234568999999999999984
Q ss_pred --EEeeCCCCcHhHhHhhccC-----------------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCC
Q 047195 352 --FMSMSPNGTLFDRLHRVQS-----------------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSN 412 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~N 412 (559)
++||+++++|.+++..... .....+++..++.++.|++.||+||| .++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 6788999999999874321 11235788899999999999999999 7899999999999
Q ss_pred eeecCCCCEEEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccc
Q 047195 413 ILLDEKLDAKISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEE 490 (559)
Q Consensus 413 ill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~ 490 (559)
||+++++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875532221 11112235678999999988889999999999999999997 777875433211
Q ss_pred cccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
. ........... ........+.+++.+||+.+|++|||+.||++.|++
T Consensus 241 ------~-~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ------V-IYYVRDGNVLS------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------H-HHHHhcCCCCC------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 11111111100 001233678889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=279.50 Aligned_cols=236 Identities=30% Similarity=0.407 Sum_probs=185.8
Q ss_pred CccccCCccEEEEEEecC----CcEEEEEEeecCCCCC-hhhHHHHHHHHHhcCCCc---------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILDD----ETITAVKRAKLGNTKG-IDPILNEVRILCQLNHRS---------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~----~~~~avk~~~~~~~~~-~~~~~~E~~~l~~l~h~n---------------iv~~~~~~ 358 (559)
+.||+|+||.||++...+ +..+++|.+....... .+.+.+|+++++.++|+| ++++|.++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999654 7889999987654433 578999999999999998 47899999
Q ss_pred CcHhHhHhhccCC----CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 359 GTLFDRLHRVQSG----NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 359 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
++|.+++...... ....+++..+..++.|++.||+||| +++++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998764211 1246899999999999999999999 88999999999999999999999999999987654
Q ss_pred CCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 435 GAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 435 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... .......++..|+|||.+....++.++||||||+++|||++ |..||......+ .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 321 11223447889999999988889999999999999999999 588886542211 111111110
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
..........++.+++.+||+.+|++|||+.++++.|+
T Consensus 225 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00011123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=286.19 Aligned_cols=235 Identities=25% Similarity=0.327 Sum_probs=180.4
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
|+..+.||+|+||+||++.. .+++.+|+|.+..... .....+.+|++++++++|+|+ ++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999985 4688999999865432 223457899999999999884 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+.+..... ..+++..+..++.|++.||.||| +++|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999888865322 35899999999999999999999 888999999999999999999999999998765432
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
.. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... ......... ...
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~------~~~ 224 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE------EVY 224 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc------ccc
Confidence 21 1233589999999999888899999999999999999999999975432211111 000000000 001
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
. ......+.+|+.+||+.+|++||| +.++++
T Consensus 225 ~-------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 S-------AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred C-------ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1 122356788999999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.21 Aligned_cols=252 Identities=19% Similarity=0.277 Sum_probs=182.0
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||+|+||.||+|..+ ++..+|+|.+..... .....+.+|+.+++.++|+|| |+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46899999999999999999854 578999999875433 233568899999999999994 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+. ++|.+.+.... ..+++..+..++.|++.||+||| +++|+|+||||+|||+++++.+||+|||++......
T Consensus 86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 76 58887776532 24788999999999999999999 889999999999999999999999999998764432
Q ss_pred CceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc--
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID-- 512 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 512 (559)
... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+................+...++
T Consensus 158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 221 1223478999999988654 578899999999999999999999975543221111110000000001100000
Q ss_pred -------cccccC-CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 -------PMLKEG-ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 -------~~l~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+..... ...........+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00001123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.30 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=186.9
Q ss_pred hCCCCCCCccccCCccEEEEEEec--------CCcEEEEEEeecCC-CCChhhHHHHHHHHHhc-CCCce----------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD--------DETITAVKRAKLGN-TKGIDPILNEVRILCQL-NHRSL---------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni---------- 351 (559)
..+|++.+.||+|+||.||++... +...+|+|.++... ....+++.+|+++++++ +|+||
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 456899999999999999999742 12368999876432 23356799999999999 79985
Q ss_pred -----EEeeCCCCcHhHhHhhccC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 352 -----FMSMSPNGTLFDRLHRVQS-----------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
++||+++|+|.+++..... .....+++..+..++.|++.||+||| .++++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 5789999999999875321 11235788999999999999999999 7899999999999999
Q ss_pred cCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccccc
Q 047195 416 DEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVN 493 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~ 493 (559)
++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 244 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 244 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 999999999999998654322111 122234568999999988889999999999999999998 788876433211
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
............ ........+.+++.+||+.+|++|||+.|+++.|++++
T Consensus 245 ----~~~~~~~~~~~~------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 ----LFKLLKEGHRMD------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHHHcCCCCC------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111111110000 01122357889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=284.08 Aligned_cols=237 Identities=33% Similarity=0.475 Sum_probs=182.6
Q ss_pred CCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChh--hHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 295 FSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGID--PILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~--~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
|++.+.||+|+||+||+++.. +++.+|+|.+......... ...+|+.++++++|+|| +++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999965 4568999999876544322 34569999999999984 68999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++... ..+++..+..++.|+++||++|| +.+|+|+||||+|||+++++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred cccccccccccc-----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc-
Confidence 999999999832 24899999999999999999999 778999999999999999999999999999764222
Q ss_pred ceeeeeccccCCccCccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYI-NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
........++..|+|||++. +..++.++||||||+++++|++|..|+......+..... ............
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~----- 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKILKRPLPSSS----- 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHHHTHHHHHT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhcccccccccc-----
Confidence 22333445899999999998 778999999999999999999999999755211111111 111100000000
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .......+.+++.+||+.+|++|||+.++++
T Consensus 224 ~~-----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQ-----SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TS-----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc-----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011277899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.32 Aligned_cols=248 Identities=25% Similarity=0.283 Sum_probs=179.9
Q ss_pred hCCCCCCCccccCCccEEEEEEec---CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCceE---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD---DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF---------------M 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~niv---------------~ 353 (559)
..+|.+.+.||+|+||.||++... .+..+|+|.+... ....+|+++|++++|+||| +
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 347999999999999999999743 3577888887542 3456899999999999964 4
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+++ .++|.+++... ..+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 166 e~~-~~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 166 PKY-KCDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hhc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 444 36777777432 35899999999999999999999 7889999999999999999999999999997654
Q ss_pred CCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh----
Q 047195 434 NGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV---- 508 (559)
Q Consensus 434 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 508 (559)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||.........................
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 33222 1223459999999999998899999999999999999999999997655433222221111111100000
Q ss_pred ------h---ccccccccCCCh----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 ------D---AIDPMLKEGASE----IELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ------~---~~d~~l~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. .+....+..... ........+.+++++||+.+|++|||+.|++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 000000000000 00112356778999999999999999999986
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=283.09 Aligned_cols=235 Identities=25% Similarity=0.341 Sum_probs=181.5
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK---GIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
|+..+.||+|+||.||++.. .+++.+|+|.+...... ....+.+|+.++++++|+++ |+||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67788999999999999985 46789999988654322 23457889999999999884 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+.+..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999988865322 35889999999999999999999 788999999999999999999999999998765433
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
.. .....|+..|+|||++.+..++.++||||||+++|||++|+.||............ ...... .. ...
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~--~~----~~~ 224 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE--VQ----EEY 224 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh--hh----hhc
Confidence 22 12235899999999998888999999999999999999999999754321110000 000000 00 001
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
. ......+.+|+.+||+.||++||| +.|+++
T Consensus 225 ~-------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 S-------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred C-------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1 112356788999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=285.24 Aligned_cols=253 Identities=21% Similarity=0.233 Sum_probs=181.0
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|++.+.||+|++|.||+|..+ ++..+|+|++..... .....+.+|+.++++++|+|+ |++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999864 688999999865432 234568899999999999985 6688
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+. ++|.+.+..... ...+++..+..++.|++.||+||| +++++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 86 688888765432 235889999999999999999999 888999999999999999999999999998765332
Q ss_pred CceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH-----Hhh----cc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN-----ILK----QE 505 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~----~~ 505 (559)
.. ......+++.|+|||++.+. .++.++||||||++++||++|+.||................. .+. ..
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 VR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred cc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 21 11223478899999988654 478899999999999999999999975432211110000000 000 00
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
......+................++.+++.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000000000123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.18 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=186.1
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.++||+|+||.||+|... .++.||+|++..... ...+++.+|++++++++|||| +|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999854 588999999865322 223568999999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCC------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 354 SMSPNGTLFDRLHRVQSG------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
||+++++|.+++...... ....+++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988753211 1124567788999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCc-----------------eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccc
Q 047195 428 LSRLALNGAS-----------------HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490 (559)
Q Consensus 428 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~ 490 (559)
+++....... .......||+.|+|||++.+..++.++||||||+++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 00112359999999999999899999999999999999999999996532211
Q ss_pred cccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhh
Q 047195 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-SIKEVADEIERI 558 (559)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~i 558 (559)
. .. .... .++.-... ....+..+.+++.+||+.||++|| ++.++++.|+.+
T Consensus 239 i----~~-~~~i--------~~P~~~~p----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 I----SY-RDVI--------LSPIEVAP----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h----hh-hhhc--------cChhhccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 00 0000 00000000 012335678899999999999995 677788877764
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=285.15 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=189.4
Q ss_pred CCCCCCCccccCCccEEEEEEec-----CCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-----DETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
.+|++.+.||+|+||.||++++. .+..+|||.+...... ..+.+.+|+++++.++|+||
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35778899999999999999853 3678999998765443 45689999999999999884
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
++||.++++|.+++.... ..+++..+..++.|++.||+||| +++++|+||||+|||++.++.+||+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 568889999999987543 24899999999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCcee--eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 430 RLALNGASHV--TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 430 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
.......... .....++..|+|||.+.+..++.++||||||++++||++|+.|+............. .........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRL 235 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHH
Confidence 8765322211 112235667999999988889999999999999999999999875432211000000 0000000001
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
...+........ ......++.+++.+||+.+|++||||.||+++|++|
T Consensus 236 ~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111000 112336788999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=289.98 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=186.0
Q ss_pred hCCCCCCCccccCCccEEEEEEec--------CCcEEEEEEeecCC-CCChhhHHHHHHHHHhc-CCCce----------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD--------DETITAVKRAKLGN-TKGIDPILNEVRILCQL-NHRSL---------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni---------- 351 (559)
..+|.+.+.||+|+||.||++... ....+|+|.++... ......+.+|+++++++ +|+||
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457889999999999999999742 24578899876532 23345788999999999 59985
Q ss_pred -----EEeeCCCCcHhHhHhhccC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 352 -----FMSMSPNGTLFDRLHRVQS-----------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
++||+++|+|.+++..... .....+++..+..++.|++.||.||| +++++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 5789999999999876321 11235889999999999999999999 8899999999999999
Q ss_pred cCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccccc
Q 047195 416 DEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVN 493 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~ 493 (559)
++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-- 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-- 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999998654322111 112224568999999988889999999999999999999 8888864432111
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
........... . .......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 246 -----~~~~~~~~~~~-----~-------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 246 -----FKLLREGHRMD-----K-------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred -----HHHHHcCCCCC-----C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111110000 0 112235677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.75 Aligned_cols=240 Identities=22% Similarity=0.277 Sum_probs=179.5
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCc---------------eEE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRS---------------LFM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~n---------------iv~ 353 (559)
++|++.+.||+|+||.||+++.+ .++.+|+|.+... .......+.+|+.++..++|+| +|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999965 4678999988542 2223345889999999999987 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999997532 24888999999999999999999 7889999999999999999999999999997654
Q ss_pred CCCceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
...........||+.|+|||++. ...++.++||||||+++|||++|+.||......+ ............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~ 227 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERF 227 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCccc
Confidence 33333333345999999999986 2457889999999999999999999997443211 111111110000
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQN--RPSIKEVADE 554 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~ 554 (559)
............+.+|+.+|+..++++ ||++.|+++.
T Consensus 228 ---------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000001123456778888888654444 6889888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.67 Aligned_cols=227 Identities=29% Similarity=0.366 Sum_probs=172.7
Q ss_pred CccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHH-HHHhcCCCce---------------EEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVR-ILCQLNHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~-~l~~l~h~ni---------------v~~~~~~ 358 (559)
+.||+|+||+||+++.. +++.+|+|++.... ......+..|.. +++.++|+|| |+||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 56889999986532 222334555554 4678999984 6899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|.+.+.... .+.+..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 99999887532 4778888899999999999999 88899999999999999999999999999975432221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..... .... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~-~~~~------~~~-- 216 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNIL-NKPL------QLK-- 216 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHHHH-hCCc------CCC--
Confidence 22334599999999999998999999999999999999999999975432211 11111 0000 001
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
......+.+++.+||+.+|.+||++.+.+..
T Consensus 217 -----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 217 -----PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -----CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1223567889999999999999998865443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=279.60 Aligned_cols=234 Identities=25% Similarity=0.335 Sum_probs=183.5
Q ss_pred CccccCCccEEEEEEecC--C--cEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------EEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAILDD--E--TITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------FMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~--~--~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~~g 359 (559)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ...+++.+|++++++++|+|| ++||++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 469999999999998643 2 3689999877655 556789999999999999985 56888999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
+|.+.+..... ..+++..+..++.|++.||+||| +++++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 81 SLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred cHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 99999876432 35899999999999999999999 8899999999999999999999999999998765422211
Q ss_pred --eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 440 --TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 440 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .... ..... .+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~---~~~~~-------~~~ 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKI---DKEGE-------RLE 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---HhcCC-------cCC
Confidence 122347789999999988889999999999999999998 9999864432211 1100 00000 000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.....+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 222 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=295.56 Aligned_cols=226 Identities=29% Similarity=0.360 Sum_probs=173.0
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHH-HHHhcCCCce---------------EEeeCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVR-ILCQLNHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~-~l~~l~h~ni---------------v~~~~~~ 358 (559)
+.||+|+||+||+++. .+++.+|+|++... .......+..|.. +++.++|||| |+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 46889999998653 2233345666665 4677999984 6899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|...+... ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 9998888653 25889999999999999999999 78899999999999999999999999999875432221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ........ . ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~-~------~~~~~- 217 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHK-P------LVLRP- 217 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcC-C------ccCCC-
Confidence 1233459999999999999899999999999999999999999997543211 11111110 0 00111
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.....+.+++.+||+.+|.+||++.+.++
T Consensus 218 ------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 ------GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ------CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 12356778999999999999999874443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=282.49 Aligned_cols=237 Identities=24% Similarity=0.354 Sum_probs=183.2
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
++|++.+.||+|+||.||+|.. .+++.+|+|.++.........+.+|+.+++.++|||| ++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999985 4688999999877655555678899999999999984 67899
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++... ..+++..+..++.|++.||+||| +++++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999988653 24889999999999999999999 7889999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
. ......|+..|+|||++. ...++.++||||||+++|||++|+.|+.......... .. .... ...+
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~--~~-----~~~~---~~~~ 229 (267)
T cd06645 161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LM-----TKSN---FQPP 229 (267)
T ss_pred c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH--hh-----hccC---CCCC
Confidence 1 122335899999999874 4458889999999999999999999986433211100 00 0000 0000
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... . ......+.+++.+||+.+|++|||+.+|++
T Consensus 230 ~~~~-~----~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKD-K----MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc-c----CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0100 0 012346788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=278.07 Aligned_cols=240 Identities=23% Similarity=0.308 Sum_probs=172.5
Q ss_pred CccccCCccEEEEEEecC---CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAILDD---ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~---~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g 359 (559)
+.||+|+||+||+|...+ ...+++|.+..... .....+.+|+.+++.++|+|| |+||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 35678887654332 223568899999999999994 68999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
+|.+++............+.....++.|++.||+||| +++|+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997654332234567888999999999999999 7889999999999999999999999999986543222111
Q ss_pred -eeeccccCCccCcccccc-------CCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 440 -TTFAQGTLGYLDPEYYIN-------FQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 440 -~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ .. ....... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~---~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VL---KQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH---HHHhhcc-CccC
Confidence 122336778999998743 356789999999999999999 677775433211 11 1111111 0111
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.++.+. ......+.+++..|+ .||++|||++||++.|.
T Consensus 231 ~~~~~~-------~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD-------LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc-------ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 123355667778888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=277.32 Aligned_cols=234 Identities=26% Similarity=0.383 Sum_probs=186.4
Q ss_pred CCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
++|++.+.||+|+||.||++...+ ++.+++|.+..... .+++.+|++++++++|+|+ ++||.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 579999999999999999999765 78999999875433 5789999999999999985 67889
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
.+++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 81 GAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999886532 35899999999999999999999 7889999999999999999999999999988765432
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.|+......... .. ... ...+.+.
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---~~----~~~-----~~~~~~~ 220 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---FM----IPN-----KPPPTLS 220 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---hh----hcc-----CCCCCCC
Confidence 2 122234789999999998888999999999999999999999998743322110 00 000 0000000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........+.+++.+||+.+|++|||+.||++
T Consensus 221 -----~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -----DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -----chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01123357888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.42 Aligned_cols=236 Identities=25% Similarity=0.371 Sum_probs=183.7
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
+.|++.+.||+|+||.||+|+.. ++..+++|.+...+....+.+.+|++++++++|+|+ |+||.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46899999999999999999965 478999999877666666789999999999999984 67999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|..++.... ..+++..+..++.|++.+|+||| +++++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 92 PGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999988775432 24889999999999999999999 8899999999999999999999999999987543322
Q ss_pred ceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 437 SHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
.. .....+++.|+|||++. ...++.++||||||+++|||++|+.||....... .........
T Consensus 165 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~------ 231 (292)
T cd06644 165 QR-RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE------ 231 (292)
T ss_pred cc-cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcCC------
Confidence 11 12234889999999984 3457889999999999999999999986433211 111111000
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.+. ........+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 PPTLS-----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CccCC-----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 01123356788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=286.55 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=183.7
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||+|+||.||++... ++..+|+|.+..... ....++.+|++++++++|||| |+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36899999999999999999854 577888888765422 233568899999999999984 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++... ..+++..+..++.|++.||+|||+ ..+++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999998754 248899999999999999999993 258999999999999999999999999998755332
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc----------
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE---------- 505 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 505 (559)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...........
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCccccc
Confidence 1 1223588999999999888899999999999999999999999864432111 10000000000
Q ss_pred ----------hhhhccccccccCCChh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 506 ----------RLVDAIDPMLKEGASEI-ELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 506 ----------~~~~~~d~~l~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
...+..+.......... .......+.+++.+||+.+|++|||+.+|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000000 01133568899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=266.53 Aligned_cols=240 Identities=26% Similarity=0.330 Sum_probs=186.7
Q ss_pred HHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC----C----hhhHHHHHHHHHhc-CCCce------
Q 047195 288 ITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK----G----IDPILNEVRILCQL-NHRSL------ 351 (559)
Q Consensus 288 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~----~----~~~~~~E~~~l~~l-~h~ni------ 351 (559)
-+...+.|.-.+.||+|..++|-+... ..+...|+|++...... . .++-..|+.||+++ .||+|
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 344556788889999999999988774 56788899987654221 1 23457899999995 79996
Q ss_pred ---------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEE
Q 047195 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAK 422 (559)
Q Consensus 352 ---------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~k 422 (559)
|.+.++.|.|+|+|...- .++++...+|.+|+.++++||| .+.|+||||||+|||+|++.++|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceE
Confidence 457889999999997643 5899999999999999999999 88899999999999999999999
Q ss_pred EeecccceeccCCCceeeeeccccCCccCcccccc------CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 047195 423 ISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN------FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496 (559)
Q Consensus 423 l~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~ 496 (559)
|+|||+++....+.. ....+|||+|+|||.+.- ..|+..+|+|+.|+|+|.|+.|-+||..... .
T Consensus 164 isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------m 234 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------M 234 (411)
T ss_pred EeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------H
Confidence 999999998876543 344569999999998742 3588899999999999999999999963321 1
Q ss_pred HHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 497 YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 497 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...+.+.+++.. .-..+. .+......+|+.+||+.||.+|.|++|+++
T Consensus 235 lMLR~ImeGkyq-----F~speW----adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 235 LMLRMIMEGKYQ-----FRSPEW----ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHhcccc-----cCCcch----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 122222222210 001111 234466788999999999999999999885
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=285.05 Aligned_cols=244 Identities=26% Similarity=0.336 Sum_probs=185.7
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||+|+||+||++... +++.+|+|.+..... .....+.+|+++++.++|+|| |+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888899999999999999854 578899998765433 334678999999999999984 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++... ..+++..+..++.+++.+|.|||+ .++++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999888653 248899999999999999999994 257999999999999999999999999998654322
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
.. ....|+..|+|||++.+..++.++||||||+++|+|++|+.||......+...... ..+.+.+...+
T Consensus 158 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~ 226 (284)
T cd06620 158 IA---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP--------MGILDLLQQIV 226 (284)
T ss_pred cc---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh--------hHHHHHHHHHh
Confidence 11 23358999999999988889999999999999999999999997544321110000 00000000000
Q ss_pred ccCCChh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 516 KEGASEI-ELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 516 ~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
....... .......+.+|+.+||+.+|++|||+.||+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 01234678899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.04 Aligned_cols=239 Identities=23% Similarity=0.285 Sum_probs=179.7
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCc---------------eEE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRS---------------LFM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~n---------------iv~ 353 (559)
++|++.+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.++..++|+| +||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999954 5788999988642 2233455888999999999987 478
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999997532 24888999999999999999999 8889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYIN-----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
...........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+..+. ...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~ 227 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEERF 227 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCcc
Confidence 433322333459999999999865 4578899999999999999999999974432211 11111100000
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQN--RPSIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~ 553 (559)
.+.... ......+.+++.+||..++++ |+++.++++
T Consensus 228 -----~~p~~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 -----QFPSHI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -----cCCCcc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 000000 123356778889999866544 467777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=281.23 Aligned_cols=242 Identities=26% Similarity=0.382 Sum_probs=183.2
Q ss_pred CCCCCccccCCccEEEEEEec----CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce-----------------
Q 047195 295 FSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
|.+.+.||+|+||.||+|.+. .+..+|||++.... ....+++.+|++++++++|||+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 35789999886542 2335678999999999999985
Q ss_pred ----EEeeCCCCcHhHhHhhcc-CCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 ----FMSMSPNGTLFDRLHRVQ-SGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
+++|..+|+|.+++.... ..+...+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 345777888887765322 122235788899999999999999999 788999999999999999999999999
Q ss_pred ccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhc
Q 047195 427 GLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 427 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
|+++......... .....+++.|++||.+.+..++.++||||||+++|||++ |+.|+......+ ...+ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNY----LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHH----HHc
Confidence 9998654322111 112235678999999988889999999999999999999 778876433211 1111 111
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
... +.. .......+.+++.+||+.+|++|||+.|+++.|++|
T Consensus 231 ~~~-------~~~-----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR-------LKQ-----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc-------CCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 000 012236788999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=277.06 Aligned_cols=239 Identities=25% Similarity=0.356 Sum_probs=188.3
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|++.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+|+ ++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357899999999999999999864 578899999887766667889999999999999984 6789
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
..+++|.+++.... ..+++..+..++.|++.||+||| +++++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 82 CGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999887542 25889999999999999999999 788999999999999999999999999998765432
Q ss_pred CceeeeeccccCCccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF---QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+......... .. .....+ ..
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~-----~~~~~~---~~ 223 (262)
T cd06613 155 IA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FL-----ISKSNF---PP 223 (262)
T ss_pred hh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-----HHhccC---CC
Confidence 21 11223488899999998776 7889999999999999999999998644322110 00 000000 00
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+. ........+.+++.+||+.+|.+|||+.+|+.
T Consensus 224 ~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLK-----DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccc-----chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0010 11234567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=286.69 Aligned_cols=240 Identities=26% Similarity=0.388 Sum_probs=183.4
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCc----EEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DET----ITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
++|+..+.||+|+||.||+|.+. ++. .+|+|.+..... ....++.+|+.+++.++|+|| +
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 46788899999999999999853 343 468887764432 223468899999999999995 5
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++|+++|+|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccc
Confidence 67889999999886532 25788999999999999999999 889999999999999999999999999999866
Q ss_pred cCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~---- 228 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-------PDLLEKGE---- 228 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCC----
Confidence 4332221 122335778999999988889999999999999999997 8888864332111 11111110
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.+.. .......+.+++.+||..+|++||++.+|++.|+.+
T Consensus 229 ---~~~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 229 ---RLPQ-----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---CCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000 011225678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=276.16 Aligned_cols=233 Identities=27% Similarity=0.390 Sum_probs=181.6
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcHh
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL---------------FMSMSPNGTLF 362 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L~ 362 (559)
++||+|+||.||++...+++.+++|.+...... ....+.+|++++++++|+|| |++|+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999988765443 44679999999999999984 67889999999
Q ss_pred HhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceee-e
Q 047195 363 DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT-T 441 (559)
Q Consensus 363 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~-~ 441 (559)
+.+.... ..+++..+..++.+++.+|+||| +++++||||||+|||++.++.+||+|||++........... .
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9886532 24788999999999999999999 88899999999999999999999999999976543222111 1
Q ss_pred eccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCC
Q 047195 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGAS 520 (559)
Q Consensus 442 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 520 (559)
....+..|+|||.+.+..++.++||||||+++|||++ |..||........ . ....... .+. .
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~----~~~~~~~-------~~~--~- 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---R----ERIESGY-------RMP--A- 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---H----HHHhcCC-------CCC--C-
Confidence 1224667999999988889999999999999999999 7778754432111 0 0010000 000 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 521 EIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 521 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
....+..+.+++.+||+.+|++|||+.||++.|+.
T Consensus 217 --~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 --PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 11233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=288.05 Aligned_cols=184 Identities=26% Similarity=0.348 Sum_probs=144.3
Q ss_pred CCccccCCccEEEEEEec---CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCceE-----------------EeeCC
Q 047195 298 GNLLGSGGFGEVFKAILD---DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLF-----------------MSMSP 357 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~---~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~niv-----------------~~~~~ 357 (559)
..+||+|+||+||+|+.+ ++..+|+|.+.... ....+.+|++++++++||||+ ++|+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999864 34789999876432 234688999999999999963 45654
Q ss_pred CCcHhHhHhhccC----CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee----cCCCCEEEeecccc
Q 047195 358 NGTLFDRLHRVQS----GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL----DEKLDAKISDFGLS 429 (559)
Q Consensus 358 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill----~~~~~~kl~DFG~a 429 (559)
++|.+.+..... .....+++..+..++.|++.||.||| +++|+||||||+|||+ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 467666643211 11235788899999999999999999 8889999999999999 56678999999999
Q ss_pred eeccCCCce--eeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 047195 430 RLALNGASH--VTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNR 487 (559)
Q Consensus 430 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~ 487 (559)
+........ ......+|+.|+|||++.+. .++.++||||||+++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876433221 11234589999999998764 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=279.22 Aligned_cols=233 Identities=24% Similarity=0.418 Sum_probs=183.8
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc--------------eEEeeCCC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS--------------LFMSMSPN 358 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n--------------iv~~~~~~ 358 (559)
++|++.+.||+|+||.||++.. .++.+|+|..+... ..+.+.+|+.++++++|+| +++||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence 4588999999999999999974 56778999876532 3367899999999999998 47899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|.+++..... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 83 GNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999875432 35788999999999999999999 8899999999999999999999999999987643221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......... .+ .
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~---~~--~-- 218 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGYR---ME--P-- 218 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCCC---CC--C--
Confidence 11224678999999988889999999999999999998 8888864432211 111111100 00 0
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
....+..+.+++.+||+.+|++||++++|++.|++
T Consensus 219 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01223677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=279.81 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=182.8
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
+.+++++.....||+|+||.||+|+. +++..+++|.+........+.+.+|++++++++|+|| +
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34556666667899999999999984 4678899998877665566789999999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCC--ChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEeecccc
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPL--KWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFGLS 429 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~DFG~a 429 (559)
+||+++++|.+.+..... .+ ++..+..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||++
T Consensus 84 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 84 MEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EecCCCCCHHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 789999999999875321 24 77888899999999999999 789999999999999986 678999999998
Q ss_pred eeccCCCceeeeeccccCCccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINF--QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
......... .....+++.|+|||++... .++.++||||||+++|+|++|+.|+........ ..+......
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~---- 228 (268)
T cd06624 157 KRLAGINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK---- 228 (268)
T ss_pred eecccCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc----
Confidence 765432221 2223488999999998654 378899999999999999999999864321110 000000000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.+ +......+..++.+||+.+|++|||+.|+++
T Consensus 229 ---~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ---IHPEI-------PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---cCCCC-------CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00111 1223466888999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=277.26 Aligned_cols=236 Identities=29% Similarity=0.389 Sum_probs=187.3
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|+..+.||+|+||.||.++. .++..+++|.+.... .....++.+|++++++++|+|| ++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999884 567889999876543 3445678999999999999995 5799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+.+..... ..+++..+..++.|++.+|+||| +.+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 999999999876432 35889999999999999999999 788999999999999999999999999999876543
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
.. ......+++.|+|||.+.+..++.++||||||++++||++|+.||......+. .... ..+...
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~-~~~~~~------- 219 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKI-VQGNYT------- 219 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH-HcCCCC-------
Confidence 32 22234589999999999888889999999999999999999999864332111 1111 111110
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
.........+.+++.+||+.+|++|||++++++.+
T Consensus 220 -----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 -----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 00112346688899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=297.17 Aligned_cols=249 Identities=23% Similarity=0.249 Sum_probs=177.4
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
...|.+.+.||+|+||.||++... .++.||||... ...+.+|+++|++++|+|| |+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999965 46889999633 2457799999999999996 3455
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+ .++|.+.+.... ..+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 242 ~-~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 Y-RSDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 5 467777775422 25899999999999999999999 788999999999999999999999999999865432
Q ss_pred Cce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcc-ccccHHHHHHHHhhcchh------
Q 047195 436 ASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE-EDVNLVVYFGNILKQERL------ 507 (559)
Q Consensus 436 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~------ 507 (559)
... ......||+.|+|||++.+..++.++|||||||+||||++|..++...... ..........+.+.....
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 221 122345999999999999989999999999999999999988765432211 100000001111111000
Q ss_pred -------hhccccc----cccCCChhh----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 508 -------VDAIDPM----LKEGASEIE----LDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 508 -------~~~~d~~----l~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
...+... ......... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 000000000 0122467889999999999999999999873
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=278.61 Aligned_cols=225 Identities=22% Similarity=0.303 Sum_probs=170.8
Q ss_pred CccccCCccEEEEEEecC-------------CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------
Q 047195 299 NLLGSGGFGEVFKAILDD-------------ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-------------~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
+.||+|+||.||+|++.+ ...+++|.+..........+.+|+.++++++||||
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 23578888765555555678999999999999995
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC-------EEE
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD-------AKI 423 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~-------~kl 423 (559)
++||+++++|..++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++. +|+
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 568889999988776432 25889999999999999999999 889999999999999987654 899
Q ss_pred eecccceeccCCCceeeeeccccCCccCccccc-cCCCCcccchhHHHHHHHHHH-hCCCCCCCCCccccccHHHHHHHH
Q 047195 424 SDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI-NFQLTDKSDVYSFGVVLVELL-TSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~el~-tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+|||++....... ...++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+. ...
T Consensus 154 ~d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~ 221 (262)
T cd05077 154 SDPGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERF 221 (262)
T ss_pred CCCCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHH
Confidence 9999986543221 223788999999886 456889999999999999998 57777653321110 000
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
. .... .+. ......+.+|+.+||+.||++||++++|++.|.
T Consensus 222 ~-~~~~------~~~-------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 Y-EGQC------MLV-------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred H-hcCc------cCC-------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0000 000 012356788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=291.36 Aligned_cols=222 Identities=29% Similarity=0.348 Sum_probs=170.0
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHH-HHHhcCCCce---------------EEeeCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVR-ILCQLNHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~-~l~~l~h~ni---------------v~~~~~~ 358 (559)
+.||+|+||.||+|+. .+++.+|+|++.... ......+.+|.. +++.++|||| |+||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999996 467899999986432 222345666655 5788999984 6799999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|...+... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE- 151 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence 9998887643 24788889999999999999999 78899999999999999999999999999875432221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+... ....... .. ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~-~~------~~~~-- 216 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILH-KP------LQLP-- 216 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhc-CC------CCCC--
Confidence 1223458999999999988889999999999999999999999997543211 1111111 00 0011
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
......+.+++.+||+.+|.+||++.
T Consensus 217 -----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 -----GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12235678899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=281.64 Aligned_cols=247 Identities=20% Similarity=0.271 Sum_probs=186.2
Q ss_pred hHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCce-----------
Q 047195 285 SREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRSL----------- 351 (559)
Q Consensus 285 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni----------- 351 (559)
.+.+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++.+ +|+|+
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 345556778999999999999999999985 457889999875432 2235688999999999 69874
Q ss_pred ---------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEE
Q 047195 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAK 422 (559)
Q Consensus 352 ---------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~k 422 (559)
|+||+++++|.+.+..... ....+++..+..++.|++.||.||| +++++||||||+||++++++.+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence 5688899999988764321 1235788899999999999999999 78899999999999999999999
Q ss_pred EeecccceeccCCCceeeeeccccCCccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 047195 423 ISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN-----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 423 l~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~ 497 (559)
|+|||+++........ .....|++.|+|||++.. ..++.++||||||+++|||++|+.|+.........
T Consensus 165 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~----- 238 (286)
T cd06638 165 LVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL----- 238 (286)
T ss_pred EccCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-----
Confidence 9999999866432221 223358999999998753 34788999999999999999999998644321110
Q ss_pred HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 498 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.. ..........++ ......+..++.+||+.+|++|||+.||++.
T Consensus 239 -~~-~~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 -FK-IPRNPPPTLHQP----------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -hh-ccccCCCcccCC----------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 000000000000 0122468889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=278.09 Aligned_cols=234 Identities=24% Similarity=0.366 Sum_probs=184.5
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|++.+.||+|+||.||++.. .+++.+|+|.+.... .....++.+|+.++++++|+|| |+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999984 567899999987542 2334579999999999999984 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+.+..... ..+++..+..++.|++.||+||| +++++|+||+|+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999998875322 24788999999999999999999 788999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
... .....|++.|+|||++.+..++.++|+||||+++++|++|+.|+......+ ...... .
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~----------- 215 (256)
T cd08218 155 VEL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKII-R----------- 215 (256)
T ss_pred hhh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHh-c-----------
Confidence 211 122347889999999988889999999999999999999999986432211 111110 0
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.............+.+++.+||+.+|++||++.+|++
T Consensus 216 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 216 -GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0011111233467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=281.48 Aligned_cols=240 Identities=24% Similarity=0.359 Sum_probs=185.8
Q ss_pred CCCCCCCccccCCccEEEEEEecC-C----cEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-E----TITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-~----~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
.+|++.+.||+|+||.||+|..++ + ..+|+|....... ....++.+|+.++++++|+|+ |
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 468888999999999999998543 3 2588888765433 234678999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 78899999999987532 24899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCceeee-eccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASHVTT-FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
......... ...++..|+|||.+....++.++||||||+++|||++ |+.||......+. ......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~--~ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI-------PDLLEKGER--L 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHhCCCC--C
Confidence 533322211 1224568999999988889999999999999999998 9999875432211 111111100 0
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
-. +......+.+++.+||..+|.+|||+.++++.|+++
T Consensus 231 ~~----------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 PQ----------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00 011224578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=280.35 Aligned_cols=234 Identities=24% Similarity=0.358 Sum_probs=180.7
Q ss_pred CCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCCC
Q 047195 295 FSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSPN 358 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~ 358 (559)
|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+|+ |+||.++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677789999999999999965 467888888876555556789999999999999984 6799999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|...+.... .++++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 99988776422 35899999999999999999999 78899999999999999999999999999876533221
Q ss_pred eeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 439 VTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
......+++.|+|||++. +..++.++||||||+++|||++|+.||........ ........ .+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~------~~ 226 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE------PP 226 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhcC------CC
Confidence 122234899999999974 34577899999999999999999999864332110 01110000 00
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.. +......+.+++.+||+.+|++|||+.++++
T Consensus 227 ~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 TLAQ-----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCC-----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 1122356889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.62 Aligned_cols=187 Identities=27% Similarity=0.380 Sum_probs=157.6
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||+||++... +++.+|+|++... .......+.+|+.++.+++|+|| ||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999854 6789999998643 23344678899999999999974 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999998753 24889999999999999999999 8899999999999999999999999999987543
Q ss_pred CCCc----------------------------------eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhC
Q 047195 434 NGAS----------------------------------HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTS 479 (559)
Q Consensus 434 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg 479 (559)
.... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 2110 001123599999999999998999999999999999999999
Q ss_pred CCCCCCCC
Q 047195 480 KKAVDFNR 487 (559)
Q Consensus 480 ~~p~~~~~ 487 (559)
+.||....
T Consensus 233 ~~Pf~~~~ 240 (360)
T cd05627 233 YPPFCSET 240 (360)
T ss_pred CCCCCCCC
Confidence 99997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.19 Aligned_cols=177 Identities=25% Similarity=0.379 Sum_probs=146.1
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
..+|++.+.||+|+||.||+|+.. ++..+|+|.... .....|+.++++++|+|| |+++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 357999999999999999999965 467888887432 234679999999999995 4566
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+ .++|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 139 ~-~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 139 Y-SSDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred c-CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 5 467887775432 35899999999999999999999 788999999999999999999999999999754322
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVD 484 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~ 484 (559)
. ......||+.|+|||++.+..++.++||||||+++|||+++..++.
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred c--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1 1123458999999999998899999999999999999999766653
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=283.44 Aligned_cols=234 Identities=24% Similarity=0.337 Sum_probs=186.7
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
++|++.+.||+|+||.||++.. .+++.+|+|.+........+.+.+|+.+++.++|+|+ |+||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5799999999999999999985 5789999999887666666778999999999999984 67899
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999998854 24788999999999999999999 7889999999999999999999999999987654332
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
... ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........... . ...+ .+.+.
T Consensus 170 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---~---~~~~------~~~~~ 236 (297)
T cd06656 170 SKR-STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---I---ATNG------TPELQ 236 (297)
T ss_pred cCc-CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---e---ccCC------CCCCC
Confidence 221 223488999999999888899999999999999999999999965432211100 0 0000 00000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........+.+++.+||+.+|++|||+.+|++
T Consensus 237 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 -----NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123356788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=280.54 Aligned_cols=252 Identities=23% Similarity=0.264 Sum_probs=183.2
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
++|++.+.||+|++|.||+|..+ +++.+|+|++..... ...+.+.+|++++++++|+|+ |+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999965 588999998865432 233568899999999999984 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|++++.|..++... ..+++..+..++.|++.+|+||| +++++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99888777765432 24899999999999999999999 78899999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH--------hhcc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI--------LKQE 505 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 505 (559)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+........... +...
T Consensus 153 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 153 PGDD-YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred Cccc-ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 3221 122347889999999876 45788999999999999999999999755432221111100000 0000
Q ss_pred hhh-hccccccccCCC--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLV-DAIDPMLKEGAS--EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~-~~~d~~l~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ....+....... .........+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 000000000000 000123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.82 Aligned_cols=229 Identities=27% Similarity=0.414 Sum_probs=185.5
Q ss_pred ccccCCccEEEEEEecC-CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcHhH
Q 047195 300 LLGSGGFGEVFKAILDD-ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSPNGTLFD 363 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L~~ 363 (559)
+||+|.||+||-|+..+ ....|||.+...+....+.+..|+...++|+|+|| +||-.+||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999544 56789999998888888999999999999999995 678899999999
Q ss_pred hHhhccCCCCCCC--ChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEeecccceeccCCCceee
Q 047195 364 RLHRVQSGNWPPL--KWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFGLSRLALNGASHVT 440 (559)
Q Consensus 364 ~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~ 440 (559)
+|+.. +.++ .+...-.+.+||++||.||| .+.|+|||||-+|||++- .|.+||+|||.++....-.....
T Consensus 662 LLrsk----WGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 662 LLRSK----WGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred HHHhc----cCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 99763 3456 67778889999999999999 788999999999999974 68899999999987654333323
Q ss_pred eeccccCCccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 441 TFAQGTLGYLDPEYYINF--QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 441 ~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
+ ..||..|||||++-.+ .|..++|||||||++.||.||++||....+..... +. -+ +-+.
T Consensus 735 T-FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM----Fk----VG---------myKv 796 (1226)
T KOG4279|consen 735 T-FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM----FK----VG---------MYKV 796 (1226)
T ss_pred c-cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh----hh----hc---------ceec
Confidence 3 3499999999999654 58999999999999999999999997554322111 11 00 0111
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
-+.++.+...+...++++|+.++|.+||+++++++
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 23334567788889999999999999999999985
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=280.60 Aligned_cols=237 Identities=24% Similarity=0.373 Sum_probs=185.6
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|++.+.||+|++|.||++... ++..+|+|..........+.+.+|++++++++|+|+ |+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356899999999999999999864 678999999887666666789999999999999984 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++.... ..+++..+..++.|++.||.||| +++|+|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 84 CDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred cCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999887532 25899999999999999999999 888999999999999999999999999998765432
Q ss_pred CceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
... .....+++.|+|||.+. ...++.++||||||+++|||++|+.||....... ...... ....
T Consensus 157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~--- 225 (280)
T cd06611 157 LQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKIL-KSEP--- 225 (280)
T ss_pred ccc-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHh-cCCC---
Confidence 221 12234899999999875 3356789999999999999999999986442211 011110 0000
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+.. +......+.+++.+||+.+|++|||+.+|++
T Consensus 226 --~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 --PTLDQ-----PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred --CCcCC-----cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00000 1122356788999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.57 Aligned_cols=236 Identities=31% Similarity=0.448 Sum_probs=184.1
Q ss_pred CCCCCccccCCccEEEEEEecC-----CcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 295 FSTGNLLGSGGFGEVFKAILDD-----ETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~~-----~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
+++.+.||+|+||.||++...+ +..+|+|.+...... ..+.+.+|+.+++.++|+|+ ++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4577899999999999998654 478999998765443 45689999999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+|.++++|.+++...... .+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||+++...
T Consensus 81 e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 889999999998764321 2899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
...........+++.|+|||.+.+..++.++||||||+++++|++ |+.|+....... .... .......
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~~~-~~~~~~~---- 223 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VLEY-LKKGYRL---- 223 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HhcCCCC----
Confidence 442222222337789999999988889999999999999999998 777775422111 1111 1111100
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
.. ......++.+++.+||+.+|++|||+.++++.|
T Consensus 224 -~~-------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PK-------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CC-------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 011346788899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=277.45 Aligned_cols=240 Identities=24% Similarity=0.365 Sum_probs=188.3
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce-----------------EE
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL-----------------FM 353 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni-----------------v~ 353 (559)
+|++.+.||.|+||.||++.. .++..+|+|.+.... ....+.+.+|++++++++|+|+ ++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999984 567889999886543 2334568899999999999984 56
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC--CCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA--TPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||+++++|.+++..... ....+++..+..++.|++.||+|||..+ +.+++|+||||+||++++++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 78889999998876422 2246899999999999999999999664 67899999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
........ ....+++.|+|||++.+..++.++||||||+++++|++|+.|+....... . .........
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~----~~~~~~~~~---- 227 (265)
T cd08217 160 LGHDSSFA-KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---L----ASKIKEGKF---- 227 (265)
T ss_pred ccCCcccc-cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---H----HHHHhcCCC----
Confidence 65433212 22358999999999988889999999999999999999999997543111 1 111111110
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
+.+ +......+.+++.+||+.+|++|||+.+|++.
T Consensus 228 -~~~-------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RRI-------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCC-------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011 12334678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=278.06 Aligned_cols=244 Identities=26% Similarity=0.336 Sum_probs=186.3
Q ss_pred CCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce--------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
++|++.+.||+|+||.||+|+.+ +...+++|.+...... ..+++.+|++++++++|+||
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888999999999999999853 3467888887654433 34679999999999999984
Q ss_pred -EEeeCCCCcHhHhHhhccCCC----CCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGN----WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
|+||.++++|.+++....... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 679999999999987644211 125899999999999999999999 888999999999999999999999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
|+++..............++..|+|||.+.+...+.++||||||+++|+|++ |..||....... . .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~----~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---V----LNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---H----HHHHHcC
Confidence 9987543322222222346778999999988888999999999999999999 677775332111 1 1111111
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
..... . ....+..+.+++.+||+.+|++|||+.|++++|.+
T Consensus 235 ~~~~~----~-------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLELP----V-------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcCCC----C-------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11000 0 01233678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=279.47 Aligned_cols=233 Identities=28% Similarity=0.416 Sum_probs=185.3
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||.|++|.||+|... ++..+|+|.+.... ......+.+|+++++.++|+|+ |+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888999999999999999954 67899999987654 3344678999999999999984 6789
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
.++++|.+++... .+++..+..++.|++.||.||| +++++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999988652 5899999999999999999999 888999999999999999999999999999876543
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...+... ... ..... ..+.+
T Consensus 152 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~----~~~~~-----~~~~~ 218 (274)
T cd06609 152 MSK-RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLF----LIPKN-----NPPSL 218 (274)
T ss_pred ccc-cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHH----Hhhhc-----CCCCC
Confidence 221 222348889999999988889999999999999999999999996443211 000 00000 01111
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ......+.+++.+||..+|++|||++++++
T Consensus 219 ~~------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 EG------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 013356888999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=283.35 Aligned_cols=234 Identities=24% Similarity=0.348 Sum_probs=186.5
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.+|++.+.||.|++|.||+|.. .+++.+++|.+........+.+.+|+.+++.++|+|+ |+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999984 5788999999877666666789999999999999984 67899
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|..++.. ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999988854 24889999999999999999999 8889999999999999999999999999987654332
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... .... ... . +.+.
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~---~~~~---~~~-~-----~~~~ 236 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIA---TNG-T-----PELQ 236 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH---hcC-C-----cccC
Confidence 21 12234889999999998888999999999999999999999999754432111 0000 000 0 0000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........+.+++.+||..+|++|||+.++++
T Consensus 237 -----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 -----NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -----CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01123356788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.96 Aligned_cols=224 Identities=23% Similarity=0.339 Sum_probs=173.6
Q ss_pred CccccCCccEEEEEEecCCc-----------EEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EE
Q 047195 299 NLLGSGGFGEVFKAILDDET-----------ITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FM 353 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~-----------~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~ 353 (559)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++|+|+ |+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 46999999999999975433 4677776554433 5789999999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-------CEEEeec
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-------DAKISDF 426 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-------~~kl~DF 426 (559)
||+++++|.+++..... .+++..+..++.|++.||+||| +++|+||||||+|||++.++ .+||+||
T Consensus 80 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 80 EYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 89999999999876432 5889999999999999999999 88999999999999999887 7999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccC--CCCcccchhHHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhh
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINF--QLTDKSDVYSFGVVLVELLTS-KKAVDFNREEEDVNLVVYFGNILK 503 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~ 503 (559)
|++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+........ .. .+.
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~----~~~ 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ER----FYQ 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HH----HHh
Confidence 99976543 1123367889999998776 788999999999999999995 666653321110 00 010
Q ss_pred cchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 504 QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 504 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
... .+.. .....+.+++.+||..+|++|||+.+|++.|+
T Consensus 221 ~~~-------~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQH-------RLPM-------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCC-------CCCC-------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0000 01167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=278.44 Aligned_cols=238 Identities=20% Similarity=0.288 Sum_probs=182.5
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC-CCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||+|+||.||++..+ ++..+|+|.+... .....+.+.+|+.++++++|+|| |+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36889999999999999999965 6889999988754 22334678999999999999984 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|..++..... ...+++..+..++.|++.||.|||. +.+|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999888865321 2358999999999999999999993 358999999999999999999999999998765322
Q ss_pred CceeeeeccccCCccCccccccC------CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF------QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ ..... .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~---------~ 221 (286)
T cd06622 157 L---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLS---------A 221 (286)
T ss_pred c---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHH---------H
Confidence 1 1223478899999998543 357899999999999999999999964322111 00000 0
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+. ............+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 222 IVDG----DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred Hhhc----CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0000 001111234467888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=277.34 Aligned_cols=241 Identities=26% Similarity=0.357 Sum_probs=185.2
Q ss_pred CCCCCCccccCCccEEEEEEecC--CcEEEEEEeecCCC----------CChhhHHHHHHHHHh-cCCCce---------
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDD--ETITAVKRAKLGNT----------KGIDPILNEVRILCQ-LNHRSL--------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~avk~~~~~~~----------~~~~~~~~E~~~l~~-l~h~ni--------- 351 (559)
+|++.+.||+|+||.||++..+. ++.+|+|.+..... ....++.+|+.++.+ ++|+|+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999755 68899998764321 223457889998875 799984
Q ss_pred ------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 352 ------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 352 ------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
++||+++++|.+.+..... ....+++..+..++.|++.+|.|||. ..+++|+||+|+|||+++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 6799999999998865322 12358899999999999999999992 26799999999999999999999999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. .....
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~-~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------AT-KIVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HH-HHhhc
Confidence 99998654432 22334589999999999888899999999999999999999999864322110 00 01111
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
... +... ......+.+++.+||+.||++|||+.||.++|++
T Consensus 229 ~~~----~~~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VYE----PLPE-------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCC----cCCc-------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 100 0000 1223568889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.67 Aligned_cols=243 Identities=17% Similarity=0.211 Sum_probs=168.9
Q ss_pred hCCCCCCCccccCCccEEEEEEecCC----cEEEEEEeecCCCCChh-----------hHHHHHHHHHhcCCCceEEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDE----TITAVKRAKLGNTKGID-----------PILNEVRILCQLNHRSLFMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~avk~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~~~~ 356 (559)
.++|++.++||+|+||+||+|...+. ..+|+|........... ....+...+..+.|+|++..+.
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35799999999999999999996543 45566654333221111 1223334455678887644321
Q ss_pred --------------C----CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC
Q 047195 357 --------------P----NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418 (559)
Q Consensus 357 --------------~----~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~ 418 (559)
. ..++.+.+... ...++..+..++.|++.||+||| +++|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCC
Confidence 1 12333333322 13567888999999999999999 7889999999999999999
Q ss_pred CCEEEeecccceeccCCCce------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccc
Q 047195 419 LDAKISDFGLSRLALNGASH------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV 492 (559)
Q Consensus 419 ~~~kl~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~ 492 (559)
+.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999876432211 112235999999999999989999999999999999999999999765322211
Q ss_pred cHHH--HHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 493 NLVV--YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 493 ~~~~--~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.... .+...+..+. +. . ......+.+++..|++.+|++||++.++++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~--------~~--~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKRLHEGK--------IK--I----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHHhhhhh--------hc--c----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1110 0111111111 00 0 112467889999999999999999999999874
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=280.30 Aligned_cols=249 Identities=24% Similarity=0.253 Sum_probs=184.8
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|++.+.||+|++|.||+|.. .++..+++|++.... ......+.+|+.++++++|+|| |++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999995 468899999987654 2334679999999999999984 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+ +++|.+++.... ..+++..+..++.|++.||+||| +++++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 8 999999887543 35899999999999999999999 788999999999999999999999999999876543
Q ss_pred CceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc---------
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE--------- 505 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 505 (559)
.........++..|+|||.+.+. .++.++||||||++++||++|+.+|......... ..........
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhcc
Confidence 32222334589999999998654 4688999999999999999998777644322111 1111110000
Q ss_pred ---hhhhccccccc-cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 ---RLVDAIDPMLK-EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ---~~~~~~d~~l~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+..+... ........+....+.+++.+||+.+|++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0000000123477899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=277.42 Aligned_cols=238 Identities=29% Similarity=0.378 Sum_probs=185.8
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|+..+.||+|++|.||++..+ +++.+++|.+..... ....++.+|++++++++|+|| +++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999865 678999998876533 334678999999999999984 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCC-CCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT-PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
+++++|.+++.... ..+++..+..++.|++.||+||| + .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999987642 35888999999999999999999 7 8999999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
..... ..++..|+|||.+.+..++.++||||||+++++|++|+.|+........ ............. .+.
T Consensus 154 ~~~~~---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~------~~~ 223 (265)
T cd06605 154 SLAKT---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEP------PPR 223 (265)
T ss_pred HHhhc---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcCC------CCC
Confidence 22211 4488999999999888999999999999999999999999864432111 1111111111100 001
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.. ......+.+++.+||..+|++|||+.++++
T Consensus 224 ~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPS------GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCh------hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 110 114466889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.65 Aligned_cols=249 Identities=20% Similarity=0.228 Sum_probs=178.8
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|++.+.||+|+||.||+|+.. ++..+|+|.+..... .....+.+|++++++++|+|+ ++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999964 688999999865422 223568899999999999985 5688
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+. ++|.+.+.... ..+++..+..++.||++||.||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 76 57777765432 24899999999999999999999 788999999999999999999999999998765432
Q ss_pred CceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc------hhh
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE------RLV 508 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~ 508 (559)
.... ....+++.|+|||++.+. .++.++||||||+++|||++|+.|+........ ............ ...
T Consensus 153 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 VRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CCCc-CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhh
Confidence 2211 223478999999998764 478899999999999999999998643322111 111110000000 000
Q ss_pred hccccccccCC------ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 DAIDPMLKEGA------SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...+....... ..........+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000 0011123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=272.50 Aligned_cols=236 Identities=25% Similarity=0.280 Sum_probs=188.6
Q ss_pred CCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCc---------------eEE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRS---------------LFM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~n---------------iv~ 353 (559)
+.|+++++||.|.-|+||+++.++ +..+|+|++.... .+...+...|-+||+.++||. ++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 357778999999999999999765 5899999987643 344567889999999999997 589
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||++||+|+.+.+++.. ..+++..++.++.+++-||+||| -.|||.|||||+||||-++|++-|+||.|+....
T Consensus 157 eyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999988655 35999999999999999999999 7889999999999999999999999999864321
Q ss_pred C---------------------------------C-Cc---------------------eeeeeccccCCccCccccccC
Q 047195 434 N---------------------------------G-AS---------------------HVTTFAQGTLGYLDPEYYINF 458 (559)
Q Consensus 434 ~---------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~ 458 (559)
. . .. .....-+||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 00 001122499999999999999
Q ss_pred CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhc
Q 047195 459 QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACL 538 (559)
Q Consensus 459 ~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl 538 (559)
..+.++|+|+||++||||+.|.-||.+.+..+.. ..++-+.+.- .+ ....+....+||++.|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~F--p~-~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKF--PE-EPEVSSAAKDLIRKLL 372 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcC--CC-CCcchhHHHHHHHHHh
Confidence 9999999999999999999999999988765432 2222222211 11 1245677889999999
Q ss_pred ccCCCCCCC----HHHHH
Q 047195 539 DERRQNRPS----IKEVA 552 (559)
Q Consensus 539 ~~~p~~RPt----~~evl 552 (559)
.+||.+|.- +.||-
T Consensus 373 vKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred ccChhhhhccccchHHhh
Confidence 999999987 55553
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=276.15 Aligned_cols=235 Identities=27% Similarity=0.391 Sum_probs=183.1
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC------CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT------KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~------~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
+|++.+.||+|+||.||+|...++..+|+|.+..... .....+.+|++++++++|+|| +
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999988889999998865422 123458899999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 79999999999986532 4788999999999999999999 788999999999999999999999999998764
Q ss_pred cCC-----CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 433 LNG-----ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 433 ~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
... .........++..|+|||++.+..++.++||||||+++|+|++|+.||......... .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~ 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHRGL 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhccCC
Confidence 321 111122345899999999998888999999999999999999999999643221110 000000000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.+. ......+.+++++||+.+|++|||+.++++
T Consensus 227 ----~~~~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ----MPRLP-------DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCC-------CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111 123366788999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=280.36 Aligned_cols=252 Identities=23% Similarity=0.270 Sum_probs=182.7
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCc---------------eEEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRS---------------LFMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~n---------------iv~~ 354 (559)
++|++.+.||+|+||.||++..+ +++.+|+|++...... ..+.+.+|+++++.++|+| +|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 5789999987654322 2456889999999999998 4789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|++++.|..+.... ..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99988887765432 24899999999999999999999 78899999999999999999999999999886544
Q ss_pred CCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh--------hcc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL--------KQE 505 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~ 505 (559)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+...........+ ...
T Consensus 153 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 153 PGEV-YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred Cccc-cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 3322 222347899999999875 347789999999999999999999886543221111111000000 000
Q ss_pred hhh-hccccccccCC--ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLV-DAIDPMLKEGA--SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~-~~~d~~l~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ....+...... ..........+.+++.+||+.+|++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 00000000000 0001123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=276.08 Aligned_cols=233 Identities=27% Similarity=0.426 Sum_probs=181.9
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCC---------hhhHHHHHHHHHhcCCCce------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKG---------IDPILNEVRILCQLNHRSL------------ 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~---------~~~~~~E~~~l~~l~h~ni------------ 351 (559)
+|.+.+.||+|++|.||+|.. .++..+|+|.+....... .+.+.+|+.++++++|+||
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999985 457889999886543321 2458899999999999984
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
++||.++++|.+++... ..+++..+..++.|++.||+||| +++++||||+|+||++++++.+||+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCC
Confidence 67899999999998653 24788899999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCce-----eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh
Q 047195 429 SRLALNGASH-----VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503 (559)
Q Consensus 429 a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 503 (559)
++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~- 225 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKIG- 225 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHHh-
Confidence 8866522111 11123478899999999888889999999999999999999999974322110 00000
Q ss_pred cchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 504 QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 504 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+.+ .......+.+++.+||+.+|.+||++.||++
T Consensus 226 -----~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 -----ENASPEI-------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----ccCCCcC-------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0011111 1223467888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=273.70 Aligned_cols=239 Identities=20% Similarity=0.267 Sum_probs=171.3
Q ss_pred CccccCCccEEEEEEecCC---cEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAILDDE---TITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~---~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g 359 (559)
+.||+|+||.||++...++ ..+++|.+..... ...+.+.+|+.+++.++|||| |+||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 3455666554332 345679999999999999984 78999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC-ce
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA-SH 438 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~-~~ 438 (559)
+|.+++...... ....++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999998764321 234677778899999999999999 7889999999999999999999999999986432211 11
Q ss_pred eeeeccccCCccCcccccc-------CCCCcccchhHHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 439 VTTFAQGTLGYLDPEYYIN-------FQLTDKSDVYSFGVVLVELLTS-KKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
......++..|+|||++.. ..++.++||||||+++|||+++ ..||......+ ....... +.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~-~~~~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIK-DQQVKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh-hccccc
Confidence 1223347889999998743 2457899999999999999975 55664332211 1111111 111222
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.++.+... ....+.+++..|| .+|++|||+++|+++|.
T Consensus 230 ~~~~~~~~-------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELP-------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCC-------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 23332221 2256777888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=285.48 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=194.0
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCCh-hhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGI-DPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~-~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
+...+.++||+|-||.|.+.......+||||.++....+.. .+|.+|+++|.+|+|||| ++||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45677899999999999999999899999999988765544 789999999999999996 46999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC-
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG- 435 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~- 435 (559)
++|+|.+++...... .+.-.....|+.||+.|++||. +-+++||||.+.|+|++.++++||+|||+++-...+
T Consensus 618 EnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred hcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999875432 2344556789999999999999 666999999999999999999999999999855443
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT--SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
........+-...|||||.+....++.+||||+||+++||+++ ...|+.....+. ........+.......
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~---- 764 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQV---- 764 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcce----
Confidence 3334445557889999999999999999999999999999876 677775332211 1111111121111111
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
....+..++..+.+++.+||..+-++|||+++|...|++.
T Consensus 765 -----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 -----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111234557888999999999999999999999988764
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=281.85 Aligned_cols=233 Identities=21% Similarity=0.315 Sum_probs=181.9
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc---------------eEEeeCCC
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSPN 358 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~~~ 358 (559)
|.....||+|+||.||++.. .++..+|||.+........+.+.+|+.++++++|+| +|+||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34446799999999999985 467899999987655555667899999999999998 47899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.........
T Consensus 104 ~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 104 GALTDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 999988753 24788999999999999999999 788999999999999999999999999998755432221
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ... ....+.+.+...
T Consensus 175 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~---------~~~~~~~~~~~~ 241 (292)
T cd06658 175 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRR---------IRDNLPPRVKDS 241 (292)
T ss_pred -CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH---------HHhcCCCccccc
Confidence 1223488999999999888899999999999999999999999864332111 000 001111111110
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
......+..++.+||..+|.+|||++++++.
T Consensus 242 -----~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 -----HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -----cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1223567789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=275.62 Aligned_cols=234 Identities=29% Similarity=0.392 Sum_probs=178.1
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-----CChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-----KGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
.+|+..+.||+|+||.||+|.. ..+..+++|++..... +....+.+|+.++++++|+||
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999985 4588999998765322 223468899999999999985
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
++||.++++|.+.+.... .+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 567888899998886532 4788899999999999999999 788999999999999999999999999998
Q ss_pred eeccCCCc--eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 430 RLALNGAS--HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 430 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
+....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~-- 225 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQP-- 225 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCC--
Confidence 76532111 11122348899999999988889999999999999999999999986332111 011100000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.+ +......+..++ +||..+|++|||++||++
T Consensus 226 ---~~~~~-------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 ---TNPQL-------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCCCC-------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01111 112234556666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=279.66 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=187.2
Q ss_pred cChHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCce---------
Q 047195 283 FSSREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRSL--------- 351 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni--------- 351 (559)
++..++..+.++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++++ +|+|+
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44455566678999999999999999999986 567889999876532 2235678999999998 78874
Q ss_pred -----------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC
Q 047195 352 -----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420 (559)
Q Consensus 352 -----------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~ 420 (559)
|+||+++++|.+++..... ....+++..+..++.|++.||+||| +.+++||||||+||++++++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence 5788899999998865322 1235889999999999999999999 788999999999999999999
Q ss_pred EEEeecccceeccCCCceeeeeccccCCccCccccccC-----CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHH
Q 047195 421 AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-----QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~ 495 (559)
+||+|||++......... .....++..|+|||.+... .++.++||||||+++|||++|+.||........
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---- 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---- 241 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH----
Confidence 999999998765432211 1223488999999987543 367899999999999999999999864332111
Q ss_pred HHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 496 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ........+ .......+.+++.+||+.+|++||++.|+++
T Consensus 242 --~~~~~-~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 --LFKIP-RNPPPTLLH----------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HHHHh-cCCCCCCCc----------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000 000000000 0122356888999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=313.26 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=183.0
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
...++|++.+.||+|+||+||+++.. .+..+|+|.+.... ......+..|+.+|++|+||||
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999954 56788999876542 2334678999999999999984
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC----CCCeEECCCCCCCeeecC--------
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA----TPPIYHRDIKSSNILLDE-------- 417 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----~~~iiH~Dikp~Nill~~-------- 417 (559)
||||+++++|.++|..... ....+++..++.|+.||+.||+|||... .++||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 6799999999999875322 1235899999999999999999999532 156999999999999964
Q ss_pred ---------CCCEEEeecccceeccCCCceeeeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 047195 418 ---------KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAVDFN 486 (559)
Q Consensus 418 ---------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~ 486 (559)
...+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999998654322 1223459999999999864 45889999999999999999999999643
Q ss_pred CccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 487 REEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... .... .+... +.+. . ......+.+|+..||+.+|++|||+.++++
T Consensus 247 ~~~~-----qli~-~lk~~-------p~lp--i----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFS-----QLIS-ELKRG-------PDLP--I----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHH-----HHHH-HHhcC-------CCCC--c----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3211 1111 11110 0000 0 012356888999999999999999999983
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=279.69 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=185.5
Q ss_pred ChHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCc-----------
Q 047195 284 SSREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRS----------- 350 (559)
Q Consensus 284 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~n----------- 350 (559)
+..++....+.|++.+.||+|+||.||+|.. .+++.+|+|...... ....++..|+.+++++ +|+|
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3444555667899999999999999999995 567889999876543 2345788999999998 6876
Q ss_pred ----------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC
Q 047195 351 ----------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420 (559)
Q Consensus 351 ----------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~ 420 (559)
+++||+++|+|.+++..... ..+++..+..++.|++.||+||| +++|+|+||||+||++++++.
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCC
Confidence 46788999999998875432 24788889999999999999999 788999999999999999999
Q ss_pred EEEeecccceeccCCCceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHH
Q 047195 421 AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~ 495 (559)
++|+|||++......... .....|++.|+|||++. ...++.++||||||+++|||++|+.||..........
T Consensus 160 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-- 236 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-- 236 (282)
T ss_pred EEEeeCcchhhhhccccC-CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence 999999998755322111 12234899999999875 3457889999999999999999999986432211100
Q ss_pred HHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 496 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .....+.+. .......+.+++.+||+.+|++|||+.||++
T Consensus 237 ----~~------~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ----LI------PRNPPPKLK------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----hH------hhCCCCCCc------ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000000010 1123467889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=274.23 Aligned_cols=237 Identities=27% Similarity=0.379 Sum_probs=189.6
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||+|++|.||++... +++.+++|++..... ...+++.+|++++.+++|+|+ ++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999965 489999999876654 345789999999999999984 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCC-CCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT-PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999998754 35899999999999999999999 7 8999999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
..... ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.............. .. ... .+.
T Consensus 153 ~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---~~-~~~-----~~~ 222 (264)
T cd06623 153 TLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA---IC-DGP-----PPS 222 (264)
T ss_pred CCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---Hh-cCC-----CCC
Confidence 33322 233488999999999888899999999999999999999999875542111111111 11 000 001
Q ss_pred cccCCChhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 515 LKEGASEIELD-SMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 515 l~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
+ ... .+..+.+++.+||+.+|++|||+.++++.
T Consensus 223 ~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 L-------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C-------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 112 34678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=278.91 Aligned_cols=231 Identities=28% Similarity=0.408 Sum_probs=181.8
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCc---------------eEEeeC
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRS---------------LFMSMS 356 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~ 356 (559)
.|+..+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|++++++++|+| +|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 356678899999999999985 457889999876543 233457899999999999998 478999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++.. ..+++..+..++.|+++|+.||| +++++|+||+|+||++++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 85 GGGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999988753 24888999999999999999999 8899999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.. .....++..|+|||++.+..++.++||||||+++|||++|+.|+........ . . ..... ..+.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~---~-~~~~~-----~~~~~- 221 (277)
T cd06642 156 IK-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L---F-LIPKN-----SPPTL- 221 (277)
T ss_pred hh-hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H---h-hhhcC-----CCCCC-
Confidence 11 1223478899999999888899999999999999999999999863322110 0 0 00000 01111
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.......+.+++.+||+.+|++||||.+|++
T Consensus 222 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 222 ------EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ------CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1133467889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=278.08 Aligned_cols=224 Identities=22% Similarity=0.312 Sum_probs=169.8
Q ss_pred ccccCCccEEEEEEecC-------------------------CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---
Q 047195 300 LLGSGGFGEVFKAILDD-------------------------ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--- 351 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~-------------------------~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--- 351 (559)
.||+|+||.||+|.+.. ...+++|.+.........++.+|+.++++++|+||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13578888765444444678899999999999984
Q ss_pred ------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC
Q 047195 352 ------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL 419 (559)
Q Consensus 352 ------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~ 419 (559)
|+||+++|+|..++.... ..+++..+..++.|+++||+||| +++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccC
Confidence 679999999988886432 25788999999999999999999 88999999999999997643
Q ss_pred -------CEEEeecccceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHH-hCCCCCCCCCccc
Q 047195 420 -------DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELL-TSKKAVDFNREEE 490 (559)
Q Consensus 420 -------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~-tg~~p~~~~~~~~ 490 (559)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 38999999976433221 1237888999998865 56889999999999999994 6888886443221
Q ss_pred cccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
. ..... .. ..+.. .....+.+++.+||+.+|++|||+.+|++.|.
T Consensus 230 ~---~~~~~----~~-------~~~~~-------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K---ERFYE----KK-------HRLPE-------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---HHHHH----hc-------cCCCC-------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 11100 00 00000 11245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=291.18 Aligned_cols=221 Identities=23% Similarity=0.290 Sum_probs=166.7
Q ss_pred cccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhc---CCCc---------------eEEeeCCC
Q 047195 301 LGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQL---NHRS---------------LFMSMSPN 358 (559)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l---~h~n---------------iv~~~~~~ 358 (559)
||+|+||+||+|+.. +++.+|+|++.... ......+..|..++..+ +||| +|+||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 58899999986432 22334566777777765 5876 47899999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 9999888653 24889999999999999999999 888999999999999999999999999998754322211
Q ss_pred eeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 439 VTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+. .. ....+.. .+..
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~-~i~~~~~------~~~~ 218 (330)
T cd05586 153 -TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YR-NIAFGKV------RFPK 218 (330)
T ss_pred -ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HH-HHHcCCC------CCCC
Confidence 2234599999999998764 488999999999999999999999975432111 11 1111100 0110
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
......+.+++.+||+.+|++||++.
T Consensus 219 ------~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 219 ------NVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred ------ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 11235677899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=279.71 Aligned_cols=253 Identities=24% Similarity=0.246 Sum_probs=184.6
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
++|++.+.||+|++|.||+|..+ +++.+|+|+++... ....+.+.+|++++++++|+|+ ++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999865 57899999876532 3334678999999999999984 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|++++.+..+.... ..+++..+..++.|++.||+||| .++++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 88876665544331 24889999999999999999999 78899999999999999999999999999987655
Q ss_pred CCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc-cc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA-ID 512 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d 512 (559)
..........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.................... .+
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 433222334578999999999887 7899999999999999999999998754432211111110000000000000 00
Q ss_pred ccccc-----CCC------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKE-----GAS------EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~-----~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.... ... ..+......+.+++++||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000 000112577899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=277.47 Aligned_cols=225 Identities=22% Similarity=0.343 Sum_probs=171.6
Q ss_pred CccccCCccEEEEEEecC--------CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 299 NLLGSGGFGEVFKAILDD--------ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~--------~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.++++++|+|+ |+||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 23477787765555555778999999999999984 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC--------EEEeecc
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD--------AKISDFG 427 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~--------~kl~DFG 427 (559)
+++|+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++. +|++|||
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999987532 25889999999999999999999 888999999999999987765 6999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCC-CCCCCCccccccHHHHHHHHhhcc
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKK-AVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
++...... ....++..|+|||++.+. .++.++||||||+++|||++|.. |+....... ... .....
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~----~~~~~ 221 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQ----FYEDR 221 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHH----HHHcc
Confidence 88654321 123478899999998764 57899999999999999999954 443222111 000 00000
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
..+. .....++.+++.+||+.+|++|||++++++.|+
T Consensus 222 -------~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -------HQLP-------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------ccCC-------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0011 112256889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=277.90 Aligned_cols=230 Identities=24% Similarity=0.323 Sum_probs=181.1
Q ss_pred CCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCCCCc
Q 047195 297 TGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSPNGT 360 (559)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~ 360 (559)
....||+|+||.||++.. .+++.+|+|.+........+.+.+|+.+++.++|||+ ++||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 345799999999999985 4688999999876655556778999999999999984 779999999
Q ss_pred HhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceee
Q 047195 361 LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT 440 (559)
Q Consensus 361 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 440 (559)
|..++.. ..+++..+..++.|++.||+||| +++++||||||+|||++.++.+||+|||++......... .
T Consensus 105 L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~ 174 (297)
T cd06659 105 LTDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-R 174 (297)
T ss_pred HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-c
Confidence 9887743 24789999999999999999999 888999999999999999999999999998755433221 1
Q ss_pred eeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCC
Q 047195 441 TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGAS 520 (559)
Q Consensus 441 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 520 (559)
....++..|+|||++.+..++.++||||||+++|||++|+.||......+. .. ....... .....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~----~~~~~~~-----~~~~~--- 239 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MK----RLRDSPP-----PKLKN--- 239 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHhccCC-----CCccc---
Confidence 223489999999999888899999999999999999999999874432111 10 0111000 00000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 521 EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 521 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.......+.+++.+||+.+|++|||+++|++
T Consensus 240 --~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 240 --AHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred --cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0122356788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=276.58 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=179.7
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|+..+.||.|++|.||+|+. .++..+|||++..... ...+.+.+|++++++++|+|| |+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999985 4688999998865432 223568899999999999994 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+. ++|..++..... ..+++..+..++.|++.||+||| +++++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 85 578877765332 35889999999999999999999 788999999999999999999999999998765432
Q ss_pred CceeeeeccccCCccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc--h------
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQ-LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE--R------ 506 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~------ 506 (559)
... .....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||......... ..... ..... .
T Consensus 154 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~ 229 (284)
T cd07860 154 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFR-TLGTPDEVVWPGVT 229 (284)
T ss_pred ccc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHH-HhCCCChhhhhhhh
Confidence 211 12223688999999887644 688999999999999999999999754432211 11100 00000 0
Q ss_pred ----hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 ----LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ----~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.......................+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000000122356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=272.89 Aligned_cols=233 Identities=27% Similarity=0.391 Sum_probs=183.0
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCc---------------eEEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRS---------------LFMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~n---------------iv~~~ 355 (559)
+|+..+.||+|++|.||++.. .++..+|+|.+.... ......+.+|++++++++|+| +|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999985 467889999886542 233567899999999999998 47899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC-CCEEEeecccceeccC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGLSRLALN 434 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~-~~~kl~DFG~a~~~~~ 434 (559)
.++++|.+++..... ..+++..+..++.|++.+|+||| +++++|+||||+||+++++ ..+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999976432 35889999999999999999999 8899999999999999865 4689999999987654
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... .. .... .....
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~---~~~~-~~~~~------ 219 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LV---LKIM-SGTFA------ 219 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HH---HHHH-hcCCC------
Confidence 322 122348899999999988888999999999999999999999986443211 11 1100 00000
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.........+.+++.+||+.+|++|||+.|+++
T Consensus 220 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 ------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 001123466889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=274.97 Aligned_cols=233 Identities=25% Similarity=0.398 Sum_probs=185.0
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
..|+..+.||.|+||.||+|... ++..+|+|.+.... ....+.+.+|+.++++++|+|+ |+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999864 57899999887543 2335678999999999999984 6899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++.. ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999998853 24788899999999999999999 888999999999999999999999999999766443
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
... .....++..|+|||++.+..++.++|+||||+++|||++|+.|+.......... . ...
T Consensus 155 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-~~~----------- 215 (277)
T cd06640 155 QIK-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------L-IPK----------- 215 (277)
T ss_pred ccc-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------h-hhc-----------
Confidence 221 222347889999999988889999999999999999999999986443221100 0 000
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.............+.+++.+||+.+|++||++.++++.
T Consensus 216 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 -NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00011123455778899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=275.39 Aligned_cols=237 Identities=26% Similarity=0.409 Sum_probs=180.4
Q ss_pred CccccCCccEEEEEEecC-------CcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 299 NLLGSGGFGEVFKAILDD-------ETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-------~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++|+|| ++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 2578888876543 2345678999999999999985 5788
Q ss_pred CCCCcHhHhHhhccCC--CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-----CEEEeeccc
Q 047195 356 SPNGTLFDRLHRVQSG--NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-----DAKISDFGL 428 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-----~~kl~DFG~ 428 (559)
+++++|.+++...... ....+++..+..++.|++.||.||| +.+++|+||||+|||++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998754321 1234788999999999999999999 78899999999999999877 899999999
Q ss_pred ceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 429 SRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 429 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH----HhcCC
Confidence 8765432211 1112235788999999998889999999999999999998 999986443211 1111 11100
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
.+. .....+..+.+++.+||+.+|++||++.+|+++|++
T Consensus 231 -------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 -------RLQ-----KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------ccC-----CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 011234678899999999999999999999999974
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=278.17 Aligned_cols=249 Identities=23% Similarity=0.250 Sum_probs=182.9
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC-----ChhhHHHHHHHHHhcCCCc---------------eE
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK-----GIDPILNEVRILCQLNHRS---------------LF 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~-----~~~~~~~E~~~l~~l~h~n---------------iv 352 (559)
+|++.+.||+|++|.||+|... +++.+|+|.+...... ....+.+|++++++++|+| +|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999854 6889999998765433 2345778999999999998 47
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+ +++|.+++.... ..+++..+..++.||++||+||| +++|+|+||||+|||++.++.+||+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 8999 899999886532 25899999999999999999999 888999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc------
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE------ 505 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 505 (559)
....... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..+|......+.... ........
T Consensus 153 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 228 (298)
T cd07841 153 GSPNRKM-THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK---IFEALGTPTEENWP 228 (298)
T ss_pred cCCCccc-cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH---HHHHcCCCchhhhh
Confidence 5432211 22236888999998855 4578899999999999999999877764433221111 11100000
Q ss_pred ---hhhhcccccccc--CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 506 ---RLVDAIDPMLKE--GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 506 ---~~~~~~d~~l~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.+.......... ............+.+++.+||+.+|++|||++||++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 0000112234678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.29 Aligned_cols=258 Identities=21% Similarity=0.242 Sum_probs=169.5
Q ss_pred HhCCCCCCCccccCCccEEEEEEecC--CcEEEEE------------------EeecCCCCChhhHHHHHHHHHhcCCCc
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDD--ETITAVK------------------RAKLGNTKGIDPILNEVRILCQLNHRS 350 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~avk------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 350 (559)
..++|++.+.||+|+||+||++..+. +...++| .+. ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45689999999999999999987432 1112222 111 11122346889999999999999
Q ss_pred eEE---------------eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 351 LFM---------------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 351 iv~---------------~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
||. ++. .++|++.+...............+..++.|++.||+||| +++|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 742 333 345666554322111122345667789999999999999 7889999999999999
Q ss_pred cCCCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHH
Q 047195 416 DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~ 495 (559)
+.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|+.++............
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999999876544333333345999999999999989999999999999999999988654332211111111
Q ss_pred HHHHHHhh--c-------chhhhccccc-cccCCChh-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 496 VYFGNILK--Q-------ERLVDAIDPM-LKEGASEI-----ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 496 ~~~~~~~~--~-------~~~~~~~d~~-l~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........ . ..+.+.++.. +....... .......+.+++.+||+.||.+|||+.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11110000 0 0011111000 00000000 0112245677899999999999999999986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=273.36 Aligned_cols=253 Identities=28% Similarity=0.391 Sum_probs=186.4
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHh--cCCCc-------------------eE
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQ--LNHRS-------------------LF 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~--l~h~n-------------------iv 352 (559)
..++.++||+|.||.||||.+++ +.||||++...+ .+.|++|-+|.+. |.|+| ||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhccC-ceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 45667889999999999999875 899999987643 3568888888875 68988 47
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHc------CCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL------ATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
++|.++|+|.++|... .++|....+|+..+++||+|||.. ++.+|+|||||+.||||.+|++..|+||
T Consensus 287 t~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 8999999999999763 589999999999999999999964 3567999999999999999999999999
Q ss_pred ccceeccCCCcee-eeeccccCCccCccccccCC-CC-----cccchhHHHHHHHHHHhCCCCCCC-CCccccccHHHHH
Q 047195 427 GLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQ-LT-----DKSDVYSFGVVLVELLTSKKAVDF-NREEEDVNLVVYF 498 (559)
Q Consensus 427 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~SlG~il~el~tg~~p~~~-~~~~~~~~~~~~~ 498 (559)
|+|..+..+.... ....+||.+|||||++.+.. .. .+.||||+|.|||||+++-...+. .-++-+.......
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998876543332 22356999999999987642 22 368999999999999998665531 1111111111111
Q ss_pred HHHhh-----cchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 499 GNILK-----QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 499 ~~~~~-----~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..... .--+++...|.+...... ...+..+.+.+..||..||+-|.|+.=|.+++.++
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~--h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRK--HAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhc--CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 11111 111111122222222211 23456788899999999999999999999988765
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=286.52 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=179.0
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCceE-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSLF----------------- 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~niv----------------- 352 (559)
.++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++|+||+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 568899999986432 23346688999999999999853
Q ss_pred ---EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 353 ---MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 353 ---~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
++|+. ++|...+.. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 34443 355555532 25889999999999999999999 888999999999999999999999999999
Q ss_pred eeccCCCcee--eeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc--
Q 047195 430 RLALNGASHV--TTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ-- 504 (559)
Q Consensus 430 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 504 (559)
+......... .....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPS 230 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence 7654322111 122358899999998755 4688999999999999999999999965432111 1111111100
Q ss_pred -chhhhcccccc-----------ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 505 -ERLVDAIDPML-----------KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 505 -~~~~~~~d~~l-----------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
..+..+.+... ..............+.+++.+||+.+|++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00100000000 000000001234668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=273.84 Aligned_cols=246 Identities=25% Similarity=0.296 Sum_probs=186.2
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-----------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL-----------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni-----------------v~ 353 (559)
++|+..+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++|+|| |+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3578889999999999999996 4578899998875433 334679999999999999984 56
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++..... ....+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 88999999888765332 2245788999999999999999999 8889999999999999999999999999987554
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...... ........ +
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~-----~ 226 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELL-SYIVNMPN-----P 226 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHH-HHHhcCCc-----h
Confidence 3221 123378899999999888899999999999999999999999975532111 111111 11111000 0
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+... ..........+.+++.+||+.+|++|||+.||++
T Consensus 227 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 ELKDE-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhccC-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11100 0001123467899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=288.13 Aligned_cols=235 Identities=24% Similarity=0.371 Sum_probs=184.6
Q ss_pred CCCCCCccccCCccEEEEEEecCC-cEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCC
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDE-TITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSP 357 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~-~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~ 357 (559)
.|+++..||.|+||.||+|..++. ...|.|.+...+....++++-||+||....||+| +.||+.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 466778899999999999986554 4556788877777888999999999999999985 469999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
||-+..++-.... .+.+.++.-+++|++.||.||| ++.|||||||..|||++-+|.++|+|||.+........
T Consensus 113 GGAVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred CchHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999887766543 6999999999999999999999 88999999999999999999999999999754432222
Q ss_pred eeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 438 HVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
...++ .|||.|||||++. +.+|+.++||||||++|.||..+.+|....++ ...........+ .
T Consensus 186 kRDsF-IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaKSeP-P---- 253 (1187)
T KOG0579|consen 186 KRDSF-IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP-P---- 253 (1187)
T ss_pred hhccc-cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhhcCC-C----
Confidence 22333 3999999999874 56899999999999999999999998653322 111111111110 0
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.|. .+......+.+++.+||..||+.||+++++++
T Consensus 254 -TLl-----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 -TLL-----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -ccc-----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111 02345578999999999999999999999986
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=271.22 Aligned_cols=232 Identities=25% Similarity=0.380 Sum_probs=182.5
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-----CChhhHHHHHHHHHhcCCCc---------------eE
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-----KGIDPILNEVRILCQLNHRS---------------LF 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-----~~~~~~~~E~~~l~~l~h~n---------------iv 352 (559)
+|+..+.||+|++|+||+|... ++..+++|.+..... +..+.+.+|+.+++.++|+| ++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999965 789999999876432 23467899999999999998 46
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||.++++|.+++... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 7999999999988653 24789999999999999999999 788999999999999999999999999998765
Q ss_pred cCCCceeeeeccccCCccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQ-LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
.... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... ........... .
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~-~-- 221 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKEL-P-- 221 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccC-C--
Confidence 4332 122344889999999987766 8899999999999999999999986433111 01110000000 0
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+ .......+.+++++||+.+|++|||+.++++
T Consensus 222 --~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --PI-------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --Cc-------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00 1123366788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=272.30 Aligned_cols=234 Identities=28% Similarity=0.371 Sum_probs=179.8
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-----CChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-----KGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
.+|++.+.||+|+||.||++.. .++..+|+|.+..... ...+.+.+|+.++++++|+||
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999985 4588999998764321 123568889999999999884
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
++||.++++|.+++.... .+++..+.+++.|++.||+||| +++++|+||||+|||++.++.+||+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 568889999999886432 4788889999999999999999 888999999999999999999999999998
Q ss_pred eeccCCCc--eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 430 RLALNGAS--HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 430 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
+....... .......++..|+|||++.+..++.++||||||+++|||++|+.||....... . ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~-- 225 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP-- 225 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhcCC--
Confidence 75432111 11122348899999999988888999999999999999999999986332111 0 11110000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+ ..+......+..++.+|+. +|++|||++||++
T Consensus 226 ---~~~-------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ---TNP-------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCC-------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 001 1122344667788889985 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=278.42 Aligned_cols=231 Identities=26% Similarity=0.329 Sum_probs=185.7
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
+.|..-++||+||||.||-.. ...|+.+|.|++.... .+...-.++|-.||.+++.+.| |+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 567888999999999999887 4568899988875432 2333457899999999988864 66
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
..|.||+|.-+|..... +.+++..++.++.+|+.||++|| ...|+.||+||+|||+|+.|++.|+|+|+|..+.
T Consensus 265 tlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 88999999988876554 45999999999999999999999 8889999999999999999999999999999887
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.+..... .+||.+|||||++.+..|+...|+|||||+||||+.|+.||...-.... .+.+|+
T Consensus 339 ~g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~eEvdr 400 (591)
T KOG0986|consen 339 EGKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------REEVDR 400 (591)
T ss_pred CCCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HHHHHH
Confidence 7655433 3699999999999999999999999999999999999999964332211 122333
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPS 547 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt 547 (559)
++.......+....++...+.+..|+.||++|.-
T Consensus 401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 3333333333455567778888899999999963
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=276.93 Aligned_cols=253 Identities=21% Similarity=0.200 Sum_probs=180.5
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcC-CCce-----------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLN-HRSL----------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~-h~ni----------------- 351 (559)
++|++.+.||+|+||.||+|.. .+++.+|+|....... .....+.+|+.+++.+. |+|+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688999999999999999995 4688999998765432 23356889999999995 4663
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEeecc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFG 427 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~DFG 427 (559)
+++|+++ +|.+.+..........+++..+..++.||+.||+||| +++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 5677764 7888776544332346899999999999999999999 788999999999999998 8899999999
Q ss_pred cceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||........... +........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH---IFKLLGTPT 232 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHhCCCC
Confidence 98765332111 122236889999998865 4578999999999999999999999975433221111 111100000
Q ss_pred h---hhcc--------ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 L---VDAI--------DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~---~~~~--------d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. .... ..................+.+++.+||+.+|++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000 000000000000123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=271.88 Aligned_cols=236 Identities=28% Similarity=0.418 Sum_probs=184.4
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|++.+.||+|+||.||++.. .+++.+++|.++..... ..+.+.+|+.++++++|+|| |+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 488889999999999999985 46889999998766543 56789999999999999983 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
.++++|.+++... ..+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999988753 24788899999999999999999 788999999999999999999999999998876543
Q ss_pred Cceeee---eccccCCccCccccccCC---CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 436 ASHVTT---FAQGTLGYLDPEYYINFQ---LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 436 ~~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
...... ...+++.|+|||++.+.. ++.++||||||++++||++|+.||....... ...... . ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~--~-~~---- 222 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHV--G-AG---- 222 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHH--h-cC----
Confidence 322211 234788999999988765 8899999999999999999999996432111 000000 0 00
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.+.. .......+.+++.+||+.+|++|||+.|++.
T Consensus 223 -~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPD-----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCc-----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011111 0122456778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=283.42 Aligned_cols=248 Identities=19% Similarity=0.213 Sum_probs=176.5
Q ss_pred CCCccccC--CccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 297 TGNLLGSG--GFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 297 ~~~~lG~G--~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
++++||+| +|++||++.. .+++.||+|++..... ...+.+.+|+++++.++|||| |+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6889999985 5789999999876432 223467789999999999995 67999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.++++||+.........
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999865322 24889999999999999999999 7889999999999999999999999998754332111
Q ss_pred ce------eeeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc----
Q 047195 437 SH------VTTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ---- 504 (559)
Q Consensus 437 ~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 504 (559)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~ 232 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE-KLNGTVPCLLD 232 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH-HhcCCcccccc
Confidence 00 1112236778999999875 4588999999999999999999999964322110 000 0000000
Q ss_pred ------chh-----hhccccccc--------------cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ------ERL-----VDAIDPMLK--------------EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ------~~~-----~~~~d~~l~--------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+ ....+..+. .............+.+|+.+||+.||++|||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000000000 0000111233467889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.06 Aligned_cols=237 Identities=25% Similarity=0.377 Sum_probs=182.1
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcC-CCceE---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLG--NTKGIDPILNEVRILCQLN-HRSLF---------------M 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv---------------~ 353 (559)
...|+++++||.||.+.||++...+.+.+|+|++... +.+..+.|.+|+..|.+|+ |.+|| |
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3579999999999999999999888899999887553 4556778999999999996 55543 3
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
|+- +-+|..+|..... ....| .++.+..|++.|+.++| .++|||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 440 E~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred ecc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 332 3366677765332 12334 78899999999999999 889999999999998865 579999999999887
Q ss_pred CCCceee-eeccccCCccCccccccCC-----------CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 434 NGASHVT-TFAQGTLGYLDPEYYINFQ-----------LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 434 ~~~~~~~-~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
.+..... ....||+.||+||.+.... .+.++||||||||||+|+.|+.||.....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------------- 577 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------------- 577 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------------
Confidence 7665554 3456999999999985432 45799999999999999999999852210
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.-.++..+.|+.-..++...+.. .++.++++.||..||.+|||..|||+
T Consensus 578 -~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 578 -QIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11234455555444444444322 23889999999999999999999986
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=277.23 Aligned_cols=248 Identities=21% Similarity=0.284 Sum_probs=179.6
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||+|++|.||+|..+ +++.+|+|.+...... ....+.+|++++++++|+|| |+||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57899999999999999999964 6789999998754332 23457899999999999984 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+.+ +|.+++.... ..+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 874 8888876532 25789999999999999999999 788999999999999999999999999998754322
Q ss_pred CceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc---chhhhc-
Q 047195 436 ASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ---ERLVDA- 510 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 510 (559)
... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||....... .........+.. ..+...
T Consensus 157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhh
Confidence 111 112236889999999875 457889999999999999999999996443111 111111111100 000000
Q ss_pred -------------cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 -------------IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 -------------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+...... ......+.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPR--LDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcC--CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000000 111256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=272.62 Aligned_cols=242 Identities=27% Similarity=0.409 Sum_probs=187.3
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||.|+||+||+|.. .++..+++|++.... ....+.+.+|+++++.++|+|+ ++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4789999999999999999995 467889999886543 2345779999999999999984 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+.+..... ...+++..+..++.|++.||+||| +++++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999876432 135889999999999999999999 888999999999999999999999999998766543
Q ss_pred Cce---eeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 436 ASH---VTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 436 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
... ......|+..|+|||++... .++.++|+||||++++||++|+.||........ ........
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~------ 223 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQND------ 223 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCC------
Confidence 322 12233488999999998776 788999999999999999999999964432211 11111110
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.+..... .......+.+++.+||+.+|++|||+++|++
T Consensus 224 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGAD--YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccc--cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011111000 0133467889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=270.47 Aligned_cols=234 Identities=24% Similarity=0.383 Sum_probs=188.7
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc---------------eEEeeCC
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSP 357 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~~ 357 (559)
-|.+.++||+|+||.||+|++ ..|..+|||++... .+.++++.|+.||++...++ |||||+.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 477889999999999999995 56899999998764 45689999999999998765 6899999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
.|++.++++..+ .++.+.++..+++..+.||+|||.+ .=||||||.-|||++-+|++||+|||.|-.+.+...
T Consensus 112 AGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 112 AGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred CCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 999999997644 4799999999999999999999955 479999999999999999999999999977654333
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
... .+.|||-|||||++..-.|+.++||||||++..||..|++|+....+..... +.+.. -.+..++
T Consensus 185 KRN-TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------MIPT~----PPPTF~K 251 (502)
T KOG0574|consen 185 KRN-TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------MIPTK----PPPTFKK 251 (502)
T ss_pred hhC-ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------eccCC----CCCCCCC
Confidence 322 3449999999999999999999999999999999999999986332211100 00000 0011111
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
+...+.++-+++++||-.+|++|-|+.++++.
T Consensus 252 -----PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 -----PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -----hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 24566889999999999999999999998763
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=270.32 Aligned_cols=238 Identities=25% Similarity=0.413 Sum_probs=180.7
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC----------ChhhHHHHHHHHHhcCCCce-----------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK----------GIDPILNEVRILCQLNHRSL----------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~----------~~~~~~~E~~~l~~l~h~ni----------- 351 (559)
+|.+.+.||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|+.++++++|+|+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999985 46889999987643211 12357889999999999984
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
|+||.++++|.+.+... ..+++..+..++.|++.||.||| +++++||||+|+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 67999999999988754 25888999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCce-eeeeccccCCccCccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 047195 428 LSRLALNGASH-VTTFAQGTLGYLDPEYYINFQ--LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 428 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
+++........ ......++..|+|||.+.... ++.++|+||||++++||++|..|+....... .. .... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~-~~~~-~ 226 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AM-FKLG-N 226 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HH-HHhh-c
Confidence 99765432211 122345889999999987654 7889999999999999999999985322111 00 0000 0
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
......+...+ .......+.+++.+||+.+|++|||+.+|++
T Consensus 227 ~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 KRSAPPIPPDV-------SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cccCCcCCccc-------cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000111111 1123467888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=275.06 Aligned_cols=251 Identities=19% Similarity=0.209 Sum_probs=178.7
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCC-hhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKG-IDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
+++|.+.+.||+|+||.||+|.. .++..+|+|.+....... ...+.+|+.+++.++|+|| |+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999985 468899999987544332 2467899999999999995 567
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+. +++.+.+.... ..+.+..+..++.|++.||+||| +.+|+|+||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 84 YMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred ccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 775 67766654322 24778888999999999999999 78899999999999999999999999999876433
Q ss_pred CCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc---------
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ--------- 504 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 504 (559)
.... .....+++.|+|||++.+. .++.++||||||+++|||++|+.||....... ......+.....
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhh
Confidence 2211 1223478999999998754 57889999999999999999999997543321 111111110000
Q ss_pred ---chhhhccccc-cccCCChh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ---ERLVDAIDPM-LKEGASEI--ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ---~~~~~~~d~~-l~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.......... ........ .......+.+++.+|++.+|++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 00000000 0112356788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=283.25 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=182.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
..+|++.+.||+|++|.||++.. .++..+|+|++.... ......+.+|+.+|++++|+||
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36799999999999999999985 468999999987542 2344678899999999999984
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
|++|+. ++|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 556664 5777766532 24899999999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCce---eeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH----
Q 047195 430 RLALNGASH---VTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI---- 501 (559)
Q Consensus 430 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---- 501 (559)
......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 765432211 1123358899999999865 46889999999999999999999999754432211111110000
Q ss_pred ----hhcchhhhcccc---ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 ----LKQERLVDAIDP---MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ----~~~~~~~~~~d~---~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.....+....+. ................+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000001110000 0000000001123577899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=283.19 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=182.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|.+.+.||+|+||+||+++. .++..+|||.+... .......+.+|+.+++.++|+||
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999985 46889999988653 23334568899999999999985
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
+++|+. ++|.+.+... ..+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 345554 5777766532 25899999999999999999999 88899999999999999999999999999
Q ss_pred ceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH-------
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN------- 500 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~------- 500 (559)
++...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.................
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 98654332 12223347889999998865 4688999999999999999999999975432211111110000
Q ss_pred -Hhhcchhhhcccc---ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 501 -ILKQERLVDAIDP---MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 501 -~~~~~~~~~~~d~---~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
..........+.. ................+.+++++||+.+|++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000000 00000001112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=271.33 Aligned_cols=237 Identities=24% Similarity=0.404 Sum_probs=182.7
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC------CChhhHHHHHHHHHhcCCCce---------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT------KGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~------~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
+|+..+.||+|++|.||++.. .++..+|+|.+..... ...+.+.+|++++++++|+||
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999984 6688999998865331 124578999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeecccce
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDFGLSR 430 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DFG~a~ 430 (559)
|++|+++++|.+++... .++++..+..++.|++.||+||| +++++|+||+|+||+++.++ .+||+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 67999999999988653 25888999999999999999999 88999999999999998776 59999999987
Q ss_pred eccCCCce---eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 431 LALNGASH---VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 431 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
........ ......++..|+|||.+.+..++.++||||||+++++|++|+.||.......... ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~--- 226 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIASA--- 226 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhcc---
Confidence 65432111 1122347889999999988889999999999999999999999986433211111 11100000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
......+......+.+++.+||+.+|++|||+.|+++
T Consensus 227 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ---------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0001111234467888999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=277.81 Aligned_cols=237 Identities=27% Similarity=0.319 Sum_probs=183.5
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK---GIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|++|.||++... +++.+|+|.+...... ..+.+.+|+++++.++|+|| ++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999965 4899999998764332 44568999999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||..+++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+|||++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999998875322 35899999999999999999999 7889999999999999999999999999987543
Q ss_pred CCCce----------------------------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCC
Q 047195 434 NGASH----------------------------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDF 485 (559)
Q Consensus 434 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~ 485 (559)
..... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 21110 00112478899999999888899999999999999999999999975
Q ss_pred CCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 047195 486 NREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS----IKEVAD 553 (559)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt----~~evl~ 553 (559)
.+.... ..... +....-.. .......+.+++.+||+.+|++||| +.|+++
T Consensus 235 ~~~~~~------~~~~~---------~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRDET------FSNIL---------KKEVTFPG---SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchHHH------HHHHh---------cCCccCCC---ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 432211 01111 10000000 0114477899999999999999999 666554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=279.04 Aligned_cols=250 Identities=26% Similarity=0.300 Sum_probs=180.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.+.||+|+||.||+|.. .++..+|+|.+...... ....+.+|+.++++++|+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45799999999999999999996 45889999998754332 22356789999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+. ++|.+.+.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++..
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 456665 46777766432 35899999999999999999999 88899999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc--hhh
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE--RLV 508 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 508 (559)
....... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... ....... ...
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~~ 233 (309)
T cd07845 158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI---IQLLGTPNESIW 233 (309)
T ss_pred cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChhhc
Confidence 6533211 122236788999999865 45789999999999999999999999755432221111 1110000 000
Q ss_pred hcc------cc-cccc----CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 DAI------DP-MLKE----GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ~~~------d~-~l~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+ .. .+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 00 0000 000000112466788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=278.48 Aligned_cols=256 Identities=20% Similarity=0.227 Sum_probs=181.4
Q ss_pred CCCCCCccccCCccEEEEEEec---CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce----------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD---DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
.|++.+.||+|++|.||+|... ++..+|+|.+.... ....+.+.+|+.++++++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999987643 3344678899999999999984
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC----CCCEEEeec
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE----KLDAKISDF 426 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~----~~~~kl~DF 426 (559)
|+||+++ ++.+.+..........+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 5677654 6666665433322246889999999999999999999 788999999999999999 899999999
Q ss_pred ccceeccCCCce--eeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccH------HHH
Q 047195 427 GLSRLALNGASH--VTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNL------VVY 497 (559)
Q Consensus 427 G~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~------~~~ 497 (559)
|+++........ ......++..|+|||++.+. .++.++||||||+++++|++|+.||........... ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 999865433221 11223478899999987664 578999999999999999999999976543321000 000
Q ss_pred HHHHhhc------------chhhhccccccccCCC--hhhH------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 498 FGNILKQ------------ERLVDAIDPMLKEGAS--EIEL------DSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 498 ~~~~~~~------------~~~~~~~d~~l~~~~~--~~~~------~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+.. .......+........ .... .....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0000000000000000 0000 23356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=275.33 Aligned_cols=240 Identities=23% Similarity=0.286 Sum_probs=183.4
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||.||++... .++.+++|.+..... ...+.+.+|+++++.++|+|| |+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999854 568899998876432 334578899999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++... ..+++..+..++.|++.||+||| +++++||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998653 24889999999999999999999 7889999999999999999999999999987421
Q ss_pred CCCc--------------eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 047195 434 NGAS--------------HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG 499 (559)
Q Consensus 434 ~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 499 (559)
.... .......++..|+|||.+....++.++||||||+++|||++|..||......+ ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~ 226 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFG 226 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence 1100 01112347889999999988889999999999999999999999986433211 111
Q ss_pred HHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 500 NILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 500 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
.... .. ...+... ......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 227 ~~~~-~~---~~~~~~~-------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 227 QVIS-DD---IEWPEGD-------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHh-cc---cCCCCcc-------ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1100 00 0000000 1233567899999999999999998777776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=272.64 Aligned_cols=249 Identities=22% Similarity=0.246 Sum_probs=179.7
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
|++.+.||.|++|.||+|.. .++..+|+|++..... .....+.+|++++++++|+|+ +++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67789999999999999985 4789999999875432 223568899999999999984 56887
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
+ ++|.+++..... ..+++..+..++.|+++||+||| +++++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 4 688888765432 35899999999999999999999 7889999999999999999999999999997654322
Q ss_pred ceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc-----------
Q 047195 437 SHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ----------- 504 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 504 (559)
... ....++..|+|||++.+. .++.++||||||+++|||++|+.||........... ........
T Consensus 154 ~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 RTY-THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred ccc-CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCCCChHHhhhhhhc
Confidence 111 122368899999987664 578899999999999999999999875543221111 00000000
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.........................+.+++.+||+.+|++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000000001122356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.99 Aligned_cols=237 Identities=29% Similarity=0.389 Sum_probs=167.1
Q ss_pred HHhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCceEEee------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSLFMSM------------ 355 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~------------ 355 (559)
.-.++|+.++.||+||||.||+++ .=||+.+|||++.... .+....+.+|++.|++|+|||+|..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 345678899999999999999999 4589999999987753 23335689999999999999975311
Q ss_pred --------------------------------------------------------------------------------
Q 047195 356 -------------------------------------------------------------------------------- 355 (559)
Q Consensus 356 -------------------------------------------------------------------------------- 355 (559)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------------------------CCCCcHhHhHhhccCCCCCCC--ChHHHHHHHHHHHHH
Q 047195 356 ------------------------------------------SPNGTLFDRLHRVQSGNWPPL--KWHHRLHIARQTAQA 391 (559)
Q Consensus 356 ------------------------------------------~~~g~L~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~ 391 (559)
++.-.+.+++++. .+ .....++++++|++|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N------~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN------HFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc------ccchhhHHHHHHHHHHHHH
Confidence 1111111111110 01 234567899999999
Q ss_pred HHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc-----------------CCCceeeeeccccCCccCccc
Q 047195 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL-----------------NGASHVTTFAQGTLGYLDPEY 454 (559)
Q Consensus 392 l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~ 454 (559)
|+|+| +++||||||||.||+++++..|||+|||+|+... .......+...||.-|+|||+
T Consensus 710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 99999 8889999999999999999999999999998721 011112344569999999999
Q ss_pred cccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHH
Q 047195 455 YINF---QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFG 531 (559)
Q Consensus 455 ~~~~---~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 531 (559)
+.+. .|+.|+|+||||+||+||+. ||....+ ... ....++.+. +... .....+....=+
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~----iL~~LR~g~--------iP~~-~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RAS----ILTNLRKGS--------IPEP-ADFFDPEHPEEA 848 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHH--HHH----HHHhcccCC--------CCCC-cccccccchHHH
Confidence 9765 49999999999999999984 4542221 111 111122222 2211 111122334446
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 047195 532 LLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 532 ~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.++++|++.||.+|||+.|++.
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 7899999999999999999985
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=271.38 Aligned_cols=241 Identities=27% Similarity=0.389 Sum_probs=185.0
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCc-----------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRS----------------- 350 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~n----------------- 350 (559)
..+++|++.+.||+|++|.||+|..+ +++.+++|.+..... ..+.+.+|+.+++++ +|+|
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 34678999999999999999999964 578899998876543 346799999999998 6876
Q ss_pred ----eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 351 ----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 351 ----iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
+|++|+++++|.+++..... ....+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence 46788999999998876431 1235889999999999999999999 889999999999999999999999999
Q ss_pred ccceeccCCCceeeeeccccCCccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYIN-----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
|++......... .....++..|+|||++.. ..++.++||||||+++|+|++|+.||........ ....
T Consensus 158 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~ 230 (275)
T cd06608 158 GVSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LFKI 230 (275)
T ss_pred ccceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HHHh
Confidence 998765432221 223348999999998753 3467899999999999999999999863321110 0000
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... .+.+.. .......+.+++.+||..||++|||+.+|++
T Consensus 231 -~~~~-----~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 -PRNP-----PPTLKS-----PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -hccC-----CCCCCc-----hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 001110 1123467889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=274.65 Aligned_cols=250 Identities=24% Similarity=0.258 Sum_probs=180.7
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce-----------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL-----------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni-----------------v 352 (559)
++|++.+.||+|+||.||+|..+ +++.+++|.++..... ....+.+|+.++++++|||| |
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999965 5788999998754332 22357889999999999995 4
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+. ++|.+++.... ..+++..+..++.|++.||+||| +++++|+||||+|||+++++.+||+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 45655 47777776532 25899999999999999999999 788999999999999999999999999998866
Q ss_pred cCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHhh
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF--------GNILK 503 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~ 503 (559)
...... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||............... +..+.
T Consensus 157 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 157 GSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 543211 1223478899999998754 4688999999999999999999999755432211111000 00000
Q ss_pred c------chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 504 Q------ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 504 ~------~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ..........+...... ......+.+++++||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPA--LSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccc--cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00000000011111110 002466889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=281.89 Aligned_cols=239 Identities=25% Similarity=0.387 Sum_probs=196.8
Q ss_pred CCCCCccccCCccEEEEEEec---CC--cEEEEEEeecC-CCCChhhHHHHHHHHHhcCCCce--------------EEe
Q 047195 295 FSTGNLLGSGGFGEVFKAILD---DE--TITAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL--------------FMS 354 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~---~~--~~~avk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni--------------v~~ 354 (559)
....++||.|-||.||+|... .| -.||||.-+.. .....+.|+.|..+|++++|||| |||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE 470 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME 470 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence 345678999999999999842 22 45788877663 44556789999999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
..+.|.|..+|+... ..++......++.||+.||+||| +...+||||...|||+....-+||+|||+++.+.+
T Consensus 471 L~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred cccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999998643 36888999999999999999999 88899999999999999999999999999999887
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
+.....+...-...|||||.+.-..++.+||||-||+.+||++. |.+||.+-.+.+-...+ +
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------E---------- 606 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------E---------- 606 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------c----------
Confidence 76665555557889999999999999999999999999999876 89999865433211110 0
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.++....+..++..+..|+.+||..+|.+||++.|+...|++++
T Consensus 607 --nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 607 --NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred --CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 11222334566788999999999999999999999999998763
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.84 Aligned_cols=235 Identities=24% Similarity=0.346 Sum_probs=186.4
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
++|.+.+.||+|+||.||++.. .++..+++|.+........+.+.+|+.++++++|||+ |+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5789999999999999999985 4678899999876655556789999999999999984 67899
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999988642 4788899999999999999999 8889999999999999999999999999987654332
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
... ....+++.|+|||.+....++.++||||||+++|+|++|+.||...+........ ...+. +..
T Consensus 170 ~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~------~~~- 235 (293)
T cd06647 170 SKR-STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PEL- 235 (293)
T ss_pred ccc-ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC------CCC-
Confidence 221 2234888999999998888899999999999999999999999754332211100 00000 000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
. ........+.+++++||..+|++||++.+++..
T Consensus 236 ---~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 ---Q-NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---C-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011234568889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=275.47 Aligned_cols=229 Identities=25% Similarity=0.318 Sum_probs=182.6
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++|||| ++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999854 57899999886532 2345678999999999999984 68
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+.+... ..+++..+..++.|++.||+||| +++++|+||+|+|||+++++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998764 25889999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||....... ......... .
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~------~ 215 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEKILEGK------V 215 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCC------c
Confidence 43 122348999999999988888999999999999999999999986443111 000011110 0
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
.+.. .....+.+++.+||..+|.+|| +++|+++
T Consensus 216 ~~~~-------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 RFPS-------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCc-------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111 1236778899999999999999 6777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=269.37 Aligned_cols=234 Identities=27% Similarity=0.395 Sum_probs=182.7
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCc---------------eEEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRS---------------LFMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~n---------------iv~~~ 355 (559)
+|++.+.||+|+||.||++..+ ++..+|+|.+.... ....+.+.+|++++++++|+| +++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999964 57889999986542 234467889999999999998 47899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeecccceeccC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDFGLSRLALN 434 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DFG~a~~~~~ 434 (559)
+++++|.+.+..... ..+++..+..++.|+++||+||| +.+++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999998865322 24789999999999999999999 78899999999999999886 469999999876543
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
... ......|++.|+|||++.+..++.++|+||||++++||++|+.|+....... ...... ... +.+
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~----~~~- 221 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC-QGY----FAP- 221 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-ccc----CCC-
Confidence 322 2223358999999999988889999999999999999999999986443211 111111 111 000
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........+.+++.+||+.+|++|||+.||++
T Consensus 222 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 -------ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01122356888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.04 Aligned_cols=250 Identities=20% Similarity=0.215 Sum_probs=180.4
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce----------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
..++|++.+.||+|+||.||++.. .+++.+|+|.+... .......+.+|+.++++++|+||
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999985 46889999987643 22334568899999999999985
Q ss_pred -----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
|+||+. ++|.+.+.. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccC
Confidence 345553 466665542 2788889999999999999999 788999999999999999999999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH--------
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF-------- 498 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~-------- 498 (559)
|+++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+...........
T Consensus 163 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 163 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred ccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99986543221 22234789999999999989999999999999999999999999755422111110000
Q ss_pred HH--------Hhhcc------hhhhccccccc-cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 499 GN--------ILKQE------RLVDAIDPMLK-EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 499 ~~--------~~~~~------~~~~~~d~~l~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ..... .+.......+. .............+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00000 00000000000 0000001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=273.39 Aligned_cols=248 Identities=23% Similarity=0.259 Sum_probs=180.5
Q ss_pred CCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce-----------------EEe
Q 047195 295 FSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL-----------------FMS 354 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni-----------------v~~ 354 (559)
|++.+.||+|++|.||+|+.. ++..+|+|.+.... ......+.+|++++++++|+|+ |++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999865 57899999988763 3334568899999999999984 456
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|++ ++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 665 36766665421 35899999999999999999999 78899999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh----
Q 047195 435 GASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD---- 509 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 509 (559)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......................+..
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 43222233447889999998765 3578999999999999999999999975543222111110000000000000
Q ss_pred ----------ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 ----------AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ----------~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.....+.... .......+.+++.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFF---KHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHh---cccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000 0012567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=273.56 Aligned_cols=232 Identities=21% Similarity=0.308 Sum_probs=182.6
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCCC
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSPN 358 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~ 358 (559)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+|+ +++|+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 5678999999876655556678999999999999984 6788999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|.+++.. ..+++..+..++.|++.||+||| +++++||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 101 GALTDIVTH------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred CCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 999998865 14788999999999999999999 788999999999999999999999999988765433222
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
. ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+.... ... .... ..+.+..
T Consensus 172 ~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~-~~~~-----~~~~~~~- 237 (285)
T cd06648 172 R-KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKR-IRDN-----LPPKLKN- 237 (285)
T ss_pred c-ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHH-HHhc-----CCCCCcc-
Confidence 1 223489999999999888899999999999999999999999864332111 110 0000 0011111
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.......+.+++.+||+.+|++|||+.++++
T Consensus 238 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 ----LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ----cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0113357889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=272.44 Aligned_cols=232 Identities=24% Similarity=0.324 Sum_probs=188.5
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCceEE---------------e
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSLFM---------------S 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~---------------~ 354 (559)
.-|.+.+-||+|.|+.|-+|++ -.|..||||++..... .....++.|++.|+-++|||||. |
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577888999999999999984 5789999999865432 33457899999999999999754 5
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee-cCCCCEEEeecccceecc
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL-DEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill-~~~~~~kl~DFG~a~~~~ 433 (559)
.-.+|+|++++.+... .+.+..+.+++.||+.|+.|+|++| ++||||||+||.+ ..-|-+||.|||++..+.
T Consensus 98 LGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 5688999999987654 4899999999999999999999555 9999999999866 456889999999998876
Q ss_pred CCCceeeeeccccCCccCccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLT-DKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.+..- +..+|+..|-|||++.+..|+ +++||||||+|||-|+.|+.||+..++.+....+ +|
T Consensus 171 PG~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mD 233 (864)
T KOG4717|consen 171 PGKKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MD 233 (864)
T ss_pred Ccchh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hc
Confidence 65432 334599999999999999887 5789999999999999999999866654432221 11
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
=. -..+.-+..+..+||.+||..||.+|.|.+||+.
T Consensus 234 CK-----YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 CK-----YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc-----ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11 1223456678899999999999999999999874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=270.90 Aligned_cols=253 Identities=18% Similarity=0.230 Sum_probs=182.9
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
+|++.+.||+|++|.||+|+.. ++..+|||.++..... ..+.+.+|++++++++|+|+ |+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4888999999999999999964 6889999998765432 34668899999999999984 67888
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++ +|.+++..... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 DK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred Cc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 74 78777765332 235899999999999999999999 7889999999999999999999999999997554322
Q ss_pred ceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh--------
Q 047195 437 SHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL-------- 507 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 507 (559)
.. .....++..|++||.+.+. .++.++||||||+++|+|++|+.||......+................+
T Consensus 155 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 NT-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred cc-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 11 1223478899999988654 5688999999999999999999999765433221111100000000000
Q ss_pred -hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 -VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 -~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
......................+.+++.+||+.+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000000111123466789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=269.54 Aligned_cols=250 Identities=21% Similarity=0.219 Sum_probs=183.5
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
|++.+.||+|++|.||++.. .++..+++|.+...... ....+.+|++++++++|+|| ++||.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999986 46888999988654332 34678899999999999984 67887
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++ +|.+.+.... ..+++..+..++.|++.||.||| +++|+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 64 7877776532 35899999999999999999999 7889999999999999999999999999998765443
Q ss_pred ceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc---
Q 047195 437 SHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID--- 512 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 512 (559)
. ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+................+....+
T Consensus 153 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 R-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred c-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 1 12223478899999998776 788999999999999999999999875543222111110000000000000000
Q ss_pred ---ccc----ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 ---PML----KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ---~~l----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ..............+.+++.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00001112245678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=264.50 Aligned_cols=234 Identities=26% Similarity=0.389 Sum_probs=186.7
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCC
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSP 357 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~ 357 (559)
+|+..+.||+|++|.||++... ++..+++|++..........+.+|++++++++|+|+ +++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999965 688999999877665566789999999999999984 678999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+.+.... ..+++..+..++.|++.||+||| ..+++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999886532 35899999999999999999999 78999999999999999999999999999877654432
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+........ ..... ..... .+..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~----~~~~~-----~~~~ 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFKIA----TNGPP-----GLRN 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHH----hcCCC-----CcCc
Confidence 2233488999999999888889999999999999999999999864431111 00000 00000 0000
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 220 -----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0112467889999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=268.14 Aligned_cols=232 Identities=26% Similarity=0.284 Sum_probs=184.4
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
+|++.+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|++++++++|||| |++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999965 588999999875432 345789999999999999984 689
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+.+++|.+.+... .++++..+..++.|+++||.||| .++++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999988653 25889999999999999999999 78899999999999999999999999999876544
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .......... . ..
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~----~~- 219 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--A----DV- 219 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--c----cc-
Confidence 32 1223448889999999988889999999999999999999999997554321 1111111110 0 00
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSI--KEVA 552 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~--~evl 552 (559)
..+......+.+++.+||+.+|++||++ +|++
T Consensus 220 ------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 ------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111234678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=306.61 Aligned_cols=238 Identities=29% Similarity=0.375 Sum_probs=188.0
Q ss_pred HhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.+-+|+-...||.|.||.||-+. .++|...|+|.++... .+....+.+|+.+|..|+|||+ .
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44578888999999999999998 6678899999887643 3455678999999999999996 4
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++|+|.++++..+. .++.....+..|++.|++||| .++||||||||+||||+.+|.+|+.|||.|..+
T Consensus 1313 MEyC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEe
Confidence 699999999999987542 566677788899999999999 889999999999999999999999999999887
Q ss_pred cCCCcee---eeeccccCCccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 433 LNGASHV---TTFAQGTLGYLDPEYYINF---QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 433 ~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
....... .....||+-|||||++.+. ....++||||||||++||+||++||...+.+= .+.+.-.
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~------ 1455 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVA------ 1455 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHh------
Confidence 6543222 1234599999999999764 34568999999999999999999997443221 1111111
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.+..++.+.....+-.+++.+||+.||++|.++.++++.
T Consensus 1456 ---------~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 ---------AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---------ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111222333455667789999999999999999988874
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=265.84 Aligned_cols=236 Identities=30% Similarity=0.416 Sum_probs=187.9
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCc---------------eEEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRS---------------LFMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~n---------------iv~~~ 355 (559)
+|++.+.||.|++|.||++... ++..+++|++..... ...+.+.+|++++++++|+| +++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999964 578999999876543 45567899999999999998 47799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
.++++|.+.+..... ....+++..+..++.+++.||+||| +++++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999876431 1246899999999999999999999 789999999999999999999999999999876544
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
. .......|++.|+|||.+.+..++.++|+||+|+++++|++|+.|+....... ...... .... . .+
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~----~-~~ 223 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKIL-KGQY----P-PI 223 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHh-cCCC----C-CC
Confidence 3 22233458899999999988889999999999999999999999986443111 111111 1110 0 11
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+......+.+++.+||..+|++|||+.|+++
T Consensus 224 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 -------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123367888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=256.62 Aligned_cols=194 Identities=26% Similarity=0.354 Sum_probs=157.3
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec---C--CcEEEEEEeecCCCC-C-hhhHHHHHHHHHhcCCCce-----------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD---D--ETITAVKRAKLGNTK-G-IDPILNEVRILCQLNHRSL----------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---~--~~~~avk~~~~~~~~-~-~~~~~~E~~~l~~l~h~ni----------- 351 (559)
+....|+..+.||+|.||.||+|... + ...+|||+++-.... + -....+|+.+++.++|+|+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 44557999999999999999999632 2 237899988764321 1 2468899999999999995
Q ss_pred -----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC----CCEE
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK----LDAK 422 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~----~~~k 422 (559)
+++|.+. +|+++++..+......++...++.|+.||+.|+.||| ++-|+||||||.|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 3455544 6788877655544467899999999999999999999 8889999999999999877 8999
Q ss_pred EeecccceeccCCCcee--eeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 047195 423 ISDFGLSRLALNGASHV--TTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNR 487 (559)
Q Consensus 423 l~DFG~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~ 487 (559)
|+|||+++.+.+.-... ...++-|.+|.|||.+.+. .||.+.|||+.|||+.||+|-.+.|.+..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999999886543332 2345579999999999886 69999999999999999999998887543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=282.77 Aligned_cols=236 Identities=24% Similarity=0.342 Sum_probs=189.5
Q ss_pred CCCCCccccCCccEEEEEEecC--C--cEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce--------------EEee
Q 047195 295 FSTGNLLGSGGFGEVFKAILDD--E--TITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL--------------FMSM 355 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~~--~--~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni--------------v~~~ 355 (559)
..+.++||+|.||.|++|.|.. | ..||||.++..... .+++|++|+.+|.+|+|+|+ |+|.
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL 191 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL 191 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence 3455789999999999999753 3 56899999876554 67899999999999999996 4577
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
.+.|+|.+.|+.. ....+.......++.|||.|+.||. ++++|||||...|+||-....+||+||||.+.+..+
T Consensus 192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 8999999999872 2346888889999999999999999 889999999999999999999999999999977654
Q ss_pred Cceee--eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 436 ASHVT--TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 436 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... ....-...|.|||.+....++.+||||+||++||||+| |..||.+.+...... .+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~----------------~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK----------------NID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH----------------hcc
Confidence 33322 22335678999999999999999999999999999998 677987665432211 111
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
.++.-..+..+.+.|.++++.||..+|++|||+..|.+.+
T Consensus 330 ---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 ---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 0111112345678999999999999999999999997543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=284.61 Aligned_cols=237 Identities=27% Similarity=0.383 Sum_probs=192.2
Q ss_pred CCCCccccCCccEEEEEEe-cCC----cEEEEEEeecC-CCCChhhHHHHHHHHHhcCCCce--------------EEee
Q 047195 296 STGNLLGSGGFGEVFKAIL-DDE----TITAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL--------------FMSM 355 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~----~~~avk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni--------------v~~~ 355 (559)
...++||+|+||+||+|.+ .++ .+||||++... ..+..+++++|+-+|.+|.|+|| |.+|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 4457899999999999985 333 57888887654 33455789999999999999995 5699
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
++.|.|.++++..+ ..+..+..+.|..|||+|+.||| .+.++||||-.+||||..-.++||.|||+++....+
T Consensus 779 mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred cccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999998743 36888999999999999999999 889999999999999999999999999999988765
Q ss_pred Cceeee-eccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 436 ASHVTT-FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 436 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
..+... ...-.+.|||=|.+....|+.++|||||||++||++| |.+|+++....+..++ ++.+..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~geR------ 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKGER------ 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhcccc------
Confidence 544332 2335678999999999999999999999999999998 8889886665443222 222110
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
| ..+......+..++.+||..|+..||+++++.+++.++
T Consensus 919 -L-----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 919 -L-----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred -C-----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 1 11223457788899999999999999999999988765
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=268.98 Aligned_cols=232 Identities=25% Similarity=0.392 Sum_probs=181.8
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcC---CCce---------------EE
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN-TKGIDPILNEVRILCQLN---HRSL---------------FM 353 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~---h~ni---------------v~ 353 (559)
.|+..+.||+|+||.||+|.. .++..+|+|.+.... .....++.+|+.++++++ |+|+ |+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 578889999999999999995 568899999886543 344567889999999997 8884 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 899999999887542 5889999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... . ..... ..
T Consensus 153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------~-~~~~~-----~~ 219 (277)
T cd06917 153 QNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM------M-LIPKS-----KP 219 (277)
T ss_pred CCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh------h-ccccC-----CC
Confidence 43322 223358999999998865 45788999999999999999999999644321110 0 00000 00
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+... .....+.+++.+||+.+|++|||+.|+++
T Consensus 220 ~~~~~~------~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLEDN------GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCcc------cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111110 13367888999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=270.83 Aligned_cols=237 Identities=24% Similarity=0.342 Sum_probs=186.9
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.++.|+..+.||+|++|.||++..+ ++..+++|.+..... ....+.+|++++++++|+|+ ++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3556888899999999999999976 678899999876554 45678999999999999984 568
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|.++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 899999999998643 25899999999999999999999 78999999999999999999999999999865443
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... .... ..... .
T Consensus 169 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~-----~ 235 (286)
T cd06614 169 EKSK-RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FLIT-TKGIP-----P 235 (286)
T ss_pred chhh-hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hcCCC-----C
Confidence 2211 12234788999999998888999999999999999999999998643322110 0000 00000 0
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.. .......+.+++.+||+.+|.+|||+.+|++
T Consensus 236 ~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 LKN-----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred Ccc-----hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 000 0113467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.15 Aligned_cols=255 Identities=23% Similarity=0.271 Sum_probs=191.5
Q ss_pred CCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecC-CCCChhhHHHHHHHHHhcCCCce--------------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL-------------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni-------------------- 351 (559)
.|...+.||+|+||.||+|+ ...|+.||||.+... .....+...+|+++|++|+|+||
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 36667899999999999999 678999999998753 45566788999999999999995
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec--CCC--CEEEeec
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD--EKL--DAKISDF 426 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~--~~~--~~kl~DF 426 (559)
||||+.+|+|...|+.... -..+++.+.+.++.+++.||.||| .++|+||||||.||++- ++| .-||+||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEEeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 6899999999999987543 346999999999999999999999 88999999999999983 334 3699999
Q ss_pred ccceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
|.|+...++. ......||..|++||.+.. ..|+..+|.|||||++||.+||..||.............|....-.+.
T Consensus 169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 9999887655 4455569999999999984 789999999999999999999999997554433222222222221111
Q ss_pred hhhhcccccccc---------CCChhhHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHH
Q 047195 506 RLVDAIDPMLKE---------GASEIELDSMKAFGLLGAACLDERRQNRP--SIKEVADEI 555 (559)
Q Consensus 506 ~~~~~~d~~l~~---------~~~~~~~~~~~~l~~l~~~cl~~~p~~RP--t~~evl~~L 555 (559)
...-..++...+ ............+..++..+|..+|++|- ...+.-..+
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV 307 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence 111111111110 01122244556677788889999999997 444443333
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=265.39 Aligned_cols=234 Identities=26% Similarity=0.382 Sum_probs=186.2
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|++.+.||+|++|.||++.. .++..+++|.+.... .....++.+|++++++++|+|| |++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999985 467889999987543 2334578899999999999984 6789
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
.++++|.+++..... ....+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999998876332 1246889999999999999999999 888999999999999999999999999999876544
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
. .....+++.|++||.+.+..++.++|+||||++++||++|+.||....... .........
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~--------- 217 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGK--------- 217 (256)
T ss_pred C---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCC---------
Confidence 1 222348899999999988889999999999999999999999986443211 011111111
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+......+.+++.+||+.+|++|||+.++++
T Consensus 218 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 ---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111234467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=272.91 Aligned_cols=241 Identities=27% Similarity=0.323 Sum_probs=174.8
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcC-CCceE---------------Eee
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLN-HRSLF---------------MSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv---------------~~~ 355 (559)
+|+..+.||+|+||.||++.. .+++.+|+|.+..... .....+.+|+.++.++. |+||+ ++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 456678899999999999985 4578999999875432 33457899999999996 99974 344
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+. +++.++...........+++..+..++.|++.||+|||+ ..+++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 43 344443332211112358999999999999999999993 348999999999999999999999999998765432
Q ss_pred CceeeeeccccCCccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF---QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... ....|+..|+|||++.+. .++.++||||||+++|||++|+.||.... ............. .
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------~ 228 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD------P 228 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC------C
Confidence 211 222488999999998765 68899999999999999999999986432 1111111111000 0
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+.... .......+.+|+.+||+.+|++|||+.+|++
T Consensus 229 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 229 PILSNSE---EREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcCCCcC---CCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111110 1234467889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=277.76 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=181.5
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC--CCCChhhHHHHHHHHHhc-CCCce---------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG--NTKGIDPILNEVRILCQL-NHRSL--------------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni--------------- 351 (559)
..++|++.+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +|+||
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567999999999999999999965 5788999987542 233445688999999999 99985
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
|+||+. ++|...+... .+.+..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 456665 4676666431 4788889999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCc----eeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH---
Q 047195 430 RLALNGAS----HVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI--- 501 (559)
Q Consensus 430 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 501 (559)
........ .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||..................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 86643322 12223358999999998765 45788999999999999999999999654332211111110000
Q ss_pred -----hhcchhhhcccccc---ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 502 -----LKQERLVDAIDPML---KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 502 -----~~~~~~~~~~d~~l---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
+........++... ..............+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000111000 000001111234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=271.95 Aligned_cols=231 Identities=30% Similarity=0.400 Sum_probs=176.8
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK---GIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
+.|++.+.||+|+||+||+|... +++.+|+|.+...... ..+++.+|+++++.++|||+ |+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999854 6889999988654332 23568899999999999995 44
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+. |++.+.+.... ..+++..+..++.|++.||.||| +.+|+||||+|+||++++++.+||+|||++....
T Consensus 95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 6665 56666665322 25899999999999999999999 7889999999999999999999999999987653
Q ss_pred CCCceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
... ...+++.|+|||++. ...++.++||||||+++|||++|+.|+........ ........
T Consensus 167 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~~----- 230 (307)
T cd06607 167 PAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND----- 230 (307)
T ss_pred CCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcCC-----
Confidence 321 234788999999874 34688899999999999999999999864332111 00000000
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.+.+. .......+.+++.+||+.+|++||++.+|+..
T Consensus 231 -~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 -SPTLS------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCCC------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 11234678999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=271.96 Aligned_cols=250 Identities=20% Similarity=0.247 Sum_probs=178.0
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
++|++.+.||+|++|+||+|..+ +++.+|+|.+..... ...+.+.+|++++++++|+|+ |+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999864 678999998865432 233568899999999999995 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEeecccceecc
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFGLSRLAL 433 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~DFG~a~~~~ 433 (559)
|++ ++|.+.+..... ..+++..+..++.||+.||+||| +++++|+||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 885 577777654322 23578888899999999999999 788999999999999985 5579999999997654
Q ss_pred CCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc---hhh-
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE---RLV- 508 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~- 508 (559)
..... .....+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||......+..... ...+... .+.
T Consensus 155 ~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~ 230 (294)
T PLN00009 155 IPVRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPNEETWPG 230 (294)
T ss_pred CCccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChhhccc
Confidence 32211 122347889999998866 35788999999999999999999999754432211111 0000000 000
Q ss_pred -----hccc--cccc-cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 -----DAID--PMLK-EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 -----~~~d--~~l~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... +... .............+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000 0000001123356788999999999999999999986
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=267.70 Aligned_cols=245 Identities=22% Similarity=0.235 Sum_probs=175.9
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcC-CCce-----------------EEe
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLN-HRSL-----------------FMS 354 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni-----------------v~~ 354 (559)
|++.+.||+|+||.||++.. .++..+|+|+++.... .......+|+.++.++. |+|+ |+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778999999999999985 4688999998865422 22234568999999885 8884 567
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+. ++|.+.+.... ..+++..+..++.|++.||+||| +.+++||||||+||+++. +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 775 57777765422 35899999999999999999999 788999999999999999 9999999999986543
Q ss_pred CCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh----------
Q 047195 435 GASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK---------- 503 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 503 (559)
.... ....++..|+|||.+.. ..++.++||||||+++|||++|+.||...+..+.. ........
T Consensus 152 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 152 KPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred CCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHHHhh
Confidence 2221 12347889999997654 45788999999999999999999999755432211 11111100
Q ss_pred -cchhhhcccc-ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 504 -QERLVDAIDP-MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 504 -~~~~~~~~d~-~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.........+ .............+..+.+++.+||+.+|++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 0000000011234578999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=269.76 Aligned_cols=237 Identities=25% Similarity=0.342 Sum_probs=175.7
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHH-HHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRI-LCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~-l~~l~h~ni---------------v~~ 354 (559)
++|++.+.||+|+||.||++..+ ++..+|+|+++.... .....+..|+.+ ++.++|+|+ ++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999864 689999999876432 233456677775 566789986 456
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC-CeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP-PIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~-~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
|++ ++|.+.+...... ...+++..+..++.|++.||+||| ++ +++||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 665 6777777653322 246899999999999999999999 66 89999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccCcccccc----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYIN----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
.... .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... . ....... .
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~---~~~~~~~-~---- 223 (283)
T cd06617 156 DSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--Q---QLKQVVE-E---- 223 (283)
T ss_pred cccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--H---HHHHHHh-c----
Confidence 3211 122348899999998754 456889999999999999999999985322110 0 0000000 0
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.+.. ...+..+.+++.+||..+|++|||+.++++
T Consensus 224 -~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PSPQLPA------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCCc------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011100 123366888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=268.41 Aligned_cols=232 Identities=27% Similarity=0.411 Sum_probs=181.9
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
-|++.+.||+|+||.||+|.. .++..+|+|....... ...+.+.+|+.++++++|+|| |+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 377788999999999999985 4678999998765432 334568899999999999984 67999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++.. ..+++..+..++.|++.++.||| ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999988863 24789999999999999999999 8899999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.. .....++..|+|||.+.+...+.++||||||+++|+|++|..|+....... .... ..... .+.+
T Consensus 156 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~-----~~~~- 221 (277)
T cd06641 156 IK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-IPKNN-----PPTL- 221 (277)
T ss_pred hh-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-HhcCC-----CCCC-
Confidence 11 122347889999999988888999999999999999999999986432111 0000 00000 0011
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11233667889999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=278.82 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=184.8
Q ss_pred cccChHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCceEE----
Q 047195 281 RIFSSREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSLFM---- 353 (559)
Q Consensus 281 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---- 353 (559)
+....+++..++++|++.+.||+|+||.||++.. .++..+|+|++.... ....+.+.+|+.++++++|+||+.
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3445567778889999999999999999999984 568899999887532 223456889999999999999743
Q ss_pred ----------------eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC
Q 047195 354 ----------------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE 417 (559)
Q Consensus 354 ----------------~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~ 417 (559)
++..+++|.+++.. ..+++..+..++.|+++||+||| +++|+||||||+||++++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhcccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcC
Confidence 11234566555532 24889999999999999999999 788999999999999999
Q ss_pred CCCEEEeecccceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 047195 418 KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496 (559)
Q Consensus 418 ~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~ 496 (559)
++.+||+|||+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............
T Consensus 156 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 156 DCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CCCEEEecccccccccccc----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999987643221 22347899999998866 468889999999999999999999986543222111110
Q ss_pred HHHHHhhcchh-----------hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 497 YFGNILKQERL-----------VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 497 ~~~~~~~~~~~-----------~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........... ...+..................+.+|+.+||+.+|++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00000000000 0000000000000000012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=271.96 Aligned_cols=249 Identities=28% Similarity=0.335 Sum_probs=180.2
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCceE--------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSLF-------------- 352 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~niv-------------- 352 (559)
...++|++.+.||+|+||.||+|..+ +++.+|+|.+..... .....+.+|++++++++|||++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34568999999999999999999965 578999999876432 2234678999999999998854
Q ss_pred -----------EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCE
Q 047195 353 -----------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421 (559)
Q Consensus 353 -----------~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~ 421 (559)
+||+++ ++...+... ...+++..+..++.|++.||+||| +++|+|+||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcE
Confidence 344443 555555432 235899999999999999999999 7889999999999999999999
Q ss_pred EEeecccceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 047195 422 KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN 500 (559)
Q Consensus 422 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 500 (559)
||+|||++...............++..|+|||.+.+. .++.++||||||++++||++|+.||......+.... ...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~---~~~ 232 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL---ISR 232 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHH
Confidence 9999999987654332222223367889999988653 578899999999999999999999875432221111 111
Q ss_pred Hhhcc---hhhhc--------cc------cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 501 ILKQE---RLVDA--------ID------PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 501 ~~~~~---~~~~~--------~d------~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... .+..+ .+ ..+..... ..+..+.+++.+||+.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS----FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcC----CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11000 00000 00 00001111 12467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=276.13 Aligned_cols=252 Identities=25% Similarity=0.276 Sum_probs=183.8
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
+|++.+.||+|++|.||+++.. .+..+|+|++.... ....+.+.+|+.++++++|+||
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999965 48899999887543 3345679999999999999884
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
+++|+. ++|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 455555 4676666532 25899999999999999999999 8889999999999999999999999999998
Q ss_pred eccCCCc--eeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh----
Q 047195 431 LALNGAS--HVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK---- 503 (559)
Q Consensus 431 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 503 (559)
....... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+.............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 7654321 112223478899999999887 789999999999999999999999976653322111111000000
Q ss_pred ----cchhhhccc---cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 504 ----QERLVDAID---PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 504 ----~~~~~~~~d---~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.......+. .................+.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 000000000111234678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=271.09 Aligned_cols=240 Identities=25% Similarity=0.280 Sum_probs=182.7
Q ss_pred CCCCCCccccCCccEEEEEEe----cCCcEEEEEEeecCC----CCChhhHHHHHHHHHhc-CCCc--------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGN----TKGIDPILNEVRILCQL-NHRS-------------- 350 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~~avk~~~~~~----~~~~~~~~~E~~~l~~l-~h~n-------------- 350 (559)
+|++.+.||+|++|.||+++. .++..+|||.++... ....+.+.+|+.++.++ +|+|
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999874 356889999886432 22345688999999999 5776
Q ss_pred -eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 351 -LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 351 -iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
+|+||+.+++|.+.+... ..+++..+..++.|++++|.||| +.+++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 478999999999888642 24888999999999999999999 788999999999999999999999999998
Q ss_pred eeccCCCceeeeeccccCCccCccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQ--LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
+..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||........ ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~--- 227 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS--- 227 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc---
Confidence 765443322223345899999999987654 78899999999999999999999864322111 11111111000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
.+... ......+.+++.+||+.+|++|||++++.+.|+.
T Consensus 228 ----~~~~~-------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ----KPPFP-------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCCCC-------cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01111 1233567889999999999999999988877753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=274.14 Aligned_cols=254 Identities=24% Similarity=0.248 Sum_probs=178.1
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCC--hhhHHHHHHHHHhcCCCceE----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKG--IDPILNEVRILCQLNHRSLF---------------- 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~--~~~~~~E~~~l~~l~h~niv---------------- 352 (559)
.++|++.+.||+|+||.||+|... +++.+|+|++....... ...+.+|++++++++|+||+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999954 67899999886544322 24678999999999999864
Q ss_pred -------EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 353 -------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 353 -------~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
++|+. +++...+... ...+++..+..++.|+++||+||| +++|+|+||||+|||+++++.+||+|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence 23433 3455544432 135899999999999999999999 78899999999999999999999999
Q ss_pred cccceeccCCCce----------eeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccH
Q 047195 426 FGLSRLALNGASH----------VTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNL 494 (559)
Q Consensus 426 FG~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~ 494 (559)
||++......... ..+...+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999765432211 11223478889999987654 578999999999999999999999875543322111
Q ss_pred HHHHHHHhhcch------hhhccc----cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 495 VVYFGNILKQER------LVDAID----PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 495 ~~~~~~~~~~~~------~~~~~d----~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.........+.. +....+ ..........-......+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111100000000 000000 00000000000112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=272.86 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=177.6
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.+.||+|+||.||+|... +++.+|||.+...... ....+.+|++++++++||||
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999864 6889999988654322 22356789999999999975
Q ss_pred ------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 352 ------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 352 ------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
|+||+. ++|.+.+.... ..+++..+..++.|++.||+||| +++++|+||||+|||++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECc
Confidence 345554 46666665422 25899999999999999999999 78899999999999999999999999
Q ss_pred cccceeccCCCce---eeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 426 FGLSRLALNGASH---VTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 426 FG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..................
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999765432211 11223478899999987664 4788999999999999999999998755433222111111100
Q ss_pred hhcchhhh-----cccc-ccccCCC-hh-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LKQERLVD-----AIDP-MLKEGAS-EI-----ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~~~~~~~-----~~d~-~l~~~~~-~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........ ..+. .+..... .. .......+.+++.+||+.+|++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000 0000 0000000 00 0001245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=280.32 Aligned_cols=229 Identities=25% Similarity=0.388 Sum_probs=176.0
Q ss_pred CCCccccCCccEEEEEEec-CCcEEE---EEEeec-CCCCChhhHHHHHHHHHhcCCCceE-----------------Ee
Q 047195 297 TGNLLGSGGFGEVFKAILD-DETITA---VKRAKL-GNTKGIDPILNEVRILCQLNHRSLF-----------------MS 354 (559)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-~~~~~a---vk~~~~-~~~~~~~~~~~E~~~l~~l~h~niv-----------------~~ 354 (559)
...+||+|+|-+||+|... +|..|| ||.-.. .++...++|..|+.+|+.|+|+||| .|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3467999999999999854 355554 222222 2344458899999999999999974 47
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEeecccceecc
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFGLSRLAL 433 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~DFG~a~~~~ 433 (559)
.+..|+|..++.+.+. ++.+.++.|++||++||.|||+. ..+|||||||.+||+|+. -|.|||+|+|||+...
T Consensus 124 L~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 7899999999987654 78889999999999999999964 579999999999999985 5799999999998865
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... ..+.|||.|||||++. ..|+..+||||||+.++||+|+..|+..-...- .+.+....+...+.+
T Consensus 198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A------QIYKKV~SGiKP~sl-- 265 (632)
T KOG0584|consen 198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA------QIYKKVTSGIKPAAL-- 265 (632)
T ss_pred cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH------HHHHHHHcCCCHHHh--
Confidence 4332 2356999999999976 689999999999999999999999986433221 122222222211111
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+-. -.++.++|.+||.. .++|||+.|+|+
T Consensus 266 --~kV~-------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 --SKVK-------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --hccC-------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1101 14677899999999 999999999985
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=277.31 Aligned_cols=247 Identities=21% Similarity=0.259 Sum_probs=173.7
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCceEE---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSLFM--------------- 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 353 (559)
.++|.+.+.||+|+||.||+|.. .++..+|+|++.... ......+.+|+.++++++|+||+.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999985 468999999886532 222356889999999999999753
Q ss_pred ------eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 354 ------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 354 ------~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
+|+. .+|...+ . ..+++..+..++.|++.||+||| +++++||||||+|||++.++.+||+|||
T Consensus 94 ~~~lv~e~~~-~~l~~~~----~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM----G---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEecccc-cCHHHHH----c---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 2221 1222221 1 24888999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH-------
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG------- 499 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~------- 499 (559)
+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+............
T Consensus 163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 163 LARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 987643221 22347889999999876 468899999999999999999999997544222111110000
Q ss_pred -HHhhcchhhhccc---cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 500 -NILKQERLVDAID---PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 500 -~~~~~~~~~~~~d---~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...........+. ..........-......+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000000 00000000000112356789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=268.07 Aligned_cols=227 Identities=23% Similarity=0.305 Sum_probs=169.4
Q ss_pred ccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHh---cCCCc---------------eEEeeCC
Q 047195 300 LLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQ---LNHRS---------------LFMSMSP 357 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~---l~h~n---------------iv~~~~~ 357 (559)
.||+|+||.||++.. .+++.+|+|.+..... .....+.+|..+++. .+|+| +|+||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 4578999998865422 112334555544443 36776 4789999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 99999888643 25899999999999999999999 78899999999999999999999999999875533221
Q ss_pred eeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ..... ...+..+
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~------~~~~~~~- 218 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT------LTVNVEL- 218 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHh------hcCCcCC-
Confidence 22348999999999864 568899999999999999999999997543222110 00000 0011111
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVADE 554 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~ 554 (559)
+......+.+++.+||+.||++|| |++|+++.
T Consensus 219 ------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112346788899999999999999 59988773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=277.50 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=179.2
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
..+|++.+.||.|+||.||+|.. .++..+|+|++........+.+.+|++++++++|+||
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36799999999999999999985 4678999999887766666789999999999999974
Q ss_pred ----------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec-CCCC
Q 047195 352 ----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD-EKLD 420 (559)
Q Consensus 352 ----------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~-~~~~ 420 (559)
|+||+. ++|.+.+.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++ +++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCce
Confidence 445554 466666542 24889999999999999999999 78899999999999997 4567
Q ss_pred EEEeecccceeccCCCce--eeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 047195 421 AKISDFGLSRLALNGASH--VTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~ 497 (559)
+||+|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+.......
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 899999999765322111 1122347889999998754 4678899999999999999999999975543221111100
Q ss_pred HHHHhhc---chhhhccccccc-------cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 498 FGNILKQ---ERLVDAIDPMLK-------EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 498 ~~~~~~~---~~~~~~~d~~l~-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....... ......+...+. ............++.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 000000000000 0000000123356788999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=262.84 Aligned_cols=232 Identities=25% Similarity=0.395 Sum_probs=184.8
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+|++.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|+|+ +++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999854 578899999876654 345679999999999999984 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
.++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 8999999988754 25899999999999999999999 889999999999999999999999999999876543
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... .. .... ... .+.+
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~-~~~~-~~~-----~~~~ 219 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----AL-FRIV-QDD-----HPPL 219 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HH-HHHh-ccC-----CCCC
Confidence 332 122348899999999888778899999999999999999999986432111 00 0000 000 0011
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+......+.+++.+||+.+|++|||+.+++.
T Consensus 220 -------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 -------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1123467889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=264.80 Aligned_cols=250 Identities=22% Similarity=0.264 Sum_probs=180.3
Q ss_pred CCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcC-CCc---------------eEEeeC
Q 047195 295 FSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLN-HRS---------------LFMSMS 356 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~-h~n---------------iv~~~~ 356 (559)
|++.+.||+|++|+||+|+.. +++.++||++..... .......+|+..+++++ |+| +|+||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999965 478899998765432 22234567999999999 988 478998
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
+++|.+.+..... ..+++..+..++.|++.+|.||| +++++|+||+|+||++++++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 8899988876431 35899999999999999999999 7889999999999999999999999999998654322
Q ss_pred ceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH-----hhc-chhhh
Q 047195 437 SHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI-----LKQ-ERLVD 509 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~-~~~~~ 509 (559)
. .....++..|+|||++.. ..++.++|+||||++++||++|+.||......+........... +.. ..+..
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 2 122347889999998754 45789999999999999999999998755432221111000000 000 00000
Q ss_pred ccccccccCC----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGA----SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.++..+.... ..........+.+++++||+.+|++|||++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1110100000 0000111366889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=264.91 Aligned_cols=248 Identities=23% Similarity=0.262 Sum_probs=177.9
Q ss_pred CCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC--ChhhHHHHHHHHHhc---CCCce-----------------
Q 047195 295 FSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK--GIDPILNEVRILCQL---NHRSL----------------- 351 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l---~h~ni----------------- 351 (559)
|++.+.||+|+||.||+|+.+ ++..+|+|.+...... ....+.+|+.+++++ +|+|+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 4899999998754322 234577888887766 58885
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
++||+. ++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 334554 467777765322 25899999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh-
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL- 507 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 507 (559)
+......... ....++..|+|||++.+..++.++||||||+++|||++|+.||......+.... ...........
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (287)
T cd07838 154 ARIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK--IFDVIGLPSEEE 229 (287)
T ss_pred ceeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH--HHHHcCCCChHh
Confidence 9776433221 122378899999999888899999999999999999999998875443221111 11100000000
Q ss_pred --------hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 --------VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 --------~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.................+....+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000011111111112244567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=247.96 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=178.9
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC-CCCChhhHHHHHHHHHhcC-CCceEEe---eCCCCcHhHhHh
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG-NTKGIDPILNEVRILCQLN-HRSLFMS---MSPNGTLFDRLH 366 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~---~~~~g~L~~~l~ 366 (559)
++.+.+..||.|.-|+||+.+.+ .+...|||.+... +.+...+++..+.++.+-+ .|.||.- |+.+-+++--++
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 44556678999999999999954 5889999998764 4555678888888887655 6888763 344444432221
Q ss_pred h-------ccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee
Q 047195 367 R-------VQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 367 ~-------~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
- .....+.++++..+-++...+..||.||.. .++|||||+||+|||+|+.|++||+|||++-.+.+...
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 1 111223468888888999999999999996 67899999999999999999999999999876654332
Q ss_pred eeeccccCCccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 440 TTFAQGTLGYLDPEYYIN---FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 440 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.+...|-+.|||||.+-- ..|+-++||||||+.|+||.||+.||.+...+- .....+.+ + .-|.|.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltkvln---~------ePP~L~ 316 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTKVLN---E------EPPLLP 316 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHHHHh---c------CCCCCC
Confidence 233349999999999853 368889999999999999999999998654322 11111111 1 112232
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ...+..+.+++..||+.|+.+||...++++
T Consensus 317 ~~-----~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GH-----MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cc-----cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 21 124578899999999999999999999876
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=263.53 Aligned_cols=234 Identities=29% Similarity=0.372 Sum_probs=180.2
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC-----CCChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN-----TKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
.+|++.+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|++++++++|+||
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4789999999999999999985 458899999875421 2233578899999999999984
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
++||.++++|.+.+... ..+++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 56888899999888643 24788899999999999999999 888999999999999999999999999999
Q ss_pred eeccCCCc--eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 430 RLALNGAS--HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 430 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
+....... .......++..|+|||.+.+...+.++||||||++++||++|+.||....... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-- 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQP-- 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcCC--
Confidence 76532111 11122348899999999988888999999999999999999999986432111 011111000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.+ +......+.+++.+||+ +|..|||+.+++.
T Consensus 226 ---~~~~~-------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ---TKPML-------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCC-------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00111 12344678889999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=263.40 Aligned_cols=230 Identities=28% Similarity=0.386 Sum_probs=179.3
Q ss_pred cccCCccEEEEEEecC-CcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCc---------------eEEeeCCCCcH
Q 047195 301 LGSGGFGEVFKAILDD-ETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRS---------------LFMSMSPNGTL 361 (559)
Q Consensus 301 lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~n---------------iv~~~~~~g~L 361 (559)
||+|+||.||+++..+ ++.+++|.+..... ...+.+.+|++++++++|+| ++++|+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999865433 34567899999999999998 47899999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc----
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS---- 437 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~---- 437 (559)
.+++.... .+++..+..++.|+++||+||| .++++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99987642 5899999999999999999999 78899999999999999999999999999876543311
Q ss_pred ---eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 438 ---HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 438 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
.......++..|+|||.+.....+.++||||||++++||++|+.||......+ ....... ... .
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~----~-- 219 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILN-GKI----E-- 219 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhc-CCc----C--
Confidence 12223447889999999988888999999999999999999999986443211 1111110 000 0
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
... .......+..++.+||+.+|++|||+.++.+.|+
T Consensus 220 ~~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPE-----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCc-----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000 0012467889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=269.96 Aligned_cols=231 Identities=28% Similarity=0.408 Sum_probs=176.9
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.|+..+.||+|+||.||+++. .++..+|+|.+..... .....+.+|++++++++|+|+ |+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999999999985 4678999998865422 223568899999999999984 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+. |++.+.+.... .++++..+..++.|++.||.||| +++|+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 886 57777765432 35899999999999999999999 88899999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
. ....+++.|+|||++. ...++.++||||||+++|||++|+.||........ .........
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~----- 241 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNES----- 241 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhccC-----
Confidence 2 1234889999999974 34688899999999999999999999864321111 000000000
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
+... .......+.+++.+||+.+|++|||+.+|++.+
T Consensus 242 -~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 -PTLQ------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -CCCC------CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0000 112335688899999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=260.19 Aligned_cols=235 Identities=27% Similarity=0.394 Sum_probs=186.7
Q ss_pred CCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------EE
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL-----------------FM 353 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni-----------------v~ 353 (559)
+|...+.||+|++|.||+|... ++..+++|++..... ...+.+.+|+.++++++|+|| ++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999965 688999999876543 445789999999999999984 56
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||.++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 7888999999887542 5899999999999999999999 7889999999999999999999999999998766
Q ss_pred CCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... ......++..|+|||.+.....+.++||||||+++++|++|+.||..... .............
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~------ 221 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGE------ 221 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCC------
Confidence 54321 12234488999999999888899999999999999999999999975441 1111111110000
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+......+.+++.+|++.+|++||++.++++
T Consensus 222 ------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 ------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111223477899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=258.01 Aligned_cols=226 Identities=25% Similarity=0.310 Sum_probs=179.6
Q ss_pred hCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCc---------------eE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRS---------------LF 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~n---------------iv 352 (559)
.++|+.+++||+|.||+|-+.+ ...++.+|+|+++..- ......-+.|-++|+..+||. .|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4689999999999999999998 5678999999987643 334456788999999999997 38
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||..+|.|+-+|.+.+ .+++...+.+-.+|..||.||| +++||.||||.+|.|+|.+|++||+|||+++..
T Consensus 247 MeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999997743 4888888899999999999999 889999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
-...... ...+|||.|+|||++....|...+|+|.+|+++|||+.|+.||...+... +...+. . .++
T Consensus 319 I~~g~t~-kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLIl---~----ed~-- 385 (516)
T KOG0690|consen 319 IKYGDTT-KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELIL---M----EDL-- 385 (516)
T ss_pred cccccee-ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHHH---h----hhc--
Confidence 4333333 33459999999999999999999999999999999999999997443221 111110 0 011
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCC
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRP 546 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 546 (559)
.. +.....+...|+.-.|..||.+|.
T Consensus 386 -kF-------Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 -KF-------PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -cC-------CccCCHHHHHHHHHHhhcChHhhc
Confidence 00 112224455677778899999995
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=268.84 Aligned_cols=229 Identities=21% Similarity=0.312 Sum_probs=179.3
Q ss_pred CCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc---------------eEEeeCCCCcH
Q 047195 298 GNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSPNGTL 361 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~~~g~L 361 (559)
...||+|+||.||++.. .++..+|||++..........+.+|+.+++.++|+| +++||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36799999999999986 568899999987655555567999999999999998 47899999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeee
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 441 (559)
.+++.. ..+++..+..++.|++.||+||| +++++|+||+|+||++++++.++|+|||++......... ..
T Consensus 105 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~ 174 (292)
T cd06657 105 TDIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RK 174 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-cc
Confidence 987743 14788999999999999999999 788999999999999999999999999998765433221 12
Q ss_pred eccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 442 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
...+++.|+|||.+.+..++.++|+||||+++|||++|+.||......... .. ... .+...+.. .
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~----~~~-----~~~~~~~~-~-- 239 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KM----IRD-----NLPPKLKN-L-- 239 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH----HHh-----hCCcccCC-c--
Confidence 234889999999988888899999999999999999999998643322110 00 000 00111100 0
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 --~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 --HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred --ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112356778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=264.94 Aligned_cols=229 Identities=26% Similarity=0.329 Sum_probs=174.9
Q ss_pred cccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcH
Q 047195 301 LGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FMSMSPNGTL 361 (559)
Q Consensus 301 lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L 361 (559)
||+|+||+||++.. .+++.+|+|.+.... ......+.+|++++++++|||+ |+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 468899999886532 2233457889999999999984 6799999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeee
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 441 (559)
.+.+..... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 152 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IK 152 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cc
Confidence 998875432 35889999999999999999999 78899999999999999999999999999876543221 12
Q ss_pred eccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 442 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
...++..|+|||++.+..++.++||||||+++++|++|+.||........... ....... ....+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~------~~~~~------ 217 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE---LKRRTLE------MAVEY------ 217 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH---HHhcccc------ccccC------
Confidence 23478899999999888899999999999999999999999965443211110 0000000 00001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
.......+.+++.+||+.+|++|| ++.++++
T Consensus 218 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 -PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 112246788999999999999999 6665654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=263.23 Aligned_cols=250 Identities=24% Similarity=0.268 Sum_probs=182.1
Q ss_pred CCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCc---------------eEEeeC
Q 047195 295 FSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRS---------------LFMSMS 356 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~ 356 (559)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+.+|+.++++++|+| +|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999987653 333467889999999999998 467888
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
. ++|.+++.... ..+++..+..++.|++.||+||| +++|+||||+|+||++++++.+||+|||+++......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 58998887642 25899999999999999999999 7889999999999999999999999999997654332
Q ss_pred ceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh--------
Q 047195 437 SHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL-------- 507 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 507 (559)
... ....++..|+|||.+.+. .++.++||||||++++||++|+.||......+.............+..+
T Consensus 153 ~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 153 RTY-THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccc-CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 211 122367889999998766 7889999999999999999999998755432211111000000000000
Q ss_pred -hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 -VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 -~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
......................+.+++++||+.+|++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000001122467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=273.61 Aligned_cols=251 Identities=22% Similarity=0.262 Sum_probs=175.2
Q ss_pred CCCCCCccccCCccEEEEEEec-C--CcEEEEEEeecCC--CCChhhHHHHHHHHHhc-CCCceEE--------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD-D--ETITAVKRAKLGN--TKGIDPILNEVRILCQL-NHRSLFM-------------- 353 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~-~--~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~-------------- 353 (559)
+|++.+.||+|+||.||++... . +..+|+|++.... ....+.+.+|+++++++ +|+||+.
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999954 3 6789999876432 22345688999999999 5988642
Q ss_pred -----eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 354 -----SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 354 -----~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
+++ +++|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~e~~-~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELM-EADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEecc-cCCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 333 35666666432 35889999999999999999999 88899999999999999999999999999
Q ss_pred ceeccCCCce---eeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH-----
Q 047195 429 SRLALNGASH---VTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG----- 499 (559)
Q Consensus 429 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~----- 499 (559)
++........ ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...+............
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9865432211 1122358999999998765 468899999999999999999999987544221111100000
Q ss_pred ---HHhhcchhhhc---cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 500 ---NILKQERLVDA---IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 500 ---~~~~~~~~~~~---~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+........ ....-..............+.+++.+||+.+|++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0000000000000112357889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=265.05 Aligned_cols=236 Identities=25% Similarity=0.306 Sum_probs=178.6
Q ss_pred CCCCCCccccCCccEEEEEEe----cCCcEEEEEEeecCC----CCChhhHHHHHHHHHhc-CCCc--------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGN----TKGIDPILNEVRILCQL-NHRS-------------- 350 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~~avk~~~~~~----~~~~~~~~~E~~~l~~l-~h~n-------------- 350 (559)
+|++.+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|+++++++ +|+|
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 367899999986532 22345688999999999 4776
Q ss_pred -eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 351 -LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 351 -iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
+|+||+++++|.+.+... ..+++..+..++.|++.||.||| +.+++||||+|+|||+++++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 468999999999988653 24788899999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINF--QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
...............|+..|+|||.+... .++.++||||||+++|+|++|+.|+........ ............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~-- 228 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE-- 228 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC--
Confidence 86544322222234488999999998653 467899999999999999999999864432211 111111111100
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
+.. .......+.+++.+||+.+|++|| ++.++++
T Consensus 229 -----~~~-------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -----PPY-------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----CCC-------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001 112235678899999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=260.64 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=186.3
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHh--cCCCce------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQ--LNHRSL------------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~--l~h~ni------------------ 351 (559)
..+..+.+.||+|.||.||+|.++ |..||||++...++ +.+.+|.+|.+. |+|+||
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 456788899999999999999997 56799999875433 557888888875 799994
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHH-----cCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL-----LATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
|.+|.++|+|+|+|.+. +++....++++..+|.||+|||- .+...|.|||||+.|||+..+++.-|+|
T Consensus 286 LvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 78999999999999862 58999999999999999999994 2456799999999999999999999999
Q ss_pred cccceeccCCCcee---eeeccccCCccCccccccC------CCCcccchhHHHHHHHHHHhC----------CCCCCCC
Q 047195 426 FGLSRLALNGASHV---TTFAQGTLGYLDPEYYINF------QLTDKSDVYSFGVVLVELLTS----------KKAVDFN 486 (559)
Q Consensus 426 FG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~el~tg----------~~p~~~~ 486 (559)
+|||-....+.... ....+||.+|||||++... +--..+||||||.|+||+.-+ +.||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99997766544332 2345699999999998542 112368999999999999753 3444322
Q ss_pred CccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 487 REEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
-+.+. .. .... +--..+.+.|.+..... ..+.+..+.++++.||..+|.-|-|+--+-+.|.++
T Consensus 440 Vp~DP-s~-eeMr----kVVCv~~~RP~ipnrW~--s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 440 VPSDP-SF-EEMR----KVVCVQKLRPNIPNRWK--SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred CCCCC-CH-HHHh----cceeecccCCCCCcccc--cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 11111 00 0001 11111112222222221 356788999999999999999999999998888765
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=260.14 Aligned_cols=235 Identities=24% Similarity=0.305 Sum_probs=176.8
Q ss_pred CCCCCCccccCCccEEEEEEecC-CcEEEEEEeecC-----CCCChhhHHHHHHHHHhcCCCc---------------eE
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLG-----NTKGIDPILNEVRILCQLNHRS---------------LF 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~-----~~~~~~~~~~E~~~l~~l~h~n---------------iv 352 (559)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||| +|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48888999999999999998543 344445544332 1223345778999999999998 47
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+.+..... ....+++..+..++.|++.||.||| +++++|+||||+||++++ +.+||+|||+++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 899999999998875322 1246899999999999999999999 788999999999999976 56999999998776
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ....... ... .
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~-~~~-----~ 222 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIV-EGP-----T 222 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHH-cCC-----C
Confidence 43322 122334889999999988888899999999999999999999998532211 1111100 000 0
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+. .+......+.+++.+||+.+|++||++.|+++
T Consensus 223 ~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PS-------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC-------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 11234467888999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=274.41 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=179.0
Q ss_pred HHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCceE------------
Q 047195 288 ITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSLF------------ 352 (559)
Q Consensus 288 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~niv------------ 352 (559)
+....++|++.+.||+|+||.||++.. .++..+|||++.... ......+.+|++++++++|+||+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344567899999999999999999984 578899999885432 22235688999999999999863
Q ss_pred ---------EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 353 ---------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 353 ---------~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
++|+ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEE
Confidence 3444 4566655542 25889999999999999999999 788999999999999999999999
Q ss_pred eecccceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH-----
Q 047195 424 SDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY----- 497 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~----- 497 (559)
+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..............
T Consensus 160 ~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 160 LDFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred eecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999997654322 12347889999999876 4578899999999999999999999975432211100000
Q ss_pred ---HHHHhhcchhhhccc---cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 498 ---FGNILKQERLVDAID---PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 498 ---~~~~~~~~~~~~~~d---~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+...+........+. .................+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000 00000000000123346789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=260.67 Aligned_cols=227 Identities=28% Similarity=0.333 Sum_probs=177.3
Q ss_pred cccCCccEEEEEEec-CCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcH
Q 047195 301 LGSGGFGEVFKAILD-DETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FMSMSPNGTL 361 (559)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L 361 (559)
||.|++|.||+++.. ++..+|+|.+..... ...+.+.+|+.++++++|+|| ++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999965 478999999865432 334679999999999999994 6789999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeee
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 441 (559)
.+.+.... .+++..+..++.|++.||+||| +++++|+||+|+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 99987532 4888999999999999999999 8899999999999999999999999999998765432 122
Q ss_pred eccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 442 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... ............. ...
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~------------~~~ 214 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG------------KLE 214 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC------------CCC
Confidence 234889999999988888999999999999999999999999754321 1111111110000 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
.+......+.+++.+||+.+|++||| ++|+++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 01112467899999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=266.71 Aligned_cols=249 Identities=20% Similarity=0.243 Sum_probs=175.5
Q ss_pred CCCCccccCCccEEEEEEecCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce---------------EEeeCCC
Q 047195 296 STGNLLGSGGFGEVFKAILDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL---------------FMSMSPN 358 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~ 358 (559)
.+.+.+|.|+++.||++.. +++.+|||++... .....+.+.+|++++++++|+|| ++||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444555555555555544 6889999998764 34455789999999999999984 6799999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc-
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS- 437 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~- 437 (559)
++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 84 GSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999876432 24788899999999999999999 78899999999999999999999999998875532211
Q ss_pred -----eeeeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH----hhcch
Q 047195 438 -----HVTTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI----LKQER 506 (559)
Q Consensus 438 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~ 506 (559)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||........ ........ +....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCc
Confidence 11122347788999999865 3588999999999999999999999974432111 10000000 00000
Q ss_pred -------hhh----cccccccc-CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 -------LVD----AIDPMLKE-GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 -------~~~----~~d~~l~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ..++.... ............+.+++.+||+.+|++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 00000000 001112234467889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=271.49 Aligned_cols=249 Identities=25% Similarity=0.264 Sum_probs=177.8
Q ss_pred CCCC-CCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCC--------------hhhHHHHHHHHHhcCCCce-----
Q 047195 293 NNFS-TGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKG--------------IDPILNEVRILCQLNHRSL----- 351 (559)
Q Consensus 293 ~~y~-~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~--------------~~~~~~E~~~l~~l~h~ni----- 351 (559)
++|. +.+.||+|+||+||+|.. .+++.+|||.++...... ...+.+|++++++++|+||
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 457799999999999985 468899999986543221 1247899999999999985
Q ss_pred ----------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCE
Q 047195 352 ----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421 (559)
Q Consensus 352 ----------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~ 421 (559)
++||+. ++|.+.+... ..+++.....++.|++.||+||| +.+++|+||+|+|||++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence 567775 6888887542 24889999999999999999999 7889999999999999999999
Q ss_pred EEeecccceeccCCC-------------ceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 047195 422 KISDFGLSRLALNGA-------------SHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNR 487 (559)
Q Consensus 422 kl~DFG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~ 487 (559)
||+|||+++...... ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987654110 0111122368899999998764 46889999999999999999999997655
Q ss_pred ccccccHHHHHHHHhhcch---hhhc--------cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 488 EEEDVNLVVYFGNILKQER---LVDA--------IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~---~~~~--------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+... .......... +... ...................+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 332211 1111111000 0000 0000000000001122466889999999999999999999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=275.19 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=180.9
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce---------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
+..++|++.+.||+|++|.||+|+.. ++..+|+|++... .....+.+.+|+.++++++|+|+
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 44678999999999999999999964 5788999987643 22334567899999999999885
Q ss_pred ------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 352 ------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 352 ------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
|++|+ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcc
Confidence 34554 5678777754 25899999999999999999999 78899999999999999999999999
Q ss_pred cccceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH------
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF------ 498 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~------ 498 (559)
||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 9999765432 122347889999998865 36788999999999999999999999754432211110000
Q ss_pred --HHHhhcchhhhcccccccc---CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 499 --GNILKQERLVDAIDPMLKE---GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 499 --~~~~~~~~~~~~~d~~l~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...+........+...... ............+.+++.+||+.+|++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000000000 000000112467889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=262.04 Aligned_cols=250 Identities=24% Similarity=0.308 Sum_probs=184.4
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC--Cc-----------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNH--RS----------------- 350 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h--~n----------------- 350 (559)
.+++|.+.+.+|+|.||.|-....+ .+..+|||+++... +..+..+-|+++|+++++ |+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3778999999999999999998854 36899999987643 334678889999999943 22
Q ss_pred --eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-----------
Q 047195 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE----------- 417 (559)
Q Consensus 351 --iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~----------- 417 (559)
||.|.+ |-++++.|.. ++..+++...+..+++|+++++++|| +.+++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred eEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCC
Confidence 233433 4488888865 34467999999999999999999999 888999999999999821
Q ss_pred ---------CCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCc
Q 047195 418 ---------KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNRE 488 (559)
Q Consensus 418 ---------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~ 488 (559)
+..+||+|||.|+...... ...+.|..|.|||++.+-.++.++||||+||||+||.||...|+...+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 2358999999998765443 334579999999999999999999999999999999999999987765
Q ss_pred cccccHHHHHHH--------------Hhhcchhhhcccccccc-------------CCChhhHHHHHHHHHHHHHhcccC
Q 047195 489 EEDVNLVVYFGN--------------ILKQERLVDAIDPMLKE-------------GASEIELDSMKAFGLLGAACLDER 541 (559)
Q Consensus 489 ~~~~~~~~~~~~--------------~~~~~~~~~~~d~~l~~-------------~~~~~~~~~~~~l~~l~~~cl~~~ 541 (559)
.+.......+.. .+..+++ ++-+....+ ..-.........|.+|++.||..|
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rl-dw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRL-DWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccc-cCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 554322221110 0111100 000000000 000001234456999999999999
Q ss_pred CCCCCCHHHHHH
Q 047195 542 RQNRPSIKEVAD 553 (559)
Q Consensus 542 p~~RPt~~evl~ 553 (559)
|.+|+|+.|++.
T Consensus 394 P~~RiTl~EAL~ 405 (415)
T KOG0671|consen 394 PARRITLREALS 405 (415)
T ss_pred ccccccHHHHhc
Confidence 999999999985
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=259.49 Aligned_cols=229 Identities=24% Similarity=0.261 Sum_probs=171.6
Q ss_pred CccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHH-HhcCCCc---------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRIL-CQLNHRS---------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l-~~l~h~n---------------iv~~~~~~ 358 (559)
+.||+|+||.||+|.. .+++.+|+|.+..... .....+..|..++ ...+|+| +++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999985 4578999998865432 1223345555544 4558887 46799999
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 150 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--- 150 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc---
Confidence 99999886532 4889999999999999999999 788999999999999999999999999998754331
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
....++..|+|||.+.+..++.++||||||+++|||++|..||....... .... ....... ...
T Consensus 151 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~--~~~----- 214 (260)
T cd05611 151 --KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDN-ILSRRIN--WPE----- 214 (260)
T ss_pred --ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHhcccC--CCC-----
Confidence 22348899999999988888999999999999999999999996443211 0111 1010000 000
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.........+.+++.+||+.+|++|||+.++.+.|.
T Consensus 215 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 --EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 001123467889999999999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=270.47 Aligned_cols=251 Identities=24% Similarity=0.263 Sum_probs=179.3
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce--------------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
..++++|++.+.||+|+||.||++.. .++..+|+|++... .....+.+.+|++++++++|||+
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678899999999999999999984 47889999987542 22334678899999999999996
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
+++|+ +++|..++.. ..+++..+..++.|++.||+||| +++|+||||+|+|||+++++.+||+|||++
T Consensus 86 ~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 34554 4566666542 24788888899999999999999 788999999999999999999999999998
Q ss_pred eeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH--------HH
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF--------GN 500 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~--------~~ 500 (559)
....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............... ..
T Consensus 156 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 156 RIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 7543211 22347889999998766 56899999999999999999999999755432111111000 00
Q ss_pred Hhhcchhhhccccccc-cCCC--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 501 ILKQERLVDAIDPMLK-EGAS--EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 501 ~~~~~~~~~~~d~~l~-~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........+.+..... .... .........+.+++.+||+.+|++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 0000 000113467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=265.84 Aligned_cols=230 Identities=27% Similarity=0.387 Sum_probs=175.2
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.|+..+.||+|+||.||+|+. .++..+|+|.+..... ....++.+|+++++.++|+|+ |+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 477778899999999999995 4578899998864322 233568899999999999983 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+. |++.+.+.... ..+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 886 67777665322 24788999999999999999999 78899999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
. ....+++.|+|||.+. ...++.++||||||+++|||++|+.|+......... .. ......
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~-~~~~~~---- 231 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YH-IAQNES---- 231 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HH-HhhcCC----
Confidence 2 1234788999999975 345788999999999999999999998543211100 00 000000
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
+... .......+.+++.+||+.+|++||++.+|++.
T Consensus 232 -~~~~------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 -PALQ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -CCcC------cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0000 11234668899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=260.74 Aligned_cols=226 Identities=23% Similarity=0.305 Sum_probs=168.6
Q ss_pred ccccCCccEEEEEEe-cCCcEEEEEEeecCCCC---ChhhHHHHHHHH---HhcCCCce---------------EEeeCC
Q 047195 300 LLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK---GIDPILNEVRIL---CQLNHRSL---------------FMSMSP 357 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~---~~~~~~~E~~~l---~~l~h~ni---------------v~~~~~ 357 (559)
.||+|+||.||++.. .+++.+|+|.+...... ....+..|..++ +...|+++ |+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 45789999988654321 112244454443 44567774 679999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 99999887642 25899999999999999999999 78899999999999999999999999999875533221
Q ss_pred eeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||........... ..... .....+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~------~~~~~~~ 219 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TMAVELP 219 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhh------ccCCCCC
Confidence 123489999999998754 688999999999999999999999975432211110 00000 0011111
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
......+.+++.+||..+|++|| ++.++++
T Consensus 220 -------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 -------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 12246788899999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=257.36 Aligned_cols=233 Identities=25% Similarity=0.319 Sum_probs=173.6
Q ss_pred HHHHHhCCCCCCCcc--ccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCce-----------
Q 047195 287 EITEATNNFSTGNLL--GSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRSL----------- 351 (559)
Q Consensus 287 ~~~~~~~~y~~~~~l--G~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni----------- 351 (559)
+.....++|++.+.+ |+|+||.||++.. .++..+|+|.......... |+.....+ +|+|+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344445677777776 9999999999985 4678889998765432211 22222222 68874
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeec
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDF 426 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DF 426 (559)
|+||+++++|.+++.... .+++..+..++.|+++||.||| +.+++||||||+||+++.++ .++|+||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 679999999999986532 5899999999999999999999 78899999999999999988 9999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
|+++...... ...++..|+|||++.+..++.++||||||+++|||++|+.||...... ......+.... ...
T Consensus 155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~ 226 (267)
T PHA03390 155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QKK 226 (267)
T ss_pred ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--ccc
Confidence 9987654321 224889999999998888999999999999999999999999743322 11111111111 000
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-IKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~ 553 (559)
. +. .......+.+++.+||+.+|++||+ ++++++
T Consensus 227 ~-----~~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 L-----PF--------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred C-----Cc--------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 00 0123467888999999999999996 588874
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=263.87 Aligned_cols=238 Identities=26% Similarity=0.375 Sum_probs=175.5
Q ss_pred hCCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCC-CChhhHHHHHHHHHhcC-CCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNT-KGIDPILNEVRILCQLN-HRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni---------------v~ 353 (559)
.++|++.+.||+|++|.||+|..++ ++.+|||.++.... .....+..|+.++.++. |+|| ++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4578899999999999999999765 88999999875432 23356777888777765 8884 56
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+|+. +.+.+++.... ..+++..+..++.|++.||+|||+ ..+|+||||+|+||++++++.+||+|||++....
T Consensus 94 e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 7764 46666655432 258899999999999999999993 2589999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccCccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQ----LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
..... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... .......... .
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~-~-- 236 (296)
T cd06618 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEE-P-- 236 (296)
T ss_pred CCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCC-C--
Confidence 32221 2234788999999987543 7889999999999999999999986422110 0011111110 0
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
+.+... .....++.+++.+||+.+|++|||+.++++.
T Consensus 237 ---~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 ---PSLPPN-----EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CCCCCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 0123568899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=266.54 Aligned_cols=244 Identities=20% Similarity=0.258 Sum_probs=174.3
Q ss_pred CccccC--CccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEeeCCC
Q 047195 299 NLLGSG--GFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMSMSPN 358 (559)
Q Consensus 299 ~~lG~G--~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~ 358 (559)
..||+| +||+||++.. .+++.||+|.+..... ...+.+.+|+.+++.++|+|| |++|+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 9999999986 4789999999875432 234678899999999999995 5688899
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999998876432 24888999999999999999999 788999999999999999999999999865332211100
Q ss_pred e------eeeccccCCccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH----------
Q 047195 439 V------TTFAQGTLGYLDPEYYINF--QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN---------- 500 (559)
Q Consensus 439 ~------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 500 (559)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccc
Confidence 0 0112256679999998763 4788999999999999999999999654321110 000000
Q ss_pred ------Hhh-----------cchhh-----hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 501 ------ILK-----------QERLV-----DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 501 ------~~~-----------~~~~~-----~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+. +.... ...+..+. ..........+.+|+++||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR---TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhcccccccccccccc---chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 00000 00000111 1112345577899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=270.98 Aligned_cols=232 Identities=27% Similarity=0.310 Sum_probs=188.9
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
...|.+.+.||+|.|++|.+|++ ..+..||||.+... +....+.+.+|+++|+.|+|||| ||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45789999999999999999995 46889999988764 33344568999999999999995 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||..+|.+++++..... +.+..+..++.|+..|++||| ++.|+|||||.+||||+.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999987543 556888999999999999999 8899999999999999999999999999998876
Q ss_pred CCCceeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
. ........|++.|.|||++.+..| .+.+|+||+|++||.|+.|.-||++..-.+...
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------------------- 265 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------------------- 265 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-------------------
Confidence 3 233344569999999999998876 579999999999999999999998654332111
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+.+ .-.++.-+..+..++++++|-.+|.+|+++.++++
T Consensus 266 rvl~g-k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 266 RVLRG-KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred hheee-eecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 01111 11122334456778999999999999999999875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=261.87 Aligned_cols=233 Identities=26% Similarity=0.373 Sum_probs=183.5
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcC-CCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLN-HRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~-h~ni---------------v 352 (559)
++|.+.+.||+|++|.||++... ++..+|+|++.... ....+.+.+|++++++++ |+|| |
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999964 68999999886532 233467899999999998 9984 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++++++++|.+.+.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 89999999999987642 5899999999999999999999 788999999999999999999999999998765
Q ss_pred cCCCc-------------------eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcccccc
Q 047195 433 LNGAS-------------------HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVN 493 (559)
Q Consensus 433 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~ 493 (559)
..... .......++..|+|||++....++.++||||||+++++|++|+.||.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--- 229 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--- 229 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---
Confidence 43221 11122347889999999888888999999999999999999999987443111
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI----KEVAD 553 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~----~evl~ 553 (559)
.+.... . ....+ +......+.+++.+||+.+|++|||+ .++++
T Consensus 230 ---~~~~~~-~------~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 ---TFQKIL-K------LEYSF-------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHH-h------cCCCC-------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 011110 0 00001 11224678899999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=288.88 Aligned_cols=241 Identities=24% Similarity=0.278 Sum_probs=183.5
Q ss_pred HHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCC-------------
Q 047195 286 REITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNH------------- 348 (559)
Q Consensus 286 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h------------- 348 (559)
.++....++|.++++||+|+||.|.+++. ..++++|+|++... ......-|..|-.+|..-+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34444457899999999999999999985 56789999998762 23344568888888875543
Q ss_pred --CceEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 349 --RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 349 --~niv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
-++||+|++||+|..+|.... .+++..++.++..|.-||+-|| +.|+|||||||+|||||..|++||+||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccc
Confidence 336999999999999997643 4899999999999999999999 777999999999999999999999999
Q ss_pred ccceeccCCCceeeeeccccCCccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYIN-----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
|.+-.+..+..-.....+|||.|++||++.. ..|+..+|+||+||++|||+.|..||+.+.-.+....+......
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 9998777655555666779999999999863 46889999999999999999999999855433322222111111
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC---HHHH
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS---IKEV 551 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~ev 551 (559)
+ .++ .+.+++.+..+||.+.+. +|+.|.. +.++
T Consensus 300 l---------------~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedi 335 (1317)
T KOG0612|consen 300 L---------------SFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDI 335 (1317)
T ss_pred c---------------CCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHH
Confidence 1 111 123345666677777665 6667765 5544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=249.09 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=179.9
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCC--hhhHHHHHHHHHhcCCCceE------------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKG--IDPILNEVRILCQLNHRSLF------------------ 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~--~~~~~~E~~~l~~l~h~niv------------------ 352 (559)
.|+-..+||+|.||.||+|+. +.++.||+|++...+.+. -...++|+++|+.|+|+|++
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 456667899999999999994 567888988876544332 24578999999999999852
Q ss_pred -----EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 353 -----MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 353 -----~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
+.+++. +|..+|.. ....++..++.++..++..||.|+| ...|+|||+|++|+||+.++.+||+|||
T Consensus 98 t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 222221 23333322 2245888999999999999999999 8889999999999999999999999999
Q ss_pred cceeccCCC---ceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH-----
Q 047195 428 LSRLALNGA---SHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF----- 498 (559)
Q Consensus 428 ~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~----- 498 (559)
+++.+.... ....+..+-|.+|.+||.+.+. +|+++.|||..|||+.||+||.+.+.++.+.....++...
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 998765322 2233455679999999998864 7999999999999999999999999877665554443321
Q ss_pred ---HHHhhcchhhhcc--ccccccCCChhhHHHH------HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 499 ---GNILKQERLVDAI--DPMLKEGASEIELDSM------KAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 499 ---~~~~~~~~~~~~~--d~~l~~~~~~~~~~~~------~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
|....+-.+.+.+ .|...+..... .+.. ..-.+|+..+|..||.+|+++.+++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv-~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKV-KNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhh-hhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1111122222222 11111111111 1111 25678899999999999999998874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=260.13 Aligned_cols=228 Identities=29% Similarity=0.395 Sum_probs=173.6
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
|...+.||+|+||+||+|+. .++..+++|++..... ...+.+.+|++++++++|+|+ |+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56667899999999999985 4678999999865433 223568899999999999984 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+. +++.+.+.... .++++..+..++.|++.||.||| +++++|+||+|+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~ 174 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence 75 57777765422 35889999999999999999999 788999999999999999999999999998643221
Q ss_pred CceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
....|+..|+|||++. ...++.++||||||+++|||++|+.|+......... ...... ..
T Consensus 175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~-~~----- 237 (313)
T cd06633 175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-DS----- 237 (313)
T ss_pred -----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc-CC-----
Confidence 2234889999999974 356788999999999999999999998644321111 100000 00
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+... .......+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 PTLQ------SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCCC------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0112245788999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=280.74 Aligned_cols=253 Identities=23% Similarity=0.220 Sum_probs=160.8
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-C----CcEEEEEEeecCCCCChhhHHHHHH----------HHHhc---------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-D----ETITAVKRAKLGNTKGIDPILNEVR----------ILCQL--------- 346 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~----~~~~avk~~~~~~~~~~~~~~~E~~----------~l~~l--------- 346 (559)
..++|++.+.||+|+||.||+|+.. + +..+|+|++...... +...+|.. .+..+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNERVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHHHHHhhchhhHHHHHHhhhcccccccC
Confidence 3568999999999999999999964 4 689999987543221 11111110 00110
Q ss_pred CCCceEEeeCCCCcHhHhHhhccCC---------------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCC
Q 047195 347 NHRSLFMSMSPNGTLFDRLHRVQSG---------------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSS 411 (559)
Q Consensus 347 ~h~niv~~~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~ 411 (559)
.+..||++|..+++|.+++...... .........+..++.|++.||+||| +++|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHH
Confidence 1234799999999999988643210 0001123445679999999999999 788999999999
Q ss_pred CeeecC-CCCEEEeecccceeccCCCceeeeeccccCCccCccccccC----------------------CCCcccchhH
Q 047195 412 NILLDE-KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF----------------------QLTDKSDVYS 468 (559)
Q Consensus 412 Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv~S 468 (559)
|||+++ ++.+||+|||+++..............+|+.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 57999999999986654433333344589999999976422 2345679999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccccHHHHHHH-Hhhcchhhhccccccc----cCCChhhHHHHHHHHHHHHHhcccCCC
Q 047195 469 FGVVLVELLTSKKAVDFNREEEDVNLVVYFGN-ILKQERLVDAIDPMLK----EGASEIELDSMKAFGLLGAACLDERRQ 543 (559)
Q Consensus 469 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~d~~l~----~~~~~~~~~~~~~l~~l~~~cl~~~p~ 543 (559)
|||+||||+++..+.+.. .......... ......+...+.+... ..+... ........+|+.+||+.||+
T Consensus 365 lGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVL-DLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhc-cccchHHHHHHHHHccCCcc
Confidence 999999999876553211 0000000000 0000011111111100 000000 00112345899999999999
Q ss_pred CCCCHHHHHH
Q 047195 544 NRPSIKEVAD 553 (559)
Q Consensus 544 ~RPt~~evl~ 553 (559)
+|||+.++++
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=254.80 Aligned_cols=225 Identities=24% Similarity=0.335 Sum_probs=173.6
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCC----------------ceE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT---KGIDPILNEVRILCQLNHR----------------SLF 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~----------------niv 352 (559)
.+|..+.+||+|+||+|-+|..+ ....+|||+++.... .+.+--+.|-++|.-...| ..|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999855 457899999876422 2223344566666544333 369
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||..+|+|.-+++.... +.+..+..++.+||-||-+|| +++||.||||.+|||+|.+|++||+|||+++.-
T Consensus 429 MEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999987653 788889999999999999999 999999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.-+..... ...|||.|+|||++...+|...+|+||||++||||+.|++||++.++.+- +...+ +
T Consensus 501 i~~~~TTk-TFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------F~aI~-e-------- 564 (683)
T KOG0696|consen 501 IFDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQAIM-E-------- 564 (683)
T ss_pred ccCCccee-eecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-H--------
Confidence 44433333 34599999999999999999999999999999999999999987664331 11111 1
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCC
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRP 546 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 546 (559)
... ..+...+.+...+.+..|..+|.+|.
T Consensus 565 hnv-----syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HNV-----SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ccC-----cCcccccHHHHHHHHHHhhcCCcccc
Confidence 111 11123445566677778889998885
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=245.72 Aligned_cols=237 Identities=23% Similarity=0.269 Sum_probs=183.2
Q ss_pred HhCCCCCC-CccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCc-----------------
Q 047195 291 ATNNFSTG-NLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRS----------------- 350 (559)
Q Consensus 291 ~~~~y~~~-~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~n----------------- 350 (559)
++++|.+. ++||-|-.|.|-... ...+..+|+|++... ....+|++..-+. .|+|
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34556553 579999999998887 456888999987643 4467888876554 5887
Q ss_pred --eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEee
Q 047195 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKISD 425 (559)
Q Consensus 351 --iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~D 425 (559)
||||+++||.|+..++.... ..+++.++..|..||+.|+.||| +.+|.||||||+|+|... +..+||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecc
Confidence 47899999999999987543 46999999999999999999999 778999999999999964 45799999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||+|+.... .......+.||.|.|||++....|+...|+||+|+++|-|+.|.+||...... .+..-....+..+
T Consensus 208 fGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~g 282 (400)
T KOG0604|consen 208 FGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTG 282 (400)
T ss_pred cccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhcc
Confidence 999987543 22334456899999999998889999999999999999999999999754321 1111222222222
Q ss_pred hhhhccccccccCCChhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIEL-DSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ++...++ .+++...++++.+|..+|.+|.|+.+++.
T Consensus 283 qy----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 QY----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred Cc----------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11 2233333 35567788999999999999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=281.45 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=194.2
Q ss_pred HHHHHhCCCCCCCccccCCccEEEEEEec--------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcC-CCce-----
Q 047195 287 EITEATNNFSTGNLLGSGGFGEVFKAILD--------DETITAVKRAKLGNT-KGIDPILNEVRILCQLN-HRSL----- 351 (559)
Q Consensus 287 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni----- 351 (559)
.++...++..+.+.||.|.||.|++|... ....||||.++.... ...+.+..|+++|+.+. |+|+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45555566677789999999999999732 146789999876433 45678999999999985 8884
Q ss_pred ----------EEeeCCCCcHhHhHhhcc---------CCCC--CCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCC
Q 047195 352 ----------FMSMSPNGTLFDRLHRVQ---------SGNW--PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKS 410 (559)
Q Consensus 352 ----------v~~~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp 410 (559)
|+||...|+|.++++..+ .... ..+...+.+.++.|||.|++||+ +.++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 679999999999998766 1111 23889999999999999999999 88899999999
Q ss_pred CCeeecCCCCEEEeecccceeccCCCceeeeeccc--cCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCC
Q 047195 411 SNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG--TLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNR 487 (559)
Q Consensus 411 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~ 487 (559)
+|||+.++..+||+|||+|+..............+ ...|||||.+....++.|+||||||++|||++| |..|+.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999766555444332222 446999999999999999999999999999999 566765421
Q ss_pred ccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 488 EEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
... . ......++...+ .+..+..++.++++.||+.+|++||++.++++.|+.+
T Consensus 527 ~~~-----~-l~~~l~~G~r~~------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTE-----E-LLEFLKEGNRME------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cHH-----H-HHHHHhcCCCCC------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111 1 111222222111 1123347788999999999999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=268.38 Aligned_cols=248 Identities=21% Similarity=0.229 Sum_probs=168.9
Q ss_pred hCCCCCCCccccCCccEEEEEEe-----------------cCCcEEEEEEeecCCCCChhh--------------HHHHH
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-----------------DDETITAVKRAKLGNTKGIDP--------------ILNEV 340 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-----------------~~~~~~avk~~~~~~~~~~~~--------------~~~E~ 340 (559)
.++|++.++||+|+||+||+|.. .+++.||||++........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999963 245689999987543322223 34566
Q ss_pred HHHHhcCCCc----------------------------eEEeeCCCCcHhHhHhhccCC-------------------CC
Q 047195 341 RILCQLNHRS----------------------------LFMSMSPNGTLFDRLHRVQSG-------------------NW 373 (559)
Q Consensus 341 ~~l~~l~h~n----------------------------iv~~~~~~g~L~~~l~~~~~~-------------------~~ 373 (559)
.++.+++|.+ +|+||+++++|.++++..... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 7777766542 688999999999998743210 01
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCcc
Q 047195 374 PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453 (559)
Q Consensus 374 ~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE 453 (559)
..+++..+..++.|++.+|.||| +++|+||||||+|||++.++.+||+|||++...............+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23567788999999999999999 788999999999999999999999999999765433222222223588999999
Q ss_pred ccccCC--------------------C--CcccchhHHHHHHHHHHhCCC-CCCCCCccc----cccHHHHHHHHhhcch
Q 047195 454 YYINFQ--------------------L--TDKSDVYSFGVVLVELLTSKK-AVDFNREEE----DVNLVVYFGNILKQER 506 (559)
Q Consensus 454 ~~~~~~--------------------~--~~~~Dv~SlG~il~el~tg~~-p~~~~~~~~----~~~~~~~~~~~~~~~~ 506 (559)
.+.... + ..+.||||+||+++||+++.. |+....... ........+.......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 875422 1 235799999999999999875 553211000 0000001111111111
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERR---QNRPSIKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPt~~evl~ 553 (559)
. + +.. .........+|+.+||..+| .+|+|++|+++
T Consensus 461 ~----~------~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y----D------FSL-LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----C------ccc-ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 0 000 01223567788999999766 68999999985
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=249.65 Aligned_cols=221 Identities=28% Similarity=0.352 Sum_probs=174.9
Q ss_pred cccCCccEEEEEEec-CCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCCc---------------eEEeeCCCCcH
Q 047195 301 LGSGGFGEVFKAILD-DETITAVKRAKLGNTK---GIDPILNEVRILCQLNHRS---------------LFMSMSPNGTL 361 (559)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~n---------------iv~~~~~~g~L 361 (559)
||+|+||.||++... ++..+++|.+...... ..+.+.+|+.++++++|+| +++++.++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999965 5889999988765332 3457899999999999998 47899999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeee
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 441 (559)
.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 99987542 4889999999999999999999 78899999999999999999999999999977644321 122
Q ss_pred eccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 442 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
...++..|+|||...+...+.++|+||||+++|+|++|+.||....... .... ..... ..+.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~------~~~~----- 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE------IYEK-ILKDP------LRFP----- 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-HhcCC------CCCC-----
Confidence 3348889999999988888999999999999999999999996443211 0111 00000 0011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRPSIKE 550 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~e 550 (559)
......+.+++.+||..+|++|||+++
T Consensus 214 --~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 --EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 112467788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=222.56 Aligned_cols=251 Identities=20% Similarity=0.254 Sum_probs=179.2
Q ss_pred CCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCC--hhhHHHHHHHHHhcCCCceEE---------------ee
Q 047195 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKG--IDPILNEVRILCQLNHRSLFM---------------SM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~---------------~~ 355 (559)
+|...++||+|.||+||+|+ ++.+..||+|+++..+..+ ....++|+-+|+.++|+|||. ||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45666889999999999999 5678999999998764432 346899999999999999865 33
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+ ...|..+..... ..++.+.+..++.|+++||.+.| ++++.|||+||+|.||+.+|++||+|||+++.+.-.
T Consensus 83 c-dqdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred h-hHHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 2 223333333332 24788889999999999999999 888999999999999999999999999999877544
Q ss_pred CceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc---
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA--- 510 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 510 (559)
..... ..+-|.+|.+|.++.+. .|+...|+||.|||+.|+.. |++.|.+.+-.++...+.+......++.+..+
T Consensus 155 vrcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 VRCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eEeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 32222 22379999999999886 58899999999999999986 55556555544443333333333333322211
Q ss_pred cccccc------cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLK------EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
-|-..- ....++.......=.+++...|.-+|..|.++.+.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111000 0111222223334467788889999999999998875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=265.20 Aligned_cols=225 Identities=22% Similarity=0.254 Sum_probs=176.3
Q ss_pred HhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHh-cCCCce---------------EE
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQ-LNHRSL---------------FM 353 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~-l~h~ni---------------v~ 353 (559)
.+..|++...+|.|+|+.|-... ..+++..++|++.... .+-.+|+.++.. -+|+|+ |+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 35678888999999999998887 4567888999987652 234467766555 468874 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee-cCCCCEEEeecccceec
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL-DEKLDAKISDFGLSRLA 432 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill-~~~~~~kl~DFG~a~~~ 432 (559)
|.+.++.+.+.+.... .....+..|+.+|+.|+.||| .++|+||||||+|||+ ++.++++|+|||.++..
T Consensus 396 e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred hhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 8888888888776543 222677889999999999999 8899999999999999 69999999999999877
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... ....+-|..|.|||++....|+.++||||||++||+|++|+.|+...... ......+..++..
T Consensus 467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s---- 532 (612)
T KOG0603|consen 467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS---- 532 (612)
T ss_pred chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc----
Confidence 654 12223688999999999999999999999999999999999999755443 1111112121111
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..++....+|+.+||+.+|.+||+|.++..
T Consensus 533 -----------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 -----------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 245567788999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=280.69 Aligned_cols=131 Identities=25% Similarity=0.365 Sum_probs=114.1
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|.+.++||+|+||+||+|... +++.||||+++.... .....+.+|+.+++.++|+|| |
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357899999999999999999965 688999999875432 223568899999999999984 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|||+.+++|.+++.... .+++..++.++.||+.||+||| .++|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 89999999999986532 4788899999999999999999 7889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=242.04 Aligned_cols=233 Identities=22% Similarity=0.333 Sum_probs=182.2
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeec---CCCCChhhHHHHHHHHHhc-CCCce---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKL---GNTKGIDPILNEVRILCQL-NHRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~---~~~~~~~~~~~E~~~l~~l-~h~ni--------------- 351 (559)
.++|.++++||+|+|++|-++++ +..+.+|+|+++. ++.+.++-.+.|-.+..+. +||.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 36799999999999999999985 4578899998865 3556667788888888775 56764
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|.||.++|+|..++++.+ .++++.+..+..+|.-||.||| +++||.||||.+|+|+|..|++||.|+|+++.
T Consensus 329 vieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhc
Confidence 679999999998888765 3999999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCc-cccccHHHHHHHHhhcchhhhc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNRE-EEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
.........+ ..|||.|+|||++.+..|...+|+|+||++++||+.|+.||+.-.. ..+.....+..+.+-+
T Consensus 401 ~l~~gd~tst-fcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile------ 473 (593)
T KOG0695|consen 401 GLGPGDTTST-FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE------ 473 (593)
T ss_pred CCCCCccccc-ccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh------
Confidence 6554443333 4599999999999999999999999999999999999999974321 1111222222222222
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP 546 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 546 (559)
..++. +...+.+...+++.-|..||.+|.
T Consensus 474 --kqiri-----prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 --KQIRI-----PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --hcccc-----cceeehhhHHHHHHhhcCCcHHhc
Confidence 22221 112234455677888999999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-31 Score=243.15 Aligned_cols=238 Identities=26% Similarity=0.319 Sum_probs=171.8
Q ss_pred CCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCceEE---------------eeCC
Q 047195 296 STGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSLFM---------------SMSP 357 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~---------------~~~~ 357 (559)
+-+..||.|+||+|+|-.+ ..++..|||+++..+. +++.+++.|.+...+- +-||||. |.|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3446799999999999874 5689999999987655 5667888888876554 5678754 3332
Q ss_pred CCcH---hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 358 NGTL---FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 358 ~g~L---~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
-+| +..+..... ..+++...-+|...+..||+||.. ...|||||+||+|||++..|.+||+|||++-...+
T Consensus 147 -~SlDklYk~vy~vq~---~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQK---SRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred -hhHHHHHHHHHHHHh---ccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 233 333333322 358888888899999999999986 56799999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
. -..+.-.|-..|||||.+.. ..|+-+|||||||++|||+.||+.|+..-++. ........ .+..
T Consensus 221 S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~Vv-~gdp----- 287 (361)
T KOG1006|consen 221 S--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQVV-IGDP----- 287 (361)
T ss_pred H--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHHH-cCCC-----
Confidence 2 22233458899999999854 35899999999999999999999998644321 11111111 1110
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
|.|..... .......+..++.-||..|..+||...++.++
T Consensus 288 p~l~~~~~--~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLFDKE--CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecCccc--ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111111 13345678889999999999999999998753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=254.91 Aligned_cols=228 Identities=24% Similarity=0.287 Sum_probs=175.4
Q ss_pred CCccccCCccEEEEEE-ecCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCceE---------------EeeCCCC
Q 047195 298 GNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSLF---------------MSMSPNG 359 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~niv---------------~~~~~~g 359 (559)
.+.||.|.||+||-|+ .++|+.||||++... ..+...++.+|+.||+++.||-|| ||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 4789999999999999 467999999998653 234457899999999999999864 3333 45
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC---CCEEEeecccceeccCCC
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK---LDAKISDFGLSRLALNGA 436 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~---~~~kl~DFG~a~~~~~~~ 436 (559)
+..+++-.... ..+++.....++.||+.||.||| -++|+|.||||+|||+.+. -++||+|||.|+.+.+
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-- 719 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-- 719 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch--
Confidence 66666554433 35889999999999999999999 7789999999999999643 4799999999998865
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
......++|||.|+|||++.+..|...-|+||+|+|+|--++|..||..+. +..+.++.+.-++-...+.
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~-------- 789 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWS-------- 789 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchh--------
Confidence 344556779999999999999999999999999999999999999996432 2222222222222222222
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl 552 (559)
+......+||...|+..-++|-|...-+
T Consensus 790 --------eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 790 --------EISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred --------hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 2234566788888888888888876543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=240.48 Aligned_cols=205 Identities=18% Similarity=0.144 Sum_probs=158.2
Q ss_pred CCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc---------------eEEeeCCCCcHhHhHhh
Q 047195 304 GGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHR 367 (559)
Q Consensus 304 G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n---------------iv~~~~~~g~L~~~l~~ 367 (559)
|.+|.||++.. .+++.+|+|++.... .+.+|...+....||| +++||+++++|.+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999985 567899999987543 2334555556666777 47899999999998865
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccC
Q 047195 368 VQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447 (559)
Q Consensus 368 ~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~ 447 (559)
.. .+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++|||.+....... ....++.
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~ 146 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVEN 146 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCc
Confidence 32 4889999999999999999999 7889999999999999999999999999876544321 1223577
Q ss_pred CccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHH
Q 047195 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSM 527 (559)
Q Consensus 448 ~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 527 (559)
.|+|||.+....++.++||||+|+++|||++|+.|+........ . .....+ +....
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~-----~~~~~~-------~~~~~ 202 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------T-----HTTLNI-------PEWVS 202 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------c-----ccccCC-------cccCC
Confidence 89999998888889999999999999999999987643211000 0 000000 11223
Q ss_pred HHHHHHHHHhcccCCCCCCCHH
Q 047195 528 KAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 528 ~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
..+.+++.+||+.||++|||+.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCC
Confidence 5678899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=260.62 Aligned_cols=239 Identities=25% Similarity=0.373 Sum_probs=191.9
Q ss_pred HHhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCc-----------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRS----------------- 350 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~n----------------- 350 (559)
..+.-|++.+.||+|.+|.||+++ .++++.+|+|++......+ +++..|.+||+.+ .|||
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 345678999999999999999999 6778999999987665544 6788999999987 4677
Q ss_pred ---eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 351 ---LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 351 ---iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
+||||+.+|+.-|++..... ..+.|..+.-|++.++.|+.+|| .+.+||||||-.|||++.++.+||.|||
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeee
Confidence 59999999999999987663 35999999999999999999999 8889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYIN-----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 502 (559)
++...........+.+ |||.|||||++.- ..|+..+|+||||++..||--|.+|+-...+... .....
T Consensus 169 vSaQldsT~grRnT~i-GtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------LF~Ip 241 (953)
T KOG0587|consen 169 VSAQLDSTVGRRNTFI-GTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIP 241 (953)
T ss_pred eeeeeecccccccCcC-CCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------hccCC
Confidence 9988765444444444 9999999999853 3477899999999999999999999853322110 00000
Q ss_pred hcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 503 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+ .+.|+. +....+++.+++..||..|-+.||++.++++
T Consensus 242 RNP------PPkLkr-----p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 RNP------PPKLKR-----PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCC------Cccccc-----hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 000 111111 3467789999999999999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=250.27 Aligned_cols=240 Identities=28% Similarity=0.433 Sum_probs=181.7
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCC-------CChhhHHHHHHHHHhcCCCceE------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNT-------KGIDPILNEVRILCQLNHRSLF------------ 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv------------ 352 (559)
++|-++.+||+|||+.||+|. +...+.||+|+-..... .......+|-+|.+.|.||.||
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 467778899999999999998 66788999998654321 1234578999999999999874
Q ss_pred ----EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec---CCCCEEEee
Q 047195 353 ----MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD---EKLDAKISD 425 (559)
Q Consensus 353 ----~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~---~~~~~kl~D 425 (559)
.||+++.+|..+|.... .++++++..|+.||+.||.||... +.+|||-||||.|||+- .-|.+||.|
T Consensus 543 FCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 58899999988887643 489999999999999999999966 68999999999999995 357899999
Q ss_pred cccceeccCCCce------eeeeccccCCccCccccccC----CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHH
Q 047195 426 FGLSRLALNGASH------VTTFAQGTLGYLDPEYYINF----QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495 (559)
Q Consensus 426 FG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~ 495 (559)
||+++.+..+... .+.-..||.+|++||-+.-. ..+.|+||||+|+|+|+.+.|++||..+....+ .+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--IL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--IL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HH
Confidence 9999988754322 22334599999999977532 468899999999999999999999976543322 11
Q ss_pred HHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047195 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552 (559)
Q Consensus 496 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl 552 (559)
. ...+...-+.. ++. ...+..+...+|++||++.-++|....+++
T Consensus 695 q-------eNTIlkAtEVq----FP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 Q-------ENTILKATEVQ----FPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h-------hhchhcceecc----CCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 11111111100 110 112334567799999999999998877765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=226.48 Aligned_cols=246 Identities=18% Similarity=0.245 Sum_probs=177.6
Q ss_pred hCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-CCceEE----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLN-HRSLFM---------------- 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~---------------- 353 (559)
.++|++.+++|+|-++.||.|+ ..+...++||+++.... ..+.+|+.||+.|. ||||+.
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4689999999999999999998 56778889999876543 45889999999997 999754
Q ss_pred -eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC-CCEEEeeccccee
Q 047195 354 -SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGLSRL 431 (559)
Q Consensus 354 -~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~-~~~kl~DFG~a~~ 431 (559)
||..+.+...+. +.++...+...+.+++.||.|+| +.||+|||+||.|++||.. -.++|+|+|+|.+
T Consensus 114 FE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 444444333322 34777788899999999999999 8999999999999999964 5799999999998
Q ss_pred ccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCcc-ccccHHHHHH------HH--
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREE-EDVNLVVYFG------NI-- 501 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~-~~~~~~~~~~------~~-- 501 (559)
+..+..... .+.+..|--||.+.+. .|+..-|+|||||+|..|+..+.||....+. ++...+.... ..
T Consensus 183 YHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 183 YHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred cCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 876554332 2367788999999875 4788999999999999999999999654322 2222211110 00
Q ss_pred ----hhcchhhhccccccccCCCh---h--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 ----LKQERLVDAIDPMLKEGASE---I--ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ----~~~~~~~~~~d~~l~~~~~~---~--~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.-+.++.+++.+..+..... . ..-...+..+|+.+.|..|..+|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01122222222222211100 0 0112356788999999999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=232.54 Aligned_cols=249 Identities=20% Similarity=0.264 Sum_probs=184.4
Q ss_pred HHHHHHhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCc-------------
Q 047195 286 REITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRS------------- 350 (559)
Q Consensus 286 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~n------------- 350 (559)
+++-+.++ +.||+|+|+.|--.+ +.++..+|||++.........++.+|++++.+. .|+|
T Consensus 76 ~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 76 EDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 44444443 579999999999887 788999999999888777778899999999986 5888
Q ss_pred --eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC---EEEee
Q 047195 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD---AKISD 425 (559)
Q Consensus 351 --iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~---~kl~D 425 (559)
+|+|-+.+|.|..+++... .+++.++.++.++|+.||.+|| .++|.||||||+|||..+..+ +||+|
T Consensus 151 FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred EEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeec
Confidence 4788899999999998753 4999999999999999999999 999999999999999976543 79999
Q ss_pred cccceecc--CCC----ceeeeeccccCCccCccccc---c--CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccc--
Q 047195 426 FGLSRLAL--NGA----SHVTTFAQGTLGYLDPEYYI---N--FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV-- 492 (559)
Q Consensus 426 FG~a~~~~--~~~----~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~-- 492 (559)
|.+..-.. .+- .......+|+..|||||+.. + ..|+.+.|.||||+|||-|++|..||.+....+-.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 98864332 111 11223445999999999863 2 24889999999999999999999999876432211
Q ss_pred --cHHHHHHHHhhcchhhhccccccccCCChhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 493 --NLVVYFGNILKQERLVDAIDPMLKEGASEIEL-DSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 493 --~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
......++.+.+ .+-+-. -++++.++ ..+.+-.++++..|..++.+|.++..++.
T Consensus 303 rGe~Cr~CQ~~LFe----sIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFE----SIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHH----HHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111211111 111111 12222222 23445667888899999999999988875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=235.67 Aligned_cols=223 Identities=31% Similarity=0.379 Sum_probs=175.5
Q ss_pred CccEEEEEEecC-CcEEEEEEeecCCCCC-hhhHHHHHHHHHhcCCCce---------------EEeeCCCCcHhHhHhh
Q 047195 305 GFGEVFKAILDD-ETITAVKRAKLGNTKG-IDPILNEVRILCQLNHRSL---------------FMSMSPNGTLFDRLHR 367 (559)
Q Consensus 305 ~~g~Vy~~~~~~-~~~~avk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L~~~l~~ 367 (559)
+||.||+++..+ +..+++|++....... .+.+.+|++.+++++|+|+ +++|..+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8899999987765544 6789999999999999983 6789999999998875
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccC
Q 047195 368 VQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447 (559)
Q Consensus 368 ~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~ 447 (559)
.. .+++..+..++.++++++.||| +.+++|+||+|+||++++++.++|+|||.+....... ......++.
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 32 2788999999999999999999 7789999999999999999999999999998765432 222334888
Q ss_pred CccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHH
Q 047195 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSM 527 (559)
Q Consensus 448 ~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 527 (559)
.|++||.+....++.++||||||+++++|++|..|+....... . ............ ........
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~----~~~~~~~~~~~~----------~~~~~~~~ 214 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--E----LFKKIGKPKPPF----------PPPEWKIS 214 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H----HHHHHhccCCCC----------ccccccCC
Confidence 9999999988888999999999999999999999986432111 0 111111111000 00000034
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 528 KAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 528 ~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.+++.+||..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 67888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=246.90 Aligned_cols=227 Identities=23% Similarity=0.261 Sum_probs=179.8
Q ss_pred CCCCCCCccccCCccEEEEEEecCCc-EEEEEEeec---CCCCChhhHHHHHHHHHhcCCCceE---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDET-ITAVKRAKL---GNTKGIDPILNEVRILCQLNHRSLF---------------M 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~avk~~~~---~~~~~~~~~~~E~~~l~~l~h~niv---------------~ 353 (559)
++++.+.-||-|+||.|-++..+... .+|+|.++. .+.+..+.+..|-+||.+.+.+.|| |
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 46677778999999999999866544 367666554 4566667899999999999888764 3
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
|-+-+|.|+.+|.... .+.......++..+++|++||| +++||.|||||+|.|++.+|-+||.|||+|+.+.
T Consensus 500 EaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 5567999999997643 4888888999999999999999 8889999999999999999999999999999887
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.+... ...+|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++.....++..-...+.-
T Consensus 572 ~g~KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~--------- 640 (732)
T KOG0614|consen 572 SGRKT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF--------- 640 (732)
T ss_pred cCCce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc---------
Confidence 65543 3445999999999999999999999999999999999999999877655443333221111111
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPS 547 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt 547 (559)
+....+.-.+|+++....+|.+|.-
T Consensus 641 ---------Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 ---------PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---------ccccchhHHHHHHHHHhcCcHhhhc
Confidence 1122345567888888999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=231.52 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=176.4
Q ss_pred CCCCccccCCccEEEEEE-ecCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCceEEee----CCCCcHh------
Q 047195 296 STGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSLFMSM----SPNGTLF------ 362 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~----~~~g~L~------ 362 (559)
+-.+.||-|+||.||.+. -++++.+|+|++... +....+.+.+|+++|..++|.|++... .++-+.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 445789999999999988 468999999987543 223346799999999999999963210 0111111
Q ss_pred -HhH----hhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 363 -DRL----HRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 363 -~~l----~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++ ++.- -+.+.++...++-+++||++||.||| +.+|.||||||.|.|++.+-.+||+|||+++.-+.+..
T Consensus 136 TELmQSDLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQSDLHKII-VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHhhhhhee-ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 111 1111 12346888888999999999999999 88899999999999999999999999999997765555
Q ss_pred eeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh----ccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD----AID 512 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~d 512 (559)
...+-.+-|-.|.|||++++. .|+.+.||||.|||+.||+.++-.|...++.++..++.........+.+.. .-.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 555555578899999999886 699999999999999999999999987766655555432221111110000 000
Q ss_pred cccccCCChh----------hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 513 PMLKEGASEI----------ELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 513 ~~l~~~~~~~----------~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
..++...... ....-.+-..+...++.++|+.|.+..+.+.-
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 0111100000 00111233456677899999999998887653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=253.69 Aligned_cols=232 Identities=29% Similarity=0.347 Sum_probs=167.5
Q ss_pred CCCCCccccCCcc-EEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCceEEeeC--------------CC
Q 047195 295 FSTGNLLGSGGFG-EVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRSLFMSMS--------------PN 358 (559)
Q Consensus 295 y~~~~~lG~G~~g-~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~--------------~~ 358 (559)
|.-.+.+|.|+.| .||+|... ++.||||++-... .+-+.+||..|+.- .|||||.-|+ -.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3445678999887 56899764 6799999976432 24578999999885 6999987654 24
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---C--CCEEEeecccceecc
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---K--LDAKISDFGLSRLAL 433 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~--~~~kl~DFG~a~~~~ 433 (559)
.+|.++++.. ........-...+.+..|++.||++|| +-+||||||||+||||+. + ..++|+|||+++...
T Consensus 587 ~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 CSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5788888763 111111222456788999999999999 667999999999999975 3 468999999999887
Q ss_pred CCCceeee--eccccCCccCccccccCCCCcccchhHHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 434 NGASHVTT--FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTS-KKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 434 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
.+...... ...||.+|+|||++....-+.++||||||||+|+.++| .+||...-..+ . +......-..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~-------NIl~~~~~L~- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-A-------NILTGNYTLV- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-h-------hhhcCcccee-
Confidence 66655433 45599999999999988888899999999999999887 78886332111 0 1111110000
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.. . .+. +..+||.+|++++|..||++.+|+.
T Consensus 734 ---~L~~-~----~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 ---HLEP-L----PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---eecc-C----chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0111 0 011 5678999999999999999999973
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=210.73 Aligned_cols=193 Identities=25% Similarity=0.338 Sum_probs=146.0
Q ss_pred HHHHhCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecC-CCCChhhHHHHHHHHHhc-CCCceEE-----------
Q 047195 288 ITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG-NTKGIDPILNEVRILCQL-NHRSLFM----------- 353 (559)
Q Consensus 288 ~~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~----------- 353 (559)
++...+....+..||+|++|.|-+-+ ..+|...|+|++... +.+.+++.++|+.+..+- .-|.+|.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 44445566667889999999998877 467899999998764 334456788888887664 4455544
Q ss_pred ----eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 354 ----SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 354 ----~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
|.| .-+|..+-.... .....+++..+-+|+..+..||.|||+ ...+||||+||+|||++.+|++|++|||.+
T Consensus 121 wIcME~M-~tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccc
Confidence 333 223333322221 122468888999999999999999996 568999999999999999999999999998
Q ss_pred eeccCCCceeeeeccccCCccCcccccc----CCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYIN----FQLTDKSDVYSFGVVLVELLTSKKAVDFN 486 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~il~el~tg~~p~~~~ 486 (559)
-...+.-. .+...|...|||||.+.. ..|+-||||||||+++.||.+++.|++..
T Consensus 197 G~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 197 GYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 76654321 222348899999998753 47899999999999999999999998743
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-28 Score=241.56 Aligned_cols=192 Identities=27% Similarity=0.367 Sum_probs=156.9
Q ss_pred hCCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCc---------------eE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRS---------------LF 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~n---------------iv 352 (559)
..-|..++-||-|+||+|-++...| ...+|+|-+...+ .........|-.||.....+. .|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3568888999999999999998544 5678888876543 234456788999999887765 37
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|+|++||++..+|-+.. -+.+..++.++.++..|+++.| ..|+|||||||+|||||.+|++||.||||++-+
T Consensus 708 MdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccc
Confidence 89999999999887764 3889999999999999999999 888999999999999999999999999997532
Q ss_pred ---------cCCCce--------------------------------eeeeccccCCccCccccccCCCCcccchhHHHH
Q 047195 433 ---------LNGASH--------------------------------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGV 471 (559)
Q Consensus 433 ---------~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ 471 (559)
.++... ..-..+||+.|+|||++....|+..+|+||.|+
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 111000 001234999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCcccc
Q 047195 472 VLVELLTSKKAVDFNREEED 491 (559)
Q Consensus 472 il~el~tg~~p~~~~~~~~~ 491 (559)
|||||+.|+.||-.+.+.+.
T Consensus 860 il~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcc
Confidence 99999999999976655443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=228.30 Aligned_cols=246 Identities=23% Similarity=0.291 Sum_probs=188.0
Q ss_pred HHhCCCCCCCccccCCccEEEEEEecCC------cEEEEEEeecC-CCCChhhHHHHHHHHHhcCCCce-----------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILDDE------TITAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL----------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~avk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni----------- 351 (559)
....+++...++-+|.||.||.|+|.+. +.+-+|-++.. ++-....++.|...+..+.|||+
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 3345788888899999999999976543 34445555433 23344668899999999999995
Q ss_pred -----EEeeCCCCcHhHhHhhccC---CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 -----FMSMSPNGTLFDRLHRVQS---GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
++.++.-|+|..++...+. ..-+.+...+...++.|++.|++||| +++|||.||..+|.+||+..++||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEe
Confidence 3466677899888874332 22346777888999999999999999 899999999999999999999999
Q ss_pred eecccceecc-CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 047195 424 SDFGLSRLAL-NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+|=.+++..- .+..........+..||+||.+.+..|+.++||||||++||||+| |+.|+...++.+ ...+
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~y 510 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHY 510 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHH
Confidence 9999998653 333333333336778999999999999999999999999999998 777775443322 1222
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
+.++. .-..+.++++++..++.-||...|++||++++++.-|.+
T Consensus 511 lkdGy------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 511 LKDGY------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred Hhccc------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 22221 112245777899999999999999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=228.73 Aligned_cols=117 Identities=25% Similarity=0.338 Sum_probs=93.2
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-----CCc----------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLN-----HRS---------------- 350 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-----h~n---------------- 350 (559)
.+|.+.++||-|.|++||++.. .+.+.||+|+.+.. ....+..+.||++|++++ |++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5789999999999999999984 56789999998753 444577899999999883 222
Q ss_pred ----eEEeeC-CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 351 ----LFMSMS-PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 351 ----iv~~~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
+.|.|. -|-+|..++.+... ..++...+++|++||+.||.|||.. -+|||-||||+|||+
T Consensus 157 NG~HVCMVfEvLGdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhhhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 333332 25577777776443 4699999999999999999999974 489999999999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=232.48 Aligned_cols=262 Identities=21% Similarity=0.213 Sum_probs=190.7
Q ss_pred cChHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC--------------
Q 047195 283 FSSREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLN-------------- 347 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-------------- 347 (559)
|.+.-.+..-++|.+....|+|-|++|.+|.. ..+..||||++..+.. ....=+.|++||++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 44444556667899999999999999999984 4467999999886533 2345578999999883
Q ss_pred ----CCc-eEEeeC-CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC-CC
Q 047195 348 ----HRS-LFMSMS-PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-LD 420 (559)
Q Consensus 348 ----h~n-iv~~~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~-~~ 420 (559)
|.| |.+.|. -..+|.++|...... -.|....+..++.|+.-||..|. .-+|+|.||||+|||+++. ..
T Consensus 501 r~F~hknHLClVFE~LslNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLSLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhhhchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcce
Confidence 222 334332 245888888876433 35888999999999999999999 7779999999999999975 46
Q ss_pred EEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH-
Q 047195 421 AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG- 499 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~- 499 (559)
+||||||.|-...... .+.+.-+.-|.|||++.+.+|+...|+||+||.||||.||+-.|++........+.....
T Consensus 576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 8999999997665433 233335667999999999999999999999999999999999998776554333322111
Q ss_pred ----HHhhcchh-hhcccccc--------------------------------cc--CCChhhHHHHHHHHHHHHHhccc
Q 047195 500 ----NILKQERL-VDAIDPML--------------------------------KE--GASEIELDSMKAFGLLGAACLDE 540 (559)
Q Consensus 500 ----~~~~~~~~-~~~~d~~l--------------------------------~~--~~~~~~~~~~~~l~~l~~~cl~~ 540 (559)
.++..+.+ .++.|..+ .. ..+...+....+|.+|+..||..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 11111111 01111110 00 12233466778899999999999
Q ss_pred CCCCCCCHHHHHH
Q 047195 541 RRQNRPSIKEVAD 553 (559)
Q Consensus 541 ~p~~RPt~~evl~ 553 (559)
||++|.|..+.|+
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=217.44 Aligned_cols=247 Identities=20% Similarity=0.205 Sum_probs=173.1
Q ss_pred hCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCceEE---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSLFM--------------- 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 353 (559)
..+|.-++.+|.|.- .|-.+. .-.++.||+|++... +.....+..+|...+..++|+|++.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777888999987 555554 335788999987543 3334467889999999999999754
Q ss_pred ------eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 354 ------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 354 ------~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
|+| ..+|...+.. .++-.....|+.|++.|+.||| +.+|+||||||+||++..+..+||.|||
T Consensus 95 e~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccch
Confidence 333 2334443331 2555677899999999999999 8899999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh-----
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL----- 502 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 502 (559)
+|+..... -..+....|..|.|||++.+..+...+||||+||++.||++|+..|.+...-++..++.......
T Consensus 164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 99754332 34566778999999999999899999999999999999999999987554333322222111000
Q ss_pred ----------hcc-------hhhhcc-ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 503 ----------KQE-------RLVDAI-DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 503 ----------~~~-------~~~~~~-d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ...+.+ |...... .+.+........+++.+||..+|++|-++.++++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~-~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVV-LEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCccccccc-ccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 000000 0000000 0111122344677999999999999999999885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-25 Score=209.10 Aligned_cols=195 Identities=36% Similarity=0.532 Sum_probs=165.3
Q ss_pred cccCCccEEEEEEecC-CcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCc---------------eEEeeCCCCcHhH
Q 047195 301 LGSGGFGEVFKAILDD-ETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRS---------------LFMSMSPNGTLFD 363 (559)
Q Consensus 301 lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~n---------------iv~~~~~~g~L~~ 363 (559)
||+|.+|.||++...+ ++.+++|........ ..+.+.+|++.++.+.|++ +++++..+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999998765443 3467999999999999987 3678889899999
Q ss_pred hHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEeecccceeccCCCceeeee
Q 047195 364 RLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFGLSRLALNGASHVTTF 442 (559)
Q Consensus 364 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~ 442 (559)
++.... ..+++..+..++.++++++++|| +.+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 887542 25889999999999999999999 789999999999999999 89999999999986654321 1222
Q ss_pred ccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCCh
Q 047195 443 AQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASE 521 (559)
Q Consensus 443 ~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 521 (559)
..+...|++||.+... ..+.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 3478899999998776 788999999999999999
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 522 IELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 522 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 456778899999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=230.65 Aligned_cols=181 Identities=24% Similarity=0.373 Sum_probs=148.5
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--------CCChhhHHHHHHHHHhcC---CCceEE-------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--------TKGIDPILNEVRILCQLN---HRSLFM------- 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~------- 353 (559)
.+|...+.+|.|+||.|++++++ +...|+||.+.... .+..-.+-.|+.||..++ |+||+.
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999965 45778888876532 122233568999999998 999853
Q ss_pred --------ee-CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEe
Q 047195 354 --------SM-SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKIS 424 (559)
Q Consensus 354 --------~~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~ 424 (559)
|- -++-+|+++++... .+.+.++.-|++||+.|+++|| +++|||||||-+|+.++.+|-+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEe
Confidence 11 14567888888643 5999999999999999999999 9999999999999999999999999
Q ss_pred ecccceeccCCCceeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCC
Q 047195 425 DFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVD 484 (559)
Q Consensus 425 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~ 484 (559)
|||.|.+...+.- .. .+||.+|.|||++.+..| ...-|||++|++||.++....|+.
T Consensus 713 dfgsaa~~ksgpf--d~-f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGPF--DV-FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCCc--ce-eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999987654332 22 349999999999998876 456799999999999999998875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=204.34 Aligned_cols=167 Identities=22% Similarity=0.225 Sum_probs=124.0
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
|+|.+++.... ..+++..+..++.|++.||+||| +++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc--
Confidence 67888886532 35999999999999999999999 554 999999999999999 99998754322
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
..||+.|||||++.+..++.++||||||+++|||++|+.||........ ............ ++.-.
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~------~~~~~-- 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPAD------DPRDR-- 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccC------Ccccc--
Confidence 1489999999999999999999999999999999999999864332111 111111000000 00000
Q ss_pred CChhhHHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 519 ASEIELDSM--KAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 519 ~~~~~~~~~--~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
....... ..+.+++.+||+.+|++|||+.|+++.+..+
T Consensus 130 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 --SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred --ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0011222 2689999999999999999999999988653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=233.94 Aligned_cols=238 Identities=24% Similarity=0.332 Sum_probs=188.1
Q ss_pred hCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
..+|+...++|.|.||.|||++ .+.+...|+|+++........-+..|+-+++.-+|+|| .|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4579999999999999999999 56789999999999888777888999999999999995 6899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+.+|+|.+.-+... ++++.++..++++.+++++||| +.+=+|||||-.|||+++.+.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred cCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999998877543 5888899999999999999999 888999999999999999999999999998665432
Q ss_pred CceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
-.... ...||+.|||||+.. ...|..++|||++|+...|+---+.|.....+.. ....+.... .+
T Consensus 166 i~Krk-sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTkS~----~q 233 (829)
T KOG0576|consen 166 IAKRK-SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTKSG----FQ 233 (829)
T ss_pred hhhhh-cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhccC----CC
Confidence 22222 233999999999863 4579999999999999999987777754222111 111111111 11
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.-.++. ......+.++++.++..+|++|||+..+++
T Consensus 234 pp~lkDk----~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKDK----TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccCC----ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111111 244577889999999999999999988765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=206.29 Aligned_cols=184 Identities=34% Similarity=0.480 Sum_probs=155.8
Q ss_pred CCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCc---------------eEEeeCC
Q 047195 295 FSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRS---------------LFMSMSP 357 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~n---------------iv~~~~~ 357 (559)
|.+.+.||.|++|.||++...+ +..+++|.+...... ..+.+.+|++.+++++|+| +++++.+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667889999999999999765 789999998876554 5678999999999999988 3678889
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+++|.+++..... .+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999998876432 1788999999999999999999 77999999999999999999999999999987765431
Q ss_pred eeeeeccccCCccCcccc-ccCCCCcccchhHHHHHHHHHHhCCCCCCC
Q 047195 438 HVTTFAQGTLGYLDPEYY-INFQLTDKSDVYSFGVVLVELLTSKKAVDF 485 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~il~el~tg~~p~~~ 485 (559)
.......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 112223478899999998 566778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=214.63 Aligned_cols=185 Identities=26% Similarity=0.342 Sum_probs=148.7
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC-c-------------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNTKGIDPILNEVRILCQLNHR-S------------- 350 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~-n------------- 350 (559)
....+.|...++||.|.|++||++++. ..+.||+|.+...+.. ..+.+|+++|..+.-. |
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344567899999999999999999843 4688999998765544 5699999999988432 2
Q ss_pred --eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEeecc
Q 047195 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFG 427 (559)
Q Consensus 351 --iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~DFG 427 (559)
+|++|.+.....++... ++...+..+++.++.||.++| .+|||||||||+|+|.+. .+.-.|.|||
T Consensus 110 v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEech
Confidence 68999999888887764 678889999999999999999 999999999999999985 4567999999
Q ss_pred cceeccCCC-------------------------------------------ceeeeeccccCCccCccccccC-CCCcc
Q 047195 428 LSRLALNGA-------------------------------------------SHVTTFAQGTLGYLDPEYYINF-QLTDK 463 (559)
Q Consensus 428 ~a~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 463 (559)
+|....... ........||+||.|||++... ..+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 987211000 0001123499999999999865 46889
Q ss_pred cchhHHHHHHHHHHhCCCCCCCC
Q 047195 464 SDVYSFGVVLVELLTSKKAVDFN 486 (559)
Q Consensus 464 ~Dv~SlG~il~el~tg~~p~~~~ 486 (559)
+||||.|+|++.+++++.||...
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred cceeeccceeehhhccccccccC
Confidence 99999999999999999999643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-25 Score=200.20 Aligned_cols=237 Identities=20% Similarity=0.266 Sum_probs=169.9
Q ss_pred hCCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCCCChhhHHHHHHHHHhcC-CCce----------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTKGIDPILNEVRILCQLN-HRSL----------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni----------------v~ 353 (559)
.+.|.+.+.||+|-||.+-+++++. ...+++|.+... .....+|.+|...--.|. |.|| ++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4679999999999999999999654 567777876543 334578999988766665 5554 57
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec--CCCCEEEeeccccee
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD--EKLDAKISDFGLSRL 431 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~--~~~~~kl~DFG~a~~ 431 (559)
||.+.|+|...+... .+.+....+++.|++.||.||| +++++|||||.+||||- +...+||+|||+.+.
T Consensus 102 E~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred ccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999998877652 3788889999999999999999 88999999999999994 344799999999875
Q ss_pred ccCCCceeeeeccccCCccCccccccC-----CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINF-----QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
...- .....-+..|.+||..... ...+.+|||.||++++..+||..||+..... +..-|.+..|..+.
T Consensus 173 ~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 173 VGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQWLKRK 245 (378)
T ss_pred cCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHHHhccc
Confidence 4321 1122356789999986432 3567899999999999999999999833221 11122222222222
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.+.+...+.. .......+.++-|..++++|=...++.++
T Consensus 246 -----~~~~P~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 246 -----NPALPKKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred -----CccCchhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 2223333332 22456667788899999999555554444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=242.70 Aligned_cols=172 Identities=19% Similarity=0.207 Sum_probs=121.0
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---------------
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE--------------- 417 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~--------------- 417 (559)
+|++ +++|++++.... ..+++..++.++.||++||+||| +++|+||||||+||||+.
T Consensus 59 ~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~ 130 (793)
T PLN00181 59 LECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDS 130 (793)
T ss_pred hccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeeccccCcc
Confidence 4554 669999986422 35899999999999999999999 889999999999999954
Q ss_pred ----CCCEEEeecccceeccCCC---------------ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh
Q 047195 418 ----KLDAKISDFGLSRLALNGA---------------SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478 (559)
Q Consensus 418 ----~~~~kl~DFG~a~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t 478 (559)
++.+|++|||+++...... ........||+.|||||++.+..++.++|||||||+||||++
T Consensus 131 ~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~ 210 (793)
T PLN00181 131 GSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFC 210 (793)
T ss_pred cccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhh
Confidence 4456666777665321100 000111348899999999999899999999999999999999
Q ss_pred CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 479 SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 479 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
|..|+.... ........ ..+.+.. .........++.+||+.+|.+||||.||++
T Consensus 211 ~~~~~~~~~-----~~~~~~~~--------~~~~~~~--------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 211 PVSSREEKS-----RTMSSLRH--------RVLPPQI--------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCchhhHH-----HHHHHHHH--------hhcChhh--------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 888754211 00000000 0011110 011233457788999999999999999975
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=167.57 Aligned_cols=97 Identities=30% Similarity=0.624 Sum_probs=75.9
Q ss_pred CCC-CCCCcccCCCCCCCCCCCC-CCceEEeCCCC-cccccCCCceEEEEEEeCCCcEEEEcCCCccccccccccC---C
Q 047195 1 SCT-NCGHIPVPYPLSTGPGCGD-QSYKVRCNAGM-LWFDGLNGSSYMITSINPLSQSLIIRPPGLIKNKCIAADY---H 74 (559)
Q Consensus 1 ~C~-~CG~~~I~yPFg~~~~C~~-~~f~l~C~~~~-~~~~~~~~~~~~V~~i~~~~~~~~~~~~~~~~~~c~~~~~---~ 74 (559)
.|| +|||++||||||++++|++ |+|+|+|++++ ++.+++++..|+|++|++++++++|.++. ...|..... .
T Consensus 3 ~C~~~CGnv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~--~~~~~~~~~~~~~ 80 (106)
T PF13947_consen 3 GCPSSCGNVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPI--SSNCYSSSSSNSS 80 (106)
T ss_pred CCCCccCCEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEecc--ccceecCCCCccc
Confidence 599 9999999999999999999 99999999883 44444577889999999999999998743 445554332 1
Q ss_pred CcccccCCCCCccccC-CCcEEEEcccc
Q 047195 75 GQGLQLDNNLRFNISS-SNTVMVMNCSI 101 (559)
Q Consensus 75 ~~~~~~~~~~~f~~s~-~n~~~~~gC~~ 101 (559)
..++++ ..||.+++ .|.|+++||++
T Consensus 81 ~~~~~~--~~~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 81 NSNLSL--NGPFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred ccEEee--cCCceEccCCcEEEEECCCC
Confidence 123334 34888875 59999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=203.19 Aligned_cols=154 Identities=18% Similarity=0.144 Sum_probs=119.1
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEec--CCcEEEEEEeecCC-----CCChhhHHHHHHHHHhcCCCce----------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAILD--DETITAVKRAKLGN-----TKGIDPILNEVRILCQLNHRSL---------- 351 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~avk~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni---------- 351 (559)
.....+|.+.+.||+|+||+||+|..+ +++.+|||++.... ....+.+.+|+++|++++|+|+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~ 93 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKD 93 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCc
Confidence 345678999999999999999999864 57778999865321 1123568999999999999884
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCC-CCCCeeecCCCCEEEeeccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDI-KSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Di-kp~Nill~~~~~~kl~DFG~ 428 (559)
||||+++++|... . . .. ...++.|++++|.||| +++|+|||| ||+|||++.++.+||+|||+
T Consensus 94 ~LVmE~~~G~~L~~~-~---~-----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-R---P-----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred EEEEEccCCCCHHHh-C---c-----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 6789988888621 1 0 11 1467889999999999 889999999 99999999999999999999
Q ss_pred ceeccCCCce-e------eeeccccCCccCcccccc
Q 047195 429 SRLALNGASH-V------TTFAQGTLGYLDPEYYIN 457 (559)
Q Consensus 429 a~~~~~~~~~-~------~~~~~gt~~y~aPE~~~~ 457 (559)
|+........ . .+...+++.|+|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9876532211 1 134558889999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-20 Score=189.07 Aligned_cols=243 Identities=21% Similarity=0.229 Sum_probs=173.5
Q ss_pred CCCCCCccccCCccEEEEEEecCC--cEEEEEEeecCCCCChhhHHHHHHHHHhcCC------C-------------c-e
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDE--TITAVKRAKLGNTKGIDPILNEVRILCQLNH------R-------------S-L 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h------~-------------n-i 351 (559)
+|.+.+.||+|+||.||++...+. ..+|+|............+..|+.++..+.+ - | |
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996553 4788888766544433368889999988872 1 1 3
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC-----CCEEEeec
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-----LDAKISDF 426 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~-----~~~kl~DF 426 (559)
||. ..+.+|.++..... ...++...++.|+.|++.+|++|| +.+++||||||+|+++... ..+.|.||
T Consensus 99 VM~-l~G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMS-LLGPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEe-ccCccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 333 34778888775543 246899999999999999999999 8899999999999999864 46999999
Q ss_pred ccce--eccCCCce----e---eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 047195 427 GLSR--LALNGASH----V---TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 427 G~a~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~ 497 (559)
|+++ .+...... . .....||..|.++....+.+.+.+.|+||++-++.|++.|..||............
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~-- 249 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF-- 249 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH--
Confidence 9998 43222111 1 12234999999999999999999999999999999999999999654432221111
Q ss_pred HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 498 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
....... .... .. ...+..+.++...+-..+..++|....+.+.|++.
T Consensus 250 -~~~~~~~----~~~~-----~~---~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 250 -EKDPRKL----LTDR-----FG---DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred -HHHhhhh----cccc-----cc---CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111110 0000 00 11123445555555568999999999998887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=172.96 Aligned_cols=243 Identities=18% Similarity=0.216 Sum_probs=178.8
Q ss_pred hCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC----C-----------c-eEEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH----R-----------S-LFMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h----~-----------n-iv~~ 354 (559)
...|.+.++||.|+||.+|.|. ..+|..||||.-+.... ..++..|.++...|++ | | +||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4579999999999999999998 68899999998654333 3568889999988865 2 1 4666
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEeeccccee
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKISDFGLSRL 431 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~DFG~a~~ 431 (559)
.. +.+|.++...... .++.+.++-++-|++.-++|+| .+++|||||||+|+|..- ...+.|+|||+|+.
T Consensus 92 LL-GPsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cc-CccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhh
Confidence 64 6788887766543 4888999999999999999999 888999999999999964 34689999999998
Q ss_pred ccCCCce------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 432 ALNGASH------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 432 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
+.+.... ......||..|.+--...+.+.+.+.|+=|+|-+|..+--|..||++............+. +.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~----Ek 239 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS----EK 239 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH----Hh
Confidence 7543222 1233459999999888888888899999999999999999999998765443222211111 11
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.+......+....+.++...+.-|-...-++-|.-.-+-+.+.
T Consensus 240 --------K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 240 --------KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred --------hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 1111111222233456777777788888888887766655544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=210.17 Aligned_cols=238 Identities=22% Similarity=0.257 Sum_probs=172.7
Q ss_pred CCCCccccCCccEEEEEEe-cCCcEEEEEEeec-----CCCCC-hhhHHHHHHHHHhcCCCce---------------EE
Q 047195 296 STGNLLGSGGFGEVFKAIL-DDETITAVKRAKL-----GNTKG-IDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~-----~~~~~-~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
....++|.|++|.|+.... ......+.|.... ..... ...+..|.-+-..|.|+|+ +|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3457899999998877663 3333344443221 11111 1115566667777899984 46
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||++. +|+.++.... .+...++-.++.|++.|+.||| ..+|.|||+|++|+++..++.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 88888 9999887642 3777888999999999999999 8889999999999999999999999999998765
Q ss_pred CCCc---eeeeeccccCCccCccccccCCCCc-ccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 434 NGAS---HVTTFAQGTLGYLDPEYYINFQLTD-KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 434 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
.+.. .......|+..|+|||++.+..|++ ..||||.|+++..|++|+.||......+.... ....
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----~~~~------- 540 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----TNNY------- 540 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----hhcc-------
Confidence 4333 3445566999999999999999876 68999999999999999999975544332210 0000
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.-...+..+...+...++.+-..++.+||+.+|.+|-|+++|++
T Consensus 541 ~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 541 SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00001111222333456677888999999999999999999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-21 Score=176.60 Aligned_cols=235 Identities=22% Similarity=0.273 Sum_probs=172.9
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
...+..+|.+...|..|+|+++.+..| +|++... ......+|..|.-.|+-+.|||| +..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 445567789999999999999877655 4444332 23334678999999999999984 67999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEe--ecccceeccC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKIS--DFGLSRLALN 434 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~--DFG~a~~~~~ 434 (559)
+.|+|+.+++.... -..+..++.+++.++++|++|||++. .-|...-|.+..+++|++.+++|+ |--++...
T Consensus 270 p~gslynvlhe~t~---vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe-- 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-- 343 (448)
T ss_pred cchHHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec--
Confidence 99999999987543 23566788999999999999999874 334445788999999999987764 32222110
Q ss_pred CCceeeeeccccCCccCccccccCCCC---cccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLT---DKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
....-.|.||+||.++..+-+ ..+|+|||++++|||.|+..||....+.+-. .....+.++-.+
T Consensus 344 ------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mkialeglrv~i 410 (448)
T KOG0195|consen 344 ------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKIALEGLRVHI 410 (448)
T ss_pred ------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhhhhccccccC
Confidence 111257899999999877543 4789999999999999999999755443321 111122222222
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
+.....++.+|+.-|+..||.+||.+..|+-+||++.
T Consensus 411 -----------ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 -----------PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----------CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2344577888999999999999999999999999874
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=170.95 Aligned_cols=187 Identities=20% Similarity=0.280 Sum_probs=151.7
Q ss_pred CCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC----Cc------------eEEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH----RS------------LFMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h----~n------------iv~~~ 355 (559)
-+|.++++||.|+||.++.|+ +-++..||||.-...+. .-++..|-+..+.|.+ |+ +|++.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999998 66789999997554333 3567888888888864 22 24444
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-----CEEEeecccce
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-----DAKISDFGLSR 430 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-----~~kl~DFG~a~ 430 (559)
-+-+|.|+...... .++.+.+.-+|.|++.-++|+| .+.+|.|||||+|+||...+ .+.|+|||+|+
T Consensus 106 -LGPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 106 -LGPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred -hCcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 46788888776543 5899999999999999999999 88899999999999997543 48999999999
Q ss_pred eccCCCcee------eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcc
Q 047195 431 LALNGASHV------TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE 489 (559)
Q Consensus 431 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~ 489 (559)
.+.+..... .....||..||+=-...+.+.+.+.|.=|||-|++..+-|..||.+.-..
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 886543221 12344999999999999999999999999999999999999999876443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-19 Score=179.07 Aligned_cols=245 Identities=30% Similarity=0.385 Sum_probs=178.4
Q ss_pred CCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCC-c---------------eEEee
Q 047195 295 FSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK---GIDPILNEVRILCQLNHR-S---------------LFMSM 355 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~-n---------------iv~~~ 355 (559)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ + +++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999876 77888888765443 357799999999999987 3 46788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeecccceeccC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDFGLSRLALN 434 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DFG~a~~~~~ 434 (559)
..++++.+.+...... ..+.......+..|++.++.|+| ..+++|||+||+||+++... .++++|||+++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 8899998666543211 25888899999999999999999 78899999999999999988 799999999986544
Q ss_pred CCce-----eeeeccccCCccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 435 GASH-----VTTFAQGTLGYLDPEYYIN---FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 435 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
.... ......||..|+|||.+.+ ..+....|+||+|++++++++|..|+....... .............
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS---ATSQTLKIILELP 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc---cHHHHHHHHHhcC
Confidence 3322 2344569999999999987 578889999999999999999999965443210 0000111111110
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ........... ......+.+++..++..+|..|.++.+...
T Consensus 232 ~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 232 TP-SLASPLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred Cc-ccccccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 00 00000000000 122356778889999999999999987665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-20 Score=197.75 Aligned_cols=236 Identities=21% Similarity=0.243 Sum_probs=164.5
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecCC-CCChhhHHHHHHH--HHhcCCCce---------------EEee
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGN-TKGIDPILNEVRI--LCQLNHRSL---------------FMSM 355 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~-~~~~~~~~~E~~~--l~~l~h~ni---------------v~~~ 355 (559)
++...+.||.+.|=+|.+++.++|. ++||++.... .-..+.|.++++- ...++|||. |.+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777789999999999999988887 7788876544 4444555544444 445688883 3455
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec--c
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA--L 433 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~--~ 433 (559)
.. -+|+|.+.. ++-+...+.+.|+-|++.||.-+| ..+|+|||||.+||||+....+.|+||..-+.. .
T Consensus 103 vk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 43 367777753 235778888999999999999999 888999999999999999999999999876543 2
Q ss_pred CCCceee----eeccccCCccCccccccC----------C-CCcccchhHHHHHHHHHHhC-CCCCCCCCccccccHHHH
Q 047195 434 NGASHVT----TFAQGTLGYLDPEYYINF----------Q-LTDKSDVYSFGVVLVELLTS-KKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 434 ~~~~~~~----~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~SlG~il~el~tg-~~p~~~~~~~~~~~~~~~ 497 (559)
++..... .....-..|+|||.+... . .+++.||||+||+++||++- +++|... .+..+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH
Confidence 2222211 112244569999987542 1 57789999999999999985 6666411 11111
Q ss_pred HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 498 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.. +. ....+..|.+-.+ ..+..|++.|++.||+.|.++.+.++.-.++
T Consensus 248 r~-----~~-~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 RS-----GN-ADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred hc-----cC-ccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11 10 1111111111111 2577899999999999999999999876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=167.68 Aligned_cols=126 Identities=19% Similarity=0.112 Sum_probs=100.2
Q ss_pred CCccccCCccEEEEEEecCCcEEEEEEeecCCCCC---------hhhH-----------------HHHHHHHHhcCCCc-
Q 047195 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG---------IDPI-----------------LNEVRILCQLNHRS- 350 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~---------~~~~-----------------~~E~~~l~~l~h~n- 350 (559)
.+.||+|++|.||+|...+|+.||||+++...... ...| .+|++++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999998789999999987643211 1122 34999999986432
Q ss_pred ------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHH-HHcCCCCeEECCCCCCCeeecC
Q 047195 351 ------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL-HLLATPPIYHRDIKSSNILLDE 417 (559)
Q Consensus 351 ------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiH~Dikp~Nill~~ 417 (559)
|||||++++++...+... ..+++..+..++.|++.+|.|| | +.+|+||||||+|||++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-
Confidence 689999987765443221 2478889999999999999999 6 77899999999999998
Q ss_pred CCCEEEeecccceec
Q 047195 418 KLDAKISDFGLSRLA 432 (559)
Q Consensus 418 ~~~~kl~DFG~a~~~ 432 (559)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.1e-19 Score=169.04 Aligned_cols=219 Identities=23% Similarity=0.293 Sum_probs=142.0
Q ss_pred CCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCC---CChhhHHHHHHHHHhcCC-Cc-------------------
Q 047195 295 FSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNT---KGIDPILNEVRILCQLNH-RS------------------- 350 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h-~n------------------- 350 (559)
+...+.||.|+++.||.++..+ ++.+|+|+...... ...+++.+|.-....+.+ .|
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4456789999999999999754 89999999766542 234556666655544333 11
Q ss_pred --------------------e--EEeeCCCCcHhHhHhhccCCC--CCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEEC
Q 047195 351 --------------------L--FMSMSPNGTLFDRLHRVQSGN--WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHR 406 (559)
Q Consensus 351 --------------------i--v~~~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~ 406 (559)
. ++.- ..++|.+++....... ...+....++.+..|+++.+++|| ..+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~-~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPR-AQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccch-hhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 0 1111 3456766655422211 112344556677799999999999 7889999
Q ss_pred CCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCcccccc--------CCCCcccchhHHHHHHHHHHh
Q 047195 407 DIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN--------FQLTDKSDVYSFGVVLVELLT 478 (559)
Q Consensus 407 Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~il~el~t 478 (559)
||||+|+|++.+|.++|+||+....... .. .. ...+..|.+||.... ..++.+.|.|+||+++|.|..
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~--~~-~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT--RY-RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE--EE-EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc--ee-ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987654322 11 11 335678999997643 247889999999999999999
Q ss_pred CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCC
Q 047195 479 SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNR 545 (559)
Q Consensus 479 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 545 (559)
+..||........... .+.... +.++.+..|+..+|+.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~-----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986543322111 122233 667889999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=161.19 Aligned_cols=126 Identities=21% Similarity=0.139 Sum_probs=101.8
Q ss_pred CCccccCCccEEEEEEecCCcEEEEEEeecCCCCC--------------------------hhhHHHHHHHHHhcCCCc-
Q 047195 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG--------------------------IDPILNEVRILCQLNHRS- 350 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n- 350 (559)
.+.||+|++|.||+|...+|+.||||++....... ...+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999997789999999987653210 112357889999887764
Q ss_pred ------------eEEeeCCCCcHhHh-HhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCC-CCeEECCCCCCCeeec
Q 047195 351 ------------LFMSMSPNGTLFDR-LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT-PPIYHRDIKSSNILLD 416 (559)
Q Consensus 351 ------------iv~~~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~Dikp~Nill~ 416 (559)
+||||++++++... +.. ..++......++.|++.++.+|| . .+|+||||||+|||++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE
Confidence 68999988855433 322 13677889999999999999999 6 8999999999999999
Q ss_pred CCCCEEEeecccceecc
Q 047195 417 EKLDAKISDFGLSRLAL 433 (559)
Q Consensus 417 ~~~~~kl~DFG~a~~~~ 433 (559)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.9e-19 Score=167.08 Aligned_cols=156 Identities=12% Similarity=0.040 Sum_probs=119.2
Q ss_pred HhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhh---------HHHHHHHHHhcCCCc-----------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDP---------ILNEVRILCQLNHRS----------- 350 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~---------~~~E~~~l~~l~h~n----------- 350 (559)
..++|.+.++||+|+||.||++.. ++..+|||.+.......... +.+|+..+.++.|++
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999765 56789999987554333222 579999999998876
Q ss_pred ------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC
Q 047195 351 ------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418 (559)
Q Consensus 351 ------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~ 418 (559)
|+|||++|.+|.+... ++. ....+++.+|..|| ..+++|||+||+||+++.+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCC
Confidence 3778888888876531 222 34568999999999 8899999999999999998
Q ss_pred CCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHH
Q 047195 419 LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477 (559)
Q Consensus 419 ~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~ 477 (559)
+ ++|+|||........... ..++....+..++|+||||+++.-+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988654322110 11334445778999999999987654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=190.81 Aligned_cols=191 Identities=21% Similarity=0.222 Sum_probs=146.3
Q ss_pred ChHHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCC---hhhHHHHHH--HHHhc----------CC
Q 047195 284 SSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG---IDPILNEVR--ILCQL----------NH 348 (559)
Q Consensus 284 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~---~~~~~~E~~--~l~~l----------~h 348 (559)
...+.+.-...|.+.+.||+|+||+||+|...+++.+|+|+-+..+.-. ..++...++ ++..+ +-
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3334444456799999999999999999998889999999976554321 112222222 11111 11
Q ss_pred CceEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec-------CCCCE
Q 047195 349 RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD-------EKLDA 421 (559)
Q Consensus 349 ~niv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~-------~~~~~ 421 (559)
..||++|.+.|+|.+++... ..++|..+..+..|+++.+++|| ..+|||+||||+|+||. +...+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccce
Confidence 23789999999999999832 35899999999999999999999 88899999999999994 23458
Q ss_pred EEeecccceeccC-CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCC
Q 047195 422 KISDFGLSRLALN-GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKA 482 (559)
Q Consensus 422 kl~DFG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p 482 (559)
+|+|||.+..+.- ..........+|-.|-.+|...+..++..+|-|.|+.+++-|+.|+.-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999999865431 111233445589999999999999999999999999999999999853
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-18 Score=155.82 Aligned_cols=176 Identities=18% Similarity=0.124 Sum_probs=128.6
Q ss_pred CCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChh-----hHHHHHHHHHhcCC-Cc-----------eEEeeCCC
Q 047195 296 STGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGID-----PILNEVRILCQLNH-RS-----------LFMSMSPN 358 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~-----~~~~E~~~l~~l~h-~n-----------iv~~~~~~ 358 (559)
.+...|++|+||+||.+.. ++..++.+.+..... ... .+.+|+++|++|.| ++ ++|+|+.+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~-~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPW-WLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchh-hhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecC
Confidence 4567899999999997765 667777666654332 112 47899999999964 32 47888888
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCC-CCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDI-KSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Di-kp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
.+|...+.. ....++.|++++|.++| .++|+|||| ||+|||++.++.++|+|||++........
T Consensus 83 ~~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 83 AAMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ccHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 887643311 11357789999999999 889999999 79999999999999999999986543221
Q ss_pred e----e--------eeeccccCCccCccccccC-CCC-cccchhHHHHHHHHHHhCCCCCCCCCc
Q 047195 438 H----V--------TTFAQGTLGYLDPEYYINF-QLT-DKSDVYSFGVVLVELLTSKKAVDFNRE 488 (559)
Q Consensus 438 ~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~SlG~il~el~tg~~p~~~~~~ 488 (559)
. . ......++.|++|+...-. ..+ ...+.++.|..+|.++|++.+...+++
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 0 1123378889999864322 222 467889999999999999988765543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.1e-19 Score=179.82 Aligned_cols=215 Identities=26% Similarity=0.263 Sum_probs=153.7
Q ss_pred ccccCCccEEEEEE----ecCCcEEEEEEeecCCCCC--hhhHHHHHHHHHhcC-CCceEE---eeCCCCcHhHhHhhcc
Q 047195 300 LLGSGGFGEVFKAI----LDDETITAVKRAKLGNTKG--IDPILNEVRILCQLN-HRSLFM---SMSPNGTLFDRLHRVQ 369 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~----~~~~~~~avk~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~---~~~~~g~L~~~l~~~~ 369 (559)
.+|+|+||.|+++. .+.+..+|+|..+...... ......|..++...+ ||.+|. -+...+.|+..+...+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 3456778888776543211 124567788888887 777653 2233444444444333
Q ss_pred CC-------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeee
Q 047195 370 SG-------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442 (559)
Q Consensus 370 ~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 442 (559)
.+ ....+.+.........++-+++++| +.+|+|||+|++||+++.+|++|+.|||+++........
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 21 1234666777778888999999999 778999999999999999999999999999877654433
Q ss_pred ccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChh
Q 047195 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEI 522 (559)
Q Consensus 443 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 522 (559)
+||..|||||++. .....+|.||||++++||+||..||.. + .. .. |.......
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~---~~---~~--------------Il~~~~~~ 206 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D---TM---KR--------------ILKAELEM 206 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H---HH---HH--------------HhhhccCC
Confidence 6999999999987 567889999999999999999999974 1 00 00 00111122
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 523 ELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 523 ~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
+.+.......++..++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 33455666778888888888888655
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.6e-18 Score=162.40 Aligned_cols=160 Identities=21% Similarity=0.218 Sum_probs=110.1
Q ss_pred CChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec--CCC--CEEEeecccceeccC-----CCceeeeecccc
Q 047195 376 LKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD--EKL--DAKISDFGLSRLALN-----GASHVTTFAQGT 446 (559)
Q Consensus 376 l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~--~~~--~~kl~DFG~a~~~~~-----~~~~~~~~~~gt 446 (559)
.+.....-++.|+++|+.||| .++|.|||+|++|||+. +|+ .+.|+|||.+-.... .........-|.
T Consensus 338 ~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGN 414 (598)
T KOG4158|consen 338 RSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGN 414 (598)
T ss_pred CchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCc
Confidence 455566678899999999999 89999999999999993 443 579999998753221 011111122367
Q ss_pred CCccCccccccCCC------CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCC
Q 047195 447 LGYLDPEYYINFQL------TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGAS 520 (559)
Q Consensus 447 ~~y~aPE~~~~~~~------~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 520 (559)
...||||+....+- -.|+|.|+.|.+.||+++...||..... ...+... +.+.++ |.+
T Consensus 415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~-----Yqe~qL-----Pal----- 478 (598)
T KOG4158|consen 415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT-----YQESQL-----PAL----- 478 (598)
T ss_pred ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh-----hhhhhC-----CCC-----
Confidence 78899999865431 2489999999999999999999975321 1111111 122221 111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 521 EIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 521 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
+..+...+.+|+...|+.||.+||+..-....|+
T Consensus 479 --p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 479 --PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred --cccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 2234466788999999999999999876666554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-18 Score=180.10 Aligned_cols=209 Identities=25% Similarity=0.296 Sum_probs=145.5
Q ss_pred hCCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCceEEeeCCCCcHhHhHhhccC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLFMSMSPNGTLFDRLHRVQS 370 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~g~L~~~l~~~~~ 370 (559)
.++|+.++.|..|+||.||..+++. .+.+|+|+-+. ..+++- |+.....|.+| |+-...+...
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq------~lilRn--ilt~a~npfvv------gDc~tllk~~-- 145 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ------NLILRN--ILTFAGNPFVV------GDCATLLKNI-- 145 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc------chhhhc--cccccCCccee------chhhhhcccC--
Confidence 4689999999999999999998654 45677743221 111111 55555666655 3333333221
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc-------------
Q 047195 371 GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS------------- 437 (559)
Q Consensus 371 ~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~------------- 437 (559)
.+++.. ++.+++||| +-+|+|||+||+|.||..-|++|+.|||+.+.......
T Consensus 146 ---g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~ 211 (1205)
T KOG0606|consen 146 ---GPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTH 211 (1205)
T ss_pred ---CCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHH
Confidence 123322 278999999 88899999999999999999999999999876432111
Q ss_pred ee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 438 HV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 438 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
+. ...+.||+.|+|||++....|...+|+|++|+|+||.+-|..||.++.+++.........-.|-
T Consensus 212 Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp------------- 278 (1205)
T KOG0606|consen 212 EFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP------------- 278 (1205)
T ss_pred HhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc-------------
Confidence 11 1224599999999999999999999999999999999999999988766543222221111111
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCC
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPS 547 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt 547 (559)
+.......+..+++.+.|+.+|.+|--
T Consensus 279 ----E~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 279 ----EEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ----ccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 111233466788899999999999953
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3e-18 Score=171.97 Aligned_cols=123 Identities=34% Similarity=0.480 Sum_probs=104.2
Q ss_pred CCceEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 348 HRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 348 h~niv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
+.+|.|+++...+|.++|.+.... ...++...+.++.|++.|++| ++.+|+|+||.||+...+.++||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 456788889999999999754433 356778889999999999999 579999999999999999999999999
Q ss_pred cceeccCCC-----ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh
Q 047195 428 LSRLALNGA-----SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478 (559)
Q Consensus 428 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t 478 (559)
+........ ....+...||..||+||++.+..|+.|+||||||++|+||+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 988766544 112233459999999999999999999999999999999997
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=152.77 Aligned_cols=130 Identities=18% Similarity=0.104 Sum_probs=103.5
Q ss_pred CCCCCCccccCCccEEEEEE--ecCCcEEEEEEeecCCCCC------------------------hhhHHHHHHHHHhcC
Q 047195 294 NFSTGNLLGSGGFGEVFKAI--LDDETITAVKRAKLGNTKG------------------------IDPILNEVRILCQLN 347 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~--~~~~~~~avk~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 347 (559)
.|.+.+.||+|++|.||+|. ..+++.||+|.+....... ...+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48888999999999999998 5689999999987543110 012568999999886
Q ss_pred CC-------------ceEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC-eEECCCCCCCe
Q 047195 348 HR-------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP-IYHRDIKSSNI 413 (559)
Q Consensus 348 h~-------------niv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-iiH~Dikp~Ni 413 (559)
+. .+||||+++.+|....... ..+.......++.|++.++.+|| .++ |+||||||+||
T Consensus 109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEecCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 42 2789999988876543221 13455667899999999999999 888 99999999999
Q ss_pred eecCCCCEEEeecccceec
Q 047195 414 LLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 414 ll~~~~~~kl~DFG~a~~~ 432 (559)
|++ ++.++|+|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 789999999998643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=162.60 Aligned_cols=192 Identities=28% Similarity=0.444 Sum_probs=138.1
Q ss_pred eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCe-EECCCCCCCeeecCCCCEEEeecccc
Q 047195 351 LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI-YHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 351 iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i-iH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
+|.+|+..|+|.|.+.... ..+++.....+.++++.||+||| ..+| .|+.+++.|.++|....+||+|||+.
T Consensus 24 ~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~ 96 (484)
T KOG1023|consen 24 VIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKSSNCLVDSRWVLKLTDFGLN 96 (484)
T ss_pred EEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeeccccceeeeeEEEEechhhhc
Confidence 3679999999999997622 35889999999999999999999 4444 99999999999999999999999998
Q ss_pred eeccCC-CceeeeeccccCCccCccccccC-------CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 430 RLALNG-ASHVTTFAQGTLGYLDPEYYINF-------QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 430 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
...... .........-..-|.|||.+... ..+.+.||||||++++|+++++.||+.........-+ +...
T Consensus 97 ~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~ei--i~~~ 174 (484)
T KOG1023|consen 97 SLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEI--ILRV 174 (484)
T ss_pred ccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHH--HHHH
Confidence 766421 11111111245579999998763 1467899999999999999999999865444332111 1111
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. . .......|.+... .+....+..++.+||..+|++||++..|-..++.+
T Consensus 175 ~-~-~~~~~~rP~i~~~-----~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 175 K-K-GGSNPFRPSIELL-----NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred H-h-cCCCCcCcchhhh-----hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 1 1 0111111222110 13334788999999999999999999998888764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.7e-16 Score=144.44 Aligned_cols=127 Identities=22% Similarity=0.181 Sum_probs=101.6
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCC----------------------ChhhHHHHHHHHHhcCCCc
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK----------------------GIDPILNEVRILCQLNHRS 350 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n 350 (559)
..|.+.+.||+|+||.||++...+++.+|||++...... ....+.+|..++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 347888999999999999999888999999987643210 0113677888888886652
Q ss_pred -------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC
Q 047195 351 -------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE 417 (559)
Q Consensus 351 -------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~ 417 (559)
++|||+++++|...... .....++.+++.++.++| ..+|+||||||+||++++
T Consensus 95 i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 95 FPVPKPIDWNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCCceeecCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcC
Confidence 58899999888654321 234678899999999999 788999999999999999
Q ss_pred CCCEEEeecccceecc
Q 047195 418 KLDAKISDFGLSRLAL 433 (559)
Q Consensus 418 ~~~~kl~DFG~a~~~~ 433 (559)
++.++|+|||++....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.7e-16 Score=143.38 Aligned_cols=121 Identities=18% Similarity=0.228 Sum_probs=90.5
Q ss_pred CCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-----CCCce-------------------
Q 047195 296 STGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQL-----NHRSL------------------- 351 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni------------------- 351 (559)
.-.+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 433333479988765555567899999999999 56885
Q ss_pred EEee--CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHH-HHHHHcCCCCeEECCCCCCCeeecC----CCCEEEe
Q 047195 352 FMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI-AYLHLLATPPIYHRDIKSSNILLDE----KLDAKIS 424 (559)
Q Consensus 352 v~~~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~iiH~Dikp~Nill~~----~~~~kl~ 424 (559)
|++| ..+++|.+++... .+++. ..++.|++.++ +||| +++|+||||||+|||++. +..++|+
T Consensus 83 I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 3566 4467888888542 24444 35577777777 9999 888999999999999974 3479999
Q ss_pred ecccc
Q 047195 425 DFGLS 429 (559)
Q Consensus 425 DFG~a 429 (559)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.5e-15 Score=139.76 Aligned_cols=119 Identities=20% Similarity=0.309 Sum_probs=97.5
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCCCC--------hhhHHHHHHHHHhcCCCc---------------eEEee
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG--------IDPILNEVRILCQLNHRS---------------LFMSM 355 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~--------~~~~~~E~~~l~~l~h~n---------------iv~~~ 355 (559)
+.||+|++|.||+|.. .+..+++|+........ ...+.+|++++..+.|++ ++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 56678888765432211 235788999999988765 47899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
+++++|.+.+... .. .+..++.+++.+|.+|| +.+++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888542 12 77899999999999999 88899999999999999 78899999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-14 Score=136.52 Aligned_cols=115 Identities=20% Similarity=0.289 Sum_probs=92.9
Q ss_pred ccccCCccEEEEEEecCCcEEEEEEeecCCCC--------ChhhHHHHHHHHHhcCCCc---------------eEEeeC
Q 047195 300 LLGSGGFGEVFKAILDDETITAVKRAKLGNTK--------GIDPILNEVRILCQLNHRS---------------LFMSMS 356 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~--------~~~~~~~E~~~l~~l~h~n---------------iv~~~~ 356 (559)
.||+|++|.||+|.+ ++..+++|........ ....+.+|++++..+.|++ ++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 4677888885543211 1245778999999987654 578999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
++++|.+.+.... . .++.+++.+|.+|| +.+++|+|++|.|||++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988764311 0 78999999999999 88899999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.5e-15 Score=157.32 Aligned_cols=122 Identities=21% Similarity=0.305 Sum_probs=95.4
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecC-CC------CChhhHHHHHHHHHhcCCCc---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLG-NT------KGIDPILNEVRILCQLNHRS--------------- 350 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~-~~------~~~~~~~~E~~~l~~l~h~n--------------- 350 (559)
..|...+.||+|+||+||++.+.+...++.++.... .. ...+.+.+|++++++++|++
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 445677899999999999998765543332222211 11 11245889999999999876
Q ss_pred eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 351 LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 351 iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
+||||+++++|.+.+. ....++.+++++|.||| +.+++||||||+|||+ +++.++|+|||+++
T Consensus 413 lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 4789999999988774 24678999999999999 8889999999999999 67789999999987
Q ss_pred e
Q 047195 431 L 431 (559)
Q Consensus 431 ~ 431 (559)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=134.28 Aligned_cols=125 Identities=25% Similarity=0.241 Sum_probs=92.3
Q ss_pred CCccccCCccEEEEEEecCCcEEEEEEeecCCCC--ChhhH----------------------HHHHHHHHhcCC-----
Q 047195 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK--GIDPI----------------------LNEVRILCQLNH----- 348 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h----- 348 (559)
.+.||+|+||+||+|...+++.+|||+....... ..... ..|...+.++.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5789999999999999888999999987653221 11111 356666655533
Q ss_pred --------CceEEeeCCCCcHhH-hHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCC-CCeEECCCCCCCeeecCC
Q 047195 349 --------RSLFMSMSPNGTLFD-RLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT-PPIYHRDIKSSNILLDEK 418 (559)
Q Consensus 349 --------~niv~~~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~Dikp~Nill~~~ 418 (559)
..+|++|.+++.+.. .+.... .. .....++.+++.++.++| . ++|+|+||||+||+++ +
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 237899999865432 121110 11 567789999999999999 6 8899999999999999 8
Q ss_pred CCEEEeecccceecc
Q 047195 419 LDAKISDFGLSRLAL 433 (559)
Q Consensus 419 ~~~kl~DFG~a~~~~ 433 (559)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.4e-13 Score=127.46 Aligned_cols=119 Identities=24% Similarity=0.319 Sum_probs=91.4
Q ss_pred Cccc-cCCccEEEEEEecCCcEEEEEEeecCC-------------CCChhhHHHHHHHHHhcCCCc--------------
Q 047195 299 NLLG-SGGFGEVFKAILDDETITAVKRAKLGN-------------TKGIDPILNEVRILCQLNHRS-------------- 350 (559)
Q Consensus 299 ~~lG-~G~~g~Vy~~~~~~~~~~avk~~~~~~-------------~~~~~~~~~E~~~l~~l~h~n-------------- 350 (559)
..|| .||.|+||++... +..++||+..... ......+.+|++++.+|.|++
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4587 7888999998765 5677888764311 122346789999999998754
Q ss_pred -------eEEeeCCC-CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEE
Q 047195 351 -------LFMSMSPN-GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAK 422 (559)
Q Consensus 351 -------iv~~~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~k 422 (559)
+|++++++ .+|.+++... .++. ..+.+++.+|.+|| ..+|+||||||.|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~----~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSE----EQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCH----HHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEE
Confidence 57788886 5787776431 2343 24678999999999 88999999999999999988999
Q ss_pred Eeeccccee
Q 047195 423 ISDFGLSRL 431 (559)
Q Consensus 423 l~DFG~a~~ 431 (559)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.1e-13 Score=116.99 Aligned_cols=120 Identities=26% Similarity=0.219 Sum_probs=93.1
Q ss_pred CCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC--c---------------eEEeeCCCC
Q 047195 297 TGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR--S---------------LFMSMSPNG 359 (559)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~--n---------------iv~~~~~~g 359 (559)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.+.|. . ++++|++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999998765 6788998765433 46789999999999763 2 233444333
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
.+. .++......++.++++++++||.....+++|+|++|.|||+++.+.++++|||.+..
T Consensus 79 ~~~------------~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLD------------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecc------------cCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 332 124566778899999999999965556899999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.6e-14 Score=153.57 Aligned_cols=240 Identities=28% Similarity=0.311 Sum_probs=168.7
Q ss_pred hCCCCCCCccccCCccEEEEEEec--CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcC-CCce---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD--DETITAVKRAKLGN--TKGIDPILNEVRILCQLN-HRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni--------------- 351 (559)
...|.+.+.||+|+|+.|-..... ....+|+|.+.... ......+..|..+-+.+. |+|+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 346788888999999999887743 34556666655443 222344556777777777 8885
Q ss_pred EEeeCCCCcHhHhH-hhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeecccc
Q 047195 352 FMSMSPNGTLFDRL-HRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDFGLS 429 (559)
Q Consensus 352 v~~~~~~g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DFG~a 429 (559)
+.++..++++++.+ +... ...+...+-..+.|+..++.|+|. ..++.|+||||+|.+++..+ .+|++|||+|
T Consensus 99 ~~~~s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred ccCcccccccccccccCCc----cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhh
Confidence 34777788887777 3221 135556677899999999999995 56799999999999999999 9999999999
Q ss_pred eeccC--CCceeeeeccc-cCCccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 430 RLALN--GASHVTTFAQG-TLGYLDPEYYINFQ-LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 430 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
..+.. +.........| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+......... ...|.... .
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~ 248 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---G 248 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---c
Confidence 88765 33333444568 99999999988854 456889999999999999999999866543311 11111100 0
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl 552 (559)
..... . . .........++.+++..+|..|.+.+++.
T Consensus 249 ~~~~~----~---~----~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 RFTQL----P---W----NSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccC----c---c----ccCChhhhhcccccccCCchhcccccccc
Confidence 00000 0 0 12224456677788889999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.7e-12 Score=130.87 Aligned_cols=130 Identities=22% Similarity=0.212 Sum_probs=94.6
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCCh---------------------------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGI--------------------------------------- 333 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~--------------------------------------- 333 (559)
..|+ .+.||.|++|.||+|++++|+.||||+.+....+..
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 368999999999999999999999999765321100
Q ss_pred -hhHHHHHHHHHhcC-----CCc---------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHH-H
Q 047195 334 -DPILNEVRILCQLN-----HRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ-A 391 (559)
Q Consensus 334 -~~~~~E~~~l~~l~-----h~n---------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~ 391 (559)
-+|.+|++.+.++. +++ |||||+++++|.+....... .. ....++.+++. .
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~ 269 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSF 269 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHH
Confidence 02455666555552 121 68999999999887653211 11 23456666665 3
Q ss_pred HHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 392 l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+..+| ..+++|+|++|.||++++++.++|+|||++....
T Consensus 270 l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 270 LNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 56777 7899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.5e-10 Score=103.83 Aligned_cols=116 Identities=16% Similarity=0.087 Sum_probs=84.3
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC--------------ceEEeeCCCCcHhHh
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR--------------SLFMSMSPNGTLFDR 364 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~--------------niv~~~~~~g~L~~~ 364 (559)
+.|+.|.++.||++... +..+++|....... ....+.+|+++++.+.+. .+||||+++.++...
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 56899999999999865 66789998654432 224568899999887542 256777777665432
Q ss_pred HhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC--CCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 365 LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA--TPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 365 l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
......++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 82 -------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 82 -------------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred -------------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 0112346778999999999432 12259999999999999 5689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-10 Score=122.19 Aligned_cols=133 Identities=17% Similarity=0.145 Sum_probs=88.1
Q ss_pred HhCCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCCCC----------------------------------h--
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTKG----------------------------------I-- 333 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~~----------------------------------~-- 333 (559)
....|+. +.||.|++|.||+|++++ |+.||||+.+..-.+. .
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999887 9999999986431100 0
Q ss_pred ----hhHHHHHHHHHhcC----CC----------------ceEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHH
Q 047195 334 ----DPILNEVRILCQLN----HR----------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTA 389 (559)
Q Consensus 334 ----~~~~~E~~~l~~l~----h~----------------niv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~ 389 (559)
-++.+|+..+.++. +. -|||||+.|+.+.+.......+ .+ ...++...+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g----~d---~~~la~~~v 269 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG----TD---MKLLAERGV 269 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC----CC---HHHHHHHHH
Confidence 12455555555542 11 1789999999997743211111 11 112222222
Q ss_pred HHHHHHHHcCCCCeEECCCCCCCeeecCCC----CEEEeecccceecc
Q 047195 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKL----DAKISDFGLSRLAL 433 (559)
Q Consensus 390 ~~l~yLH~~~~~~iiH~Dikp~Nill~~~~----~~kl~DFG~a~~~~ 433 (559)
.. |+++....+++|+|+||.||+++.++ .++++|||++....
T Consensus 270 ~~--~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 270 EV--FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HH--HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 21 23333367899999999999999888 99999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.9e-10 Score=118.52 Aligned_cols=233 Identities=21% Similarity=0.237 Sum_probs=152.9
Q ss_pred CCCCCCcccc--CCccEEEEEEe---cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhc-CCCceEE------------
Q 047195 294 NFSTGNLLGS--GGFGEVFKAIL---DDETITAVKRAKLGNT--KGIDPILNEVRILCQL-NHRSLFM------------ 353 (559)
Q Consensus 294 ~y~~~~~lG~--G~~g~Vy~~~~---~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~------------ 353 (559)
.|.+.+.+|. |.+|.||.+.. .+...+|+|+-+..-. .....=.+|+.....+ .|+|.|.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999885 5678889988443322 2222234555554444 3666554
Q ss_pred --eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHH----HHHHHHHcCCCCeEECCCCCCCeeecCC-CCEEEeec
Q 047195 354 --SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ----AIAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDF 426 (559)
Q Consensus 354 --~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~iiH~Dikp~Nill~~~-~~~kl~DF 426 (559)
....+.+|..+.+... ..++......++.+..+ ||.++| +.+++|-|+||.||++..+ ...++.||
T Consensus 195 iqtE~~~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeccccchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence 2223344444443322 23566667777777777 999999 8899999999999999999 78999999
Q ss_pred ccceeccCCCce----eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 047195 427 GLSRLALNGASH----VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502 (559)
Q Consensus 427 G~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 502 (559)
|+...+....-. ......|...|++||...+ .++.+.|||++|.++++..++..+....-... |..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~--- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQ--- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccc---
Confidence 999877654311 1122258888999998654 67889999999999999999877654221111 000
Q ss_pred hcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 503 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
++... +..++. .....++..++..|++.+|..|++.+.+..
T Consensus 338 ----~r~~~---ip~e~~---~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ----LRQGY---IPLEFC---EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----ccccc---Cchhhh---cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000 000000 011233444888899999999999988754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-09 Score=99.58 Aligned_cols=126 Identities=18% Similarity=0.109 Sum_probs=90.2
Q ss_pred CCccccCCccEEEEEEecC-------CcEEEEEEeecCCC----------------------CChhhH----HHHHHHHH
Q 047195 298 GNLLGSGGFGEVFKAILDD-------ETITAVKRAKLGNT----------------------KGIDPI----LNEVRILC 344 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~-------~~~~avk~~~~~~~----------------------~~~~~~----~~E~~~l~ 344 (559)
...||.|--+.||.|...+ +..+|||+.+.... .....+ .+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 47899998653210 001122 38999998
Q ss_pred hcCCC-------------ceEEeeCCCCcHhH-hHhhccCCCCCCCChHHHHHHHHHHHHHHHHH-HHcCCCCeEECCCC
Q 047195 345 QLNHR-------------SLFMSMSPNGTLFD-RLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL-HLLATPPIYHRDIK 409 (559)
Q Consensus 345 ~l~h~-------------niv~~~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiH~Dik 409 (559)
++... -|||||..+..+.. .+.. ..++......+..+++.+|..| | ..+|+|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 87432 27899997654322 2221 1244456677889999999999 7 7789999999
Q ss_pred CCCeeecCCCCEEEeecccceecc
Q 047195 410 SSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 410 p~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+.|||+++ +.+.|+|||.+-...
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCC
Confidence 99999974 679999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-09 Score=103.91 Aligned_cols=178 Identities=20% Similarity=0.266 Sum_probs=117.3
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
+.+|+.-|++..+|++... ....+......+++-||+.||.|||+. ..+|+|+++..+-|++..++-+|+.----...
T Consensus 150 iteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~ 227 (458)
T KOG1266|consen 150 ITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDST 227 (458)
T ss_pred EEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCcccc
Confidence 5699999999999987653 335677888899999999999999975 68999999999999999998887742111100
Q ss_pred c--cCCC-ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 432 A--LNGA-SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 432 ~--~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
. .... ........+-++|.|||.=.....+.++|||+||+-.+||..+........ ..........+.. .
T Consensus 228 h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnse--S~~~~ee~ia~~i-----~ 300 (458)
T KOG1266|consen 228 HPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSE--SKVEVEENIANVI-----I 300 (458)
T ss_pred chhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCc--ceeehhhhhhhhe-----e
Confidence 0 0000 000111226789999998555566779999999999999988765422111 1100000011000 0
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..-++ .=..++..|++..|..||+|.+++.
T Consensus 301 ~len~---------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 301 GLENG---------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eccCc---------------cccCcCcccccCCCCCCcchhhhhc
Confidence 00000 0123566799999999999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.8e-10 Score=114.48 Aligned_cols=242 Identities=21% Similarity=0.236 Sum_probs=155.9
Q ss_pred ccccChHH-HHHHhCCCCCCCccccCCccEEEEEEe--cCCcEEEEEEeecCCCCChhh--HHHHHHHHHhc----CCCc
Q 047195 280 ARIFSSRE-ITEATNNFSTGNLLGSGGFGEVFKAIL--DDETITAVKRAKLGNTKGIDP--ILNEVRILCQL----NHRS 350 (559)
Q Consensus 280 ~~~~~~~~-~~~~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~~avk~~~~~~~~~~~~--~~~E~~~l~~l----~h~n 350 (559)
..+|...+ ......+|.....||.|.|+.|++... .++..+++|.+........++ -+.|+-+...+ .+.+
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 34444444 333446789999999999999998764 467889998876543322222 12333333333 2222
Q ss_pred ------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC
Q 047195 351 ------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418 (559)
Q Consensus 351 ------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~ 418 (559)
|--||+.++++....... ..+.+..++++..|++.++.++| +..++|+|+||+||++..+
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~ 402 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISND 402 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccc
Confidence 223667777665544221 24677778899999999999999 8889999999999999886
Q ss_pred -CCEEEeecccceeccCCCceeeeeccccCCcc--CccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHH
Q 047195 419 -LDAKISDFGLSRLALNGASHVTTFAQGTLGYL--DPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495 (559)
Q Consensus 419 -~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~ 495 (559)
+.-++.|||.++.+.- ...... +..+++ +|+......+..+.|++|||.-+.|.+++.........-
T Consensus 403 ~~~~~~~~~~~~t~~~~---~~~~~~-~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~------ 472 (524)
T KOG0601|consen 403 GFFSKLGDFGCWTRLAF---SSGVFH-HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS------ 472 (524)
T ss_pred hhhhhccccccccccce---eccccc-ccccccccchhhccccccccccccccccccccccccCcccCcccccc------
Confidence 7789999999864211 111112 333344 555555667888999999999999999988754311100
Q ss_pred HHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047195 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556 (559)
Q Consensus 496 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~ 556 (559)
.....+. + .........+..+...++..++..||.+.++....+
T Consensus 473 ----~~i~~~~--------~-----p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 473 ----LTIRSGD--------T-----PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----eeeeccc--------c-----cCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0000110 0 000112255666777799999999999988866543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-08 Score=88.12 Aligned_cols=116 Identities=23% Similarity=0.317 Sum_probs=86.8
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEee-cC-CCCC------hhhHHHHHHHHHhcCC-------------Cc--eEEee
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAK-LG-NTKG------IDPILNEVRILCQLNH-------------RS--LFMSM 355 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~-~~-~~~~------~~~~~~E~~~l~~l~h-------------~n--iv~~~ 355 (559)
..+++|+-+.+|.+.+.+.. +++|.-. +. .... ...-.+|++++.++.- .| |+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999765433 4455422 11 1111 2346789999988732 23 79999
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
.++..|.+.+... ...++..+-..+.-|| ..+|+|+||.++||++.... +.++||||+..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888753 2467778888889999 89999999999999998775 99999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.3e-08 Score=104.38 Aligned_cols=161 Identities=18% Similarity=0.136 Sum_probs=108.4
Q ss_pred ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCceEEee---CCCCcHhHhHhhccCCC--CCCCChHHHHHHHHHH
Q 047195 314 LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLFMSM---SPNGTLFDRLHRVQSGN--WPPLKWHHRLHIARQT 388 (559)
Q Consensus 314 ~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~---~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~i 388 (559)
..++..+.|...+..+....+...+-++.|+.++||||+..+ ...+.+|-.-++...-. ...+....+...+.||
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qI 113 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQI 113 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHHH
Confidence 557788888888776665556788999999999999986533 23343433333221100 0112344556678899
Q ss_pred HHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhH
Q 047195 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYS 468 (559)
Q Consensus 389 ~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 468 (559)
+.||.+||. ..+++|++|.-+.|+++..|..||++|-++.....-.. ......---.|..|+.+.... ...|.|-
T Consensus 114 l~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~ 188 (690)
T KOG1243|consen 114 LAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWG 188 (690)
T ss_pred HHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhh
Confidence 999999984 66899999999999999999999999988754332111 001111122356666542222 3469999
Q ss_pred HHHHHHHHHhC
Q 047195 469 FGVVLVELLTS 479 (559)
Q Consensus 469 lG~il~el~tg 479 (559)
||++++|++.|
T Consensus 189 Lg~li~el~ng 199 (690)
T KOG1243|consen 189 LGCLIEELFNG 199 (690)
T ss_pred HHHHHHHHhCc
Confidence 99999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-09 Score=118.47 Aligned_cols=234 Identities=22% Similarity=0.200 Sum_probs=149.9
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCC---------------ce
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHR---------------SL 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~---------------ni 351 (559)
..+.+.+.+-+-.|+++.++.+.- ..+...++|...... ....+....+-.++-...+| +|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 345677788889999999998762 223333343332221 11122223333332212222 25
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
+++|..+++|...|+... .............+.++++||| +..+.|+|++|.|+|...+++.+++|||....
T Consensus 882 ~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccc
Confidence 677778888888877643 2444445566667889999999 66799999999999999999999999984322
Q ss_pred cc-C------------------------CCc-----eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCC
Q 047195 432 AL-N------------------------GAS-----HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK 481 (559)
Q Consensus 432 ~~-~------------------------~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~ 481 (559)
.. . ... .......+|+.|.|||.+.+......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 10 0 000 01122348999999999999999999999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 482 AVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 482 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
||.....+.. +.+. +...+ .....+.+.......++...+..+|.+|-.|.
T Consensus 1034 p~na~tpq~~------f~ni---------~~~~~--~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI------FENI---------LNRDI--PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhh------hhcc---------ccCCC--CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9975443221 1111 10000 11111223335566677778888999997765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.4e-08 Score=88.57 Aligned_cols=114 Identities=28% Similarity=0.295 Sum_probs=76.5
Q ss_pred EEEEEEecCCcEEEEEEeecCCC-------------C---------C----hhhHHHHHHHHHhcCCCc-----------
Q 047195 308 EVFKAILDDETITAVKRAKLGNT-------------K---------G----IDPILNEVRILCQLNHRS----------- 350 (559)
Q Consensus 308 ~Vy~~~~~~~~~~avk~~~~~~~-------------~---------~----~~~~~~E~~~l~~l~h~n----------- 350 (559)
.||.|...++..+|||..+.... . . .....+|.+.|.++....
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 38999998999999999764211 0 0 123678999999986532
Q ss_pred --eEEeeCC--CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHH-HHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 351 --LFMSMSP--NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY-LHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 351 --iv~~~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~y-LH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
|||||.+ +..+.. +.... +.......++.+++..+.. +| ..+|+|+||.+.|||++++ .+.|+|
T Consensus 81 ~~ivME~I~~~G~~~~~-l~~~~------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPR-LKDVD------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp TEEEEE--EETTEEGGC-HHHCG------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred CEEEEEecCCCccchhh-HHhcc------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 6899998 544433 33221 1234456777888885555 57 8899999999999999988 899999
Q ss_pred cccceec
Q 047195 426 FGLSRLA 432 (559)
Q Consensus 426 FG~a~~~ 432 (559)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.4e-07 Score=91.54 Aligned_cols=178 Identities=19% Similarity=0.208 Sum_probs=115.6
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCcc
Q 047195 371 GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL 450 (559)
Q Consensus 371 ~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~ 450 (559)
.+.+...|...+++++.++.+.+-|| ..|.+-+|+.++|+|+++++.+.|.|=..-....++ ......+|...|.
T Consensus 109 qs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng--~~~~cpVg~~eft 183 (637)
T COG4248 109 QSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG--TLHLCPVGVSEFT 183 (637)
T ss_pred ccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeeccCC--ceEecccCccccC
Confidence 34556899999999999999999999 788999999999999999999999985543333222 2233445899999
Q ss_pred Cccccc-----cCCCCcccchhHHHHHHHHHHhC-CCCCCCCCcccccc--HH---HHHHHHhhcchhhhccccccccCC
Q 047195 451 DPEYYI-----NFQLTDKSDVYSFGVVLVELLTS-KKAVDFNREEEDVN--LV---VYFGNILKQERLVDAIDPMLKEGA 519 (559)
Q Consensus 451 aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg-~~p~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~d~~l~~~~ 519 (559)
+||... +..-+..+|.|.||+++++|+.| ++||.+........ .. ....-.+.+..-....-+...-.+
T Consensus 184 PPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~ 263 (637)
T COG4248 184 PPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPL 263 (637)
T ss_pred CHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCCh
Confidence 999754 34567789999999999999887 88997543221110 00 000000001110111111111111
Q ss_pred ChhhHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHhh
Q 047195 520 SEIELDSMKAFGLLGAACLDER--RQNRPSIKEVADEIER 557 (559)
Q Consensus 520 ~~~~~~~~~~l~~l~~~cl~~~--p~~RPt~~evl~~L~~ 557 (559)
. -....+.-|..+|+..- +.-|||++-.+..|..
T Consensus 264 ~----~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 264 S----MLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred h----hcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 1 12234555666676543 5689999999887754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.3e-08 Score=85.51 Aligned_cols=128 Identities=22% Similarity=0.269 Sum_probs=88.9
Q ss_pred CCCccccCCccEEEEEEecCCcEEEEEE-eecC-------CCCChhhHHHHHHHHHhcCC---------------CceEE
Q 047195 297 TGNLLGSGGFGEVFKAILDDETITAVKR-AKLG-------NTKGIDPILNEVRILCQLNH---------------RSLFM 353 (559)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~~~~~avk~-~~~~-------~~~~~~~~~~E~~~l~~l~h---------------~niv~ 353 (559)
....|-||+-+.|+++.+.. +...||. .... ..-...+..+|++.|.++.- .-|+|
T Consensus 11 ~l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 56789999999999998764 4445554 2221 11123456789999887631 12789
Q ss_pred eeCCC-CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC---CEEEeecccc
Q 047195 354 SMSPN-GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL---DAKISDFGLS 429 (559)
Q Consensus 354 ~~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~---~~kl~DFG~a 429 (559)
||.++ .++.+++...... .........++..|-+.+.-|| .++|||+||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecch
Confidence 99977 3566666543221 1222233678889999999999 88999999999999996554 3589999997
Q ss_pred ee
Q 047195 430 RL 431 (559)
Q Consensus 430 ~~ 431 (559)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 53
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.2e-08 Score=92.00 Aligned_cols=127 Identities=24% Similarity=0.314 Sum_probs=92.8
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCc--------------------eEEeeCC
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRS--------------------LFMSMSP 357 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~n--------------------iv~~~~~ 357 (559)
+.|+.|..+.||++...++..+++|....... .....+.+|+++++.+.+.. +|++|++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778899998755432 23467899999999885421 4566666
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA-------------------------------------- 399 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------------------------------------- 399 (559)
+.++.+.+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 6655443321 13566667777888888888887421
Q ss_pred ---------------CCCeEECCCCCCCeeecC--CCCEEEeeccccee
Q 047195 400 ---------------TPPIYHRDIKSSNILLDE--KLDAKISDFGLSRL 431 (559)
Q Consensus 400 ---------------~~~iiH~Dikp~Nill~~--~~~~kl~DFG~a~~ 431 (559)
...++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=8.3e-09 Score=107.97 Aligned_cols=151 Identities=19% Similarity=0.260 Sum_probs=102.7
Q ss_pred HHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc--------eeeeeccccCCccCccccc
Q 047195 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS--------HVTTFAQGTLGYLDPEYYI 456 (559)
Q Consensus 385 ~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~--------~~~~~~~gt~~y~aPE~~~ 456 (559)
+.+++.|+.|+|. +.++||++|.|++|.++..+..||+.|+.+-....... ......+....|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999995 67899999999999999999999999998754332111 1111223677899999999
Q ss_pred cCCCCcccchhHHHHHHHHHH-hCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHH
Q 047195 457 NFQLTDKSDVYSFGVVLVELL-TSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGA 535 (559)
Q Consensus 457 ~~~~~~~~Dv~SlG~il~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~ 535 (559)
....+.++|+||+|+++|.+. .|+.-+............. ...+-..... ..+.+.++.+=+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~------------~~~~~~~~~~----s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR------------NLLNAGAFGY----SNNLPSELRESLK 246 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh------------cccccccccc----cccCcHHHHHHHH
Confidence 888899999999999999999 4555444332221111100 0001011111 1234466667778
Q ss_pred HhcccCCCCCCCHHHHHH
Q 047195 536 ACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 536 ~cl~~~p~~RPt~~evl~ 553 (559)
+++..++.-||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 899999999998877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.2e-07 Score=85.66 Aligned_cols=125 Identities=22% Similarity=0.199 Sum_probs=91.7
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCC----------------------ChhhHHHHHHHHHhcCCC--
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK----------------------GIDPILNEVRILCQLNHR-- 349 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~-- 349 (559)
-..++.+||-|--+.||.|...++..+|||.-+..... ......+|.++|++|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35667899999999999999999999999986543111 122467999999998532
Q ss_pred -----------ceEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC
Q 047195 350 -----------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418 (559)
Q Consensus 350 -----------niv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~ 418 (559)
-+|||+.++-.|+..- ++......++..|++-+.-+- ..||||+|+.+-|||++++
T Consensus 172 ~VP~P~~~nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIAWNRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCccccccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence 2799999886664322 122333445555555555555 5679999999999999999
Q ss_pred CCEEEeeccccee
Q 047195 419 LDAKISDFGLSRL 431 (559)
Q Consensus 419 ~~~kl~DFG~a~~ 431 (559)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999977653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.9e-06 Score=83.78 Aligned_cols=119 Identities=15% Similarity=0.081 Sum_probs=84.5
Q ss_pred CccEEEEEEecCCcEEEEEEeecCCC-----------CChhhHHHHHHHHHhcCCC----------------------ce
Q 047195 305 GFGEVFKAILDDETITAVKRAKLGNT-----------KGIDPILNEVRILCQLNHR----------------------SL 351 (559)
Q Consensus 305 ~~g~Vy~~~~~~~~~~avk~~~~~~~-----------~~~~~~~~E~~~l~~l~h~----------------------ni 351 (559)
....|.+..+ +|+.+.||+...... .....+.+|...+.++... .|
T Consensus 34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 3344666655 456788886533221 1112477888888877321 16
Q ss_pred EEeeCCCC-cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-------CCCEEE
Q 047195 352 FMSMSPNG-TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-------KLDAKI 423 (559)
Q Consensus 352 v~~~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-------~~~~kl 423 (559)
|+|++++. +|.+++..... .+.....+..++.+++..+.-|| ..+|+|+|+++.|||++. +..+.|
T Consensus 113 Vte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred EEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 78888875 78877753211 23456677889999999999999 889999999999999975 467999
Q ss_pred eecccce
Q 047195 424 SDFGLSR 430 (559)
Q Consensus 424 ~DFG~a~ 430 (559)
+||+.+.
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999875
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.4e-06 Score=76.44 Aligned_cols=124 Identities=19% Similarity=0.119 Sum_probs=92.1
Q ss_pred cccCCccEEEEEEecCCcEEEEEEeecC------CCCChhhHHHHHHHHHhcCCCc---------------------eEE
Q 047195 301 LGSGGFGEVFKAILDDETITAVKRAKLG------NTKGIDPILNEVRILCQLNHRS---------------------LFM 353 (559)
Q Consensus 301 lG~G~~g~Vy~~~~~~~~~~avk~~~~~------~~~~~~~~~~E~~~l~~l~h~n---------------------iv~ 353 (559)
-|+||-+.|++....+. .+-+|+-... .+.....|.+|...|.+|.... ||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46789999999776554 5778875411 1335567999999999985432 455
Q ss_pred eeCC-CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC--EEEeecccce
Q 047195 354 SMSP-NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD--AKISDFGLSR 430 (559)
Q Consensus 354 ~~~~-~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~--~kl~DFG~a~ 430 (559)
+-+. -.+|.+.+... ...+.+...+..++.+++.++.-|| ..++.|+|+.+.|||++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 5443 35677776442 2234677778899999999999999 889999999999999986666 9999997665
Q ss_pred e
Q 047195 431 L 431 (559)
Q Consensus 431 ~ 431 (559)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.3e-05 Score=78.81 Aligned_cols=157 Identities=17% Similarity=0.162 Sum_probs=114.7
Q ss_pred CccEEEEEE-ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------------EEeeCCC-CcHhH
Q 047195 305 GFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL-------------------FMSMSPN-GTLFD 363 (559)
Q Consensus 305 ~~g~Vy~~~-~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-------------------v~~~~~~-g~L~~ 363 (559)
--.+.|++. ..||..+++|++.............-+++++++.|.|+ |++|.++ ++|++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 345789998 56889999999844333333344566889999999995 4566654 57777
Q ss_pred hHhhccCCC----------CCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 364 RLHRVQSGN----------WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 364 ~l~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
.-....... ....++...+.++.|+..||.++| +.|+.-+-|.|.+||++.+..++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 654322211 124677889999999999999999 7889889999999999999999999888876654
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCC
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKA 482 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p 482 (559)
.+.. |-+. --.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 4331 1111 12356888999999999999765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.21 E-value=6.5e-06 Score=77.23 Aligned_cols=91 Identities=31% Similarity=0.348 Sum_probs=72.0
Q ss_pred hhhHHHHHHHHHhcCCC---------------------ceEEeeCCCC-cHhHhHhhccCCCCCCCChHHHHHHHHHHHH
Q 047195 333 IDPILNEVRILCQLNHR---------------------SLFMSMSPNG-TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390 (559)
Q Consensus 333 ~~~~~~E~~~l~~l~h~---------------------niv~~~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 390 (559)
...+.+|...+.+|... .||+++.++. +|.+++..... ++......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHH
Confidence 34678888888777421 2577888774 78887765322 455667889999999
Q ss_pred HHHHHHHcCCCCeEECCCCCCCeeecCCC---CEEEeeccccee
Q 047195 391 AIAYLHLLATPPIYHRDIKSSNILLDEKL---DAKISDFGLSRL 431 (559)
Q Consensus 391 ~l~yLH~~~~~~iiH~Dikp~Nill~~~~---~~kl~DFG~a~~ 431 (559)
.+.-|| ..+|+|+|+++.|||++.+. .+.|+||+-++.
T Consensus 130 ~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 88999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.5e-05 Score=83.98 Aligned_cols=131 Identities=21% Similarity=0.226 Sum_probs=86.9
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCCh---------------------------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGI--------------------------------------- 333 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~--------------------------------------- 333 (559)
..|+. +.|+.++-|.||+|++++|+.||||+.+..-.+..
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 44553 68999999999999999999999999765322110
Q ss_pred -hhHHHHHHHHHhcCC-----Cc---------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHH
Q 047195 334 -DPILNEVRILCQLNH-----RS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392 (559)
Q Consensus 334 -~~~~~E~~~l~~l~h-----~n---------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l 392 (559)
-++.+|+.-+.++.+ ++ ++|||++|-.+.+....... ..+ ...++..++++
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d---~k~ia~~~~~~- 276 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GID---RKELAELLVRA- 276 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCC---HHHHHHHHHHH-
Confidence 012334444433321 11 57899999998887533222 133 23344433333
Q ss_pred HHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 393 ~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
|+.+.-..++.|.|..|-||+++.++.+.+.|||+.....
T Consensus 277 -f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 277 -FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred -HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 2222225689999999999999999999999999976544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00016 Score=67.79 Aligned_cols=142 Identities=18% Similarity=0.126 Sum_probs=92.9
Q ss_pred cChHHHHHHhCCCCCCCc---cccCCccEEEEEEecCCcEEEEEEeecCCCCC-------------------hh-----h
Q 047195 283 FSSREITEATNNFSTGNL---LGSGGFGEVFKAILDDETITAVKRAKLGNTKG-------------------ID-----P 335 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~~~---lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~-------------------~~-----~ 335 (559)
.+.+.+....+...+... |..|--+.||+|...++..+|||+.+...... .. .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 344555555555555444 55666779999998889999999976542211 00 1
Q ss_pred HHHHHHHHHhcCC------------Cc-eEEeeCCCCc-HhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC
Q 047195 336 ILNEVRILCQLNH------------RS-LFMSMSPNGT-LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401 (559)
Q Consensus 336 ~~~E~~~l~~l~h------------~n-iv~~~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~ 401 (559)
..+|..-|+++.. .| |||||+.... -.-.|.. .++...+...+..++++.+.-|-. ..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~--~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK--EA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH--hc
Confidence 3456666666521 12 6899985431 1111111 123333566777788888777773 36
Q ss_pred CeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 402 ~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+++|+||..-|||+. ++.+.|+|||-|....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 899999999999999 8889999999886443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00018 Score=66.81 Aligned_cols=121 Identities=19% Similarity=0.164 Sum_probs=80.6
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhh---------HHHHHHHHHhcCC--------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDP---------ILNEVRILCQLNH-------------- 348 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~---------~~~E~~~l~~l~h-------------- 348 (559)
.++|.+.+++-......|.+-..+ +..+++|..........+. ..+++..+..+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 467888888888777777776554 4667788766543332221 1233333333211
Q ss_pred --------Cc-eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC
Q 047195 349 --------RS-LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL 419 (559)
Q Consensus 349 --------~n-iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~ 419 (559)
.. +++||++|..|.+... ++. .++..+.+++.-|| ..|+.|+|+.|.|+++++++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc
Confidence 11 5889999887765432 222 34556778888999 88899999999999999655
Q ss_pred CEEEeecccce
Q 047195 420 DAKISDFGLSR 430 (559)
Q Consensus 420 ~~kl~DFG~a~ 430 (559)
++++||+..+
T Consensus 173 -i~iID~~~k~ 182 (229)
T PF06176_consen 173 -IRIIDTQGKR 182 (229)
T ss_pred -EEEEECcccc
Confidence 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00016 Score=64.10 Aligned_cols=117 Identities=17% Similarity=0.137 Sum_probs=78.2
Q ss_pred CCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc------------eEEeeCCCCcHhH
Q 047195 296 STGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------------LFMSMSPNGTLFD 363 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n------------iv~~~~~~g~L~~ 363 (559)
...+.|++|.+|.||++.+.++ .+|+|+-...++. ..+..|+++|..++-.. +.|||..+-.|.+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~ 101 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhh
Confidence 4457899999999999988755 6788876654443 56889999999987644 3466666655544
Q ss_pred hHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCC-C-CCeeecCCCCEEEeeccccee
Q 047195 364 RLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIK-S-SNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 364 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dik-p-~Nill~~~~~~kl~DFG~a~~ 431 (559)
.-.. .+ .+....++++---|. ..+|-|+.|. | .||++.+ ..+.|+||..|+.
T Consensus 102 ~~~~--------~~----rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIG--------GD----RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhc--------cc----HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 3321 01 233334444433344 6679998887 4 4455544 4899999998873
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00016 Score=76.06 Aligned_cols=132 Identities=20% Similarity=0.207 Sum_probs=86.1
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCC-------------------------------------hhh
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG-------------------------------------IDP 335 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~-------------------------------------~~~ 335 (559)
..|. .+.||.-+.|.||+|++++|+.||||+-+..-.+. .-+
T Consensus 162 ~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 162 SEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred HhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 3444 36899999999999999999999999965432111 001
Q ss_pred HHHHHHHHHhc----CCCc-------------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHH
Q 047195 336 ILNEVRILCQL----NHRS-------------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392 (559)
Q Consensus 336 ~~~E~~~l~~l----~h~n-------------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l 392 (559)
|.+|++-..+. .|-+ ++|||++|..+.|.-.-... .++.. .++..+.++
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~---~i~~~l~~~- 312 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR----GISPH---DILNKLVEA- 312 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc----CCCHH---HHHHHHHHH-
Confidence 33333332222 1111 58999999988776432222 23333 444444444
Q ss_pred HHHHHcCCCCeEECCCCCCCeeecC----CCCEEEeecccceeccC
Q 047195 393 AYLHLLATPPIYHRDIKSSNILLDE----KLDAKISDFGLSRLALN 434 (559)
Q Consensus 393 ~yLH~~~~~~iiH~Dikp~Nill~~----~~~~kl~DFG~a~~~~~ 434 (559)
|++.+...|++|.|-.|-||++.. ++.+.+-|||+......
T Consensus 313 -~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 313 -YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 334444678999999999999983 67899999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00045 Score=65.69 Aligned_cols=123 Identities=18% Similarity=0.196 Sum_probs=70.2
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC-----C------------ceEEeeCCCCc-
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH-----R------------SLFMSMSPNGT- 360 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h-----~------------niv~~~~~~g~- 360 (559)
..||+|..+.||+. .+..+++|...... ......+|.++++.+.. | -+||++++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 23456677765422 33567899999987742 1 15678877753
Q ss_pred HhHh---------------------HhhccCCCCCCCChHHHH-HHHH----------HH-HHHHHHHHHcC-CCCeEEC
Q 047195 361 LFDR---------------------LHRVQSGNWPPLKWHHRL-HIAR----------QT-AQAIAYLHLLA-TPPIYHR 406 (559)
Q Consensus 361 L~~~---------------------l~~~~~~~~~~l~~~~~~-~i~~----------~i-~~~l~yLH~~~-~~~iiH~ 406 (559)
+... ++..... ........ .+.. .+ .....+|.... ...++|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 1100 1111000 11111100 0000 00 11122222221 3457899
Q ss_pred CCCCCCeeecCCCCEEEeecccce
Q 047195 407 DIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 407 Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|+.|.||++++++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=1e-05 Score=84.34 Aligned_cols=177 Identities=19% Similarity=0.096 Sum_probs=115.2
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCceEEeeCCCCcHhHhH---hhc
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLFMSMSPNGTLFDRL---HRV 368 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~g~L~~~l---~~~ 368 (559)
+..+...+-++++++++++|.+-...+....+.+... ....-++++|.+.+|||.+..|.......+++ +..
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3344445668999999999987433333334444332 45667899999999999554444333332221 222
Q ss_pred cCCCCCC----------CChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 369 QSGNWPP----------LKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 369 ~~~~~~~----------l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
....+.. +...+...+.+.-++++++|| +..=+|+| |||..+ ...|..||+....+....
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 1111111 122223345556678889998 44357888 777766 578999999987665443
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAV 483 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~ 483 (559)
......+|+.++|||+.....+..+.|+|++|.--.++--|-+|-
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 223344899999999999999999999999998777776666554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0003 Score=67.06 Aligned_cols=128 Identities=24% Similarity=0.306 Sum_probs=73.3
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC-----c---------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR-----S---------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~-----n---------------iv~~~~~~ 358 (559)
+.|+.|..+.||+....+ ..+++|..... .....+.+|+.+++.+... . +++++.++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999877 57888886543 3346688898888877422 1 36677777
Q ss_pred CcHhH----------------h---HhhccCCCCCCCChHHH---------HHH------------HHHHHH-HHHHHHH
Q 047195 359 GTLFD----------------R---LHRVQSGNWPPLKWHHR---------LHI------------ARQTAQ-AIAYLHL 397 (559)
Q Consensus 359 g~L~~----------------~---l~~~~~~~~~~l~~~~~---------~~i------------~~~i~~-~l~yLH~ 397 (559)
..+.. . ++.... .......... ... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPP-PFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHT-TCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccc-cccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 76665 1 112111 1111111100 000 111222 3333332
Q ss_pred c----CCCCeEECCCCCCCeeec-CCCCEEEeecccce
Q 047195 398 L----ATPPIYHRDIKSSNILLD-EKLDAKISDFGLSR 430 (559)
Q Consensus 398 ~----~~~~iiH~Dikp~Nill~-~~~~~kl~DFG~a~ 430 (559)
. ....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 346799999999999999 56666899998874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0023 Score=61.65 Aligned_cols=30 Identities=23% Similarity=0.197 Sum_probs=26.7
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999998778999998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0014 Score=60.36 Aligned_cols=94 Identities=18% Similarity=0.192 Sum_probs=71.7
Q ss_pred HHHHHHHHhcCCCc------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeE
Q 047195 337 LNEVRILCQLNHRS------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIY 404 (559)
Q Consensus 337 ~~E~~~l~~l~h~n------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii 404 (559)
.+|.-+|+.+.+.. ++.|+...++++..-.. -......+|..+.+||.++++.+++|++.....+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 45788888887732 46788877766543100 01112468999999999999999999976656788
Q ss_pred ECCCCCCCeeecCCCCEEEeecccceec
Q 047195 405 HRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 405 H~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
-.|++++|+-+++++++|++|...+...
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchh
Confidence 8999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00035 Score=67.78 Aligned_cols=123 Identities=19% Similarity=0.189 Sum_probs=86.5
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC------------------CC----hhhHHHHHHHHHhcCC---
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT------------------KG----IDPILNEVRILCQLNH--- 348 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~------------------~~----~~~~~~E~~~l~~l~h--- 348 (559)
-+.++++||-|--+-||.+-..+|+..++|.-..... .+ .-...+|...|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4678899999999999999988899988887543211 11 1235688888888742
Q ss_pred ---------Cc-eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC
Q 047195 349 ---------RS-LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418 (559)
Q Consensus 349 ---------~n-iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~ 418 (559)
++ +||++..+..|...-+. .....+...+..-+--|- .+|+||+|..--||+++++
T Consensus 173 pVPkpiD~~RH~Vvmelv~g~Pl~~v~~v-----------~d~~~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 173 PVPKPIDHNRHCVVMELVDGYPLRQVRHV-----------EDPPTLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCcccccceeeHHHhhcccceeeeeec-----------CChHHHHHHHHHHHHHHH---HcCceecccchheeEEecC
Confidence 12 57787777666544322 112234444444455555 8899999999999999999
Q ss_pred CCEEEeecccce
Q 047195 419 LDAKISDFGLSR 430 (559)
Q Consensus 419 ~~~kl~DFG~a~ 430 (559)
+.++++||--..
T Consensus 239 ~~i~vIDFPQmv 250 (465)
T KOG2268|consen 239 DKIVVIDFPQMV 250 (465)
T ss_pred CCEEEeechHhh
Confidence 999999997543
|
|
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.00049 Score=55.41 Aligned_cols=45 Identities=24% Similarity=0.568 Sum_probs=37.2
Q ss_pred CCCCCCceEEeeeCCCCCCCCCCcccCCCCCCeeecCCCCCCcceeEecCC
Q 047195 161 SKWPEPGVKIEWALPREPTCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAG 211 (559)
Q Consensus 161 ~~~~~~~~~l~W~i~~~~~C~~~~~C~~~~~s~C~~~~~~~~gy~C~C~~G 211 (559)
...++.||+|+|.+... .| .+|..+ ++.|+++.+. ..+.|+|++|
T Consensus 49 ~~~L~~GF~L~w~~~~~-~C---~~C~~S-gG~Cgy~~~~-~~f~C~C~dg 93 (94)
T PF14380_consen 49 EEVLKKGFELEWNADSG-DC---RECEAS-GGRCGYDSNS-EQFTCFCSDG 93 (94)
T ss_pred HHHHhcCcEEEEeCCCC-cC---cChhcC-CCEeCCCCCC-ceEEEECCCC
Confidence 33467999999998443 67 679999 9999998876 7899999987
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.004 Score=60.53 Aligned_cols=128 Identities=15% Similarity=0.053 Sum_probs=71.2
Q ss_pred ccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC----Cc--------eEEeeCCCCcHhH----
Q 047195 300 LLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH----RS--------LFMSMSPNGTLFD---- 363 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h----~n--------iv~~~~~~g~L~~---- 363 (559)
.+..|-...+|+.. .++..+++|..........-...+|.++++.+.. |. +|++|.++..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNEHWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeCCEEEEEeccCccccccccc
Confidence 35667788999887 4455677776543322211246789999988753 22 4688887755431
Q ss_pred ----------h---HhhccCCCCCCCChHHH-HHHHHH---------HHHHHHHHHHc-----CCCCeEECCCCCCCeee
Q 047195 364 ----------R---LHRVQSGNWPPLKWHHR-LHIARQ---------TAQAIAYLHLL-----ATPPIYHRDIKSSNILL 415 (559)
Q Consensus 364 ----------~---l~~~~~~~~~~l~~~~~-~~i~~~---------i~~~l~yLH~~-----~~~~iiH~Dikp~Nill 415 (559)
. ++...... .++..... .....+ +...+..+-.. ....++|+|+.|.||++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~ 160 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFG-YPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVV 160 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEE
Confidence 1 12111111 11222111 111111 11112222211 12358999999999999
Q ss_pred cCCCCEEEeecccce
Q 047195 416 DEKLDAKISDFGLSR 430 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~ 430 (559)
++++ +.|+||..+.
T Consensus 161 ~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 161 TPQG-LKLIDWEYAS 174 (256)
T ss_pred eCCC-CEEEeccccC
Confidence 9877 7899998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0036 Score=59.88 Aligned_cols=62 Identities=19% Similarity=0.147 Sum_probs=41.5
Q ss_pred CccccCCccEEEEEEecC--CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC------------ceEEeeCCCCcH
Q 047195 299 NLLGSGGFGEVFKAILDD--ETITAVKRAKLGNTKGIDPILNEVRILCQLNHR------------SLFMSMSPNGTL 361 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~--~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~------------niv~~~~~~g~L 361 (559)
+.|..|-...+|+....+ +..+++|........ .....+|+.+++.+... .+++||.++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQNGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeCCcEEEEeeCCCcC
Confidence 567778888999987664 567878866543222 22345788888887432 267899877654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0065 Score=55.84 Aligned_cols=127 Identities=25% Similarity=0.308 Sum_probs=76.7
Q ss_pred CCCCCCCccccCCc-cEEEEEEecCCcEEEEEEeec---CCC------------------CChhhHHHHHHHHHhcCCC-
Q 047195 293 NNFSTGNLLGSGGF-GEVFKAILDDETITAVKRAKL---GNT------------------KGIDPILNEVRILCQLNHR- 349 (559)
Q Consensus 293 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~avk~~~~---~~~------------------~~~~~~~~E~~~l~~l~h~- 349 (559)
.+++.++.||.|.. |.||+++.. ++.+|+|..+. ... ...+.|..|.+...+|+.-
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999875 45999999322 111 1234688898888877532
Q ss_pred --ce--EE--eeCCCCcHhHhHhhc---cCCCCC-----------CCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCC
Q 047195 350 --SL--FM--SMSPNGTLFDRLHRV---QSGNWP-----------PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIK 409 (559)
Q Consensus 350 --ni--v~--~~~~~g~L~~~l~~~---~~~~~~-----------~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dik 409 (559)
.+ |. -|+.-.. ..-+... ...... +........-+.+|.+-+.-+| ..+|+-+|++
T Consensus 116 ~e~~~Avkc~Gyl~L~~-~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~---k~gI~~~Dv~ 191 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTE-DQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILH---KLGIVPRDVK 191 (207)
T ss_pred ccCceEEEeeEEEEEch-HHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHH---HCCeeeccCc
Confidence 33 22 1110000 1111111 000000 0111123344556667777778 8889999999
Q ss_pred CCCeeecCCCCEEEeecccc
Q 047195 410 SSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 410 p~Nill~~~~~~kl~DFG~a 429 (559)
+.|.. .-||+|||.+
T Consensus 192 ~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 192 PRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccccc-----CCEEEecccC
Confidence 99975 3589999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0048 Score=61.37 Aligned_cols=129 Identities=16% Similarity=0.136 Sum_probs=75.1
Q ss_pred CCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc-----------------------eEEe
Q 047195 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-----------------------LFMS 354 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n-----------------------iv~~ 354 (559)
.+.|..|....+|+....++ .+++|+... ...+.+..|++++..+.+.. +|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677788889999876554 577787653 22355677888887774321 3678
Q ss_pred eCCCCcHhH--------------hHhhccCC-C-----CCCCChHHHH----------HHHHHHHHHHHHHHH----cCC
Q 047195 355 MSPNGTLFD--------------RLHRVQSG-N-----WPPLKWHHRL----------HIARQTAQAIAYLHL----LAT 400 (559)
Q Consensus 355 ~~~~g~L~~--------------~l~~~~~~-~-----~~~l~~~~~~----------~i~~~i~~~l~yLH~----~~~ 400 (559)
|.+|..+.. .++..... . .....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 877655421 11211110 0 0011111110 111223344455442 113
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
.+++|+|+.|.|||++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 569999999999999998778999998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0096 Score=67.90 Aligned_cols=63 Identities=14% Similarity=0.217 Sum_probs=43.2
Q ss_pred CCccccCCccEEEEEEecCC---cEEEEEEeecCC-CCChhhHHHHHHHHHhcC-CCc--------------------eE
Q 047195 298 GNLLGSGGFGEVFKAILDDE---TITAVKRAKLGN-TKGIDPILNEVRILCQLN-HRS--------------------LF 352 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~---~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~-h~n--------------------iv 352 (559)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.+ +|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876553 356666654332 223356889999998884 433 57
Q ss_pred EeeCCCCc
Q 047195 353 MSMSPNGT 360 (559)
Q Consensus 353 ~~~~~~g~ 360 (559)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 88887654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0051 Score=58.91 Aligned_cols=30 Identities=27% Similarity=0.516 Sum_probs=25.8
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
..++|+|+.+.|||++++...-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 458999999999999877666799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.011 Score=59.36 Aligned_cols=31 Identities=19% Similarity=0.290 Sum_probs=26.7
Q ss_pred CCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 400 ~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
..+++|+|+.|.|||++++...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4579999999999999977666899999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0087 Score=59.71 Aligned_cols=31 Identities=26% Similarity=0.359 Sum_probs=27.2
Q ss_pred CCCeEECCCCCCCeeecCC----CCEEEeecccce
Q 047195 400 TPPIYHRDIKSSNILLDEK----LDAKISDFGLSR 430 (559)
Q Consensus 400 ~~~iiH~Dikp~Nill~~~----~~~kl~DFG~a~ 430 (559)
...++|+|+.|.|||++++ +.++|+||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4568999999999999985 789999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.023 Score=58.42 Aligned_cols=61 Identities=18% Similarity=0.113 Sum_probs=43.7
Q ss_pred CccccCCccEEEEEEecCC-cEEEEEEeecC-----C--CCChhhHHHHHHHHHhcCC------C----------ceEEe
Q 047195 299 NLLGSGGFGEVFKAILDDE-TITAVKRAKLG-----N--TKGIDPILNEVRILCQLNH------R----------SLFMS 354 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~-~~~avk~~~~~-----~--~~~~~~~~~E~~~l~~l~h------~----------niv~~ 354 (559)
+.||.|.+..||++...++ +.++||..... . +...+.+..|.+.|+.+.- | .+|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 5799999999999998777 47889985421 1 2245667889999887521 1 26888
Q ss_pred eCCCC
Q 047195 355 MSPNG 359 (559)
Q Consensus 355 ~~~~g 359 (559)
+.++.
T Consensus 112 ~L~~~ 116 (401)
T PRK09550 112 DLSDH 116 (401)
T ss_pred cCCCc
Confidence 87653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.027 Score=52.16 Aligned_cols=114 Identities=22% Similarity=0.277 Sum_probs=72.2
Q ss_pred CCCccccCCccEEEEEEecCCcEEEEEEeecCC----------------CCChhhHHHHHHHHHhcC-CCc---------
Q 047195 297 TGNLLGSGGFGEVFKAILDDETITAVKRAKLGN----------------TKGIDPILNEVRILCQLN-HRS--------- 350 (559)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~----------------~~~~~~~~~E~~~l~~l~-h~n--------- 350 (559)
-...||+|+.-.||. +.+.....||+..... ....++..+|+....++. +.+
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999996 4555566788776655 223467888998888887 443
Q ss_pred -----------eEEeeCC--CC----cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCe
Q 047195 351 -----------LFMSMSP--NG----TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNI 413 (559)
Q Consensus 351 -----------iv~~~~~--~g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Ni 413 (559)
+|+|... +| +|.+++... .++. ...+ .+-+-..||- .++|+.+|++|.||
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~---~L~~f~~~l~---~~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQ---ALDEFKRYLL---DHHIVIRDLNPHNI 149 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHH---HHHHHHHHHH---HcCCeecCCCcccE
Confidence 2444431 23 455555321 2443 3333 3334445565 66799999999999
Q ss_pred eecCCC----CEEEee
Q 047195 414 LLDEKL----DAKISD 425 (559)
Q Consensus 414 ll~~~~----~~kl~D 425 (559)
++.... .+.|+|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 996432 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.01 Score=48.39 Aligned_cols=86 Identities=14% Similarity=0.306 Sum_probs=48.0
Q ss_pred CCCCCcccccccccCCCCccccCCCCceEEEEEe--------ccCcceeEEeeecCCC------CCCCCCCCCceEEeee
Q 047195 108 FNCSSTSICHSYIRDNPVAKRTGGSINEYRIRVR--------AERCAAYQSFVDLDLS------LPVSKWPEPGVKIEWA 173 (559)
Q Consensus 108 ~~c~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~c~~~~~~~~~~~~------~~~~~~~~~~~~l~W~ 173 (559)
..|+|.+||++.++.+ .+..+.+.+. ..+|+..|........ ..+.....+|++|+|.
T Consensus 2 ~~CsG~~CCQt~iP~~--------~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n~t~p~~~~~~~y~pv~L~W~ 73 (103)
T PF08488_consen 2 SSCSGIGCCQTSIPSG--------LLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSNITDPEDFHAMGYVPVVLDWF 73 (103)
T ss_pred CccCCcceeccCCCCC--------CceEEEEEeEecCCCcccCCCceEEEEeccccccccCCChHHhccCCeeEEEEEEE
Confidence 5799999999987532 2333444332 2578865544333221 1233345689999999
Q ss_pred CCCCC-CCCCCcccCCCCCCeeecCCCCCCcceeEec
Q 047195 174 LPREP-TCKLPVDCQDLLNSMCLQDAESAGQKRCLYK 209 (559)
Q Consensus 174 i~~~~-~C~~~~~C~~~~~s~C~~~~~~~~gy~C~C~ 209 (559)
|.... .-...++|.. +.. +. ...+|.|.
T Consensus 74 i~t~~~~~~~s~~C~~--~~~--y~----~~~~C~C~ 102 (103)
T PF08488_consen 74 IDTSDSSFSNSLACKN--NTE--YS----SSNRCSCS 102 (103)
T ss_pred EecCCcCcCcCccCCC--cee--cc----CCCcEeCC
Confidence 96331 1122367875 333 21 22378884
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.043 Score=54.86 Aligned_cols=143 Identities=13% Similarity=0.116 Sum_probs=79.7
Q ss_pred hHHHHHHhCCCCC-----CCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC----------
Q 047195 285 SREITEATNNFST-----GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR---------- 349 (559)
Q Consensus 285 ~~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~---------- 349 (559)
.+++...-+.|.+ .+.++.|....+|+....++ .+++|+..... ..+.+..|++++..|...
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 3444444334433 45677777789999876555 46677654321 234566777777776321
Q ss_pred -------------ceEEeeCCCCcHh--------------HhHhhccCCC-CC------CCChHHHH------------H
Q 047195 350 -------------SLFMSMSPNGTLF--------------DRLHRVQSGN-WP------PLKWHHRL------------H 383 (559)
Q Consensus 350 -------------niv~~~~~~g~L~--------------~~l~~~~~~~-~~------~l~~~~~~------------~ 383 (559)
.++++|.+|..+. -.++....+- .. ...|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 1467887764431 1122211110 00 01111100 1
Q ss_pred HHHHHHHHHHHHHH----cCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 384 IARQTAQAIAYLHL----LATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 384 i~~~i~~~l~yLH~----~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
....+.+.++++.. ....+++|+|+.+.||++++++...|+||+.+.
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 11223345555542 124689999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.027 Score=55.33 Aligned_cols=31 Identities=23% Similarity=0.471 Sum_probs=25.8
Q ss_pred CCeEECCCCCCCeeecCCCC-EEEeeccccee
Q 047195 401 PPIYHRDIKSSNILLDEKLD-AKISDFGLSRL 431 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~-~kl~DFG~a~~ 431 (559)
..++|+|+.|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.01 Score=66.97 Aligned_cols=180 Identities=19% Similarity=0.180 Sum_probs=112.9
Q ss_pred HHHHHHHHHhcCCCceEE-------------------eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHH
Q 047195 336 ILNEVRILCQLNHRSLFM-------------------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396 (559)
Q Consensus 336 ~~~E~~~l~~l~h~niv~-------------------~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH 396 (559)
..-|...+..+.|.|++. +++..-++...+... ...+....+.+..+...+++|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHHH
Confidence 456777888899999743 222333333344332 24777888889999999999999
Q ss_pred HcCCCCeEECCCCCC---CeeecCCCCEEEe--ecccceeccCCCceeeeeccccCCccCccccccCCCCc--ccchhHH
Q 047195 397 LLATPPIYHRDIKSS---NILLDEKLDAKIS--DFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD--KSDVYSF 469 (559)
Q Consensus 397 ~~~~~~iiH~Dikp~---Nill~~~~~~kl~--DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~Sl 469 (559)
.. ...|.-+..+ +.-.+..+.+.+. ||+..+........... .-+..+.|||.......+. ..|+|.+
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHHH
Confidence 44 3444444333 4444566667766 99888766543332221 2455677888776655544 4799999
Q ss_pred HHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 470 GVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 470 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
|..+..+..|..+....... ...++. .....+.+....|+..++++|+++.
T Consensus 379 gll~~~~~~~~~i~~~~~~~------------------~~~l~~-----------~~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVP------------------VSLLDV-----------LSTSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHhhhhhcCcccccccch------------------hhhhcc-----------ccchhhhhhhhhhcchhhhhccchh
Confidence 99999999887654311100 000000 0001345566779999999999999
Q ss_pred HHHHH
Q 047195 550 EVADE 554 (559)
Q Consensus 550 evl~~ 554 (559)
+++..
T Consensus 430 ~ll~~ 434 (1351)
T KOG1035|consen 430 ELLTH 434 (1351)
T ss_pred hhhhc
Confidence 98864
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.023 Score=57.82 Aligned_cols=30 Identities=27% Similarity=0.454 Sum_probs=26.2
Q ss_pred CCeEECCCCCCCeeecC-CCCEEEeecccce
Q 047195 401 PPIYHRDIKSSNILLDE-KLDAKISDFGLSR 430 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~-~~~~kl~DFG~a~ 430 (559)
..++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 46899999999999986 4689999998875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.0012 Score=75.64 Aligned_cols=145 Identities=14% Similarity=0.052 Sum_probs=98.5
Q ss_pred HHHHHHHHhcCCCce-----------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC
Q 047195 337 LNEVRILCQLNHRSL-----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399 (559)
Q Consensus 337 ~~E~~~l~~l~h~ni-----------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~ 399 (559)
+.|...++...|+++ .+++...|.+++.+.+... ..+++...-+...-.+...+..-.|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e-e~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE-ESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc-cCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344445555678775 3466677888888765432 2233433333333333355555555432
Q ss_pred --CCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHH
Q 047195 400 --TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477 (559)
Q Consensus 400 --~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~ 477 (559)
++-.+|+++|+-|.+|..+..+|+.++|+.+...+.... .....+++.|++|++.....++.++|+|..|+-+|++-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 345789999999999999999999999999843332222 22334788899999988888998999999999999887
Q ss_pred hCCCCC
Q 047195 478 TSKKAV 483 (559)
Q Consensus 478 tg~~p~ 483 (559)
-|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 766554
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.099 Score=51.96 Aligned_cols=61 Identities=8% Similarity=-0.003 Sum_probs=41.9
Q ss_pred CCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC---------------------CceEEeeC
Q 047195 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH---------------------RSLFMSMS 356 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h---------------------~niv~~~~ 356 (559)
.+.||.|..+.||+....+++ +.+|..+... ....+.+|.+.|+.|.. +.||||+.
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 467999999999998766664 5556543211 22568899999987632 23688998
Q ss_pred CCCcH
Q 047195 357 PNGTL 361 (559)
Q Consensus 357 ~~g~L 361 (559)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 87654
|
|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.017 Score=33.13 Aligned_cols=22 Identities=23% Similarity=0.578 Sum_probs=17.6
Q ss_pred cceeEecCCCccCCCCCccccc
Q 047195 203 QKRCLYKAGFQWDPISGICKSL 224 (559)
Q Consensus 203 gy~C~C~~Gy~gnpy~~~c~~~ 224 (559)
+|+|.|+.||.-+|-...|+++
T Consensus 1 sy~C~C~~Gy~l~~d~~~C~DI 22 (24)
T PF12662_consen 1 SYTCSCPPGYQLSPDGRSCEDI 22 (24)
T ss_pred CEEeeCCCCCcCCCCCCccccC
Confidence 5899999999977765567765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.18 Score=50.90 Aligned_cols=29 Identities=28% Similarity=0.401 Sum_probs=25.1
Q ss_pred CeEECCCCCCCeeecC-CCCEEEeecccce
Q 047195 402 PIYHRDIKSSNILLDE-KLDAKISDFGLSR 430 (559)
Q Consensus 402 ~iiH~Dikp~Nill~~-~~~~kl~DFG~a~ 430 (559)
-..|.|+.+.|||+++ ++.++++||..|-
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 3799999999999975 5689999998874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.37 Score=48.69 Aligned_cols=47 Identities=23% Similarity=0.228 Sum_probs=34.1
Q ss_pred ccccCCccEEEEEEecCC-cEEEEEEeec-----C--CCCChhhHHHHHHHHHhc
Q 047195 300 LLGSGGFGEVFKAILDDE-TITAVKRAKL-----G--NTKGIDPILNEVRILCQL 346 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~-~~~avk~~~~-----~--~~~~~~~~~~E~~~l~~l 346 (559)
.||.|....||++...++ +.++||.... . -+...++..-|.+.|+..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~ 56 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQ 56 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHh
Confidence 589999999999997654 5788988532 1 134456677888888765
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.035 Score=34.54 Aligned_cols=26 Identities=23% Similarity=0.599 Sum_probs=21.7
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCcc
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQW 214 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~g 214 (559)
-|.. +++|.+.. . .+|.|.|+.||.|
T Consensus 5 ~C~n--~g~C~~~~-~-~~y~C~C~~G~~G 30 (32)
T PF00008_consen 5 PCQN--GGTCIDLP-G-GGYTCECPPGYTG 30 (32)
T ss_dssp SSTT--TEEEEEES-T-SEEEEEEBTTEES
T ss_pred cCCC--CeEEEeCC-C-CCEEeECCCCCcc
Confidence 4765 89998877 3 7899999999987
|
The list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied. The functional significance of EGF domains in what appear to be unrelated proteins is not yet clear. However, a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase). The EGF domain includes six cysteine residues which have been shown (in EGF) to be involved in disulphide bonds. The main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet. Subdomains between the conserved cysteines vary in length.; GO: 0005515 protein binding; PDB: 1WHE_A 1CCF_A 1APO_A 1WHF_A 2VJ3_A 1TOZ_A 4D90_B 3CFW_A 1EDM_B 1IXA_A .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.96 E-value=0.4 Score=48.08 Aligned_cols=127 Identities=20% Similarity=0.176 Sum_probs=86.4
Q ss_pred CCCCccccCCccEEEEEEecCCcEEEEEEeecCC------------------------CCCh--hhHHHHHHHHHhcCCC
Q 047195 296 STGNLLGSGGFGEVFKAILDDETITAVKRAKLGN------------------------TKGI--DPILNEVRILCQLNHR 349 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~------------------------~~~~--~~~~~E~~~l~~l~h~ 349 (559)
.+...|..|--+.||.|.-.+|..+|||+.+-+- +..+ -....|++-|++|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788899999999999999999999865321 0000 1245788888887541
Q ss_pred -------------ceEEeeCCCCc-HhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 350 -------------SLFMSMSPNGT-LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 350 -------------niv~~~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
-|||+|+.... ..-.|.. ..++...+..+-.|++.-+.-|.+ .-++||.||.=-|+|+
T Consensus 227 GIP~PePIlLk~hVLVM~FlGrdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 227 GIPCPEPILLKNHVLVMEFLGRDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCCceeeecceEeeeeccCCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE
Confidence 16888874211 1111211 245666677777788777777775 3479999999999887
Q ss_pred cCCCCEEEeeccccee
Q 047195 416 DEKLDAKISDFGLSRL 431 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~ 431 (559)
-+ |.+.|+|-+-+-.
T Consensus 299 hd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVE 313 (520)
T ss_pred EC-CEEEEEEcccccc
Confidence 54 6799999887643
|
|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.09 Score=35.07 Aligned_cols=28 Identities=21% Similarity=0.704 Sum_probs=22.1
Q ss_pred cccCCCCCCeeecCCCCCCcceeEecCCCccCC
Q 047195 184 VDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDP 216 (559)
Q Consensus 184 ~~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gnp 216 (559)
..|.. ++.|.+.. ++|.|.|+.||..++
T Consensus 10 ~~C~~--~~~C~N~~---Gsy~C~C~~Gy~~~~ 37 (42)
T PF07645_consen 10 HNCPE--NGTCVNTE---GSYSCSCPPGYELND 37 (42)
T ss_dssp SSSST--TSEEEEET---TEEEEEESTTEEECT
T ss_pred CcCCC--CCEEEcCC---CCEEeeCCCCcEECC
Confidence 35744 89998865 789999999998544
|
Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A .... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.91 Score=45.21 Aligned_cols=33 Identities=24% Similarity=0.464 Sum_probs=29.3
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
..++|+|+.+.|++++...-+-|.||+++.+..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 459999999999999998889999999987643
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.33 E-value=1.6 Score=43.88 Aligned_cols=126 Identities=24% Similarity=0.300 Sum_probs=73.6
Q ss_pred cccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC-------------------------ceEEee
Q 047195 301 LGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR-------------------------SLFMSM 355 (559)
Q Consensus 301 lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~-------------------------niv~~~ 355 (559)
|.. .--.||+....+++. ++|..... ....++..|+..|..|.-. --+.+|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789988887777 77776654 3446677888888776321 135677
Q ss_pred CCCCcHhH---------------hHhhccCC-------CCCCCChHH----H---------HHHHHHHHHHHHHHHHc--
Q 047195 356 SPNGTLFD---------------RLHRVQSG-------NWPPLKWHH----R---------LHIARQTAQAIAYLHLL-- 398 (559)
Q Consensus 356 ~~~g~L~~---------------~l~~~~~~-------~~~~l~~~~----~---------~~i~~~i~~~l~yLH~~-- 398 (559)
++|..+.. .|+....+ ......|.. . .....++...++.+...
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 77766551 11111110 011122320 0 11233444444444421
Q ss_pred --CCCC---eEECCCCCCCeeecCCCC-EEEeecccce
Q 047195 399 --ATPP---IYHRDIKSSNILLDEKLD-AKISDFGLSR 430 (559)
Q Consensus 399 --~~~~---iiH~Dikp~Nill~~~~~-~kl~DFG~a~ 430 (559)
-... +||+|+.|.|||++.+.. +.++||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1223 999999999999998874 8999999764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.09 E-value=0.25 Score=50.13 Aligned_cols=56 Identities=11% Similarity=0.128 Sum_probs=39.0
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD 416 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~ 416 (559)
-+|+.+-++...+... ..+++...+++.-.++|+.-|-. -.+.+|.|+.|.||++-
T Consensus 324 E~~~~Gl~v~~~v~~~------~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 324 ETYERGLSVLRFVKWK------SQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR 379 (565)
T ss_pred eeccccccHHhhhhcc------cChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence 3566666666666542 24556667777767777666553 45799999999999994
|
|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
Probab=93.07 E-value=0.069 Score=34.21 Aligned_cols=28 Identities=29% Similarity=0.702 Sum_probs=20.2
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccCCC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPI 217 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gnpy 217 (559)
.|-. |+.|.+.. +.|.|.|+.||.||.+
T Consensus 7 ~C~~--nA~C~~~~---~~~~C~C~~Gy~GdG~ 34 (36)
T PF12947_consen 7 GCHP--NATCTNTG---GSYTCTCKPGYEGDGF 34 (36)
T ss_dssp GS-T--TCEEEE-T---TSEEEEE-CEEECCST
T ss_pred CCCC--CcEeecCC---CCEEeECCCCCccCCc
Confidence 4554 88998865 4799999999999864
|
; PDB: 2NPR_A 1N1I_C 1B9W_A 1YO8_A 2RHP_A. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.48 E-value=0.15 Score=50.15 Aligned_cols=39 Identities=26% Similarity=0.178 Sum_probs=28.1
Q ss_pred HHHHHHHHHHHHHHHHHHHcC-CCCeEECCCCCCCeeecC
Q 047195 379 HHRLHIARQTAQAIAYLHLLA-TPPIYHRDIKSSNILLDE 417 (559)
Q Consensus 379 ~~~~~i~~~i~~~l~yLH~~~-~~~iiH~Dikp~Nill~~ 417 (559)
+-++.++.||+--.-.+-.+. ....+|-||||+|||+-+
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 445678888876654454333 567999999999999943
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.68 E-value=2.6 Score=42.48 Aligned_cols=43 Identities=16% Similarity=0.003 Sum_probs=30.1
Q ss_pred CCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC
Q 047195 304 GGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLN 347 (559)
Q Consensus 304 G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~ 347 (559)
+.--.||+....++..+++|..... .....++..|++.+..|.
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~ 78 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELA 78 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHH
Confidence 3446799998888888888876532 234466778888887663
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.43 E-value=2.2 Score=49.94 Aligned_cols=31 Identities=29% Similarity=0.435 Sum_probs=26.1
Q ss_pred CCCeEECCCCCCCeeecCCC--CEE-Eeecccce
Q 047195 400 TPPIYHRDIKSSNILLDEKL--DAK-ISDFGLSR 430 (559)
Q Consensus 400 ~~~iiH~Dikp~Nill~~~~--~~k-l~DFG~a~ 430 (559)
...+||+|+.+.|||++.+. .+. |+|||-+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 46799999999999999875 554 99999874
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.06 E-value=1.3 Score=45.52 Aligned_cols=29 Identities=24% Similarity=0.250 Sum_probs=24.1
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
....|.|+-+.|||.+++ .+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 467999999999997654 59999997764
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=90.78 E-value=0.23 Score=49.14 Aligned_cols=53 Identities=26% Similarity=0.299 Sum_probs=32.8
Q ss_pred HHHHHHHHHHHHHHHHHHc-CCCCeEECCCCCCCeeecCC------------------CCEEEeecccceec
Q 047195 380 HRLHIARQTAQAIAYLHLL-ATPPIYHRDIKSSNILLDEK------------------LDAKISDFGLSRLA 432 (559)
Q Consensus 380 ~~~~i~~~i~~~l~yLH~~-~~~~iiH~Dikp~Nill~~~------------------~~~kl~DFG~a~~~ 432 (559)
-++.++.|||--.--+-.+ +....+|-||||+|||+-+. ...+|.||.++...
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3456677765432113233 24679999999999999332 23567777776543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.60 E-value=0.52 Score=47.05 Aligned_cols=30 Identities=27% Similarity=0.402 Sum_probs=25.9
Q ss_pred CCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 400 ~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
..+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 367999999999999988 678999998754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 559 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-32 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-107
Identities = 105/322 (32%), Positives = 158/322 (49%), Gaps = 29/322 (9%)
Query: 257 SNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDD 316
S + + +S + + ++ EATNNF L+G G FG+V+K +L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 317 ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------------------FMSMSPN 358
A+KR +++GI+ E+ L H L +M N
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM---EN 119
Query: 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418
G L L+ + W RL I A+ + YLH T I HRD+KS NILLDE
Sbjct: 120 GNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDEN 175
Query: 419 LDAKISDFGLSRLALNG-ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
KI+DFG+S+ +H++T +GTLGY+DPEY+I +LT+KSDVYSFGVVL E+L
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 478 TSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAAC 537
++ A+ + E VNL + +L +DP L +I +S++ FG C
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA---DKIRPESLRKFGDTAVKC 292
Query: 538 LDERRQNRPSIKEVADEIERII 559
L ++RPS+ +V ++E +
Sbjct: 293 LALSSEDRPSMGDVLWKLEYAL 314
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 3e-96
Identities = 104/293 (35%), Positives = 162/293 (55%), Gaps = 28/293 (9%)
Query: 280 ARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDP-ILN 338
+ FS RE+ A++NFS N+LG GGFG+V+K L D T+ AVKR K T+G +
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 339 EVRILCQLNHRSL------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHH 380
EV ++ HR+L +M NG++ L PPL W
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM---ANGSVASCLRERPESQ-PPLDWPK 132
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT 440
R IA +A+ +AYLH P I HRD+K++NILLDE+ +A + DFGL++L +HVT
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 441 TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNR--EEEDVNLVVYF 498
T +GT+G++ PEY + ++K+DV+ +GV+L+EL+T ++A D R ++DV L+ +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+LK+++L +D L+ + E++ + LL C RP + EV
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL---CTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 2e-87
Identities = 105/308 (34%), Positives = 155/308 (50%), Gaps = 46/308 (14%)
Query: 281 RIFSSREITEATNNFS------TGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK--- 331
FS E+ TNNF GN +G GGFG V+K +++ T+ AVK+
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTE 71
Query: 332 -GIDPILNEVRILCQLNHRSL------------------FMSMSPNGTLFDRLHRVQSGN 372
E++++ + H +L +M PNG+L DRL
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM---PNGSLLDRLSC--LDG 126
Query: 373 WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432
PPL WH R IA+ A I +LH HRDIKS+NILLDE AKISDFGL+R +
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 433 LNGA-SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEED 491
A + +T+ GT Y+ PE ++T KSD+YSFGVVL+E++T AVD +RE +
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ- 241
Query: 492 VNLVVYFGNILKQER-LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
L+ I +E+ + D ID + + + S++A + + CL E++ RP IK+
Sbjct: 242 -LLLDIKEEIEDEEKTIEDYIDKKMNDA----DSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 551 VADEIERI 558
V ++ +
Sbjct: 297 VQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-58
Identities = 77/316 (24%), Positives = 117/316 (37%), Gaps = 53/316 (16%)
Query: 283 FSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRI 342
+ + + + G FG V+KA L +E + AVK + + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSWQ-NEYEVYS 71
Query: 343 LCQLNHRSL----------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHH 380
L + H ++ F G+L D L + W+
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFH---EKGSLSDFLKA------NVVSWNE 122
Query: 381 RLHIARQTAQAIAYLH-------LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433
HIA A+ +AYLH P I HRDIKS N+LL L A I+DFGL+
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 434 NGASHVTTFAQ-GTLGYLDPEY-----YINFQLTDKSDVYSFGVVLVELLTSKKAVDFNR 487
G S T Q GT Y+ PE + D+Y+ G+VL EL + A D
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 488 EEEDVNLVVYFGNILKQERLVDAI-----DPMLKEGASEIELDSMKAFGLLGAACLDERR 542
+E + G E + + + P+L++ + M C D
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA--GMAMLCETIEECWDHDA 300
Query: 543 QNRPSIKEVADEIERI 558
+ R S V + I ++
Sbjct: 301 EARLSAGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-51
Identities = 81/282 (28%), Positives = 122/282 (43%), Gaps = 46/282 (16%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRS--LFM 353
+G+G FG V +A + AVK + + ++ L EV I+ +L H + LFM
Sbjct: 42 KEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 354 --SMSP-----------NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
P G+L+ LH+ + L RL +A A+ + YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE--QLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL 460
PPI HR++KS N+L+D+K K+ DFGLSRL + + A GT ++ PE +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPS 216
Query: 461 TDKSDVYSFGVVLVELLTSKKAVDFNREE--EDVNLV-VYFGNILKQERLVDAIDPMLKE 517
+KSDVYSFGV+L EL T ++ ++N V K +RL
Sbjct: 217 NEKSDVYSFGVILWELAT--------LQQPWGNLNPAQVVAAVGFKCKRL---------- 258
Query: 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
EI + + C RPS + D + +I
Sbjct: 259 ---EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-50
Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 40/281 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL- 351
++G G FG V KA + + A+K ++ + + E+R L ++NH ++
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIK--QIESESERKAFIVELRQLSRVNHPNIV 64
Query: 352 -FMSMS-----------PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
G+L++ LH + P H + Q +Q +AYLH +
Sbjct: 65 KLYGACLNPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 400 TPPIYHRDIKSSNILLDEKLD-AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ HRD+K N+LL KI DFG + T +G+ ++ PE +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGS 178
Query: 459 QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518
++K DV+S+G++L E++T +K F +E + R
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKP--F--DEIGGPAFRIMWAVHNGTRP----------- 223
Query: 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
+ + K L C + RPS++E+ + ++
Sbjct: 224 --PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-47
Identities = 54/293 (18%), Positives = 97/293 (33%), Gaps = 62/293 (21%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHR------ 349
G L+G G FG+V+ E A++ + N + EV Q H
Sbjct: 38 GELIGKGRFGQVYHGRWHGEV--AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 350 ---------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
++ S+ TL+ + + L + IA++ + + YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH---A 148
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRL----ALNGASHVTTFAQGTLGYLDPEYYI 456
I H+D+KS N+ D I+DFGL + G L +L PE
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 457 NFQL---------TDKSDVYSFGVVLVELLTSKKAVDFNREE--EDVNLVVYFGNILKQE 505
+ SDV++ G + EL RE + +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHA--------REWPFKTQPAEAIIWQMGTGM 259
Query: 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+ + ++ K + C ++ RP+ ++ D +E++
Sbjct: 260 KP------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-47
Identities = 68/290 (23%), Positives = 113/290 (38%), Gaps = 55/290 (18%)
Query: 298 GNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPI-------LNEVRILCQLNHR 349
+G GGFG V K + D+++ A+K LG+++G + EV I+ LNH
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 350 S--LFM--SMSP---------NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
+ +P G L+ RL P+KW +L + A I Y+
Sbjct: 84 NIVKLYGLMHNPPRMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 397 LLATPPIYHRDIKSSNILLDEK-----LDAKISDFGLSRLALNGASHVTTFAQGTLGYLD 451
PPI HRD++S NI L + AK++DFGLS+ + H + G ++
Sbjct: 140 NQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNFQWMA 194
Query: 452 PE--YYINFQLTDKSDVYSFGVVLVELLTSKKA-VDFNREEEDVNLVVYFGNILKQERLV 508
PE T+K+D YSF ++L +LT + +++ + ++ R
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG----LRP- 249
Query: 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
I D + C + RP + E+ +
Sbjct: 250 ------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-46
Identities = 73/294 (24%), Positives = 121/294 (41%), Gaps = 67/294 (22%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGN----TKGIDPILNEVRILCQLNHRSL-- 351
++G GGFG+V++A + + AVK A+ ++ I+ + E ++ L H ++
Sbjct: 12 EEIIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 352 ----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
F G L L + ++ A Q A+ + YL
Sbjct: 71 LRGVCLKEPNLCLVMEFA---RGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYL 121
Query: 396 HLLATPPIYHRDIKSSNILLDEKLD--------AKISDFGLSRLALNGASHVTTFAQGTL 447
H A PI HRD+KSSNIL+ +K++ KI+DFGL+R + + A G
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAY 178
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE--EDVNLV-VYFGNILKQ 504
++ PE + SDV+S+GV+L ELLT E ++ + V +G + +
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLT--------GEVPFRGIDGLAVAYGVAMNK 230
Query: 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
L I + F L C + +RPS + D++ I
Sbjct: 231 LAL-------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-46
Identities = 79/282 (28%), Positives = 121/282 (42%), Gaps = 43/282 (15%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRS--LFM 353
G +GSG FG V+K + AVK + + + NEV +L + H + LFM
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 354 ------------SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP 401
+L+ LH + + + IARQTA+ + YLH
Sbjct: 87 GYSTAPQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH---AK 139
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRL-ALNGASHVTTFAQGTLGYLDPE---YYIN 457
I HRD+KS+NI L E KI DFGL+ + SH G++ ++ PE +
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 458 FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517
+ +SDVY+FG+VL EL+T + + + +V G+ L
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS--------------LSP 245
Query: 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
S++ + K L A CL ++R RPS + EIE +
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 57/289 (19%), Positives = 100/289 (34%), Gaps = 63/289 (21%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRS--LFM 353
L GE++K I VK K+ +T+ E L +H + +
Sbjct: 15 LTKLNENHSGELWKGRWQGNDI-VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 354 --SMSP-------------NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
SP G+L++ LH G + + A A+ +A+LH L
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE----- 453
P I + S ++++DE + A+IS + S + ++ PE
Sbjct: 131 -EPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKK 183
Query: 454 -YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE--EDVN-LVVYFGNILKQERLVD 509
N +D++SF V+L EL+T RE D++ + + L+ R
Sbjct: 184 PEDTN---RRSADMWSFAVLLWELVT--------REVPFADLSNMEIGMKVALEGLRP-- 230
Query: 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
I L C++E RP + +E++
Sbjct: 231 -----------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 7e-44
Identities = 65/326 (19%), Positives = 116/326 (35%), Gaps = 60/326 (18%)
Query: 283 FSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRI 342
++ E + +N L+G G +G V+K LD+ + AVK N + +NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFANRQNF---INEKNI 58
Query: 343 --LCQLNHRSL--FMSMS------------------PNGTLFDRLHRVQSGNWPPLKWHH 380
+ + H ++ F+ PNG+L L W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVS 112
Query: 381 RLHIARQTAQAIAYLH------LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL--- 431
+A + +AYLH P I HRD+ S N+L+ ISDFGLS
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 432 ----ALNGASHVTTFAQGTLGYLDPEYY---INFQ----LTDKSDVYSFGVVLVELLTSK 480
+ GT+ Y+ PE +N + + D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 481 KAVDFNREEEDVNLVVY--FGNILKQERLVDAID-----PMLKEGASEIELDSMKAFGLL 533
+ + + GN E + + P E E L ++++
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVRSLKET 291
Query: 534 GAACLDERRQNRPSIKEVADEIERII 559
C D+ + R + + + + ++
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELM 317
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-41
Identities = 59/315 (18%), Positives = 103/315 (32%), Gaps = 62/315 (19%)
Query: 285 SREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRI-- 342
+R+IT +G G +GEV++ E + AVK + K E +
Sbjct: 7 ARDIT-------LLECVGKGRYGEVWRGSWQGENV-AVKIFSSRDEKSW---FRETELYN 55
Query: 343 LCQLNHR-------------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLH 383
L H L G+L+D L L L
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLR 109
Query: 384 IARQTAQAIAYLH-----LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438
I A +A+LH P I HRD+KS NIL+ + I+D GL+ + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 439 V---TTFAQGTLGYLDPE------YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE 489
+ GT Y+ PE F + D+++FG+VL E+ + +
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 490 EDVNLVVYFGNILKQERLVDAIDPMLKEG------ASEIELDSMKAFGLLGAACLDERRQ 543
+ ++ + D + + ++ + L C +
Sbjct: 230 K----PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 544 NRPSIKEVADEIERI 558
R + + + +I
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 62/295 (21%), Positives = 105/295 (35%), Gaps = 61/295 (20%)
Query: 298 GNLLGSGGFGEVFKAILDDETIT-AVKRAKLGNTKGIDPILNEVRILCQLNHRSL----- 351
G +LG G FG+ K + +K + + L EV+++ L H ++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 352 -------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
++ GTL + W R+ A+ A +AYLH
Sbjct: 75 VLYKDKRLNFITEYI---KGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLH-- 125
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ-------------G 445
+ I HRD+ S N L+ E + ++DFGL+RL ++ + G
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 446 TLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAV-DFNREEEDVNLVVYFGNILKQ 504
++ PE +K DV+SFG+VL E++ A D+ D L V
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----- 239
Query: 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
+ +F + C D + RPS ++ +E +
Sbjct: 240 LDR-------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 60/303 (19%), Positives = 104/303 (34%), Gaps = 55/303 (18%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRI--LCQLNHRS--LFM 353
+G G +GEV+ E + AVK E I + H + F+
Sbjct: 42 VKQIGKGRYGEVWMGKWRGEKV-AVKVFFTTEEASW---FRETEIYQTVLMRHENILGFI 97
Query: 354 SMS-----------------PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
+ NG+L+D L L L +A + + +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLH 151
Query: 397 LLAT-----PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV---TTFAQGTLG 448
P I HRD+KS NIL+ + I+D GL+ ++ + V GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 449 YLDPE------YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502
Y+ PE +FQ +D+YSFG++L E+ + E + + Y +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ----LPYHDLVP 267
Query: 503 KQERLVDAIDPMLKEG------ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556
D + + + + ++ G L C +R + V +
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 557 RII 559
++
Sbjct: 328 KMS 330
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 55/302 (18%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRI--LCQLNHRSL--FM 353
+G G FGEV++ E + AVK + E I L H ++ F+
Sbjct: 47 QESIGKGRFGEVWRGKWRGEEV-AVKIFSSREERSW---FREAEIYQTVMLRHENILGFI 102
Query: 354 SMS-----------------PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
+ +G+LFD L+R + + +A TA +A+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLH 156
Query: 397 -----LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT---TFAQGTLG 448
P I HRD+KS NIL+ + I+D GL+ + + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 449 YLDPE------YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502
Y+ PE +F+ ++D+Y+ G+V E+ + + + + Y+ +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----LPYYDLVP 272
Query: 503 KQERLVDAIDPMLKEG------ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556
+ + + ++ ++++ + C R + + +
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 557 RI 558
++
Sbjct: 333 QL 334
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 54/317 (17%), Positives = 105/317 (33%), Gaps = 52/317 (16%)
Query: 273 ANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTK 331
++SGR F + ++ LG GGF V L D A+KR +
Sbjct: 9 HHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ 68
Query: 332 GIDPILNEVRILCQLNHR-----------------SLFMSMS--PNGTLFDRLHRVQSGN 372
+ E + NH ++ + GTL++ + R++
Sbjct: 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG 128
Query: 373 WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432
L L + + + +H HRD+K +NILL ++ + D G A
Sbjct: 129 -NFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
Query: 433 LNGASHVTTFAQ--------GTLGYLDPE---YYINFQLTDKSDVYSFGVVLVELLTSKK 481
T+ Y PE + + +++DV+S G VL ++ +
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 482 AVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDER 541
++ + + V ++ + + S + LL + +
Sbjct: 245 P--YDMVFQKGDSVAL---AVQNQLSIPQSPRH-----------SSALWQLL-NSMMTVD 287
Query: 542 RQNRPSIKEVADEIERI 558
RP I + ++E +
Sbjct: 288 PHQRPHIPLLLSQLEAL 304
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 72/308 (23%), Positives = 116/308 (37%), Gaps = 79/308 (25%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH-- 348
++F +LG G FG+V KA D A+K+ + K + IL+EV +L LNH
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 349 ------------------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRL 382
+LF+ M NGTL+D +H W
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--- 120
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
+ RQ +A++Y+H I HRD+K NI +DE + KI DFGL++ +
Sbjct: 121 -LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 443 AQ-------------GTLGYLDPE------YYINFQLTDKSDVYSFGVVLVELLTSKKAV 483
+Q GT Y+ E +Y +K D+YS G++ E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP---- 227
Query: 484 DFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQ 543
F+ E VN+ + P + ++E + +D
Sbjct: 228 -FSTGMERVNI---LKKLRSVSI---EFPPDFDDNKMKVEKK-------IIRLLIDHDPN 273
Query: 544 NRPSIKEV 551
RP + +
Sbjct: 274 KRPGARTL 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 52/212 (24%), Positives = 83/212 (39%), Gaps = 24/212 (11%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNH- 348
++ +G+G +G K D I K G +++EV +L +L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 349 --------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
+L++ M G L + + L L + Q A+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 393 AYLH--LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL 450
H + HRD+K +N+ LD K + K+ DFGL+R+ + S TF GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 451 DPEYYINFQLTDKSDVYSFGVVLVELLTSKKA 482
PE +KSD++S G +L EL
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 60/278 (21%), Positives = 103/278 (37%), Gaps = 40/278 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN---TKGIDPILNEVRILCQLNH 348
NF +G G F EV++A L D A+K+ ++ + K + E+ +L QLNH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 349 -------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L + + G L + + + Q A+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALE 150
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
++H + + HRDIK +N+ + K+ D GL R + + + GT Y+ PE
Sbjct: 151 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 206
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513
KSD++S G +L E+ + F + +NL I + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP--F--YGDKMNLYSLCKKIEQ-----CDYPP 257
Query: 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+ + SE L C++ + RP + V
Sbjct: 258 LPSDHYSE-------ELRQLVNMCINPDPEKRPDVTYV 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 44/221 (19%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH--- 348
+F L+GSGGFG+VFKA D +KR K N K EV+ L +L+H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK----AEREVKALAKLDHVNI 66
Query: 349 --------------------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHH 380
+ LF+ M GTL + + + +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL--- 123
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT 440
L + Q + + Y+H + + +RD+K SNI L + KI DFGL +L T
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT-SLKNDGKRT 179
Query: 441 TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK 481
GTL Y+ PE + + D+Y+ G++L ELL
Sbjct: 180 RSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 59/226 (26%), Positives = 86/226 (38%), Gaps = 45/226 (19%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN-TKGIDPILNEVRILCQLNH-- 348
+F LG GGFG VF+A D+ A+KR +L N + ++ EV+ L +L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 349 -----------------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLH 383
L++ M L D ++ + LH
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLH 122
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
I Q A+A+ +LH + HRD+K SNI K+ DFGL T
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 444 Q-----------GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
GT Y+ PE + K D++S G++L ELL
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 54/208 (25%), Positives = 84/208 (40%), Gaps = 25/208 (12%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN--TKGIDPILNEVRILCQLNH- 348
+ +G G FG+ +D +K + +K + EV +L + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 349 ------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
SL++ M G LF R++ + + L Q A+ +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV---LFQEDQILDWFVQICLALKH 140
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
+H I HRDIKS NI L + ++ DFG++R+ + GT YL PE
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196
Query: 455 YINFQLTDKSDVYSFGVVLVELLTSKKA 482
N +KSD+++ G VL EL T K A
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 56/207 (27%), Positives = 80/207 (38%), Gaps = 35/207 (16%)
Query: 298 GNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNT--KGIDPILNEVRILCQLNHR---- 349
+G G F V+K LD ET A + E +L L H
Sbjct: 31 DIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 350 ---------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
L + +GTL L R + L+ RQ + + +
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-----SWCRQILKGLQF 144
Query: 395 LHLLATPPIYHRDIKSSNILLDEKL-DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
LH TPPI HRD+K NI + KI D GL+ L AS GT ++ PE
Sbjct: 145 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA--TLKRASFAKAV-IGTPEFMAPE 200
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSK 480
Y + + DVY+FG+ ++E+ TS+
Sbjct: 201 MYEE-KYDESVDVYAFGMCMLEMATSE 226
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 41/248 (16%)
Query: 271 SGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN 329
S SGR F + + +L GGF V++A + A+KR
Sbjct: 6 SLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE 65
Query: 330 TKGIDPILNEVRILCQL-NHRS---------------------LFMSMS-PNGTLFDRLH 366
+ I+ EV + +L H + + G L + L
Sbjct: 66 EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK 125
Query: 367 RVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426
+++S PL L I QT +A+ ++H PPI HRD+K N+LL + K+ DF
Sbjct: 126 KMESRG--PLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 427 GLSRLALNGASHVTTFAQ-----------GTLGYLDPE---YYINFQLTDKSDVYSFGVV 472
G + + + + + T Y PE Y NF + +K D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
Query: 473 LVELLTSK 480
L L +
Sbjct: 243 LYLLCFRQ 250
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 9e-29
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 44/214 (20%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDET--ITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+ G LG GGF + F+ D +T + A K ++ L + + E+ I L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 349 RS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQ 387
+ + + + +L + R L + RQ
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEARYYLRQ 123
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
YLH + HRD+K N+ L+E L+ KI DFGL+ GT
Sbjct: 124 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTP 179
Query: 448 GYLDPEYYINFQLTD-KSDVYSFGVVLVELLTSK 480
Y+ PE ++ + + DV+S G ++ LL K
Sbjct: 180 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 55/211 (26%), Positives = 79/211 (37%), Gaps = 39/211 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETIT-AVKRAKLGNTKG-IDPILNEVRILCQLNHRS 350
+ G +G G FGEVF L + AVK + L E RIL Q +H +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 351 L------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
+ + G L L+ L + A +
Sbjct: 174 IVRLIGVCTQKQPIYIVMELV---QGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGM 226
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL-- 450
YL HRD+ + N L+ EK KISDFG+SR +G A G L +
Sbjct: 227 EYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPV 279
Query: 451 ---DPEYYINFQLTDKSDVYSFGVVLVELLT 478
PE + + +SDV+SFG++L E +
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 54/245 (22%), Positives = 94/245 (38%), Gaps = 43/245 (17%)
Query: 267 QKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAK 326
S + G F S ++ +S +GSGG +VF+ + + + I A+K
Sbjct: 4 HHHHSSGVDLGTENLYFQS--MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 327 LGNT--KGIDPILNEVRILCQLNHRS-----------------LFMSMSPNGTLFDRLHR 367
L + +D NE+ L +L S + M N L L +
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK 120
Query: 368 VQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427
+S + R + +A+ +H I H D+K +N L+ + K+ DFG
Sbjct: 121 KKS-----IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFG 171
Query: 428 LSRLALNGASHVTTFAQ-GTLGYLDPE-----------YYINFQLTDKSDVYSFGVVLVE 475
++ + V +Q GT+ Y+ PE +++ KSDV+S G +L
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 476 LLTSK 480
+ K
Sbjct: 232 MTYGK 236
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 32/206 (15%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+F G LG G FG V+ A + I A+K +A+L + EV I L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 349 -------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+++ + +P GT++ L ++ + A A++
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 123
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
Y H + HRDIK N+LL + KI+DFG S A + GTL YL PE
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--DLC-GTLDYLPPE 177
Query: 454 YYINFQLTDKS-DVYSFGVVLVELLT 478
I ++ D+ D++S GV+ E L
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLV 202
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 44/214 (20%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDET--ITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+ G LG GGF + F+ D +T + A K ++ L + + E+ I L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 349 RS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQ 387
+ + + + +L + R L + RQ
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEARYYLRQ 149
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
YLH + HRD+K N+ L+E L+ KI DFGL+ GT
Sbjct: 150 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTP 205
Query: 448 GYLDPEYYINFQLTD-KSDVYSFGVVLVELLTSK 480
Y+ PE ++ + + DV+S G ++ LL K
Sbjct: 206 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 31/205 (15%)
Query: 298 GNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR------- 349
+LG G +G V+ L ++ A+K +++ P+ E+ + L H+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 350 --------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL--HIARQTAQAIAYLHLLA 399
+FM P G+L L W PLK + + +Q + + YLH
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRS----KWGPLKDNEQTIGFYTKQILEGLKYLH--- 139
Query: 400 TPPIYHRDIKSSNILLDEKL-DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
I HRDIK N+L++ KISDFG S+ TF GTL Y+ PE I+
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPE-IIDK 197
Query: 459 QLTD---KSDVYSFGVVLVELLTSK 480
+D++S G ++E+ T K
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 41/227 (18%)
Query: 285 SREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRI 342
+ I+ +S +GSGG +VF+ + + + I A+K L + +D NE+
Sbjct: 1 NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 60
Query: 343 LCQLNHRS-----------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIA 385
L +L S + M N L L + +S + R
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS-----IDPWERKSYW 114
Query: 386 RQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ- 444
+ +A+ +H I H D+K +N L+ + K+ DFG++ + V +Q
Sbjct: 115 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 445 GTLGYLDPE-----------YYINFQLTDKSDVYSFGVVLVELLTSK 480
GT+ Y+ PE +++ KSDV+S G +L + K
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 51/255 (20%), Positives = 98/255 (38%), Gaps = 39/255 (15%)
Query: 256 QSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILD 315
++ + + A ++ I+ +S +GSGG +VF+ + +
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE 78
Query: 316 DETITAVKRAKLGNT--KGIDPILNEVRILCQLNH---------------RSLFMSMS-P 357
+ I A+K L + +D NE+ L +L + ++M M
Sbjct: 79 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG 138
Query: 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE 417
N L L + +S + R + +A+ +H I H D+K +N L+ +
Sbjct: 139 NIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD 190
Query: 418 KLDAKISDFGLSRLALNGASHVTTFAQ-GTLGYLDPE-----------YYINFQLTDKSD 465
+ K+ DFG++ + V +Q G + Y+ PE +++ KSD
Sbjct: 191 GM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 466 VYSFGVVLVELLTSK 480
V+S G +L + K
Sbjct: 250 VWSLGCILYYMTYGK 264
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 50/220 (22%), Positives = 77/220 (35%), Gaps = 44/220 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRA-----KLGNTKGIDPILNEVRILCQLN 347
+ + ++LG G VF+ T A + + +D + E +L +LN
Sbjct: 9 HLWLLSDILGQGATANVFRGR---HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 348 H---------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
H R + M P G+L+ L + N L L + R
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVG 123
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDA----KISDFGLSRLALNGASHVTTFAQGT 446
+ +L I HR+IK NI+ D K++DFG +R L + GT
Sbjct: 124 GMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GT 178
Query: 447 LGYLDPEYYINFQLTD--------KSDVYSFGVVLVELLT 478
YL P+ Y L D++S GV T
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 50/220 (22%), Positives = 77/220 (35%), Gaps = 44/220 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRA-----KLGNTKGIDPILNEVRILCQLN 347
+ + ++LG G VF+ T A + + +D + E +L +LN
Sbjct: 9 HLWLLSDILGQGATANVFRGR---HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 348 H---------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
H R + M P G+L+ L + N L L + R
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVG 123
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDA----KISDFGLSRLALNGASHVTTFAQGT 446
+ +L I HR+IK NI+ D K++DFG +R L + GT
Sbjct: 124 GMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GT 178
Query: 447 LGYLDPEYYINFQLTD--------KSDVYSFGVVLVELLT 478
YL P+ Y L D++S GV T
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 62/219 (28%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 285 SREITEATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVK---RAKLGNTKGIDPILNE 339
+ I E +F GNLLG G F V++A T A+K + + + + NE
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAE-SIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 340 VRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHI 384
V+I CQL H S L + M NG + L + P + H
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVK---PFSENEARHF 117
Query: 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ 444
Q + YLH I HRD+ SN+LL ++ KI+DFGL+ T
Sbjct: 118 MHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC- 173
Query: 445 GTLGYLDPE-----YYINFQLTDKSDVYSFGVVLVELLT 478
GT Y+ PE + +SDV+S G + LL
Sbjct: 174 GTPNYISPEIATRSAH-----GLESDVWSLGCMFYTLLI 207
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 35/210 (16%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH----- 348
+F ++LG G G + + D AVKR D EV++L + +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVI 81
Query: 349 ---------RSLFMSMSP-NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
+ ++++ TL + + + + + +QT +A+LH L
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSL 137
Query: 399 ATPPIYHRDIKSSNILLDEK-----LDAKISDFGLSRLALNGAS--HVTTFAQGTLGYLD 451
I HRD+K NIL+ + A ISDFGL + G + GT G++
Sbjct: 138 N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 452 PEYY---INFQLTDKSDVYSFGVVLVELLT 478
PE T D++S G V +++
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 58/219 (26%), Positives = 84/219 (38%), Gaps = 39/219 (17%)
Query: 289 TEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA-----KLGNTKGIDPILNEVRIL 343
T+ + LG+GGFG V + I T + A + + K + E++I+
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWI---HQDTGEQVAIKQCRQELSPKNRERWCLEIQIM 66
Query: 344 CQLNH-------------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRL 382
+LNH ++M G L L Q N LK
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIR 124
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA---KISDFGLSRLALNGASHV 439
+ + A+ YLH I HRD+K NI+L KI D G ++ L+
Sbjct: 125 TLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELC 180
Query: 440 TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
T F GTL YL PE + T D +SFG + E +T
Sbjct: 181 TEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 30/205 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
++F G LG G FG V+ A ++ I A+K +++L + E+ I L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 349 -------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+ +++ + +P G L+ L + + A A+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALH 128
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
Y H + HRDIK N+L+ K + KI+DFG S A + T GTL YL PE
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--TMC-GTLDYLPPE 182
Query: 454 YYINFQLTDKSDVYSFGVVLVELLT 478
+K D++ GV+ E L
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLV 207
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 51/222 (22%), Positives = 80/222 (36%), Gaps = 42/222 (18%)
Query: 285 SREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVR 341
SR + +F + LG G +GEVFK +D + AVKR+ K L EV
Sbjct: 49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 342 ILCQLNHRSLFMSMSPN----------------------GTLFDRLHRVQSGNWPPLKWH 379
++ P +L + L
Sbjct: 109 SHEKVGQ-------HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA----SLPEA 157
Query: 380 HRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439
R T A+A+LH + + H D+K +NI L + K+ DFGL L A
Sbjct: 158 QVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAG 213
Query: 440 TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK 481
G Y+ PE + +DV+S G+ ++E+ + +
Sbjct: 214 EVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 39/222 (17%), Positives = 78/222 (35%), Gaps = 41/222 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKA----------ILDDETITAVKRAKLGNTKGIDP------I 336
N++ L G F ++ + + + N I
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 337 LNEVRILCQLNH-------------RSLFMSM--SPNGTLFDRL---HRVQSGNWPPLKW 378
NE++I+ + + +++ N ++ + +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 379 HHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438
I + + +Y+H I HRD+K SNIL+D+ K+SDFG S ++
Sbjct: 151 QVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--K 206
Query: 439 VTTFAQGTLGYLDPEYYINFQLTD--KSDVYSFGVVLVELLT 478
+ GT ++ PE++ N + K D++S G+ L +
Sbjct: 207 IKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 27/198 (13%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------ 351
LG G FGEV+ + T A+K K G L E +++ +L H L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 247
Query: 352 -----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
+M G+L D L + L+ + +A Q A +AY+ +
Sbjct: 248 VSEEPIYIVTEYM---SKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMN- 300
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL 460
HRD++++NIL+ E L K++DFGL+RL + A+ + + PE + +
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 461 TDKSDVYSFGVVLVELLT 478
T KSDV+SFG++L EL T
Sbjct: 359 TIKSDVWSFGILLTELTT 376
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 69/302 (22%), Positives = 108/302 (35%), Gaps = 66/302 (21%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQL-NH--- 348
N + +LG G G V AVKR + D L E+++L + +H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 349 ----------RSLFMSMSP-NGTLFDRLHRVQSGNWPPLKWHHR--LHIARQTAQAIAYL 395
R L++++ N L D + + + + RQ A +A+L
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 396 HLLATPPIYHRDIKSSNILLDEK-------------LDAKISDFGLSRLALNGASHVTTF 442
H L I HRD+K NIL+ L ISDFGL + +G S T
Sbjct: 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 443 AQ---GTLGYLDPE-------YYINFQLTDKSDVYSFGVVLVELLTSKK---AVDFNREE 489
GT G+ PE +LT D++S G V +L+ K ++RE
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 490 EDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIK 549
NI++ +D + + D L + +D RP+
Sbjct: 249 ----------NIIRGIFSLDEMKCLHDRSLIAEATD-------LISQMIDHDPLKRPTAM 291
Query: 550 EV 551
+V
Sbjct: 292 KV 293
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 29/200 (14%)
Query: 298 GNLLGSGGFGEVFKAILDDETIT-AVKRAKLGNTKGIDPILNEVRILCQLNHRSL----- 351
+ LG G +GEV++ + ++T AVK K + + L E ++ ++ H +L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 283
Query: 352 -------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
FM G L D L + N + L++A Q + A+ YL
Sbjct: 284 VCTREPPFYIITEFM---TYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
HR++ + N L+ E K++DFGLSRL A+ + + PE
Sbjct: 338 N---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 459 QLTDKSDVYSFGVVLVELLT 478
+ + KSDV++FGV+L E+ T
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 27/198 (13%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------ 351
LG G FGEV+ + T A+K K G L E +++ +L H L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 330
Query: 352 -----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
+M G+L D L + L+ + +A Q A +AY+
Sbjct: 331 VSEEPIYIVTEYM---SKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYV---ER 381
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL 460
HRD++++NIL+ E L K++DFGL+RL + A+ + + PE + +
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 461 TDKSDVYSFGVVLVELLT 478
T KSDV+SFG++L EL T
Sbjct: 442 TIKSDVWSFGILLTELTT 459
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 75/366 (20%), Positives = 122/366 (33%), Gaps = 99/366 (27%)
Query: 248 IKFYKHFHQSNREVSLTKVQKDISGANNSG--RLARIFSSREITEATNNFSTGNLLGSGG 305
+ +Y H H + ++ T+ ++ R F R + LG G
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLK-------FLQQLGKGN 53
Query: 306 FGEVFKAILD-----DETITAVKRAKLGNTKGIDPILNEVRILCQLNH------------ 348
FG V D + AVK+ + + + E+ IL L H
Sbjct: 54 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113
Query: 349 ---RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403
R+L + M P G+L D L + + + L Q + + YL
Sbjct: 114 AGRRNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKR---Y 166
Query: 404 YHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYY-------- 455
HRD+ + NIL++ + KI DFGL+++ D EYY
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVL----------------PQDKEYYKVKEPGES 210
Query: 456 ---------INFQL-TDKSDVYSFGVVLVELLT--SKKAVDFNREEEDVNLVVYFGNILK 503
+ + SDV+SFGVVL EL T K + +
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ--MI 268
Query: 504 QERLVDAIDPMLKEGA---------SEI-ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553
L++ +LK EI + M C + RPS +++A
Sbjct: 269 VFHLIE----LLKNNGRLPRPDGCPDEIYMI--MT-------ECWNNNVNQRPSFRDLAL 315
Query: 554 EIERII 559
+++I
Sbjct: 316 RVDQIR 321
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 27/198 (13%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------ 351
LG+G FGEV+ A + T AVK K G+ L E ++ L H L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 251
Query: 352 -----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
FM G+L D L +S + + Q A+ +A++
Sbjct: 252 VTKEPIYIITEFM---AKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFI---EQ 302
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL 460
HRD++++NIL+ L KI+DFGL+R+ + A+ + + PE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 461 TDKSDVYSFGVVLVELLT 478
T KSDV+SFG++L+E++T
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 55/223 (24%), Positives = 81/223 (36%), Gaps = 46/223 (20%)
Query: 286 REITEATNNFSTGNLLGSGGFGEVFKAIL---DDETIT-AVKRAKLGNT---KGIDPILN 338
I E + LG G FG V + +T++ AVK K + +D +
Sbjct: 13 CLIGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 339 EVRILCQLNHRSL-----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHR 381
EV + L+HR+L P G+L DRL + +
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELA---PLGSLLDRLRK----HQGHFLLGTL 123
Query: 382 LHIARQTAQAIAYL---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438
A Q A+ + YL + HRD+ + N+LL + KI DFGL R L
Sbjct: 124 SRYAVQVAEGMGYLESKRFI------HRDLAARNLLLATRDLVKIGDFGLMRA-LPQNDD 176
Query: 439 VTTFAQGT---LGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ + PE + SD + FGV L E+ T
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 49/301 (16%), Positives = 84/301 (27%), Gaps = 43/301 (14%)
Query: 254 FHQSNREVSLTKVQKDISGANN----SGRLARIFSSREITEATNNFSTGNLLGSGGFGEV 309
+ L+ + K +S N +L I E + +LLG G F +V
Sbjct: 22 WDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQV 81
Query: 310 FKAILDDET------ITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------------- 350
++A D +K K N + L
Sbjct: 82 YEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141
Query: 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDI 408
L + GTL + ++ ++ + + A + I +H I H DI
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDI 198
Query: 409 KSSNILL-----------DEKLDAKISDFGLSRLALNGASHVTTFAQ--GTLGYLDPEYY 455
K N +L D + D G S + T F T G+ E
Sbjct: 199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-DMKLFPKGTIFTAKCETSGFQCVEML 257
Query: 456 INFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515
N + D + + +L + E + F + + + ML
Sbjct: 258 SNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVML 316
Query: 516 K 516
Sbjct: 317 N 317
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 43/211 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL- 351
LG+G FGEV+ + T AVK K G+ L E ++ QL H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLV 71
Query: 352 ----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
+M NG+L D L ++ + L + L +A Q A+ +A++
Sbjct: 72 RLYAVVTQEPIYIITEYM---ENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG---ASHVTTF-----AQGTL 447
HRD++++NIL+ + L KI+DFGL+RL + A F A
Sbjct: 126 ---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA---- 178
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
PE T KSDV+SFG++L E++T
Sbjct: 179 ----PEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 41/205 (20%)
Query: 301 LGSGGFGEVFKAILDDETIT---AVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---- 351
LGSG FG V K + + AVK K D +L E ++ QL++ +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 352 -------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL--- 395
G L L + + +K + + + Q + + YL
Sbjct: 85 GICEAESWMLVMEMA---ELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLEES 136
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL--GYLDPE 453
+ + HRD+ + N+LL + AKISDFGLS+ ++ G + PE
Sbjct: 137 NFV------HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 454 YYINFQLTDKSDVYSFGVVLVELLT 478
++ + KSDV+SFGV++ E +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 53/206 (25%), Positives = 79/206 (38%), Gaps = 43/206 (20%)
Query: 300 LLGSGGFGEVFKA---ILDDETITAVK--RAKLGNTKGIDPIL-----NEVRILCQLNH- 348
L+G GG G+V++A + + A+K L + DP+ E R +L
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIV--ALKLMSETLSS----DPVFRTRMQREARTAGRLQEP 94
Query: 349 ------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
L++ M L L R PL + I RQ A+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDA 149
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ--GTLGYLDP 452
H HRD+K NIL+ A + DFG++ +T GTL Y+ P
Sbjct: 150 AHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAP 204
Query: 453 EYYINFQLTDKSDVYSFGVVLVELLT 478
E + T ++D+Y+ VL E LT
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLT 230
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 1e-24
Identities = 24/242 (9%), Positives = 50/242 (20%), Gaps = 59/242 (24%)
Query: 287 EITEATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVK---RAKLGNTKGIDPILNEVR 341
+++ L G VF D E A+K + ++ +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVR-DVERLEDFALKVFTMGAENSRSELERLHEATF 114
Query: 342 ILCQLNHR---------------------------------------SLFMSM----SPN 358
+L + + M
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418
LF L V + Q + A L + + H N+ +
Sbjct: 175 ELLFSTLDFVYVFR-GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPD 230
Query: 419 LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYY--INFQLTDKSDVYSFGVVLVEL 476
+ D + + Y E+ T + + G+ + +
Sbjct: 231 GRLMLGDVSALWK----VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 477 LT 478
Sbjct: 287 WC 288
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 46/222 (20%)
Query: 286 REITEATNNFSTGNLLGSGGFGEVFKAILDD-----ETITAVKRAKLGNT-KGIDPILNE 339
R + E F +LGSG FG V+K + + A+K + + K IL+E
Sbjct: 10 RILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 340 VRILCQLNHRSL-----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL 382
++ +++ + M P G L D + + + + L
Sbjct: 68 AYVMASVDNPHVCRLLGICLTSTVQLITQLM---PFGCLLDYVRE----HKDNIGSQYLL 120
Query: 383 HIARQTAQAIAYL---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439
+ Q A+ + YL L+ HRD+ + N+L+ KI+DFGL++L
Sbjct: 121 NWCVQIAKGMNYLEDRRLV------HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 440 TTFAQGT---LGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+G + ++ E ++ T +SDV+S+GV + EL+T
Sbjct: 175 HA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/258 (21%), Positives = 97/258 (37%), Gaps = 52/258 (20%)
Query: 255 HQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI- 313
H + S + N ++ +E + + G LLGSGGFG V+ I
Sbjct: 5 HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIR 64
Query: 314 LDDETITAVK---RAKLGNTKGID---PILNEVRILCQLNH---------------RSLF 352
+ D A+K + ++ + + + EV +L +++ S
Sbjct: 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124
Query: 353 MSM---SPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQTAQAIAYLHLLATPPI 403
+ + P LFD + L Q +A+ + H +
Sbjct: 125 LILERPEPVQDLFDFITE-----------RGALQEELARSFFWQVLEAVRHCHNCG---V 170
Query: 404 YHRDIKSSNILLD-EKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
HRDIK NIL+D + + K+ DFG L + T F GT Y PE +I +
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFD-GTRVYSPPE-WIRYHRYH 226
Query: 463 --KSDVYSFGVVLVELLT 478
+ V+S G++L +++
Sbjct: 227 GRSAAVWSLGILLYDMVC 244
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 66/314 (21%), Positives = 106/314 (33%), Gaps = 90/314 (28%)
Query: 298 GNLLGSGGFGEVFKAILD-----DETITAVKRAKLGNTKGIDPILNEVRILCQLNH---- 348
LG G FG V D + AVK+ + + + E+ IL L H
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 349 -----------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
R+L + M P G+L D L + + + L Q + + YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYL 130
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYY 455
HRD+ + NIL++ + KI DFGL+++ D E++
Sbjct: 131 GTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL----------------PQDKEFF 171
Query: 456 -----------------INFQL-TDKSDVYSFGVVLVELLT--SKKAVDFNREEEDVNLV 495
+ + SDV+SFGVVL EL T K +
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 496 VYFGNILKQERLVDAIDPMLKEGA---------SEI-ELDSMKAFGLLGAACLDERRQNR 545
+ L++ +LK EI + M C + R
Sbjct: 232 KQGQ--MIVFHLIE----LLKNNGRLPRPDGCPDEIYMI--MT-------ECWNNNVNQR 276
Query: 546 PSIKEVADEIERII 559
PS +++A +++I
Sbjct: 277 PSFRDLALRVDQIR 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 48/219 (21%), Positives = 83/219 (37%), Gaps = 36/219 (16%)
Query: 284 SSREITEATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPILNEVR 341
E E + + +G G FGEV + D +T AVK+ +L + + E+
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRM-KDKQTGFQCAVKKVRLEVFR-----VEELV 102
Query: 342 ILCQLNHR---------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
L+ ++FM + G+L + + L L+
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ-----MGCLPEDRALYYLG 157
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGLS-RLALNGASHVTTFA- 443
Q + + YLH T I H D+K+ N+LL A + DFG + L +G
Sbjct: 158 QALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 444 --QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
GT ++ PE + K D++S +++ +L
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 63/222 (28%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETIT-AVKRAKLGNTKGIDPILNEVRILCQLNHRSL 351
+ + + LG G +GEV++ + ++T AVK K + + L E ++ ++ H +L
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNL 71
Query: 352 ------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
FM G L D L + N + L++A Q + A+
Sbjct: 72 VQLLGVCTREPPFYIITEFM---TYGNLLDYL---RECNRQEVSAVVLLYMATQISSAME 125
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YL HRD+ + N L+ E K++DFGLSRL
Sbjct: 126 YL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-----------------MTGDT 165
Query: 454 YY----------------INFQL-TDKSDVYSFGVVLVELLT 478
Y + + + KSDV++FGV+L E+ T
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 71/313 (22%), Positives = 109/313 (34%), Gaps = 88/313 (28%)
Query: 298 GNLLGSGGFGEVFKAILD-----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNH--- 348
LG G FG+V D AVK K + I + E+ IL L H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 349 ------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
+ + M P+G+L + L + N + +L A Q + + Y
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDY 141
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
L HRD+ + N+L++ + KI DFGL++ D EY
Sbjct: 142 LGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI----------------ETDKEY 182
Query: 455 Y-----------------INFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496
Y + SDV+SFGV L ELLT + +
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 497 YFGNILKQERLVDAIDPMLKEGA---------SEI-ELDSMKAFGLLGAACLDERRQNRP 546
G + RLV+ LKEG E+ +L M+ C + + NR
Sbjct: 243 THGQM-TVTRLVN----TLKEGKRLPCPPNCPDEVYQL--MR-------KCWEFQPSNRT 288
Query: 547 SIKEVADEIERII 559
S + + + E ++
Sbjct: 289 SFQNLIEGFEALL 301
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 55/217 (25%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL- 351
+ + +GSG FG V ++ A+K + G D + E ++ +L+H L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLV 66
Query: 352 -----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
FM +G L D L L + + +AY
Sbjct: 67 QLYGVCLEQAPICLVTEFM---EHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAY 119
Query: 395 L---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG---ASHVTTF-----A 443
L ++ HRD+ + N L+ E K+SDFG++R L+ +S T F +
Sbjct: 120 LEEACVI------HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 173
Query: 444 QGTLGYLDPE--YYINFQLTDKSDVYSFGVVLVELLT 478
PE + + + KSDV+SFGV++ E+ +
Sbjct: 174 --------PEVFSFSRY--SSKSDVWSFGVLMWEVFS 200
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 52/210 (24%), Positives = 79/210 (37%), Gaps = 45/210 (21%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL- 351
+G G FG+V + AVK K T L E ++ QL H +L
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 352 ------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+M G+L D L +S L L + +A+
Sbjct: 250 QLLGVIVEEKGGLYIVTEYM---AKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF-----AQGTLG 448
YL HRD+ + N+L+ E AK+SDFGL++ + A
Sbjct: 304 YL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPVKWTA----- 354
Query: 449 YLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
PE + + KSDV+SFG++L E+ +
Sbjct: 355 ---PEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 47/221 (21%), Positives = 82/221 (37%), Gaps = 63/221 (28%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL- 351
+ LGSG FG V + AVK K G+ + E + + +L+H L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE-FFQEAQTMMKLSHPKLV 66
Query: 352 -----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
++ NG L + L + L+ L + + +A+
Sbjct: 67 KFYGVCSKEYPIYIVTEYI---SNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAF 119
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
L + HRD+ + N L+D L K+SDFG++R LD +Y
Sbjct: 120 L---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-----------------LDDQY 159
Query: 455 Y----------------INFQL-TDKSDVYSFGVVLVELLT 478
++ + KSDV++FG+++ E+ +
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 45/212 (21%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL- 351
+ + LG+G FG V + A+K K G+ + + E +++ L+H L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLV 82
Query: 352 -----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
+M NG L + L + L + + +A+ Y
Sbjct: 83 QLYGVCTKQRPIFIITEYM---ANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEY 135
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG---ASHVTTF-----AQGT 446
L + HRD+ + N L++++ K+SDFGLSR L+ +S + F
Sbjct: 136 L---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--- 189
Query: 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
PE + + + KSD+++FGV++ E+ +
Sbjct: 190 -----PEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 39/204 (19%)
Query: 301 LGSGGFGEVFKAIL---DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL----- 351
LG G FG V + + + A+K K G + ++ E +I+ QL++ +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 352 ------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL---H 396
G L L G + + + Q + + YL +
Sbjct: 78 VCQAEALMLVMEMA---GGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL--GYLDPEY 454
+ HRD+ + N+LL + AKISDFGLS+ S+ T + G + PE
Sbjct: 131 FV------HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 455 YINFQLTDKSDVYSFGVVLVELLT 478
+ + +SDV+S+GV + E L+
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS 208
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 61/212 (28%), Positives = 86/212 (40%), Gaps = 45/212 (21%)
Query: 298 GNLLGSGGFGEVFKA---ILDDETITAVK--RAKLGNTKGIDPIL-----NEVRILCQLN 347
G +LG GG EV A + AVK RA L DP E + LN
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDV--AVKVLRADLAR----DPSFYLRFRREAQNAAALN 70
Query: 348 HRSL-----------------FMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQT 388
H ++ ++ M TL D +H P+ + +
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADA 125
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ--GT 446
QA+ + H I HRD+K +NI++ K+ DFG++R + + VT A GT
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
YL PE + +SDVYS G VL E+LT
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 55/205 (26%), Positives = 81/205 (39%), Gaps = 41/205 (20%)
Query: 300 LLGSGGFGEVFKA---ILDDETITAVK--RAKLGNTKGIDPIL-----NEVRILCQLNHR 349
LG GG V+ A IL+ A+K EV QL+H+
Sbjct: 18 KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPRE----KEETLKRFEREVHNSSQLSHQ 71
Query: 350 SL-------------FMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
++ ++ M TL + + PL ++ Q I +
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKH 126
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT-FAQGTLGYLDPE 453
H + I HRDIK NIL+D KI DFG+++ AL+ S T GT+ Y PE
Sbjct: 127 AHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPE 182
Query: 454 YYINFQLTDKSDVYSFGVVLVELLT 478
+ +D+YS G+VL E+L
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLV 207
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/233 (24%), Positives = 88/233 (37%), Gaps = 65/233 (27%)
Query: 286 REITEATNNFSTGNLLGSGGFGEVFKAILD-----DETITAVKRAKLGNTKGIDPILNEV 340
E + + LG G FG V D + AVK+ + E+
Sbjct: 18 TIFEE--RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 75
Query: 341 RILCQLNH---------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLH 383
+IL L+ +SL + M P+G L D L R + L L
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR----HRARLDASRLLL 131
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
+ Q + + YL HRD+ + NIL++ + KI+DFGL++L
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL----------- 177
Query: 444 QGTLGYLDPEYY-----------------INFQL-TDKSDVYSFGVVLVELLT 478
LD +YY ++ + + +SDV+SFGVVL EL T
Sbjct: 178 -----PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 39/219 (17%)
Query: 284 SSREITEATNNFSTGNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKGIDPI 336
S + N+ +G G F +V A +T A+K + +L N + +
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLAR---HILTGREVAIKIIDKTQL-NPTSLQKL 61
Query: 337 LNEVRILCQLNH-------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHR 381
EVRI+ LNH ++L++ M + G +FD L V G +K
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHG---RMKEKEA 116
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
RQ A+ Y H I HRD+K+ N+LLD ++ KI+DFG S G +
Sbjct: 117 RSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDA 172
Query: 442 FAQGTLGYLDPEYYINFQLTD--KSDVYSFGVVLVELLT 478
F G Y PE + D + DV+S GV+L L++
Sbjct: 173 FC-GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-23
Identities = 38/208 (18%), Positives = 75/208 (36%), Gaps = 52/208 (25%)
Query: 300 LLGSGGFGEVFKA---ILDDETITAVK--RAKLGNTKGIDPILNEVRILCQLNHRSL--- 351
+ GG G ++ A ++ + +K G+ + + E + L ++ H S+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPV-VLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 352 ---------------FMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
++ M +L + L + + A++Y
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSY 197
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
LH + + + D+K NI+L E+ K+ D G +N ++ GT G+ PE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPE- 247
Query: 455 YINFQL----TDKSDVYSFGVVLVELLT 478
+ T +D+Y+ G L L
Sbjct: 248 ----IVRTGPTVATDIYTVGRTLAALTL 271
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 72/228 (31%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGNT-KGIDPILNEVRILCQLN 347
+ +LG G FGEV++ + ++ AVK K T + ++E I+ L+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 348 HRSL-----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
H + P G L L R N LK + + Q +
Sbjct: 72 HPHIVKLIGIIEEEPTWIIMELY---PYGELGHYLER----NKNSLKVLTLVLYSLQICK 124
Query: 391 AIAYL---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
A+AYL + + HRDI NIL+ K+ DFGLSR
Sbjct: 125 AMAYLESINCV------HRDIAVRNILVASPECVKLGDFGLSRYI--------------- 163
Query: 448 GYLDPEYY----------------INFQL-TDKSDVYSFGVVLVELLT 478
D +YY INF+ T SDV+ F V + E+L+
Sbjct: 164 --EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 41/251 (16%), Positives = 74/251 (29%), Gaps = 68/251 (27%)
Query: 287 EITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRI 342
E+ E G +LG +A + V + + I + EV
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 343 LCQLNHRS-------------------------------------------LFMSMSPN- 358
L L L+ M N
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418
T + L S + L H RL + Q + +A LH + H ++ +I+LD++
Sbjct: 187 QTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 242
Query: 419 LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY-----------YINFQLTDKSDVY 467
++ F +GA V++ + G+ PE +T D +
Sbjct: 243 GGVFLTGFEHLV--RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297
Query: 468 SFGVVLVELLT 478
+ G+V+ +
Sbjct: 298 ALGLVIYWIWC 308
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 33/209 (15%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRILCQLN 347
++ + +LG G FGEV AVK + ++ + +L EV++L QL+
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 348 HRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
H + L + G LFD + + + I RQ I
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSE---VDAARIIRQVLSGI 139
Query: 393 AYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGY 449
Y+H I HRD+K N+LL + + +I DFGLS GT Y
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYY 194
Query: 450 LDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ PE ++ +K DV+S GV+L LL+
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLS 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 71/314 (22%), Positives = 106/314 (33%), Gaps = 92/314 (29%)
Query: 298 GNLLGSGGFGEVFKAILDD-----ETITAVKRAKLGNT-KGIDPILNEVRILCQLNH--- 348
LG G FG+V D + AVK K + E+ IL L H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 349 ------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
SL + M P G+L D L R + L A+Q + +AY
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAY 149
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
LH HRD+ + N+LLD KI DFGL++ EY
Sbjct: 150 LHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV----------------PEGHEY 190
Query: 455 Y-----------------INFQL-TDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLV 495
Y + SDV+SFGV L ELLT + + ++ +
Sbjct: 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
Query: 496 VYFGNILKQERLVDAIDPMLKEGA---------SEI-ELDSMKAFGLLGAACLDERRQNR 545
+ RL + +L+ G +E+ L MK C + R
Sbjct: 251 AQGQ--MTVLRLTE----LLERGERLPRPDKCPAEVYHL--MK-------NCWETEASFR 295
Query: 546 PSIKEVADEIERII 559
P+ + + ++ +
Sbjct: 296 PTFENLIPILKTVH 309
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 285 SREITEATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPILNEVRI 342
S + T F +LGSG F EVF T + A+K K + NE+ +
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVK-QRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 343 LCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL--HIA 385
L ++ H + L M + G LFDR+ ++ G + + +
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI--LERG-----VYTEKDASLVI 112
Query: 386 RQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGASHVTTF 442
+Q A+ YLH I HRD+K N+L +E I+DFGLS++ NG ++T
Sbjct: 113 QQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTA 167
Query: 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
GT GY+ PE + D +S GV+ LL
Sbjct: 168 C-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 44/260 (16%)
Query: 248 IKFYKHFHQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFG 307
+ +Y H H + ++ T+ + A + + EI + + ++G+G FG
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEI--HPSCVTRQKVIGAGEFG 58
Query: 308 EVFKAIL-----DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------- 351
EV+K +L E A+K K G T K L E I+ Q +H ++
Sbjct: 59 EVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118
Query: 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403
+M NG L L + + R A + YL +
Sbjct: 119 KPMMIITEYM---ENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMN---- 167
Query: 404 Y-HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT---LGYLDPEYYINFQ 459
Y HRD+ + NIL++ L K+SDFGLSR+ + T G + + PE I+++
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-TSGGKIPIRWTAPE-AISYR 225
Query: 460 L-TDKSDVYSFGVVLVELLT 478
T SDV+SFG+V+ E++T
Sbjct: 226 KFTSASDVWSFGIVMWEVMT 245
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 39/204 (19%)
Query: 301 LGSGGFGEVFKAIL---DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL----- 351
LG G FG V + + + A+K K G + ++ E +I+ QL++ +
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 352 ------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL---H 396
G L L + + + Q + + YL +
Sbjct: 404 VCQAEALMLVMEMA---GGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGY--LDPEY 454
+ HR++ + N+LL + AKISDFGLS+ S+ T + G PE
Sbjct: 457 FV------HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 455 YINFQLTDKSDVYSFGVVLVELLT 478
+ + +SDV+S+GV + E L+
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 44/221 (19%)
Query: 286 REITEATNNFSTGNLLGSGGFGEVFKAILDD-----ETITAVKRAKLGNT-KGIDPILNE 339
R + E F +LGSG FG V+K + + A+K + + K IL+E
Sbjct: 10 RILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 340 VRILCQLNHRSL-----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL 382
++ +++ + M P G L D + + + + L
Sbjct: 68 AYVMASVDNPHVCRLLGICLTSTVQLITQLM---PFGCLLDYVRE----HKDNIGSQYLL 120
Query: 383 HIARQTAQAIAYL---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439
+ Q A+ + YL L+ HRD+ + N+L+ KI+DFGL++L L
Sbjct: 121 NWCVQIAKGMNYLEDRRLV------HRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKE 173
Query: 440 TTFAQGTL--GYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
G + ++ E ++ T +SDV+S+GV + EL+T
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 52/228 (22%), Positives = 74/228 (32%), Gaps = 72/228 (31%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGNT-KGIDPILNEVRILCQLN 347
G +G G FG+V + I + A+K K + + L E + Q +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 348 HRSL-----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
H + G L L L + A Q +
Sbjct: 75 HPHIVKLIGVITENPVWIIMELC---TLGELRSFLQV----RKYSLDLASLILYAYQLST 127
Query: 391 AIAYL---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
A+AYL + HRDI + N+L+ K+ DFGLSR
Sbjct: 128 ALAYLESKRFV------HRDIAARNVLVSSNDCVKLGDFGLSRYM--------------- 166
Query: 448 GYLDPEYY----------------INF-QLTDKSDVYSFGVVLVELLT 478
D YY INF + T SDV+ FGV + E+L
Sbjct: 167 --EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 53/210 (25%), Positives = 80/210 (38%), Gaps = 45/210 (21%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL- 351
+G G FG+V + AVK K T L E ++ QL H +L
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 352 ------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+M G+L D L +S L L + +A+
Sbjct: 78 QLLGVIVEEKGGLYIVTEYM---AKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF-----AQGTLG 448
YL HRD+ + N+L+ E AK+SDFGL++ A + A
Sbjct: 132 YL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-TQDTGKLPVKWTA----- 182
Query: 449 YLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
PE + + KSDV+SFG++L E+ +
Sbjct: 183 ---PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 53/236 (22%)
Query: 272 GANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETIT-----AVKRAK 326
GA LARIF E+ +LGSG FG V K + E + +K +
Sbjct: 1 GAMKV--LARIFKETELR-------KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE 51
Query: 327 LGNT-KGIDPILNEVRILCQLNHRSL-----------------FMSMSPNGTLFDRLHRV 368
+ + + + + + L+H + ++ P G+L D + +
Sbjct: 52 DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYL---PLGSLLDHVRQ- 107
Query: 369 QSGNWPPLKWHHRLHIARQTAQAIAYL---HLLATPPIYHRDIKSSNILLDEKLDAKISD 425
+ L L+ Q A+ + YL ++ HR++ + N+LL +++D
Sbjct: 108 ---HRGALGPQLLLNWGVQIAKGMYYLEEHGMV------HRNLAARNVLLKSPSQVQVAD 158
Query: 426 FGLSRLALNGASHVTTFAQGT---LGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
FG++ L + + ++ E + T +SDV+S+GV + EL+T
Sbjct: 159 FGVADLLPPDDKQLLY--SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 2e-22
Identities = 35/246 (14%), Positives = 62/246 (25%), Gaps = 57/246 (23%)
Query: 286 REITEATNNFSTGNLLGSGGFGEVFKA------------------ILDDETITAVKR--- 324
E+ E G +LG +A I +K
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 325 --AKLGNTKGIDPILNEVRILCQLNH---------------------RSLFMSM----SP 357
L K +R + + S F S
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE 417
T + L S + L H RL + Q + +A LH + H ++ +I+LD+
Sbjct: 191 LQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQ 246
Query: 418 KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ-----LTDKSDVYSFGVV 472
+ ++ F A Q +T D ++ G+
Sbjct: 247 RGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 473 LVELLT 478
+ +
Sbjct: 307 IYWIWC 312
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-22
Identities = 48/211 (22%), Positives = 77/211 (36%), Gaps = 38/211 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGNT-KGIDPILNEVRILCQLN 347
G +G G FG+V + I + A+K K + + L E + Q +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 348 HRSL-----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
H + G L L L + A Q +
Sbjct: 450 HPHIVKLIGVITENPVWIIMELC---TLGELRSFLQV----RKFSLDLASLILYAYQLST 502
Query: 391 AIAYL---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
A+AYL + HRDI + N+L+ K+ DFGLSR + + + + +
Sbjct: 503 ALAYLESKRFV------HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
++ PE + T SDV+ FGV + E+L
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGNT-KGIDPILNEVRILCQLN 347
N S ++G+G FGEV L E A+K K+G T K L E I+ Q +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 348 HRSL------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTA 389
H ++ +M NG+L L + + + + R A
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYM---ENGSLDSFLRK----HDAQFTVIQLVGMLRGIA 157
Query: 390 QAIAYLHLLATPPIY-HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG 448
+ YL + Y HRD+ + NIL++ L K+SDFGL R+ + T G +
Sbjct: 158 SGMKYLSDMG----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 449 YL--DPEYYINFQLTDKSDVYSFGVVLVELLT 478
PE + T SDV+S+G+VL E+++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 65/250 (26%), Positives = 96/250 (38%), Gaps = 42/250 (16%)
Query: 251 YKHFHQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVF 310
+ H H S RE Q D+ F + + + + LGSG +GEV
Sbjct: 3 HHHHHSSGRE--NLYFQGDLQATPGM------FITSKKGHLSEMYQRVKKLGSGAYGEVL 54
Query: 311 KAI-LDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNHRS---------------L 351
A+K + + +T +L EV +L L+H + L
Sbjct: 55 LCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113
Query: 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSS 411
M G LFD + + + I +Q + YLH I HRD+K
Sbjct: 114 VMECYKGGELFDEI--IHRMKFNE---VDAAVIIKQVLSGVTYLHKHN---IVHRDLKPE 165
Query: 412 NILL---DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYS 468
N+LL ++ KI DFGLS + N GT Y+ PE + + +K DV+S
Sbjct: 166 NLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPE-VLRKKYDEKCDVWS 222
Query: 469 FGVVLVELLT 478
GV+L LL
Sbjct: 223 IGVILFILLA 232
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 51/224 (22%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDD----ETITAVKRAKLGNTKGIDPI--LNEVRILCQL 346
N G +LG G FG V + L AVK KL N+ + L+E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 347 NHRSL-----------------------FMSMSPNGTL--FDRLHRVQSGNWPPLKWHHR 381
+H ++ FM G L + R+++G +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFM---KYGDLHTYLLYSRLETGP-KHIPLQTL 149
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
L A + YL + HRD+ + N +L + + ++DFGLS+ +G
Sbjct: 150 LKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG----DY 202
Query: 442 FAQGTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
+ QG + + E + T KSDV++FGV + E+ T
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVY--TSKSDVWAFGVTMWEIAT 244
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 47/230 (20%), Positives = 76/230 (33%), Gaps = 52/230 (22%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQL-- 346
T F +GSG FG VFK + D I A+KR+K + L EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 347 --------------NHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
+H + G+L D + K + Q + +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE-NYRIMSYFKEAELKDLLLQVGRGL 128
Query: 393 AYLHLLATPPIYHRDIKSSNILLDE-------------------KLDAKISDFGLSRLAL 433
Y+H + + H DIK SNI + K+ KI D G
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 434 NGASHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSK 480
+ G +L E + N+ K+D+++ + +V ++
Sbjct: 186 SPQVEE-----GDSRFLANE--VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 55/225 (24%), Positives = 84/225 (37%), Gaps = 42/225 (18%)
Query: 284 SSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGID---PI 336
++ + G LLG GGFG VF L D A+K R ++ +
Sbjct: 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 337 LNEVRILCQLNH-----------------RSLFMSM---SPNGTLFDRLHRVQSGNWPPL 376
EV +L ++ + + P LFD + + G L
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGP---L 136
Query: 377 KWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD-EKLDAKISDFGLSRLALNG 435
Q AI + H + HRDIK NIL+D + AK+ DFG L +
Sbjct: 137 GEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193
Query: 436 ASHVTTFAQGTLGYLDPEYYINFQLTD--KSDVYSFGVVLVELLT 478
T F GT Y PE +I+ + V+S G++L +++
Sbjct: 194 --PYTDFD-GTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVC 234
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 66/271 (24%), Positives = 95/271 (35%), Gaps = 72/271 (26%)
Query: 274 NNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETIT----AVK-----R 324
++SGR F + E + +G G +G V AI E T A+K +
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAI---ENQTRAIRAIKIMNKNK 63
Query: 325 AKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQ 369
+ N K ++ I EVR++ +L+H + L M + G L D+L+
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 370 SGNWPPLKWHHRL-----------------------------------HIARQTAQAIAY 394
+ +I RQ A+ Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDA--KISDFGLSRL---ALNGASHVTTFAQGTLGY 449
LH I HRDIK N L K+ DFGLS+ NG + T GT +
Sbjct: 184 LHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 450 LDPE--YYINFQLTDKSDVYSFGVVLVELLT 478
+ PE N K D +S GV+L LL
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 58/218 (26%), Positives = 85/218 (38%), Gaps = 50/218 (22%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDP-----ILNEVRILC 344
+ST + LGSG FG V+ A+ + VK + K+ I+ + E+ IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 345 QLNH-------------RSLFMSM---SPNGTLFDRLHRVQSGNWPPLKWHHRL------ 382
++ H + M LF + R H RL
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-----------HPRLDEPLAS 133
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
+I RQ A+ YL L I HRDIK NI++ E K+ DFG + G TF
Sbjct: 134 YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTF 189
Query: 443 AQGTLGYLDPEYYINFQLTD--KSDVYSFGVVLVELLT 478
GT+ Y PE + + +++S GV L L+
Sbjct: 190 C-GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 62/255 (24%), Positives = 100/255 (39%), Gaps = 48/255 (18%)
Query: 256 QSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILD 315
+N E++L+ + + + + + + + + LGSG GEV A
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRD---EYIMSKTLGSGACGEVKLAF-- 155
Query: 316 DETIT----AVK---RAKLGNTKGIDP-----ILNEVRILCQLNH------------RSL 351
E T A++ + K + + E+ IL +LNH
Sbjct: 156 -ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 214
Query: 352 FMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIK 409
++ + G LFD++ V + LK Q A+ YLH I HRD+K
Sbjct: 215 YIVLELMEGGELFDKV--VGNKR---LKEATCKLYFYQMLLAVQYLHENG---IIHRDLK 266
Query: 410 SSNILL---DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL---TDK 463
N+LL +E KI+DFG S++ S + T GT YL PE ++
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC-GTPTYLAPEVLVSVGTAGYNRA 324
Query: 464 SDVYSFGVVLVELLT 478
D +S GV+L L+
Sbjct: 325 VDCWSLGVILFICLS 339
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 45/211 (21%)
Query: 298 GNLLGSGGFGEVFKAIL----DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL- 351
++GSG GEV L + A+K K G T + L+E I+ Q +H ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 352 -----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
+M NG+L L + + + R + Y
Sbjct: 114 RLEGVVTRGRLAMIVTEYM---ENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRY 166
Query: 395 L---HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL- 450
L + HRD+ + N+L+D L K+SDFGLSR+ + T G +
Sbjct: 167 LSDLGYV------HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 451 -DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
PE + F + SDV+SFGVV+ E+L
Sbjct: 221 TAPEAIAFRTF--SSASDVWSFGVVMWEVLA 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 64/227 (28%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 274 NNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGN 329
++S ++ E ++ +LG G FGEV K + AVK +A N
Sbjct: 6 HHSSGRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 330 TKGIDPILNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWP 374
K IL EV +L +L+H + + + G LFD + ++ +
Sbjct: 63 -KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFS 119
Query: 375 PLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRL 431
H I +Q I Y+H I HRD+K NILL ++ D KI DFGLS
Sbjct: 120 E---HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
GT Y+ PE + +K DV+S GV+L LL+
Sbjct: 174 FQQNTKMKDRI--GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLS 217
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 74/231 (32%)
Query: 298 GNLLGSGGFGEVFKAIL---DDETITAVKRAKLGNTKGIDPI--LNEVRILCQLNH---- 348
+++G G FG+V KA + A+KR K +K D E+ +LC+L H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPNI 88
Query: 349 ----------RSLFMSM--SPNGTLFD--RLHRVQSGNW---------PPLKWHHRLHIA 385
L++++ +P+G L D R RV + L LH A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 386 RQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG 445
A+ + YL + HRD+ + NIL+ E AKI+DFGLSR
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------------- 190
Query: 446 TLGYLDPEYY-----------------INFQL-TDKSDVYSFGVVLVELLT 478
E Y +N+ + T SDV+S+GV+L E+++
Sbjct: 191 -----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 45/231 (19%), Positives = 78/231 (33%), Gaps = 70/231 (30%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL--------DDETITAVKRAKLGNTKGIDPILNEVRILC 344
+ LG G F ++FK + ET +K + + ++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 345 QLNHRSL------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
+L+H+ L F+ G+L L + N + +L +A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFV---KFGSLDTYLKK----NKNCINILWKLEVAK 120
Query: 387 QTAQAIAYL---HLLATPPIYHRDIKSSNILLDEKLD--------AKISDFGLSRLALNG 435
Q A A+ +L L+ H ++ + NILL + D K+SD G+S L
Sbjct: 121 QLAAAMHFLEENTLI------HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP- 173
Query: 436 ASHVTTF-----AQGTLGYLDPE---YYINFQLTDKSDVYSFGVVLVELLT 478
+ PE N +D +SFG L E+ +
Sbjct: 174 -KDILQERIPWVP--------PECIENPKNL--NLATDKWSFGTTLWEICS 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/219 (28%), Positives = 82/219 (37%), Gaps = 47/219 (21%)
Query: 298 GNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGIDPILNEVRILCQLNH--- 348
LG G FG+VF A D+ + AVK K + E +L L H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 349 ------------RSLFMSMSPNGTL--FDRLHRVQSGNWP--------PLKWHHRLHIAR 386
+ +G L F R H + PL L +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGT 446
Q A + YL A HRD+ + N L+ + L KI DFG+SR + + G
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGG 218
Query: 447 LGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
L PE Y F T +SDV+SFGVVL E+ T
Sbjct: 219 RTMLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIFT 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 58/223 (26%), Positives = 82/223 (36%), Gaps = 49/223 (21%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQ 345
N + LG G FGEV++ + AVK + + L E I+ +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 346 LNHRSL------------------FMSMSPNGTL--FDRLHRVQSGNWPPLKWHHRLHIA 385
NH+++ M G L F R R + L LH+A
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELM---AGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 386 RQTAQAIAYLHLLATPPIYHRDIKSSNILLD---EKLDAKISDFGLSRLALNGASHVTTF 442
R A YL HRDI + N LL AKI DFG++R + +
Sbjct: 147 RDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YY 199
Query: 443 AQGTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
+G L PE F T K+D +SFGV+L E+ +
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIFS 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 38/209 (18%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKGIDPILNEVRILCQL 346
++ G+ LG G FG+V +T AVK R K+ + + I E++ L
Sbjct: 12 HYVLGDTLGVGTFGKVKIGE---HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 347 NH-------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQA 391
H FM M G LFD + + G ++ + +Q A
Sbjct: 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHG---RVEEMEARRLFQQILSA 123
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLD 451
+ Y H + HRD+K N+LLD ++AKI+DFGLS + +G + T G+ Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAA 178
Query: 452 PEYYINFQLTD--KSDVYSFGVVLVELLT 478
PE I+ +L + D++S GV+L LL
Sbjct: 179 PE-VISGRLYAGPEVDIWSCGVILYALLC 206
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 55/223 (24%), Positives = 82/223 (36%), Gaps = 48/223 (21%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDD----ETITAVKRAKLGNTKGIDPI--LNEVRILCQL 346
F+ G +LG G FG V +A L AVK K D L E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 347 NHRSL------------------------FMSMSPNGTL--FDRLHRVQSGNWPPLKWHH 380
+H + FM +G L F R+ N L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFM---KHGDLHAFLLASRI-GENPFNLPLQT 138
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT 440
+ A + YL ++ HRD+ + N +L E + ++DFGLSR +G
Sbjct: 139 LVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----D 191
Query: 441 TFAQGTLGYL-----DPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ QG L E + T SDV++FGV + E++T
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 61/241 (25%), Positives = 86/241 (35%), Gaps = 60/241 (24%)
Query: 278 RLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNT 330
R A + S N+ +LG G V + I T AVK G+
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCI---HKPTCKEYAVKIIDVTGGGSF 58
Query: 331 KGIDP------ILNEVRILCQLN-HRS---------------LFMSMSPNGTLFDRLHRV 368
+ L EV IL +++ H + L + G LFD L
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--T 116
Query: 369 QSGNWPPLKWHHRL------HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAK 422
+ L I R + I LH L I HRD+K NILLD+ ++ K
Sbjct: 117 EKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIK 164
Query: 423 ISDFGLSRLALNGASHVTTFAQGTLGYLDPE------YYINFQLTDKSDVYSFGVVLVEL 476
++DFG S G GT YL PE + + D++S GV++ L
Sbjct: 165 LTDFGFSCQLDPGEKLREVC--GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222
Query: 477 L 477
L
Sbjct: 223 L 223
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 57/221 (25%), Positives = 85/221 (38%), Gaps = 45/221 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGIDPI--LNEVRILC 344
+ LG G FG V++ + + ET A+K + + I LNE ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMK 83
Query: 345 QLNH-------------RSLFMSMS--PNGTL--FDRLHRVQSGNWP---PLKWHHRLHI 384
+ N + + M G L + R R N P P + +
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ 444
A + A +AYL HRD+ + N ++ E KI DFG++R + +
Sbjct: 144 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRK 196
Query: 445 GTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
G G L PE F T SDV+SFGVVL E+ T
Sbjct: 197 GGKGLLPVRWMSPESLKDGVF--TTYSDVWSFGVVLWEIAT 235
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 51/259 (19%), Positives = 89/259 (34%), Gaps = 49/259 (18%)
Query: 251 YKHFHQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFS----TGNLLGSGGF 306
+ H H ++ K + + + + + + LGSG F
Sbjct: 5 HHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAF 64
Query: 307 GEVFKAILDDETIT----AVKRAKLGNTKGIDPILNEVRILCQLNHRS------------ 350
G V + + E T K + NE+ I+ QL+H
Sbjct: 65 GVVHRCV---EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 351 ---LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQTAQAIAYLHLLATP 401
L + G LFDR+ +++ + RQ + + ++H +
Sbjct: 122 EMVLILEFLSGGELFDRI--AAED--------YKMSEAEVINYMRQACEGLKHMHEHS-- 169
Query: 402 PIYHRDIKSSNILLDEKLDA--KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I H DIK NI+ + K + KI DFGL+ T T + PE
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREP 226
Query: 460 LTDKSDVYSFGVVLVELLT 478
+ +D+++ GV+ LL+
Sbjct: 227 VGFYTDMWAIGVLGYVLLS 245
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 54/224 (24%), Positives = 83/224 (37%), Gaps = 47/224 (20%)
Query: 287 EITEATNNFSTGNLLGSGGFGEVFKAILDD----ETITAVKRAKLGNT-KGIDPILNEVR 341
I + ++G G FG V+ D A+K + ++ L E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 342 ILCQLNHRSL-------------------FMSMSPNGTLFD--RLHRVQSGNWPPLKWHH 380
++ LNH ++ +M +G L R +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYM---CHGDLLQFIRSPQ------RNPTVKD 125
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT 440
+ Q A+ + YL A HRD+ + N +LDE K++DFGL+R L+
Sbjct: 126 LISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD--REYY 180
Query: 441 TFAQGTLGYL-----DPEYYINFQL-TDKSDVYSFGVVLVELLT 478
+ Q L E + T KSDV+SFGV+L ELLT
Sbjct: 181 SVQQHRHARLPVKWTALE-SLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 66/234 (28%), Positives = 95/234 (40%), Gaps = 53/234 (22%)
Query: 274 NNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETIT----AVK---RAK 326
++S ++ E ++ +LG G FGEV K + IT AVK +A
Sbjct: 6 HHSSGRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCK---DRITQQEYAVKVINKAS 59
Query: 327 LGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSG 371
K IL EV +L +L+H + + + G LFD + ++
Sbjct: 60 A-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRK 116
Query: 372 NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGL 428
H I +Q I Y+H I HRD+K NILL ++ D KI DFGL
Sbjct: 117 R---FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 429 SRLALNGASHVTTFAQGTLGYLDPE-----YYINFQLTDKSDVYSFGVVLVELL 477
S + + GT Y+ PE Y +K DV+S GV+L LL
Sbjct: 171 STCFQQN-TKMKDRI-GTAYYIAPEVLRGTY------DEKCDVWSAGVILYILL 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 58/223 (26%), Positives = 81/223 (36%), Gaps = 49/223 (21%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQ 345
N + LG G FGEV++ + AVK + + L E I+ +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 346 LNHRSL------------------FMSMSPNGTL--FDRLHRVQSGNWPPLKWHHRLHIA 385
NH+++ M G L F R R + L LH+A
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELM---AGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 386 RQTAQAIAYLHLLATPPIYHRDIKSSNILLD---EKLDAKISDFGLSRLALNGASHVTTF 442
R A Y L HRDI + N LL AKI DFG++R +
Sbjct: 188 RDIACGCQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YY 240
Query: 443 AQGTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
+G L PE F T K+D +SFGV+L E+ +
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIFS 281
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 47/218 (21%), Positives = 75/218 (34%), Gaps = 39/218 (17%)
Query: 347 NHRSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIY 404
L++ M L D ++R S LHI Q A+A+ +LH +
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG--VCLHIFIQIAEAVEFLHSKG---LM 186
Query: 405 HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ-----------GTLGYLDPE 453
HRD+K SNI K+ DFGL T GT Y+ PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513
+ K D++S G++L ELL S F+ + E V ++ ++ +
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRII----TDVRNLKFPLLFTQ 297
Query: 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+ ++ L RP ++
Sbjct: 298 KYPQEHMMVQD------------MLSPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 2/58 (3%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN-TKGIDPILNEVRILCQLNH 348
+F +G GGFG VF+A D+ A+KR +L N + ++ EV+ L +L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 62/299 (20%), Positives = 106/299 (35%), Gaps = 51/299 (17%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKL-GNTKGIDPILNEVRILCQLNHR- 349
++F + LG+G G VFK + A K L + I+ E+++L + N
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 350 --------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
S+ M G+L L + L ++ + + YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 147
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYY 455
I HRD+K SNIL++ + + K+ DFG+S ++ S +F GT Y+ PE
Sbjct: 148 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERL 202
Query: 456 INFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515
+ +SD++S G+ LVE+ + + +E + E P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 516 KEGASEIELDSMKA-FGLLG-----------------------AACLDERRQNRPSIKE 550
++ A F LL CL + R +K+
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 55/263 (20%), Positives = 89/263 (33%), Gaps = 59/263 (22%)
Query: 255 HQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAIL 314
++ + + + G + E + +++G G V + +
Sbjct: 56 AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV- 114
Query: 315 DDETIT----AVK---RAKLGNTKG-----IDPILNEVRILCQL-NH------------- 348
T AVK + + E IL Q+ H
Sbjct: 115 --HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 349 RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQTAQAIAYLHLLAT 400
+F+ G LFD L + L I R +A+++LH
Sbjct: 173 SFMFLVFDLMRKGELFDYL--TEKV---------ALSEKETRSIMRSLLEAVSFLHANN- 220
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE------Y 454
I HRD+K NILLD+ + ++SDFG S L + GT GYL PE
Sbjct: 221 --IVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGEKLRELC-GTPGYLAPEILKCSMD 276
Query: 455 YINFQLTDKSDVYSFGVVLVELL 477
+ + D+++ GV+L LL
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLL 299
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 54/213 (25%), Positives = 81/213 (38%), Gaps = 47/213 (22%)
Query: 298 GNLLGSGGFGEVFKAILDD----ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL- 351
++G G FG V+ L D + AVK + L E I+ +H ++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 352 ------------------FMSMSPNGTL--FDRLHRVQSGNWPPLKWHHRLHIARQTAQA 391
+M +G L F R + Q A+
Sbjct: 154 SLLGICLRSEGSPLVVLPYM---KHGDLRNFIRNET------HNPTVKDLIGFGLQVAKG 204
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL- 450
+ +L A+ HRD+ + N +LDEK K++DFGL+R + T L
Sbjct: 205 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLP 259
Query: 451 ----DPEYYINFQL-TDKSDVYSFGVVLVELLT 478
E + Q T KSDV+SFGV+L EL+T
Sbjct: 260 VKWMALE-SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 55/231 (23%), Positives = 87/231 (37%), Gaps = 44/231 (19%)
Query: 274 NNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKR-AKLGNT 330
++S ++ I + F LGSG FG+V + + +K K +
Sbjct: 6 HHSSGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVE-ERSSGLERVIKTINKDRSQ 61
Query: 331 KGIDPILNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPP 375
++ I E+ +L L+H + + M G L +R+ Q
Sbjct: 62 VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQ------ 115
Query: 376 LKWHHRL------HIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDF 426
L + +Q A+AY H + H+D+K NIL KI DF
Sbjct: 116 -ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDF 171
Query: 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
GL+ L + GT Y+ PE +T K D++S GVV+ LL
Sbjct: 172 GLAELFKSDEHSTNAA--GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLL 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 60/224 (26%), Positives = 84/224 (37%), Gaps = 57/224 (25%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKGIDP-----ILNE 339
+ + LGSG GEV A E T A+K + K + + E
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAF---ERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 340 VRILCQLNH------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRL--- 382
+ IL +LNH ++ + G LFD++ V + RL
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNK---------RLKEA 114
Query: 383 ---HIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGA 436
Q A+ YLH I HRD+K N+LL +E KI+DFG S++
Sbjct: 115 TCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET- 170
Query: 437 SHVTTFAQGTLGYLDPE---YYINFQLTDKSDVYSFGVVLVELL 477
S + T GT YL PE D +S GV+L L
Sbjct: 171 SLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 59/234 (25%), Positives = 89/234 (38%), Gaps = 61/234 (26%)
Query: 283 FSSREITEATNNFS------TGNLLGSGGFGEVFKAILDDETIT----AVKRAKLGNTKG 332
F R +T + +LG G FG+V K ET T A K K K
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE---ETATGLKLAAKIIKTRGMKD 129
Query: 333 IDPILNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLK 377
+ + NE+ ++ QL+H + L M G LFDR+ +
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDES------ 181
Query: 378 WHHRL------HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA--KISDFGLS 429
+ L +Q + I ++H + I H D+K NIL + KI DFGL+
Sbjct: 182 --YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 430 RLALNGASHVTTFAQGTLGYLDPE-----YYINFQLTDKSDVYSFGVVLVELLT 478
R F GT +L PE + + +D++S GV+ LL+
Sbjct: 237 RRYKPREKLKVNF--GTPEFLAPEVVNYDFV-----SFPTDMWSVGVIAYMLLS 283
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 43/211 (20%)
Query: 298 GNLLGSGGFGEVFKAILDD----ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL- 351
++G G FG V+ L D + AVK + L E I+ +H ++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 352 ------------------FMSMSPNGTL--FDRLHRVQSGNWPPLKWHHRLHIARQTAQA 391
+M +G L F R + Q A+
Sbjct: 90 SLLGICLRSEGSPLVVLPYM---KHGDLRNFIRNET------HNPTVKDLIGFGLQVAKG 140
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG---ASHVTTFAQGTLG 448
+ YL A+ HRD+ + N +LDEK K++DFGL+R + + H T A+ +
Sbjct: 141 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 449 YLDPEYYINFQL-TDKSDVYSFGVVLVELLT 478
++ E + Q T KSDV+SFGV+L EL+T
Sbjct: 198 WMALE-SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 57/260 (21%), Positives = 91/260 (35%), Gaps = 63/260 (24%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKG---------------- 332
N ++ + +G G +G V A +D T A+K + KL G
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 333 -------IDPILNEVRILCQLNH---------------RSLFMSM--SPNGTLFDRLHRV 368
I+ + E+ IL +L+H L+M G + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---P 129
Query: 369 QSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428
PL + + I YLH I HRDIK SN+L+ E KI+DFG+
Sbjct: 130 TLK---PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 429 SRLALNGASHVTTFAQGTLGYLDPEYYINFQLT---DKSDVYSFGVVLVELLTSKKAVDF 485
S + ++ GT ++ PE + DV++ GV L + + F
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ--CPF 240
Query: 486 NREEEDVNLVVYFGNILKQE 505
D ++ I Q
Sbjct: 241 ----MDERIMCLHSKIKSQA 256
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 52/240 (21%), Positives = 85/240 (35%), Gaps = 26/240 (10%)
Query: 253 HFHQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKA 312
H H S ++ + + A + + + + +G G G V A
Sbjct: 5 HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 313 I-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMS 356
AVK L + + + NEV I+ H + + M
Sbjct: 65 REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD 416
G L D + +V L + QA+AYLH + HRDIKS +ILL
Sbjct: 125 QGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLT 175
Query: 417 EKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVEL 476
K+SDFG + GT ++ PE + D++S G++++E+
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 3e-20
Identities = 57/207 (27%), Positives = 83/207 (40%), Gaps = 41/207 (19%)
Query: 298 GNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKGIDPILNEVRILCQLNH-- 348
LG G +GEV A+ +T AVK + + + I E+ I LNH
Sbjct: 12 VQTLGEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHEN 66
Query: 349 -----------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
++ + G LFDR+ + Q + YL
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDI---GMPEPDAQRFFHQLMAGVVYL 121
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS--HVTTFAQGTLGYLDPE 453
H + I HRDIK N+LLDE+ + KISDFGL+ + + GTL Y+ PE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 454 YYINFQLTD--KSDVYSFGVVLVELLT 478
+ + DV+S G+VL +L
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 64/220 (29%), Positives = 82/220 (37%), Gaps = 48/220 (21%)
Query: 298 GNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGIDPILNEVRILCQLNH--- 348
LG G FG+VF A D+ + AVK K E +L L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 349 ----------RSLFMSMS--PNGTL--FDRLHRVQSGNWP---------PLKWHHRLHIA 385
L M +G L F R H + L LHIA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 386 RQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG 445
Q A + YL A+ HRD+ + N L+ L KI DFG+SR + + G
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST----DYYRVG 192
Query: 446 TLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
L PE Y F T +SDV+SFGV+L E+ T
Sbjct: 193 GHTMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIFT 230
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 37/210 (17%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA------KLGNTKGIDPILNEVRILCQ 345
++N+ LG G F V + + T ++ A K + + + E RI +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCV---HKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 346 LNH-------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
L H ++ G LF+ + V + H +Q +
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASH---CIQQILE 116
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDA---KISDFGLSRLALNGASHVTTFAQGTL 447
+IAY H I HR++K N+LL K K++DFGL+ + FA GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFA-GTP 171
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
GYL PE + D+++ GV+L LL
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-20
Identities = 59/256 (23%), Positives = 97/256 (37%), Gaps = 47/256 (18%)
Query: 255 HQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI- 313
H + S ++ ++ ++ + ++ LGSG +GEV
Sbjct: 2 HHHHHHSS----GRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKE 57
Query: 314 LDDETITAVK---RAKLGNTKGIDP----------ILNEVRILCQLNHRS---------- 350
+ + A+K +++ + D I NE+ +L L+H +
Sbjct: 58 KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117
Query: 351 -----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYH 405
L G LF+++ + + +I +Q I YLH I H
Sbjct: 118 KKYFYLVTEFYEGGELFEQI--INRHKFDE---CDAANIMKQILSGICYLHKHN---IVH 169
Query: 406 RDIKSSNILL---DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
RDIK NILL + L+ KI DFGLS GT Y+ PE + + +
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPE-VLKKKYNE 226
Query: 463 KSDVYSFGVVLVELLT 478
K DV+S GV++ LL
Sbjct: 227 KCDVWSCGVIMYILLC 242
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 47/215 (21%), Positives = 88/215 (40%), Gaps = 29/215 (13%)
Query: 278 RLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPI 336
+L I S + + ++ +G G G V+ A+ + A+++ L + I
Sbjct: 8 KLRSIVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI 64
Query: 337 LNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHR 381
+NE+ ++ + + + + M G+L D + +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQI 118
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
+ R+ QA+ +LH + + HRDIKS NILL K++DFG S +T
Sbjct: 119 AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVEL 476
GT ++ PE K D++S G++ +E+
Sbjct: 176 MV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 57/207 (27%), Positives = 83/207 (40%), Gaps = 41/207 (19%)
Query: 298 GNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKGIDPILNEVRILCQLNH-- 348
LG G +GEV A+ +T AVK + + + I E+ I LNH
Sbjct: 12 VQTLGEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHEN 66
Query: 349 -----------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
++ + G LFDR+ + Q + YL
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDI---GMPEPDAQRFFHQLMAGVVYL 121
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS--HVTTFAQGTLGYLDPE 453
H + I HRDIK N+LLDE+ + KISDFGL+ + + GTL Y+ PE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 454 YYINFQLTD--KSDVYSFGVVLVELLT 478
+ + DV+S G+VL +L
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 48/227 (21%), Positives = 76/227 (33%), Gaps = 43/227 (18%)
Query: 282 IFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVK---RAKLGNTKGIDP- 335
+ + + + + ++G G F V + I + ET AVK AK ++ G+
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCI-NRETGQQFAVKIVDVAKFTSSPGLSTE 71
Query: 336 -ILNEVRILCQLNH-------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWH 379
+ E I L H L+M L + V+
Sbjct: 72 DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRA-----DAG 124
Query: 380 HRL------HIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSR 430
H RQ +A+ Y H I HRD+K +LL + K+ FG++
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
GT ++ PE DV+ GV+L LL
Sbjct: 182 QLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 37/208 (17%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKGIDPILNEVRILCQL 346
+ LG G FG+V A T A+K R L + + E+ L L
Sbjct: 10 PYIIRETLGEGSFGKVKLAT---HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL 66
Query: 347 NH-------------RSLFMSMS-PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
H + M + G LFD + V+ + +Q AI
Sbjct: 67 RHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI--VEKK---RMTEDEGRRFFQQIICAI 121
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
Y H I HRD+K N+LLD+ L+ KI+DFGLS + +G + + T G+ Y P
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSC-GSPNYAAP 176
Query: 453 EYYINFQLTD--KSDVYSFGVVLVELLT 478
E IN +L + DV+S G+VL +L
Sbjct: 177 E-VINGKLYAGPEVDVWSCGIVLYVMLV 203
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 61/243 (25%), Positives = 90/243 (37%), Gaps = 58/243 (23%)
Query: 298 GNLLGSGGFGEVFKAILDDETIT--AVK---RAKLGNTKGIDP-ILNEVRILCQLNH--- 348
G+LLG G +G+V + + D ET+ AVK + KL + + E+++L +L H
Sbjct: 10 GDLLGEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 349 ------------RSLFMSM--SPNGT--LFDRLHRVQSGNWPPLKWHHRL--HIAR---- 386
+ ++M M G + D + R A
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP------------EKRFPVCQAHGYFC 116
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA--SHVTTFAQ 444
Q + YLH I H+DIK N+LL KIS G++ A T Q
Sbjct: 117 QLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-Q 172
Query: 445 GTLGYLDPEYYINFQLTD--KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502
G+ + PE K D++S GV L + T F E N+ F NI
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL--YPF----EGDNIYKLFENIG 226
Query: 503 KQE 505
K
Sbjct: 227 KGS 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 9e-20
Identities = 51/210 (24%), Positives = 79/210 (37%), Gaps = 40/210 (19%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS 350
++ N +G G +GEV A+ A K+ + +D E+ I+ L+H +
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 351 ---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
L M + G LF+R+ V + I + A+AY
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRE---SDAARIMKDVLSAVAYC 122
Query: 396 HLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
H L + HRD+K N L K+ DFGL+ G T GT Y+ P
Sbjct: 123 HKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSP 177
Query: 453 E-----YYINFQLTDKSDVYSFGVVLVELL 477
+ Y + D +S GV++ LL
Sbjct: 178 QVLEGLY------GPECDEWSAGVMMYVLL 201
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 38/209 (18%)
Query: 294 NFSTGNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKGIDPILNEVRILCQL 346
++ G+ LG G FG+V +T AVK R K+ + + I E++ L
Sbjct: 17 HYILGDTLGVGTFGKVKVGK---HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 347 NH-------------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQA 391
H +FM M G LFD + ++G L + +Q
Sbjct: 74 RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CKNG---RLDEKESRRLFQQILSG 128
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLD 451
+ Y H + HRD+K N+LLD ++AKI+DFGLS + +G + T G+ Y
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAA 183
Query: 452 PEYYINFQLTD--KSDVYSFGVVLVELLT 478
PE I+ +L + D++S GV+L LL
Sbjct: 184 PE-VISGRLYAGPEVDIWSSGVILYALLC 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 29/231 (12%)
Query: 262 SLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETIT 320
SL VQ +L +++ E F LG G +G V+KAI + I
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEE---VFDVLEKLGEGSYGSVYKAIHKETGQIV 57
Query: 321 AVKRAKLGNTKGIDPILNEVRILCQLNHR-------------SLFMSMS--PNGTLFDRL 365
A+K+ + + I+ E+ I+ Q + L++ M G++ D +
Sbjct: 58 AIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII 115
Query: 366 HRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425
L I + T + + YLH HRDIK+ NILL+ + AK++D
Sbjct: 116 RLRNK----TLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLAD 168
Query: 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVEL 476
FG++ + + T GT ++ PE +D++S G+ +E+
Sbjct: 169 FGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEM 218
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 49/285 (17%), Positives = 99/285 (34%), Gaps = 53/285 (18%)
Query: 227 SHGKGCKHKKPKTAVIGVLATIKFYKHFHQSNREVSLTKVQKDIS--GANNSGRLARIFS 284
HG+ TA + + + + + + + + + + +S N + + +
Sbjct: 87 KHGQS--KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 285 SREITEATNNFST----GNLLGSGGFGEVFKAILDDETIT----AVKRAKLGNTKGIDPI 336
+ + ++ LG+G FG V + E T A K + + +
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT---ERATGNNFAAKFVMTPHESDKETV 201
Query: 337 LNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHR 381
E++ + L H + + G LF+++ H++
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV----------ADEHNK 251
Query: 382 L------HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA--KISDFGLSRLAL 433
+ RQ + + ++H H D+K NI+ K K+ DFGL+
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
S T GT + PE + +D++S GV+ LL+
Sbjct: 309 PKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 51/221 (23%), Positives = 82/221 (37%), Gaps = 49/221 (22%)
Query: 298 GNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNH-- 348
LG FG+V+K L + A+K K + +E + +L H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 349 -----------RSLFMSMS--PNGTL--FDRLHRVQSGNWPPLKWHHR---------LHI 384
+ L M S +G L F + S +H+
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ 444
Q A + YL ++ + H+D+ + N+L+ +KL+ KISD GL R +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD----YYKL 186
Query: 445 GTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
L PE Y F + SD++S+GVVL E+ +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKF--SIDSDIWSYGVVLWEVFS 225
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 46/213 (21%), Positives = 77/213 (36%), Gaps = 44/213 (20%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA-KLGNTKGIDP--ILNEVRILCQLNH 348
+ LG G FG V + + ET + K KG D + E+ IL H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCV---ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 349 RS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQ 387
R+ + +F+R+ S L Q
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAF--------ELNEREIVSYVHQ 110
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA--KISDFGLSRLALNGASHVTTFAQG 445
+A+ +LH I H DI+ NI+ + + KI +FG +R G + F
Sbjct: 111 VCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--T 165
Query: 446 TLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
Y PE + + ++ +D++S G ++ LL+
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 61/226 (26%), Positives = 86/226 (38%), Gaps = 47/226 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT--------------KG 332
+ G LG G FG+V +A AVK K G T
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 333 IDPILNEVRIL--CQLNHRSLFMSM--SPNGTLFD--RLHRVQSGNW---------PPLK 377
I LN V +L C L + + G L R R + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
H + + Q A+ + +L A+ HRD+ + NILL EK KI DFGL+R
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 438 HVTTFAQGTLGYL-----DPEYYINFQLTDKSDVYSFGVVLVELLT 478
+V + L PE + T +SDV+SFGV+L E+ +
Sbjct: 204 YV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 40/204 (19%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKL-GNTKGIDPILNEVRILCQLNHRSLFMSMSPN 358
LG G +G V K + I AVKR + N++ +L ++ I + P
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-------CPF 67
Query: 359 -----GTLF----------------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
G LF D+ ++ + IA +A+ +LH
Sbjct: 68 TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH- 126
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
+ + HRD+K SN+L++ K+ DFG+S L A G Y+ PE IN
Sbjct: 127 -SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDA-GCKPYMAPE-RIN 182
Query: 458 FQLTD-----KSDVYSFGVVLVEL 476
+L KSD++S G+ ++EL
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIEL 206
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 51/205 (24%), Positives = 77/205 (37%), Gaps = 41/205 (20%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKL-GNTKGIDPILNEVRILCQLNHRSLFMSMSPN 358
+G G +G V K + I AVKR + + K +L ++ ++ + + P
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD-------CPY 82
Query: 359 ----------------------GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
+ V S + I T +A+ +L
Sbjct: 83 IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
I HRDIK SNILLD + K+ DFG+S S T G Y+ PE I
Sbjct: 143 --ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSIAKTRDAGCRPYMAPE-RI 197
Query: 457 NFQLTD-----KSDVYSFGVVLVEL 476
+ + +SDV+S G+ L EL
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+ F +LG GGFGEVF + + A K + +L KG + E +IL +++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 349 R-------------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
R L + M+ G + ++ V N + + A Q +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLE 303
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
+LH I +RD+K N+LLD+ + +ISD GL+ G + +A GT G++ PE
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 454 YYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505
+ + D S D ++ GV L E++ ++ F E V +L+Q
Sbjct: 360 -LLLGEEYDFSVDYFALGVTLYEMIAARGP--FRARGEKVENKELKQRVLEQA 409
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 55/247 (22%), Positives = 89/247 (36%), Gaps = 41/247 (16%)
Query: 255 HQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAIL 314
++ S++ V + S ++ F + LG G V++
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCK- 73
Query: 315 DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS---------------LFMSMSPNG 359
T L T + E+ +L +L+H + L + + G
Sbjct: 74 QKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133
Query: 360 TLFDRLHRVQSGNWPPLKWHHRL------HIARQTAQAIAYLHLLATPPIYHRDIKSSNI 413
LFDR+ V+ G +Q +A+AYLH I HRD+K N+
Sbjct: 134 ELFDRI--VEKG---------YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENL 179
Query: 414 LL---DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFG 470
L KI+DFGLS++ + T GT GY PE + D++S G
Sbjct: 180 LYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 471 VVLVELL 477
++ LL
Sbjct: 238 IITYILL 244
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 38/234 (16%)
Query: 268 KDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA-- 325
++G GR + F T+ ++N+ LG G F V + + T ++ A
Sbjct: 5 ASMTGGQQMGRGSE-FMMNASTKFSDNYDVKEELGKGAFSVVRRCV---HKTTGLEFAAK 60
Query: 326 ----KLGNTKGIDPILNEVRILCQLNH-------------RSLFMSMS--PNGTLFDRLH 366
K + + + E RI +L H ++ G LF+ +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI- 119
Query: 367 RVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA---KI 423
V + H +Q ++IAY H I HR++K N+LL K K+
Sbjct: 120 -VAREFYSEADASH---CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKL 172
Query: 424 SDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
+DFGL+ + FA GT GYL PE + D+++ GV+L LL
Sbjct: 173 ADFGLAIEVNDS-EAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 51/218 (23%), Positives = 83/218 (38%), Gaps = 36/218 (16%)
Query: 284 SSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA------KLGNTKGIDPIL 337
++ T T + LG G F V + + + + + A K + + +
Sbjct: 2 ATITCTRFTEEYQLFEELGKGAFSVVRRCV---KVLAGQEYAAMIINTKKLSARDHQKLE 58
Query: 338 NEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL 382
E RI L H + L + G LF+ + V +
Sbjct: 59 REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADAS--- 113
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA---KISDFGLSRLALNGASHV 439
H +Q +A+ + H + + HR++K N+LL KL K++DFGL+
Sbjct: 114 HCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 440 TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
FA GT GYL PE D+++ GV+L LL
Sbjct: 171 FGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 42/216 (19%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKG---IDPILNEVR 341
+ + G LGSG F V K E T A K + + ++ + I EV
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCR---EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 342 ILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
IL Q+ H + L + + G LFD L Q + L +
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES---LSEEEATSFIK 122
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILL----DEKLDAKISDFGLSRLALNGASHVTTF 442
Q + YLH I H D+K NI+L K+ DFGL+ +G F
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
GT ++ PE L ++D++S GV+ LL+
Sbjct: 180 --GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 29/203 (14%)
Query: 295 FSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR---- 349
+ LG G FG+V+KA + + A K + + + ++ + E+ IL +H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 350 ---------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
L++ + P G + + + L + RQ +A+ +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLH-- 134
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ I HRD+K+ N+L+ + D +++DFG+S L +F GT ++ PE +
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCE 192
Query: 459 QLTD-----KSDVYSFGVVLVEL 476
+ D K+D++S G+ L+E+
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEM 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+F G +LG G F V A A+K + + + + E ++ +L+H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 349 -------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L+ +S NG L + ++ S + R + A + A+
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALE 144
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ-GTLGYLDP 452
YLH I HRD+K NILL+E + +I+DFG +++ + + GT Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 453 EYYINFQLTDKS-DVYSFGVVLVELLT 478
E + + KS D+++ G ++ +L+
Sbjct: 202 E-LLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 42/216 (19%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKG---IDPILNEVR 341
+++ G LGSG F V K + T A K + +L +++ + I EV
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCR---QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 342 ILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
IL ++ H + L + + G LFD L + + + +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDE---ATQFLK 115
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA----KISDFGLSRLALNGASHVTTF 442
Q + YLH I H D+K NI+L +K K+ DFG++ G F
Sbjct: 116 QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
GT ++ PE L ++D++S GV+ LL+
Sbjct: 173 --GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 59/231 (25%), Positives = 90/231 (38%), Gaps = 56/231 (24%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGIDPI--LNEVRILC 344
N S G LG+G FG+V +A D AVK K + + ++E+++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLS 81
Query: 345 QL-NHRSL------------------FMSMSPNGTLFD--RLHR-----------VQSGN 372
L NH ++ + G L + R R + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYC---CYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 373 WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432
L L + Q A+ +A+L A+ HRD+ + NILL KI DFGL+R
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 433 LNGASHVTTFAQGTLGYL-----DPEYYINFQLTDKSDVYSFGVVLVELLT 478
N + + L PE N T +SDV+S+G+ L EL +
Sbjct: 196 KND----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 54/214 (25%), Positives = 79/214 (36%), Gaps = 38/214 (17%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDET--------ITAVKRAKLGNTKGIDPILNEVRIL 343
+ + G LGSG F V K + T I + + I EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 344 CQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQT 388
Q+ H + L + + G LFD L Q + L +Q
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKES---LSEEEATSFIKQI 124
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILL----DEKLDAKISDFGLSRLALNGASHVTTFAQ 444
+ YLH I H D+K NI+L K+ DFGL+ +G F
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
GT ++ PE L ++D++S GV+ LL+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 295 FSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKG-IDPILNEVRILCQLNHR--- 349
F+ +G G FGEVFK I + + A+K L + I+ I E+ +L Q +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 350 ----------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
L++ M G+ D L PL I R+ + + YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLH- 136
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
+ HRDIK++N+LL E + K++DFG++ + TF GT ++ PE
Sbjct: 137 --SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 193
Query: 458 FQLTDKSDVYSFGVVLVELLTSK 480
K+D++S G+ +EL +
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 28/197 (14%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKL-GNTKGIDPILNEVRILCQLNH---------- 348
+GSG G+V+K + AVK+ + GN + IL ++ ++ + +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 349 ----RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIY 404
+F++M GT ++L + G P+ + +A+ YL +
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQG---PIPERILGKMTVAIVKALYYLK--EKHGVI 147
Query: 405 HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD-- 462
HRD+K SNILLDE+ K+ DFG+S ++ + A G Y+ PE T
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSA-GCAAYMAPERIDPPDPTKPD 205
Query: 463 ---KSDVYSFGVVLVEL 476
++DV+S G+ LVEL
Sbjct: 206 YDIRADVWSLGISLVEL 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 32/208 (15%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
++F +G G FG+V D + + A+K + K + + E++I+ L H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 349 -------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+FM + G L L + +L I + A+
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE----TVKLFIC-ELVMALD 129
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YL I HRD+K NILLDE I+DF ++ + TT A GT Y+ PE
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMA-GTKPYMAPE 184
Query: 454 YYINFQLT--DKS-DVYSFGVVLVELLT 478
+ + + + D +S GV ELL
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLR 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 59/235 (25%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNTKG--IDPILNEVRILC 344
NN +G G FG VF+A + T+ AVK K + D E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMA 105
Query: 345 QLNH-------------RSLFMSM--SPNGTL--FDRLHRVQSGNW-------------- 373
+ ++ + + + G L F R +
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 374 ---PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
PPL +L IARQ A +AY L+ HRD+ + N L+ E + KI+DFGLSR
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 431 LALNGASHVTTFAQGTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
+ + + PE +Y + T +SDV+++GVVL E+ +
Sbjct: 223 NIYSA----DYYKADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFS 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 55/238 (23%), Positives = 86/238 (36%), Gaps = 74/238 (31%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQ 345
NN G LG+G FG+V +A D AVK K + +++E++I+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 346 L-NHRSL------------------FMSMSPNGTLFD--RLHR-------VQSGNWPPLK 377
L H ++ + G L + R +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYC---CYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
LH + Q AQ +A+L A+ HRD+ + N+LL AKI DFGL+R
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----- 214
Query: 438 HVTTFAQGTLGYLDPEYY----------------INFQL-TDKSDVYSFGVVLVELLT 478
D Y I + T +SDV+S+G++L E+ +
Sbjct: 215 -----------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 63/237 (26%), Positives = 93/237 (39%), Gaps = 63/237 (26%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQ 345
N G LG G FG+V KA T AVK K + + +L+E +L Q
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 346 LNHRSL------------------FMSMSPNGTLFD--RLHR-----------------V 368
+NH + + G+L R R +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYA---KYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 369 QSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428
+ L + A Q +Q + YL A + HRD+ + NIL+ E KISDFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 429 SRLALNGASHVTTFAQGTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
SR S+V + + G + E + + T +SDV+SFGV+L E++T
Sbjct: 197 SRDVYEEDSYV----KRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVT 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 58/232 (25%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL--------DDETITAVKRAKLGNT-KGIDPILNEVRIL 343
+ + G LG G FG+V A + AVK K T K + +++E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 344 CQL-NHRSL------------------FMSMSPNGTL--FDRLHR---------VQSGNW 373
+ H+++ + G L + R R +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYA---SKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 374 PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433
+ + + Q A+ + YL A+ HRD+ + N+L+ E KI+DFGL+R
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 434 NGASHVTTFAQGTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
N + + T G L PE + + T +SDV+SFGV++ E+ T
Sbjct: 209 NIDYYK----KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 48/213 (22%), Positives = 73/213 (34%), Gaps = 48/213 (22%)
Query: 297 TGNLLGSGGFGEVFKAILDDETITAVKRA------KLGNTKGIDPILNEVRILCQLNHRS 350
T LG G F V + I T + A + IL+E+ +L
Sbjct: 33 TSKELGRGKFAVVRQCI---SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 351 ----------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQT 388
L + + G +F + + + +Q
Sbjct: 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLP---------ELAEMVSENDVIRLIKQI 140
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGASHVTTFAQG 445
+ + YLH I H D+K NILL D KI DFG+SR + G
Sbjct: 141 LEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--G 195
Query: 446 TLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
T YL PE +T +D+++ G++ LLT
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 42/216 (19%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA-------KLGNTKG---IDPILNEVR 341
+ + TG LGSG F V K E T ++ A + +++ + I EV
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCR---EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 342 ILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
IL ++ H + L + + G LFD L + + + +
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEE---ATEFLK 121
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA----KISDFGLSRLALNGASHVTTF 442
Q + YLH L I H D+K NI+L ++ KI DFGL+ G F
Sbjct: 122 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
GT ++ PE L ++D++S GV+ LL+
Sbjct: 179 --GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 44/208 (21%)
Query: 296 STGNLLGSGGFGEVFKAILDDETITAVKRA-KLGNTKGIDPILNEVRILCQL-NHRS--- 350
LG G F K + + A K+ + + E+ L H +
Sbjct: 14 LKDKPLGEGSFSICRKCV---HKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 351 ------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
L M + G LF+R+ + ++ +I R+ A++++H +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERI--KKKKHFSE---TEASYIMRKLVSAVSHMHDV 125
Query: 399 ATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE-- 453
+ HRD+K N+L ++ L+ KI DFG +RL + T TL Y PE
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 454 ---YYINFQLTDKS-DVYSFGVVLVELL 477
Y D+S D++S GV+L +L
Sbjct: 182 NQNGY------DESCDLWSLGVILYTML 203
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 58/227 (25%)
Query: 298 GNLLGSGGFGEVFKAIL--------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-N 347
G LG G FG+V A + T AVK K T K + +++E+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 348 HRSL------------------FMSMSPNGTLFD--RLHRVQSGNW---------PPLKW 378
H+++ + G L + + R + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYA---SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 379 HHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438
+ A Q A+ + YL A+ HRD+ + N+L+ E KI+DFGL+R + +
Sbjct: 191 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 439 VTTFAQGTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
+ T G L PE + + T +SDV+SFGV+L E+ T
Sbjct: 248 K----KTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT 288
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 30/212 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKL-GNTKGIDPILNEVRILCQLNH-- 348
+++ ++GSG V A + A+KR L +D +L E++ + Q +H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 349 -----------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIA---RQTAQAI 392
L++ M G++ D + + + IA R+ + +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS-RLALNGASHV----TTFAQGTL 447
YLH HRD+K+ NILL E +I+DFG+S LA G TF GT
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTP 190
Query: 448 GYLDPEYYINFQLTD-KSDVYSFGVVLVELLT 478
++ PE + D K+D++SFG+ +EL T
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 58/232 (25%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL--------DDETITAVKRAKLGNT-KGIDPILNEVRIL 343
+ + G LG G FG+V A + AVK K T K + +++E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 344 CQL-NHRSL------------------FMSMSPNGTL--FDRLHR---------VQSGNW 373
+ H+++ + G L + R R +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYA---SKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 374 PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433
+ + + Q A+ + YL A+ HRD+ + N+L+ E KI+DFGL+R
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 434 NGASHVTTFAQGTLGYL-----DPE--YYINFQLTDKSDVYSFGVVLVELLT 478
N + + T G L PE + + T +SDV+SFGV++ E+ T
Sbjct: 255 NIDYYK----KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 300
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 38/211 (18%)
Query: 295 FSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPILNEVRILCQL-NHR-- 349
F L+G+G +G+V+K +T + A+K + + + I E+ +L + +HR
Sbjct: 26 FELVELVGNGTYGQVYKGR-HVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNI 83
Query: 350 -----------------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
L++ M G++ D + + LK +I R+ +
Sbjct: 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILR 140
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL 450
+++LH + HRDIK N+LL E + K+ DFG+S TF GT ++
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 196
Query: 451 DPEYYINFQLTD-----KSDVYSFGVVLVEL 476
PE + D KSD++S G+ +E+
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 31/233 (13%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
N F +LG GGFGEV + + A K + ++ KG LNE +IL ++N
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 349 R-------------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
R +L + ++ G L ++ + +P + A + +
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA--RAVFYAA-EICCGLE 300
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
LH I +RD+K NILLD+ +ISD GL+ G + + GT+GY+ PE
Sbjct: 301 DLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPE 355
Query: 454 YYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505
+ + S D ++ G +L E++ + F + ++ + + +
Sbjct: 356 -VVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQRKKKIKREEVERLVKEVP 405
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 59/235 (25%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQ 345
N G +LGSG FG+V A AVK K + +++E++++ Q
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 346 L-NHRSL------------------FMSMSPNGTL--FDRLHR----------------V 368
L +H ++ + G L + R R
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYC---CYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 369 QSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428
+ + L + L A Q A+ + + L HRD+ + N+L+ KI DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEF---LEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 429 SRLALNGASHVTTFAQGTLGYL-----DPEYYINFQLTDKSDVYSFGVVLVELLT 478
+R ++ + + L PE T KSDV+S+G++L E+ +
Sbjct: 219 ARDIMSDS----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 60/233 (25%), Positives = 93/233 (39%), Gaps = 51/233 (21%)
Query: 285 SREIT-EATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDP------ 335
+ I +++F +LLG G +G V A T I A+K+ I+P
Sbjct: 2 PKRIVYNISSDFQLKSLLGEGAYGVVCSAT-HKPTGEIVAIKK--------IEPFDKPLF 52
Query: 336 ---ILNEVRILCQLNHR---SLFMSMSPNGTLFDR------------LHRVQSGNWPPLK 377
L E++IL H ++F P+ LHRV S L
Sbjct: 53 ALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLS 110
Query: 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
H + QT +A+ LH + HRD+K SN+L++ D K+ DFGL+R+ A+
Sbjct: 111 DDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 438 HVTTFAQGTLG---------YLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
+ G Y PE + ++ DV+S G +L EL +
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 50/241 (20%), Positives = 84/241 (34%), Gaps = 42/241 (17%)
Query: 272 GANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK 331
G G A E+ + ++ + SG +G V + + A+K ++ NT
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIK--RVFNTV 58
Query: 332 GIDP-------------ILNEVRILCQLNHR---SLF-MSMSPNGTLFDR---------- 364
+L E+R+L +H L + + +
Sbjct: 59 SDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT 118
Query: 365 -LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423
L +V + H + + LH + HRD+ NILL + D I
Sbjct: 119 DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITI 175
Query: 424 SDFGLSRLALNGAS---HVTTFAQGTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTS 479
DF L+R A+ +VT Y PE + F+ K D++S G V+ E+
Sbjct: 176 CDFNLAREDTADANKTHYVT-----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 480 K 480
K
Sbjct: 231 K 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 5e-17
Identities = 71/326 (21%), Positives = 116/326 (35%), Gaps = 52/326 (15%)
Query: 194 CLQDAESAGQKRCLYKAGFQWDPIS----------GICKSLKCSHGKGCKHKKPKTAVIG 243
CL+ E A Y+ +++ + I + C H K+A+
Sbjct: 72 CLKHLEEAKPLVEFYEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEH 131
Query: 244 V---LATIKFYKHFHQSNREVSLTKVQKDISGANNSGRLARIFSSREITEAT-----NNF 295
V L + Q E ++ D+ F + E N+F
Sbjct: 132 VQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDF 191
Query: 296 STGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNHRS- 350
S ++G GGFGEV+ D + A+K + ++ +G LNE +L ++
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 351 ---------------LFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L + G L L + + R + A + +
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA-EIILGLE 306
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
++H + +RD+K +NILLDE +ISD GL+ H GT GY+ PE
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPE 360
Query: 454 YYINFQLTDKS-DVYSFGVVLVELLT 478
D S D +S G +L +LL
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLR 386
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 37/208 (17%), Positives = 66/208 (31%), Gaps = 42/208 (20%)
Query: 302 GSGGFGEVFKAI-LDDETITAVKRAKL--GNTKGIDPILNEVRILCQLNHR--------- 349
G V A V+R L + + + + E+ + NH
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 350 ----SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403
L++ S G+ D + + +I + +A+ Y+H +
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMD---GMNELAIAYILQGVLKALDYIHHMG---Y 149
Query: 404 YHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ------GTLGYLDPE---- 453
HR +K+S+IL+ +S + ++ L +L PE
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 454 ---YYINFQLTDKSDVYSFGVVLVELLT 478
Y KSD+YS G+ EL
Sbjct: 210 NLQGY-----DAKSDIYSVGITACELAN 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 67/290 (23%), Positives = 108/290 (37%), Gaps = 48/290 (16%)
Query: 253 HFHQSNREVSLTKVQKDISGANNSGRLARIFSSREITEAT----------NNFSTGNLLG 302
H H E + S G + E+ A NF +LG
Sbjct: 4 HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLG 63
Query: 303 SGGFGEVF----KAILDDETITAVKRAK----LGNTKGIDPILNEVRILCQLNHR----- 349
+G +G+VF + D + A+K K + K + E ++L +
Sbjct: 64 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 123
Query: 350 ---------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
L + + G LF L + + ++++ + A+ +LH L
Sbjct: 124 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH----EVQIYVG-EIVLALEHLHKL 178
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVT-TFAQGTLGYLDPE-YYI 456
I +RDIK NILLD ++DFGLS+ + + F GT+ Y+ P+
Sbjct: 179 G---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRG 234
Query: 457 NFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505
DK+ D +S GV++ ELLT F + E + ILK E
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSE 282
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 44/220 (20%), Positives = 79/220 (35%), Gaps = 60/220 (27%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRA-KLGNTKGIDPILNEVRILCQL-NHR 349
T+ + +G G + + I T ++ A K+ + DP E+ IL + H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCI---HKATNMEFAVKIIDKSKRDP-TEEIEILLRYGQHP 76
Query: 350 S---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQT 388
+ + + G L D++ R + +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-----------FSEREASAVLFTI 125
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA----KISDFGLSRLALNGASHVTTFAQ 444
+ + YLH + HRD+K SNIL ++ +I DFG ++ + T
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC- 181
Query: 445 GTLGYLDPE------YYINFQLTDKS-DVYSFGVVLVELL 477
T ++ PE Y D + D++S GV+L +L
Sbjct: 182 YTANFVAPEVLERQGY-------DAACDIWSLGVLLYTML 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 50/223 (22%), Positives = 72/223 (32%), Gaps = 61/223 (27%)
Query: 297 TGNLLGSGGFGEVFKAILDDETIT----AVKRAKLGNTKGIDPILNEVRILCQL-NHRS- 350
++LG G V I IT AVK + + EV +L Q HR+
Sbjct: 17 QEDVLGEGAHARVQTCI---NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 351 --------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLH--------IARQT 388
L G++ +H+ R H + +
Sbjct: 74 LELIEFFEEEDRFYLVFEKMRGGSILSHIHK-------------RRHFNELEASVVVQDV 120
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGASHVTTFAQ- 444
A A+ +LH I HRD+K NIL ++ KI DF L
Sbjct: 121 ASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 445 -----GTLGYLDPEYYINFQLTDKS-----DVYSFGVVLVELL 477
G+ Y+ PE F D++S GV+L LL
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 33/213 (15%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGN--TKGIDP--ILNEVRIL 343
+ +GSG G V A D A+K KL E+ ++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAY-DAILERNVAIK--KLSRPFQNQTHAKRAYRELVLM 78
Query: 344 CQLNHR---SLFMSMSPNGTLFDR-------------LHRVQSGNWPPLKWHHRLHIARQ 387
+NH+ L +P +L + L +V L ++ Q
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQ 135
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
I +LH + I HRD+K SNI++ KI DFGL+R A G S + T T
Sbjct: 136 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTR 190
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
Y PE + + D++S G ++ E++
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 52/207 (25%), Positives = 79/207 (38%), Gaps = 44/207 (21%)
Query: 298 GNLLGSGGFGEVFKAILDDETIT----AVK---RAKLGNTKGIDPILNEVRILCQLNH-- 348
+GSG FG + +T AVK R + + E+ L H
Sbjct: 25 VKDIGSGNFGVARLMR---DKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPN 77
Query: 349 -----------RSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
L + M + G L++R+ +G +Q ++Y
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERI--CNAGR---FSEDEARFFFQQLLSGVSYC 132
Query: 396 HLLATPPIYHRDIKSSNILLDEK--LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
H + I HRD+K N LLD KI DFG S+ ++ + +T GT Y+ PE
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPE 187
Query: 454 YYINFQLTD--KSDVYSFGVVLVELLT 478
+ Q D +DV+S GV L +L
Sbjct: 188 -VLLRQEYDGKIADVWSCGVTLYVMLV 213
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 35/214 (16%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGN--TKGIDP--ILNEVRIL 343
E + +GSG +G V A+ D T A+K KL + E+R+L
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAV-DGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLL 78
Query: 344 CQLNHR---SLFMSMSPNGTLFDR-------------LHRVQSGNWPPLKWHHRLHIARQ 387
+ H L +P+ TL D L ++ L + Q
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQ 136
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
+ + Y+H I HRD+K N+ ++E + KI DFGL+R A T T
Sbjct: 137 MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVTR 189
Query: 448 GYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
Y PE +N+ ++ D++S G ++ E++T K
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 38/221 (17%)
Query: 278 RLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKG--- 332
+A +F + + FS +G G FG V+ A D + A+K+ +
Sbjct: 42 DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSGKQSNEK 97
Query: 333 IDPILNEVRILCQLNHR-------------SLFMSMS-PNGTLFDRLHRVQSGNWPPLKW 378
I+ EVR L +L H + ++ M G+ D L V PL+
Sbjct: 98 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD-LLEVHKK---PLQE 153
Query: 379 HHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438
+ Q +AYLH + + HRD+K+ NILL E K+ DFG + + +
Sbjct: 154 VEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAP 206
Query: 439 VTTFAQGTLGYLDPEYYINFQLTD---KSDVYSFGVVLVEL 476
+F GT ++ PE + K DV+S G+ +EL
Sbjct: 207 ANSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGN--TKGIDP--ILNEVRILCQ 345
E + + +GSG +G V A D +T V KL I E+R+L
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 84
Query: 346 LNHR---SLFMSMSPNGTLFDR-------------LHRVQSGNWPPLKWHHRLHIARQTA 389
+ H L +P +L + L+ + L H + Q
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQIL 142
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGY 449
+ + Y+H + I HRD+K SN+ ++E + KI DFGL+R A +T + T Y
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVA-TRWY 195
Query: 450 LDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
PE +N+ +++ D++S G ++ ELLT +
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 54/213 (25%), Positives = 82/213 (38%), Gaps = 33/213 (15%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGN--TKGIDP--ILNEVRIL 343
+ +GSG G V A D A+K KL E+ ++
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAY-DAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLM 115
Query: 344 CQLNHR---SLFMSMSPNGTLFD-------------RLHRVQSGNWPPLKWHHRLHIARQ 387
+NH+ SL +P TL + L +V L ++ Q
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQ 172
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
I +LH + I HRD+K SNI++ KI DFGL+R A G S + T T
Sbjct: 173 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTR 227
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
Y PE + + D++S G ++ E++ K
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 43/220 (19%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDP---------ILN 338
+ ++ + +G G +G V A D+ A+K+ I P L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAY-DNLNKVRVAIKK--------ISPFEHQTYCQRTLR 74
Query: 339 EVRILCQLNHR---SLFMSMSPNGTLFDR------------LHRVQSGNWPPLKWHHRLH 383
E++IL + H + + + L+++ L H +
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICY 132
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
Q + + Y+H + + HRD+K SN+LL+ D KI DFGL+R+A H
Sbjct: 133 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 444 Q--GTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
+ T Y PE +N + KS D++S G +L E+L+++
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 49/213 (23%), Positives = 77/213 (36%), Gaps = 35/213 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
++F ++G G F EV + + A+K + + + E +L +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 349 R-------------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
R L++ M G L L + G P + R ++A + AI
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMA-RFYLA-EIVMAID 176
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS-RLALNGASHVTTFAQGTLGYLDP 452
+H L HRDIK NILLD +++DFG +L +G GT YL P
Sbjct: 177 SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232
Query: 453 EYYINFQLTDKSDVY-------SFGVVLVELLT 478
E + Y + GV E+
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 33/206 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKA-ILDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+ F LG+G FG V + A+K + K+ K I+ LNE RIL +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 349 -------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+L+M M G +F L R+ + P H R + A Q
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFE 155
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YLH L + +RD+K N+L+D++ +++DFG ++ T GT L PE
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---TLC-GTPEALAPE 208
Query: 454 YYINFQLTDKS-DVYSFGVVLVELLT 478
I + +K+ D ++ GV++ E+
Sbjct: 209 -IILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGN--TKGIDP--ILNEVRIL 343
E + + +GSG +G V AI D + A+K KL I E+ +L
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAI-DKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLL 77
Query: 344 CQLNH------RSLFMSMSPNGTLFD----------RLHRVQSGNWPPLKWHHRLHIARQ 387
+ H +F S +D L ++ ++ Q
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQ 134
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
+ + Y+H + + HRD+K N+ ++E + KI DFGL+R A + +T + T
Sbjct: 135 MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVV-TR 187
Query: 448 GYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
Y PE +++ +++ D++S G ++ E+LT K
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 39/152 (25%), Positives = 59/152 (38%), Gaps = 18/152 (11%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPI--LNEVRILCQLNH 348
+ +G G +G VFK + +T I A+K+ + L E+R+L QL H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCR-NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 349 R---SLFMSMSPNGTLF------DR-LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
+L L D + + H I QT QA+ + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
HRD+K NIL+ + K+ DFG +R
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 40/212 (18%)
Query: 301 LGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDP--ILNEVRILCQLNHR---SLFM 353
LG GG G VF A+ D++ A+K K+ T L E++I+ +L+H +F
Sbjct: 19 LGCGGNGLVFSAV-DNDCDKRVAIK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVFE 75
Query: 354 SMSPNGTLFDR---------------------LHRVQSGNWPPLKWHHRLHIARQTAQAI 392
+ P+G+ L V PL H Q + +
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG--PLLEEHARLFMYQLLRGL 133
Query: 393 AYLHLLATPPIYHRDIKSSNILLD-EKLDAKISDFGLSRLALNGASHVTTFAQ--GTLGY 449
Y+H + + HRD+K +N+ ++ E L KI DFGL+R+ SH ++ T Y
Sbjct: 134 KYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 450 LDPEYYINFQLTDKS-DVYSFGVVLVELLTSK 480
P ++ K+ D+++ G + E+LT K
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 49/211 (23%), Positives = 73/211 (34%), Gaps = 56/211 (26%)
Query: 300 LLGSGGFGEVFKAILDDETITAVKRAKLGNTKGID---PILNEVRILCQL-NHRS----- 350
+LG G G+V + T K A K + EV Q
Sbjct: 36 VLGLGVNGKVLECF---HRRTGQKCA----LKLLYDSPKARQEVDHHWQASGGPHIVCIL 88
Query: 351 --------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQTAQ 390
+ M G LF R+ + I R
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQE---------RGDQAFTEREAAEIMRDIGT 139
Query: 391 AIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
AI +LH I HRD+K N+L ++ K++DFG ++ A + T T
Sbjct: 140 AIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTP 193
Query: 448 GYLDPEYYINFQLTDKS-DVYSFGVVLVELL 477
Y+ PE + + DKS D++S GV++ LL
Sbjct: 194 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILL 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 36/161 (22%), Positives = 68/161 (42%), Gaps = 28/161 (17%)
Query: 291 ATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPI--LNEVRILCQL 346
+++ F LG+G + V+K + + T A+K KL + +G P + E+ ++ +L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGL-NKTTGVYVALKEVKLDSEEGT-PSTAIREISLMKEL 60
Query: 347 NH-------------RSLFMSM----SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTA 389
H L + + D + L+ + + Q
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPR--GLELNLVKYFQWQLL 118
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
Q +A+ H I HRD+K N+L++++ K+ DFGL+R
Sbjct: 119 QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 49/216 (22%), Positives = 83/216 (38%), Gaps = 43/216 (19%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+F ++G G FGEV L + + + A+K + ++ E +L +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 349 R-------------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRL--HIAR----Q 387
+ +L++ M G L L + + RL +AR +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE----------DRLPEEMARFYLAE 183
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
AI +H L HRDIK NIL+D +++DFG + + ++ A GT
Sbjct: 184 MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240
Query: 448 GYLDPEYYINFQLTDKS-----DVYSFGVVLVELLT 478
Y+ PE + D +S GV + E+L
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 42/200 (21%), Positives = 82/200 (41%), Gaps = 27/200 (13%)
Query: 252 KHFHQSNREVSLTKVQKDISGANNSGRLARIFSSREIT-EATNNFSTGNLLGSGGFGEVF 310
+H + VS ++ + ++S + + + + +L+G+G +G V
Sbjct: 11 QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVC 70
Query: 311 KAILDDET--ITAVKRAKLGNTKGIDP--ILNEVRILCQLNHR---SLF-MSMSPNGTLF 362
+A D + A+K+ ID IL E+ IL +LNH + + + + F
Sbjct: 71 EAY-DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129
Query: 363 DR-----------LHRV-QSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKS 410
D ++ ++ L H + + Y+H + I HRD+K
Sbjct: 130 DELYVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKP 184
Query: 411 SNILLDEKLDAKISDFGLSR 430
+N L+++ K+ DFGL+R
Sbjct: 185 ANCLVNQDCSVKVCDFGLAR 204
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 66/294 (22%), Positives = 105/294 (35%), Gaps = 50/294 (17%)
Query: 226 CSHGKGCKHKKPKTAVIGVLATIKFYKHFHQSN---REVSLTKVQKDISGANNSGRLARI 282
C K + + + + T + FH RE T +Q G
Sbjct: 60 CQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMD 119
Query: 283 FSSREITEAT------------------NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK 323
F S ++ + N F LLG G FG+V A+K
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK 179
Query: 324 ---RAKLGNTKGIDPILNEVRILCQLNH-------------RSLFMSMS--PNGTLFDRL 365
+ + + L E R+L H L M G LF L
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239
Query: 366 HRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425
R + + R + A + A+ YLH + + +RD+K N++LD+ KI+D
Sbjct: 240 SRERVFSED----RARFYGA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITD 292
Query: 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKS-DVYSFGVVLVELLT 478
FGL + + + + TF GT YL PE + ++ D + GVV+ E++
Sbjct: 293 FGLCKEGIKDGATMKTFC-GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMC 344
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 57/253 (22%), Positives = 97/253 (38%), Gaps = 52/253 (20%)
Query: 274 NNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGN-- 329
++SGR F + +N+ +L+G G +G V+ A D T A+K K+
Sbjct: 7 HSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAY-DKNTEKNVAIK--KVNRMF 63
Query: 330 TKGIDP--ILNEVRILCQLNHR---SLF-MSMSPNGTLFDR-----------LHRV-QSG 371
ID IL E+ IL +L L+ + + + FD L ++ ++
Sbjct: 64 EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP 123
Query: 372 NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR- 430
L H I ++H I HRD+K +N LL++ K+ DFGL+R
Sbjct: 124 I--FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178
Query: 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTD--------------------KS-DVYSF 469
+ +++ + + QLT KS D++S
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238
Query: 470 GVVLVELLTSKKA 482
G + ELL ++
Sbjct: 239 GCIFAELLNMLQS 251
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 35/152 (23%), Positives = 58/152 (38%), Gaps = 18/152 (11%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPI--LNEVRILCQLNH 348
+ L+G G +G V K + +T I A+K+ + + + E+++L QL H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCR-NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 349 R---SLFMSMSPNGTLF------DR-LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
+L + D + L + Q I + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-- 141
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
+ I HRDIK NIL+ + K+ DFG +R
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 7e-15
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 38/214 (17%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK-GIDPI--LNEVRILCQLN 347
+ +G G +G VFKA + ET I A+KR +L + G+ P L E+ +L +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAK-NRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELK 59
Query: 348 HR---SLFMSMSPNGTLF--------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
H+ L + + L D L + L Q + + + H
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG--TLGYLDPE- 453
+ + HRD+K N+L++ + K+++FGL+R V ++ TL Y P+
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTLWYRPPDV 172
Query: 454 -----YYINFQLTDKSDVYSFGVVLVELLTSKKA 482
Y + D++S G + EL + +
Sbjct: 173 LFGAKLY-----STSIDMWSAGCIFAELANAGRP 201
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPI--LNEVRILCQLNH 348
+ + LG G + V+K T + A+K +L + +G P + EV +L L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGK-SKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKH 59
Query: 349 R---SLFMSMSPNGTLF--------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
+L + +L D L + + H+ Q + +AY H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH- 117
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
+ HRD+K N+L++E+ + K++DFGL+R A + + TL Y P+ I
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPD--IL 172
Query: 458 FQLTDKS---DVYSFGVVLVELLTSK 480
TD S D++ G + E+ T +
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 43/222 (19%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDPI-----LNEVRI 342
+ + F + G G FG V + T A+K+ DP L ++
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGK-EKSTGMSVAIKKVIQ------DPRFRNRELQIMQD 72
Query: 343 LCQLNH------RSLFMSMSPNGT----------LFDR-LHRV-----QSGNWPPLKWHH 380
L L+H +S F ++ LHR + PP
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI-LI 131
Query: 381 RLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGLSRLALNGASHV 439
++ + Q ++I LHL + + HRDIK N+L++E K+ DFG ++ +V
Sbjct: 132 KVFL-FQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 440 TTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSK 480
+ Y PE Q T D++S G + E++ +
Sbjct: 190 AYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 9e-15
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 34/203 (16%)
Query: 300 LLGSGGFGEVF----KAILDDETITAVKRAK----LGNTKGIDPILNEVRILCQLNH--- 348
+LG GG+G+VF + I A+K K + N K E IL ++ H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 349 ----------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
L++ + G LF +L R ++A + + A+ +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED----TACFYLA-EISMALGHLH 138
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
I +RD+K NI+L+ + K++DFGL + +++ + TF GT+ Y+ PE +
Sbjct: 139 QKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPE-IL 193
Query: 457 NFQLTDKS-DVYSFGVVLVELLT 478
+++ D +S G ++ ++LT
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLT 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 36/250 (14%)
Query: 254 FHQSNREVSLTKVQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI 313
F SN ++ K+ LA + E + ++ ++G+G FG VF+A
Sbjct: 3 FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGE--QREIAYTNCKVIGNGSFGVVFQAK 60
Query: 314 LDDETITAVKRAKLGNTKGIDP--ILNEVRILCQLNHR---SLFMSMSPNGTLFDR---- 364
L + A+K+ D E++I+ + H L NG D
Sbjct: 61 LVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 365 ---------LHRVQSGNWPPLKWHHRLHIAR---QTAQAIAYLHLLATPPIYHRDIKSSN 412
++R + L I Q +++AY+H + I HRDIK N
Sbjct: 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQN 171
Query: 413 ILLDEKLDA-KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFG 470
+LLD K+ DFG +++ + G +V+ + Y PE T D++S G
Sbjct: 172 LLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTG 229
Query: 471 VVLVELLTSK 480
V+ EL+ +
Sbjct: 230 CVMAELMQGQ 239
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 35/161 (21%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK-GIDPI--LNEVRILCQLN 347
NF +G G +G V+KA + T + A+K+ +L G+ P + E+ +L +LN
Sbjct: 3 ENFQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKELN 60
Query: 348 H-------------RSLFMSMSPNGTLFDRLHR-----VQSGNWPPLKWHHRLHIARQTA 389
H L++ +F+ LH+ + + + Q
Sbjct: 61 HPNIVKLLDVIHTENKLYL-------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
Q +A+ H + + HRD+K N+L++ + K++DFGL+R
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 38/218 (17%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK-GIDPI--LNEVRILCQLN 347
+ + +G G FGEVFKA +T A+K+ + N K G PI L E++IL L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKVLMENEKEGF-PITALREIKILQLLK 74
Query: 348 HRS-----------LFMSMSPNGTLF--------DRLHRVQSGNWPPLKWHHRLHIARQT 388
H + G+++ D L + S + +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQML 133
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL-ALNGASHVTTFAQG-- 445
+ Y+H I HRD+K++N+L+ K++DFGL+R +L S +
Sbjct: 134 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 446 TLGYLDPEYYINFQLTDKS---DVYSFGVVLVELLTSK 480
TL Y PE + D D++ G ++ E+ T
Sbjct: 191 TLWYRPPE--LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 39/212 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK-GIDPI--LNEVRILCQLN 347
+ +G G +G V+KA D I A+KR +L GI P + E+ +L +L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAEDEGI-PSTAIREISLLKELH 77
Query: 348 HR---SLFMSMSPNGTLF--------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
H SL + L D L +V N L+ Q + +A+ H
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQG--TLGYLDPE- 453
I HRD+K N+L++ K++DFGL+R V ++ TL Y P+
Sbjct: 137 ---QHRILHRDLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVVTLWYRAPDV 190
Query: 454 -----YYINFQLTDKSDVYSFGVVLVELLTSK 480
Y + D++S G + E++T K
Sbjct: 191 LMGSKKY-----STSVDIWSIGCIFAEMITGK 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 35/213 (16%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR- 349
+++ ++G+G FG V++A L D + A+K+ E++I+ +L+H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCN 108
Query: 350 --SLFMSMSPNGTLFDR-------------LHRV-----QSGNWPPLKWHHRLHIARQTA 389
L +G D ++RV ++ P+ + +L++ Q
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYM-YQLF 166
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDA-KISDFGLSRLALNGASHVTTFAQGTLG 448
+++AY+H I HRDIK N+LLD K+ DFG ++ + G +V+ +
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 221
Query: 449 YLDPEYYINFQL-TDKSDVYSFGVVLVELLTSK 480
Y PE T DV+S G VL ELL +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 51/253 (20%), Positives = 87/253 (34%), Gaps = 53/253 (20%)
Query: 260 EVSLTKVQKDISGANNSGRLARIFSSREITEAT-NNFSTGNLLGSGGFGEVFKA-ILDDE 317
++ ++K+ + N R + ++ ++G G FGEV
Sbjct: 35 DLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 94
Query: 318 TITAVK---RAKLGNTKGIDPILNEVRILCQLNH-------------RSLFMSMS--PNG 359
+ A+K + ++ E I+ N R L+M M P G
Sbjct: 95 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154
Query: 360 TLFDRLHRVQSGNWPPLKWHHRL--HIAR----QTAQAIAYLHLLATPPIYHRDIKSSNI 413
L + + + + AR + A+ +H + HRD+K N+
Sbjct: 155 DLVNLMSN------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNM 199
Query: 414 LLDEKLDAKISDFGLS-RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVY----- 467
LLD+ K++DFG ++ G T GT Y+ PE + Y
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEV---LKSQGGDGYYGRECD 255
Query: 468 --SFGVVLVELLT 478
S GV L E+L
Sbjct: 256 WWSVGVFLYEMLV 268
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 51/220 (23%), Positives = 79/220 (35%), Gaps = 67/220 (30%)
Query: 297 TGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGID---PILNEVRILCQL-NHRS-- 350
T +LG G G+V + T K A K + EV + +
Sbjct: 66 TSQVLGLGINGKVLQIF---NKRTQEKFA----LKMLQDCPKARREVELHWRASQCPHIV 118
Query: 351 -----------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQ 387
+ M G LF R+ + I +
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD---------RGDQAFTEREASEIMKS 169
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILL-DEKLDA--KISDFGLSRLALNGASHVTTFAQ 444
+AI YLH + I HRD+K N+L ++ +A K++DFG ++ + +TT
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPC- 224
Query: 445 GTLGYLDPE------YYINFQLTDKS-DVYSFGVVLVELL 477
T Y+ PE Y DKS D++S GV++ LL
Sbjct: 225 YTPYYVAPEVLGPEKY-------DKSCDMWSLGVIMYILL 257
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 35/212 (16%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH 348
+++ LG G + EVF+AI + + VK K K I E++IL L
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRG 89
Query: 349 RSLFMSMSPN-GTLFDRLHRVQSGN----------------WPPLKWHHRLHIARQTAQA 391
PN TL D + S + L + + +A
Sbjct: 90 -------GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKA 142
Query: 392 IAYLHLLATPPIYHRDIKSSNILLD-EKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL 450
+ Y H + I HRD+K N+++D E ++ D+GL+ G + + +
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFK 197
Query: 451 DPEYYINFQLTDKS-DVYSFGVVLVELLTSKK 481
PE +++Q+ D S D++S G +L ++ K+
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 46/159 (28%), Positives = 68/159 (42%), Gaps = 28/159 (17%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK-GIDPI--LNEVRILCQLN 347
+ + LG G +GEV+KAI D T A+KR +L + + G+ P + EV +L +L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAI-DTVTNETVAIKRIRLEHEEEGV-PGTAIREVSLLKELQ 91
Query: 348 HR---SLFMSMSPNGTLF--------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
HR L + N L D L + N P + Q + + H
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKN-PDVSMRVIKSFLYQLINGVNFCH 149
Query: 397 LLATPPIYHRDIKSSNILLDEKLDA-----KISDFGLSR 430
+ HRD+K N+LL + KI DFGL+R
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 34/202 (16%)
Query: 300 LLGSGGFGEVF----KAILDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH---- 348
+LG G FG+VF + D + A+K +A L + E IL ++NH
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFIV 89
Query: 349 ---------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
L++ + G LF RL + + ++A + A A+ +LH
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE----DVKFYLA-ELALALDHLHS 144
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
L I +RD+K NILLDE+ K++DFGLS+ +++ +F GT+ Y+ PE +N
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE-VVN 199
Query: 458 FQLTDKS-DVYSFGVVLVELLT 478
+ +S D +SFGV++ E+LT
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLT 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 33/206 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+F LG+G FG V + A+K + + K ++ +E +L + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 349 -------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+ +FM M G LF L + Q P + + A + A+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----VAKFYAA-EVCLALE 120
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YLH I +RD+K NILLD+ KI+DFG ++ + T GT Y+ PE
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY---TLC-GTPDYIAPE 173
Query: 454 YYINFQLTDKS-DVYSFGVVLVELLT 478
++ + +KS D +SFG+++ E+L
Sbjct: 174 -VVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 36/233 (15%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
N+F LLG G FG+V A+K + + + + E R+L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 349 -------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L M G LF L R + R + A + A+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----RARFYGA-EIVSALE 119
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YLH + +RDIK N++LD+ KI+DFGL + ++ + + TF GT YL PE
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPE 175
Query: 454 YYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505
+ ++ D + GVV+ E++ + N++ E + F IL +E
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERL-----FELILMEE 221
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 7e-14
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 23/154 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK-GIDPI--LNEVRILCQLN 347
+ +G G +G V+KA + A+K+ +L GI P + E+ IL +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGI-PSTTIREISILKELK 58
Query: 348 HR---SLFMSMSPNGTLF--------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
H L+ + L D L ++ L+ Q IAY H
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
+ HRD+K N+L++ + + KI+DFGL+R
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 58/222 (26%), Positives = 88/222 (39%), Gaps = 52/222 (23%)
Query: 301 LGSGGFGEVFKAILDDET--ITAVKRAKLGN--TKGIDP--ILNEVRILCQLN-HR---S 350
LG G +G V+K+I D T + AVK K+ + D E+ IL +L+ H +
Sbjct: 17 LGKGAYGIVWKSI-DRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 351 LFMSMSPNGTLFDR-----------LHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
L + + LH V N L+ H+ ++ Q + I YLH
Sbjct: 74 LLNVLRADN--DRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH--- 126
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
+ + HRD+K SNILL+ + K++DFGLSR +N +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 460 LTD---------------------KSDVYSFGVVLVELLTSK 480
LTD D++S G +L E+L K
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 38/232 (16%)
Query: 300 LLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQ-LNH------ 348
++G G + +V L + I A+K + + + + ID + E + Q NH
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 349 -------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
LF + G L + R + H R + A + + A+ YLH
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSA-EISLALNYLHERG 130
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I +RD+K N+LLD + K++D+G+ + L +TF GT Y+ PE + +
Sbjct: 131 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-ILRGE 185
Query: 460 LTDKS-DVYSFGVVLVELLT-----SKKAVDFNREEEDVNLVVYFGNILKQE 505
S D ++ GV++ E++ N ++ + + F IL+++
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--FQVILEKQ 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 31/200 (15%)
Query: 300 LLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQ-LNH------ 348
++G G FG+V A +E AVK + + K I++E +L + + H
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 349 -------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
L+ + G LF L R + P R + A + A A+ YLH L
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAA-EIASALGYLHSLN 159
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I +RD+K NILLD + ++DFGL + + S +TF GT YL PE ++ Q
Sbjct: 160 ---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPE-VLHKQ 214
Query: 460 LTDKS-DVYSFGVVLVELLT 478
D++ D + G VL E+L
Sbjct: 215 PYDRTVDWWCLGAVLYEMLY 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 38/232 (16%)
Query: 300 LLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLN-------- 347
++G G + +V L + I A++ + + + + ID + E + Q +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 348 HRS------LFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
H LF + G L + R + H R + A + + A+ YLH
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSA-EISLALNYLHERG 173
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I +RD+K N+LLD + K++D+G+ + L +TF GT Y+ PE + +
Sbjct: 174 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-ILRGE 228
Query: 460 LTDKS-DVYSFGVVLVELLT-----SKKAVDFNREEEDVNLVVYFGNILKQE 505
S D ++ GV++ E++ N ++ + + F IL+++
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--FQVILEKQ 278
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 12/110 (10%)
Query: 374 PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433
L H + + Q A+ + +L A+ HRD+ + NILL EK KI DFGL+R
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 434 NGASHVTTFAQGTLGYLD-----PEYYINFQLTDKSDVYSFGVVLVELLT 478
+V + L PE + T +SDV+SFGV+L E+ +
Sbjct: 245 KDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+F+ +LG G FG+V + + + AVK + + ++ + E R+L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 349 R----SLF------------MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
L M G L + +V P H + A + A +
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAA-EIAIGL 455
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
+L I +RD+K N++LD + KI+DFG+ + + TF GT Y+ P
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAP 511
Query: 453 EYYINFQLTDKS-DVYSFGVVLVELLT 478
E I +Q KS D ++FGV+L E+L
Sbjct: 512 E-IIAYQPYGKSVDWWAFGVLLYEMLA 537
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 30/166 (18%)
Query: 291 ATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK-GIDPI----LNEVRIL 343
AT+ + +G G +G V+KA D + A+K ++ N G + + EV +L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKAR-DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 344 CQLN---HR---SLF-MSMSPNGTLFDRLHRV------------QSGNWPPLKWHHRLHI 384
+L H L + + ++ V P L +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
RQ + + +LH I HRD+K NIL+ K++DFGL+R
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 49/166 (29%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 287 EITEATNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK----GIDPI--LN 338
++ + + LG G F V+KA D T I A+K+ KLG+ GI L
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKAR-DKNTNQIVAIKKIKLGHRSEAKDGI-NRTALR 61
Query: 339 EVRILCQLNH------RSLFMSMSPNGTLF--------DRLHRVQSGNWPPLKWHHRLHI 384
E+++L +L+H F S + D L + N L H
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKS---NISLVFDFMETD-LEVIIKDNSLVLTPSHIKAY 117
Query: 385 ARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
T Q + YLH I HRD+K +N+LLDE K++DFGL++
Sbjct: 118 MLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 55/207 (26%), Positives = 86/207 (41%), Gaps = 31/207 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQ-LN 347
+F +LG G FG+VF A A+K + + ++ + E R+L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 348 H-------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
H +LF M G L + + + A + +
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS----RATFYAA-EIILGL 131
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
+LH I +RD+K NILLD+ KI+DFG+ + + G + TF GT Y+ P
Sbjct: 132 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAP 187
Query: 453 EYYINFQLTDKS-DVYSFGVVLVELLT 478
E + Q + S D +SFGV+L E+L
Sbjct: 188 E-ILLGQKYNHSVDWWSFGVLLYEMLI 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 20/200 (10%), Positives = 47/200 (23%), Gaps = 61/200 (30%)
Query: 300 LLGSGGFGEVFKAILDDETIT---AVK--RAKLGNTKG-IDPILNEVRILCQLNHRSL-- 351
G + ++A+ D + A+ + + L+ L +++ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 352 -----------FMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
+ G+L + + + A A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAH-- 146
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
+ S + + D ++ T+ +P+
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYP------------------ATMPDANPQ----- 182
Query: 459 QLTDKSDVYSFGVVLVELLT 478
D+ G L LL
Sbjct: 183 -----DDIRGIGASLYALLV 197
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 31/200 (15%)
Query: 300 LLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNHR------ 349
+LG G FG+V + + + AVK + + ++ + E R+L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 350 --------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
L+ M G L + +V P H + A + A + +L
Sbjct: 87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAA-EIAIGLFFLQSKG 141
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I +RD+K N++LD + KI+DFG+ + + TF GT Y+ PE I +Q
Sbjct: 142 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE-IIAYQ 196
Query: 460 LTDKS-DVYSFGVVLVELLT 478
KS D ++FGV+L E+L
Sbjct: 197 PYGKSVDWWAFGVLLYEMLA 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 28/162 (17%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTK-GIDPI--LNEVRILCQLN 347
+ +G G +G+VFKA A+KR ++ + G+ P+ + EV +L L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLE 69
Query: 348 ---HR---SLF-MSMSPNGTLFDRLHRV------------QSGNWPPLKWHHRLHIARQT 388
H LF + +L V P + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
+ + +LH + + HRD+K NIL+ K++DFGL+R
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 31/200 (15%)
Query: 300 LLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNHR------ 349
+LG G FG+V A + + + AVK + + ++ + E RIL +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 350 --------SLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
LF M G L + + + + R + A + A+ +LH
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARFYAA-EIISALMFLHDKG 144
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
I +RD+K N+LLD + K++DFG+ + + TF GT Y+ PE +
Sbjct: 145 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPE-ILQEM 199
Query: 460 LTDKS-DVYSFGVVLVELLT 478
L + D ++ GV+L E+L
Sbjct: 200 LYGPAVDWWAMGVLLYEMLC 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 50/246 (20%), Positives = 83/246 (33%), Gaps = 69/246 (28%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAILDDET--ITAVKRAKLGNTKGIDP--ILNEVRILCQLN 347
+ +S G LG+G FG V + D E+ A+K+ DP E+ I+ L+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVF-DIESGKRFALKKVL------QDPRYKNRELDIMKVLD 58
Query: 348 H------RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHR-------------------- 381
H F + + + +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 382 -----LH-IAR-------------------QTAQAIAYLHLLATPPIYHRDIKSSNILLD 416
LH + + Q +A+ ++H L I HRDIK N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVN 175
Query: 417 EKLDA-KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLV 474
K + K+ DFG ++ + V + Y PE + T D++S G V
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 475 ELLTSK 480
EL+ K
Sbjct: 234 ELILGK 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 67/226 (29%)
Query: 301 LGSGGFGEVFKAI-LDDET--ITAVKRAKLGNTKGIDP-ILNEVRILCQLNH-------- 348
+G G +G V+KA D + A+K+ + GI E+ +L +L H
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACREIALLRELKHPNVISLQK 85
Query: 349 -------RSLFMSMSPNGTLFD----------RLHRVQSGNWPPLKWHHRL--HIARQTA 389
R +++ LFD + HR N P++ + + Q
Sbjct: 86 VFLSHADRKVWL-------LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDA----KISDFGLSRLALNGASHVTTFAQG 445
I YLH + HRD+K +NIL+ + KI+D G +RL S + A
Sbjct: 139 DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLADL 192
Query: 446 -----TLGYLDPE------YYINFQLTDKSDVYSFGVVLVELLTSK 480
T Y PE +Y T D+++ G + ELLTS+
Sbjct: 193 DPVVVTFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 50/204 (24%), Positives = 76/204 (37%), Gaps = 38/204 (18%)
Query: 300 LLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLN----------- 347
++G G FG+V KA A+K + + E+RIL L
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 348 -------HRS----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
R+ F +S N L++ + + + A Q + LH
Sbjct: 163 HMLENFTFRNHICMTFELLSMN--LYELI---KKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 397 LLATPPIYHRDIKSSNILLDE--KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
I H D+K NILL + + K+ DFG S V T+ Q + Y PE
Sbjct: 218 KNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFYRAPEV 270
Query: 455 YINFQLTDKSDVYSFGVVLVELLT 478
+ + D++S G +L ELLT
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLT 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 48/212 (22%), Positives = 82/212 (38%), Gaps = 40/212 (18%)
Query: 300 LLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSLFMSMSPN 358
LG G F V+ A + + T A+K + G+ + +E+++L ++N S
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 359 GTLFDRL-----HRVQSGN---------WPPL-----KWHHR-------LHIARQTAQAI 392
+L H+ +G L K+ HR I++Q +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 393 AYLHLLATPPIYHRDIKSSNILLDE------KLDAKISDFGLSRLALNGASHVTTFAQGT 446
Y+H I H DIK N+L++ + KI+D G + H T Q T
Sbjct: 145 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQ-T 198
Query: 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
Y PE + +D++S ++ EL+T
Sbjct: 199 REYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 42/213 (19%), Positives = 64/213 (30%), Gaps = 74/213 (34%)
Query: 297 TGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGID---PILNEVRILCQL------- 346
T +LG G G+V + T K A K + EV + +
Sbjct: 22 TSQVLGLGINGKVLQIF---NKRTQEKFA----LKMLQDCPKARREVELHWRASQCPHIV 74
Query: 347 -------------NHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL------HIARQ 387
+ M G LF R+ + I +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD---------RGDQAFTEREASEIMKS 125
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLALNGASHVTTFAQ 444
+AI YLH + I HRD+K N+L K++DFG ++
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE--------- 173
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELL 477
Y D D++S GV++ LL
Sbjct: 174 ---KY-DKS----------CDMWSLGVIMYILL 192
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 36/205 (17%)
Query: 299 NLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLN---------- 347
+L+G G FG+V KA ++ A+K K ++ EVR+L +N
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 348 --------HRS----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
R+ +F +S N L+D L ++ N+ + + A+Q A+ +L
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYN--LYDLL---RNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 396 HLLATPPIYHRDIKSSNILL--DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
I H D+K NILL ++ KI DFG S + + Q + Y PE
Sbjct: 174 AT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQ-SRFYRSPE 228
Query: 454 YYINFQLTDKSDVYSFGVVLVELLT 478
+ D++S G +LVE+ T
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 35/201 (17%), Positives = 69/201 (34%), Gaps = 37/201 (18%)
Query: 272 GANNSGRLARIFSSREITEAT--NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG 328
G N + F ++ + N + G +GSGGFG ++ A + A K+
Sbjct: 14 GTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE 73
Query: 329 NTKGIDPILNEVRILCQLNHRSLFMSMSPNGTLFDR---------LHRVQSGNW------ 373
+ P+ +E++ ++ + L L + ++
Sbjct: 74 YQEN-GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME 132
Query: 374 ---PPL----KWHHR------LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420
L + L + + + Y+H H DIK++N+LL K
Sbjct: 133 RLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189
Query: 421 AKI--SDFGLSRLALNGASHV 439
++ +D+GLS +H
Sbjct: 190 DQVYLADYGLSYRYCPNGNHK 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 1e-08
Identities = 34/196 (17%), Positives = 55/196 (28%), Gaps = 59/196 (30%)
Query: 291 ATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDP--------ILNEVRI 342
T +G G FGEVF+ I D T A+K + ++ IL E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 343 LCQLNH-RSLFMSMSPNGTLFDRLHRVQSGNWPPL------------------------- 376
+L+ + + + +H VQ P L
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 377 ----------------------KWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNIL 414
I Q ++A A+ HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVL 194
Query: 415 LDEKLDAKISDFGLSR 430
L + K+ +
Sbjct: 195 LKKTSLKKLHYTLNGK 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 30/181 (16%), Positives = 59/181 (32%), Gaps = 38/181 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKR---AKLGNTKGIDPILNEVRILCQLNHR 349
+ G +G GGFG ++ A ++ K+ + P+ E++ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKP 93
Query: 350 SLFMSMSPNGTLFDR---------LHRVQSGNW---------PPL----KWHHR------ 381
L LH ++ L + + +
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153
Query: 382 -LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI--SDFGLSRLALNGASH 438
L ++ + + Y+H H DIK+SN+LL+ K ++ D+GL+ H
Sbjct: 154 VLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 439 V 439
Sbjct: 211 K 211
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 53/256 (20%), Positives = 74/256 (28%), Gaps = 86/256 (33%)
Query: 301 LGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH----------- 348
LG G F V+ + + + A+K K + L+E+R+L + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 349 RSL---FMSMSPNGT------------LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L F NGT L + + P I +Q Q +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPL---PCVKKIIQQVLQGLD 160
Query: 394 YLHLLATPPIYHRDIKSSNILL-------------------------------------- 415
YLH I H DIK NILL
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 416 -----------DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKS 464
EKL KI+D G + H T Q T Y E I +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ-TRQYRSLEVLIGSGYNTPA 274
Query: 465 DVYSFGVVLVELLTSK 480
D++S + EL T
Sbjct: 275 DIWSTACMAFELATGD 290
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 39/161 (24%), Positives = 61/161 (37%), Gaps = 36/161 (22%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPIL-NEVRILCQL---- 346
N + G +GSG FG+++ + A+K K P L E +I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYKMMQGGV 65
Query: 347 ------------NHRSLFMSM-SPN-GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
++ + M + P+ LF+ R S LK L +A Q I
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFS-----LK--TVLLLADQMISRI 118
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAK---ISDFGLSR 430
Y+H + HRD+K N L+ I DFGL++
Sbjct: 119 EYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 34/171 (19%), Positives = 59/171 (34%), Gaps = 38/171 (22%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPIL-NEVRILCQL---- 346
++ G +G G FG +F+ L + A+K + P L +E R L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP---RRSDAPQLRDEYRTYKLLAGCT 66
Query: 347 ------------NHRSLFMSM-SPN-GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
H L + + P+ L D R S +K A+Q +
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS-----VK--TVAMAAKQMLARV 119
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAK-----ISDFGLSRLALNGASH 438
+H + + +RDIK N L+ + DFG+ + + +
Sbjct: 120 QSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 47/226 (20%), Positives = 75/226 (33%), Gaps = 64/226 (28%)
Query: 300 LLGSGGFGEVFKAI--LDDETITAVKRAKLGNTKGIDPILNEVRILCQLN---------- 347
LG G FG+V + + ++ A+K + K + E+ +L ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR-NVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 348 --------HRS----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
F + N F+ L + N+ P H H+A Q A+ +L
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKN--TFEFL---KENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 396 HLLATPPIYHRDIKSSNILLDE-------------------KLDAKISDFGLSRLALNGA 436
H + H D+K NIL +++DFG A
Sbjct: 140 HENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-------SA 189
Query: 437 S----HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
+ H TT T Y PE + DV+S G +L E
Sbjct: 190 TFDHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 44/170 (25%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPIL-NEVRILCQL---- 346
N F G +GSG FGE++ + A+K K P L E +I L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHPQLLYESKIYRILQGGT 63
Query: 347 ------------NHRSLFMSM-SPN-GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
++ L M + P+ LF+ R S LK L +A Q +
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLS-----LK--TVLMLADQMINRV 116
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAK---ISDFGLSRLALNGASHV 439
++H + HRDIK N L+ A I DFGL++ + ++H
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 48/230 (20%), Positives = 78/230 (33%), Gaps = 68/230 (29%)
Query: 300 LLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLN----------- 347
+G G FG V +D++ AVK + K E IL ++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 348 ------HRS----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
+ +F + P+ L++ + N+ + +A+ YL
Sbjct: 101 YHGKFMYYDHMCLIFEPLGPS--LYEII---TRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 398 LATPPIYHRDIKSSNILLDE-------------------------KLDAKISDFGLSRLA 432
++ + H D+K NILLD+ K+ DFG
Sbjct: 156 MS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG----- 207
Query: 433 LNGAS----HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
A+ + + T Y PE +N SD++SFG VL EL T
Sbjct: 208 --CATFKSDYHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 42/163 (25%), Positives = 61/163 (37%), Gaps = 38/163 (23%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILN-EVRILCQL---- 346
NF G +G G FGE+ L A+K L K P L+ E R QL
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 347 ------------NHRSLFMSM-SPN-GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
+ ++ + + P+ LFD R S LK L IA Q +
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFS-----LK--TVLMIAIQLISRM 118
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAK-----ISDFGLSR 430
Y+H + +RD+K N L+ + I DF L++
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 56/222 (25%)
Query: 300 LLGSGGFGEVFKAILDDET---ITAVK--RAKLGNTKGIDPILNEVRILCQLN------- 347
LG G FG+V + I D + AVK + + + +E+++L LN
Sbjct: 21 TLGEGAFGKVVECI-DHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNST 76
Query: 348 -----------HRS----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
H +F + + +D + + + P + H +A Q +++
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLS--TYDFI---KENGFLPFRLDHIRKMAYQICKSV 131
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS--------------- 437
+LH + H D+K NIL + + + + R +
Sbjct: 132 NFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 438 -HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT 478
H +T T Y PE + + DV+S G +L+E
Sbjct: 189 EHHSTLVS-TRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 24/190 (12%), Positives = 50/190 (26%), Gaps = 56/190 (29%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRA-------KLGNTKGIDPILNEVRILCQ 345
+ + G +++A T+T KL G + NE +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAA-PTSTLTCDSGPQKQKFSLKLDAKDG--RLFNEQNFFQR 98
Query: 346 LNHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWH------HR------------------ 381
+L+ P +R
Sbjct: 99 AAKPLQVNKWK-------KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVS 151
Query: 382 ----------LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI--SDFGLS 429
L +A + A+ +LH H ++ + NI +D + +++ + +G +
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 430 RLALNGASHV 439
HV
Sbjct: 209 FRYCPSGKHV 218
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 559 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.71 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.64 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.62 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.89 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.64 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.58 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.44 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.4 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.32 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.78 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.48 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.87 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.7 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.61 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.27 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 90.72 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 90.46 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 89.98 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 89.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.57 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 89.15 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 88.66 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 88.56 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 88.42 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 87.4 | |
| 3e50_C | 50 | Protransforming growth factor alpha; IDE, TGF-alph | 84.99 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 84.19 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 82.94 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 82.81 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 82.71 | |
| 3ltf_D | 58 | Protein spitz; receptor-ligand complex ectodomain | 81.33 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 81.31 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 80.98 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 80.56 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 80.38 | |
| 2rnl_A | 50 | Amphiregulin; AR, colorectum cell-derived growth f | 80.14 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=401.84 Aligned_cols=245 Identities=29% Similarity=0.454 Sum_probs=189.9
Q ss_pred HhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce--------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL--------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni--------------v~~ 354 (559)
..+++++.++||+|+||+||+|++++ .||||+++.... ...+.|.+|+++|++++|||| |||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmE 111 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQ 111 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEE
Confidence 34678889999999999999998764 589999875433 334679999999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.++|.... ..+++..+..|+.|||.||+||| +++||||||||+||||++++++||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999997543 35999999999999999999999 78899999999999999999999999999987653
Q ss_pred CC-ceeeeeccccCCccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 435 GA-SHVTTFAQGTLGYLDPEYYIN---FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 435 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
.. ........||+.|||||++.+ ..|+.++|||||||+||||+||+.||...+..... ......+ .
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~----~ 254 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRG----Y 254 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTT----C
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC----C
Confidence 22 222344569999999999864 35899999999999999999999999754432211 1111111 1
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..+.+.. .....+..+.+|+.+||+.||++||||.||++.|+.|
T Consensus 255 ~~p~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 255 ASPDLSK----LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCCCSTT----SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCCCccc----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111111 1123346788999999999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=406.57 Aligned_cols=244 Identities=27% Similarity=0.361 Sum_probs=195.7
Q ss_pred CCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++|.+.+.||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++||||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999999999999863 478899999987666666789999999999999994
Q ss_pred EEeeCCCCcHhHhHhhcc--------CCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 FMSMSPNGTLFDRLHRVQ--------SGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
||||+++|+|.++|+... ......++|..++.++.||+.||+||| +++||||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 789999999999997632 122346999999999999999999999 788999999999999999999999
Q ss_pred eecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 047195 424 SDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+|||+|+......... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||......+ .. ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~----~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI----EC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HH
Confidence 9999998765433322 223459999999999999999999999999999999999 899997554322 11 11
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
...+... . .+...+.++.+|+.+||+.||++||||+||+++|+++
T Consensus 243 i~~~~~~-----~-------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGRVL-----Q-------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCCC-----C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCC-----C-------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111110 0 0112346788999999999999999999999999876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=407.93 Aligned_cols=244 Identities=27% Similarity=0.352 Sum_probs=190.1
Q ss_pred CCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++|.+.++||+|+||+||+|+++ +++.||||+++..+....++|.+|+++|++++||||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777889999999999999864 478999999987666666789999999999999994
Q ss_pred EEeeCCCCcHhHhHhhccCC----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCE
Q 047195 352 FMSMSPNGTLFDRLHRVQSG----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~ 421 (559)
||||+++|+|.++++..... ...+++|..++.|+.||+.||+||| +++||||||||+||||++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 78999999999999764321 1246999999999999999999999 7889999999999999999999
Q ss_pred EEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 047195 422 KISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFG 499 (559)
Q Consensus 422 kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 499 (559)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+. ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~--- 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---ID--- 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HH---
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HH---
Confidence 9999999987654322 22334569999999999999999999999999999999999 8999975443221 11
Q ss_pred HHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 500 NILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 500 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
....+. .... +...+..+.+|+.+||+.||++||||+||+++|+.|
T Consensus 272 -~i~~g~-----~~~~-------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 272 -CITQGR-----ELER-------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp -HHHHTC-----CCCC-------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHcCC-----CCCC-------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111111 0001 112346788999999999999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=399.84 Aligned_cols=243 Identities=22% Similarity=0.318 Sum_probs=193.4
Q ss_pred CCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++++.++||+|+||+||+|++. +++.||||+++.... ...++|.+|+.+|++++||||
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999863 568899999875433 345689999999999999994
Q ss_pred EEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC
Q 047195 352 FMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD 420 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~ 420 (559)
||||+++|+|.++|...... ....++|..++.|+.|||+||+||| +++||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence 78999999999999653211 1236899999999999999999999 788999999999999999999
Q ss_pred EEEeecccceeccCCC-ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 047195 421 AKISDFGLSRLALNGA-SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYF 498 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 498 (559)
+||+|||+|+...... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||......+ ..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~--- 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VV--- 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HH---
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HH---
Confidence 9999999998764332 222344569999999999999999999999999999999999 899997554322 11
Q ss_pred HHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 499 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.....+... ..+...+..+.+|+.+||+.||++||||+||+++|+.+
T Consensus 258 -~~i~~~~~~------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 -EMIRNRQVL------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HHHHTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HHHHcCCCC------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111110 01113346788999999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=394.75 Aligned_cols=234 Identities=21% Similarity=0.301 Sum_probs=193.3
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
+.|++.++||+|+||+||+|+. .+++.||||++........+.+.+|+++|++++|||| ||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4689999999999999999996 4689999999987777777889999999999999994 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+++... .+++..+..++.||+.||+||| +++||||||||+||||+.++++||+|||+|+......
T Consensus 154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999998752 4899999999999999999999 7889999999999999999999999999999775543
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.. .....||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+. ...+. .. ..+.+.
T Consensus 225 ~~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~----~~-----~~~~~~ 291 (346)
T 4fih_A 225 PR-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIR----DN-----LPPRLK 291 (346)
T ss_dssp CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHH----HS-----SCCCCS
T ss_pred Cc-ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHH----cC-----CCCCCC
Confidence 32 2345699999999999999999999999999999999999999975433221 11111 10 111111
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. .......+.+|+.+||+.||++|||+.|+++
T Consensus 292 ~-----~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 N-----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp C-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0123367888999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=403.38 Aligned_cols=235 Identities=25% Similarity=0.388 Sum_probs=185.1
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
++|++++.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++|+|||| |||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999995 5689999999876532 335679999999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.+++..... ..+++..++.++.||+.||+||| +++||||||||+||||++++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999976432 35789999999999999999999 78899999999999999999999999999987643
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
.. .......||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+. ..... .+.. +.
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~-~~~~-----~~ 244 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VLKII-SGSF-----PP 244 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH-HTCC-----CC
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHH-cCCC-----CC
Confidence 21 122334599999999999999999999999999999999999999975543221 11111 1110 00
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+ ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~-------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 V-------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp C-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1123367889999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=388.75 Aligned_cols=237 Identities=19% Similarity=0.232 Sum_probs=188.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.+.|++.++||+|+||+||+|+. .+++.||||+++.... ..+|+.+|++++|||| ||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34678888999999999999995 4689999999975422 3479999999999994 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeecccceeccC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDFGLSRLALN 434 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DFG~a~~~~~ 434 (559)
+++|+|.+++.... .+++..+..++.||+.||+||| +++||||||||+||||+.++ ++||+|||+|+....
T Consensus 132 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred cCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 99999999997643 4999999999999999999999 88999999999999999987 699999999997754
Q ss_pred CCce----eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 435 GASH----VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 435 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
+... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.......... .+.. ......+
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~--~~~~~~~- 277 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIAS--EPPPIRE- 277 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHH--SCCGGGG-
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHc--CCCCchh-
Confidence 3221 1223469999999999999999999999999999999999999997654333211 1110 0001000
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+ .......+.+|+.+||+.||++|||+.||++.|..+
T Consensus 278 ----~-------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 278 ----I-------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp ----S-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----c-------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 112346788899999999999999999999988764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=395.88 Aligned_cols=234 Identities=21% Similarity=0.307 Sum_probs=193.6
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
+.|++.++||+|+||+||+|+. .+++.||||++........+.+.+|+.+|++++|||| ||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4699999999999999999995 4689999999988777777889999999999999994 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+++... .+++..+..++.||+.||+||| +++||||||||+||||+.++.+||+|||+|+......
T Consensus 231 ~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999998652 4899999999999999999999 7889999999999999999999999999998775443
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.. .....||+.|||||++.+..|+.++|||||||++|||++|+.||......+. ...+ .. ...+.+.
T Consensus 302 ~~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i----~~-----~~~~~~~ 368 (423)
T 4fie_A 302 PR-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMI----RD-----NLPPRLK 368 (423)
T ss_dssp CC-BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----HH-----SCCCCCS
T ss_pred cc-ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHH----Hc-----CCCCCCc
Confidence 32 2344599999999999999999999999999999999999999975433221 1111 11 1111111
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. . ......+.+|+.+||+.||++|||+.|+++
T Consensus 369 ~-~----~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 N-L----HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C-T----TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-c----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 0 122367888999999999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=387.93 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=185.9
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHH--HHHHHHHhcCCCce-------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPIL--NEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~--~E~~~l~~l~h~ni------------------- 351 (559)
++|.+.++||+|+||+||+|++ +++.||||++.... .+.+. .|+..+.+++||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 3577789999999999999987 57899999986532 23344 45556678999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHc-----CCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL-----ATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
||||+++|+|.++++.. .++|..+.+++.|++.||+|||+. +..+||||||||+||||++++++||+||
T Consensus 79 V~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 78999999999999752 489999999999999999999932 1238999999999999999999999999
Q ss_pred ccceeccCCCcee---eeeccccCCccCccccccC------CCCcccchhHHHHHHHHHHhCCCCCCCCCccccc-----
Q 047195 427 GLSRLALNGASHV---TTFAQGTLGYLDPEYYINF------QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV----- 492 (559)
Q Consensus 427 G~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~----- 492 (559)
|+|+......... .....||+.|||||++.+. .++.++|||||||+||||+||+.|+.........
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 9998876544332 2234699999999998754 4678999999999999999998877543221110
Q ss_pred ---cHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 493 ---NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 493 ---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
............. .+++.+.... ...+....+.+|+.+||+.||++||||.||+++|++|
T Consensus 233 ~~~~~~~~~~~~~~~~----~~rp~~p~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQ----KLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CSSCCHHHHHHHHTTS----CCCCCCCGGG--GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcc----cCCCCCCccc--cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0011111111111 1222221111 1235567889999999999999999999999999886
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=396.05 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=203.3
Q ss_pred cChHHHHHHhCCCCCCCccccCCccEEEEEEecC------CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCC-Cce---
Q 047195 283 FSSREITEATNNFSTGNLLGSGGFGEVFKAILDD------ETITAVKRAKLGNT-KGIDPILNEVRILCQLNH-RSL--- 351 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h-~ni--- 351 (559)
+...+++...++|++.+.||+|+||+||+|.+.. ++.||||++..... ...+.|.+|+++|++++| |||
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556677777899999999999999999998543 36799999876543 234679999999999976 774
Q ss_pred -------------EEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECC
Q 047195 352 -------------FMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRD 407 (559)
Q Consensus 352 -------------v~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~D 407 (559)
||||+++|+|.++|+..... ....+++..++.++.|||.||+||| +++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 78999999999999764321 1245899999999999999999999 78899999
Q ss_pred CCCCCeeecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 047195 408 IKSSNILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDF 485 (559)
Q Consensus 408 ikp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~ 485 (559)
|||+|||+++++++||+|||+|+....+... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977544333 3334569999999999999999999999999999999998 8999975
Q ss_pred CCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 486 NREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
....+. +......+.. +... ...+.++.+++.+||+.||++||||.||++.|++|+
T Consensus 291 ~~~~~~------~~~~i~~g~~-----~~~p-------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 291 VKIDEE------FCRRLKEGTR-----MRAP-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCCSHH------HHHHHHHTCC-----CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHH------HHHHHHcCCC-----CCCC-------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 543221 1111111110 0111 122367888999999999999999999999998874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=387.89 Aligned_cols=232 Identities=22% Similarity=0.334 Sum_probs=190.9
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++++|||| ||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999995 56899999998753 33455779999999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||+++++++||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 9999999999997643 4999999999999999999999 7889999999999999999999999999999875
Q ss_pred CCC-ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGA-SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... ........||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+. ..... ...+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~-~~~~----- 251 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI------FAKII-KLEY----- 251 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-HTCC-----
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-cCCC-----
Confidence 432 2233445699999999999999999999999999999999999999975542221 11111 1110
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl 552 (559)
.+.. ....++.+|+.+||+.||++|||+.|++
T Consensus 252 -~~p~-------~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -DFPE-------KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCT-------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCc-------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111 1235678899999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=375.38 Aligned_cols=229 Identities=23% Similarity=0.359 Sum_probs=180.9
Q ss_pred CCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce-------------------EE
Q 047195 296 STGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL-------------------FM 353 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni-------------------v~ 353 (559)
++.++||+|+||+||+|.. .++..||+|++.... ....+.|.+|+++|++++|||| ||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5567899999999999995 457899999986543 2334679999999999999994 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC--eEECCCCCCCeeecC-CCCEEEeecccce
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP--IYHRDIKSSNILLDE-KLDAKISDFGLSR 430 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dikp~Nill~~-~~~~kl~DFG~a~ 430 (559)
||+++|+|.+++.... .+++..+..++.||+.||+||| +++ ||||||||+||||+. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 9999999999997643 5899999999999999999999 666 999999999999984 7899999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
..... ......||+.|||||++.+ .|+.++|||||||+||||+||+.||........ .. .....+...
T Consensus 181 ~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-----~~-~~i~~~~~~-- 248 (290)
T 3fpq_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IY-RRVTSGVKP-- 248 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HH-HHHTTTCCC--
T ss_pred eCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-----HH-HHHHcCCCC--
Confidence 64332 2234569999999998865 699999999999999999999999964432211 11 111111100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.. ..+.++.+|+.+||+.||++|||++|+++
T Consensus 249 --~~~~~-------~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 --ASFDK-------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGG-------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCCc-------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111 12246788999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=373.56 Aligned_cols=230 Identities=27% Similarity=0.336 Sum_probs=174.0
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++|++++|||| ||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999995 568999999986542 3334679999999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+ +|+|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||+++++++||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 998 68999998763 25999999999999999999999 7889999999999999999999999999998764
Q ss_pred CCCceeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... ......||+.|||||++.+..+ +.++|||||||++|||++|+.||...+... .... ......
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~~-i~~~~~----- 229 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFKN-ISNGVY----- 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHTCC-----
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHcCCC-----
Confidence 432 2233569999999999998876 579999999999999999999997543211 1111 111110
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.. ..+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 -~~p~-------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -TLPK-------FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCCT-------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCC-------CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0111 12356788999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=379.61 Aligned_cols=227 Identities=28% Similarity=0.346 Sum_probs=176.5
Q ss_pred CCCCCCCccccCCccEEEEEEe----cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++|++.+.||+|+||+||+|+. ..++.||||++.... ......+.+|+++|++++||||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999985 246899999986532 2233468899999999999995
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||+++++++||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 789999999999997643 4899999999999999999999 78899999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
....... .....||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+. ..... ....
T Consensus 176 ~~~~~~~-~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~-~~~~---- 243 (304)
T 3ubd_A 176 SIDHEKK-AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------MTMIL-KAKL---- 243 (304)
T ss_dssp -----CC-CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-HCCC----
T ss_pred ccCCCcc-ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------HHHHH-cCCC----
Confidence 5443222 2334699999999999999999999999999999999999999975543221 11111 1110
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
.+. ...+.++.+|+.+||+.||++|||+
T Consensus 244 --~~p-------~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 --GMP-------QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CCC-------TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCC-------CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 011 1223567889999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=371.75 Aligned_cols=235 Identities=27% Similarity=0.361 Sum_probs=174.1
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce-------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
++|++.+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+++|++++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4589999999999999999995 56899999998765432 34578999999999999985
Q ss_pred --------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 --------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
||||+++|+|.+++..... .....+..++.++.||+.||+||| +++|+||||||+|||++.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence 5789999999999975322 223566778899999999999999 788999999999999999999999
Q ss_pred eecccceeccCCCce-----------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccc
Q 047195 424 SDFGLSRLALNGASH-----------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV 492 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~ 492 (559)
+|||+|+........ ..+...||+.|||||++.+..|+.++|||||||++|||++ ||.... +
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~-- 232 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E-- 232 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H--
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H--
Confidence 999999876543221 1123459999999999999999999999999999999996 654211 1
Q ss_pred cHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 493 NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...... .... .............+.+|+.+||+.||++|||+.|+++
T Consensus 233 -~~~~~~-~~~~------------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 -RVRTLT-DVRN------------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHH-HHHT------------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHH-HHhc------------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 100000 0001 0111112233345678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=374.20 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=187.1
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
++|++++.||+|+||+||+|+. .+++.||||+++.... ...+.+++|+++|++++||||
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999995 5689999999865432 234568899999999999984
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
||||+. |+|.+++... ..+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecce
Confidence 678885 6788888653 35999999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCC---ceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 047195 429 SRLALNGA---SHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 429 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
|+.+.... ........||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98764321 1223345699999999998875 4689999999999999999999999876544332222211110000
Q ss_pred chh--------hhc---cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ERL--------VDA---IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~~~--------~~~---~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ... +.+................+.+|+.+||+.||++|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000 0000000000000112356788999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=363.09 Aligned_cols=185 Identities=23% Similarity=0.319 Sum_probs=155.0
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCce-------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRSL------------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni------------- 351 (559)
...++|++.++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +||||
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45578999999999999999999853 46889999886533 346789999999998 69984
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC-CCEEEeeccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGL 428 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~-~~~kl~DFG~ 428 (559)
||||+++|+|.+++. .+++..+..++.|++.||+||| +++|+||||||+|||++.+ +.+||+|||+
T Consensus 96 ~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 789999999999884 3889999999999999999999 7889999999999999876 7999999999
Q ss_pred ceeccCCCc---------------------------eeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCC
Q 047195 429 SRLALNGAS---------------------------HVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSK 480 (559)
Q Consensus 429 a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~ 480 (559)
|+....... .......||+.|||||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 986543211 112234599999999999876 4899999999999999999999
Q ss_pred CCCCCCC
Q 047195 481 KAVDFNR 487 (559)
Q Consensus 481 ~p~~~~~ 487 (559)
.||....
T Consensus 245 ~Pf~~~~ 251 (361)
T 4f9c_A 245 YPFYKAS 251 (361)
T ss_dssp SSSSCCS
T ss_pred CCCCCCC
Confidence 9996544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=355.47 Aligned_cols=269 Identities=38% Similarity=0.588 Sum_probs=222.4
Q ss_pred cChHHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-----------
Q 047195 283 FSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL----------- 351 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni----------- 351 (559)
++..++...+++|++.+.||+|+||+||+|+.++++.||||++........+.+.+|++++++++||||
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 344445567789999999999999999999988899999999887766667789999999999999994
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
|+||+++|+|.+++..... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 7899999999998865332 2235899999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCC-ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 428 LSRLALNGA-SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 428 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 998754322 2222334589999999999888999999999999999999999999987766665556555555555555
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+...+++.+.... .......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 265 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 265 LEQIVDPNLADKI---RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCSSSSSSCTTCS---CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcChhhcccc---CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 5555555544332 356778899999999999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=352.71 Aligned_cols=274 Identities=37% Similarity=0.609 Sum_probs=224.4
Q ss_pred ccccChHHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-------
Q 047195 280 ARIFSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------- 351 (559)
Q Consensus 280 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------- 351 (559)
.+.++..++....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|++++++++||||
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456899999999999999999999999999999988899999999876543 233478999999999999994
Q ss_pred --------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 --------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
|+||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+..+|+||||||+|||+++++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 7899999999999976432 3346899999999999999999999443339999999999999999999999
Q ss_pred eecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCC--ccccccHHHHHHHH
Q 047195 424 SDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNR--EEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~--~~~~~~~~~~~~~~ 501 (559)
+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||.... .........+....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999998876555555555569999999999988889999999999999999999999996321 12233444455555
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
.....+....+..+.... .......+.+++.+||+.+|++|||+.||+++|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNY---KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTSC---CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhcccc---CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 555555555555554433 35667889999999999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.69 Aligned_cols=237 Identities=20% Similarity=0.266 Sum_probs=191.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|++.+.||+|+||+||+|+. .+++.+|+|.+........+.+.+|+++|++++|||| ||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 35799999999999999999995 5689999999987666556779999999999999995 6899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC--CCEEEeecccceecc
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK--LDAKISDFGLSRLAL 433 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~--~~~kl~DFG~a~~~~ 433 (559)
+++|+|++++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 236 ~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 236 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred cCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999886432 25899999999999999999999 7889999999999999854 899999999999876
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... .....||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+.. ... ..... ....
T Consensus 309 ~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~------~~i-~~~~~--~~~~ 377 (573)
T 3uto_A 309 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------RNV-KSCDW--NMDD 377 (573)
T ss_dssp TTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHH-HTTCC--CCCS
T ss_pred CCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHH-HhCCC--CCCc
Confidence 5432 23346999999999999999999999999999999999999999765432211 111 11000 0000
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 378 ~~-------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SA-------FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GG-------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc-------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0122356788999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=368.30 Aligned_cols=232 Identities=24% Similarity=0.315 Sum_probs=181.6
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHH---HHHHHhcCCCce--------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNE---VRILCQLNHRSL-------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E---~~~l~~l~h~ni-------------- 351 (559)
++|++++.||+|+||+||+|+. .+++.||||++.... ......+.+| +.+++.++||||
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999995 468999999986432 2233334444 566677899994
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
||||+++|+|.++|.... .+++..+..++.||+.||+||| +++||||||||+||||+.+|++||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceee
Confidence 789999999999997643 4999999999999999999999 8999999999999999999999999999998
Q ss_pred eccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
....... ...+||+.|||||++.. ..|+.++|||||||+||||++|+.||......+.... ....... .
T Consensus 341 ~~~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~~-~--- 410 (689)
T 3v5w_A 341 DFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTM-A--- 410 (689)
T ss_dssp ECSSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHHC-C---
T ss_pred ecCCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcCC-C---
Confidence 7654332 23469999999999964 5799999999999999999999999975433221111 1111100 0
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVA 552 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl 552 (559)
..+. .....++.+|+.+||+.||.+|++ +.||+
T Consensus 411 ---~~~p-------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 ---VELP-------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp ---CCCC-------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred ---CCCC-------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 0011 122366788999999999999998 56664
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=339.72 Aligned_cols=254 Identities=29% Similarity=0.330 Sum_probs=193.4
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL-------------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-------------------v 352 (559)
.++|++.+.||+|+||+||+|+.. ++.||||++..... ....+.+|+.++++++|||| |
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 457999999999999999999875 78999999865432 23456779999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC----------CeEECCCCCCCeeecCCCCEE
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP----------PIYHRDIKSSNILLDEKLDAK 422 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~----------~iiH~Dikp~Nill~~~~~~k 422 (559)
+||+++|+|.+++... .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+|
T Consensus 101 ~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 7999999999999752 4899999999999999999999 77 999999999999999999999
Q ss_pred EeecccceeccCCCce-eeeeccccCCccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 047195 423 ISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYIN-----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496 (559)
Q Consensus 423 l~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~ 496 (559)
|+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999876543322 1223459999999999876 356678999999999999999999998654433222211
Q ss_pred HHHHHhhcchh-----hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 497 YFGNILKQERL-----VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 497 ~~~~~~~~~~~-----~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..........+ .....+.+.... ........+.+|+.+||+.||++|||+.||+++|++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11000000000 011111111111 1124557799999999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=332.48 Aligned_cols=243 Identities=24% Similarity=0.390 Sum_probs=193.7
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|.+.+.||+|+||+||++.. .+++.+|+|++...+....+.+.+|++++++++|||| |+||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35688899999999999999996 4689999999876666666789999999999999994 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999997643 35899999999999999999999 788999999999999999999999999999876433
Q ss_pred Ccee-------------eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 047195 436 ASHV-------------TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502 (559)
Q Consensus 436 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 502 (559)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~------ 235 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN------ 235 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC------
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh------
Confidence 2211 113459999999999999999999999999999999999999987543322111000
Q ss_pred hcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 503 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
....++..... ..+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 236 ----~~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 236 ----VRGFLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp ----HHHHHHHTCCT-------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----hhccccccCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000001111 1224578899999999999999999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=324.21 Aligned_cols=267 Identities=37% Similarity=0.575 Sum_probs=211.0
Q ss_pred ccccChHHHHHHhCCCCCC------CccccCCccEEEEEEecCCcEEEEEEeecCC----CCChhhHHHHHHHHHhcCCC
Q 047195 280 ARIFSSREITEATNNFSTG------NLLGSGGFGEVFKAILDDETITAVKRAKLGN----TKGIDPILNEVRILCQLNHR 349 (559)
Q Consensus 280 ~~~~~~~~~~~~~~~y~~~------~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~----~~~~~~~~~E~~~l~~l~h~ 349 (559)
...|+..++..++++|... +.||+|+||.||+|.. +++.+|||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568999999999988877 8999999999999986 57889999986532 22346789999999999999
Q ss_pred ce---------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCee
Q 047195 350 SL---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNIL 414 (559)
Q Consensus 350 ni---------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nil 414 (559)
|| |++|+++++|.+++..... ...+++..+..++.|++.||+||| +++|+||||||+|||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil 165 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANIL 165 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEE
Confidence 94 6899999999999975432 236899999999999999999999 788999999999999
Q ss_pred ecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcccccc
Q 047195 415 LDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVN 493 (559)
Q Consensus 415 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~ 493 (559)
+++++.+||+|||+++........ ......||+.|+|||++.+ .++.++||||||+++|||++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 999999999999999876543322 2233459999999998765 57899999999999999999999998655433222
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.... ........+.+.+++.+. .........+.+++.+||+.+|++|||+.+|++.|++|
T Consensus 245 ~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKE-EIEDEEKTIEDYIDKKMN----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHH-HHHTTSCCHHHHSCSSCS----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHH-Hhhhhhhhhhhhcccccc----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111 111112223333443332 22346678899999999999999999999999999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=327.12 Aligned_cols=235 Identities=23% Similarity=0.334 Sum_probs=192.1
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++|||| ||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35799999999999999999984 6789999999987776667889999999999999994 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999998752 4889999999999999999999 788999999999999999999999999999876544
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ........ +.+
T Consensus 170 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~~------~~~ 236 (297)
T 3fxz_A 170 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGT------PEL 236 (297)
T ss_dssp TCC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHCS------CCC
T ss_pred ccc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCC------CCC
Confidence 332 23345999999999999999999999999999999999999999754322211 00000000 000
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QN-----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SC-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC-----ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 1123366888999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=335.81 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=186.6
Q ss_pred HHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce--------------
Q 047195 288 ITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 288 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
+....++|++.+.||+|+||+||+|+. +++.+|||++..... ...+.+.+|++++++++||||
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 334456899999999999999999976 578899999875433 234578999999999999994
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC--eEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP--IYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
|+||+++++|.+++..... ...+++..+..++.|++.||+||| +++ |+||||||+|||++.++.+||+|||+
T Consensus 111 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 7899999999999975321 123889999999999999999999 788 99999999999999999999999999
Q ss_pred ceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. . ........
T Consensus 186 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---~---~~~~~~~~-- 256 (309)
T 3p86_A 186 SRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---V---AAVGFKCK-- 256 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---H---HHHHHSCC--
T ss_pred Ccccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhcCC--
Confidence 976543322 12334599999999999999999999999999999999999999975432211 0 00000000
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
...+. ......+.+|+.+||+.+|++|||+.+|++.|+.++
T Consensus 257 ---~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 257 ---RLEIP-------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp ---CCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCC-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111 122356889999999999999999999999998763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=323.99 Aligned_cols=240 Identities=25% Similarity=0.376 Sum_probs=195.8
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.++|++.+.||+|+||.||++..+++..+|+|++..... ..+++.+|++++++++|||| |+||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457899999999999999999999888999999876443 34679999999999999984 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++..... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999976432 4899999999999999999999 7889999999999999999999999999998776554
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ .... .... .. ..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~-~~~~--~~---~~ 226 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKV-SQGH--RL---YR 226 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHH-HTTC--CC---CC
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHHH-HcCC--CC---CC
Confidence 443444457788999999988889999999999999999999 9999875432211 0100 0000 00 00
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. ......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 227 ~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 227 P-------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp C-------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred C-------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0 11235688899999999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.54 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=193.8
Q ss_pred hCCCCCCCccccCCccEEEEEEec--------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce----------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD--------DETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL---------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni---------- 351 (559)
.++|++.+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|+++++++ +||||
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357889999999999999999852 346799999876432 3346799999999999 89994
Q ss_pred -----EEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
|+||+++|+|.+++...... ....+++..++.++.||+.||+||| +++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 78999999999999864321 1235889999999999999999999 7889999999999999
Q ss_pred cCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccccc
Q 047195 416 DEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVN 493 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~ 493 (559)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 99999999999999876543221 1223347889999999999899999999999999999999 9999875443221
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.. ....... ..+ +......+.+++.+||+.+|++|||+.|+++.|++|+
T Consensus 315 -~~----~~~~~~~-----~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 315 -FK----LLKEGHR-----MDK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -HH----HHHTTCC-----CCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HH----HHhcCCC-----CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1111100 001 1123367889999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.27 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=196.8
Q ss_pred cccChHHHHHHhCC----------CCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC
Q 047195 281 RIFSSREITEATNN----------FSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHR 349 (559)
Q Consensus 281 ~~~~~~~~~~~~~~----------y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ 349 (559)
..++.++++.+++. |+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777776653 666778999999999999965 7899999999877777778899999999999999
Q ss_pred ce---------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCee
Q 047195 350 SL---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNIL 414 (559)
Q Consensus 350 ni---------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nil 414 (559)
|| ||||+++++|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+|||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEE
Confidence 94 6899999999998864 24899999999999999999999 788999999999999
Q ss_pred ecCCCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccH
Q 047195 415 LDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNL 494 (559)
Q Consensus 415 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~ 494 (559)
++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--- 249 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--- 249 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---
T ss_pred ECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 999999999999999876543322 2334599999999999988999999999999999999999999975432211
Q ss_pred HHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 495 VVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 495 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .... ...+.+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 250 ---~~-~~~~-----~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 ---MK-RLRD-----SPPPKLKN-----SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---HH-HHHH-----SSCCCCTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HH-HHhc-----CCCCCcCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1111 11111111 1122356888999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.44 Aligned_cols=240 Identities=23% Similarity=0.359 Sum_probs=194.0
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.++|++.+.||+|+||.||++...++..+|+|++..... ..+++.+|++++++++|||| |+||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357889999999999999999988899999999876433 34679999999999999984 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 88 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp TTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999996532 35899999999999999999999 7889999999999999999999999999998654432
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ... .... .....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~------~~~-~~~~-----~~~~~ 228 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VED-ISTG-----FRLYK 228 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHH-HHTT-----CCCCC
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH------HHH-HhcC-----ccCCC
Confidence 222233447788999999998899999999999999999999 8999875432211 111 1110 00001
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. ......+.+++.+||+.+|++|||+.++++.|++|
T Consensus 229 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 229 P-------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 1 11235688899999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=334.57 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=190.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-----cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-----DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
.++|++.+.||+|+||+||++++ .+++.||||++........+.+.+|++++++++||||
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35789999999999999999984 3678999999887666666789999999999999984
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
|+||+++++|.+++..... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred EEEEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 7899999999999976432 4899999999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCce--eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh----
Q 047195 430 RLALNGASH--VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK---- 503 (559)
Q Consensus 430 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 503 (559)
+........ ......++..|+|||++.+..++.++||||||+++|||++|..|+....... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF----MRMIGNDKQGQMI 237 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH----HHHHCTTCCTHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH----HhhhcCccccchh
Confidence 876543221 2223347788999999999999999999999999999999999886321110 000000000
Q ss_pred cchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 504 QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 504 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
...+.+.+.. ......+...+..+.+++.+||+.||++|||+.||+++|++|
T Consensus 238 ~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 238 VFHLIELLKN---NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhc---cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000000000 000011123346788999999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.63 Aligned_cols=247 Identities=18% Similarity=0.237 Sum_probs=192.5
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc----------------eEE
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS----------------LFM 353 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n----------------iv~ 353 (559)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.++++++|++ +|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 6789999998665433 256899999999999876 578
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee---cCCCCEEEeecccce
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSR 430 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill---~~~~~~kl~DFG~a~ 430 (559)
||+ +++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp ECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred Ecc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 999 999999987543 25899999999999999999999 7889999999999999 788999999999998
Q ss_pred eccCCCce------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 047195 431 LALNGASH------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 431 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 76543321 122345999999999999989999999999999999999999999865544333332222111111
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.... .+. ...+..+.+++.+||+.+|++|||+.+|++.|++++
T Consensus 237 ~~~~-----~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 237 TPIE-----VLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SCHH-----HHT-------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred chhh-----hhh-------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 1100 000 112367889999999999999999999999998863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.09 Aligned_cols=241 Identities=24% Similarity=0.369 Sum_probs=189.7
Q ss_pred CCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
++|++.+.||+|+||.||+|... .+..||||+++... ....+.+.+|+.++++++|||| |
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888999999999999999963 45569999987643 2334679999999999999994 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 129 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred eeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 89999999999996532 25899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCce--eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 433 LNGASH--VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 433 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. . .. ....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~---~~-~~~~---- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---I---SS-VEEG---- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---H---HH-HHTT----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---H---HH-HHcC----
Confidence 543222 2222346788999999988899999999999999999999 9999865432211 1 10 1110
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... .......+.+|+.+||+.||++|||+.+|+++|+.++
T Consensus 271 -~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 -YRLPA-------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp -CCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCC-------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 1123367889999999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=353.18 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=198.7
Q ss_pred HHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------
Q 047195 286 REITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 286 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
.+++...++|++.+.||+|+||.||+|..+++..||||.++... ...+.|.+|+++|++++||||
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~l 259 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYI 259 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEE
Confidence 34445567899999999999999999999888999999987644 446789999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||||+++|+|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 260 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 7899999999999975432 24788999999999999999999 78899999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
.............+|+.|+|||++....++.++||||||+++|||++ |+.||......+. .. ....+.
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~~----~i~~~~---- 402 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IR----ALERGY---- 402 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH----HHHHTC----
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCC----
Confidence 64322222223346789999999998899999999999999999999 9999975432211 11 111110
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.... +...+..+.+|+.+||+.||++|||+.+|+++|++++
T Consensus 403 -~~~~-------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 403 -RMPR-------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp -CCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -CCCC-------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0000 1123467889999999999999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=320.33 Aligned_cols=245 Identities=16% Similarity=0.196 Sum_probs=193.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCc---------------eEEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRS---------------LFMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~n---------------iv~~ 354 (559)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +|+| +|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45799999999999999999995 678999999886543 335789999999999 6766 4789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC-----EEEeecccc
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD-----AKISDFGLS 429 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~-----~kl~DFG~a 429 (559)
|+ +++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++. +||+|||++
T Consensus 87 ~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 98 999999997642 25899999999999999999999 889999999999999987766 999999999
Q ss_pred eeccCCCce------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh
Q 047195 430 RLALNGASH------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503 (559)
Q Consensus 430 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 503 (559)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 876543221 12334599999999999998999999999999999999999999986543332222211111111
Q ss_pred cchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 504 QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 504 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
...... +. ...+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 239 ~~~~~~-----~~-------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 239 STPLRE-----LC-------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HSCHHH-----HT-------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CccHHH-----HH-------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 111110 00 12236788999999999999999999999999886
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=322.18 Aligned_cols=249 Identities=21% Similarity=0.314 Sum_probs=190.4
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHh--cCCCce------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQ--LNHRSL------------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~--l~h~ni------------------ 351 (559)
.++|++.+.||+|+||+||+|+. +++.||||++... ....+.+|.+++.. ++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999987 6889999998643 33567778888877 899984
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHc-----CCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL-----ATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
|+||+++|+|.+++.. ..+++..+..++.|++.||+|||.. ++++|+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 6788999999999953 2589999999999999999999932 156799999999999999999999999
Q ss_pred cccceeccCCCceee---eeccccCCccCccccccC------CCCcccchhHHHHHHHHHHhC----------CCCCCCC
Q 047195 426 FGLSRLALNGASHVT---TFAQGTLGYLDPEYYINF------QLTDKSDVYSFGVVLVELLTS----------KKAVDFN 486 (559)
Q Consensus 426 FG~a~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~el~tg----------~~p~~~~ 486 (559)
||+++.......... ....||+.|+|||++.+. .++.++||||||+++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999987655443321 223599999999998876 455799999999999999999 7777644
Q ss_pred CccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 487 REEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
........ . ......... ..+.+.. ..........+.+|+.+||+.||++|||+.||+++|++|
T Consensus 237 ~~~~~~~~-~-~~~~~~~~~----~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFE-D-MRKVVCVDQ----QRPNIPN--RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHH-H-HHHHHTTSC----CCCCCCG--GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchh-h-hhHHHhccC----CCCCCCh--hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 33222111 1 111111111 1111111 111234667899999999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=319.23 Aligned_cols=245 Identities=18% Similarity=0.237 Sum_probs=195.2
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc----------------eEEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS----------------LFMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n----------------iv~~ 354 (559)
.++|++.+.||+|+||.||+|+. .+++.+|||++..... .+.+.+|+.++++++|++ +|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999995 6789999999875443 357999999999999876 5789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee---cCCCCEEEeeccccee
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRL 431 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill---~~~~~~kl~DFG~a~~ 431 (559)
|+ +++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||+ ++++.+||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 99 999999997533 25899999999999999999999 7889999999999999 4888999999999987
Q ss_pred ccCCCce------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 432 ALNGASH------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 432 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 6544321 1233459999999999999899999999999999999999999998654433322222221111111
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
... .+. ...+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 238 ~~~-----~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 238 PIE-----VLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp CHH-----HHT-------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred chH-----HHH-------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 000 001 11236788999999999999999999999999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=325.63 Aligned_cols=245 Identities=23% Similarity=0.327 Sum_probs=189.4
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCC---hhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKG---IDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||+++. .+++.+|+|.+....... .+.+.+|+.++++++|||| |
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45799999999999999999985 468899999986543332 3568999999999999984 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 89999999999997643 4899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
............||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........ ... ..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~~-~~ 233 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-VPN-VT 233 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-CCC-HH
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-CCC-cc
Confidence 54333333344599999999999998999999999999999999999999975432211 11111110 000 00
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhC
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-SIKEVADEIERII 559 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~i~ 559 (559)
.... ...+..+.+++.+||+.||++|| +++++.+.|+.++
T Consensus 234 ~~~~-------~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 TDVR-------KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHSC-------TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hhcc-------cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0001 12336788999999999999998 9999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.86 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=186.8
Q ss_pred HhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
..++|++.+.||+|+||+||+|+..+++.+|+|++...... ..+.+.+|++++++++|||| |+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34689999999999999999999988999999998754332 23578999999999999994 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||++ ++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 99 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 8887 47777776432 35899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+................+....+
T Consensus 171 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 171 IPVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 33222 233458999999999876 5689999999999999999999999986654433222211111000000000000
Q ss_pred ---------ccccc-CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 ---------PMLKE-GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ---------~~l~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ...........++.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 000001112356789999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=326.20 Aligned_cols=244 Identities=16% Similarity=0.206 Sum_probs=192.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCc---------------eEEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRS---------------LFMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~n---------------iv~~ 354 (559)
.++|++.+.||+|+||+||+|+. .+++.||||.+..... .+.+.+|+++++++ +|+| +|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35799999999999999999995 6789999999875433 35799999999999 9998 4789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC-----EEEeecccc
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD-----AKISDFGLS 429 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~-----~kl~DFG~a 429 (559)
|+ +++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++. +||+|||++
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred eC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99 999999998642 35899999999999999999999 778999999999999998887 999999999
Q ss_pred eeccCCCcee------eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh
Q 047195 430 RLALNGASHV------TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503 (559)
Q Consensus 430 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 503 (559)
+......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 8765432211 1344599999999999999999999999999999999999999986543332222111111100
Q ss_pred cchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 504 QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 504 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.... ..+. ...+ .+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 238 ~~~~-----~~~~-------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 238 ATPI-----EVLC-------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HSCH-----HHHT-------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cCCH-----HHHh-------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000 0000 0122 788999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=323.01 Aligned_cols=241 Identities=23% Similarity=0.386 Sum_probs=191.7
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.++|++.+.||+|+||.||++..+++..+|+|++..... ..+++.+|++++++++|+|| |+||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457899999999999999999999889999999875433 34779999999999999984 68999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++..... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 102 ANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp TTCBHHHHHHCGGG----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred CCCcHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999976432 4899999999999999999999 7889999999999999999999999999998654332
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ ... .... .....
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~------~~~-~~~~-----~~~~~ 242 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEH-IAQG-----LRLYR 242 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHH-HHTT-----CCCCC
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH------HHH-Hhcc-----cCCCC
Confidence 222233347788999999998899999999999999999998 9999875432211 111 1110 00111
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.. .....+.+++.+||+.+|++|||+.++++.|++++
T Consensus 243 ~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 243 PH-------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 11 11256888999999999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=332.00 Aligned_cols=232 Identities=25% Similarity=0.327 Sum_probs=188.0
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++|+.++|||| |+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999996 678999999987543 2334678899999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 94 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999997643 4899999999999999999999 7889999999999999999999999999998665
Q ss_pred CCCceeeeeccccCCccCccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLT-DKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.... .....||+.|+|||++.+..++ .++||||||+++|||++|+.||...+..+. .. ....+..
T Consensus 166 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~-~i~~~~~----- 231 (328)
T 3fe3_A 166 VGGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL------RE-RVLRGKY----- 231 (328)
T ss_dssp SSCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH-HHHHCCC-----
T ss_pred CCCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH------HH-HHHhCCC-----
Confidence 4322 2334599999999999887765 799999999999999999999975542211 11 1111100
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+ +......+.+|+.+||+.||.+|||+.|+++
T Consensus 232 -~~-------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 -RI-------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -CC-------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -CC-------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 1122356788999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.72 Aligned_cols=240 Identities=26% Similarity=0.415 Sum_probs=180.3
Q ss_pred CCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
++|++.+.||+|+||.||+|+.. ++..||||.++.... ...+.+.+|+.++++++|||| |
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57999999999999999999864 567899999876432 334679999999999999994 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 125 ~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 89999999999997532 35899999999999999999999 778999999999999999999999999999876
Q ss_pred cCCCceee--eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 433 LNGASHVT--TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 433 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
........ ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. . ......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~----~~i~~~---- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---I----KAVDEG---- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---H----HHHHTT----
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcC----
Confidence 54322211 12235788999999998899999999999999999998 9999865432211 1 111111
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..... .......+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 267 -----~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 -----YRLPP---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -----EECCC---CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCC---CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 00000 112336788999999999999999999999999876
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.78 Aligned_cols=233 Identities=27% Similarity=0.349 Sum_probs=188.0
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||+||+++.+ +++.+|+|++... .....+.+.+|+.+|+.++|||| |
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357899999999999999999964 6899999998753 33455678999999999999984 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 89999999999987643 4899999999999999999999 788999999999999999999999999999864
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+... ...... ...
T Consensus 156 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~-~~~------ 221 (337)
T 1o6l_A 156 ISDGAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELIL-MEE------ 221 (337)
T ss_dssp CCTTCC-BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCC------
T ss_pred ccCCCc-ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHHHHH-cCC------
Confidence 332222 233459999999999999899999999999999999999999997543221 111111 110
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
..+.. .....+.+|+.+||+.||++|| ++.||++
T Consensus 222 ~~~p~-------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 IRFPR-------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCT-------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCC-------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 00111 2235688899999999999999 8888875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.78 Aligned_cols=257 Identities=19% Similarity=0.237 Sum_probs=196.0
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce-----------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL-----------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni-----------------v~ 353 (559)
++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++|||| ||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46899999999999999999965 48999999987543 3445778999999999999984 68
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee----cCCCCEEEeecccc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL----DEKLDAKISDFGLS 429 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill----~~~~~~kl~DFG~a 429 (559)
||+++++|.+++...... ..+++..+..++.|++.||+||| +++|+||||||+|||+ +.++.+||+|||++
T Consensus 89 e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp ECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred eCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999864332 24899999999999999999999 7889999999999999 78888999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccc--------cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHH-HHHH
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYI--------NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV-YFGN 500 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~ 500 (559)
+........ ....||+.|+|||++. +..++.++||||||+++|||++|+.||............. ....
T Consensus 164 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp EECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred eecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 876543322 2345999999999986 4678999999999999999999999997544332221111 1111
Q ss_pred Hhhcchhhhc---cc------cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 501 ILKQERLVDA---ID------PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 501 ~~~~~~~~~~---~d------~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
......+... .+ ..+. ............+.+++.+||+.||++|||+.|+++...+
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 1000000000 00 0000 0112235677889999999999999999999999998765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=345.07 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=191.8
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EEe
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FMS 354 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~~ 354 (559)
+...++|++.+.||+|+||.||+|.++++..||||.++... ...+.|.+|+++|++++|||| |+|
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e 258 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 258 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEeh
Confidence 34456788999999999999999999888889999987654 345789999999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999975332 24889999999999999999999 78899999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
..........+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. .. ....+. ..
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------~~-~i~~~~-----~~ 400 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LD-QVERGY-----RM 400 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HH-HHHTTC-----CC
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH------HH-HHHcCC-----CC
Confidence 33322333447889999999998899999999999999999999 8999875432211 11 111110 00
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.. +...+..+.+|+.+||+.+|++|||+.+|+++|+.++
T Consensus 401 ~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 401 PC-------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 00 1123467889999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=324.48 Aligned_cols=243 Identities=29% Similarity=0.412 Sum_probs=196.0
Q ss_pred HHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EEee
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FMSM 355 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~~~ 355 (559)
...++|++.+.||+|+||.||+|..+++..+|+|.+.... ...+.+.+|++++++++|||| |+||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 88 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY 88 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEec
Confidence 3456789999999999999999998888899999987543 345789999999999999984 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++......
T Consensus 89 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 89 MENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999875321 24899999999999999999999 788999999999999999999999999999877554
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ... .... ....
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~~-~~~~-----~~~~ 230 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V---IQN-LERG-----YRMV 230 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H---HHH-HHTT-----CCCC
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---H---HHH-Hhcc-----cCCC
Confidence 3333333447889999999988889999999999999999999 898987543221 1 111 1111 0000
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.. ......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 231 ~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 231 RP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc-------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 11 12236788999999999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=324.08 Aligned_cols=242 Identities=23% Similarity=0.328 Sum_probs=181.9
Q ss_pred hCCCCCCCccccCCccEEEEEEecC----CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD----ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
.++|++.+.||+|+||.||+|.... +..+|+|....... ...+.+.+|+.++++++|||| |
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 4578999999999999999998642 45799998765432 234578999999999999994 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 89999999999997532 25899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. .... .....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i----~~~~~---- 235 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI----ENGER---- 235 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH----HTTCC----
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHH----HcCCC----
Confidence 5443333333447889999999988899999999999999999997 8999875543221 1111 11100
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..+. ......+.+++.+||+.||++|||+.||++.|++++
T Consensus 236 -~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 -LPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0011 123367888999999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.39 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=196.3
Q ss_pred HhCCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
..++|++.+.||+|+||.||+|.++. +..||||.++... ...++|.+|+.+|++++|||| |||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 35578889999999999999999765 7899999987643 346789999999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.+++..... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 297 ~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 297 FMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred ccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999976432 35899999999999999999999 78899999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
..........+++.|+|||++....++.++||||||+++|||++ |+.||......+. ... ....
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~~-------- 435 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YEL----LEKD-------- 435 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH----HHTT--------
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcC--------
Confidence 43333333446789999999988889999999999999999999 8899875543221 111 1110
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... +......+.+|+.+||+.||++|||+.+|+++|+.++
T Consensus 436 -~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 -YRMER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -CCCCC---CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 00000 1123367888999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=316.08 Aligned_cols=240 Identities=29% Similarity=0.536 Sum_probs=189.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCC-------hhhHHHHHHHHHhcCCCce------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKG-------IDPILNEVRILCQLNHRSL------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~-------~~~~~~E~~~l~~l~h~ni------------ 351 (559)
.++|++.+.||+|+||+||+|+. .+++.+|+|++....... .+.+.+|+.++++++||||
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 35799999999999999999996 578999999987644322 2678999999999999984
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC--eEECCCCCCCeeecCCCC-----EEE
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP--IYHRDIKSSNILLDEKLD-----AKI 423 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dikp~Nill~~~~~-----~kl 423 (559)
|+||+++++|.+.+.... ..+++..+..++.|++.||+||| +++ |+||||||+|||++.++. +||
T Consensus 98 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred EEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 789999999998886532 36899999999999999999999 788 999999999999988776 999
Q ss_pred eecccceeccCCCceeeeeccccCCccCccccc--cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 424 SDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI--NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+|||+++..... .....||+.|+|||++. ...++.++||||||+++|||++|+.||........ ... . .
T Consensus 171 ~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~---~-~ 241 (287)
T 4f0f_A 171 ADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFI---N-M 241 (287)
T ss_dssp CCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHH---H-H
T ss_pred CCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHH---H-H
Confidence 999999754332 23345999999999984 44578899999999999999999999975443221 111 1 1
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..... ..+.+.. .....+.+++.+||+.||++|||+.||++.|++|
T Consensus 242 ~~~~~----~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREEG----LRPTIPE-------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSC----CCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HhccC----CCCCCCc-------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111 1111111 2236788999999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=335.59 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=199.5
Q ss_pred cChHHHHHHhCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce---
Q 047195 283 FSSREITEATNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL--- 351 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni--- 351 (559)
+...+++...++|++.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|+++++++ +||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45566666778999999999999999999973 3457899999876433 2345699999999999 78884
Q ss_pred -------------EEeeCCCCcHhHhHhhccCCC----------------------------------------------
Q 047195 352 -------------FMSMSPNGTLFDRLHRVQSGN---------------------------------------------- 372 (559)
Q Consensus 352 -------------v~~~~~~g~L~~~l~~~~~~~---------------------------------------------- 372 (559)
|+||+++|+|.+++.......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 689999999999997643210
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 373 ---------------WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 373 ---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999 78899999999999999999999999999987644332
Q ss_pred -eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 438 -HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 438 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
.......||+.|+|||++.+..++.++||||||+++|||++ |+.||......... ......... ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~~~-----~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTR-----MRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCC-----CCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcCCC-----CCC
Confidence 22334458999999999999899999999999999999998 99999755432211 111111100 001
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
. ......+.+++.+||+.||++|||+.||++.|++++
T Consensus 318 ~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 318 P-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1 112356888999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=338.11 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=192.3
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
...++|.+.+.||+|+||.||+|... +++.||||.++.... ...+.+.+|+++|++++|||| |
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 33567899999999999999999975 789999999875432 233578999999999999994 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 191 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 89999999999997643 24889999999999999999999 788999999999999999999999999999865
Q ss_pred cCCCceee-eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASHVT-TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
........ ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ......+..
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~--- 333 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKGGR--- 333 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTTCC---
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC---
Confidence 43221111 11235778999999988889999999999999999998 9999875432211 111111100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.... ...+..+.+|+.+||+.||++|||+.+|++.|++|
T Consensus 334 --~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 --LPCP-------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0000 12235788899999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=325.66 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=191.5
Q ss_pred CCCCCCCccccCCccEEEEEEe-----cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-----DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++|++.+.||+|+||.||++++ .+++.+|+|++.... ....+.+.+|++++++++||||
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3588899999999999999983 468999999987543 3445779999999999999984
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
|+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence 679999999999996543 25899999999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCce--eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 430 RLALNGASH--VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 430 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
+........ ......+|..|+|||++.+..++.++||||||+++|||++|+.|+...... ..............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTV 249 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCH
Confidence 877654332 223345888899999999888999999999999999999999986422100 00000000000000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
......................+.+|+.+||+.||++|||+.+++++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000000000000011123467889999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=321.35 Aligned_cols=245 Identities=31% Similarity=0.494 Sum_probs=182.4
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce--------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL--------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni--------------v~~~ 355 (559)
.++|++.+.||+|+||+||+|+..+ .+|+|+++.... ...+.+.+|++++++++|+|| |++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 4579999999999999999998654 599999876543 234678999999999999984 6899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 101 CEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999886432 35899999999999999999999 788999999999999999999999999999765432
Q ss_pred C-ceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 436 A-SHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 436 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
. ........||+.|+|||++. +..++.++||||||+++|||++|+.||......+. . .........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~----~~~~~~~~~---- 243 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--I----IEMVGRGSL---- 243 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--H----HHHHHHTSC----
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--H----HHHhccccc----
Confidence 1 12223345999999999986 55688899999999999999999999975443221 1 111111111
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.+.+.. .....+..+.+|+.+||+.+|++|||+.+++++|+++.
T Consensus 244 ~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSK----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTS----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccchhh----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111111 01123367889999999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.76 Aligned_cols=246 Identities=26% Similarity=0.351 Sum_probs=181.3
Q ss_pred hCCCCCCCccccCCccEEEEEEecCC----cEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce--------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDE----TITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
.++|++.+.||+|+||.||+|..... ..||||++... .....+.+.+|++++++++||||
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 45799999999999999999986543 27999998764 33445779999999999999984
Q ss_pred -------EEeeCCCCcHhHhHhhccCC-CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 -------FMSMSPNGTLFDRLHRVQSG-NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 -------v~~~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
|++|+++++|.+++...... ....+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence 57889999999998754422 2235899999999999999999999 788999999999999999999999
Q ss_pred eecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 047195 424 SDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~---- 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---YNY---- 251 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH----
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---HHH----
Confidence 999999876443221 1223347889999999999899999999999999999999 8999875543221 110
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
...... ... .......+.+++.+||+.||++|||+.++++.|++++
T Consensus 252 ~~~~~~-----~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 252 LIGGNR-----LKQ-------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHTTCC-----CCC-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCC-----CCC-------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 101000 000 1123367889999999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=328.64 Aligned_cols=240 Identities=24% Similarity=0.354 Sum_probs=185.0
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCc----EEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce--------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DET----ITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
++|++.+.||+|+||+||+|+.. +++ .+|+|.+.... ....+.+.+|+.++++++|||| |
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 46889999999999999999853 343 35788775433 3455789999999999999995 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++|+.+|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 78999999999997643 25899999999999999999999 778999999999999999999999999999876
Q ss_pred cCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
....... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ .. .......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~~~~~~~--- 237 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGER--- 237 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCC---
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HH----HHHcCCC---
Confidence 5433222 223347889999999999999999999999999999999 9999975543221 11 1111100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
... .......+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 238 --~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 --LPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --CCC-------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --CCC-------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 012235688899999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.19 Aligned_cols=235 Identities=22% Similarity=0.341 Sum_probs=182.3
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhc-CCCce---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQL-NHRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni--------------- 351 (559)
.++|++.+.||+|+||+||+++.+ +++.+|+|+++.. .....+.+.+|..++.++ +||||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357999999999999999999965 5789999998754 233446689999999887 89984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 789999999999997643 4899999999999999999999 78899999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccc--cHHHHHHHHhhcchhhh
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV--NLVVYFGNILKQERLVD 509 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 509 (559)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..............+
T Consensus 203 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 203 GLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCCTTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred cccCCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 433222 223345999999999999999999999999999999999999999754322211 011111111111110
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
.+. ......+.+|+.+||+.||++||++
T Consensus 280 ----~~p-------~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ----RIP-------RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCC-------TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CCC-------CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 011 1233567889999999999999996
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.54 Aligned_cols=257 Identities=20% Similarity=0.276 Sum_probs=175.7
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.++|++.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|++++++++|||| |+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45799999999999999999985 4689999999876543 344678999999999999994 678
Q ss_pred eCCCCcHhHhHhhccCC-CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 355 MSPNGTLFDRLHRVQSG-NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
|++ ++|.+++...... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 887 5898888764322 2235899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh---
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD--- 509 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 509 (559)
..... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+................+..
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 33222 2233589999999998764 689999999999999999999999976554332211111100000000000
Q ss_pred --cccccccc----CCC-----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 --AIDPMLKE----GAS-----EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 --~~d~~l~~----~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...+.+.. ... .........+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000 000 000012357889999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.41 Aligned_cols=245 Identities=21% Similarity=0.306 Sum_probs=194.9
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc----------------eEEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS----------------LFMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n----------------iv~~ 354 (559)
.++|++.++||+|+||.||+|+. .+++.||||++...... .++.+|+++++.++|++ ||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999995 66899999987754433 56899999999998854 5789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee---cCCCCEEEeeccccee
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRL 431 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill---~~~~~~kl~DFG~a~~ 431 (559)
|+ +++|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+|||| +.++.+||+|||+++.
T Consensus 84 ~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 98 999999997543 25899999999999999999999 7889999999999999 6889999999999987
Q ss_pred ccCCCcee------eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 432 ALNGASHV------TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 432 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
........ .....||+.|+|||++.+..++.++||||||++||||++|+.||..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---- 231 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---- 231 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----
Confidence 66433211 12445999999999999999999999999999999999999999865443322222211111
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.+...++. +. .....++.+|+.+||+.+|++||++.+|+++|+++
T Consensus 232 ~~~~~~~~-l~-------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 232 KVATSIEA-LC-------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHSCHHH-HH-------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccccHHH-Hh-------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111110 01 12236788999999999999999999999999886
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=322.24 Aligned_cols=240 Identities=26% Similarity=0.423 Sum_probs=184.3
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------EEeeCCCC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL-------------FMSMSPNG 359 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-------------v~~~~~~g 359 (559)
++|++.+.||+|+||+||+++.. ++.+|||++... ...+.+.+|++++++++|||| |+||++++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCC
Confidence 46888999999999999999875 678999998643 334679999999999999994 78999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC-EEEeecccceeccCCCce
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD-AKISDFGLSRLALNGASH 438 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~-~kl~DFG~a~~~~~~~~~ 438 (559)
+|.+++..... ...+++..+..++.|+++||+|||+.+.++|+||||||+|||++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 85 SLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp BHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 99999975322 234788899999999999999999543389999999999999998886 799999999755322
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+... ... .+.+..
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~-~~~-----~~~~~~- 227 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVH-NGT-----RPPLIK- 227 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHH-TTC-----CCCCBT-
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHh-cCC-----CCCccc-
Confidence 122348999999999998899999999999999999999999997443221 11111110 000 011111
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.....+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 228 ------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 228 ------NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2235688899999999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=328.75 Aligned_cols=251 Identities=16% Similarity=0.209 Sum_probs=187.4
Q ss_pred hCCCCCCCccccCCccEEEEEEecC------CcEEEEEEeecCCCC-----------ChhhHHHHHHHHHhcCCCc----
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD------ETITAVKRAKLGNTK-----------GIDPILNEVRILCQLNHRS---- 350 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~avk~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n---- 350 (559)
.++|++.+.||+|+||.||+|...+ ++.||||++...... ....++.|+..+..++|+|
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999998754 478999998654321 1122344555566667886
Q ss_pred ---------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 351 ---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 351 ---------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
|||||+ +++|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEE
Confidence 467888 999999997632 35999999999999999999999 7789999999999999
Q ss_pred c--CCCCEEEeecccceeccCCCcee------eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 047195 416 D--EKLDAKISDFGLSRLALNGASHV------TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNR 487 (559)
Q Consensus 416 ~--~~~~~kl~DFG~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~ 487 (559)
+ .++.+||+|||+++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998764322111 123349999999999999899999999999999999999999997433
Q ss_pred ccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 488 EEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.... ...... ......+...+++.+.. ...+..+.+++.+||+.+|++|||+.+|+++|++++
T Consensus 266 ~~~~--~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 266 KDPK--YVRDSK-IRYRENIASLMDKCFPA------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp TCHH--HHHHHH-HHHHHCHHHHHHHHSCT------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCHH--HHHHHH-HHhhhhHHHHHHHhccc------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 2211 111111 11112222333332211 112367889999999999999999999999998763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=329.71 Aligned_cols=256 Identities=24% Similarity=0.314 Sum_probs=195.4
Q ss_pred CCCCCCCccccCCccEEEEEEe-----cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce----------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-----DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++|+||
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4689999999999999999983 4678999999987666666779999999999999984
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|+||+++++|.+++..... .+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 6799999999999976432 4899999999999999999999 7889999999999999999999999999998
Q ss_pred eccCCCcee--eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 431 LALNGASHV--TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 431 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
......... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||......... .............+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHH
Confidence 765443322 22344888899999998888999999999999999999999998633211000 000000000000001
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..+..... ..........+.+|+.+||+.||++|||+.||++.|+.++
T Consensus 255 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 255 ELLEEGQR---LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHhhcccC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111000 0111233467889999999999999999999999999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=327.61 Aligned_cols=236 Identities=26% Similarity=0.306 Sum_probs=188.1
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC------ChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK------GIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|+||+||+++.. +++.+|+|.+...... ..+.+.+|+.+|++++||||
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457999999999999999999964 6899999998765432 24678999999999999994
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC----CEEEee
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL----DAKISD 425 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~----~~kl~D 425 (559)
|+||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||+++++ .+||+|
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 78999999999998653 35899999999999999999999 78899999999999998876 799999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ... +...
T Consensus 163 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~------~~~-i~~~ 233 (361)
T 2yab_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LAN-ITAV 233 (361)
T ss_dssp CSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHH-HHTT
T ss_pred cCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhc
Confidence 999987654322 2334599999999999988999999999999999999999999975543221 111 1010
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ..++... ......+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~--~~~~~~~-------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY--DFDEEFF-------SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCCHHHH-------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCCchhc-------cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0000000 122356788999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=338.24 Aligned_cols=236 Identities=24% Similarity=0.317 Sum_probs=190.8
Q ss_pred HhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce----------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL----------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni----------------v~~ 354 (559)
..++|++.+.||+|+||.||+|..+ ++.||||.++... ..+.|.+|+++|++++|||| |+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467889999999999999999875 6799999987543 45789999999999999984 689
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.+++..... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 268 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999986432 24789999999999999999999 78899999999999999999999999999985432
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.. ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. .. ....+. ..
T Consensus 342 ~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~----~i~~~~-----~~ 405 (450)
T 1k9a_A 342 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----RVEKGY-----KM 405 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH----HHHTTC-----CC
T ss_pred cc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCC-----CC
Confidence 21 12247899999999999999999999999999999998 9999975543221 11 111110 00
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.. +...+..+.+|+.+||+.||++|||+.+|++.|+.|
T Consensus 406 ~~-------p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 406 DA-------PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00 112336788999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.20 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=194.8
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec--------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce--------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD--------DETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL-------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni-------- 351 (559)
...++|.+.+.||+|+||+||+|+.. ++..+|||++..... .....+.+|+++++++ +||||
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34568999999999999999999852 336799999876433 3346789999999999 99984
Q ss_pred -------EEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCe
Q 047195 352 -------FMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNI 413 (559)
Q Consensus 352 -------v~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Ni 413 (559)
|+||+++|+|.+++...... ....+++..++.++.|++.||+||| +++|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 78999999999999865421 1235899999999999999999999 78899999999999
Q ss_pred eecCCCCEEEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccc
Q 047195 414 LLDEKLDAKISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEED 491 (559)
Q Consensus 414 ll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~ 491 (559)
|+++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~- 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999986643221 22233447889999999999999999999999999999999 999987543221
Q ss_pred ccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 492 VNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.......... .... ......+.+|+.+||+.+|++|||+.||++.|++++
T Consensus 302 ------~~~~~~~~~~-----~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 302 ------LFKLLKEGHR-----MDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp ------HHHHHHTTCC-----CCCC-------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHHcCCC-----CCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111110 0011 122367889999999999999999999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.54 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=190.6
Q ss_pred hCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ......+.+|+.++++++||||
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357899999999999999999843 45789999986542 2334568999999999999994
Q ss_pred --EEeeCCCCcHhHhHhhccCC--CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC---CEEEe
Q 047195 352 --FMSMSPNGTLFDRLHRVQSG--NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL---DAKIS 424 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~---~~kl~ 424 (559)
|+||+++|+|.+++...... ....+++..++.++.||+.||+||| +++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 78999999999999875421 2235899999999999999999999 78899999999999999554 59999
Q ss_pred ecccceeccCCC-ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHh
Q 047195 425 DFGLSRLALNGA-SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNIL 502 (559)
Q Consensus 425 DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 502 (559)
|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+. . ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~------~-~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV------L-EFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH------H-HHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------H-HHH
Confidence 999997653221 112233458999999999999899999999999999999998 9999875432211 1 111
Q ss_pred hcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 503 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..... ... .......+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 300 ~~~~~-----~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TSGGR-----MDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HTTCC-----CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCC-----CCC-------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11100 000 112235688999999999999999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=323.38 Aligned_cols=236 Identities=20% Similarity=0.264 Sum_probs=188.0
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|++.+.||+|+||+||++... +++.+|+|.+.... .....+.+|+.+++.++|||| |+||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999964 57899999887543 334568899999999999994 6899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC--CCCEEEeecccceecc
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE--KLDAKISDFGLSRLAL 433 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~--~~~~kl~DFG~a~~~~ 433 (559)
+++++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+||+|||+++...
T Consensus 83 ~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999986432 35899999999999999999999 788999999999999987 7899999999998775
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..... ..... .+.
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~-~~~~~--~~~ 224 (321)
T 1tki_A 156 PGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIM-NAEYT--FDE 224 (321)
T ss_dssp TTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH-HTCCC--CCH
T ss_pred CCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHH-cCCCC--CCh
Confidence 4432 2334599999999999888889999999999999999999999975443221 11111 10000 000
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~-------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 EA-------FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HH-------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hh-------hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0122367889999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=319.04 Aligned_cols=249 Identities=21% Similarity=0.245 Sum_probs=183.6
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||+|+||+||+|...+++.+|+|++..... ...+.+.+|++++++++|||| |+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46889999999999999999988899999999865432 234678999999999999995 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++ +|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 774 8888886532 35889999999999999999999 788999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch---hh---
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER---LV--- 508 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~--- 508 (559)
... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+... .......... +.
T Consensus 154 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 154 VRK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGG
T ss_pred ccc-cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHHCCCChhhchhhh
Confidence 221 2233589999999998764 58999999999999999999999997654322211 1111111100 00
Q ss_pred --hcccccccc----CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 --DAIDPMLKE----GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 --~~~d~~l~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...++.... ............+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000111000 000000123366789999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=337.43 Aligned_cols=247 Identities=20% Similarity=0.262 Sum_probs=193.4
Q ss_pred hHHHHHHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------
Q 047195 285 SREITEATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL--------- 351 (559)
Q Consensus 285 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni--------- 351 (559)
.+++....++|++.++||+|+||+||+|+.+ +++.+|+|++... .....+.+.+|+.++..++||||
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444455688999999999999999999965 4789999998652 22334569999999999999984
Q ss_pred ------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 352 ------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 352 ------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcc
Confidence 789999999999997632 25899999999999999999999 78899999999999999999999999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN 500 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 500 (559)
||+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||...+..+....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~------ 292 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------ 292 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh------
Confidence 9999877655444444456999999999987 45689999999999999999999999975543222111
Q ss_pred HhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 047195 501 ILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQN--RPSIKEVAD 553 (559)
Q Consensus 501 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~ 553 (559)
...... .. .+..... .....+.+|+++||..+|++ ||++.|+++
T Consensus 293 i~~~~~--~~---~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 293 IMNHKE--RF---QFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHTHHH--HC---CCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhccc--cc---cCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111000 00 0000000 12356788999999888888 999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=317.26 Aligned_cols=240 Identities=23% Similarity=0.356 Sum_probs=192.9
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.++|++.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|++++++++|||| |+||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888999999999999999988889999999876543 34779999999999999994 68999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 86 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp TTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999997642 25889999999999999999999 7889999999999999999999999999998654322
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
........+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ... .... .....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~-i~~~-----~~~~~ 226 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VED-ISTG-----FRLYK 226 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHH-HHTT-----CCCCC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------HHH-HhcC-----CcCCC
Confidence 222223347788999999988889999999999999999999 8989875432211 111 1111 00000
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. ......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 227 ~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 227 P-------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 11235688899999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.80 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=194.0
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-----------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL----------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni----------- 351 (559)
...++|++.+.||+|+||.||+|+.. +++.||||.++.... ...+.+.+|+.++++++||||
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999964 348899999875433 234678999999999999994
Q ss_pred ----EEeeCCCCcHhHhHhhccCC-------------------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCC
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSG-------------------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDI 408 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Di 408 (559)
|+||+++++|.+++...... ....+++..++.++.||+.||+||| +++|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 78999999999999764311 1146899999999999999999999 788999999
Q ss_pred CCCCeeecCCCCEEEeecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCC
Q 047195 409 KSSNILLDEKLDAKISDFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFN 486 (559)
Q Consensus 409 kp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~ 486 (559)
||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999976543221 12233458899999999998899999999999999999999 99998754
Q ss_pred CccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 487 REEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
...+. .......... .+. ......+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 281 ~~~~~-------~~~~~~~~~~-----~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 281 AHEEV-------IYYVRDGNIL-----ACP-------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp CHHHH-------HHHHHTTCCC-----CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ChHHH-------HHHHhCCCcC-----CCC-------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 32211 1111111110 011 122357889999999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=333.03 Aligned_cols=242 Identities=21% Similarity=0.278 Sum_probs=191.0
Q ss_pred HHHHHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce-----------
Q 047195 287 EITEATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL----------- 351 (559)
Q Consensus 287 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni----------- 351 (559)
++....++|++.+.||+|+||+||+++.+ +++.+|+|++... .....+.+.+|+.+++.++||||
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999965 5789999998652 23344668999999999999984
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
||||+++|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccc
Confidence 78999999999988652 4889999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQ----LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 503 (559)
+++..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+..+.. .....
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~ 287 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMN 287 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH------HHHHh
Confidence 99877654433344556999999999998665 788999999999999999999999755432211 11111
Q ss_pred cchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 047195 504 QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQN--RPSIKEVAD 553 (559)
Q Consensus 504 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~ 553 (559)
....... + . . ......+.+|+.+||+.+|.+ ||++.||++
T Consensus 288 ~~~~~~~--p---~-~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 288 HKNSLTF--P---D-D----NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHCCC--C---T-T----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ccccccC--C---C-c----ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0000000 0 0 0 012366788999999999988 999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.30 Aligned_cols=236 Identities=25% Similarity=0.283 Sum_probs=187.4
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC------ChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK------GIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|+||.||++... +++.+|+|.+...... ..+.+.+|+.+|++++||||
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346889999999999999999964 6899999998764332 34679999999999999994
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC----CEEEee
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL----DAKISD 425 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~----~~kl~D 425 (559)
|+||+++++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++ .+||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 78999999999998642 35899999999999999999999 78899999999999999887 799999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..... ...
T Consensus 162 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~--~~~ 234 (326)
T 2y0a_A 162 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSA--VNY 234 (326)
T ss_dssp CTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH--TCC
T ss_pred CCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHHh--cCC
Confidence 999987654322 22345999999999998889999999999999999999999999754322211 00000 000
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ..... .......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~----~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E----FEDEY-------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C----CCHHH-------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C----cCccc-------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000 0122356788999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.36 Aligned_cols=228 Identities=25% Similarity=0.355 Sum_probs=180.7
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhc-CCCce---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQL-NHRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni--------------- 351 (559)
.++|++.+.||+|+||+||+|+.+ +++.+|||+++.. .....+.+.+|+++++.+ +||||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999964 5899999998753 234456788999999998 79984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||+++.
T Consensus 102 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 789999999999997643 4899999999999999999999 78899999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ..... ....
T Consensus 174 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~-~~~~---- 241 (353)
T 3txo_A 174 GICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAIL-NDEV---- 241 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-HCCC----
T ss_pred cccCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------HHHHH-cCCC----
Confidence 433222 22334599999999999988899999999999999999999999975543221 11111 1100
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
... ......+.+|+.+||+.||++||++
T Consensus 242 --~~p-------~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 242 --VYP-------TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp --CCC-------TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred --CCC-------CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 001 1123567889999999999999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=325.50 Aligned_cols=241 Identities=22% Similarity=0.311 Sum_probs=187.3
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcE----EEEEEeecCC-CCChhhHHHHHHHHHhcCCCce--------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETI----TAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
++|++.+.||+|+||+||+|... ++.. +|+|.+.... ....+.+.+|+.++++++|||| |
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 46889999999999999999854 3443 7778765433 3444678899999999999995 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++|+.+|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 79999999999987532 25889999999999999999999 778999999999999999999999999999876
Q ss_pred cCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. . .......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~----~~~~~~~--- 235 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---D----LLEKGER--- 235 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH---H----HHHTTCB---
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH---H----HHHcCCC---
Confidence 543322 2234458889999999998899999999999999999999 99999755432211 1 1111100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.... ......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 236 --~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 --LAQP-------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp --CCCC-------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred --CCCC-------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000 011235677999999999999999999999998763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.64 Aligned_cols=242 Identities=25% Similarity=0.343 Sum_probs=196.4
Q ss_pred HhCCCCCCCccccCCccEEEEEEecC-CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
..++|++.+.||+|+||.||+|...+ +..+|+|.+... ....+.+.+|++++++++|||| |+|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45678999999999999999999654 788999998753 3345779999999999999984 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp CCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred cCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999976432 35899999999999999999999 77899999999999999999999999999987665
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ ..... .. ...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~----~~-----~~~ 231 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLE----KD-----YRM 231 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHH----TT-----CCC
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh----cc-----CCC
Confidence 54444444557889999999998899999999999999999999 8899875443221 11111 00 000
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
... ......+.+++.+||+.||++|||+.+++++|+.+
T Consensus 232 ~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 232 ERP-------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 001 12236788999999999999999999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=317.90 Aligned_cols=241 Identities=24% Similarity=0.335 Sum_probs=188.8
Q ss_pred hCCCCCCCccccCCccEEEEEEecC----CcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce--------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD----ETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
.++|.+.+.||+|+||+||+|+..+ +..+|+|.+.... ....+.+.+|+.++++++|||| |
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 4578999999999999999998543 2469999987643 2345679999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 91 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 91 MELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 89999999999997643 25899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ..... ....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~----~~~~---- 232 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLE----KGDR---- 232 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHH----HTCC----
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHh----cCCC----
Confidence 5443333334457889999999988899999999999999999998 9999975443221 11111 1000
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.... ......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 233 -~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 -LPKP-------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0000 11235688899999999999999999999999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.34 Aligned_cols=249 Identities=22% Similarity=0.196 Sum_probs=181.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.+|+.++||||
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999985 46889999998754 22334678999999999999985
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
||||+.+ +|.+.+.. .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 4567654 45555532 3889999999999999999999 7789999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc---
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ--- 504 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 504 (559)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.........
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 210 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp CC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998664322 223345999999999999999999999999999999999999999866543322221111000000
Q ss_pred ----chh---------------hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ----ERL---------------VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ----~~~---------------~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... .......+..............+.+|+.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000000111111112233567899999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.55 Aligned_cols=246 Identities=28% Similarity=0.372 Sum_probs=194.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|.+.+.||+|+||.||+|.. .++..+|||++..... ...+.+.+|++++++++||||
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 56789999999999999999985 3457899999875432 334678999999999999994
Q ss_pred --EEeeCCCCcHhHhHhhccCC-------------------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCC
Q 047195 352 --FMSMSPNGTLFDRLHRVQSG-------------------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKS 410 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp 410 (559)
|+||+++++|.+++...... ....+++..+..++.|++.||+||| +++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 68999999999999764321 1134789999999999999999999 78899999999
Q ss_pred CCeeecCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCc
Q 047195 411 SNILLDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNRE 488 (559)
Q Consensus 411 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~ 488 (559)
+|||+++++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765433322 223347889999999998889999999999999999999 9999975543
Q ss_pred cccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 489 EEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
... .. ....... .... ......+.+++.+||+.||++|||+.||++.|++++
T Consensus 259 ~~~---~~----~~~~~~~-----~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ERL---FN----LLKTGHR-----MERP-------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGH---HH----HHHTTCC-----CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH---HH----HhhcCCc-----CCCC-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 221 11 1111100 0011 123367889999999999999999999999999873
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=324.76 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=184.7
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHH--HhcCCCc-------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRIL--CQLNHRS------------------- 350 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l--~~l~h~n------------------- 350 (559)
.++|++.+.||+|+||.||+|+. +++.||||++.... .+.+..|.+++ ..++|+|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46799999999999999999976 67899999987543 24455555554 4589988
Q ss_pred -eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC---------CeEECCCCCCCeeecCCCC
Q 047195 351 -LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP---------PIYHRDIKSSNILLDEKLD 420 (559)
Q Consensus 351 -iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~---------~iiH~Dikp~Nill~~~~~ 420 (559)
+||||+++|+|.+++... ..++..+..++.|++.||+||| +. +|+||||||+|||++.++.
T Consensus 88 ~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred EEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCc
Confidence 367899999999999653 3588899999999999999999 77 9999999999999999999
Q ss_pred EEEeecccceeccCCCc-------eeeeeccccCCccCcccccc-------CCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 047195 421 AKISDFGLSRLALNGAS-------HVTTFAQGTLGYLDPEYYIN-------FQLTDKSDVYSFGVVLVELLTSKKAVDFN 486 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~el~tg~~p~~~~ 486 (559)
+||+|||+++....... .......||+.|+|||++.+ ..++.++||||||+++|||++|..|+...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999987653221 11223459999999999876 45677999999999999999998777543
Q ss_pred CccccccHHHH-----------HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 487 REEEDVNLVVY-----------FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 487 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
........... ......... ..+.+...... .......+.+|+.+||+.||++|||++||++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCccccc-ccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 32221111000 000000000 11111111111 123566799999999999999999999999999
Q ss_pred hhhC
Q 047195 556 ERII 559 (559)
Q Consensus 556 ~~i~ 559 (559)
++|+
T Consensus 314 ~~ll 317 (336)
T 3g2f_A 314 AELM 317 (336)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=326.10 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=193.8
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhc-CCCce---------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGN-TKGIDPILNEVRILCQL-NHRSL--------- 351 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni--------- 351 (559)
+...++|++.+.||+|+||.||+|.. .++..||||.+.... ....+.+.+|+.+++++ +||||
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34457899999999999999999985 245689999987542 34457799999999999 89994
Q ss_pred ------EEeeCCCCcHhHhHhhccCC------------------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECC
Q 047195 352 ------FMSMSPNGTLFDRLHRVQSG------------------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRD 407 (559)
Q Consensus 352 ------v~~~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~D 407 (559)
|+||+++|+|.+++...... ....+++..+..++.|++.||+||| +++|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence 78999999999999764321 0124789999999999999999999 78899999
Q ss_pred CCCCCeeecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 047195 408 IKSSNILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDF 485 (559)
Q Consensus 408 ikp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~ 485 (559)
|||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876543332 2233457889999999988899999999999999999998 9999975
Q ss_pred CCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 486 NREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
...... ........ ...... ......+.+|+.+||+.||++|||+.+|++.|+.++
T Consensus 278 ~~~~~~------~~~~~~~~-----~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 278 IPVDAN------FYKLIQNG-----FKMDQP-------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCCSHH------HHHHHHTT-----CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCcHHH------HHHHHhcC-----CCCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 543221 11111111 000001 122367888999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=334.21 Aligned_cols=238 Identities=21% Similarity=0.197 Sum_probs=186.6
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
..++|++.+.||+|+||+||++.. .+++.+|+|++..... ...+.+.+|++++++++|||| |
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456799999999999999999985 5688999999876432 234568999999999999995 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec---CCCCEEEeecccc
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD---EKLDAKISDFGLS 429 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~---~~~~~kl~DFG~a 429 (559)
+||+.+|+|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||++ +++.+||+|||++
T Consensus 89 ~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp ECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 8999999999998764 24899999999999999999999 78899999999999998 4678999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
+........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+. . .....+..
T Consensus 161 ~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~----~~i~~~~~-- 230 (444)
T 3soa_A 161 IEVEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---Y----QQIKAGAY-- 230 (444)
T ss_dssp BCCCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H----HHHHHTCC--
T ss_pred EEecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---H----HHHHhCCC--
Confidence 876543322 2334599999999999988999999999999999999999999975432211 1 11111110
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+. ...... .....+.+|+.+||+.||++|||+.|+++
T Consensus 231 --~~-~~~~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 --DF-PSPEWD----TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --CC-CTTTTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CC-Cccccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 000011 22366888999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=314.91 Aligned_cols=234 Identities=24% Similarity=0.310 Sum_probs=179.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--------------------------CChhhHHHHHHHHH
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--------------------------KGIDPILNEVRILC 344 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--------------------------~~~~~~~~E~~~l~ 344 (559)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36799999999999999999985 5688999999865431 12356899999999
Q ss_pred hcCCCce-----------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECC
Q 047195 345 QLNHRSL-----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRD 407 (559)
Q Consensus 345 ~l~h~ni-----------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~D 407 (559)
+++|||| ||||+++++|.+++.. ..+++..+..++.|++.||+||| +++|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 9999984 6788888888775432 35899999999999999999999 77899999
Q ss_pred CCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCccccccCC---CCcccchhHHHHHHHHHHhCCCCCC
Q 047195 408 IKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ---LTDKSDVYSFGVVLVELLTSKKAVD 484 (559)
Q Consensus 408 ikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~il~el~tg~~p~~ 484 (559)
|||+|||++.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999876543322 23345999999999987654 4778999999999999999999996
Q ss_pred CCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 485 FNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...... ... ....... ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~------~~~-~~~~~~~----~~~~~-------~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMC------LHS-KIKSQAL----EFPDQ-------PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHH------HHH-HHHHCCC----CCCSS-------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHH------HHH-HHhcccC----CCCCc-------cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 443211 111 1111100 00000 112356889999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.34 Aligned_cols=236 Identities=28% Similarity=0.374 Sum_probs=182.5
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCceE-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSLF----------------- 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~niv----------------- 352 (559)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++||||+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457899999999999999999965 789999999876543 3346799999999999999853
Q ss_pred -------------------------------------------------------EeeCCCCcHhHhHhhccCCCCCCCC
Q 047195 353 -------------------------------------------------------MSMSPNGTLFDRLHRVQSGNWPPLK 377 (559)
Q Consensus 353 -------------------------------------------------------~~~~~~g~L~~~l~~~~~~~~~~l~ 377 (559)
|||+++++|.+++..... .....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchh
Confidence 577889999999976432 23456
Q ss_pred hHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce-----------eeeecccc
Q 047195 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH-----------VTTFAQGT 446 (559)
Q Consensus 378 ~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~-----------~~~~~~gt 446 (559)
+..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++........ ......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7778999999999999999 788999999999999999999999999999876543211 11234599
Q ss_pred CCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHH
Q 047195 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDS 526 (559)
Q Consensus 447 ~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 526 (559)
+.|+|||++.+..++.++||||||+++|||++|..|+. .. ... ....... .........
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~---~~~-~~~~~~~------------~~~~~~~~~ 298 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ER---VRI-ITDVRNL------------KFPLLFTQK 298 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HH---HHH-HHHHHTT------------CCCHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HH---HHH-HHHhhcc------------CCCcccccC
Confidence 99999999999899999999999999999999876542 00 000 0000000 111112234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 527 MKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 527 ~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...+.+++.+||+.||++|||+.|+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 456788999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=321.75 Aligned_cols=237 Identities=28% Similarity=0.375 Sum_probs=184.9
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+++.++|||| |+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999865 789999999865433 234678999999999999984 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999988643 24899999999999999999999 78899999999999999999999999999987643
Q ss_pred CCc-eeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 435 GAS-HVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 435 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ .. ......... ..
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~----~~~~~~~~~---~~ 229 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY----SDWKEKKTY---LN 229 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HH----HHHHTTCTT---ST
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HH----HHHhccccc---CC
Confidence 322 22234469999999999987765 7799999999999999999999975443211 01 100000000 00
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+ .......+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~---------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 P---------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp T---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0122356778999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.12 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=183.6
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCC--hhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKG--IDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
++|++.+.||+|+||+||+|+.. +++.+|+|++....... .+.+.+|+.++++++|||| |+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47889999999999999999964 68899999987654322 3678899999999999994 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+.+ ++.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 8875 5655554422 35899999999999999999999 78899999999999999999999999999987643
Q ss_pred CCceeeeeccccCCccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc---hhhhc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQ-LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE---RLVDA 510 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 510 (559)
.... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.|+....... ............. .+...
T Consensus 154 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 154 PVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTG
T ss_pred cccc-ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhh
Confidence 3222 22345899999999988765 7999999999999999999988865333222 1111111111110 00000
Q ss_pred c---cc----c--cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 I---DP----M--LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~---d~----~--l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. +. . ...............+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00 0 000000111123467789999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=333.66 Aligned_cols=247 Identities=19% Similarity=0.222 Sum_probs=192.0
Q ss_pred ChHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCc---------
Q 047195 284 SSREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRS--------- 350 (559)
Q Consensus 284 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~n--------- 350 (559)
..+++....++|++.+.||+|+||+||+++. .+++.+|||++... .....+.+.+|+.++..++|+|
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3444555568899999999999999999996 46899999998653 2233456899999999999998
Q ss_pred ------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEe
Q 047195 351 ------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKIS 424 (559)
Q Consensus 351 ------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~ 424 (559)
+||||+++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEe
Confidence 4789999999999997643 25899999999999999999999 7889999999999999999999999
Q ss_pred ecccceeccCCCceeeeeccccCCccCccccc-------cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 047195 425 DFGLSRLALNGASHVTTFAQGTLGYLDPEYYI-------NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 425 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~ 497 (559)
|||+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||...+..+....+
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i-- 282 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI-- 282 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 99999877654443334456999999999987 356899999999999999999999999765432211111
Q ss_pred HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 047195 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNR---PSIKEVAD 553 (559)
Q Consensus 498 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Pt~~evl~ 553 (559)
..... ...-+.+. ......+.+|+.+||. +|++| |++.|+++
T Consensus 283 ----~~~~~--~~~~p~~~-------~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 ----VHYKE--HLSLPLVD-------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ----HTHHH--HCCCC-----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ----Hhccc--CcCCCccc-------cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 10000 00001111 1233678889999999 99998 58888864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.37 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=185.1
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-----CChhhHHHHHHHHHhcC---CCce----------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-----KGIDPILNEVRILCQLN---HRSL---------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-----~~~~~~~~E~~~l~~l~---h~ni---------- 351 (559)
..++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+|++++++++ ||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 5689999999875332 22346788888888775 9985
Q ss_pred ----------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCE
Q 047195 352 ----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421 (559)
Q Consensus 352 ----------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~ 421 (559)
|+|++. ++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCE
Confidence 456665 699888876432 34899999999999999999999 7889999999999999999999
Q ss_pred EEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 422 KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 422 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...........
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999997654322 223445899999999999999999999999999999999999999765433322111111100
Q ss_pred hhcchhhhcc-------ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LKQERLVDAI-------DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~~~~~~~~~-------d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.....+.... .+...........+....+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000000 000000000001123467889999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.16 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=196.7
Q ss_pred HHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EE
Q 047195 288 ITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FM 353 (559)
Q Consensus 288 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~ 353 (559)
++...++|++.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++|+|| ||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~ 340 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 340 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEee
Confidence 334456788999999999999999999888889999987654 345789999999999999984 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+.+|+|.+++..... ..+++..++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++...
T Consensus 341 e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp CCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred ehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999975432 24889999999999999999999 7889999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
...........++..|+|||++....++.++||||||++||||++ |+.||......+. . .....+. .
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~----~~i~~~~-----~ 482 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L----DQVERGY-----R 482 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---H----HHHHTTC-----C
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcCC-----C
Confidence 322111223347789999999998899999999999999999999 8999875432211 1 1111110 0
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
... .......+.+|+.+||+.||++|||+.+|+++|+.++
T Consensus 483 ~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 MPC-------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCC-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 000 0123367889999999999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=331.25 Aligned_cols=254 Identities=24% Similarity=0.300 Sum_probs=177.7
Q ss_pred HHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC--CCCChhhHHHHHHHHHhcC-CCce--------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG--NTKGIDPILNEVRILCQLN-HRSL-------------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni-------------- 351 (559)
...++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++++. |+||
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 56899999998643 2233456889999999997 9984
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
|+||+. ++|..++... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 678886 5888888652 4889999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCC--------------------CceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 047195 429 SRLALNG--------------------ASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNR 487 (559)
Q Consensus 429 a~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~ 487 (559)
++..... .....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865321 1112233469999999999886 578999999999999999999999998665
Q ss_pred ccccccHHHHHHHHhhcchhhhcccc------------------ccccCCChh---------hHHHHHHHHHHHHHhccc
Q 047195 488 EEEDVNLVVYFGNILKQERLVDAIDP------------------MLKEGASEI---------ELDSMKAFGLLGAACLDE 540 (559)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~d~------------------~l~~~~~~~---------~~~~~~~l~~l~~~cl~~ 540 (559)
...................+.....+ .....+... .......+.+|+.+||+.
T Consensus 236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 43322222111100000000000000 000000000 001235688999999999
Q ss_pred CCCCCCCHHHHHH
Q 047195 541 RRQNRPSIKEVAD 553 (559)
Q Consensus 541 ~p~~RPt~~evl~ 553 (559)
||++|||+.|+++
T Consensus 316 dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 316 NPNKRISANDALK 328 (388)
T ss_dssp SGGGSCCHHHHTT
T ss_pred CcccCCCHHHHhC
Confidence 9999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=310.75 Aligned_cols=239 Identities=28% Similarity=0.400 Sum_probs=179.4
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC----CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT----KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~----~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||+|... +..+|||++..... ...+.+.+|++++++++|||| |
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357889999999999999999865 78899999875432 334678999999999999984 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC--------CCCEEEe
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE--------KLDAKIS 424 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~--------~~~~kl~ 424 (559)
+||+++++|.+++.. ..+++..+..++.|++.||+|||+.+..+|+||||||+|||++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 899999999988853 25899999999999999999999422223999999999999986 6789999
Q ss_pred ecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 047195 425 DFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 425 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
|||+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 159 Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~ 229 (271)
T 3dtc_A 159 DFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAMN 229 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHTS
T ss_pred cCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhcC
Confidence 9999986543322 233589999999999988899999999999999999999999975432111 1111101
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. ....+. ......+.+++.+||+.+|++|||+.|+++.|++|
T Consensus 230 -~----~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -K----LALPIP-------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -C----CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -C----CCCCCC-------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 000111 12236788999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.12 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=195.2
Q ss_pred HhCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce-----------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL----------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni----------- 351 (559)
..++|++.+.||+|+||.||+|.. .+++.+|||.+..... ...+.+.+|+.+++++ +||||
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346799999999999999999984 3467899999875433 2346799999999999 99984
Q ss_pred ----EEeeCCCCcHhHhHhhccCC-------------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCee
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSG-------------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNIL 414 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nil 414 (559)
|+||+++|+|.+++...... ....+++..+..++.|++.||+||| +++|+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence 68999999999999764321 1225899999999999999999999 788999999999999
Q ss_pred ecCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccc
Q 047195 415 LDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDV 492 (559)
Q Consensus 415 l~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~ 492 (559)
++.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 9999999999999998765443322 233447889999999998899999999999999999999 99998755432211
Q ss_pred cHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 493 NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
....... ...... ......+.+++.+||+.||++|||+.|++++|++++
T Consensus 258 ------~~~~~~~-----~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 ------YKMIKEG-----FRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ------HHHHHHT-----CCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHhccC-----CCCCCc-------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111110 001111 122367888999999999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=326.26 Aligned_cols=234 Identities=26% Similarity=0.388 Sum_probs=186.9
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhc-CCCce-------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQL-NHRSL------------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l-~h~ni------------- 351 (559)
...++|++.+.||+|+||.||+|+.+ +++.+|||+++... ....+.+.+|..++..+ +||||
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999964 68999999987542 34456788999999987 89984
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 789999999999997643 4899999999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ... .....
T Consensus 166 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~-i~~~~--- 234 (345)
T 1xjd_A 166 KENMLGDAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHS-IRMDN--- 234 (345)
T ss_dssp BCCCCTTCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHHCC---
T ss_pred hhcccCCCc-ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH------HHH-HHhCC---
Confidence 864332222 2344599999999999998999999999999999999999999975442211 111 11110
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIK-EVA 552 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl 552 (559)
+.+.. .....+.+|+.+||+.||++||++. +|+
T Consensus 235 ---~~~p~-------~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ---PFYPR-------WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---CCCCT-------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCCc-------ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111 1235678899999999999999997 654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=322.77 Aligned_cols=231 Identities=24% Similarity=0.294 Sum_probs=184.5
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|.+.+.||+|+||+||+|.. .+++.||||++... .......+.+|+.+++.++|||| |
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999995 67899999998643 22334678999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+ +|+|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++...
T Consensus 88 ~E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 7888 789998887642 4899999999999999999999 778999999999999999999999999999866
Q ss_pred cCCCceeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
..... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........... +
T Consensus 159 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------------i 220 (336)
T 3h4j_B 159 TDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------V 220 (336)
T ss_dssp TTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------C
T ss_pred cCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------H
Confidence 54322 223459999999999988776 6899999999999999999999975432221100 0
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .....+......+.+|+.+||+.||.+|||+.|+++
T Consensus 221 ~~----~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NS----CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CS----SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred Hc----CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 000001122356788999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.45 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=183.7
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcE----EEEEEeecC-CCCChhhHHHHHHHHHhcCCCce--------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETI----TAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----~avk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
.++|++.+.||+|+||+||+|... +++. +|+|.+... .....+.+.+|+.++++++||||
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 357999999999999999999853 4443 577776543 33456789999999999999995
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|++++.+|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 94 v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 578899999999997643 25899999999999999999999 78899999999999999999999999999987
Q ss_pred ccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 432 ALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 432 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. .. .......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~----~~~~~~~-- 237 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGER-- 237 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCC--
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHcCCC--
Confidence 6433222 2223347889999999999999999999999999999999 9999975543321 11 1111100
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
... .......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 238 ---~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 238 ---LPQ-------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---CCC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC-------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 000 011235688899999999999999999999999876
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.54 Aligned_cols=240 Identities=21% Similarity=0.234 Sum_probs=186.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC-----CCCChhhHHHHHHHHHhcCCCce--------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG-----NTKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
.++|++.+.||+|+||+||++.. .+++.+|||++... .....+.+.+|+.++++++||||
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35699999999999999999985 46899999998642 12245779999999999999994
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC---EEEeecc
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD---AKISDFG 427 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~---~kl~DFG 427 (559)
||||+++++|.+.+...... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 78999999998887654321 235899999999999999999999 788999999999999986654 9999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ... ......
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~---~~~-i~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RL---FEG-IIKGKY 249 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HH---HHH-HHHTCC
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HH---HHH-HHcCCC
Confidence 9987654332 22334599999999999988999999999999999999999999975321 01 111 111100
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ..+... ......+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~~-------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQW-------SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHH-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCcccc-------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 000000 122367889999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.28 Aligned_cols=237 Identities=21% Similarity=0.266 Sum_probs=188.9
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+++|++++|||| |+||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457999999999999999999864 688999999876655455679999999999999994 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC--CCCEEEeecccceecc
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE--KLDAKISDFGLSRLAL 433 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~--~~~~kl~DFG~a~~~~ 433 (559)
+++|+|.+.+.... ..+++..+..++.||+.||+||| +++|+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 130 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999886432 25899999999999999999999 788999999999999974 5779999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .. . ...... ..+.
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~---~-i~~~~~--~~~~ 271 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQ---N-VKRCDW--EFDE 271 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH---H-HHHCCC--CCCS
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HH---H-HHhCCC--CCCc
Confidence 4332 2233599999999999988899999999999999999999999975432211 11 1 101000 0000
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. . ......+.+|+.+||+.||++|||+.|+++
T Consensus 272 ~~---~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 DA---F----SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ST---T----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cc---c----ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 0 122367889999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=316.52 Aligned_cols=229 Identities=25% Similarity=0.323 Sum_probs=186.7
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||+||+++.. +++.+|+|++... .....+.+.+|+.+++.++|||| ||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57899999999999999999964 6899999998753 23445678899999999999984 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 9999999999997632 4899999999999999999999 8899999999999999999999999999998754
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+... ....... ...
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~~~------ 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILN-AEL------ 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-CCC------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCC------
Confidence 32 223459999999999999899999999999999999999999997543221 1111111 100
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
.+.. .....+.+++.+||+.||++|| ++.|+++
T Consensus 221 ~~p~-------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 RFPP-------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCCT-------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC-------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0111 1235688899999999999999 8888874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.70 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=186.3
Q ss_pred HHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhc--CCCce--------------
Q 047195 288 ITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQL--NHRSL-------------- 351 (559)
Q Consensus 288 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l--~h~ni-------------- 351 (559)
.....++|++.+.||+|+||.||+|+.+ ++.||||++... ....+.+|.+++..+ +||||
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445578999999999999999999875 889999998643 234566677777665 89884
Q ss_pred -----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC--------CeEECCCCCCCeeecCC
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP--------PIYHRDIKSSNILLDEK 418 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~--------~iiH~Dikp~Nill~~~ 418 (559)
|+||+++|+|.+++... .+++..+..++.|++.||+||| ++ +|+||||||+|||++.+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCC
Confidence 67899999999999652 4899999999999999999999 66 99999999999999999
Q ss_pred CCEEEeecccceeccCCCceee---eeccccCCccCccccccCCCCcc------cchhHHHHHHHHHHhC----------
Q 047195 419 LDAKISDFGLSRLALNGASHVT---TFAQGTLGYLDPEYYINFQLTDK------SDVYSFGVVLVELLTS---------- 479 (559)
Q Consensus 419 ~~~kl~DFG~a~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlG~il~el~tg---------- 479 (559)
+.+||+|||+++.......... ....||+.|+|||++.+...+.+ +||||||+++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 9999999999987654332211 23459999999999987766655 9999999999999999
Q ss_pred CCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 480 KKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 480 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+.||......... . ........... ..+.+.... ........+.+|+.+||+.||++|||+.||++.|++|
T Consensus 259 ~~p~~~~~~~~~~-~-~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 259 QLPYHDLVPSDPS-Y-EDMREIVCIKK----LRPSFPNRW--SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCTTTTTSCSSCC-H-HHHHHHHTTSC----CCCCCCGGG--GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHhhhcCCCCc-h-hhhHHHHhhhc----cCccccccc--hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 5555433222211 1 11111111111 111111100 1135667899999999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.78 Aligned_cols=247 Identities=12% Similarity=0.179 Sum_probs=189.3
Q ss_pred hCCCCCCCccccCCccEEEEEEecC---------CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD---------ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------------ 350 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n------------ 350 (559)
.++|++.+.||+|+||.||+|+... ++.+|+|.+... +.+.+|++++++++|||
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3579999999999999999999653 789999998743 56889999999999965
Q ss_pred -------------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCC
Q 047195 351 -------------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSS 411 (559)
Q Consensus 351 -------------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~ 411 (559)
||+||+ +++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHH
Confidence 467888 9999999986422 35899999999999999999999 788999999999
Q ss_pred CeeecCCC--CEEEeecccceeccCCCce------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCC
Q 047195 412 NILLDEKL--DAKISDFGLSRLALNGASH------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAV 483 (559)
Q Consensus 412 Nill~~~~--~~kl~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~ 483 (559)
|||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 8999999999866432211 112335999999999999989999999999999999999999999
Q ss_pred CCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 484 DFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
........ ........ + ........+..... ......+.+++.+||+.||++|||+.+|+++|++++
T Consensus 269 ~~~~~~~~-~~~~~~~~-~-~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 269 TNCLPNTE-DIMKQKQK-F-VDKPGPFVGPCGHW------IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GGGTTCHH-HHHHHHHH-H-HHSCCCEECTTSCE------ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCCcCHH-HHHHHHHh-c-cCChhhhhhhcccc------CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 75432211 11111111 1 01111111110000 012367889999999999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.84 Aligned_cols=257 Identities=20% Similarity=0.270 Sum_probs=196.4
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce-----------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL-----------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni-----------------v~ 353 (559)
++|.+.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++|||| |+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46899999999999999999965 48999999987543 3445678899999999999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee----cCCCCEEEeecccc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL----DEKLDAKISDFGLS 429 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill----~~~~~~kl~DFG~a 429 (559)
||+++|+|.+++...... ..+++..++.++.|++.||+||| +++|+||||||+|||+ +.++.+||+|||++
T Consensus 89 e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp CCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred ecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999764322 24899999999999999999999 7889999999999999 77888999999999
Q ss_pred eeccCCCceeeeeccccCCccCcccccc--------CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYIN--------FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ ....
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~--~~~~ 239 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MYKI 239 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH--HHHH
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH--HHHH
Confidence 87654322 223459999999999865 46788999999999999999999999754332221111 1111
Q ss_pred hhcch--hhhccc----------cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 502 LKQER--LVDAID----------PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 502 ~~~~~--~~~~~d----------~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... ....+. ..+. ............+.+++.+||+.||++|||+.++++.|++|+
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 11110 000000 0000 111223567788999999999999999999999999998864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.34 Aligned_cols=234 Identities=23% Similarity=0.319 Sum_probs=185.8
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+++|+.++|||| |+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999954 5789999998653 23445778999999999999994 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+.+|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 95 e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999753 25899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYIN---FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||................ ...
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~---- 236 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTV---- 236 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCC----
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hcc----
Confidence 432 2234459999999999864 458999999999999999999999997554332211111111 000
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-IKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~ 553 (559)
.... ......+.+|+.+||+.||++||+ +.+|++
T Consensus 237 --~~~p-------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --VTYP-------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCCC-------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --cCCC-------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0001 122367889999999999999998 666653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=319.67 Aligned_cols=234 Identities=22% Similarity=0.338 Sum_probs=182.2
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC---CChhhHHHHHHHHHhc-CCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT---KGIDPILNEVRILCQL-NHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni---------------v 352 (559)
++|++.+.||+|+||.||+++.+ +++.+|+|++..... ...+.+.+|+.+++++ +|||| |
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46899999999999999999964 588999999876432 2345688999999987 89984 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 89999999999997643 4899999999999999999999 788999999999999999999999999999864
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccc--cHHHHHHHHhhcchhhhc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV--NLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 510 (559)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...............
T Consensus 161 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 236 (345)
T 3a8x_A 161 LRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 236 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred cCCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence 33222 223345999999999999989999999999999999999999999753222111 001111111111110
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
.+. ......+.+|+.+||+.||++||++
T Consensus 237 ---~~p-------~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ---RIP-------RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---CCC-------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCC-------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111 1223568889999999999999996
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.27 Aligned_cols=240 Identities=16% Similarity=0.166 Sum_probs=191.0
Q ss_pred HHHhCCCCCCCccccCCccEEEEEE------ecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC---CCc---------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAI------LDDETITAVKRAKLGNTKGIDPILNEVRILCQLN---HRS--------- 350 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~------~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~---h~n--------- 350 (559)
+...++|.+.+.||+|+||+||+|. ..+++.||||++... ...++.+|++++++++ |+|
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3445779999999999999999994 456889999998643 3467889999999887 666
Q ss_pred ------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-------
Q 047195 351 ------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE------- 417 (559)
Q Consensus 351 ------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~------- 417 (559)
|||||+++|+|.+++..........+++..+..++.||+.||+||| +++|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence 5789999999999998654433456999999999999999999999 889999999999999998
Q ss_pred ----CCCEEEeecccceeccC-CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccc
Q 047195 418 ----KLDAKISDFGLSRLALN-GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV 492 (559)
Q Consensus 418 ----~~~~kl~DFG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~ 492 (559)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 89999999999986542 223334455699999999999998999999999999999999999999853321110
Q ss_pred cHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhhh
Q 047195 493 NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNR-PSIKEVADEIERI 558 (559)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Pt~~evl~~L~~i 558 (559)
.+...+... .....+.+++..||+.+|.+| |+++++.+.|+++
T Consensus 294 -----------------~~~~~~~~~------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 -----------------KPEGLFRRL------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp -----------------EECSCCTTC------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred -----------------eechhcccc------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 011111111 113567778899999999999 6888888888875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.84 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=189.5
Q ss_pred CCCCCccccCCccEEEEEEe-----cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-----DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-----~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
|++.+.||+|+||+||++.+ .+++.||||++..... ...+.+.+|++++++++||||
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999998864 3678999999876532 334668999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+++++|.+++... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 67899999999998652 3899999999999999999999 78899999999999999999999999999987
Q ss_pred ccCCCcee--eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 432 ALNGASHV--TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 432 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
........ .....+|+.|+|||++.+..++.++||||||+++|||++|+.||........ ..............+.+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHH
Confidence 76543321 2334488889999999988899999999999999999999999863321100 00000000000001111
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.++..... .........+.+|+.+||+.||++|||+.||+++|+++
T Consensus 263 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 263 LLERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111110 01123346789999999999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=327.06 Aligned_cols=260 Identities=23% Similarity=0.255 Sum_probs=192.3
Q ss_pred ccChHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-----CCce----
Q 047195 282 IFSSREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLN-----HRSL---- 351 (559)
Q Consensus 282 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni---- 351 (559)
.++.++.....++|++.++||+|+||+||+|+. .+++.||||++... ....+.+..|+.+++.+. |+||
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 345555556678999999999999999999996 56889999998642 233456788999999997 8884
Q ss_pred -----------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---
Q 047195 352 -----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE--- 417 (559)
Q Consensus 352 -----------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~--- 417 (559)
|+||+ +++|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccc
Confidence 67888 8999999986432 35899999999999999999999 788999999999999975
Q ss_pred ----------------------CCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHH
Q 047195 418 ----------------------KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVE 475 (559)
Q Consensus 418 ----------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~e 475 (559)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7889999999998654322 23458999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHHHhhcchh--------hhccc-cccccC-----------------CChhhHHHHHH
Q 047195 476 LLTSKKAVDFNREEEDVNLVVYFGNILKQERL--------VDAID-PMLKEG-----------------ASEIELDSMKA 529 (559)
Q Consensus 476 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~d-~~l~~~-----------------~~~~~~~~~~~ 529 (559)
|++|+.||......+................+ ...++ ..+... ...........
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999999765433322111111000000000 00000 000000 00000111256
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 047195 530 FGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 530 l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+|+.+||+.||++|||++|+++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCCCHHHHhc
Confidence 789999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=321.58 Aligned_cols=256 Identities=24% Similarity=0.352 Sum_probs=198.2
Q ss_pred ccChHHHHHHhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---
Q 047195 282 IFSSREITEATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--- 351 (559)
Q Consensus 282 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--- 351 (559)
.+..++++...++|++.+.||+|+||.||+|+.. .++.+|||.+..... .....+.+|++++++++|+||
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3445555666788999999999999999999854 367899999875432 234568999999999999984
Q ss_pred ------------EEeeCCCCcHhHhHhhccC-----CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCee
Q 047195 352 ------------FMSMSPNGTLFDRLHRVQS-----GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNIL 414 (559)
Q Consensus 352 ------------v~~~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nil 414 (559)
|+||+++++|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEE
Confidence 7899999999999875321 12245789999999999999999999 788999999999999
Q ss_pred ecCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccc
Q 047195 415 LDEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDV 492 (559)
Q Consensus 415 l~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~ 492 (559)
++.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~- 249 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV- 249 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-
Confidence 9999999999999998654332211 122347889999999998889999999999999999999 8888864432111
Q ss_pred cHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 493 NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
. .......... . .......+.+++.+||+.+|++|||+.|+++.|++++
T Consensus 250 -----~-~~~~~~~~~~-----~-------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 -----L-RFVMEGGLLD-----K-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp -----H-HHHHTTCCCC-----C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -----H-HHHHcCCcCC-----C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1 1111111100 0 1123366888999999999999999999999998864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=315.40 Aligned_cols=253 Identities=22% Similarity=0.253 Sum_probs=183.0
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.++|++.+.||+|+||+||+|... +++.+|+|++...... ..+.+.+|++++++++|||| |+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 357899999999999999999965 5899999988654332 23568899999999999994 68
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 82 e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999998887643 24899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHhhc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG--------NILKQ 504 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~ 504 (559)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+......... ..+..
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 154 GPSDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred Ccccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 33222 223458999999999876 568999999999999999999999997665433222211110 00001
Q ss_pred chhhhccccccccCCCh---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ERLVDAIDPMLKEGASE---IELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..........-...... ........+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11000000000000000 00123456889999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.18 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=191.9
Q ss_pred hCCCCCCCccccCCccEEEEEEe--------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce----------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL--------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL---------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni---------- 351 (559)
.++|++.+.||+|+||.||+|.. .++..||||++..... ...+.+.+|+++++++ +||||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46799999999999999999985 3467899999875432 3346789999999999 89984
Q ss_pred -----EEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
|+||+++++|.+++...... ....+++..++.++.|++.||+||| +++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 78999999999999764321 1134889999999999999999999 7889999999999999
Q ss_pred cCCCCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccccc
Q 047195 416 DEKLDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVN 493 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~ 493 (559)
+.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH--
Confidence 999999999999998765433222 223347889999999988889999999999999999999 9999875432211
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
. ........ .... ......+.+++.+||+.+|++|||+.||++.|++|+
T Consensus 269 ----~-~~~~~~~~-----~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 269 ----F-KLLKEGHR-----MDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp ----H-HHHHHTCC-----CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----H-HHHhcCCC-----CCCC-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 11111100 0011 122356888999999999999999999999999873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=320.64 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=177.2
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|++.+.||+|+||+||+++.. +++.||||++...... .+.+.+|+.++++++|||| |+||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457999999999999999999965 7899999998764433 3678999999999999994 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC--EEEeecccceecc
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD--AKISDFGLSRLAL 433 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~--~kl~DFG~a~~~~ 433 (559)
+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999987643 4899999999999999999999 788999999999999987765 9999999997543
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcc-cchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDK-SDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||........... ........ ..
T Consensus 170 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--~~~~~~~~-~~----- 239 (361)
T 3uc3_A 170 LHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TIQRILSV-KY----- 239 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH--HHHHHHTT-CC-----
T ss_pred ccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH--HHHHHhcC-CC-----
Confidence 221 1223459999999999988877665 8999999999999999999975543322111 11111110 00
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 240 -~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 240 -SIPD-----DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -CCCT-----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -CCCC-----cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0000 0012356788999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.08 Aligned_cols=235 Identities=21% Similarity=0.335 Sum_probs=186.3
Q ss_pred CCCCCCCccccCCccEEEEEEecC-C-------cEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-E-------TITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-~-------~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
++|++.+.||+|+||+||+|+... + ..+|+|.+........+.+.+|++++++++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568899999999999999998543 3 4799999877666666789999999999999994
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC--------E
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD--------A 421 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~--------~ 421 (559)
|+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++. +
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccccee
Confidence 789999999999997643 24889999999999999999999 788999999999999998887 9
Q ss_pred EEeecccceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 047195 422 KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN 500 (559)
Q Consensus 422 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 500 (559)
||+|||++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++|..|+........ . ..
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~---~~- 229 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--K---LQ- 229 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--H---HH-
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--H---HH-
Confidence 99999998654321 22348999999999987 6789999999999999999997665543321111 0 00
Q ss_pred HhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 501 ILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 501 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... ..+... ....+.+++.+||+.||++|||+.|+++.|++++
T Consensus 230 ~~~~~-------~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 230 FYEDR-------HQLPAP-------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHHTT-------CCCCCC-------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred Hhhcc-------CCCCCC-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 00000 001111 1245778999999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=323.91 Aligned_cols=237 Identities=22% Similarity=0.273 Sum_probs=186.5
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
..++|++.+.||+|+||.||++..+ +++.+|+|++..... ...+.+.+|+.++++++|||| |
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999864 689999999876432 234578999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC---CCEEEeecccc
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK---LDAKISDFGLS 429 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~---~~~kl~DFG~a 429 (559)
+||+++|+|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||++
T Consensus 107 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp ECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 8999999999988653 25899999999999999999999 7889999999999999865 45999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. .....+...
T Consensus 179 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~----~~i~~~~~~- 248 (362)
T 2bdw_A 179 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LY----AQIKAGAYD- 248 (362)
T ss_dssp BCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHTCCC-
T ss_pred eEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH----HHHHhCCCC-
Confidence 87653322 223459999999999998899999999999999999999999997543211 11 111111100
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .... ......+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~----~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 YP----SPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CC----TTGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CC----cccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000 122356888999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=322.86 Aligned_cols=228 Identities=24% Similarity=0.338 Sum_probs=183.2
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhc-CCCc---------------e
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQL-NHRS---------------L 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l-~h~n---------------i 351 (559)
.++|++.+.||+|+||+||+++.+ +++.+|||++... .....+.+.+|..++..+ +||+ +
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999965 4789999998754 234456789999999987 7887 4
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||+++.
T Consensus 99 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 789999999999997643 4899999999999999999999 78899999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ..... ....
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~-~~~~---- 238 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIM-EHNV---- 238 (353)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-HCCC----
T ss_pred cccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hCCC----
Confidence 433222 22334599999999999998999999999999999999999999975432211 11111 1100
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
.+. ......+.+|+.+||+.||++||++
T Consensus 239 --~~p-------~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 239 --AYP-------KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp --CCC-------TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred --CCC-------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011 1233678889999999999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=320.02 Aligned_cols=249 Identities=19% Similarity=0.205 Sum_probs=182.2
Q ss_pred hCCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCCC-----------ChhhHHHHHHHHHhcCCCce-----
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNTK-----------GIDPILNEVRILCQLNHRSL----- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni----- 351 (559)
.++|++.+.||+|+||.||+|... ++..+|||+....... ....+.+|+.+++.++|+||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999965 5788999998765321 22347788889999999984
Q ss_pred --------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC
Q 047195 352 --------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE 417 (559)
Q Consensus 352 --------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~ 417 (559)
|+||+ +++|.+++.... .+++..++.++.||+.||+||| +++|+||||||+|||++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEcc
Confidence 67888 899999887643 5899999999999999999999 778999999999999998
Q ss_pred CC--CEEEeecccceeccCCCce------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcc
Q 047195 418 KL--DAKISDFGLSRLALNGASH------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE 489 (559)
Q Consensus 418 ~~--~~kl~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~ 489 (559)
++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 77 9999999999876432211 112345999999999999988999999999999999999999999642211
Q ss_pred ccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 490 EDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.. ........... .+...+...... ...+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 267 ~~--~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 267 PV--AVQTAKTNLLD-ELPQSVLKWAPS------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HH--HHHHHHHHHHH-TTTHHHHHHSCT------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred cH--HHHHHHHhhcc-cccHHHHhhccc------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11 11111111100 000000000000 02335788999999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=320.17 Aligned_cols=229 Identities=22% Similarity=0.312 Sum_probs=186.9
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+++|+.++|||| ||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999964 6899999998653 23455778999999999999984 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999997643 4899999999999999999999 7889999999999999999999999999998764
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ... +..+..
T Consensus 193 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~-i~~~~~------ 255 (350)
T 1rdq_E 193 GRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEK-IVSGKV------ 255 (350)
T ss_dssp SCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHHCCC------
T ss_pred CCc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH------HHH-HHcCCC------
Confidence 332 234599999999999998999999999999999999999999975432211 111 111110
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
.+.. .....+.+++.+||+.||++||+ +.||++
T Consensus 256 ~~p~-------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RFPS-------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCT-------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC-------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0111 12366889999999999999998 777764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=314.39 Aligned_cols=244 Identities=20% Similarity=0.216 Sum_probs=182.8
Q ss_pred hCCCCCC-CccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHh-cCCCce---------------EE
Q 047195 292 TNNFSTG-NLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQ-LNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~-~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~-l~h~ni---------------v~ 353 (559)
.+.|++. +.||+|+||+||+|+. .+++.||||++........+.+.+|++++.+ ++|||| |+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3568774 7899999999999984 5789999999987766667789999999999 579984 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC---EEEeecccce
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD---AKISDFGLSR 430 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~---~kl~DFG~a~ 430 (559)
||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++. +||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999999997642 4899999999999999999999 778999999999999998776 9999999987
Q ss_pred eccCCCc------eeeeeccccCCccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHH----
Q 047195 431 LALNGAS------HVTTFAQGTLGYLDPEYYIN-----FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV---- 495 (559)
Q Consensus 431 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~---- 495 (559)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 11123349999999999875 45889999999999999999999999765433211100
Q ss_pred ----HHHHHHhhcchhhhccccccccCCChh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 496 ----VYFGNILKQERLVDAIDPMLKEGASEI-ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 496 ----~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........... .. .... .......+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~i~~~~--------~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQEGK--------YE--FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHHCC--------CC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHhccC--------cc--cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00011111110 00 0000 0113367889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=317.64 Aligned_cols=233 Identities=24% Similarity=0.328 Sum_probs=176.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe----cCCcEEEEEEeecCC----CCChhhHHHHHHHHHhcCCCce------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGN----TKGIDPILNEVRILCQLNHRSL------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~avk~~~~~~----~~~~~~~~~E~~~l~~l~h~ni------------ 351 (559)
.++|++.+.||+|+||.||+++. .+++.+|+|+++... ......+.+|+.+|++++||||
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35799999999999999999986 578999999987542 2334568899999999999994
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
||||+++++|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 789999999999997643 4889999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..... ...
T Consensus 168 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~-~~~-- 237 (327)
T 3a62_A 168 CKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------IDKIL-KCK-- 237 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH-HTC--
T ss_pred ccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-hCC--
Confidence 976433221 22334599999999999988899999999999999999999999975442211 11111 000
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
..+. ......+.+|+.+||+.||++|| ++.|+++
T Consensus 238 ----~~~p-------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ----LNLP-------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----CCCC-------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CCCC-------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0011 12236688899999999999999 6667764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=318.58 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=193.5
Q ss_pred CCCCCCCccccCCccEEEEEEe-----cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce----------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-----DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4688999999999999999983 4688999999987666666789999999999999984
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 121 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 678899999999997642 25899999999999999999999 7889999999999999999999999999998
Q ss_pred eccCCCcee--eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc----
Q 047195 431 LALNGASHV--TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ---- 504 (559)
Q Consensus 431 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 504 (559)
......... .....++..|+|||++.+..++.++||||||+++|||++|..|+...... +......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--------~~~~~~~~~~~ 265 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQG 265 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--------HHHHHCTTCCT
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--------HHHhhccccch
Confidence 775443322 12234778899999998888999999999999999999999987532100 0000000
Q ss_pred ----chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 505 ----ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 505 ----~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..+.+.+..... .......+..+.+++.+||+.||++|||+.||+++|++|
T Consensus 266 ~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGR---LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000011100000 000112346788999999999999999999999999886
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.27 Aligned_cols=243 Identities=23% Similarity=0.276 Sum_probs=182.3
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK---GIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||++... +++.+|+|++...... ..+.+.+|+.++++++|||| |
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999964 6889999998754332 23678999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 79999999999997642 4899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
............||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-----~ 252 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-----P 252 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-----C
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-----C
Confidence 544333333445999999999999888999999999999999999999999744321 0111111100 0
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhC
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-SIKEVADEIERII 559 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~i~ 559 (559)
... ......+..+.+++.+||+.||++|| |+.++++.|+.++
T Consensus 253 -~~~----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 253 -RPS----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp -CGG----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred -Ccc----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 000 00112235688899999999999999 9999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.19 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=194.4
Q ss_pred HHHHHhCCCCCCCccccCCccEEEEEEecC------CcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce-------
Q 047195 287 EITEATNNFSTGNLLGSGGFGEVFKAILDD------ETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL------- 351 (559)
Q Consensus 287 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni------- 351 (559)
+++...++|++.+.||+|+||.||+|.... ...+|+|.+..... ...+.+.+|+.+++++ +||||
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344456789999999999999999998542 24799999876432 2346789999999999 89994
Q ss_pred --------EEeeCCCCcHhHhHhhccCC---------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCee
Q 047195 352 --------FMSMSPNGTLFDRLHRVQSG---------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNIL 414 (559)
Q Consensus 352 --------v~~~~~~g~L~~~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nil 414 (559)
|+||+++|+|.+++...... ....+++..+..++.|++.||+||| +++|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence 78999999999998754210 1235799999999999999999999 788999999999999
Q ss_pred ecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccc
Q 047195 415 LDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDV 492 (559)
Q Consensus 415 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~ 492 (559)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 999999999999999876543322 2233447889999999998899999999999999999998 88898754332211
Q ss_pred cHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 493 NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
....... ...... ......+.+++.+||+.+|++|||+.||++.|+++
T Consensus 277 ------~~~~~~~-----~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 ------YKLVKDG-----YQMAQP-------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ------HHHHHHT-----CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHhcC-----CCCCCC-------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111110 000000 11235688899999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=313.33 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=190.8
Q ss_pred CCCCCCC-ccccCCccEEEEEEec---CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------EE
Q 047195 293 NNFSTGN-LLGSGGFGEVFKAILD---DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------FM 353 (559)
Q Consensus 293 ~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v~ 353 (559)
++|.+.+ .||+|+||.||+|... ++..+|||++..... ...+.+.+|++++++++|||| |+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 3556655 8999999999999853 678899999876532 345679999999999999994 68
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++.... ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 89 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp ECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999986432 35899999999999999999999 7889999999999999999999999999998775
Q ss_pred CCCceee--eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 434 NGASHVT--TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 434 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
....... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. . ........
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----~~i~~~~~--- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M----AFIEQGKR--- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---H----HHHHTTCC---
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---H----HHHhcCCc---
Confidence 4433222 22346889999999988889999999999999999998 9999975443221 1 11111100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..+ +......+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 232 --~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 --MEC-------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp --CCC-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCC-------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001 112336788999999999999999999999999886
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=313.66 Aligned_cols=241 Identities=26% Similarity=0.340 Sum_probs=184.9
Q ss_pred CCCCCCCccccCCccEEEEEEecC----CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce----------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD----ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
.+|++.+.||+|+||+||+|...+ ...+|+|.+..... ...+.+.+|+.++++++||||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 358888999999999999998532 23578888765332 334678999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.
T Consensus 105 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccc
Confidence 689999999999996532 35889999999999999999999 78899999999999999999999999999986
Q ss_pred ccCCCc---eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCC-CCCCCCccccccHHHHHHHHhhcchh
Q 047195 432 ALNGAS---HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK-AVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 432 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++|.. |+......+ ...... ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~----~~~- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLL----QGR- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHH----TTC-
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHh----cCC-
Confidence 543221 11233447889999999998899999999999999999999554 554332221 111111 000
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... ......+.+++.+||+.+|++|||+.|++++|++++
T Consensus 250 ----~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 250 ----RLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp ----CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00000 112356889999999999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=316.58 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=184.4
Q ss_pred HhCCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
..++|.+.+.||+|+||.||+|... .+..+|+|.+..... ...+.+.+|+.++++++||||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3467889999999999999999854 345899999876432 334678999999999999984
Q ss_pred -------EEeeCCCCcHhHhHhhccC-CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 -------FMSMSPNGTLFDRLHRVQS-GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 -------v~~~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
|++|+++++|.+++..... .....+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 5788999999999854321 22346899999999999999999999 889999999999999999999999
Q ss_pred eecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 047195 424 SDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||........ ...
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~---- 261 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDY---- 261 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH----
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH----
Confidence 999999866433221 2233347889999999999899999999999999999999 8888875543221 111
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... ..... ......+.+++.+||+.+|++|||+.+|++.|++++
T Consensus 262 ~~~~~-----~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 LLHGH-----RLKQP-------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HHTTC-----CCCCB-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCC-----CCCCC-------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00110 00011 123367889999999999999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.20 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=179.8
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|.+.+.||+|+||+||+|... +++.||+|++...... ....+.+|++++++++|||| |+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47889999999999999999965 6889999998754332 22356789999999999994 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+. ++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 87 58888887542 25899999999999999999999 788999999999999999999999999999865433
Q ss_pred CceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc-
Q 047195 436 ASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP- 513 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~- 513 (559)
... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+................+......
T Consensus 154 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 TKT-YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred ccc-cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 222 223358999999999876 56899999999999999999999999865543322221111111111111111000
Q ss_pred --------cccc-CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 --------MLKE-GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 --------~l~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... ............+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 000001123356789999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=316.56 Aligned_cols=235 Identities=21% Similarity=0.267 Sum_probs=163.7
Q ss_pred CCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-CCce---------------EEeeCCCCc
Q 047195 298 GNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLN-HRSL---------------FMSMSPNGT 360 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni---------------v~~~~~~g~ 360 (559)
.+.||+|+||+||++... +++.+|||++... ....+.+|+.+++.+. |||| |+||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 6899999998643 3467889999999997 9984 789999999
Q ss_pred HhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC---CEEEeecccceeccCCCc
Q 047195 361 LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL---DAKISDFGLSRLALNGAS 437 (559)
Q Consensus 361 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~---~~kl~DFG~a~~~~~~~~ 437 (559)
|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 93 LFERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999763 25899999999999999999999 78899999999999997665 799999999987654332
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+... .
T Consensus 165 ~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~-- 235 (325)
T 3kn6_A 165 P-LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------F-- 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------C--
T ss_pred c-ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------C--
Confidence 2 233458999999999999899999999999999999999999997654322211111111111111110 0
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...........+.+|+.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 -EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00001123467889999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=318.02 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=198.3
Q ss_pred cChHHHHHHhCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce---
Q 047195 283 FSSREITEATNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL--- 351 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni--- 351 (559)
+...++....++|++.+.||+|+||+||+|.. .+++.+|||++..... ...+.+.+|+.+++++ +||||
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455555667899999999999999999974 3468899999876433 2345789999999999 68884
Q ss_pred -------------EEeeCCCCcHhHhHhhccCCC-----------CCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECC
Q 047195 352 -------------FMSMSPNGTLFDRLHRVQSGN-----------WPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRD 407 (559)
Q Consensus 352 -------------v~~~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~D 407 (559)
|+||+++++|.+++....... ...+++..+..++.|++.||.||| +++|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 679999999999997643210 123788999999999999999999 78899999
Q ss_pred CCCCCeeecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 047195 408 IKSSNILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDF 485 (559)
Q Consensus 408 ikp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~ 485 (559)
|||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876543322 2233458899999999999899999999999999999998 9999875
Q ss_pred CCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 486 NREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
...... .......... .... ......+.+++.+||+.||++|||+.||++.|+.++
T Consensus 254 ~~~~~~------~~~~~~~~~~-----~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDEE------FCRRLKEGTR-----MRAP-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSHH------HHHHHHHTCC-----CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHH------HHHHhccCcc-----CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 443221 1111111100 0011 112356888999999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.84 Aligned_cols=240 Identities=27% Similarity=0.407 Sum_probs=182.9
Q ss_pred CCCCCCCccccCCccEEEEEEecC-----CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-----ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++|++.+.||+|+||.||+|.... +..||||.+..... .....+.+|+.++++++||||
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778999999999999998543 24699999875432 234568999999999999994
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+++++|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 124 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 789999999999997532 35899999999999999999999 77899999999999999999999999999987
Q ss_pred ccCCCcee--eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 432 ALNGASHV--TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 432 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
........ .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .. .......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~----~~~~~~~-- 267 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VM----KAINDGF-- 267 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----HHHHTTC--
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHHCCC--
Confidence 65432211 122336788999999988899999999999999999999 999986443221 11 1111110
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.... .......+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 268 ---~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 268 ---RLPT-------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ---CCCC-------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---cCCC-------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000 112336788999999999999999999999999876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=307.16 Aligned_cols=237 Identities=19% Similarity=0.230 Sum_probs=188.0
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL-----------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni-----------------v 352 (559)
.++|++.+.||+|+||.||+|+.+ +..+|||++..... ...+.+.+|+.++++++|||| |
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357899999999999999999875 78899999876532 334579999999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC--eEECCCCCCCeeecCCCCEEEeecccce
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP--IYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
+||+++|+|.+++..... ..+++..+..++.|++.||+||| +++ |+||||||+|||++.++.++|.|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 799999999999976332 35899999999999999999999 777 9999999999999999999999998875
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCc---ccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTD---KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
..... ...||+.|+|||++.+..++. ++||||||+++|||++|+.||........ ........
T Consensus 162 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-- 227 (271)
T 3kmu_A 162 SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEG-- 227 (271)
T ss_dssp TTSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSC--
T ss_pred eeccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcC--
Confidence 43222 224899999999998765444 79999999999999999999975432211 11111111
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..+.+. ......+.+++.+||+.||++|||+.|+++.|++|.
T Consensus 228 ---~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 ---LRPTIP-------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ---CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111111 122367889999999999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.69 Aligned_cols=239 Identities=25% Similarity=0.330 Sum_probs=177.3
Q ss_pred CCCCCCccccCCccEEEEEEec--CC--cEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce----------------E
Q 047195 294 NFSTGNLLGSGGFGEVFKAILD--DE--TITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL----------------F 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~--~~--~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni----------------v 352 (559)
.|++.+.||+|+||+||+|... ++ ..+|+|.+.... ....+.+.+|+.++++++|||| |
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999853 22 467899876533 2345679999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..
T Consensus 170 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 79999999999996532 35789999999999999999999 788999999999999999999999999999865
Q ss_pred cCCCce---eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 433 LNGASH---VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 433 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ ...... ....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~----~~~~- 314 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLL----QGRR- 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHH----TTCC-
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHH----cCCC-
Confidence 432211 1223347889999999999899999999999999999999 566665443222 111111 1100
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. ... ......+.+++.+||+.+|++|||+.||++.|+++
T Consensus 315 -~---~~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 -L---LQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp -C---CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C---CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 000 11235688999999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=318.59 Aligned_cols=235 Identities=24% Similarity=0.333 Sum_probs=177.8
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCC--Cce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNH--RSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h--~ni---------------v 352 (559)
.++|++.+.||+|+||.||++...+++.||||++..... ...+.+.+|+.+|++++| +|| |
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 456999999999999999999988899999999876533 234678999999999987 764 5
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|| ..+++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred Ee-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 67 5678999999763 25899999999999999999999 78899999999999997 578999999999876
Q ss_pred cCCCce-eeeeccccCCccCcccccc-----------CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 047195 433 LNGASH-VTTFAQGTLGYLDPEYYIN-----------FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN 500 (559)
Q Consensus 433 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 500 (559)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~ 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHH
Confidence 543322 2234469999999999865 56888999999999999999999999643221 111111
Q ss_pred HhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 501 ILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 501 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+++........ .....+.+|+.+||+.||++|||+.|+++
T Consensus 233 ---------~~~~~~~~~~~~---~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 233 ---------IIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ---------HHCTTSCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------HhcCCcccCCcc---cCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 111111111111 11256788999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=312.19 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=181.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ...+.+.+|+.++++++|+|| |
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999985 5789999999875432 334568999999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++...... ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 8999999999998753321 235899999999999999999999 788999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
...... .....|++.|+|||++.+..++.++||||||+++|||++|+.||...... ...... ........
T Consensus 187 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~~---- 256 (310)
T 2wqm_A 187 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEQCDYP---- 256 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHH-HHHTTCSC----
T ss_pred cCCCcc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHH-HhhcccCC----
Confidence 433221 22335899999999999888999999999999999999999999644321 111111 11111110
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+... ......+.+++.+||+.||++|||+.+|++.|++|
T Consensus 257 ~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 257 PLPS-------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CCCT-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcc-------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000 12235788999999999999999999999999886
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.86 Aligned_cols=235 Identities=24% Similarity=0.320 Sum_probs=183.4
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce----------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL----------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni----------------v~~~ 355 (559)
.++|++.+.||+|+||+||++..+ ++.+|||.+.... ..+.+.+|++++++++|||| |+||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 457899999999999999999864 7899999987533 45779999999999999984 6788
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999876432 23788999999999999999999 788999999999999999999999999998755432
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
. ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. . ...... ....
T Consensus 171 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~----~~~~~~-----~~~~ 234 (278)
T 1byg_A 171 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PRVEKG-----YKMD 234 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H----HHHTTT-----CCCC
T ss_pred c----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHhcC-----CCCC
Confidence 1 12347899999999988899999999999999999998 9999875432211 1 011111 0011
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.. ......+.+++.+||+.||++|||+.|+++.|+.|
T Consensus 235 ~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 235 AP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc-------ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11 12236788999999999999999999999999876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.82 Aligned_cols=236 Identities=22% Similarity=0.302 Sum_probs=188.2
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
..++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++|||| |+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3457999999999999999999965 467899999987766777889999999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee---cCCCCEEEeeccccee
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRL 431 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill---~~~~~~kl~DFG~a~~ 431 (559)
|+++++|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +.++.+||+|||++..
T Consensus 87 ~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 87 LCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp CCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 999999999887643 4899999999999999999999 7889999999999999 7889999999999987
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
...... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+. . . ........
T Consensus 159 ~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~---~-~~~~~~~~--- 225 (277)
T 3f3z_A 159 FKPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV---M---L-KIREGTFT--- 225 (277)
T ss_dssp CCTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---H-HHHHCCCC---
T ss_pred ccCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH---H---H-HHHhCCCC---
Confidence 654332 223459999999999865 489999999999999999999999975432211 0 0 01111000
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... ........+.+++.+||+.||++|||+.++++
T Consensus 226 --~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 --FPEK----DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCch----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00022367889999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=321.15 Aligned_cols=249 Identities=25% Similarity=0.296 Sum_probs=186.3
Q ss_pred HHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC-----CCCChhhHHHHHHHHHhcCCCce--------
Q 047195 286 REITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG-----NTKGIDPILNEVRILCQLNHRSL-------- 351 (559)
Q Consensus 286 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni-------- 351 (559)
.++....++|++.+.||+|+||.||+|.. .++..+|+|++... .....+.+.+|++++++++||||
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 34456677899999999999999999986 56789999998653 33445779999999999999994
Q ss_pred -------EEeeCCCCcHhHhHhhccCCC-----------------------------------CCCCChHHHHHHHHHHH
Q 047195 352 -------FMSMSPNGTLFDRLHRVQSGN-----------------------------------WPPLKWHHRLHIARQTA 389 (559)
Q Consensus 352 -------v~~~~~~g~L~~~l~~~~~~~-----------------------------------~~~l~~~~~~~i~~~i~ 389 (559)
|+||+++|+|.+++....... ...+++..+..++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 789999999999885311100 11235677888999999
Q ss_pred HHHHHHHHcCCCCeEECCCCCCCeeecCCC--CEEEeecccceeccCCCc---eeeeeccccCCccCcccccc--CCCCc
Q 047195 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKL--DAKISDFGLSRLALNGAS---HVTTFAQGTLGYLDPEYYIN--FQLTD 462 (559)
Q Consensus 390 ~~l~yLH~~~~~~iiH~Dikp~Nill~~~~--~~kl~DFG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~ 462 (559)
.||+||| +++|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.
T Consensus 179 ~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999 77899999999999998776 899999999987643221 12234459999999999875 57889
Q ss_pred ccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCC
Q 047195 463 KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERR 542 (559)
Q Consensus 463 ~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p 542 (559)
++||||||+++|||++|+.||......+. .......... ...+. .......+.+|+.+||+.+|
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~--~~~~~--------~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLC--FENPN--------YNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC--TTSGG--------GGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccc--cCCcc--------cccCCHHHHHHHHHHcCCCh
Confidence 99999999999999999999975543221 1111111100 00000 01123678899999999999
Q ss_pred CCCCCHHHHHH
Q 047195 543 QNRPSIKEVAD 553 (559)
Q Consensus 543 ~~RPt~~evl~ 553 (559)
++|||+.|+++
T Consensus 320 ~~Rps~~~~l~ 330 (345)
T 3hko_A 320 DERFDAMRALQ 330 (345)
T ss_dssp TTSCCHHHHHH
T ss_pred hHCCCHHHHhc
Confidence 99999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.68 Aligned_cols=233 Identities=26% Similarity=0.332 Sum_probs=177.7
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||++.. .+++.||||++... .......+.+|+.+++.++|||| |
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999985 56899999998753 33445678899999999999984 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCC-CCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT-PPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|||+++|+|.+++.... .+++..+..++.||+.||+||| + ++|+||||||+|||++.++.+||+|||+++.
T Consensus 227 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 89999999999987643 4899999999999999999999 5 7899999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..... ...
T Consensus 299 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~-~~~----- 365 (446)
T 4ejn_A 299 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELIL-MEE----- 365 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-HCC-----
T ss_pred ccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHH-hCC-----
Confidence 443222 22335699999999999999999999999999999999999999975432211 11111 000
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
..+.. .....+.+|+.+||+.||++|| |+.|+++
T Consensus 366 -~~~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 -IRFPR-------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCCT-------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCc-------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00111 1235688899999999999999 9999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.55 Aligned_cols=231 Identities=27% Similarity=0.316 Sum_probs=179.5
Q ss_pred CCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCCCCcH
Q 047195 298 GNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSPNGTL 361 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~~g~L 361 (559)
.+.||+|+||.||+|.. .+++.+|+|++........+.+.+|+++|++++|||| |+||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999985 5689999999987665556789999999999999994 7899999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee--cCCCCEEEeecccceeccCCCcee
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL--DEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill--~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
.+.+.... ..+++..+..++.||+.||+||| +++|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99886532 24899999999999999999999 7889999999999999 5678899999999987654332
Q ss_pred eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCC
Q 047195 440 TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGA 519 (559)
Q Consensus 440 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 519 (559)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..... ... . .... ..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~-~~~-~-~~~~---~~ 312 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL------NNILA-CRW-D-LEDE---EF 312 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHH-TCC-C-SCSG---GG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-ccC-C-CChh---hh
Confidence 22335999999999998888999999999999999999999999755432211 11110 000 0 0000 00
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 520 SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 520 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
......+.+|+.+||+.||++|||+.|+++
T Consensus 313 ----~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 ----QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122367889999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=313.81 Aligned_cols=241 Identities=26% Similarity=0.334 Sum_probs=188.8
Q ss_pred hCCCCCCC-ccccCCccEEEEEEe---cCCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce--------------
Q 047195 292 TNNFSTGN-LLGSGGFGEVFKAIL---DDETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 292 ~~~y~~~~-~lG~G~~g~Vy~~~~---~~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
.++|.+.+ .||+|+||.||+|.. ..++.+|||++...... ..+.+.+|++++++++||||
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l 94 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML 94 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence 35677777 999999999999964 34688999998764332 24679999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+++++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 95 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 78999999999999763 24899999999999999999999 78899999999999999999999999999987
Q ss_pred ccCCCceee--eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 432 ALNGASHVT--TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 432 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
......... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ . .........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKGER- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTCC-
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHHcCCC-
Confidence 654433222 22346789999999988889999999999999999999 999997543221 1 111111100
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
+.. +......+.+++.+||+.||++|||+.+|++.|++++
T Consensus 239 ----~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 ----MGC-------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ----CCC-------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001 1123367889999999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=326.08 Aligned_cols=239 Identities=25% Similarity=0.271 Sum_probs=178.7
Q ss_pred HHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--------CCChhhHHHHHHHHHhcCCCce---------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--------TKGIDPILNEVRILCQLNHRSL--------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni--------- 351 (559)
...++|.+.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+.+|++++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4467899999999999999999985 457899999986532 1223468999999999999994
Q ss_pred -----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC---CCEEE
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK---LDAKI 423 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~---~~~kl 423 (559)
||||+++|+|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.+ ..+||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEE
Confidence 68999999999888643 35899999999999999999999 7789999999999999754 45999
Q ss_pred eecccceeccCCCceeeeeccccCCccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 047195 424 SDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN---FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN 500 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 500 (559)
+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~- 358 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT- 358 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHH-
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHh-
Confidence 999999876432 22233459999999999864 5678899999999999999999999975443222 111111
Q ss_pred HhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 501 ILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 501 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... . .+.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 359 ---~~~~~-~-~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 ---SGKYN-F-IPEV-------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---TTCCC-C-CHHH-------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---cCCCC-C-Cchh-------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11000 0 0000 0123367889999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=315.18 Aligned_cols=230 Identities=23% Similarity=0.273 Sum_probs=176.5
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhc-CCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQL-NHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l-~h~ni---------------v 352 (559)
.++|++.++||+|+||+||+|+.. +++.||||++..... .....+..|+..+.++ +|+|| |
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999965 789999998765432 2233456666666665 89984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+ +++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 7888 678988887643 25899999999999999999999 778999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.... ......||+.|+|||++.+ .++.++||||||+++|||++|..++..... ...+.... ..
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~----~~ 270 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGY----LP 270 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTC----CC
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccC----CC
Confidence 4322 2233459999999999876 789999999999999999999877642210 01111111 11
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+. ......+.+++.+||+.||++|||+.|+++
T Consensus 271 ~~~~-------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 PEFT-------AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHH-------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccc-------cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 123367889999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.26 Aligned_cols=256 Identities=18% Similarity=0.210 Sum_probs=186.9
Q ss_pred hCCCCCCCccccC--CccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------
Q 047195 292 TNNFSTGNLLGSG--GFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G--~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
.++|++.+.||+| +||+||+++.. +++.||||++..... ...+.+.+|+.++++++||||
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4579999999999 99999999965 689999999876432 234568889999999999994
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+++++|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 104 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 6899999999999976432 34899999999999999999999 78899999999999999999999999999875
Q ss_pred ccCCCce------eeeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH-HHH-H
Q 047195 432 ALNGASH------VTTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY-FGN-I 501 (559)
Q Consensus 432 ~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~-~ 501 (559)
....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 4322111 1122358999999999987 5789999999999999999999999976543322110000 000 0
Q ss_pred hh------------------cchhhhccccccc------cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LK------------------QERLVDAIDPMLK------EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~------------------~~~~~~~~d~~l~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ...+...+..... .............+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 0000000000000 0000011223466889999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=330.40 Aligned_cols=179 Identities=26% Similarity=0.383 Sum_probs=137.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++++|+||
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999985 4689999999865322 234678999999999999995
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
|+||+ +++|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 44554 56788877642 35899999999999999999999 77899999999999999999999999999
Q ss_pred ceeccCCCc--------------------------eeeeeccccCCccCcccc-ccCCCCcccchhHHHHHHHHHHhC
Q 047195 429 SRLALNGAS--------------------------HVTTFAQGTLGYLDPEYY-INFQLTDKSDVYSFGVVLVELLTS 479 (559)
Q Consensus 429 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~il~el~tg 479 (559)
++....... ...+...||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 987642211 112334589999999986 456799999999999999999993
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=311.09 Aligned_cols=241 Identities=25% Similarity=0.365 Sum_probs=185.9
Q ss_pred CCCCCCccccCCccEEEEEEecC-C---cEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce----------------E
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDD-E---TITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL----------------F 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~-~---~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni----------------v 352 (559)
.|.+.+.||+|+||+||+|...+ + ..+|+|.+..... ...+.+.+|+.++++++|||| |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998532 2 3789998865433 334678999999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++|+.+++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..
T Consensus 102 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp ECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 78889999999997532 35889999999999999999999 788999999999999999999999999999765
Q ss_pred cCCCc---eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 433 LNGAS---HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 433 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+........ ...... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~----~~~--- 245 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFLA----QGR--- 245 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHHH----TTC---
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHhh----cCC---
Confidence 43211 112234588999999999998999999999999999999997666543322211 111111 100
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... ......+.+++.+||+.+|++|||+.+++++|++++
T Consensus 246 --~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 246 --RLPQP-------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp --CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCC-------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 112357889999999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.50 Aligned_cols=246 Identities=20% Similarity=0.275 Sum_probs=189.7
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
.++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999996 6789999999877666666789999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+++++|.+++...... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 67899999999999864322 246899999999999999999999 77899999999999999999999999999876
Q ss_pred ccCCCce--------eeeeccccCCccCccccccCC---CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 047195 432 ALNGASH--------VTTFAQGTLGYLDPEYYINFQ---LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN 500 (559)
Q Consensus 432 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 500 (559)
....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ .......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~- 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQ- 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHH-
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhh-
Confidence 4321100 001223799999999987543 68899999999999999999999853211110 0100000
Q ss_pred HhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 501 ILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 501 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. . ..... .......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 262 ---~-~--------~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 262 ---N-Q--------LSIPQ---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp ---C-C----------CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ---c-c--------CCCCc---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 0 0 00000 012236788999999999999999999999999876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.92 Aligned_cols=234 Identities=24% Similarity=0.328 Sum_probs=178.4
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCC--Cce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNH--RSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h--~ni---------------v~ 353 (559)
.+|++.+.||+|+||+||++...+++.||||++..... ...+.+.+|+.+|++++| +|| ||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45999999999999999999988899999999876432 334678999999999974 774 56
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
| ..+++|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 7 56789999987642 4888899999999999999999 88999999999999996 5789999999998765
Q ss_pred CCCce-eeeeccccCCccCcccccc-----------CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 434 NGASH-VTTFAQGTLGYLDPEYYIN-----------FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 434 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~-- 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH-- 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHH--
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHH--
Confidence 43322 2234469999999999865 368889999999999999999999996432211 1111
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.++++........ .....+.+|+.+||+.||++|||+.||++
T Consensus 279 -------~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 279 -------AIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -------HHHCTTSCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------HHhCccccCCCCc---cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1111111111111 11256788999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=342.23 Aligned_cols=233 Identities=24% Similarity=0.354 Sum_probs=183.7
Q ss_pred ccccCCccEEEEEEec---CCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce--------------EEeeCCCCcH
Q 047195 300 LLGSGGFGEVFKAILD---DETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL--------------FMSMSPNGTL 361 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~~~---~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~~g~L 361 (559)
.||+|+||.||+|.++ ++..||||+++... ....+++.+|+++|++++|||| ||||+++|+|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 7999999999999864 45779999987653 3456789999999999999994 7899999999
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee--
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV-- 439 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-- 439 (559)
.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.........
T Consensus 423 ~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 423 HKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99986532 35899999999999999999999 7889999999999999999999999999998764332221
Q ss_pred eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccC
Q 047195 440 TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518 (559)
Q Consensus 440 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 518 (559)
.....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. . .....+... ..
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~----~~i~~~~~~-----~~--- 560 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M----AFIEQGKRM-----EC--- 560 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---H----HHHHTTCCC-----CC---
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHcCCCC-----CC---
Confidence 122336789999999998899999999999999999998 9999976543221 1 111111100 00
Q ss_pred CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 519 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+......+.+|+.+||+.+|++|||+.+|+++|+.+
T Consensus 561 ----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 561 ----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112346788999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=305.80 Aligned_cols=232 Identities=29% Similarity=0.425 Sum_probs=188.1
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce------------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
..++|++.+.||+|+||.||+|... +++.+|+|.+.... +.+.+|++++++++||||
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457899999999999999999975 78999999987543 467899999999999985
Q ss_pred -------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC
Q 047195 352 -------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418 (559)
Q Consensus 352 -------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~ 418 (559)
|+||+++++|.+++..... ..+++..+..++.|++.||.||| +++|+||||||+|||++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence 3577889999999976432 35899999999999999999999 7889999999999999999
Q ss_pred CCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 047195 419 LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF 498 (559)
Q Consensus 419 ~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~ 498 (559)
+.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+... .. .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~-~ 227 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK-F 227 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH-H
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH-H
Confidence 9999999999987654322 22335899999999999888999999999999999999999886311 00 0
Q ss_pred HHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 499 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
...... ..+.. .....+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 228 ~~~~~~--------~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 FTDLRD--------GIISD-------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHHT--------TCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhc--------ccccc-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 11111 1125578899999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=320.23 Aligned_cols=261 Identities=21% Similarity=0.243 Sum_probs=186.9
Q ss_pred cChHHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCC-----------hhhHHHHHHHHHhcCCCce
Q 047195 283 FSSREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKG-----------IDPILNEVRILCQLNHRSL 351 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~-----------~~~~~~E~~~l~~l~h~ni 351 (559)
....++....++|++.+.||+|+||.||+|...++..||||++....... .+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34567778889999999999999999999998889999999986533221 2678999999999999984
Q ss_pred --------------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCC
Q 047195 352 --------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSS 411 (559)
Q Consensus 352 --------------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~ 411 (559)
|+||+. |+|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 163 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPG 163 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChH
Confidence 567776 68888776432 35899999999999999999999 778999999999
Q ss_pred CeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccc
Q 047195 412 NILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490 (559)
Q Consensus 412 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~ 490 (559)
|||++.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp GEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HEEEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999975443222 233458999999999877 678999999999999999999999997654332
Q ss_pred cccHHHHHHHH--------hhcchhhhcccccccc----CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 491 DVNLVVYFGNI--------LKQERLVDAIDPMLKE----GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 491 ~~~~~~~~~~~--------~~~~~~~~~~d~~l~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........... +......+.+...+.. ............+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 22111110000 0001111111111110 000111122356889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.46 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=180.1
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++|++++||||
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999996 5689999999865332 224568899999999999985
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
|+||+ +++|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 55676 7788888865 24889999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH------
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN------ 500 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~------ 500 (559)
+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+..........
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99875432 223458999999999887 6799999999999999999999999986554332211111000
Q ss_pred --Hhhcchhhhc---cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 501 --ILKQERLVDA---IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 501 --~~~~~~~~~~---~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+........ +..................+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 0000001111111123467889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=312.79 Aligned_cols=238 Identities=25% Similarity=0.339 Sum_probs=180.1
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCC---hhhHHHHHHHHHhcCCCce----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKG---IDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
.++|++.+.||+|+||.||+++. .+++.||||++....... ...+.+|++++++++||||
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999995 678999999987653332 3468899999999999984
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
||||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 678999999999997642 4899999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCce--eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 429 SRLALNGASH--VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 429 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~ 236 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCC
Confidence 9876543222 12234589999999999998999999999999999999999999975443211 111111110
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. .+... .......+.+++.+||+.||++||++.++++
T Consensus 237 ~----~~~~~------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 237 I----PPSAR------HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp C----CHHHH------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred C----Ccccc------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 00000 0113367889999999999999997766553
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=316.51 Aligned_cols=243 Identities=28% Similarity=0.413 Sum_probs=186.3
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcE--EEEEEeecC-CCCChhhHHHHHHHHHhc-CCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETI--TAVKRAKLG-NTKGIDPILNEVRILCQL-NHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~--~avk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni---------------v 352 (559)
++|++.+.||+|+||.||+|+.. ++.. +|+|.+... .....+.+.+|+++++++ +|||| |
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999854 4554 488888653 334456799999999999 89984 6
Q ss_pred EeeCCCCcHhHhHhhcc-----------CCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCE
Q 047195 353 MSMSPNGTLFDRLHRVQ-----------SGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~ 421 (559)
+||+++++|.+++.... ......+++..++.++.|++.||+||| +++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 89999999999987542 012246899999999999999999999 7889999999999999999999
Q ss_pred EEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 047195 422 KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGN 500 (559)
Q Consensus 422 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 500 (559)
||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .. .
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~-~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-E 252 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH-H
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HH-H
Confidence 999999987432211 1122347889999999988889999999999999999998 999997543221 11 1
Q ss_pred HhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 501 ILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 501 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... ..... .......+.+|+.+||+.+|++|||+.|+++.|++++
T Consensus 253 ~~~~~-----~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 253 KLPQG-----YRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HGGGT-----CCCCC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcC-----CCCCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111 00000 1122367889999999999999999999999998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=319.63 Aligned_cols=237 Identities=23% Similarity=0.290 Sum_probs=172.6
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++|||| |+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34567999999999999999999965 57899999987543 33568899999999999994 68
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEeecccce
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKISDFGLSR 430 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~DFG~a~ 430 (559)
||+++++|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+||+|||+++
T Consensus 128 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 128 ELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp CCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999988653 24899999999999999999999 778999999999999975 8899999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ . ... ...... ..
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~~-i~~~~~-~~ 270 (349)
T 2w4o_A 200 IVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---FRR-ILNCEY-YF 270 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---HHH-HHTTCC-CC
T ss_pred ccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---HHH-HHhCCC-cc
Confidence 654322 22334589999999999998999999999999999999999999965432211 1 111 111100 00
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+ .. ......+.+|+.+||+.||++|||+.|+++
T Consensus 271 ~~~----~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ISP----WW----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTT----TT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc----hh----hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 123367889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.65 Aligned_cols=236 Identities=26% Similarity=0.310 Sum_probs=187.7
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC------ChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK------GIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|+||.||+++.. +++.+|+|.+...... ..+.+.+|+.++++++||||
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456899999999999999999964 6889999998765332 24679999999999999994
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC----CEEEee
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL----DAKISD 425 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~----~~kl~D 425 (559)
|+||+++++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++ .+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 68999999999999753 25899999999999999999999 78899999999999999887 799999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ... ....
T Consensus 163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-i~~~ 233 (321)
T 2a2a_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LAN-ITSV 233 (321)
T ss_dssp CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHH-HHTT
T ss_pred CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------HHH-HHhc
Confidence 999987654322 2234599999999999988999999999999999999999999975432211 110 0000
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ..++.+. ......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~--~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SY--DFDEEFF-------SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC--CCCHHHH-------TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc--ccChhhh-------cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0011111 122356888999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=322.90 Aligned_cols=235 Identities=29% Similarity=0.369 Sum_probs=177.6
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHH-HHhcCCCce---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRI-LCQLNHRSL--------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~-l~~l~h~ni--------------- 351 (559)
.++|++.+.||+|+||+||+++.+ +++.+|||++.... ......+.+|..+ ++.++||||
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999965 57899999987643 2334567778877 577899984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 789999999999997643 4889999999999999999999 78899999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ...... ..+
T Consensus 189 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~-~~~---- 256 (373)
T 2r5t_A 189 NIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILN-KPL---- 256 (373)
T ss_dssp GBCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH------HHHHHH-SCC----
T ss_pred cccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHh-ccc----
Confidence 443222 22334599999999999999999999999999999999999999975432211 111111 100
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
.+.. .....+.+|+.+||+.||++||++.+.++.+
T Consensus 257 --~~~~-------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 --QLKP-------NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp --CCCS-------SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred --CCCC-------CCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 0111 1235678899999999999999996544443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.86 Aligned_cols=252 Identities=23% Similarity=0.237 Sum_probs=179.9
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC-----ChhhHHHHHHHHHhcCCCce------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK-----GIDPILNEVRILCQLNHRSL------------ 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~-----~~~~~~~E~~~l~~l~h~ni------------ 351 (559)
...++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34568999999999999999999964 5899999998753321 13568899999999999995
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
|+||+++ +|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 6788875 7877775432 35888999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc--
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE-- 505 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 505 (559)
++....... ......||+.|+|||++.+. .++.++||||||+++|||++|..||......+.. ..........
T Consensus 159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~~ 234 (346)
T 1ua2_A 159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTE 234 (346)
T ss_dssp GSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCT
T ss_pred ceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCCh
Confidence 987643322 22334589999999998764 5889999999999999999999998765432221 1111111110
Q ss_pred -hhhh---ccccccccCCChh-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 -RLVD---AIDPMLKEGASEI-----ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 -~~~~---~~d~~l~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.. ..+.......... .......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0000000000000 0122367899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.92 Aligned_cols=253 Identities=21% Similarity=0.248 Sum_probs=184.9
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+|++++++++||||
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999996 5789999999865433 234578899999999999984
Q ss_pred -----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
|+||+. ++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 567766 46666665432 25899999999999999999999 788999999999999999999999999
Q ss_pred ccceeccCCC---ceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 047195 427 GLSRLALNGA---SHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502 (559)
Q Consensus 427 G~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 502 (559)
|+++...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...................
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998765221 122233458999999999876 458999999999999999999999998655433222221111111
Q ss_pred hcchhhhccccc-------cccCCChhh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 503 KQERLVDAIDPM-------LKEGASEIE-----LDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 503 ~~~~~~~~~d~~-------l~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+...-+.. ......... ......+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111000000000 000000000 011345789999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=316.85 Aligned_cols=227 Identities=26% Similarity=0.359 Sum_probs=184.3
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--------CChhhHHHHHHHHHhcCCCce----------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--------KGIDPILNEVRILCQLNHRSL---------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni---------- 351 (559)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456799999999999999999984 5688999999876532 134568899999999999994
Q ss_pred -----EEeeCCCC-cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 352 -----FMSMSPNG-TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 352 -----v~~~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
|+||+..| +|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEee
Confidence 67877666 998888753 24899999999999999999999 78899999999999999999999999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
||+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 174 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 174 FGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp CTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred cccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 999987654332 223459999999999988776 78999999999999999999999632110
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+.. +......+.+|+.+||+.||++|||+.++++
T Consensus 237 ------~~~~~~~-----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 ------VEAAIHP-----PYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ------TTTCCCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------HhhccCC-----CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0112356889999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.12 Aligned_cols=231 Identities=25% Similarity=0.338 Sum_probs=186.9
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++|||| |+
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999965 78999999986532 2345678999999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 96 E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999998642 25899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ... ...+..
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~-i~~~~~----- 233 (476)
T 2y94_A 168 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL------FKK-ICDGIF----- 233 (476)
T ss_dssp TTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH------HHH-HHTTCC-----
T ss_pred cccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH------HHH-HhcCCc-----
Confidence 4322 233459999999999988765 6899999999999999999999975432211 111 111100
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ......+.+|+.+||+.||++|||+.|+++
T Consensus 234 -~~p-------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -YTP-------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCC-------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 000 112256788999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.20 Aligned_cols=238 Identities=25% Similarity=0.321 Sum_probs=186.0
Q ss_pred CCCCCCCccccCCccEEEEEEe----cCCcEEEEEEeecCC----CCChhhHHHHHHHHHhc-CCCc-------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGN----TKGIDPILNEVRILCQL-NHRS------------- 350 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~avk~~~~~~----~~~~~~~~~E~~~l~~l-~h~n------------- 350 (559)
++|++.+.||+|+||.||+++. .+++.+|||+++... ....+.+.+|+++++++ +|+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999986 478999999986532 23446688999999999 6888
Q ss_pred --eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 351 --iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
|||||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 4789999999999997642 4899999999999999999999 77899999999999999999999999999
Q ss_pred ceeccCCCceeeeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
++..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... .........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~-- 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS-- 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC--
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhcc--
Confidence 98765433333334569999999999885 357889999999999999999999997554332211 111111110
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVADE 554 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~ 554 (559)
.+.+. ......+.+|+.+||+.||++|| |+.|+++.
T Consensus 282 -----~~~~~-------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 -----EPPYP-------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -----CCCCC-------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCCC-------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 01111 12235678899999999999999 89998763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=342.43 Aligned_cols=233 Identities=27% Similarity=0.340 Sum_probs=183.5
Q ss_pred CccccCCccEEEEEEe---cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce--------------EEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAIL---DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL--------------FMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~---~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~~g 359 (559)
+.||+|+||.||+|.+ +.++.||||+++.... ...+++.+|+++|++++|||| ||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 4799999999999964 3457899999876433 335789999999999999994 78999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce-
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH- 438 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~- 438 (559)
+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 455 ~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 455 PLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999753 24899999999999999999999 788999999999999999999999999999876543321
Q ss_pred -eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 439 -VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 439 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ......+.. ...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~-----~~~- 593 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGER-----MGC- 593 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC-----CCC-
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC-----CCC-
Confidence 2223347889999999999899999999999999999998 9999975543221 111111110 000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+...+..+.+|+.+||+.||++|||+.+|+++|+++
T Consensus 594 ------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112346788999999999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=334.61 Aligned_cols=238 Identities=26% Similarity=0.339 Sum_probs=189.5
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||+++.. +++.+|+|++... .......+.+|+++|++++|||| |
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 357999999999999999999964 6899999998653 23445678999999999999984 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++|+|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 899999999999876432 34899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||............ ....... .
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~------~ 405 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEV------P 405 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHC------C
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhcc------c
Confidence 54332 23346999999999999888999999999999999999999999765432211111 1111110 0
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
..+. ......+.+|+.+||+.||++|| ++.||++
T Consensus 406 ~~~p-------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 EEYS-------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCC-------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCC-------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0111 12236788899999999999999 6777764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=316.58 Aligned_cols=254 Identities=22% Similarity=0.259 Sum_probs=178.0
Q ss_pred HHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce---------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
...++|++.+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|++++++++||||
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456899999999999999999984 57899999998754332 24567899999999999994
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec-----CCCCEEEeec
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD-----EKLDAKISDF 426 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~-----~~~~~kl~DF 426 (559)
|+||++ ++|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++ +++.+||+||
T Consensus 111 v~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 678887 59998887642 4899999999999999999999 78899999999999994 5556999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
|+++........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+...............
T Consensus 182 g~a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 182 GLARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 999866433222 2233489999999999874 48999999999999999999999997654332211111110000000
Q ss_pred hhh------hccc--cccccCC--ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLV------DAID--PMLKEGA--SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~------~~~d--~~l~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+. .... +...... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0000 0000000 0000113367789999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.43 Aligned_cols=234 Identities=28% Similarity=0.380 Sum_probs=167.2
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||+|+. .+++.+|+|.+.... ....+.+.+|+.++++++|||| |
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999986 578999999986532 2334679999999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 79999999999987532 35899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..... +
T Consensus 163 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~------~ 228 (278)
T 3cok_A 163 KMPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------KVVLA------D 228 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS------C
T ss_pred cCCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------HHhhc------c
Confidence 432221 123458999999999988889999999999999999999999997544322110 00000 0
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+. ......+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 YEMP-------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCC-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCc-------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0011 112356788999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.03 Aligned_cols=229 Identities=15% Similarity=0.164 Sum_probs=175.7
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHH---HHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEV---RILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~---~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+ ++|++++||||
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788899999999999999995 56899999998743 333456789999 55555679874
Q ss_pred --------------------------EEeeCCCCcHhHhHhhccCCC--CCCCChHHHHHHHHHHHHHHHHHHHcCCCCe
Q 047195 352 --------------------------FMSMSPNGTLFDRLHRVQSGN--WPPLKWHHRLHIARQTAQAIAYLHLLATPPI 403 (559)
Q Consensus 352 --------------------------v~~~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 403 (559)
||||+ +|+|.+++....... ...+++..+..++.||+.||+||| +++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 45666 689999998643211 122445888899999999999999 7889
Q ss_pred EECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCccccccC-----------CCCcccchhHHHHH
Q 047195 404 YHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-----------QLTDKSDVYSFGVV 472 (559)
Q Consensus 404 iH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~i 472 (559)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986322 2233457 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047195 473 LVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVA 552 (559)
Q Consensus 473 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl 552 (559)
+|||++|+.||........... +. . ... .....+.+|+.+||+.||++|||+.|++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~---------------~~----~-~~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEW---------------IF----R-SCK----NIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHHSSCCC------CCSGG---------------GG----S-SCC----CCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHHCCCCCcccccccchhh---------------hh----h-hcc----CCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 9999999999965432221100 00 0 001 1235688899999999999999999998
Q ss_pred H
Q 047195 553 D 553 (559)
Q Consensus 553 ~ 553 (559)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.48 Aligned_cols=229 Identities=24% Similarity=0.334 Sum_probs=184.7
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhc-CCCc---------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQL-NHRS--------------- 350 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l-~h~n--------------- 350 (559)
..++|++.+.||+|+||+||+|+.+ +++.||||+++.. .....+.+.+|..+|..+ +|++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999954 5788999998753 334556789999999987 5666
Q ss_pred eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 351 LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 351 iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|||||+++|+|.+++.... .+++..++.++.||+.||+||| +++|+||||||+||||+.++++||+|||+++
T Consensus 419 lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 4789999999999998653 4899999999999999999999 7889999999999999999999999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
........ .....||+.|+|||++.+..++.++||||||++||||++|+.||...+..+. ...... ..+
T Consensus 491 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~-~~~--- 559 (674)
T 3pfq_A 491 ENIWDGVT-TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIME-HNV--- 559 (674)
T ss_dssp ECCCTTCC-BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHS-SCC---
T ss_pred ccccCCcc-cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------HHHHHh-CCC---
Confidence 65433222 3344599999999999999999999999999999999999999975543211 111111 100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI 548 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~ 548 (559)
.+. .....++.+|+.+||+.||++||++
T Consensus 560 ---~~p-------~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 ---AYP-------KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ---CCC-------TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ---CCC-------ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 011 1233678889999999999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.05 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=186.7
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
..++|++.+.||+|+||.||+|.. .+++.+|+|++..... ...+.+.+|+.++++++|||| |
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 356899999999999999999985 4588999999875432 234668899999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC---EEEeecccc
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD---AKISDFGLS 429 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~---~kl~DFG~a 429 (559)
+||+++++|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++. +||+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 89999999998887642 4899999999999999999999 788999999999999986655 999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .. .......
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~----~~~~~~~-- 224 (284)
T 3kk8_A 156 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YA----QIKAGAY-- 224 (284)
T ss_dssp EECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHTCC--
T ss_pred EEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---HH----HHHhccc--
Confidence 77654322 2234599999999999998999999999999999999999999965432211 10 1111100
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 225 --~~-~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 --DY-PSPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --CC-CTTTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cC-Cchhh----cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 00000 122356888999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=303.35 Aligned_cols=231 Identities=28% Similarity=0.392 Sum_probs=183.3
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|+.++++++|||| |
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457999999999999999999854 56789999986432 2334678999999999999984 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 89999999999987643 4899999999999999999999 889999999999999999999999999998654
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
.... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+.. . ..... .
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~-~~~~~------~ 223 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------K-RISRV------E 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H-HHHHT------C
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH------H-HHHhC------C
Confidence 3322 22345899999999999888999999999999999999999999754322111 0 00000 0
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.. .....+.+|+.+||+.+|++|||+.||++
T Consensus 224 ~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 FTFPD-------FVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCCCT-------TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCC-------cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01111 12356788999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=317.11 Aligned_cols=237 Identities=19% Similarity=0.264 Sum_probs=183.1
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCce---------------EE
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRSL---------------FM 353 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni---------------v~ 353 (559)
..++|++.+.||+|+||+||++..+ +++.+|||++..... ...+|++++.++ +|||| ||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999964 688999999875432 356799999888 79984 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC----CCEEEeecccc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK----LDAKISDFGLS 429 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~----~~~kl~DFG~a 429 (559)
||+++|+|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||+.++ +.+||+|||++
T Consensus 96 E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp CCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999998753 25899999999999999999999 7889999999999998543 35999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||............ .....+...
T Consensus 168 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~- 241 (342)
T 2qr7_A 168 KQLRAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS- 241 (342)
T ss_dssp EECBCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC-
T ss_pred ccCcCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc-
Confidence 876543322 23345899999999998888999999999999999999999999754322211111 111111110
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.... .......+.+|+.+||+.||++|||+.|+++
T Consensus 242 -----~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 -----LSGGY---WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -----CCSTT---TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----cCccc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 0123366888999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.77 Aligned_cols=236 Identities=24% Similarity=0.356 Sum_probs=187.0
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|.+.+.||+|+||.||+++.+ +++.+|+|++... .....+.+.+|+++|++++|||| ||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999964 6899999998653 23445678999999999999984 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++..... ....+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||+++...
T Consensus 265 E~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999876432 1246899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .......... ..
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~~-~~------ 410 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLEQ-AV------ 410 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHHC-CC------
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhhc-cc------
Confidence 44322 22345999999999999989999999999999999999999999765432211 1111111111 00
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
... ......+.+|+.+||+.||++||++.
T Consensus 411 ~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 TYP-------DKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp CCC-------TTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred CCC-------cccCHHHHHHHHHhccCCHhHCCCCc
Confidence 001 12236778899999999999999763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=310.41 Aligned_cols=243 Identities=22% Similarity=0.289 Sum_probs=183.8
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-CCce-----------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLN-HRSL-----------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni-----------------v~ 353 (559)
++|++.+.||+|+||+||+|+. .+++.+|||++.. ...+.+.+|+.++++++ |+|| |+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5799999999999999999985 6789999999864 33467999999999997 8884 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeecccceec
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDFGLSRLA 432 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DFG~a~~~ 432 (559)
||+.+++|.+++.. +++..+..++.|++.||+||| +++|+||||||+|||++.++ .+||+|||+++..
T Consensus 113 e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp ECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999888753 788999999999999999999 78899999999999999776 8999999999876
Q ss_pred cCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .............+.+.+
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCCchhhhHH
Confidence 54332 223358999999999877 5689999999999999999999999964432211 111111111111111100
Q ss_pred c-------c--------ccccCC-----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 D-------P--------MLKEGA-----SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d-------~--------~l~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+ + ...... ..........+.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0 000000 0001123467899999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=304.86 Aligned_cols=237 Identities=27% Similarity=0.333 Sum_probs=180.6
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|.+.+.||+|+||+||++.. .++..+|+|.+.... ....+.+.+|++++++++|||| |+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4688999999999999999985 467899999987653 3445789999999999999994 6899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee---cCCCCEEEeecccceec
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRLA 432 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill---~~~~~~kl~DFG~a~~~ 432 (559)
+++++|.+.+...... ...+++..+..++.|++.||+||| +++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 102 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 102 CEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999988654211 135899999999999999999999 7889999999999999 45678999999999865
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... .....||+.|+|||++. ..++.++||||||+++|||++|+.||......+. ........
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~------- 241 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQKATYKE------- 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC-------
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH------HhhhccCC-------
Confidence 44322 23345899999999875 4688999999999999999999999975432211 00000000
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+....... .....+.+|+.+||+.||++|||+.||++
T Consensus 242 ~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYAVECR----PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCC--C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccccC----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 12256788999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.59 Aligned_cols=241 Identities=25% Similarity=0.348 Sum_probs=181.9
Q ss_pred CCCCCCCccccCCccEEEEEEec--CC--cEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce--------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD--DE--TITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~--~~--~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
++|++.+.||+|+||+||+|++. ++ ..||||++.... ....+.+.+|++++++++||||
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 57999999999999999999853 23 368999886542 2345678999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+++++|.+.+.... ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 98 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 679999999999997643 24889999999999999999999 78899999999999999999999999999987
Q ss_pred ccCCCcee--eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 432 ALNGASHV--TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 432 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
........ .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~-- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGE-- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCC--
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------HHHHHccCC--
Confidence 65443322 223447889999999988889999999999999999999 9999975532211 111111100
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.... .......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 243 ---~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 243 ---RLPR-------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp ---CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCC-------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 0000 012336788999999999999999999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=309.28 Aligned_cols=255 Identities=20% Similarity=0.317 Sum_probs=193.7
Q ss_pred HHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHh--cCCCce------------
Q 047195 286 REITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQ--LNHRSL------------ 351 (559)
Q Consensus 286 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~--l~h~ni------------ 351 (559)
.......++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33345567899999999999999999987 4889999998643 34678899999988 789884
Q ss_pred -------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHc-----CCCCeEECCCCCCCeeecCCC
Q 047195 352 -------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL-----ATPPIYHRDIKSSNILLDEKL 419 (559)
Q Consensus 352 -------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiH~Dikp~Nill~~~~ 419 (559)
|+||+++|+|.+++... .+++..+..++.|++.||+|||.. ++++|+||||||+|||++.++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred ccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 67889999999999752 489999999999999999999932 146799999999999999999
Q ss_pred CEEEeecccceeccCCCcee---eeeccccCCccCccccccC------CCCcccchhHHHHHHHHHHhC----------C
Q 047195 420 DAKISDFGLSRLALNGASHV---TTFAQGTLGYLDPEYYINF------QLTDKSDVYSFGVVLVELLTS----------K 480 (559)
Q Consensus 420 ~~kl~DFG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~el~tg----------~ 480 (559)
.+||+|||++.......... .....||+.|+|||++.+. .++.++||||||+++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998766544332 2334599999999998765 234689999999999999999 6
Q ss_pred CCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 481 KAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 481 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.||........ ..... ........ +.+.+.... ...+....+.+|+.+||+.||++|||+.||++.|++|
T Consensus 265 ~p~~~~~~~~~-~~~~~-~~~~~~~~----~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 265 LPYYDLVPSDP-SVEEM-RKVVCEQK----LRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CTTTTTSCSSC-CHHHH-HHHHTTSC----CCCCCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCccccCcCcc-cHHHH-HHHHHHHH----hCCCCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 67754432221 11111 11111111 111111110 1235667899999999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.54 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=185.4
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 45799999999999999999985 4678899999875332 233678999999999999985
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
|++++. ++|.+++... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 456665 5888888642 4899999999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCcee--eeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 430 RLALNGASHV--TTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 430 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
+......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+................
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 8765332211 233459999999998765 4589999999999999999999999976654433222211110000000
Q ss_pred hhhccc--------ccccc---CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 LVDAID--------PMLKE---GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~~~~~d--------~~l~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+....+ ..... ............+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000 000000122356889999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=316.88 Aligned_cols=249 Identities=22% Similarity=0.219 Sum_probs=177.1
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999985 4688999999875422 234568899999999999985
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
|+||+. ++|.+.+.. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 456665 467776642 3889999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH--------HH
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY--------FG 499 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~--------~~ 499 (559)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....... ..
T Consensus 173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998654321 22334589999999999998999999999999999999999999976543221111000 00
Q ss_pred --------HHhhc------chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 500 --------NILKQ------ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 500 --------~~~~~------~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ..+.......+..............+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000 0000000011111111112334677899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=322.84 Aligned_cols=239 Identities=13% Similarity=0.055 Sum_probs=174.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC---CChhhHHHHHHHHHhc--CCCc---------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT---KGIDPILNEVRILCQL--NHRS--------------- 350 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l--~h~n--------------- 350 (559)
..+|++.+.||+|+||.||+|+. .+++.+|||++..... ...+.+.+|+.+++.| +|||
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34588999999999999999995 4789999999987543 2345677885555554 5887
Q ss_pred ------------------------eEEeeCCCCcHhHhHhhccCCCCCCCChHHH------HHHHHHHHHHHHHHHHcCC
Q 047195 351 ------------------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHR------LHIARQTAQAIAYLHLLAT 400 (559)
Q Consensus 351 ------------------------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~ 400 (559)
|||||++ ++|.+++..... .+.+..+ ..++.||+.||+||| +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~ 212 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQ---S 212 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHH---H
Confidence 3567777 899999986432 2455555 788899999999999 7
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHh
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLT 478 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~t 478 (559)
++|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||||+++|||++
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 8899999999999999999999999999986532 1113447899999999987 679999999999999999999
Q ss_pred CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 479 SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 479 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
|+.||.......... +............+.... .......+.+|+.+||+.||++|||+.++++
T Consensus 289 g~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGS---CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTT---SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccc--------hhhhhhhhccccccchhh---ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999997553321100 000000000000000000 0123467889999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.41 Aligned_cols=254 Identities=21% Similarity=0.239 Sum_probs=181.3
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce----------------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
+...++|++.+.||+|+||+||+|.. .+++.||||++..... ...+|+++|+.++|+||
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999985 6789999999865432 23479999999999985
Q ss_pred -------------------------------------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHH
Q 047195 352 -------------------------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394 (559)
Q Consensus 352 -------------------------------------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~y 394 (559)
||||++ ++|.+.+...... ...+++..+..++.|++.||+|
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHH
Confidence 345665 5777776543211 2368999999999999999999
Q ss_pred HHHcCCCCeEECCCCCCCeeec-CCCCEEEeecccceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHH
Q 047195 395 LHLLATPPIYHRDIKSSNILLD-EKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVV 472 (559)
Q Consensus 395 LH~~~~~~iiH~Dikp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~i 472 (559)
|| +++|+||||||+|||++ .++.+||+|||+++........ ....+|+.|+|||++.+. .++.++||||||++
T Consensus 157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99 88999999999999998 6889999999999876543322 233589999999998775 48999999999999
Q ss_pred HHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh-------hhccccccccC-CC-hhhHHHHHHHHHHHHHhcccCCC
Q 047195 473 LVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL-------VDAIDPMLKEG-AS-EIELDSMKAFGLLGAACLDERRQ 543 (559)
Q Consensus 473 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~d~~l~~~-~~-~~~~~~~~~l~~l~~~cl~~~p~ 543 (559)
+|||++|+.||......+................+ ....-+.+... .. ..+......+.+|+.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999865543322221111000000000 00000000000 00 00112335688999999999999
Q ss_pred CCCCHHHHHH
Q 047195 544 NRPSIKEVAD 553 (559)
Q Consensus 544 ~RPt~~evl~ 553 (559)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999984
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.66 Aligned_cols=230 Identities=28% Similarity=0.391 Sum_probs=181.7
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK---GIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
+.|++.+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|++++++++|||| |+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999985 67899999998764332 23568999999999999994 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+. |+|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 8887 68888876532 35899999999999999999999 7789999999999999999999999999997654
Q ss_pred CCCceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
.. ....||+.|+|||++. ...++.++||||||+++|||++|+.||........ ........
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~----- 269 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE----- 269 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-----
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC-----
Confidence 32 2235999999999985 45789999999999999999999999965432211 11111110
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.+.. ......+.+|+.+||+.+|++|||+.++++
T Consensus 270 -~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 -SPALQS------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp -CCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCC------CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 011110 112356788999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.61 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=183.5
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCC--hhhHHHHHHHHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKG--IDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.++|++.+.||+|+||.||+++.. +++.||||++....... .+.+.+|++++++++|||| |+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999965 58999999986544322 3457899999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||++++.|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999988888776542 24899999999999999999999 7889999999999999999999999999997654
Q ss_pred CCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHhhc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG--------NILKQ 504 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~ 504 (559)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+......... ..+..
T Consensus 176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 3322 22234589999999998775 68999999999999999999999997655433221111100 00001
Q ss_pred c-hhhhccccccccCCC--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 E-RLVDAIDPMLKEGAS--EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~-~~~~~~d~~l~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. .......+.+..... .........+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 011111111111000 000123467899999999999999999999885
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.72 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=179.4
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL-------------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-------------------- 351 (559)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+|+++|++++|+||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36888999999999999999974 58999999986532 234479999999999995
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC-CCEEEeecccc
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGLS 429 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~-~~~kl~DFG~a 429 (559)
|+||+++ +|.+.+..... ....+++..+..++.||++||+||| +++|+||||||+|||++.+ +.+||+|||++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 4566654 56665543221 1246899999999999999999999 8899999999999999965 57899999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+................+.
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87654332 2234589999999998765 78999999999999999999999998655333221111110000000110
Q ss_pred h-------ccccccccC-CC-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 D-------AIDPMLKEG-AS-EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ~-------~~d~~l~~~-~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ..-+.+... .. .........+.+|+.+||+.||++|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 000000000 00 000122367889999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.93 Aligned_cols=239 Identities=25% Similarity=0.340 Sum_probs=172.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-CCce------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLN-HRSL------------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni------------------ 351 (559)
..+|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.+++++. ||||
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45799999999999999999995 468999999987766555678999999999996 9985
Q ss_pred -----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC--eEECCCCCCCeeecCCCCEEEe
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP--IYHRDIKSSNILLDEKLDAKIS 424 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dikp~Nill~~~~~~kl~ 424 (559)
|++|+ +|+|.+++...... ..+++..++.++.|++.||+||| +++ |+||||||+|||++.++.+||+
T Consensus 107 ~~~~lv~e~~-~g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 107 AEFLLLTELC-KGQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp EEEEEEEECC-SEEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ceEEEEEEec-CCCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEe
Confidence 34666 47898888764332 35899999999999999999999 777 9999999999999999999999
Q ss_pred ecccceeccCCCcee-----------eeeccccCCccCcccc---ccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccc
Q 047195 425 DFGLSRLALNGASHV-----------TTFAQGTLGYLDPEYY---INFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490 (559)
Q Consensus 425 DFG~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~ 490 (559)
|||+++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765332211 1133489999999998 56678899999999999999999999996432211
Q ss_pred cccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. . ... ....... .....+.+|+.+||+.||++|||+.|+++.|+.+
T Consensus 261 ~------~-----~~~----~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 261 I------V-----NGK----YSIPPHD-------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp --------------------CCCCTTC-------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred h------h-----cCc----ccCCccc-------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0 000 0000000 1113467899999999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=310.97 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=187.1
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++||||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457899999999999999999964 689999999876432 334578999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC-----eEECCCCCCCeeecCCCCEEEeec
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP-----IYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-----iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
|+||+++++|.+++..... ....+++..+..++.|++.||+||| +++ |+||||||+|||++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 6799999999999976432 2245899999999999999999999 555 999999999999999999999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
|+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ . ......+.
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~----~~~i~~~~ 232 (279)
T 2w5a_A 161 GLARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---L----AGKIREGK 232 (279)
T ss_dssp CHHHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHTC
T ss_pred chheeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---H----HHHHhhcc
Confidence 999765433221 122348999999999998889999999999999999999999997543211 1 11111111
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L 555 (559)
.. .+. ......+.+++.+||+.+|++|||+.||++.+
T Consensus 233 ~~-----~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 233 FR-----RIP-------YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CC-----CCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cc-----cCC-------cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 10 111 12236788999999999999999999999765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.37 Aligned_cols=235 Identities=21% Similarity=0.254 Sum_probs=176.3
Q ss_pred CCCCCC-CccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHh-cCCCce------------------
Q 047195 293 NNFSTG-NLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQ-LNHRSL------------------ 351 (559)
Q Consensus 293 ~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~-l~h~ni------------------ 351 (559)
++|.+. +.||+|+||+||++... +++.||||++.. ...+.+|+.++.+ .+|+||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999864 688999999863 2567899998854 578883
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEeecc
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKISDFG 427 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~DFG 427 (559)
||||+++|+|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+|||++. ++.+||+|||
T Consensus 136 lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 6799999999999975322 35899999999999999999999 788999999999999997 7899999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcccccc-HHHHHHHHhhcch
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVN-LVVYFGNILKQER 506 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 506 (559)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ...... .+.
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~ 283 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQ 283 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTC
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCc
Confidence 998654322 1233458999999999988899999999999999999999999997654332111 111110 110
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. . + .... ......+.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~-~--~--~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 284 YE-F--P--NPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CC-C--C--TTTT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc-C--C--Cccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 0 0000 123366889999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=307.61 Aligned_cols=236 Identities=26% Similarity=0.369 Sum_probs=184.7
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
..++|.+.+.||+|+||.||+++.. +++.+|+|.+........+.+.+|+.++++++|||| |+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3457899999999999999999964 689999999987655555678999999999999994 679
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee---cCCCCEEEeeccccee
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLSRL 431 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill---~~~~~~kl~DFG~a~~ 431 (559)
|+++++|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||+ ++++.+||+|||+++.
T Consensus 87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 87 LVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred cCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 999999999887542 4899999999999999999999 7889999999999999 7888999999999875
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ........ . .
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~----~~i~~~~~-~-~ 226 (304)
T 2jam_A 159 EQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LF----EKIKEGYY-E-F 226 (304)
T ss_dssp CCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHCCC-C-C
T ss_pred cCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH----HHHHcCCC-C-C
Confidence 43321 122348999999999998899999999999999999999999997543211 11 11111100 0 0
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ......+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ESPFW-------DDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CTTTT-------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred Ccccc-------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000 122367889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=302.49 Aligned_cols=235 Identities=24% Similarity=0.293 Sum_probs=184.3
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC------ChhhHHHHHHHHHhcCCCce--------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK------GIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
++|++.+.||+|+||.||+++.. +++.+|+|.+...... ..+.+.+|+.++++++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46889999999999999999965 6899999998764321 35679999999999999994
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC----CEEEeec
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL----DAKISDF 426 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~----~~kl~DF 426 (559)
|+||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++ .+||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 689999999999997532 4899999999999999999999 78899999999999998877 8999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+. .. ......
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~ 227 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET------LT-NISAVN 227 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH-HHHTTC
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH------HH-HhHhcc
Confidence 99987644322 2234589999999999888899999999999999999999999975432211 00 000000
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ....... ......+.+++.+||+.||++|||+.|+++
T Consensus 228 ~--~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 Y--DFDEEYF-------SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C--CCCHHHH-------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c--CCcchhc-------ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0000000 122356888999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.47 Aligned_cols=240 Identities=24% Similarity=0.326 Sum_probs=187.8
Q ss_pred HHHHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCC--------hhhHHHHHHHHHhc-CCCce------
Q 047195 288 ITEATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKG--------IDPILNEVRILCQL-NHRSL------ 351 (559)
Q Consensus 288 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~--------~~~~~~E~~~l~~l-~h~ni------ 351 (559)
.....++|++.+.||+|+||.||+|... +++.||||++....... .+.+.+|+.+++++ +||||
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 4455678999999999999999999975 78999999987654221 34678999999999 79984
Q ss_pred ---------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEE
Q 047195 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAK 422 (559)
Q Consensus 352 ---------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~k 422 (559)
||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence 789999999999997532 4899999999999999999999 77899999999999999999999
Q ss_pred EeecccceeccCCCceeeeeccccCCccCcccccc------CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 047195 423 ISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN------FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496 (559)
Q Consensus 423 l~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~ 496 (559)
|+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...
T Consensus 241 l~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~ 315 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLR 315 (365)
T ss_dssp ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH
T ss_pred EEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence 999999987654322 233459999999999863 357889999999999999999999997543211 111
Q ss_pred HHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 497 YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 497 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........ ...+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 316 ----~i~~~~~~-~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 ----MIMEGQYQ-FSSPEW--------DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----HHHHTCCC-CCHHHH--------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHhCCCC-CCCccc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111000 000000 012356888999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=321.48 Aligned_cols=186 Identities=24% Similarity=0.286 Sum_probs=155.4
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcC------CCc--------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLN------HRS-------------- 350 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~------h~n-------------- 350 (559)
..+|++.+.||+|+||+||+|... +++.||||++... ....+.+.+|+++++.++ |+|
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999854 5899999998653 233456888999998884 445
Q ss_pred -eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC--EEEeecc
Q 047195 351 -LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD--AKISDFG 427 (559)
Q Consensus 351 -iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~--~kl~DFG 427 (559)
+|+||+. ++|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++. +||+|||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 3678875 689988876432 34899999999999999999999 678999999999999999887 9999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcc
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE 489 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~ 489 (559)
+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 248 ~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 248 SSCYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TCEETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 997654322 2345899999999999999999999999999999999999999866543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.52 Aligned_cols=231 Identities=23% Similarity=0.346 Sum_probs=181.4
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
.|.+.+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|+.++++++||||
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 477788999999999999985 467889999987543 2334678999999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC--eEECCCCCCCeeec-CCCCEEEeeccc
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP--IYHRDIKSSNILLD-EKLDAKISDFGL 428 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dikp~Nill~-~~~~~kl~DFG~ 428 (559)
|+||+++++|.+++.... .+++..+..++.|++.||.||| +++ |+||||||+|||++ +++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 578899999999997642 4889999999999999999999 777 99999999999998 789999999999
Q ss_pred ceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
+....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||........ ... .......
T Consensus 179 ~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~-~~~~~~~- 247 (290)
T 1t4h_A 179 ATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYR-RVTSGVK- 247 (290)
T ss_dssp GGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHH-HHTTTCC-
T ss_pred cccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHH-HHhccCC-
Confidence 97544332 223459999999998764 589999999999999999999999975432211 111 1111100
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ......+.+++.+||+.||++|||+.||++
T Consensus 248 ---~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 ---PASFD-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---CGGGG-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccccC-------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00111 111256889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.46 Aligned_cols=183 Identities=26% Similarity=0.346 Sum_probs=148.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++|++++|+||
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999985 4578999999875322 234578999999999999985
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
|+||+. ++|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 567665 5888888642 35899999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCce---------------------eeeeccccCCccCcccc-ccCCCCcccchhHHHHHHHHHHhCCCCC
Q 047195 429 SRLALNGASH---------------------VTTFAQGTLGYLDPEYY-INFQLTDKSDVYSFGVVLVELLTSKKAV 483 (559)
Q Consensus 429 a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~il~el~tg~~p~ 483 (559)
++........ ..+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9876533211 12445699999999986 4567999999999999999999865444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.14 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=186.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|+||.||+|+. .++..||||.+.... ......+.+|+.++++++||||
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45799999999999999999983 346789999986432 2334578999999999999994
Q ss_pred --EEeeCCCCcHhHhHhhccCC--CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEe
Q 047195 352 --FMSMSPNGTLFDRLHRVQSG--NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKIS 424 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~ 424 (559)
|+||+++++|.+++...... ....+++..++.++.|++.||.||| +++|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 78999999999999865321 1235889999999999999999999 788999999999999984 4569999
Q ss_pred ecccceeccCCCc-eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHh
Q 047195 425 DFGLSRLALNGAS-HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNIL 502 (559)
Q Consensus 425 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 502 (559)
|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ . ....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---V----LEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H----HHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---H----HHHH
Confidence 9999976543322 12233457899999999988899999999999999999998 888986543221 1 1111
Q ss_pred hcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 503 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..... .... ......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 259 ~~~~~-----~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGR-----MDPP-------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCC-----CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCC-----CCCC-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11100 0011 12235688899999999999999999999999865
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.26 Aligned_cols=237 Identities=28% Similarity=0.372 Sum_probs=186.4
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.++|++.+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|+.+++.++|||| |+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457899999999999999999965 689999999875433 334678999999999999984 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++++|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999988642 25899999999999999999999 78899999999999999999999999999987643
Q ss_pred CCc-eeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 435 GAS-HVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 435 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ .... +..... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~-----~~~~~~--~~~ 229 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD-----WKEKKT--YLN 229 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHH-----HHTTCT--TST
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHH-----hhhccc--ccC
Confidence 322 12233458999999999987665 7799999999999999999999975443211 0100 111000 000
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+ .......+.+++.+||+.||++|||+.|+++
T Consensus 230 ~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 P---------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp T---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 0122356788999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=303.32 Aligned_cols=237 Identities=23% Similarity=0.318 Sum_probs=181.7
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeCC
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMSP 357 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~~ 357 (559)
+|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++|||| |+||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355556899999999999995 5678999999987766666789999999999999994 679999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEeecccceeccCCC
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~DFG~a~~~~~~~ 436 (559)
+++|.+++..... ...+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 103 GGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999976422 234678889999999999999999 788999999999999987 8999999999998764322
Q ss_pred ceeeeeccccCCccCccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQ--LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
. ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ ....... ....+.
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~------~~~~~~ 246 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGM------FKVHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHHHH------HCCCCC
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhhcc------cccccc
Confidence 2 122345899999999987643 78999999999999999999999964322111 0000000 001111
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPE-------SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCT-------TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccc-------cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 22367888999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=305.85 Aligned_cols=233 Identities=27% Similarity=0.415 Sum_probs=188.0
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
+.|++.+.||+|+||.||+|.. .+++.+|||++.... ....+.+.+|+.++++++|||| |+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4688999999999999999985 468899999987654 3445789999999999999984 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++.. ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 102 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999998864 25899999999999999999999 788999999999999999999999999999876543
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ... .... ..+.+
T Consensus 173 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~~-----~~~~~ 239 (303)
T 3a7i_A 173 QIK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFL----IPKN-----NPPTL 239 (303)
T ss_dssp BCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH----HHHS-----CCCCC
T ss_pred ccc-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHH----hhcC-----CCCCC
Confidence 322 2234589999999999988999999999999999999999999874432111 000 0000 01111
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADE 554 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~ 554 (559)
.. .....+.+|+.+||+.+|++|||+.|+++.
T Consensus 240 ~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EG-------NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CS-------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cc-------ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 123568889999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.57 Aligned_cols=248 Identities=22% Similarity=0.289 Sum_probs=167.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCceE----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSLF---------------- 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~niv---------------- 352 (559)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999984 5689999999865322 2345788999999999999963
Q ss_pred -----EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 353 -----MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 353 -----~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
++++ +++|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 3444 5666666643 25899999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh----
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL---- 502 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 502 (559)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+............
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865432 223458999999999877 678999999999999999999999998665433222211110000
Q ss_pred ----hcchhhhcccccc---ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 503 ----KQERLVDAIDPML---KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 503 ----~~~~~~~~~d~~l---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........+.... ..............+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000000000 00000000112356889999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=316.25 Aligned_cols=250 Identities=22% Similarity=0.221 Sum_probs=185.2
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC--------CCc------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLN--------HRS------------ 350 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~--------h~n------------ 350 (559)
.++|++.+.||+|+||+||+|+. .+++.||||++... ....+.+.+|++++++++ |+|
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999985 56889999998643 233467899999999986 554
Q ss_pred -------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC-CeEECCCCCCCeeecCCC---
Q 047195 351 -------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP-PIYHRDIKSSNILLDEKL--- 419 (559)
Q Consensus 351 -------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~-~iiH~Dikp~Nill~~~~--- 419 (559)
+||||+ +++|.+.+..... ..+++..+..++.||+.||+||| ++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhh
Confidence 366777 6667666654322 35899999999999999999999 66 899999999999999775
Q ss_pred ----------------------------------------------CEEEeecccceeccCCCceeeeeccccCCccCcc
Q 047195 420 ----------------------------------------------DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453 (559)
Q Consensus 420 ----------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE 453 (559)
.+||+|||+++...... ....||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccCCh
Confidence 79999999998764332 2335899999999
Q ss_pred ccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHH---HHHHHHhhcch--------hh-hcccc--ccc---
Q 047195 454 YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV---VYFGNILKQER--------LV-DAIDP--MLK--- 516 (559)
Q Consensus 454 ~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~--------~~-~~~d~--~l~--- 516 (559)
++.+..++.++||||||+++|||++|+.||............ ........... .. ..... .+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999989999999999999999999999999765433321111 11111111000 00 00000 000
Q ss_pred -----------cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 -----------EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 -----------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+...........+.+|+.+||+.||++|||++||++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0001123456678999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.45 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=189.6
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec----CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-------------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD----DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
...++|++.+.||+|+||.||+|... .+..+|||.+..... ...+.+.+|+.++++++||||
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 466 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 466 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence 33467888899999999999999863 246789998765433 233679999999999999994
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 467 lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 789999999999997532 25899999999999999999999 7889999999999999999999999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
..............+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. ... ......
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~----i~~~~~-- 610 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----IENGER-- 610 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----HHHTCC--
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HHcCCC--
Confidence 765443333334457889999999988899999999999999999997 8999875432211 111 111100
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..+. ...+..+.+++.+||+.||++|||+.||++.|++++
T Consensus 611 ---~~~~-------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 611 ---LPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ---CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCC-------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0011 123367889999999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=317.94 Aligned_cols=250 Identities=20% Similarity=0.253 Sum_probs=179.1
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------------- 351 (559)
.+|++.+.||+|+||+||+|+..++..+|+|++..... ...+|+++++.++||||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46999999999999999999987777799998865332 23479999999999985
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec-CCCCEEEeecccce
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD-EKLDAKISDFGLSR 430 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~-~~~~~kl~DFG~a~ 430 (559)
|+||++++.+......... ...+++..+..++.|++.||+||| +++|+||||||+|||++ .++.+||+|||+++
T Consensus 116 v~e~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKL--KQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEECCSEEHHHHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeeccCccHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 4577765433333222211 236899999999999999999999 78899999999999999 79999999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+................+..
T Consensus 191 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 191 ILIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp ECCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 76543322 234589999999998765 589999999999999999999999986654332221111100000000000
Q ss_pred ----ccc---cccccC-CC-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 ----AID---PMLKEG-AS-EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ----~~d---~~l~~~-~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+ +.+... .. .........+.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000 000000 00 000113467889999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=314.54 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=186.1
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.+.||+|+||.||++... ++..+|+|++..... ...+.+.+|+.++++++|||| ||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46899999999999999999965 688999999876532 334678999999999999994 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC-CeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP-PIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~-~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
+++++|.+++.... .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999997643 4889999999999999999999 53 799999999999999999999999999875532
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH----------------
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF---------------- 498 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------- 498 (559)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+........
T Consensus 185 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred cc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 21 22335899999999999989999999999999999999999999755432211000000
Q ss_pred -------HHHhhcchhhhccccccccCCChh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 499 -------GNILKQERLVDAIDPMLKEGASEI-ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 499 -------~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..........+.++.......... .......+.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000000110000000000 0112357889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=324.78 Aligned_cols=235 Identities=28% Similarity=0.359 Sum_probs=184.6
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC--CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG--NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.++|++.+.||+|+||+||+++.. +++.||||++... .......+.+|+++|++++|||| |+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999964 6899999998643 23445779999999999999995 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec---CCCCEEEeecccce
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD---EKLDAKISDFGLSR 430 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~---~~~~~kl~DFG~a~ 430 (559)
||+.+++|.+.+.... .+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+++
T Consensus 101 e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp CCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999887643 4899999999999999999999 78899999999999995 45679999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+. . ...........
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~----~~i~~~~~~~~ 242 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---L----KRVETGKYAFD 242 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHTCCCSC
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhCCCCCC
Confidence 654332 2233459999999999876 589999999999999999999999975543221 1 11111110000
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. +. .......+.+|+.+||+.+|++|||+.++++
T Consensus 243 ~-~~--------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 243 L-PQ--------WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp S-GG--------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-cc--------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00 0122356889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=305.55 Aligned_cols=232 Identities=24% Similarity=0.349 Sum_probs=186.4
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|.+.+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++|+|| |+
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56889999999999999999965 578899999865432 234568899999999999994 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 95 e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp ECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999887542 4899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ... ..... .
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~------~ 232 (294)
T 2rku_A 167 YDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IKKNE------Y 232 (294)
T ss_dssp STTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHTTC------C
T ss_pred cCccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-Hhhcc------C
Confidence 33222 2334589999999999888899999999999999999999999975432211 111 11110 0
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SIPK-------HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCT-------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCcc-------ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1111 12356788999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=301.30 Aligned_cols=236 Identities=23% Similarity=0.338 Sum_probs=183.0
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
..++|++.+.||+|+||.||+|... +++.+|+|.+.... ..+.+.+|+.++++++|||| |+|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999865 58999999987643 34779999999999999994 689
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 105 YCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp CCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999987432 35899999999999999999999 78899999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
.... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ........ .+.
T Consensus 178 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~------~~~ 244 (314)
T 3com_A 178 TMAK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPTNP------PPT 244 (314)
T ss_dssp TBSC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC------CCC
T ss_pred hccc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCC------Ccc
Confidence 3222 2234589999999999988899999999999999999999999974432111 00000000 000
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.. .......+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 FRK-----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CSS-----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCC-----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 0112367889999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.41 Aligned_cols=230 Identities=26% Similarity=0.349 Sum_probs=186.0
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||.||+|+.. ++..+|+|.+.... ....+.+.+|++++++++|||| |+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999965 57889999986532 2334678999999999999994 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999987643 4899999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ... .... +.
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-~~~~------~~ 229 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRR-IVNV------DL 229 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHTT------CC
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHH-Hhcc------cc
Confidence 322 1234589999999999988899999999999999999999999975432211 111 1110 01
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.. .....+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPP-------FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCT-------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCC-------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111 12356788999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=318.46 Aligned_cols=188 Identities=26% Similarity=0.342 Sum_probs=140.1
Q ss_pred CCCC-CCccccCCccEEEEEEec---CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-----------------E
Q 047195 294 NFST-GNLLGSGGFGEVFKAILD---DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL-----------------F 352 (559)
Q Consensus 294 ~y~~-~~~lG~G~~g~Vy~~~~~---~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----------------v 352 (559)
.|++ .++||+|+||+||+|+.+ +++.+|||++.... ....+.+|+.+|++++|||| |
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4555 468999999999999965 57899999986432 23578999999999999995 5
Q ss_pred EeeCCCCcHhHhHhhccC----CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee----cCCCCEEEe
Q 047195 353 MSMSPNGTLFDRLHRVQS----GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL----DEKLDAKIS 424 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill----~~~~~~kl~ 424 (559)
+||+. ++|.+.+..... .....+++..++.++.||+.||+||| +++|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 67765 577777754321 11224899999999999999999999 7889999999999999 677899999
Q ss_pred ecccceeccCCCc--eeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 047195 425 DFGLSRLALNGAS--HVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNR 487 (559)
Q Consensus 425 DFG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~ 487 (559)
|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987653221 122334589999999998874 58999999999999999999999997554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=310.91 Aligned_cols=233 Identities=24% Similarity=0.347 Sum_probs=186.9
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT---KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|.+.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|+.++++++|+|| |
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357899999999999999999965 578899999865422 334678999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+.+++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 79999999999887642 4899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ... .....
T Consensus 192 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-~~~~~------ 257 (335)
T 2owb_A 192 EYDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IKKNE------ 257 (335)
T ss_dssp CSTTCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHHTC------
T ss_pred ccCccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHH-HhcCC------
Confidence 533222 2334599999999999988899999999999999999999999975432211 010 10100
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.. .....+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 YSIPK-------HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCCT-------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCc-------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111 12256788999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=305.11 Aligned_cols=237 Identities=23% Similarity=0.360 Sum_probs=183.0
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|++++++++|||| |+||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 457999999999999999999965 588999999887777777889999999999999994 6799
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++++|.+++.... ..+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999887543 25899999999999999999999 788999999999999999999999999997543221
Q ss_pred CceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
.. ......||+.|+|||++. +..++.++||||||+++|||++|+.||....... ..........
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~---- 239 (302)
T 2j7t_A 171 LQ-KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDP---- 239 (302)
T ss_dssp HH-C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC----
T ss_pred cc-ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCC----
Confidence 11 112234899999999984 5678899999999999999999999997543221 1111111100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+. ........+.+++.+||+.||++|||+.++++
T Consensus 240 --~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 --PTLL-----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --CCCS-----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --cccC-----CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 01122356889999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=308.67 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=186.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe--cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc-------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL--DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------------------- 350 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n------------------- 350 (559)
.++|++.+.||+|+||+||++.. .+++.||||++.... ...+.+.+|+++++.++|++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45799999999999999999985 367899999986432 33467899999999987654
Q ss_pred --eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-----------
Q 047195 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE----------- 417 (559)
Q Consensus 351 --iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~----------- 417 (559)
+|+||+ +++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred EEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 478998 8899999876432 35889999999999999999999 788999999999999987
Q ss_pred --------CCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcc
Q 047195 418 --------KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE 489 (559)
Q Consensus 418 --------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~ 489 (559)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 6689999999998654322 2335899999999999989999999999999999999999999765443
Q ss_pred ccccHHHHHHHHhhcchhh--------------------------hccccccccCCChhhHHHHHHHHHHHHHhcccCCC
Q 047195 490 EDVNLVVYFGNILKQERLV--------------------------DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQ 543 (559)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~--------------------------~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~ 543 (559)
+................+. ....+ +. ............+.+|+.+||+.||+
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LK-EFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GG-GGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hh-hhcccchhhHHHHHHHHHHHhCcCcc
Confidence 3221111110000000000 00000 00 00001123457889999999999999
Q ss_pred CCCCHHHHHH
Q 047195 544 NRPSIKEVAD 553 (559)
Q Consensus 544 ~RPt~~evl~ 553 (559)
+|||+.||++
T Consensus 319 ~Rpt~~ell~ 328 (339)
T 1z57_A 319 KRITLREALK 328 (339)
T ss_dssp TSCCHHHHTT
T ss_pred cccCHHHHhc
Confidence 9999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=314.21 Aligned_cols=249 Identities=18% Similarity=0.251 Sum_probs=187.5
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCCh-----------------hhHHHHHHHHHhcCCCce---
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGI-----------------DPILNEVRILCQLNHRSL--- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~-----------------~~~~~E~~~l~~l~h~ni--- 351 (559)
.++|++.+.||+|+||.||+|.. +++.||||.+........ +.+.+|+.++++++||||
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 899999999875422211 779999999999999984
Q ss_pred ------------EEeeCCCCcHhHhHhh---ccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCC-CCeEECCCCCCCeee
Q 047195 352 ------------FMSMSPNGTLFDRLHR---VQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT-PPIYHRDIKSSNILL 415 (559)
Q Consensus 352 ------------v~~~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~Dikp~Nill 415 (559)
|+||+++++|.+++.. ........+++..+..++.|++.||+||| + ++|+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 7899999999988332 11111346899999999999999999999 6 889999999999999
Q ss_pred cCCCCEEEeecccceeccCCCceeeeeccccCCccCccccccC-CCCc-ccchhHHHHHHHHHHhCCCCCCCCCcccccc
Q 047195 416 DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTD-KSDVYSFGVVLVELLTSKKAVDFNREEEDVN 493 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~ 493 (559)
+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-- 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-- 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--
Confidence 99999999999999876443 23344599999999999877 6666 99999999999999999999975543111
Q ss_pred HHHHHHHHhhcchhhh------ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 494 LVVYFGNILKQERLVD------AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~------~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ........... ...+................+.+|+.+||+.||++|||+.|+++
T Consensus 261 ~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 L----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11111111000 00000000000001223467889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.71 Aligned_cols=235 Identities=27% Similarity=0.339 Sum_probs=181.2
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.++|++.+.||+|+||+||+|+.. ++..+|+|++.... ......+.+|+.+++.++|||| |+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999964 67899999987543 3345679999999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEeecccce
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKISDFGLSR 430 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~DFG~a~ 430 (559)
||+++|+|.+.+.... .+++..+..++.||+.||+||| +++|+||||||+|||++. ++.+||+|||+++
T Consensus 116 e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999887643 4899999999999999999999 788999999999999976 4559999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
....... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||......+.. ......... .
T Consensus 188 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~-~ 256 (494)
T 3lij_A 188 VFENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL-------RKVEKGKYT-F 256 (494)
T ss_dssp ECBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCC-C
T ss_pred ECCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC-C
Confidence 7654322 23345999999999876 46899999999999999999999999755432211 111111100 0
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+. . ......+.+|+.+||+.+|++|||+.|+++
T Consensus 257 ~~~~----~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPE----W----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGG----G----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchh----c----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000 0 122356888999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=308.94 Aligned_cols=241 Identities=22% Similarity=0.250 Sum_probs=183.9
Q ss_pred HHHhCCCCCC-CccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcC-CCc-------------
Q 047195 289 TEATNNFSTG-NLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLN-HRS------------- 350 (559)
Q Consensus 289 ~~~~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~-h~n------------- 350 (559)
+...+.|.+. +.||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++++. |||
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445567776 88999999999999864 68999999987543 233567999999999995 587
Q ss_pred --eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEee
Q 047195 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKISD 425 (559)
Q Consensus 351 --iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~D 425 (559)
+|+||+++|+|.+++.... ...+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+||+|
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred EEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 4789999999999885432 235899999999999999999999 788999999999999998 78999999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ...... ..
T Consensus 178 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~--~~ 250 (327)
T 3lm5_A 178 FGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY---LNISQV--NV 250 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHT--CC
T ss_pred CccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHHHhc--cc
Confidence 999987643322 22345999999999999889999999999999999999999999754432211 000000 00
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ...... ......+.+++.+||+.||++|||+.++++
T Consensus 251 ~-------~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 251 D-------YSEETF----SSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp C-------CCTTTT----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c-------cCchhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 000000 123366888999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=323.31 Aligned_cols=236 Identities=26% Similarity=0.336 Sum_probs=183.8
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-------------CChhhHHHHHHHHHhcCCCce-----
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-------------KGIDPILNEVRILCQLNHRSL----- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni----- 351 (559)
..++|.+.++||+|+||+||+|+.. +++.+|+|++..... ...+.+.+|+.+|++++||||
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999964 578999999875431 334678999999999999994
Q ss_pred ----------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC--
Q 047195 352 ----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-- 419 (559)
Q Consensus 352 ----------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-- 419 (559)
|+||+++|+|.+.+.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCC
Confidence 789999999999887642 4899999999999999999999 78899999999999998775
Q ss_pred -CEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 047195 420 -DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF 498 (559)
Q Consensus 420 -~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~ 498 (559)
.+||+|||+++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+..
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------ 256 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII------ 256 (504)
T ss_dssp SSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------
T ss_pred ccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------
Confidence 699999999987654322 233459999999999764 6899999999999999999999999765432211
Q ss_pred HHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 499 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
......... .+... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 257 -~~i~~~~~~--~~~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 -KKVEKGKYY--FDFND-------WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -HHHHHCCCC--CCHHH-------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHcCCCC--CCccc-------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111100 00000 0112366889999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=299.71 Aligned_cols=232 Identities=25% Similarity=0.342 Sum_probs=178.7
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|.+.+.||+|+||.||+|... +++.+|||.+... .....+.+.+|+.++++++|||| |
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 457999999999999999999965 7899999998653 23445678999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
+||+++++|.+++.... .+++..+..++.|++.||+||| +++|+|+||||+|||++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 89999999999997642 4889999999999999999999 778999999999999999999999999999866
Q ss_pred cCCCceeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
..... .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... . ........
T Consensus 162 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~-~~~~~~~~----- 227 (276)
T 2h6d_A 162 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------L-FKKIRGGV----- 227 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHCC-----
T ss_pred CCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------H-HHHhhcCc-----
Confidence 44321 223358999999999987765 689999999999999999999996443211 0 11111110
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 228 -~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 -FYIPE-------YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -CCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -ccCch-------hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00111 12356888999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.61 Aligned_cols=191 Identities=27% Similarity=0.327 Sum_probs=157.3
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-CCc----------------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLN-HRS---------------- 350 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-h~n---------------- 350 (559)
....++|++.+.||+|+||+||+|... +++.||||++... .....++.+|+++++.++ |++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344678999999999999999999854 6789999998743 223456788999998885 442
Q ss_pred ----eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec--CCCCEEEe
Q 047195 351 ----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD--EKLDAKIS 424 (559)
Q Consensus 351 ----iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~--~~~~~kl~ 424 (559)
||+||+. ++|.+++..... ..+++..+..++.|++.||.|||. +..+|+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 5789886 599999876432 348999999999999999999993 136899999999999995 47789999
Q ss_pred ecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcc
Q 047195 425 DFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE 489 (559)
Q Consensus 425 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~ 489 (559)
|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 204 DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 204 DFGSSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp CCTTCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eccCceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998764322 2345899999999999989999999999999999999999999866543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.80 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=186.7
Q ss_pred HhCCCCCCCccccCCccEEEEEEe--cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhc---CCCce------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL--DDETITAVKRAKLGNT--KGIDPILNEVRILCQL---NHRSL------------ 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l---~h~ni------------ 351 (559)
+.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.+ +||||
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 356899999999999999999996 4678999999865432 2335688899888877 89985
Q ss_pred --------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 --------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
|+||+. |+|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEE
Confidence 457776 699998876433 34899999999999999999999 788999999999999999999999
Q ss_pred eecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh
Q 047195 424 SDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 503 (559)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.............
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999997654322 12234589999999999988999999999999999999999999976543322111111000000
Q ss_pred cchhhhccc---ccc----ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 504 QERLVDAID---PML----KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 504 ~~~~~~~~d---~~l----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...+..... ... ..............+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 000 00000011123467889999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=307.57 Aligned_cols=241 Identities=24% Similarity=0.371 Sum_probs=182.2
Q ss_pred HHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCce-------------
Q 047195 287 EITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRSL------------- 351 (559)
Q Consensus 287 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni------------- 351 (559)
++....++|++.+.||+|+||.||+|+. .+++.+|||++.... ...+.+.+|+.+++++ +||||
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3344567899999999999999999996 578899999987543 3347899999999999 79874
Q ss_pred --------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 --------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
|+||+++++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred cccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEE
Confidence 6788899999999976432 35889999999999999999999 778999999999999999999999
Q ss_pred eecccceeccCCCceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 047195 424 SDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF 498 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~ 498 (559)
+|||++......... .....||+.|+|||++. +..++.++||||||+++|||++|+.||........ .
T Consensus 171 ~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~ 243 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------L 243 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------H
T ss_pred eeCcCceecCcCccc-cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------H
Confidence 999999765432211 22335899999999987 45688999999999999999999999964432111 0
Q ss_pred HHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 499 GNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 499 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... ... .+.+.. ......+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~-~~~-----~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FLIP-RNP-----APRLKS------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHH-HSC-----CCCCSC------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhh-cCc-----cccCCc------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 000 011100 112357888999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=326.11 Aligned_cols=235 Identities=26% Similarity=0.342 Sum_probs=186.2
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
.++|++.+.||+|+||.||+++.. +++.+|||++.... ....+.+.+|+.++++++|||| |
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999965 78999999986543 3445679999999999999995 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee---cCCCCEEEeecccc
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL---DEKLDAKISDFGLS 429 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill---~~~~~~kl~DFG~a 429 (559)
+||+.+++|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||+ +.++.+||+|||++
T Consensus 105 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp ECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 7899999999988653 25899999999999999999999 7889999999999999 56789999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
+....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+. . ..........
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~----~~i~~~~~~~ 246 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---L----KKVEKGKYTF 246 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHCCCCC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHcCCCCC
Confidence 86654322 223459999999999866 689999999999999999999999975543221 1 1111111000
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. +. .......+.+|+.+||+.+|++|||+.|+++
T Consensus 247 ~~-~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 EL-PQ--------WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CS-GG--------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-cc--------cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 00 0123366889999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=303.20 Aligned_cols=231 Identities=24% Similarity=0.296 Sum_probs=181.7
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhc-CCCce---------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQL-NHRSL---------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l-~h~ni---------------v 352 (559)
.++|++.+.||+|+||+||+|... +++.+|+|++..... .....+.+|+.++.++ +|||| |
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457999999999999999999965 789999999876432 3346789999999999 99994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---------------
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE--------------- 417 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~--------------- 417 (559)
+||+++++|.+++..... ....+++..+..++.|++.||+||| +++|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 899999999999976432 1135899999999999999999999 788999999999999984
Q ss_pred ----CCCEEEeecccceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccc
Q 047195 418 ----KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDV 492 (559)
Q Consensus 418 ----~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~ 492 (559)
...+||+|||++........ ..||+.|+|||++.+. .++.++||||||+++|||++|..++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 44799999999987654322 2389999999998765 56789999999999999999988764221
Q ss_pred cHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 493 NLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ......... +.+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 236 -~----~~~~~~~~~-----~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -Q----WHEIRQGRL-----PRIPQ-------VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -H----HHHHHTTCC-----CCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H----HHHHHcCCC-----CCCCc-------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 011111111 11111 12367889999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=301.49 Aligned_cols=236 Identities=23% Similarity=0.304 Sum_probs=183.3
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC----CCChhhHHHHHHHHHhcCCCce--------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN----TKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~----~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
..++|++.+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|++++++++|+||
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 346899999999999999999996 467899999986532 2345679999999999999984
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
|+||+.++ |.+.+..... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 56887766 6676665432 35899999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCC-CceeeeeccccCCccCccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 429 SRLALNG-ASHVTTFAQGTLGYLDPEYYINFQ--LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 429 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
+...... .........||+.|+|||++.+.. ++.++||||||+++|||++|+.||....... .. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~i~~~ 228 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK------LF-ENIGKG 228 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HH-HHHHHC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH------HH-HHHhcC
Confidence 9876432 222233445999999999987644 4779999999999999999999997543211 11 111111
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ..+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 229 ~------~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 229 S------YAIPG-------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp C------CCCCS-------SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C------CCCCC-------ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 01111 12356788999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=308.64 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=178.5
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
.++|++.+.||+|+||.||+|... +++.||+|++...+....+.+.+|++++++++||||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 457999999999999999999965 489999999887666666789999999999999985
Q ss_pred ----------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec-CCCC
Q 047195 352 ----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD-EKLD 420 (559)
Q Consensus 352 ----------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~-~~~~ 420 (559)
|+||+. |+|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+|||++ +++.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCe
Confidence 456665 688887753 25889999999999999999999 78899999999999997 5679
Q ss_pred EEEeecccceeccCCCce--eeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 047195 421 AKISDFGLSRLALNGASH--VTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 421 ~kl~DFG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~ 497 (559)
+||+|||+++........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.......
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999876432211 1223347999999998865 6789999999999999999999999976543222111110
Q ss_pred HHHHhhcc---hhhhccc----cccccCC---ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 498 FGNILKQE---RLVDAID----PMLKEGA---SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 498 ~~~~~~~~---~~~~~~d----~~l~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........ .+...+. ....... ..........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000 0000000 0000000 0001123467889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.40 Aligned_cols=238 Identities=25% Similarity=0.285 Sum_probs=181.6
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--------CCChhhHHHHHHHHHhcCCCce----------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--------TKGIDPILNEVRILCQLNHRSL---------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni---------- 351 (559)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3457999999999999999999864 57899999986432 1223468999999999999994
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC---EEEe
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD---AKIS 424 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~---~kl~ 424 (559)
|+||+++++|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++. +||+
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred ceEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 68999999999988642 35899999999999999999999 788999999999999987654 9999
Q ss_pred ecccceeccCCCceeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 425 DFGLSRLALNGASHVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 425 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ......
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~-- 233 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT-- 233 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH--
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH--
Confidence 999998764321 122345899999999974 45688999999999999999999999975543322 111111
Q ss_pred hhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ..+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 234 --~~~~~--~~~~~-------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 --SGKYN--FIPEV-------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HTCCC--CCHHH-------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hCccc--cCchh-------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11000 00000 0122367889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.84 Aligned_cols=263 Identities=20% Similarity=0.205 Sum_probs=178.5
Q ss_pred ChHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-----------
Q 047195 284 SSREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL----------- 351 (559)
Q Consensus 284 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni----------- 351 (559)
...+.....++|++.+.||+|+||+||+|+. .+++.||||++.... .....+.+|++.++.++||||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 3455666778999999999999999999996 468999999886543 334567889999999999984
Q ss_pred -----------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CC
Q 047195 352 -----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KL 419 (559)
Q Consensus 352 -----------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~ 419 (559)
|+||+++ +|...+..... ....+++..+..++.|++.||.||| .++++|+||||||+|||++. ++
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCC
Confidence 5677765 44444432211 2246889999999999999999999 34678999999999999996 89
Q ss_pred CEEEeecccceeccCCCceeeeeccccCCccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 047195 420 DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ-LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYF 498 (559)
Q Consensus 420 ~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~ 498 (559)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||...............
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 999999999987654332 22345899999999987654 899999999999999999999999865543322211111
Q ss_pred HHHhhcchhhhcccccc-------------ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 499 GNILKQERLVDAIDPML-------------KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 499 ~~~~~~~~~~~~~d~~l-------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...... .....+++.. ..............+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSR-EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCH-HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCH-HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 0000000000 00000001123567899999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=304.70 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=170.6
Q ss_pred HHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC-CCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++|||| |
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3357899999999999999999984 468899999986543 3345678999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccC---CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 353 MSMSPNGTLFDRLHRVQS---GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
+||+++++|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 899999999999875321 12245899999999999999999999 788999999999999999999999999998
Q ss_pred eeccCCCc----eeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 047195 430 RLALNGAS----HVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 430 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ....... ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~-~~ 244 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LMLTLQN-DP 244 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHTS-SC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHHHhcc-CC
Confidence 76543211 11223458999999999876 5689999999999999999999999975543221 1100000 00
Q ss_pred chhhh-ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ERLVD-AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~~~~~-~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ..++.+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLK-------KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCC-------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccchhhh-------hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000 00111111 12256888999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.24 Aligned_cols=248 Identities=19% Similarity=0.254 Sum_probs=179.1
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce----------------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.+++.++||||
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 356899999999999999999985 46899999998764332 24678899999999999985
Q ss_pred -----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
|++|+. ++|.+.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEec
Confidence 445555 56665552 24899999999999999999999 778999999999999999999999999
Q ss_pred ccceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh---
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL--- 502 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--- 502 (559)
|+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+............
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 999865432 233458999999999887 678999999999999999999999997654332221111100000
Q ss_pred -----hcchh---hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 503 -----KQERL---VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 503 -----~~~~~---~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ...+..................+.+|+.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000 0000000000000111123467889999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=307.58 Aligned_cols=249 Identities=19% Similarity=0.241 Sum_probs=183.2
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CC-cEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc-------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DE-TITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------------------- 350 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~-~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n------------------- 350 (559)
.++|++.+.||+|+||+||++... ++ ..||+|++... ....+.+.+|++++++++|++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999864 33 78999998643 233467889999999987654
Q ss_pred --eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee-------------
Q 047195 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL------------- 415 (559)
Q Consensus 351 --iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill------------- 415 (559)
||+||+ ++++.+.+..... ..+++..+..++.||+.||+||| +++|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred EEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccc
Confidence 478888 6677777765322 35899999999999999999999 8899999999999999
Q ss_pred ------cCCCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCcc
Q 047195 416 ------DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREE 489 (559)
Q Consensus 416 ------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~ 489 (559)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 567899999999998654322 2345899999999999989999999999999999999999999765433
Q ss_pred ccccHHHHHHHHhhcchhhhcc------c-------------------cccccCCChhhHHHHHHHHHHHHHhcccCCCC
Q 047195 490 EDVNLVVYFGNILKQERLVDAI------D-------------------PMLKEGASEIELDSMKAFGLLGAACLDERRQN 544 (559)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~------d-------------------~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~ 544 (559)
+................+.... . +.+.. ...........+.+|+.+||+.||++
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS-YMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG-GCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccc-cccccchhHHHHHHHHHHHhcCChhh
Confidence 2211111110000000000000 0 00000 00001233567889999999999999
Q ss_pred CCCHHHHHH
Q 047195 545 RPSIKEVAD 553 (559)
Q Consensus 545 RPt~~evl~ 553 (559)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.73 Aligned_cols=252 Identities=23% Similarity=0.257 Sum_probs=182.0
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999964 688999999865332 234568899999999999986
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
|+||+. ++|.+.+.. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 90 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 345655 578887765 24899999999999999999999 788999999999999999999999999999
Q ss_pred eeccCCCce---------eeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 047195 430 RLALNGASH---------VTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG 499 (559)
Q Consensus 430 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 499 (559)
+........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 876532211 1122358999999998765 678999999999999999999999997654322211111000
Q ss_pred HHhh-c--------chhhhcccccc---ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 500 NILK-Q--------ERLVDAIDPML---KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 500 ~~~~-~--------~~~~~~~d~~l---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... . ....+.+.... ..............+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 0 00000000000 00000000123467889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=298.35 Aligned_cols=238 Identities=26% Similarity=0.290 Sum_probs=185.9
Q ss_pred HHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC---------CChhhHHHHHHHHHhcC-CCce-------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT---------KGIDPILNEVRILCQLN-HRSL------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~---------~~~~~~~~E~~~l~~l~-h~ni------- 351 (559)
...++|++.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+++++++. ||||
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34568999999999999999999964 678999999876532 12356889999999995 9984
Q ss_pred --------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEE
Q 047195 352 --------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKI 423 (559)
Q Consensus 352 --------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl 423 (559)
|+||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEE
Confidence 789999999999997642 4899999999999999999999 788999999999999999999999
Q ss_pred eecccceeccCCCceeeeeccccCCccCccccc------cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 047195 424 SDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI------NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 424 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~ 497 (559)
+|||++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||........
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------ 237 (298)
T 1phk_A 166 TDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------ 237 (298)
T ss_dssp CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------
T ss_pred ecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH------
Confidence 99999987654322 22345899999999985 34678899999999999999999999965432111
Q ss_pred HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 498 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.......... ...+ . .......+.+++.+||+.||++|||+.|+++
T Consensus 238 -~~~~~~~~~~-~~~~----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 -LRMIMSGNYQ-FGSP----E----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHHHHTCCC-CCTT----T----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHHhcCCcc-cCcc----c----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111100 0000 0 0123367889999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.96 Aligned_cols=245 Identities=22% Similarity=0.366 Sum_probs=184.6
Q ss_pred HHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce------------
Q 047195 286 REITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL------------ 351 (559)
Q Consensus 286 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni------------ 351 (559)
+++....++|++.+.||+|+||.||+|..++ .+|+|.+.... ....+.+.+|+.++++++|+||
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3334446789999999999999999998764 48999886543 3334668899999999999994
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
|+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++ ++.+||+|||+
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred eEEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCC
Confidence 678999999999986532 35899999999999999999999 78899999999999998 67999999999
Q ss_pred ceeccCCC----ceeeeeccccCCccCcccccc---------CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHH
Q 047195 429 SRLALNGA----SHVTTFAQGTLGYLDPEYYIN---------FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495 (559)
Q Consensus 429 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~ 495 (559)
++...... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---- 251 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---- 251 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH----
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 87643211 111223348999999999864 3478899999999999999999999975432211
Q ss_pred HHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 496 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
... .... ..+.+.. ......+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 252 --~~~-~~~~-----~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l 300 (319)
T 2y4i_B 252 --IWQ-MGTG-----MKPNLSQ------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300 (319)
T ss_dssp --HHH-HHTT-----CCCCCCC------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred --HHH-hccC-----CCCCCCc------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111 1111 1111110 01224578899999999999999999999999876
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=306.08 Aligned_cols=247 Identities=19% Similarity=0.260 Sum_probs=178.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC--ChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK--GIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 45789999999999999999995 46899999998654322 24568899999999999986
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
|++|+. ++|.+.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 345554 45555542 24899999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH------
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN------ 500 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~------ 500 (559)
+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+..........
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99765432 223458999999999877 6789999999999999999999999976543222111110000
Q ss_pred --Hhhcch---hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 501 --ILKQER---LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 501 --~~~~~~---~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.... ....+..................+.+|+.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00000000011111111233467889999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.11 Aligned_cols=249 Identities=17% Similarity=0.213 Sum_probs=181.3
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-----------CCce---------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLN-----------HRSL--------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni--------- 351 (559)
++|++.+.||+|+||+||+|+. .+++.||||++... ....+.+.+|+.++++++ |+||
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5799999999999999999995 57899999998643 223466889999999886 5553
Q ss_pred ----------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC-CeEECCCCCCCeeec----
Q 047195 352 ----------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP-PIYHRDIKSSNILLD---- 416 (559)
Q Consensus 352 ----------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~-~iiH~Dikp~Nill~---- 416 (559)
|+|++ +++|.+++..... ..+++..+..++.||+.||+||| ++ +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEET
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCC
Confidence 55677 8899999876433 24899999999999999999999 66 899999999999994
Q ss_pred --CCCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccH
Q 047195 417 --EKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNL 494 (559)
Q Consensus 417 --~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~ 494 (559)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 44579999999998764322 223589999999999998999999999999999999999999975542221111
Q ss_pred ---HHHHHHHhhcc--------hhh-hccc------c----------ccccCCChhhHHHHHHHHHHHHHhcccCCCCCC
Q 047195 495 ---VVYFGNILKQE--------RLV-DAID------P----------MLKEGASEIELDSMKAFGLLGAACLDERRQNRP 546 (559)
Q Consensus 495 ---~~~~~~~~~~~--------~~~-~~~d------~----------~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 546 (559)
........... ... ...+ . .+.......+......+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111110000 000 0000 0 000000112245678899999999999999999
Q ss_pred CHHHHHH
Q 047195 547 SIKEVAD 553 (559)
Q Consensus 547 t~~evl~ 553 (559)
|+.||++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=298.47 Aligned_cols=238 Identities=21% Similarity=0.282 Sum_probs=168.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC-C-hhhHHHHHHHHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK-G-IDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~-~-~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.++|++.+.||+|+||+||++.. .+++.+|+|++...... . .+.+.++...++.++|||| |+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46789999999999999999995 57899999998754322 1 2234455555788999984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC-CeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP-PIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~-~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
||++ |+|.+.+...... ...+++..+..++.|++.||+||| ++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 8887 5887777653221 246899999999999999999999 66 8999999999999999999999999999866
Q ss_pred cCCCceeeeeccccCCccCcccc----ccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYY----INFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ...........
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-- 231 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPS-- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCC--
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCC--
Confidence 44322 2223599999999996 45678899999999999999999999997432211 11111111110
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.... ......+.+++.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ----PQLPA------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCCT------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCccc------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00000 122356889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=301.74 Aligned_cols=239 Identities=24% Similarity=0.334 Sum_probs=178.6
Q ss_pred HHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCC--Cce------------
Q 047195 288 ITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--KGIDPILNEVRILCQLNH--RSL------------ 351 (559)
Q Consensus 288 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h--~ni------------ 351 (559)
+....++|++.+.||+|+||.||++...+++.+|||++..... ...+.+.+|++++++++| +||
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3344567999999999999999999988899999999875433 334678999999999975 774
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
|+| ..+++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+++ +.+||+|||+
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred EEEEEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccc
Confidence 556 56789999987632 5889999999999999999999 778999999999999975 7899999999
Q ss_pred ceeccCCCce-eeeeccccCCccCcccccc-----------CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 047195 429 SRLALNGASH-VTTFAQGTLGYLDPEYYIN-----------FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496 (559)
Q Consensus 429 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~ 496 (559)
++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~ 247 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S 247 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----H
Confidence 9876543222 1223458999999999865 467889999999999999999999996433211 1
Q ss_pred HHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 497 YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 497 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... +++........ .....+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~---------~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 KLHAI---------IDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHH---------HCTTSCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHH---------HhcccccCCcc---cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11111 11111111110 11256888999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=300.54 Aligned_cols=233 Identities=25% Similarity=0.394 Sum_probs=181.6
Q ss_pred ChHHHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC------ChhhHHHHHHHHHhcCC--Cce---
Q 047195 284 SSREITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK------GIDPILNEVRILCQLNH--RSL--- 351 (559)
Q Consensus 284 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~------~~~~~~~E~~~l~~l~h--~ni--- 351 (559)
...+.....++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++| +||
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3444555667899999999999999999984 57899999998765332 23567899999999975 774
Q ss_pred ------------EEeeCCC-CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec-C
Q 047195 352 ------------FMSMSPN-GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD-E 417 (559)
Q Consensus 352 ------------v~~~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~-~ 417 (559)
|+++..+ ++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++ +
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLN 185 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCC
Confidence 5677765 89999887632 4899999999999999999999 78899999999999999 7
Q ss_pred CCCEEEeecccceeccCCCceeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHH
Q 047195 418 KLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496 (559)
Q Consensus 418 ~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~ 496 (559)
++.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------- 254 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------- 254 (320)
T ss_dssp TTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred CCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------
Confidence 8899999999998765432 223458999999999887665 6789999999999999999999863210
Q ss_pred HHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 497 YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 497 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ... ..+.. .....+.+|+.+||+.||++|||+.||++
T Consensus 255 ----~~-~~~------~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ----II-RGQ------VFFRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----HH-HCC------CCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hh-ccc------ccccc-------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000 00111 12356888999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.69 Aligned_cols=236 Identities=28% Similarity=0.338 Sum_probs=184.7
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------E
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
..++|++.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++|||| |
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999965 68899999986543 3445779999999999999994 6
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC---CCEEEeecccc
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK---LDAKISDFGLS 429 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~---~~~kl~DFG~a 429 (559)
+||+++++|.+.+.... .+++..+..++.|++.||+||| +++|+||||||+|||++.+ +.+||+|||++
T Consensus 100 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 78899999998887542 4899999999999999999999 7889999999999999754 47999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
........ .....+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+. ......+...
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~- 240 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKYA- 240 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC-
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCCC-
Confidence 76543322 122348999999998865 488999999999999999999999975432211 1111111100
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+. . .......+.+++.+||+.+|++|||+.|+++
T Consensus 241 ---~~~~-~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ---FDLP-Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---CCSG-G----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCch-h----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000 0 0122366889999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=297.60 Aligned_cols=236 Identities=29% Similarity=0.425 Sum_probs=175.2
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce-------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL------------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni------------------- 351 (559)
.++|++.+.||+|+||.||+|+. .+++.+|||++... ....+.+.+|+.++++++||||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45789999999999999999995 47899999998653 2334678999999999999985
Q ss_pred ---------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEE
Q 047195 352 ---------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAK 422 (559)
Q Consensus 352 ---------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~k 422 (559)
|+||+++++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEE
Confidence 468889999999997532 24778899999999999999999 78899999999999999999999
Q ss_pred EeecccceeccCCC-------------ceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCc
Q 047195 423 ISDFGLSRLALNGA-------------SHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNRE 488 (559)
Q Consensus 423 l~DFG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~ 488 (559)
|+|||+++...... ........||+.|+|||++.+. .++.++||||||+++|||++ |+....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999998654221 1112234589999999998764 68999999999999999998 443111
Q ss_pred cccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 489 EEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ...... ..... ...+.... .......+.+++.+||+.||++|||+.++++
T Consensus 233 -~---~~~~~~-~~~~~------~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -E---RVNILK-KLRSV------SIEFPPDF---DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -H---HHHHHH-HHHST------TCCCCTTC---CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -h---HHHHHH-hcccc------ccccCccc---cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1 001111 11110 00011111 1123356788999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=301.97 Aligned_cols=242 Identities=25% Similarity=0.299 Sum_probs=162.1
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHH-HHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVR-ILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~-~l~~l~h~ni---------------v~ 353 (559)
.++|++.+.||+|+||.||+|... +++.||||++..... ....++..|+. +++.++|||| |+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467999999999999999999964 689999999876432 23345666666 6777899995 56
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC-CeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP-PIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~-~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
||+.+ +|.+++..........+++..+..++.|++.||.||| ++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 78774 7777776533222346899999999999999999999 66 8999999999999999999999999999866
Q ss_pred cCCCceeeeeccccCCccCcccc----ccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYY----INFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .... ....
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~--- 245 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ-VVKG--- 245 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCS---
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH-HhcC---
Confidence 43322 2223589999999998 455689999999999999999999999975332110 0000 0000
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.+.... .......+.+|+.+||+.||++|||+.||++
T Consensus 246 --~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 --DPPQLSNSE---EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCCCCS---SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCCcc---cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000111000 0122367889999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=299.00 Aligned_cols=237 Identities=20% Similarity=0.234 Sum_probs=157.3
Q ss_pred HhCCCCCCC-ccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHH-HHHHhcCCCc-----------------
Q 047195 291 ATNNFSTGN-LLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEV-RILCQLNHRS----------------- 350 (559)
Q Consensus 291 ~~~~y~~~~-~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~-~~l~~l~h~n----------------- 350 (559)
..++|.+.+ .||+|+||+||+|... +++.||||++... ....+|+ ..++.++|+|
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 355788854 6999999999999965 6899999998642 2233333 3456678887
Q ss_pred --eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEee
Q 047195 351 --LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKISD 425 (559)
Q Consensus 351 --iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~D 425 (559)
||+||+++|+|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+||+|
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 36899999999999976432 35899999999999999999999 788999999999999976 45599999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............ .......
T Consensus 175 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~ 248 (336)
T 3fhr_A 175 FGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG 248 (336)
T ss_dssp CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred cccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc
Confidence 99998654322 22345899999999998888999999999999999999999999754332211000 0000000
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .. . .... ......+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~-~~-~---~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 QY-GF-P---NPEW----SEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---CC-C---TTTS----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cc-cc-C---chhh----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00 0 0000 123367889999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=309.54 Aligned_cols=230 Identities=16% Similarity=0.156 Sum_probs=174.7
Q ss_pred hCCCCCCCccccCCccEEEEEE-ecCCcEEEEEEeecCCC---CChhhHHHHHHHHHhcCC-Cc----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNT---KGIDPILNEVRILCQLNH-RS---------------- 350 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~---~~~~~~~~E~~~l~~l~h-~n---------------- 350 (559)
+.+|...+.||+|+||+||+|+ ..+++.||||++..... ...+.+.+|+.+++.+.| +|
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457778899999999999999 45789999999874433 335779999999999987 21
Q ss_pred ------------------------eEEeeCCCCcHhHhHhhcc--CCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeE
Q 047195 351 ------------------------LFMSMSPNGTLFDRLHRVQ--SGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIY 404 (559)
Q Consensus 351 ------------------------iv~~~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii 404 (559)
+++....+++|.+++.... ......+++..++.++.|++.||+||| +++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 1112234678888875331 111235778899999999999999999 78899
Q ss_pred ECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCcccc----------ccCCCCcccchhHHHHHHH
Q 047195 405 HRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYY----------INFQLTDKSDVYSFGVVLV 474 (559)
Q Consensus 405 H~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlG~il~ 474 (559)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||+++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999864332 333457 999999998 5556888999999999999
Q ss_pred HHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 475 ELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 475 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
||++|+.||.......... ..+.. .. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 309 elltg~~Pf~~~~~~~~~~-------------------~~~~~-~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSE-------------------WIFRS-CK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSG-------------------GGGSS-CC----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhhHH-------------------HHHhh-cc----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999997544322111 11110 01 12266889999999999999999887754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=294.00 Aligned_cols=230 Identities=27% Similarity=0.370 Sum_probs=178.0
Q ss_pred HHHHHhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC------CChhhHHHHHHHHHhc----CCCce----
Q 047195 287 EITEATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT------KGIDPILNEVRILCQL----NHRSL---- 351 (559)
Q Consensus 287 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~------~~~~~~~~E~~~l~~l----~h~ni---- 351 (559)
+.+...++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +|+||
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4455667899999999999999999985 5688999999875432 2234577899999999 89995
Q ss_pred -----------EEee-CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec-CC
Q 047195 352 -----------FMSM-SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD-EK 418 (559)
Q Consensus 352 -----------v~~~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~-~~ 418 (559)
|+++ +.+++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++ ++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCC
Confidence 5677 68899999997642 4899999999999999999999 77899999999999999 88
Q ss_pred CCEEEeecccceeccCCCceeeeeccccCCccCccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 047195 419 LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT-DKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 419 ~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~ 497 (559)
+.+||+|||+++...... .....||+.|+|||++.+..+. .++||||||+++|||++|+.||.....
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------- 244 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------- 244 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------
Confidence 999999999998765432 2234489999999998876664 589999999999999999999863210
Q ss_pred HHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 498 FGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 498 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. . ... ..+.. .....+.+++.+||+.+|++|||+.|+++
T Consensus 245 ~---~-~~~------~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 I---L-EAE------LHFPA-------HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H---H-HTC------CCCCT-------TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H---h-hhc------cCCcc-------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 000 00111 12356788999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.28 Aligned_cols=238 Identities=26% Similarity=0.299 Sum_probs=170.3
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCce---------------EEeeCC
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRSL---------------FMSMSP 357 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni---------------v~~~~~ 357 (559)
.|.+.+.||+|+||+||.+...+++.||||++... ..+.+.+|+++|+++ +|||| |+||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 45556889999999998777778999999998653 235688999999986 89995 678885
Q ss_pred CCcHhHhHhhccCCCC--CCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC-------------CCEE
Q 047195 358 NGTLFDRLHRVQSGNW--PPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK-------------LDAK 422 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~-------------~~~k 422 (559)
|+|.+++........ ....+..+..++.||+.||+||| +++|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 699999976432111 11234456789999999999999 7889999999999999754 4899
Q ss_pred EeecccceeccCCCcee---eeeccccCCccCcccccc-------CCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccc
Q 047195 423 ISDFGLSRLALNGASHV---TTFAQGTLGYLDPEYYIN-------FQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEED 491 (559)
Q Consensus 423 l~DFG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~ 491 (559)
|+|||+++......... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999998775443221 223459999999999865 568899999999999999999 899986433211
Q ss_pred ccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 492 VNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........... .+. ..........+.+|+.+||+.||++|||+.||++
T Consensus 248 ---~~i~~~~~~~~--------~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ---SNIIRGIFSLD--------EMK---CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHTCCCCC--------CCT---TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHhcCCCCcc--------ccc---ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00000000000 000 0112355678899999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=304.09 Aligned_cols=233 Identities=26% Similarity=0.298 Sum_probs=169.0
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhc-CCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQL-NHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni---------------v~~~~ 356 (559)
.+|++.+.||+|+||+||.....+++.||||++.... ...+.+|+++|+++ +|||| |+||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4688889999999999766556788999999986432 34577999999999 79995 67887
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-----CCCEEEeeccccee
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-----KLDAKISDFGLSRL 431 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-----~~~~kl~DFG~a~~ 431 (559)
. |+|.+++..... .+.+..+..++.||+.||+||| +++|+||||||+|||++. ...+||+|||+++.
T Consensus 101 ~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 101 A-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp S-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred C-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 5 699998875432 3445567899999999999999 778999999999999953 34688999999987
Q ss_pred ccCCCc--eeeeeccccCCccCccccc---cCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 432 ALNGAS--HVTTFAQGTLGYLDPEYYI---NFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 432 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||....... ........
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccC
Confidence 654322 1223455999999999987 3567889999999999999999 888885332111 00000000
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .. + .........+.+|+.+||+.||++|||+.||++
T Consensus 246 ~~-~~----~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SL-DC----L-----HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CC-TT----S-----CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc-cc----c-----CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 00 0 001133455788999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=314.58 Aligned_cols=248 Identities=25% Similarity=0.311 Sum_probs=181.7
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC-CCCChhhHHHHHHHHHhcCCCce------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999985 56899999998654 22334678999999999999984
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCC---EEEee
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLD---AKISD 425 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~---~kl~D 425 (559)
|+||+++|+|.+++..... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++. +||+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 6789999999999976432 235889999999999999999999 788999999999999997664 99999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ +........
T Consensus 168 FG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-----~~~~i~~~~ 240 (676)
T 3qa8_A 168 LGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-----WHGKVREKS 240 (676)
T ss_dssp CCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-----SSTTCC---
T ss_pred cccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-----hhhhhhccc
Confidence 999987654322 2334599999999999989999999999999999999999999965422110 000000000
Q ss_pred h----hhhccccccc-----cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047195 506 R----LVDAIDPMLK-----EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551 (559)
Q Consensus 506 ~----~~~~~d~~l~-----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev 551 (559)
. ..+.....+. .............+.+|+.+||+.||++|||+.++
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0 0000000000 00111223456789999999999999999999883
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=286.04 Aligned_cols=236 Identities=24% Similarity=0.359 Sum_probs=160.5
Q ss_pred hCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCC-Ch-hhHHHHHHHHHhcCCCce---------------EE
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTK-GI-DPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~-~~-~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
.++|++.+.||+|+||.||+|... +++.||||++...... .. +.+..+..+++.++|||| |+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457888999999999999999964 6899999998765332 12 234455567888899985 56
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCC-CeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATP-PIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~-~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
||+ ++.+..+..... ..+++..+..++.|++.||+||| ++ +|+||||||+|||++.++.+||+|||++...
T Consensus 104 e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 777 444444443322 35899999999999999999999 53 8999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
..... .....||+.|+|||++. ...++.++||||||+++|||++|+.||....... ..........
T Consensus 176 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-- 246 (318)
T 2dyl_A 176 VDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEE-- 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSC--
T ss_pred cCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccC--
Confidence 43322 22335899999999984 4568889999999999999999999997533211 1111111110
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.+.. . ......+.+++.+||+.||++|||+.++++
T Consensus 247 ----~~~~~~-~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 ----PPLLPG-H----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCCS-S----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCCc-c----CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011110 0 012356888999999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=314.29 Aligned_cols=223 Identities=19% Similarity=0.267 Sum_probs=176.0
Q ss_pred CCCCCCCccccCCccEEEEEEec--CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD--DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
++|++.+.||+|+||+||++... +++.||||++..... .....+.+|++++++++||||
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57999999999999999999965 689999998865332 334568999999999999884
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccc
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLS 429 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a 429 (559)
||||+++++|.+.+.. .+++..++.++.||+.||+||| +++|+||||||+|||++.+ .+||+|||++
T Consensus 160 ~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccc
Confidence 6788899998876543 4899999999999999999999 7889999999999999986 8999999999
Q ss_pred eeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 430 RLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 430 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
+..... ....||+.|+|||++.+. ++.++||||||+++|||++|..|+........
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------ 284 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------ 284 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc------------------
Confidence 876543 234599999999998764 48899999999999999999888753211100
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHhhh
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-IKEVADEIERI 558 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~~L~~i 558 (559)
.. ..........+.+++.+||+.||++||+ +.++.+.|.++
T Consensus 285 ------~~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ------PE--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------CT--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------cc--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0011223467889999999999999995 66666666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=274.70 Aligned_cols=214 Identities=10% Similarity=0.043 Sum_probs=166.2
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCC---hhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKG---IDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||.||+|+.. +++.||||++....... .+.+.+|+.++++++|+|| ||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999965 48999999987654332 3678999999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++++|.+++.. ......+.+++.|++.||+||| +++|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp ECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 99999999999853 1345578899999999999999 7889999999999999999999998543
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
|++ .++.++||||||+++|||++|+.||......+...... ........+
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~ 224 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIE 224 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------BCTTSCBCC
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------HHhccCCCC
Confidence 333 36789999999999999999999998665432110000 000000000
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
. ..........+.+++.+||+.||++| |+.|+++.|+++
T Consensus 225 -~----~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 225 -P----ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp -H----HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred -h----hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0 00011234678899999999999999 999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=273.74 Aligned_cols=216 Identities=20% Similarity=0.237 Sum_probs=162.9
Q ss_pred hCCCCCC-CccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHH-HhcCCCce-----------------
Q 047195 292 TNNFSTG-NLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRIL-CQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~-~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l-~~l~h~ni----------------- 351 (559)
.++|.+. +.||+|+||.||++.. .+++.||+|++.. ...+.+|+.++ +.++||||
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3457766 7799999999999985 5688999999863 25688999998 56789884
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEeec
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKISDF 426 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~DF 426 (559)
|+||+++++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 6788999999999986432 35899999999999999999999 788999999999999998 788999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
|++.... +..++.++||||||+++|||++|+.||......... ...
T Consensus 165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~ 210 (299)
T 3m2w_A 165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGM 210 (299)
T ss_dssp TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCS
T ss_pred ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHH
Confidence 9986432 234678999999999999999999999654322100 000
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........... ...........+.+++.+||+.||++|||+.|+++
T Consensus 211 ~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 211 KTRIRMGQYEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCSSCTTCCSS-CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhccccC-CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000000 00000123467889999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=273.70 Aligned_cols=228 Identities=18% Similarity=0.226 Sum_probs=170.3
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCC--------CChhhHHHHHHHHHhcC----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNT--------KGIDPILNEVRILCQLN---------------- 347 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~--------~~~~~~~~E~~~l~~l~---------------- 347 (559)
.++|++.+.||+|+||+||+|+. +++.||||++..... ...+.+.+|+.++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688999999999999999987 679999999976532 23367899999999886
Q ss_pred ----------CC----------------------------ceEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHH
Q 047195 348 ----------HR----------------------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTA 389 (559)
Q Consensus 348 ----------h~----------------------------niv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~ 389 (559)
|| .|||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 32 257889999987776643 2489999999999999
Q ss_pred HHHHHHHHcCCCCeEECCCCCCCeeecCCC--------------------CEEEeecccceeccCCCceeeeeccccCCc
Q 047195 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKL--------------------DAKISDFGLSRLALNGASHVTTFAQGTLGY 449 (559)
Q Consensus 390 ~~l~yLH~~~~~~iiH~Dikp~Nill~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y 449 (559)
.||+|||+ +++|+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 172 ~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 172 ASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 99999992 24599999999999999887 8999999999876542 23599999
Q ss_pred cCccccccCCCCcccchhHHHHH-HHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHH
Q 047195 450 LDPEYYINFQLTDKSDVYSFGVV-LVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMK 528 (559)
Q Consensus 450 ~aPE~~~~~~~~~~~Dv~SlG~i-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 528 (559)
+|||++.+.. +.++|||||+++ .+++++|..||... .|.... ...+....... .............
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYL--TDKMLKQMTFK-TKCNTPAMKQIKR 310 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHH--HHHHHHTCCCS-SCCCSHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHH--HHhhhhhhccC-cccchhhhhhcCH
Confidence 9999998766 889999998777 77788898887310 000000 00000000000 0011122345778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH
Q 047195 529 AFGLLGAACLDERRQNRPSIKEVA 552 (559)
Q Consensus 529 ~l~~l~~~cl~~~p~~RPt~~evl 552 (559)
.+.+|+.+||+.| |+.|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 8999999999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-26 Score=250.27 Aligned_cols=170 Identities=17% Similarity=0.077 Sum_probs=111.9
Q ss_pred ccccCCccEEEEEE-ecCCcEEEEEEeecCCC----------CChhhHHHHHHHHHhc-CCCc---------------eE
Q 047195 300 LLGSGGFGEVFKAI-LDDETITAVKRAKLGNT----------KGIDPILNEVRILCQL-NHRS---------------LF 352 (559)
Q Consensus 300 ~lG~G~~g~Vy~~~-~~~~~~~avk~~~~~~~----------~~~~~~~~E~~~l~~l-~h~n---------------iv 352 (559)
.++.|+.|.+..++ .--+..+++|.+...-. ...++|.+|+++|+++ .|+| ||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566666666554 33577899999865321 2235699999999999 6777 58
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||++|++|.++|.... +++. .+|+.||+.||+||| +++||||||||+|||+++++.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~---~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDR---EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCH---HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhCC-----CCCH---HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999999997632 3544 358999999999999 889999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCC
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKA 482 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p 482 (559)
...... .....||++|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 390 ~~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 543322 233459999999999876 466789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-24 Score=229.13 Aligned_cols=169 Identities=18% Similarity=0.199 Sum_probs=130.7
Q ss_pred CCCCccccCCccEEEEEEecCCcEEEEEEeecCCCC--------ChhhHHHHHHHHHhcCCCce---------------E
Q 047195 296 STGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK--------GIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~--------~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
...++||+|+||+||++. ..+..+++|+....... ..+.+.+|+++|++++|||| |
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 345789999999999995 44677888876543221 12347999999999999985 5
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++++|.+++.. +..++.|+++||+||| +++|+||||||+|||+++ .+||+|||+++..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 899999999998864 4589999999999999 788999999999999999 9999999999987
Q ss_pred cCCCcee------eeeccccCCccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCC
Q 047195 433 LNGASHV------TTFAQGTLGYLDPEYYIN--FQLTDKSDVYSFGVVLVELLTSKKAV 483 (559)
Q Consensus 433 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el~tg~~p~ 483 (559)
....... .....||+.|||||++.. ..|+..+|+||..+-.++.+.++.++
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5432211 123459999999999976 56888999999999999988877765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.8e-22 Score=195.89 Aligned_cols=139 Identities=22% Similarity=0.208 Sum_probs=112.7
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCC------------------ChhhHHHHHHHHHhcCCCc
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK------------------GIDPILNEVRILCQLNHRS 350 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~------------------~~~~~~~E~~~l~~l~h~n 350 (559)
......|.+.+.||+|+||.||+|...+++.+|+|.++..... ....+.+|+++|++++|.+
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~ 165 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 165 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCC
Confidence 3344567778999999999999999977999999998653221 2346899999999997643
Q ss_pred -----------eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC
Q 047195 351 -----------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL 419 (559)
Q Consensus 351 -----------iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~ 419 (559)
+||||+++++|.+ +.. .....++.|++.||.||| +++|+||||||+|||++ ++
T Consensus 166 v~~~~~~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 166 VPKVYAWEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SCCEEEEETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TT
T ss_pred cCeEEeccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CC
Confidence 6899999999987 421 234579999999999999 78899999999999999 99
Q ss_pred CEEEeecccceeccCCCceeeeeccccCCccCcccccc
Q 047195 420 DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457 (559)
Q Consensus 420 ~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 457 (559)
.+||+|||+++ .+..++|||++..
T Consensus 230 ~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 230 GIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp EEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred cEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 99999999986 3556789998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.9e-18 Score=166.10 Aligned_cols=126 Identities=21% Similarity=0.162 Sum_probs=98.5
Q ss_pred CCCCCccccCCccEEEEEEe-cCCcE--EEEEEeecCCCCC------------------------hhhHHHHHHHHHhcC
Q 047195 295 FSTGNLLGSGGFGEVFKAIL-DDETI--TAVKRAKLGNTKG------------------------IDPILNEVRILCQLN 347 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~-~~~~~--~avk~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 347 (559)
|++.+.||+|+||.||+|.. .+++. +|||+++...... ...+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999997 78888 9999865432110 125789999999987
Q ss_pred CCc-------------eEEeeCC-CC----cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCC
Q 047195 348 HRS-------------LFMSMSP-NG----TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIK 409 (559)
Q Consensus 348 h~n-------------iv~~~~~-~g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dik 409 (559)
|++ |||||+. +| .|.+.... .++..+..++.|++.+|.|||. ..+|+|||||
T Consensus 129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 653 6899994 24 55544322 2345678999999999999994 4579999999
Q ss_pred CCCeeecCCCCEEEeecccceec
Q 047195 410 SSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 410 p~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|+|||+++ .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-15 Score=152.65 Aligned_cols=125 Identities=17% Similarity=0.191 Sum_probs=95.9
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCC--------------Chh--------hHHHHHHHHHhcCCC--
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK--------------GID--------PILNEVRILCQLNHR-- 349 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~--------------~~~--------~~~~E~~~l~~l~h~-- 349 (559)
-|++.+.||+|++|.||+|...+|+.+|||+++..... ... ...+|...|.++.+.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48999999999999999999989999999987542110 000 123567777776432
Q ss_pred -----------ceEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC
Q 047195 350 -----------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418 (559)
Q Consensus 350 -----------niv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~ 418 (559)
-|||||++++.|..+.. ......++.|++.+|.||| ..+||||||||.|||++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCC
Confidence 17999999888755431 1234578899999999999 7789999999999999877
Q ss_pred C----------CEEEeecccceec
Q 047195 419 L----------DAKISDFGLSRLA 432 (559)
Q Consensus 419 ~----------~~kl~DFG~a~~~ 432 (559)
+ .+.|+||+-+-..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=1.8e-09 Score=104.26 Aligned_cols=131 Identities=15% Similarity=0.113 Sum_probs=98.7
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC-C---------------ceE
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH-R---------------SLF 352 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h-~---------------niv 352 (559)
......|.+...++.|+.+.||++... +..+++|............+.+|+++++.+.+ . .+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344457888888898999999999754 57889998875332334579999999998853 1 168
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC---------------------------------
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA--------------------------------- 399 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------- 399 (559)
|++++|.+|.+.+. +......++.+++++|..||...
T Consensus 89 ~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 89 MSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 89999988876531 11233578899999999999721
Q ss_pred -----------------------CCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 400 -----------------------TPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 400 -----------------------~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876666799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.71 E-value=1.1e-08 Score=98.39 Aligned_cols=122 Identities=19% Similarity=0.194 Sum_probs=85.1
Q ss_pred CCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc-----------------eEEeeC
Q 047195 294 NFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-----------------LFMSMS 356 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n-----------------iv~~~~ 356 (559)
.+.+..+.+.|..+.||++...++..+++|..... ....+.+|+.+++.+.+.+ +||+|+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44443333456669999998777788999986543 3356889999998875432 467777
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA------------------------------------- 399 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------- 399 (559)
++.+|. .. .. ....++.++++.|..||...
T Consensus 98 ~G~~l~--~~--------~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 98 PGQDLL--SS--------HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp SSEETT--TS--------CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred CCcccC--cC--------cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 776662 11 01 12356777888888888532
Q ss_pred ------------------CCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 400 ------------------TPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 400 ------------------~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
...++|+|++|.|||++++..++|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876678999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.64 E-value=8.2e-08 Score=97.05 Aligned_cols=127 Identities=19% Similarity=0.254 Sum_probs=90.7
Q ss_pred CCccccCCccEEEEEEecCCcEEEEEEee--cCC-CCChhhHHHHHHHHHhcCCC--------------------ceEEe
Q 047195 298 GNLLGSGGFGEVFKAILDDETITAVKRAK--LGN-TKGIDPILNEVRILCQLNHR--------------------SLFMS 354 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~~avk~~~--~~~-~~~~~~~~~E~~~l~~l~h~--------------------niv~~ 354 (559)
.+.|+.|.+..||+....+ ..+++|+.. ... ......+.+|+.+++.+.+. .+||+
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999988665 567777765 322 12345788999999988642 14677
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA----------------------------------- 399 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------- 399 (559)
|+++..+.+.. ...++...+..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 122 FVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred ecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 77766553311 123677888899999999999999731
Q ss_pred --------------------CCCeEECCCCCCCeeecCCCC--EEEeecccceec
Q 047195 400 --------------------TPPIYHRDIKSSNILLDEKLD--AKISDFGLSRLA 432 (559)
Q Consensus 400 --------------------~~~iiH~Dikp~Nill~~~~~--~kl~DFG~a~~~ 432 (559)
...++|+|++|.|||++.++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 256999999999999997753 699999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.62 E-value=1.9e-08 Score=99.37 Aligned_cols=171 Identities=19% Similarity=0.181 Sum_probs=110.0
Q ss_pred CCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC-C--------------------ceEEeeC
Q 047195 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH-R--------------------SLFMSMS 356 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h-~--------------------niv~~~~ 356 (559)
.+.++.|....||+.. ..+++|..... .....+.+|+++|+.+.+ . .+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 45777775422 234678999999988732 1 2456778
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA------------------------------------- 399 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------- 399 (559)
+|..+.+.... .++...+..++.++++.+..||...
T Consensus 99 ~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 99 KGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred CCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 77776543321 3666777888888888888888621
Q ss_pred ------------------CCCeEECCCCCCCeeecC--CCCEEEeecccceeccCCCceeeee-------------cccc
Q 047195 400 ------------------TPPIYHRDIKSSNILLDE--KLDAKISDFGLSRLALNGASHVTTF-------------AQGT 446 (559)
Q Consensus 400 ------------------~~~iiH~Dikp~Nill~~--~~~~kl~DFG~a~~~~~~~~~~~~~-------------~~gt 446 (559)
...++|+|++|.|||+++ ...+.|+||+.+........-.... ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 135899999999999998 4567999999987543211000000 0000
Q ss_pred CCccC-ccccccCCCCcccchhHHHHHHHHHHhCCCCC
Q 047195 447 LGYLD-PEYYINFQLTDKSDVYSFGVVLVELLTSKKAV 483 (559)
Q Consensus 447 ~~y~a-PE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~ 483 (559)
.+... |+.... .....+.|+++.+++.+.+|..++
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01112 222111 112358999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=4.4e-05 Score=75.06 Aligned_cols=120 Identities=20% Similarity=0.169 Sum_probs=80.4
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC-------------------ceEEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR-------------------SLFMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~-------------------niv~~~~~~g 359 (559)
+.++.|....||+. +..+++|... .......+.+|+++|+.+.+. .+||++.+|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56788888899987 4557777642 222345788999999998642 2678888887
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA---------------------------------------- 399 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------- 399 (559)
.+...... .++......++.++++.|..||...
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 76552211 1344444555555555555555422
Q ss_pred -----------------CCCeEECCCCCCCeeecC---CCC-EEEeeccccee
Q 047195 400 -----------------TPPIYHRDIKSSNILLDE---KLD-AKISDFGLSRL 431 (559)
Q Consensus 400 -----------------~~~iiH~Dikp~Nill~~---~~~-~kl~DFG~a~~ 431 (559)
...++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00017 Score=69.30 Aligned_cols=120 Identities=19% Similarity=0.180 Sum_probs=81.6
Q ss_pred ccccCCcc-EEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC----------------CceEEeeCCCCcH
Q 047195 300 LLGSGGFG-EVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNH----------------RSLFMSMSPNGTL 361 (559)
Q Consensus 300 ~lG~G~~g-~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h----------------~niv~~~~~~g~L 361 (559)
.+..|..+ .||+.... ++..+.+|+.... ....+.+|..+|+.+.. +.+||+++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45555554 69987754 4567788875532 23568899999987742 2378999998887
Q ss_pred hHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 047195 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA------------------------------------------ 399 (559)
Q Consensus 362 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------------ 399 (559)
.+..... ......+..++++.|.-||...
T Consensus 108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 7654321 1223345566666666666421
Q ss_pred -------------CCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 400 -------------TPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 400 -------------~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999887778999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00024 Score=71.21 Aligned_cols=32 Identities=19% Similarity=0.353 Sum_probs=27.0
Q ss_pred CCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 400 ~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
...++|+|+.|.|||++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 45799999999999999655579999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00058 Score=69.58 Aligned_cols=62 Identities=18% Similarity=0.101 Sum_probs=41.2
Q ss_pred CCccccCCccEEEEEEec-CCcEEEEEEeecCC-------CCChhhHHHHHHHHHhcCC------C----------ceEE
Q 047195 298 GNLLGSGGFGEVFKAILD-DETITAVKRAKLGN-------TKGIDPILNEVRILCQLNH------R----------SLFM 353 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~-------~~~~~~~~~E~~~l~~l~h------~----------niv~ 353 (559)
.+.||.|..+.||++... +++.++||...... ....+.+..|.++|+.+.. | .+||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 357999999999999754 46788999754321 1234567889999987632 1 1578
Q ss_pred eeCCCC
Q 047195 354 SMSPNG 359 (559)
Q Consensus 354 ~~~~~g 359 (559)
|+.++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 888663
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00083 Score=66.66 Aligned_cols=31 Identities=26% Similarity=0.409 Sum_probs=28.1
Q ss_pred CCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 400 ~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888889999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0011 Score=64.29 Aligned_cols=66 Identities=17% Similarity=-0.021 Sum_probs=50.7
Q ss_pred CCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCC--------------ceEEeeCCCCc
Q 047195 295 FSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR--------------SLFMSMSPNGT 360 (559)
Q Consensus 295 y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~--------------niv~~~~~~g~ 360 (559)
....+.+|.|..+.||+.+..||+.+.+|+...........|..|++.|+.|... .+|+||.+.+.
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCCCCC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeecccC
Confidence 4445779999999999999999999999987655544445688999999988431 25788887654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.01 Score=58.24 Aligned_cols=145 Identities=13% Similarity=0.152 Sum_probs=80.3
Q ss_pred cChHHHHHHhCCCCCC-----CccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC-----C---
Q 047195 283 FSSREITEATNNFSTG-----NLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH-----R--- 349 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~-----~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h-----~--- 349 (559)
++.+++......|.+. +.|+.|....+|+....++ .+++|..... ...+.+..|+.+++.|.. |
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 4556666665666552 3466788889999987666 4668876542 122456678888776531 1
Q ss_pred ---------------ceEEeeCCCCcHh--------------HhHhhccCC-CCC---CC---ChHHHHH----------
Q 047195 350 ---------------SLFMSMSPNGTLF--------------DRLHRVQSG-NWP---PL---KWHHRLH---------- 383 (559)
Q Consensus 350 ---------------niv~~~~~~g~L~--------------~~l~~~~~~-~~~---~l---~~~~~~~---------- 383 (559)
.++++|.++..+. ..++..... ... .. .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 1467787765431 112222111 000 01 1211100
Q ss_pred --HHHHHHHHHHHHHHcC----CCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 384 --IARQTAQAIAYLHLLA----TPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 384 --i~~~i~~~l~yLH~~~----~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
+...+.+.++.++... ...++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 1112445556665321 3469999999999999987666899999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.021 Score=51.99 Aligned_cols=103 Identities=13% Similarity=0.088 Sum_probs=65.3
Q ss_pred CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCce
Q 047195 359 GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH 438 (559)
Q Consensus 359 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 438 (559)
-+|.++|.... .++++++++.++.|.+.+|.-+-.. ..+ ..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc--------
Confidence 47888887754 3799999999999999987766210 111 1233446889999999888764 2111
Q ss_pred eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCC
Q 047195 439 VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKA 482 (559)
Q Consensus 439 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p 482 (559)
.....+.+||... ...+.+.=|||||++||..+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0233456888753 3456788899999999998864443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.013 Score=59.96 Aligned_cols=79 Identities=10% Similarity=0.083 Sum_probs=47.1
Q ss_pred CCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCceeeeeccccCCccCccccccCC---CCcccchhHHHHHHHHH
Q 047195 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ---LTDKSDVYSFGVVLVEL 476 (559)
Q Consensus 400 ~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~il~el 476 (559)
...++|+|++|.|||++.++ ++|+||+.+........-......-...|.+|+...... -....++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 67899999999999998876 999999998754321100000000123355555442111 11234455777777777
Q ss_pred HhC
Q 047195 477 LTS 479 (559)
Q Consensus 477 ~tg 479 (559)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.02 Score=56.01 Aligned_cols=125 Identities=17% Similarity=0.145 Sum_probs=75.3
Q ss_pred CCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC------------------CceEEeeCCCC
Q 047195 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH------------------RSLFMSMSPNG 359 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h------------------~niv~~~~~~g 359 (559)
.+.|+.|....+|+... ++..+++|..... ....+..|.+.|+.|.. +.+||+++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35689999999999876 4567778876532 24568899999887732 22688999876
Q ss_pred cHh-----------HhHhhccC-CCC----------------CCCChHHHH---HHH----------------HHHHHH-
Q 047195 360 TLF-----------DRLHRVQS-GNW----------------PPLKWHHRL---HIA----------------RQTAQA- 391 (559)
Q Consensus 360 ~L~-----------~~l~~~~~-~~~----------------~~l~~~~~~---~i~----------------~~i~~~- 391 (559)
.+. -.|+.... ... -.-+|.... ++. .++...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 542 12333221 000 011343221 111 111111
Q ss_pred HHHHHH-cCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 392 IAYLHL-LATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 392 l~yLH~-~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
...|.. .....++|+|+.+.|+|++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 122321 1145699999999999999887 8899974
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.022 Score=55.26 Aligned_cols=30 Identities=27% Similarity=0.227 Sum_probs=25.3
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
..++|+|+.+.||| ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 35899999999999 5566789999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.87 E-value=0.041 Score=56.82 Aligned_cols=62 Identities=13% Similarity=0.066 Sum_probs=39.2
Q ss_pred CccccCCccEEEEEEecC-CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc------------eEEeeCCCCcH
Q 047195 299 NLLGSGGFGEVFKAILDD-ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------------LFMSMSPNGTL 361 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n------------iv~~~~~~g~L 361 (559)
+.|+.|-...+|+....+ +..+++|+..... ...-...+|..+++.|...+ +|++|+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFTNGRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEETTEEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCCeEEEEeeCCccC
Confidence 568888889999998765 4667777654322 22222368999999886433 37788876443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.70 E-value=0.067 Score=52.38 Aligned_cols=46 Identities=24% Similarity=0.133 Sum_probs=32.6
Q ss_pred CccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhc
Q 047195 299 NLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQL 346 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l 346 (559)
+.|+ |....||+....+++.+++|...... ...+.+..|..+++.+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L 77 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQL 77 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHH
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHH
Confidence 3566 77889999877777778899876321 2345677788888766
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.67 E-value=0.099 Score=51.35 Aligned_cols=33 Identities=24% Similarity=0.349 Sum_probs=28.3
Q ss_pred CCCeEECCCCCCCeeecCC----CCEEEeecccceec
Q 047195 400 TPPIYHRDIKSSNILLDEK----LDAKISDFGLSRLA 432 (559)
Q Consensus 400 ~~~iiH~Dikp~Nill~~~----~~~kl~DFG~a~~~ 432 (559)
...++|||+.+.|||++.+ ..+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4579999999999999874 67999999988654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.61 E-value=0.019 Score=58.97 Aligned_cols=59 Identities=14% Similarity=0.112 Sum_probs=39.6
Q ss_pred CccccCCccEEEEEEecC--------CcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILDD--------ETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~--------~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n------------iv~~~~~~ 358 (559)
+.|+.|-...||+....+ +..+.+|+.... ...+.+.+|..+++.|...+ +|++|+++
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~g~v~e~l~G 156 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEYIPS 156 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECCCCE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCCCEEEEEeCC
Confidence 568888889999998653 467778876321 11256778999998774322 46778765
Q ss_pred C
Q 047195 359 G 359 (559)
Q Consensus 359 g 359 (559)
.
T Consensus 157 ~ 157 (429)
T 1nw1_A 157 R 157 (429)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.47 E-value=0.052 Score=54.50 Aligned_cols=132 Identities=17% Similarity=0.179 Sum_probs=74.1
Q ss_pred CccccCCccEEEEEEec--------CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC----C--------ceEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILD--------DETITAVKRAKLGNTKGIDPILNEVRILCQLNH----R--------SLFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~--------~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h----~--------niv~~~~~~ 358 (559)
+.|..|-...+|+.... ++..+.+|+... .......+.+|.++++.|.. | .+|++|+++
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g~v~e~i~G 134 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEGRLEQYIPS 134 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTEEEEECCSE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCccEEEEecC
Confidence 56777888889998764 246777887532 22345667899999987742 2 257888876
Q ss_pred CcHhH--------------h---HhhccCCCCCCC--ChHHHHHHHHHHHH-------------------HHHHHHH---
Q 047195 359 GTLFD--------------R---LHRVQSGNWPPL--KWHHRLHIARQTAQ-------------------AIAYLHL--- 397 (559)
Q Consensus 359 g~L~~--------------~---l~~~~~~~~~~l--~~~~~~~i~~~i~~-------------------~l~yLH~--- 397 (559)
..|.. . |+.....-.... .+..+.++..++.. .++.|..
T Consensus 135 ~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~ 214 (379)
T 3feg_A 135 RPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLE 214 (379)
T ss_dssp EECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHH
T ss_pred ccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHh
Confidence 54421 1 122111000111 23444444433321 2333321
Q ss_pred -c-CCCCeEECCCCCCCeeecCC----CCEEEeeccccee
Q 047195 398 -L-ATPPIYHRDIKSSNILLDEK----LDAKISDFGLSRL 431 (559)
Q Consensus 398 -~-~~~~iiH~Dikp~Nill~~~----~~~kl~DFG~a~~ 431 (559)
. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 215 ~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 215 STPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp TSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 12469999999999999876 7899999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.45 E-value=0.063 Score=53.67 Aligned_cols=30 Identities=27% Similarity=0.438 Sum_probs=25.1
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
..++|+|+.+.|||++++. +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4699999999999998655 89999988754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.27 E-value=0.27 Score=49.69 Aligned_cols=29 Identities=38% Similarity=0.527 Sum_probs=24.7
Q ss_pred eEECCCCCCCeee------cCCCCEEEeeccccee
Q 047195 403 IYHRDIKSSNILL------DEKLDAKISDFGLSRL 431 (559)
Q Consensus 403 iiH~Dikp~Nill------~~~~~~kl~DFG~a~~ 431 (559)
++|+|+.+.|||+ +++..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998764
|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
Probab=90.72 E-value=0.12 Score=34.32 Aligned_cols=24 Identities=17% Similarity=0.385 Sum_probs=19.0
Q ss_pred CCeeecCCCCCCcceeEecCCCccC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
|+.|.+.... .+|.|.|+.||.|.
T Consensus 16 nG~C~~~~~~-~~~~C~C~~GytG~ 39 (46)
T 1k36_A 16 HGQCIYLVDM-SQNYCRCEVGYTGV 39 (46)
T ss_dssp SEEEEEETTT-TEEEEEECTTCSST
T ss_pred CCEeeccCCC-CCEEEECCCCCccC
Confidence 7899875443 68999999999874
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=90.46 E-value=0.14 Score=32.39 Aligned_cols=26 Identities=23% Similarity=0.553 Sum_probs=20.7
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|.+.. ++|.|.|+.||.|.
T Consensus 10 pC~n--gg~C~~~~---~~~~C~C~~G~~G~ 35 (39)
T 1edm_B 10 PCLN--GGSCKDDI---NSYECWCPFGFEGK 35 (39)
T ss_dssp CCCT--TCEEEEET---TEEEEECCTTCCST
T ss_pred CCCC--CCEeEcCC---CceEeECCCCCcCC
Confidence 4765 78998753 68999999999874
|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=89.98 E-value=0.18 Score=33.17 Aligned_cols=28 Identities=14% Similarity=0.310 Sum_probs=20.5
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|...... ++|+|.|+.||.|.
T Consensus 10 pC~n--gg~C~~~~~~-~~~~C~C~~G~~G~ 37 (45)
T 1a3p_A 10 YCLN--GGVXMHIESL-DSYTCNCVIGYSGD 37 (45)
T ss_dssp CCSS--SCEEEECTTT-SSEEEECCTTEETT
T ss_pred CCCC--CCEEEeecCC-CCEEEEcCCCCcCC
Confidence 3765 7899742223 68999999999874
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=89.82 E-value=0.097 Score=40.08 Aligned_cols=34 Identities=18% Similarity=0.568 Sum_probs=27.0
Q ss_pred CCeeecCCCCCCcceeEecCCCccCCC-CCccccc-Ccc
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDPI-SGICKSL-KCS 227 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnpy-~~~c~~~-~c~ 227 (559)
++.|.+.. ++|+|.|+.||.++++ ...|+++ ||.
T Consensus 15 ~g~C~n~~---g~y~C~C~~Gy~~~~~~g~~C~dideC~ 50 (86)
T 1lmj_A 15 RGQCVNTP---GDFECKCDEGYESGFMMMKNCMDIDECQ 50 (86)
T ss_dssp TSCEEEET---TEEEECCCSSEEECTTTSSSEEECCHHH
T ss_pred CCEEECCC---CCEEeeCCCCcCccCCCCCccCCccccc
Confidence 66898754 6899999999998876 5678876 664
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.57 E-value=2 Score=43.54 Aligned_cols=30 Identities=20% Similarity=0.437 Sum_probs=26.5
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
..++|+|+.+.||| +.++.+.|+||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 45899999999999 7788999999998864
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.15 E-value=0.095 Score=40.26 Aligned_cols=34 Identities=24% Similarity=0.660 Sum_probs=26.5
Q ss_pred CCeeecCCCCCCcceeEecCCCccCCCCCccccc-Ccc
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDPISGICKSL-KCS 227 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnpy~~~c~~~-~c~ 227 (559)
++.|.+.. ++|+|.|+.||.+++....|+++ +|.
T Consensus 15 ~~~C~n~~---g~y~C~C~~G~~~~~~g~~C~dideC~ 49 (87)
T 1z6c_A 15 TAVCKNIP---GDFECECPEGYRYNLKSKSCEDIDECS 49 (87)
T ss_dssp TSSCCCBT---TBCCCSSSTTCEEETTTTEEECCCHHH
T ss_pred CCEeECCC---CCEEEECCCCceECCCCCcCCCcCeeC
Confidence 77887654 68999999999998776678766 563
|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
Probab=88.66 E-value=0.24 Score=33.93 Aligned_cols=28 Identities=18% Similarity=0.449 Sum_probs=20.4
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. +++|...... ++|.|.|+.||.|.
T Consensus 13 pC~n--gg~C~~~~~~-~~~~C~C~~G~~G~ 40 (53)
T 1egf_A 13 YCLN--GGVCMHIESL-DSYTCNCVIGYSGD 40 (53)
T ss_dssp SSCS--SCEEEEESSS-SCEEEECCTTCCSS
T ss_pred cCCC--CcEEEeeCCC-CCEEEECCCCCcCC
Confidence 4765 7899842222 68999999999874
|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.56 E-value=0.22 Score=34.37 Aligned_cols=29 Identities=17% Similarity=0.342 Sum_probs=20.8
Q ss_pred ccCCCCCCeeecCC--CCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDA--ESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~--~~~~gy~C~C~~Gy~gn 215 (559)
-|.. +++|.... ++..+|.|.|+.||.|.
T Consensus 15 pC~N--gGtC~~~~~~d~~~~y~C~C~~g~~G~ 45 (55)
T 3u7u_G 15 FCVN--GGECFMVKDLSNPSRYLCKCPNEFTGD 45 (55)
T ss_dssp TSCT--TCEEEEECCC--CCCEEEEECTTEEST
T ss_pred CCCC--CCCcCCCCccCCCCCEeEeCCCCCcCC
Confidence 4776 89996432 22268999999999884
|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
Probab=88.42 E-value=0.22 Score=34.13 Aligned_cols=28 Identities=14% Similarity=0.385 Sum_probs=20.7
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. +++|...... .+|.|.|+.||.|.
T Consensus 13 pC~n--GG~C~~~~~~-~~~~C~C~~GytG~ 40 (53)
T 1nql_B 13 YCLH--DGVCMYIEAL-DKYACNCVVGYIGE 40 (53)
T ss_dssp EECT--TCEEEEETTT-TEEEEEECTTEEST
T ss_pred CCCC--CeEEeeecCC-CCEEEecCCCCcCC
Confidence 4765 7899742223 68999999999884
|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
Probab=87.40 E-value=0.28 Score=34.69 Aligned_cols=21 Identities=14% Similarity=0.331 Sum_probs=17.5
Q ss_pred CeeecCCCCCCcceeEecCCCc-cC
Q 047195 192 SMCLQDAESAGQKRCLYKAGFQ-WD 215 (559)
Q Consensus 192 s~C~~~~~~~~gy~C~C~~Gy~-gn 215 (559)
+.|.+.. ++|.|.|+.||. |.
T Consensus 25 gtC~~~~---g~y~C~C~~Gy~~G~ 46 (61)
T 2k2s_B 25 GTCKETN---SGYICRCNQGYRISL 46 (61)
T ss_dssp CEEEECS---SEEEEECCTTEEEEE
T ss_pred cccccCC---CceEeECCCCCccCC
Confidence 6898754 689999999998 74
|
| >3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A | Back alignment and structure |
|---|
Probab=84.99 E-value=0.48 Score=31.88 Aligned_cols=28 Identities=14% Similarity=0.351 Sum_probs=21.7
Q ss_pred cccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 184 VDCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 184 ~~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
.-|. ||.|.+.... ..+.|.|..||.|.
T Consensus 14 ~yC~---nG~C~~~~~~-~~~~C~C~~gy~G~ 41 (50)
T 3e50_C 14 QFCF---HGTCRFLVQE-DKPACVCHSGYVGA 41 (50)
T ss_pred Cccc---CCEEeeccCC-CCeEEECCCCCccc
Confidence 3476 7799876554 67899999999884
|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=84.19 E-value=0.63 Score=31.55 Aligned_cols=28 Identities=18% Similarity=0.483 Sum_probs=20.3
Q ss_pred CCeeecCCCCCCcceeEecCCCccCCCCCcc
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDPISGIC 221 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnpy~~~c 221 (559)
...|.+.. ++|+|.|+.||.+++-...|
T Consensus 23 ~~~C~n~~---Gsy~C~C~~Gy~~~~d~~~C 50 (53)
T 1apq_A 23 QHLCHNYV---GGYFCSCRPGYELQEDRHSC 50 (53)
T ss_dssp SSEEEEET---TEEEEECSTTCEECTTSSCE
T ss_pred CCEeECCC---CCeEEECCCCCeECCCCCcc
Confidence 34787754 68999999999986543334
|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
Probab=82.94 E-value=0.67 Score=32.87 Aligned_cols=29 Identities=17% Similarity=0.400 Sum_probs=20.8
Q ss_pred ccCCCCCCeeecCC--CCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDA--ESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~--~~~~gy~C~C~~Gy~gn 215 (559)
-|.. +++|.+.. +..++|+|.|+.||.|.
T Consensus 13 pC~n--gG~C~~~~~~~~~~~y~C~C~~Gf~G~ 43 (63)
T 1hae_A 13 FCVN--GGECFMVKDLSNPSRYLCKCQPGFTGA 43 (63)
T ss_dssp TSCT--TCEEEEEESSSSSCCEEEECCTTEEST
T ss_pred cCCC--CcEEecCCccCCCCCEEEECCCCCcCC
Confidence 3765 78998621 12268999999999884
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=82.81 E-value=0.99 Score=33.93 Aligned_cols=32 Identities=25% Similarity=0.613 Sum_probs=22.9
Q ss_pred CCeeecCCCCCCcceeEecCCCccCCCCCccccc-Ccc
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDPISGICKSL-KCS 227 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnpy~~~c~~~-~c~ 227 (559)
|+.|.+.. ++|+|.|+.||.++. ..|+++ +|.
T Consensus 16 ~g~C~n~~---g~y~C~C~~Gy~~~g--~~C~dideC~ 48 (82)
T 1emn_A 16 HGQCINTD---GSYRCECPFGYILAG--NECVDTDECS 48 (82)
T ss_dssp SSEECCCS---SCCCEECCTTEEEET--TEEEECCGGG
T ss_pred CCEEEecC---CCEEEECCCCeECCC--CccCCccccc
Confidence 67887753 689999999998532 346665 664
|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
Probab=82.71 E-value=0.5 Score=44.64 Aligned_cols=34 Identities=18% Similarity=0.253 Sum_probs=26.5
Q ss_pred cccCCCCCCeeecCCCCCCcceeEecCCCccCCCCCccccc
Q 047195 184 VDCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPISGICKSL 224 (559)
Q Consensus 184 ~~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gnpy~~~c~~~ 224 (559)
..|.. ++.|.+.. ++|.|.|+.||.||.. .|.+.
T Consensus 13 ~~C~~--~a~C~Nt~---Gsy~C~C~~Gy~GnG~--~C~d~ 46 (285)
T 1gl4_A 13 HQCSV--HAECRDYA---TGFCCRCVANYTGNGR--QCVAE 46 (285)
T ss_dssp GGSCT--TEEEEECS---SCEEEEECTTEEECSS--SEEET
T ss_pred CCCCC--CCEeEcCC---CCeEEEcCCCCCCCCC--cCCCC
Confidence 46765 88999865 6899999999999864 46554
|
| >3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=81.33 E-value=0.46 Score=33.18 Aligned_cols=28 Identities=18% Similarity=0.394 Sum_probs=20.6
Q ss_pred ccCCCCCCeeecCC--CCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDA--ESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~--~~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|.... .. .+|.|.|+.||.|.
T Consensus 15 pC~N--GGtC~~~~~~~~-~~~~C~C~~Gf~G~ 44 (58)
T 3ltf_D 15 YCLN--DAHCFAVKIADL-PVYSCECAIGFMGQ 44 (58)
T ss_dssp TSCS--SCEEEEEEETTE-EEEEEEECTTEESS
T ss_pred cCCC--CCEEeCCccCCC-CCEEeECCCCCccC
Confidence 3775 78998432 22 57999999999884
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=81.31 E-value=0.96 Score=34.00 Aligned_cols=24 Identities=29% Similarity=0.613 Sum_probs=19.8
Q ss_pred CCeeecCCCCCCcceeEecCCCccCCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDPI 217 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnpy 217 (559)
|+.|.+.. ++|.|.|+.||.|++.
T Consensus 55 ~~~C~n~~---g~y~C~C~~G~~g~~~ 78 (82)
T 1emn_A 55 NGTCKNVI---GGFECTCEEGFEPGPM 78 (82)
T ss_dssp SSCEEECS---SSEEECCSSSSCCCSS
T ss_pred CCEeECCC---CCEEeECCCCeEeCCC
Confidence 56888754 6799999999999874
|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
Probab=80.98 E-value=0.56 Score=31.87 Aligned_cols=29 Identities=17% Similarity=0.335 Sum_probs=20.8
Q ss_pred ccCCCCCCeeecCCC-CCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAE-SAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~-~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|.+... ...+|.|.|+.||.|.
T Consensus 15 pC~N--GGtC~~~~~~~~~~y~C~C~~Gf~G~ 44 (52)
T 3ca7_A 15 YCLN--DAHCFAVKIADLPVYSCECAIGFMGQ 44 (52)
T ss_dssp TSCT--TCEEEEEEETTEEEEEEECCTTEEST
T ss_pred cCCC--CCEEecCccCCCCCEEEECCCCCcCC
Confidence 4765 789986321 1157999999999884
|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
Probab=80.56 E-value=0.92 Score=31.16 Aligned_cols=32 Identities=13% Similarity=0.350 Sum_probs=22.8
Q ss_pred CeeecCCCCCCcceeEecCCCccCCCCCccccc-Cc
Q 047195 192 SMCLQDAESAGQKRCLYKAGFQWDPISGICKSL-KC 226 (559)
Q Consensus 192 s~C~~~~~~~~gy~C~C~~Gy~gnpy~~~c~~~-~c 226 (559)
..|.+.. ++|+|.|+.||.-.+-...|+++ +|
T Consensus 13 ~~C~nt~---Gsy~C~C~~Gy~L~~d~~~C~didec 45 (55)
T 2jkh_L 13 QFCHEEQ---NSVVCSCARGYTLADNGKACIPTGPY 45 (55)
T ss_dssp SEEEEET---TEEEEECCTTEEECTTSSCEEESSSS
T ss_pred cEeEcCC---CCeEEeCCCCCEECCCCCeeccCccc
Confidence 3677754 68999999999855443457776 55
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=80.38 E-value=0.63 Score=45.73 Aligned_cols=31 Identities=26% Similarity=0.369 Sum_probs=27.7
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
..++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987754
|
| >2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.14 E-value=1 Score=30.23 Aligned_cols=33 Identities=12% Similarity=0.235 Sum_probs=24.0
Q ss_pred CCCCC--cccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 179 TCKLP--VDCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 179 ~C~~~--~~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
.|... .-|. |++|.+.... ..+.|.|..||.|.
T Consensus 11 ~C~~~~~~yC~---nG~C~~i~~~-~~~~C~C~~gy~G~ 45 (50)
T 2rnl_A 11 PCNAEFQNFCI---HGECKYIEHL-EAVTCKCQQEYFGE 45 (50)
T ss_dssp TTTTTGGGTCS---SSEEEEETTT-TEEEEECCSSCCSS
T ss_pred ccCchhhCcCC---CCEEEEecCC-CCeeEECCCCcccc
Confidence 45542 3576 7899865554 67899999999884
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 559 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-39 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-56
Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 39/284 (13%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-- 350
+ G +GSG FG V+K + + + + NEV +L + H +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 351 ------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
+ +L+ LH +++ + + IARQTAQ + YLH
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLH-- 121
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG-ASHVTTFAQGTLGYLDPEYYIN 457
I HRD+KS+NI L E L KI DFGL+ + SH G++ ++ PE
Sbjct: 122 -AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 458 FQ---LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514
+ +SDVY+FG+VL EL+T + + + +V G
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG--------------Y 226
Query: 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
L S++ + KA L A CL ++R RP ++ IE +
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (446), Expect = 2e-51
Identities = 70/306 (22%), Positives = 120/306 (39%), Gaps = 50/306 (16%)
Query: 283 FSSREITEATNNFST---------GNLLGSGGFGEVFKAIL----DDETITAVKRAKLGN 329
F+ + EA F+ ++G+G FGEV L E A+K K G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 330 T-KGIDPILNEVRILCQLNHR---SLFMSMSPNGTLF--------DRLHRVQSGNWPPLK 377
T K L+E I+ Q +H L ++ + + L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
+ + R A + YL HRD+ + NIL++ L K+SDFGLSR + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 438 HVTTFA----QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVN 493
T + + + + PE + T SDV+S+G+V+ E+++ + ++ +DV
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV- 242
Query: 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553
I + RL +D A L C + R +RP ++ +
Sbjct: 243 ----INAIEQDYRL-------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 554 EIERII 559
++++I
Sbjct: 286 TLDKMI 291
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-51
Identities = 72/282 (25%), Positives = 115/282 (40%), Gaps = 43/282 (15%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-- 350
LG+G FGEV+ + T AVK K G+ D L E ++ QL H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 351 ------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
+ NG+L D L L + L +A Q A+ +A++
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
HRD++++NIL+ + L KI+DFGL+RL + A+ + + PE
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 459 QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV--DAIDPMLK 516
T KSDV+SFG++L E++T + +V N+ + R+V D L
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYRMVRPDNCPEELY 240
Query: 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+ L C ER ++RP+ + +E
Sbjct: 241 Q---------------LMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-49
Identities = 62/281 (22%), Positives = 108/281 (38%), Gaps = 39/281 (13%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-- 350
+ LG G FGEV+ + T A+K K T + L E +++ +L H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 351 ------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL 398
+ G+L D L + +A Q A +AY+
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQIASGMAYVE-- 130
Query: 399 ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINF 458
HRD++++NIL+ E L K++DFGL+RL + A+ + + PE +
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 459 QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKEG 518
+ T KSDV+SFG++L EL T + +V +D ++ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMP 234
Query: 519 ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
+S+ C + + RP+ + + +E
Sbjct: 235 CPPECPESLHDLMCQ---CWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-48
Identities = 60/282 (21%), Positives = 106/282 (37%), Gaps = 41/282 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR--- 349
+ + +GSG FG V ++ A+K + G D + E ++ +L+H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLV 63
Query: 350 ------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
L +G L D L L + + +AYL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLE- 118
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
+ HRD+ + N L+ E K+SDFG++R L+ +T + + + PE +
Sbjct: 119 --EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 458 FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517
+ + KSDV+SFGV++ E+ + K NR +V +I RL
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYK-------- 223
Query: 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
+ + C ER ++RP+ + ++ I
Sbjct: 224 --PRLASTHVYQIMNH---CWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 4e-48
Identities = 55/281 (19%), Positives = 107/281 (38%), Gaps = 41/281 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-- 350
+ + LG+G FG V + A+K K G+ D + E +++ L+H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLV 62
Query: 351 -------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
+ NG L + L + L + + +A+ YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLE- 117
Query: 398 LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYIN 457
+ HRD+ + N L++++ K+SDFGLSR L+ + ++ + + PE +
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 458 FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517
+ + KSD+++FGV++ E+ + K + +I + RL
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGLRLYR-------- 222
Query: 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+ + + C E+ RP+ K + I +
Sbjct: 223 --PHLASEKVYTIMYS---CWHEKADERPTFKILLSNILDV 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 5e-48
Identities = 73/308 (23%), Positives = 113/308 (36%), Gaps = 63/308 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNTKGIDP-ILNEVRILCQ 345
NN +G G FG VF+A + T+ AVK K + + E ++ +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 346 LNHRS---------------LFMSMSPNGTLFDRLH-------------------RVQSG 371
++ + L G L + L RV S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 372 NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431
PPL +L IARQ A +AYL HRD+ + N L+ E + KI+DFGLSR
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 432 ALNG-ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
+ + ++ PE + T +SDV+++GVVL E+ + + E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
+V V GNIL + L L C + +RPS
Sbjct: 250 EVIYYVRDGNILA---CPENCPLELYN---------------LMRLCWSKLPADRPSFCS 291
Query: 551 VADEIERI 558
+ ++R+
Sbjct: 292 IHRILQRM 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-47
Identities = 56/298 (18%), Positives = 106/298 (35%), Gaps = 47/298 (15%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------- 350
+G G FGEV++ E + AVK + E+ L H +
Sbjct: 8 QESIGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65
Query: 351 ------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL- 397
L +G+LFD L+R + + +A TA +A+LH+
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHME 119
Query: 398 ----LATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ---GTLGYL 450
P I HRD+KS NIL+ + I+D GL+ + + GT Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 451 DPEYY------INFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE----DVNLVVYFGN 500
PE +F+ ++D+Y+ G+V E+ + + + D+
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 501 ILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+++ + P + E +++ + C R + + + ++
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCE--ALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-47
Identities = 69/298 (23%), Positives = 114/298 (38%), Gaps = 50/298 (16%)
Query: 285 SREITEATNNFSTGNLLGSGGFGEVFKAILDD-----ETITAVKRAKLGNT-KGIDPILN 338
+ EI + + ++G+G FGEV+K +L E A+K K G T K L
Sbjct: 1 TTEI--HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 58
Query: 339 EVRILCQLNH---------------RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLH 383
E I+ Q +H + NG L L +
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE----KDGEFSVLQLVG 114
Query: 384 IARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFA 443
+ R A + YL HRD+ + NIL++ L K+SDFGLSR+ + T +
Sbjct: 115 MLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 444 Q--GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501
+ + PE + T SDV+SFG+V+ E++T + + +V
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--------- 222
Query: 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
+ AI+ + +D A L C + R RP ++ ++++I
Sbjct: 223 ------MKAINDGFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 8e-47
Identities = 62/284 (21%), Positives = 102/284 (35%), Gaps = 51/284 (17%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-- 350
+G G FG+V + AVK K N L E ++ QL H +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 351 --------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
+ G+L D L L L + +A+ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
HRD+ + N+L+ E AK+SDFGL++ A S + + + PE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALR 173
Query: 457 NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL--VDAIDPM 514
+ + KSDV+SFG++L E+ + + +DV + K ++ D P
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKMDAPDGCPPA 228
Query: 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+ E + C RPS ++ +++E I
Sbjct: 229 VYE---------------VMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (412), Expect = 1e-46
Identities = 60/283 (21%), Positives = 107/283 (37%), Gaps = 41/283 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL 351
+ + + LG G +GEV++ + AVK K +T ++ L E ++ ++ H +L
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 352 ---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
G L D L N + L++A Q + A+ YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
HRD+ + N L+ E K++DFGLSRL A+ + + PE
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 457 NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516
+ + KSDV++FGV+L E+ T + + ++ + ++ +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------SQVYELLEKDYR 234
Query: 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
E + + C +RPS E+ E +
Sbjct: 235 MERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-46
Identities = 59/289 (20%), Positives = 107/289 (37%), Gaps = 30/289 (10%)
Query: 291 ATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGI-DPILNEVRILCQLNH 348
++F + LG+G G VFK + A K L I + I+ E+++L + N
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 349 R---------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
S+ M G+L L + + ++ + +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLT 118
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YL I HRD+K SNIL++ + + K+ DFG+S ++ + GT Y+ PE
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPE 173
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513
+ +SD++S G+ LVE+ + + +E + E P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI---KEVADEIERII 559
+ ++ A L ++E PS E D + + +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-46
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 54/298 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETIT---AVKRAKLGNTK-GIDPILNEVRILCQLNH 348
N+ +++G G FG+V KA + + + A+KR K +K E+ +LC+L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 349 ----------------RSLFMSMSPNGTLFDRLHRVQSGNWPP-----------LKWHHR 381
L + +P+G L D L + + P L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 382 LHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT 441
LH A A+ + YL HRD+ + NIL+ E AKI+DFGLSR T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184
Query: 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501
+ + ++ E T SDV+S+GV+L E+++ ++ + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----YEKL 239
Query: 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
+ RL E L+ L C E+ RPS ++ + R++
Sbjct: 240 PQGYRL-------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-45
Identities = 60/280 (21%), Positives = 107/280 (38%), Gaps = 43/280 (15%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP--ILNEVRILCQLNH-- 348
++ +G+G +G K D I K G+ + +++EV +L +L H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 349 -------------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+L++ M G L + + L L + Q A+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALK 123
Query: 394 YLHLL--ATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLD 451
H + HRD+K +N+ LD K + K+ DFGL+R+ + S F GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMS 182
Query: 452 PEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511
PE +KSD++S G +L EL ++E G I + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKF----- 231
Query: 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+ S+ + + L+ + +RPS++E+
Sbjct: 232 -RRIPYRYSDELNEIIT-------RMLNLKDYHRPSVEEI 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-44
Identities = 64/288 (22%), Positives = 100/288 (34%), Gaps = 48/288 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLGNTKGI-DPILNEVRILCQLN 347
G +G G FG+V + I + A+K K + + + L E + Q +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 348 HRS--------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
H + M + G L L L + A Q + A+A
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALA 122
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YL + HRDI + N+L+ K+ DFGLSR + + + + + ++ PE
Sbjct: 123 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL--VDAI 511
+ T SDV+ FGV + E+L + DV G I ERL
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERLPMPPNC 234
Query: 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
P L L C RP E+ ++ I+
Sbjct: 235 PPTLYS---------------LMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-44
Identities = 67/286 (23%), Positives = 107/286 (37%), Gaps = 49/286 (17%)
Query: 298 GNLLGSGGFGEVFKAILDDETIT----AVKRAKLGNTKG-IDPILNEVRILCQLNHRS-- 350
++G G FG V+ L D AVK G + L E I+ +H +
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 351 --------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
+ + +G L + + + Q A+ + +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG---ASHVTTFAQGTLGYLDPE 453
+ HRD+ + N +LDEK K++DFGL+R + + H T A+ + ++ E
Sbjct: 148 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513
+ T KSDV+SFGV+L EL+T DVN +L+ RL+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRRLLQ---- 255
Query: 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
E D + L C + + RPS E+ I I
Sbjct: 256 ------PEYCPDPLYEVMLK---CWHPKAEMRPSFSELVSRISAIF 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-44
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 50/296 (16%)
Query: 286 REITEATNNFSTGNL-LGSGGFGEVFKAIL---DDETITAVKRAKLGNTKG-IDPILNEV 340
+++ +N ++ LG G FG V + + + A+K K G K + ++ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 341 RILCQLNHRS--------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIAR 386
+I+ QL++ L M M+ G L L G + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLH 116
Query: 387 QTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ-- 444
Q + + YL HRD+ + N+LL + AKISDFGLS+ S+ T +
Sbjct: 117 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504
L + PE + + +SDV+S+GV + E L+ + + +V I +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----MAFIEQG 228
Query: 505 ERL--VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+R+ P L L + C + ++RP V +
Sbjct: 229 KRMECPPECPPELYA---------------LMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-43
Identities = 63/281 (22%), Positives = 103/281 (36%), Gaps = 47/281 (16%)
Query: 299 NLLGSGGFGEVFKAILDDETIT---AVKRAKLGNTKG--IDPILNEVRILCQLNHRS--- 350
LGSG FG V K + + AVK K D +L E ++ QL++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 351 -----------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
L M M+ G L L + +K + + + Q + + YL
Sbjct: 73 MIGICEAESWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTT--FAQGTLGYLDPEYYIN 457
HRD+ + N+LL + AKISDFGLS+ ++ + + + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 458 FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517
++ + KSDV+SFGV++ E + + + +V + K ER+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----TAMLEKGERM---------- 229
Query: 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+ L C +NRP V +
Sbjct: 230 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-42
Identities = 70/279 (25%), Positives = 105/279 (37%), Gaps = 52/279 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+F G LG G FG V+ A + I A+K +A+L + EV I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 349 RS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
+ L + +P GT++ L + + A A++
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALS 120
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
Y H + + HRDIK N+LL + KI+DFG S + S T GTL YL PE
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPE 174
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE-RLVDAID 512
+K D++S GV+ E L K + N +E I + E D +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK------RISRVEFTFPDFVT 228
Query: 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
++ L + L RP ++EV
Sbjct: 229 EGARD---------------LISRLLKHNPSQRPMLREV 252
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-42
Identities = 56/286 (19%), Positives = 108/286 (37%), Gaps = 46/286 (16%)
Query: 295 FSTGNLLGSGGFGEVFKAI-LDDETITAVKRA-----KLGNTKGIDPILNEVRILCQLNH 348
F +LGSG FG V+K + + + + A + + K IL+E ++ +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 349 RS--------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
L + P G L D + + + + L+ Q A+ + Y
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR-LALNGASHVTTFAQGTLGYLDPE 453
L + HRD+ + N+L+ KI+DFGL++ L + + + ++ E
Sbjct: 127 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513
++ T +SDV+S+GV + EL+T ++ + K ERL
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKGERL------ 232
Query: 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
++ C +RP +E+ E ++
Sbjct: 233 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-42
Identities = 67/278 (24%), Positives = 99/278 (35%), Gaps = 44/278 (15%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGN-TKGIDPILNEVRILCQLNHRS 350
++ LG G +GEV A+ E AVK + + I E+ I LNH +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 351 ---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
LF+ G LFDR+ + Q + YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYL 119
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR-LALNGASHVTTFAQGTLGYLDPEY 454
H I HRDIK N+LLDE+ + KISDFGL+ N + GTL Y+ PE
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 455 YINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513
+ + DV+S G+VL +L + +++ + + ID
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGEL--PWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
L L E R +I ++
Sbjct: 235 APLA---------------LLHKILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-42
Identities = 58/281 (20%), Positives = 105/281 (37%), Gaps = 46/281 (16%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS 350
+ + LG G FG+V+KA + + A K + + ++ + E+ IL +H +
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 351 ---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
+ + G + + ++ PL + +QT A+ YL
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYL 126
Query: 396 HLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYY 455
H I HRD+K+ NIL D K++DFG+S +F GT ++ PE
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVV 182
Query: 456 INFQLTD-----KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510
+ D K+DV+S G+ L+E+ + ++N + I K E A
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH------ELNPMRVLLKIAKSEPPTLA 236
Query: 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+ CL++ R + ++
Sbjct: 237 QPSRWSSNFKD-----------FLKKCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-42
Identities = 59/277 (21%), Positives = 101/277 (36%), Gaps = 50/277 (18%)
Query: 298 GNLLGSGGFGEVFKAILDDETIT-AVKRAKLG--NTKGIDPILNEVRILCQLNHRS---- 350
+G G F V+K + + T+ A + E +L L H +
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 351 ---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
L + +GTL L R + +K RQ + + +L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFL 128
Query: 396 HLLATPPIYHRDIKSSNILL-DEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
H TPPI HRD+K NI + KI D GL+ L + GT ++ PE
Sbjct: 129 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPE- 183
Query: 455 YINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514
+ + DVY+FG+ ++E+ TS+ ++ + + + +K P
Sbjct: 184 MYEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+KE + C+ + + R SIK++
Sbjct: 242 VKE---------------IIEGCIRQNKDERYSIKDL 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-41
Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 57/304 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLG-NTKGIDPILNEVRILCQ 345
N S G LG+G FG+V +A D AVK K + + +++E+++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 346 L----------------NHRSLFMSMSPNGTLFDRLHR-------------VQSGNWPPL 376
L + G L + L R + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 377 KWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436
L + Q A+ +A+L + HRD+ + NILL KI DFGL+R N +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 437 SH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
++ V A+ + ++ PE N T +SDV+S+G+ L EL + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555
F ++K+ + E A D + C D RP+ K++ I
Sbjct: 257 --FYKMIKEG-----FRMLSPEHAPAEMYD-------IMKTCWDADPLKRPTFKQIVQLI 302
Query: 556 ERII 559
E+ I
Sbjct: 303 EKQI 306
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-41
Identities = 55/289 (19%), Positives = 110/289 (38%), Gaps = 43/289 (14%)
Query: 279 LARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPIL 337
L ++ S + + ++ +G G G V+ A+ + A+++ L + I+
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 338 NEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRL 382
NE+ ++ + + + + M G+L D + +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIA 119
Query: 383 HIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTF 442
+ R+ QA+ +LH + + HRDIKS NILL K++DFG S +T
Sbjct: 120 AVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 443 AQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNIL 502
GT ++ PE K D++S G++ +E++ + + L+ G
Sbjct: 177 V-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-- 233
Query: 503 KQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+ + + + + ++ CLD + R S KE+
Sbjct: 234 PELQNPEKLSAIFRD---------------FLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-40
Identities = 59/289 (20%), Positives = 101/289 (34%), Gaps = 47/289 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETIT----AVKRAK---LGNTKGIDPILNEVRILCQ 345
+ LG G FG V + D + AVK K L + +D + EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 346 LNHR--------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQA 391
L+HR + ++P G+L DRL + + A Q A+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEG 123
Query: 392 IAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASH--VTTFAQGTLGY 449
+ YL + HRD+ + N+LL + KI DFGL R H + + +
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 450 LDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509
PE + SD + FGV L E+ T + + I K+ +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLP 235
Query: 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558
+ ++ + + C + ++RP+ + D +
Sbjct: 236 RPEDCPQDIYN------------VMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 60/306 (19%), Positives = 105/306 (34%), Gaps = 62/306 (20%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETIT------AVKRAKLGNTKG-IDPILNEVRILCQ 345
N G +LGSG FG+V A + T AVK K + +++E++++ Q
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 346 L----------------NHRSLFMSMSPNGTLFDRLHR------------------VQSG 371
L L G L + L +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 372 NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431
+ L + L A Q A+ + +L HRD+ + N+L+ KI DFGL+R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 432 ALNGASHVT-TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEE 490
++ +++V A+ + ++ PE T KSDV+S+G++L E+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-------- 265
Query: 491 DVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKE 550
+ I I K + + +C + RPS
Sbjct: 266 ------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPN 316
Query: 551 VADEIE 556
+ +
Sbjct: 317 LTSFLG 322
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 2e-39
Identities = 66/295 (22%), Positives = 115/295 (38%), Gaps = 56/295 (18%)
Query: 279 LARIFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKR---AKLGNTKGID 334
+A +F + + FS +G G FG V+ A + + + A+K+ + + +
Sbjct: 4 VAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 335 PILNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWH 379
I+ EVR L +L H + L M + PL+
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEV 115
Query: 380 HRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439
+ Q +AYLH + + HRD+K+ NILL E K+ DFG + + S V
Sbjct: 116 EIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 172
Query: 440 TTFAQGTLGYLDPEYYINF---QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496
GT ++ PE + Q K DV+S G+ +EL K + ++N +
Sbjct: 173 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL------FNMNAMS 221
Query: 497 YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+I + E + SE + + +CL + Q+RP+ + +
Sbjct: 222 ALYHIAQNES-----PALQSGHWSEYFRNFVD-------SCLQKIPQDRPTSEVL 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-39
Identities = 69/303 (22%), Positives = 111/303 (36%), Gaps = 56/303 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI------LDDETITAVKRAKLGNTKG-IDPILNEVRILCQ 345
+ G LG G FG+V +A AVK K G T +++E++IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 346 LNHRS-----------------LFMSMSPNGTLFDRLHRVQSGNWP-----------PLK 377
+ H + + G L L ++ P L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 378 WHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437
H + + Q A+ + +L + HRD+ + NILL EK KI DFGL+R
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 438 HV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496
+V A+ L ++ PE + T +SDV+SFGV+L E+ + + V +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDE 244
Query: 497 YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556
F LK+ + A D E C RP+ E+ + +
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQ------------TMLDCWHGEPSQRPTFSELVEHLG 292
Query: 557 RII 559
++
Sbjct: 293 NLL 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 61/304 (20%), Positives = 115/304 (37%), Gaps = 58/304 (19%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL--------DDETITAVKRAKLGNT-KGIDPILNEVRIL 343
+ G LG G FG+V A + T AVK K T K + +++E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 344 CQLNH----------------RSLFMSMSPNGTLFDRLH-----------RVQSGNWPPL 376
+ + + + G L + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 377 KWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436
+ A Q A+ + YL + HRD+ + N+L+ E KI+DFGL+R +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 437 SHVTTFA-QGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
+ T + + ++ PE + T +SDV+SFGV+L E+ T + E++
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 246
Query: 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEI 555
F + + R+ + + ++ C RP+ K++ +++
Sbjct: 247 --FKLLKEGHRM-------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 556 ERII 559
+RI+
Sbjct: 292 DRIV 295
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 65/295 (22%), Positives = 103/295 (34%), Gaps = 49/295 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQ 345
+ LG G FG V++ + + ET A+K + + LNE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 346 LNHRS---------------LFMSMSPNGTLFDRLHRVQSG-----NWPPLKWHHRLHIA 385
N + M + G L L ++ P + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 386 RQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL-NGASHVTTFAQ 444
+ A +AYL+ HRD+ + N ++ E KI DFG++R
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 445 GTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504
+ ++ PE + T SDV+SFGVVL E+ T + E V V G +L
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD- 255
Query: 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
D ML E L C + RPS E+ I+ +
Sbjct: 256 --KPDNCPDMLFE---------------LMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (351), Expect = 3e-37
Identities = 47/277 (16%), Positives = 89/277 (32%), Gaps = 43/277 (15%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS- 350
+++ LG+G FG V + A K + + + E++ + L H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 351 --------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
+ G LF+++ + + + RQ + + ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMH 141
Query: 397 LLATPPIYHRDIKSSNILLDEKLD--AKISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
H D+K NI+ K K+ DFGL+ S T GT + PE
Sbjct: 142 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 455 YINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514
+ +D++S GV+ LL+ ++E + V + + I
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS-CDWNMDDSAFSGISED 255
Query: 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
K+ L R +I +
Sbjct: 256 GKD---------------FIRKLLLADPNTRMTIHQA 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (334), Expect = 1e-35
Identities = 64/293 (21%), Positives = 105/293 (35%), Gaps = 50/293 (17%)
Query: 292 TNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAK---LGNTKGIDPILNEVRILCQLN 347
++ + G +LG GG EV A L AVK + + E + LN
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 348 HRS-------------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQT 388
H + + M TL D +H P+ + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADA 120
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ--GT 446
QA+ + H I HRD+K +NI++ K+ DFG++R + + VT A GT
Sbjct: 121 CQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506
YL PE + +SDVYS G VL E+LT + + V + +
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSA 236
Query: 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-SIKEVADEIERI 558
+ + L + L + +NR + E+ ++ R+
Sbjct: 237 RHEGLSADLDA---------------VVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-35
Identities = 56/284 (19%), Positives = 97/284 (34%), Gaps = 50/284 (17%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNHR 349
+F G +LG G F V A L A+K + + + + E ++ +L+H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 350 S---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAY 394
+S + NG L + + + A+ Y
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEY 123
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL-ALNGASHVTTFAQGTLGYLDPE 453
LH I HRD+K NILL+E + +I+DFG +++ + GT Y+ PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE-RLVDAID 512
SD+++ G ++ +L+ F N + F I+K E +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAG----NEYLIFQKIIKLEYDFPEKFF 234
Query: 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIE 556
P ++ L L R +E+
Sbjct: 235 PKARD---------------LVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (329), Expect = 5e-35
Identities = 64/290 (22%), Positives = 97/290 (33%), Gaps = 58/290 (20%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP---------ILNEVRIL 343
N+ +LG G V + I AVK + L EV IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 344 CQLNHRS----------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQ 387
+++ L + G LFD L L I R
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
+ I LH L I HRD+K NILLD+ ++ K++DFG S G GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTP 173
Query: 448 GYLDPEYY------INFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501
YL PE + + D++S GV++ LL ++ + +++ GN
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS-GNY 232
Query: 502 LKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
D +K+ L + L + Q R + +E
Sbjct: 233 QFGSPEWDDYSDTVKD---------------LVSRFLVVQPQKRYTAEEA 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 131 bits (330), Expect = 2e-34
Identities = 52/277 (18%), Positives = 94/277 (33%), Gaps = 43/277 (15%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS- 350
+ + LGSG FG V + + + K + NE+ I+ QL+H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 351 --------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
L + G LFDR+ + ++ RQ + + ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMH 144
Query: 397 LLATPPIYHRDIKSSNILLDEKLDA--KISDFGLSRLALNGASHVTTFAQGTLGYLDPEY 454
I H DIK NI+ + K + KI DFGL+ + T + PE
Sbjct: 145 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEI 199
Query: 455 YINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514
+ +D+++ GV+ LL+ + E + V + E ++ P
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-CDWEFDEDAFSSVSPE 258
Query: 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
K+ L + + R ++ +
Sbjct: 259 AKD---------------FIKNLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-34
Identities = 50/284 (17%), Positives = 99/284 (34%), Gaps = 47/284 (16%)
Query: 286 REITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILC 344
+E+ E + LG G FG V + + + K K+ T + + E+ IL
Sbjct: 1 KELYE---KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILN 56
Query: 345 QLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTA 389
HR+ + +F+R++ + L + Q
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVC 112
Query: 390 QAIAYLHLLATPPIYHRDIKSSNILLDEKLDA--KISDFGLSRLALNGASHVTTFAQGTL 447
+A+ +LH + I H DI+ NI+ + + KI +FG +R G + F
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAP 167
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507
Y PE + + ++ +D++S G ++ LL+ ++ + ++ E
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-AEYTFDEEA 226
Query: 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
I + L + R++R + E
Sbjct: 227 FKEISIEAMD---------------FVDRLLVKERKSRMTASEA 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (314), Expect = 4e-32
Identities = 62/287 (21%), Positives = 101/287 (35%), Gaps = 52/287 (18%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRILCQL-- 346
N+FS ++G GGFGEV+ D + A+K + ++ +G LNE +L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 347 ----------------NHRSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQ 390
+ S + + G L L + A +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIIL 118
Query: 391 AIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYL 450
+ ++H + +RD+K +NILLDE +ISD GL+ H + GT GY+
Sbjct: 119 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 172
Query: 451 DPEYYINFQLTD-KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509
PE D +D +S G +L +LL F + + + + L D
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVELPD 230
Query: 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSI-KEVADEI 555
+ P L+ L L R A E+
Sbjct: 231 SFSPELRS---------------LLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (310), Expect = 4e-32
Identities = 63/283 (22%), Positives = 105/283 (37%), Gaps = 40/283 (14%)
Query: 286 REITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP-ILNEVRIL 343
++ + + + ++LG+G F EV A + + A+K +G + + NE+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 344 CQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQT 388
++ H + L M + G LFDR+ + Q
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQV 116
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLG 448
A+ YLH L + LDE ISDFGLS++ G V + A GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPG 174
Query: 449 YLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508
Y+ PE + D +S GV+ LL D N F ILK E
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF------YDENDAKLFEQILKAEY-- 226
Query: 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
D + S+ D ++ +++ + R + ++
Sbjct: 227 -EFDSPYWDDISDSAKDFIR-------HLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (308), Expect = 9e-32
Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 15/200 (7%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+F LG+G FG V + A+K + + K ++ +E +L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 349 R---SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLH----IARQTAQAIAYLHLLATP 401
++ + +F + ++ G L + A+ L L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLT 461
I +RD+K NILLD+ KI+DFG ++ VT GT Y+ PE
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 462 DKSDVYSFGVVLVELLTSKK 481
D +SFG+++ E+L
Sbjct: 180 KSIDWWSFGILIYEMLAGYT 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-31
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 29/208 (13%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRIL-CQLN 347
+F +LG G FG+VF A A+K + + ++ + E R+L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 348 HRSL---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAI 392
H L M G L + A + +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGL 116
Query: 393 AYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
+LH + I +RD+K NILLD+ KI+DFG+ + + G + TF GT Y+ P
Sbjct: 117 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAP 172
Query: 453 EYYINFQLTDKSDVYSFGVVLVELLTSK 480
E + + D +SFGV+L E+L +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 3e-31
Identities = 52/291 (17%), Positives = 102/291 (35%), Gaps = 35/291 (12%)
Query: 291 ATNNFSTGNLLGSGGFGEVFKA--ILDDETITAVKRAKLGNTKGIDP--ILNEVRILCQL 346
A + +G G +G+VFKA + + A+KR ++ + P + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 347 ---NHRSL----------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQ 387
H ++ +++ D + P + + Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTL 447
+ + +LH + + HRD+K NIL+ K++DFGL+R+ + + TL
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTL 179
Query: 448 GYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507
Y PE + D++S G + E+ K + + + + ++ + +E
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 508 VDAIDPMLKEGASEIELDSMKAFGLLGAA-------CLDERRQNRPSIKEV 551
+ + S+ K + CL R S
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 5e-31
Identities = 57/279 (20%), Positives = 99/279 (35%), Gaps = 31/279 (11%)
Query: 299 NLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP-----ILNEVRILCQLNHR--- 349
+ LG G F V+KA + I A+K+ KLG+ L E+++L +L+H
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 350 SLFMSMSPNGTLF-------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP 402
L + + L + N L H T Q + YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 120
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
I HRD+K +N+LLDE K++DFGL++ + + T T Y PE ++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 463 -KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV---------YFGNILKQERLVDAID 512
D+++ G +L ELL + + + + + + + ++ V
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
L+ R + +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLI-QGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 119 bits (299), Expect = 1e-30
Identities = 40/293 (13%), Positives = 85/293 (29%), Gaps = 46/293 (15%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS- 350
++ G +G G FG +F+ L + A+K + +E R L +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 351 -------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHL 397
+ + G + L + A+Q + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH- 118
Query: 398 LATPPIYHRDIKSSNILLDEKLD-----AKISDFGLSRLALNGASHVTTFAQ------GT 446
+ +RDIK N L+ + DFG+ + + + + GT
Sbjct: 119 --EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 447 LGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506
Y+ ++ + + + D+ + G V + L + N K ER
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---------NKQKYER 227
Query: 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
+ + E+ + F + P + +++
Sbjct: 228 IGEKKQSTPLR---ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 61/298 (20%), Positives = 111/298 (37%), Gaps = 46/298 (15%)
Query: 290 EATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKG-IDPILNEVRILCQLN 347
+ ++ + +G G +G V A ++ A+K+ + L E++IL +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 348 HRSL-------------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQT 388
H ++ ++ L+ L L H + Q
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQI 118
Query: 389 AQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQ--GT 446
+ + Y+H + + HRD+K SN+LL+ D KI DFGL+R+A H + T
Sbjct: 119 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 447 LGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505
Y PE +N + KS D++S G +L E+L+++ + +N ++ QE
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 506 RLVDAIDPMLKEGASEIELD------------SMKAFGLLGAACLDERRQNRPSIKEV 551
L I+ + + KA LL L R +++
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL-DKMLTFNPHKRIEVEQA 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-30
Identities = 50/207 (24%), Positives = 75/207 (36%), Gaps = 28/207 (13%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
N+F LLG G FG+V A+K + + + + E R+L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 349 RSL---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L M + G LF L R + A+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALE 119
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YLH + + +RDIK N++LD+ KI+DFGL + GT YL PE
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPE 175
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSK 480
+ D + GVV+ E++ +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 3e-30
Identities = 48/281 (17%), Positives = 96/281 (34%), Gaps = 26/281 (9%)
Query: 294 NFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNHR- 349
NF +G G +G V+KA + A+K+ +L + E+ +L +LNH
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 350 --SLFMSMSPNGTLF--------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA 399
L + L+ D + + + Q Q +A+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 400 TPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ 459
+ + HRD+K N+L++ + K++DFGL+R T
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 460 LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV---------YFGNILKQERLVDA 510
+ D++S G + E++T + + E + + + + + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
++ S++ + L + L R S K
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (291), Expect = 1e-29
Identities = 44/288 (15%), Positives = 86/288 (29%), Gaps = 38/288 (13%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH--- 348
N + G +GSG FG+++ + A+K + + E +I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 349 -RSLFMSMSPNGTLF-------DRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
++ + L + + L +A Q I Y+H +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 121
Query: 401 PPIYHRDIKSSNIL---LDEKLDAKISDFGLSRLALNGASHV------TTFAQGTLGYLD 451
HRD+K N L + I DFGL++ + +H GT Y
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 452 PEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511
++ + + + D+ S G VL+ + E+ +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-----SEKKMSTP 236
Query: 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559
+L +G + C R ++P + +
Sbjct: 237 IEVLCKGYPSEFATYLN-------FCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-29
Identities = 48/280 (17%), Positives = 97/280 (34%), Gaps = 22/280 (7%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP--ILNEVRILCQLNHR 349
+ +G G +G VFKA + I A+KR +L + P L E+ +L +L H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 350 SL------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQ-TAQAIAYLHLLATPP 402
++ S +F+ + + I + Q + L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 403 IYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTD 462
+ HRD+K N+L++ + K+++FGL+R + + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 463 KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID---------- 512
D++S G + EL + + + + +D ++ E ++
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 513 -PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
P + + + LL L R S +E
Sbjct: 242 YPATTSLVNVVPKLNATGRDLL-QNLLKCNPVQRISAEEA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 115 bits (288), Expect = 2e-29
Identities = 47/284 (16%), Positives = 93/284 (32%), Gaps = 32/284 (11%)
Query: 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLG--NTKGIDPILNEVRILCQLNH-- 348
+ +G G +G V+KA + A+K+ +L + + E+ IL +L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 349 ------------RSLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLH 396
R + + + L L + L+ Q IAY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCH 117
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
+ HRD+K N+L++ + + KI+DFGL+R T
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 457 NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV---------YFGNILKQERL 507
+ + + D++S G + E++ E + + + + N+ + +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
++ L + L R + K+
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 62/293 (21%), Positives = 105/293 (35%), Gaps = 34/293 (11%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP--ILNEVRILCQLNHR 349
+ + +G G FGEVFKA A+K+ + N K P L E++IL L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 350 SL-----------FMSMSPNGTLFDRLHRVQSG----NWPPLKWHHRLHIARQTAQAIAY 394
++ G+++ + L I R +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 395 LHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR---LALNGASHVTTFAQGTLGYLD 451
L+ + I HRD+K++N+L+ K++DFGL+R LA N + T TL Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 452 PEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510
PE + + D++ G ++ E+ T + N E+ + L+ + E +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 511 IDPMLKEGASEIELDSMKAFGLLGAA------------CLDERRQNRPSIKEV 551
+ L E ++ K L A L R +
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (286), Expect = 1e-28
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 31/207 (14%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK---RAKLGNTKGIDPILNEVRILCQLNH 348
+ F LG+G FG V + A+K + K+ K I+ LNE RIL +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 349 RSL---------------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L M G +F L R+ H A Q
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155
Query: 394 YLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPE 453
YLH L + +RD+K N+L+D++ +++DFG ++ + GT L PE
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPE 208
Query: 454 YYINFQLTDKSDVYSFGVVLVELLTSK 480
++ D ++ GV++ E+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-28
Identities = 59/290 (20%), Positives = 111/290 (38%), Gaps = 42/290 (14%)
Query: 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-- 350
+++ ++G+G FG V++A L D + A+K+ + E++I+ +L+H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 351 -----------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
L + + R+ R S L + Q +++A
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 394 YLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
Y+H + I HRDIK N+LLD K+ DFG ++ + G +V+ Y P
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YYRAP 191
Query: 453 EYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511
E T DV+S G VL ELL + + + + ++ +E++ +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 512 DPMLKEGASEIELD----------SMKAFGLLGAACLDERRQNRPSIKEV 551
+ +I+ +A L + L+ R + E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC-SRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-28
Identities = 64/296 (21%), Positives = 103/296 (34%), Gaps = 55/296 (18%)
Query: 282 IFSSREITEATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKG------ID 334
+F + + + TG LGSG F V K A K K TK +
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 335 PILNEVRILCQLNHRS---------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWH 379
I EV IL ++ H + L + + G LFD L L
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-----KESLTEE 113
Query: 380 HRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE----KLDAKISDFGLSRLALNG 435
+Q + YLH + I H D+K NI+L + K KI DFGL+
Sbjct: 114 EATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 168
Query: 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
+ GT ++ PE L ++D++S GV+ LL+ + ++E + V
Sbjct: 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228
Query: 496 VYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
N ++ + K+ L + + R +I++
Sbjct: 229 SA-VNYEFEDEYFSNTSALAKD---------------FIRRLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-28
Identities = 63/286 (22%), Positives = 103/286 (36%), Gaps = 64/286 (22%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP------ILNEVRILCQ 345
+ + G LLGSGGFG V+ I + D A+K + + EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 346 LNHRS------------------LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQ 387
++ + P LFD + L+ Q
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQ 118
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLD-EKLDAKISDFGLSRLALNGASHVTTFAQGT 446
+A+ + H + HRDIK NIL+D + + K+ DFG L V T GT
Sbjct: 119 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGT 172
Query: 447 LGYLDPEYYINFQLTDKS-DVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505
Y PE+ + +S V+S G++L +++ F +EE + V+F
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFFR------ 224
Query: 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+ + L CL R +RP+ +E+
Sbjct: 225 ---QRVSSECQH---------------LIRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 7e-27
Identities = 54/279 (19%), Positives = 88/279 (31%), Gaps = 49/279 (17%)
Query: 297 TGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH------- 348
T +LG G G+V + + A+K + EV + + +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRI 70
Query: 349 -----------RSLFMSMS--PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYL 395
+ L + M G LF R+ I + +AI YL
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYL 127
Query: 396 HLLATPPIYHRDIKSSNILLDEKLD---AKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
H + I HRD+K N+L K K++DFG ++ + S T T Y+ P
Sbjct: 128 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAP 182
Query: 453 EYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512
E + D++S GV++ LL N + + + E
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEV 551
+ +E I L R +I E
Sbjct: 243 EVSEEVKMLIR------------NLLKTEPTQRMTITEF 269
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-26
Identities = 69/318 (21%), Positives = 110/318 (34%), Gaps = 61/318 (19%)
Query: 266 VQKDISGANNSGRLARIFSSREITEATNNFSTGNLLGSGGFGEVFKAIL----DDETITA 321
V+ ++ AN +G ++ NF +LG+G +G+VF D + A
Sbjct: 5 VKHELRTANLTGHAEKV--------GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 56
Query: 322 VKRAK----LGNTKGIDPILNEVRILCQLNHRS----------------LFMSMSPNGTL 361
+K K + K + E ++L + L + G L
Sbjct: 57 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 116
Query: 362 FDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421
F L + H + A+ +LH I +RDIK NILLD
Sbjct: 117 FTHLSQ-----RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHV 168
Query: 422 KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQ--LTDKSDVYSFGVVLVELLTS 479
++DFGLS+ + + GT+ Y+ P+ D +S GV++ ELLT
Sbjct: 169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 480 KKAVDFNREEEDVNLVVYFGNILKQE-RLVDAIDPMLKEGASEIELDSMKAFGLLGAACL 538
F + E + ILK E + + K+ L L
Sbjct: 229 ASP--FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD---------------LIQRLL 271
Query: 539 DERRQNRPSI-KEVADEI 555
+ + R ADEI
Sbjct: 272 MKDPKKRLGCGPRDADEI 289
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 46/224 (20%), Positives = 82/224 (36%), Gaps = 37/224 (16%)
Query: 283 FSSREITEAT----NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK--RAKLGNTKGIDP 335
F +E+T+ + +GSG +G V A+ A+K +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 336 ILNEVRILCQLNHR-------------------SLFMSMSPNGTLFDRLHRVQSGNWPPL 376
E+R+L + H ++ M GT +L + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-----KL 118
Query: 377 KWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436
+ Q + + Y+H I HRD+K N+ ++E + KI DFGL+R
Sbjct: 119 GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QAD 172
Query: 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
S +T + + T D++S G ++ E++T K
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 103 bits (258), Expect = 5e-25
Identities = 51/241 (21%), Positives = 94/241 (39%), Gaps = 39/241 (16%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLN---- 347
+++ LG G + EVF+AI + + VK K K I E++IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK---IKREIKILENLRGGPN 91
Query: 348 ------------HRSLFMSM--SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIA 393
R+ + N L + + +A+
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALD 143
Query: 394 YLHLLATPPIYHRDIKSSNILLDEK-LDAKISDFGLSRLALNGASHVTTFAQGTLGYLDP 452
Y H + I HRD+K N+++D + ++ D+GL+ G + + + P
Sbjct: 144 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 453 EYYINFQLTD-KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511
E +++Q+ D D++S G +L ++ K+ F ++ + +V +L E L D I
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 512 D 512
D
Sbjct: 257 D 257
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 9e-24
Identities = 57/307 (18%), Positives = 106/307 (34%), Gaps = 50/307 (16%)
Query: 283 FSSREIT----EATNNFSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDP-- 335
F +E+ E + + +GSG +G V A AVK+ I
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 336 ILNEVRILCQLNHR-------------------SLFMSMSPNGTLFDRLHRVQSGNWPPL 376
E+R+L + H +++ G + + + Q L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KL 118
Query: 377 KWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436
H + Q + + Y+H + I HRD+K SN+ ++E + KI DFGL+
Sbjct: 119 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHT 171
Query: 437 SHVTTFAQGTLGYLDPEYYINFQLTD-KSDVYSFGVVLVELLTSKKAVDFNREEEDVNLV 495
T T Y PE +N+ + D++S G ++ ELLT + + + L+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231
Query: 496 V-----------YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQN 544
+ + + ++ M K + + + + L L
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
Query: 545 RPSIKEV 551
R + +
Sbjct: 292 RITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (244), Expect = 5e-23
Identities = 50/220 (22%), Positives = 80/220 (36%), Gaps = 21/220 (9%)
Query: 293 NNFSTGNLLGSGGFGEVFKAI-LDDETITAVK--RAKLGNTKGIDPILNEVRILCQLNHR 349
+ +GSG G V A + A+K N E+ ++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 350 ---SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLH----------IARQTAQAIAYLH 396
SL +P TL + + + Q I +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 397 LLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYI 456
+ I HRD+K SNI++ KI DFGL+R G S + T T Y PE +
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 457 NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVV 496
+ D++S G ++ E++ K + N V+
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.0 bits (214), Expect = 4e-19
Identities = 40/219 (18%), Positives = 79/219 (36%), Gaps = 40/219 (18%)
Query: 295 FSTGNLLGSGGFGEVFKAI-LDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHR---- 349
+ LG G F V+ A + + T A+K + G+ + +E+++L ++N
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 350 ----------------------SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQ 387
+ + M + L ++ + + I++Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 388 TAQAIAYLHLLATPPIYHRDIKSSNILLDEK------LDAKISDFGLSRLALNGASHVTT 441
+ Y+H I H DIK N+L++ + KI+D G + T
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYT 187
Query: 442 FAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK 480
+ T Y PE + +D++S ++ EL+T
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 4e-17
Identities = 25/150 (16%), Positives = 45/150 (30%), Gaps = 21/150 (14%)
Query: 298 GNLLGSGGFGEVFKAILDDETITAVKRAKLGNT----------KGIDPILNEVRILCQLN 347
G L+G G VF + VK K+G+T G +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 348 HRSLFMSMSPN-------GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLAT 400
R+L + + + ++ + + + +A +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---H 121
Query: 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSR 430
I H D+ N+L+ E+ I DF S
Sbjct: 122 RGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 559 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.04 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.09 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.43 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 96.09 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.91 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 94.73 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 94.55 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.54 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.12 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 94.01 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.76 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 93.72 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 93.7 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 93.35 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 93.29 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 93.15 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.8 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 92.65 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 92.59 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 92.1 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 91.86 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 91.55 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.51 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.07 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 90.82 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 90.75 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 90.26 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 89.23 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 88.63 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 87.66 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 87.06 | |
| d2i9aa1 | 40 | Plasminogen activator (urokinase-type) {Human (Hom | 85.53 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 85.11 | |
| d1ioxa_ | 50 | Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] | 83.28 | |
| d1xdtr_ | 41 | Heparin-binding epidermal growth factor, HBEGF {Hu | 82.64 | |
| d1moxc_ | 49 | Transforming growth factor alpha {Human (Homo sapi | 82.22 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 80.52 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=388.53 Aligned_cols=244 Identities=31% Similarity=0.491 Sum_probs=189.9
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce--------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL--------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni--------------v~~~ 355 (559)
.++|++.+.||+|+||+||+|++++ .||||+++... ....+.|.+|+.+|++++|||| ||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEec
Confidence 5689999999999999999998654 59999987543 3445679999999999999994 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++|+|.+++.... ..+++..++.++.||++||+||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999997543 25899999999999999999999 788999999999999999999999999999876543
Q ss_pred Cc-eeeeeccccCCccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 436 AS-HVTTFAQGTLGYLDPEYYINF---QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 436 ~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
.. .......||+.|||||++.+. .++.++|||||||+||||+||+.||.......... ..... + ..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~----~----~~ 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGR----G----YL 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHH----T----SC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhc----C----CC
Confidence 22 223445699999999998643 57899999999999999999999997544322111 11111 1 11
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.+.+... ....+..+.+|+.+||+.||++||||+||++.|+.|
T Consensus 228 ~p~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 228 SPDLSKV----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CCCGGGS----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchhc----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111111 112346788999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=391.06 Aligned_cols=243 Identities=28% Similarity=0.405 Sum_probs=197.5
Q ss_pred HhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EEeeC
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FMSMS 356 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~~~~ 356 (559)
..++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+++|++++|||| ||||+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~ 89 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM 89 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeC
Confidence 356788999999999999999999988999999987543 445789999999999999994 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+++..... ..+++..++.++.||++||+||| +++|+||||||+||||++++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999998765432 24899999999999999999999 7889999999999999999999999999999876554
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
........||+.|+|||++.+..++.++||||||+++|||+||+.|+........ ... ....+ ..+...
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~----~i~~~-----~~~~~p 232 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQ----NLERG-----YRMVRP 232 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH----HHHTT-----CCCCCC
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHhc-----CCCCCc
Confidence 4444455699999999999988999999999999999999997766543322111 111 11111 011111
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
...+..+.+|+.+||+.||++||||.||+++|+.+
T Consensus 233 -------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 233 -------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 12335788999999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=381.46 Aligned_cols=241 Identities=24% Similarity=0.367 Sum_probs=184.3
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.++|++.+.||+|+||+||+|++.++..||||++... ....++|.+|++++++++|||| ||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 3578899999999999999999988899999998754 3445789999999999999995 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999987542 35889999999999999999999 7889999999999999999999999999998776544
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
........||+.|+|||++.+..++.++||||||+++|||+|++.|+....... ....... .+. ....+
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i~----~~~--~~~~p--- 224 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDIS----TGF--RLYKP--- 224 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHHH----HTC--CCCCC---
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----hcC--CCCCc---
Confidence 444444569999999999999999999999999999999999655544322211 1111111 110 00011
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.....++.+|+.+||+.||++||||+||++.|++|
T Consensus 225 -------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 -------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-49 Score=385.40 Aligned_cols=247 Identities=25% Similarity=0.342 Sum_probs=199.5
Q ss_pred HHHHhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------
Q 047195 288 ITEATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------- 351 (559)
Q Consensus 288 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------- 351 (559)
++...++|++.+.||+|+||+||+|+++ +++.||||+++.. ....++|.+|+++|++++||||
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3344567899999999999999999965 5889999998754 3446789999999999999994
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
||||+++|+|.+++..... ..+++..++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+.
T Consensus 91 v~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EeecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceee
Confidence 7899999999999976433 36899999999999999999999 78899999999999999999999999999998
Q ss_pred ccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 432 ALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 432 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
.............||+.|+|||++.+..++.++||||||+++|||++|+.|+........ . ......+ .
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~----~~~i~~~-----~ 233 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YELLEKD-----Y 233 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H----HHHHHTT-----C
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--H----HHHHhcC-----C
Confidence 766555544555689999999999999999999999999999999998777653322211 1 1111111 0
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.+... ...+..+.+|+.+||+.||++||||.||++.|+.++
T Consensus 234 ~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 RMERP-------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCC-------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01111 123367889999999999999999999999998864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=373.11 Aligned_cols=234 Identities=23% Similarity=0.333 Sum_probs=192.1
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
++|++.+.||+|+||+||+|+. .+++.||||++........+.+.+|+++|++++|||| ||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999985 5689999999987766667889999999999999994 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|||+|+......
T Consensus 100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999887642 4899999999999999999999 7889999999999999999999999999998775443
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ......... +.+.
T Consensus 171 ~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~------~~~~ 237 (293)
T d1yhwa1 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT------PELQ 237 (293)
T ss_dssp CC-BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS------CCCS
T ss_pred cc-ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCC------CCCC
Confidence 32 2334599999999999999999999999999999999999999975432221 111111110 0000
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+......+.+|+.+||+.||++|||+.|+++
T Consensus 238 -----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 -----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -----SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01123367888999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=369.68 Aligned_cols=240 Identities=23% Similarity=0.390 Sum_probs=197.9
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
.++|++.++||+|+||+||+|++++++.||||+++.... ..++|++|++++++++|||| |+||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368999999999999999999999899999999886543 45789999999999999995 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+++..... .+++..+.+++.|+++||+||| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 82 ANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TTEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCcHHHhhhcccc----CCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999998765443 5889999999999999999999 7889999999999999999999999999998765544
Q ss_pred ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcccccc
Q 047195 437 SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPML 515 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 515 (559)
........||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+. . .....+. ....+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~---~----~~i~~~~--~~~~p-- 223 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---A----EHIAQGL--RLYRP-- 223 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---H----HHHHTTC--CCCCC--
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH---H----HHHHhCC--CCCCc--
Confidence 444444568999999999999999999999999999999998 7888875543221 1 1111110 00001
Q ss_pred ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 516 KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 516 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
......+.+|+.+||+.||++|||++||++.|.+|
T Consensus 224 --------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 --------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12236788999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=372.01 Aligned_cols=237 Identities=27% Similarity=0.349 Sum_probs=186.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++++|||| |||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 45799999999999999999996 5689999999876533 334679999999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 84 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999998643 25899999999999999999999 78899999999999999999999999999997654
Q ss_pred CCc-eeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 435 GAS-HVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 435 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... .......||+.|||||++.+..+ +.++|||||||++|||++|+.||........ .. ..........
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~---~~~~~~~~~~---- 226 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY---SDWKEKKTYL---- 226 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HH---HHHHTTCTTS----
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HH---HHHhcCCCCC----
Confidence 332 22344569999999999988776 5789999999999999999999975543221 11 1111110000
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ......+.+|+.+||+.||++|||++|+++
T Consensus 227 ----~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ----NPW----KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TTG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----Ccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 122356778999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=371.99 Aligned_cols=230 Identities=28% Similarity=0.409 Sum_probs=189.3
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||+||+|+. .+++.||+|++... .....+.+.+|++++++++|||| ||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4689999999999999999996 46889999998643 33445678999999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 9999999999997643 4899999999999999999999 7889999999999999999999999999998665
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
... .....||+.|||||++.+..++.++|||||||++|||++|+.||...+..+. ... ..... .
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~-i~~~~------~ 221 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKR-ISRVE------F 221 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHTTC------C
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH------HHH-HHcCC------C
Confidence 432 2345699999999999999999999999999999999999999975442221 111 11110 0
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.. ..+..+.+|+.+||+.||++|||++|+++
T Consensus 222 ~~p~-------~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPD-------FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCc-------cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111 12366788999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=378.20 Aligned_cols=240 Identities=23% Similarity=0.366 Sum_probs=180.7
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL-----------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni-----------------v 352 (559)
++|++.+.||+|+||+||+|+. .+++.||||.+..... ...+.+.+|+++|++++|||| |
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999985 5689999999876543 234568999999999999994 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC--CCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA--TPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 8999999999998753321 236999999999999999999999543 2459999999999999999999999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
........ .....||+.|||||++.+..++.++|||||||++|||+||+.||...+..+ .. .........
T Consensus 163 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~----~~i~~~~~~-- 232 (269)
T d2java1 163 ILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA----GKIREGKFR-- 232 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH----HHHHHTCCC--
T ss_pred ecccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HH----HHHHcCCCC--
Confidence 76543322 233559999999999999999999999999999999999999997543221 11 111111111
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+. ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 233 ---~~~-------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ---RIP-------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCC-------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 123357889999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-47 Score=379.14 Aligned_cols=241 Identities=26% Similarity=0.404 Sum_probs=181.0
Q ss_pred CCCCCCCccccCCccEEEEEEecC-C---cEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-E---TITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-~---~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v 352 (559)
++|++.++||+|+||+||+|+.+. + ..||||.+..... ...+.|.+|+++|++++|||| |
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457778899999999999998642 2 3688888765433 344679999999999999995 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++|+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+||||+.++++||+|||+++..
T Consensus 106 ~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 89999999999887532 35899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCcee----eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 433 LNGASHV----TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 433 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
....... .....||+.|||||++.+..++.++|||||||++|||+| |+.||......+ ... ....+.
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~----~i~~~~- 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VIN----AIEQDY- 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH----HHHTTC-
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCC-
Confidence 5432221 122347999999999999999999999999999999998 899987543321 111 111110
Q ss_pred hhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 508 VDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 508 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.+. .+...+..+.+|+.+||+.||++||||.||++.|++|+
T Consensus 251 ------~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 251 ------RLP-----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp ------CCC-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCC-----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 000 01223467889999999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=378.06 Aligned_cols=243 Identities=26% Similarity=0.371 Sum_probs=190.9
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce--------------EEeeCC
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------FMSMSP 357 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~ 357 (559)
.++|++.+.||+|+||+||+|+++++..||||+++... ...+.|.+|+.+|++++|+|| ||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecC
Confidence 45799999999999999999999988899999987543 345789999999999999995 789999
Q ss_pred CCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCc
Q 047195 358 NGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGAS 437 (559)
Q Consensus 358 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 437 (559)
+|+|...+..... ..++|..++.++.||+.||+||| +++|+||||||+||||++++++||+|||+++.......
T Consensus 95 ~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 95 KGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999988876443 24899999999999999999999 78899999999999999999999999999987755444
Q ss_pred eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccccccc
Q 047195 438 HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLKE 517 (559)
Q Consensus 438 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 517 (559)
.......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ ..... ..+ ......
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i----~~~-----~~~~~~- 236 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQV----ERG-----YRMPCP- 236 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH----HTT-----CCCCCC-
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHH----Hhc-----CCCCCC-
Confidence 444455699999999999999999999999999999999998777654332211 11111 111 001111
Q ss_pred CCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 518 GASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 518 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
...++++.+++.+||+.||++||||.+|+++|+.++
T Consensus 237 ------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 237 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 123367889999999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=372.12 Aligned_cols=236 Identities=24% Similarity=0.365 Sum_probs=190.2
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
+.|++.+.||+|+||+||+|+. .+++.||||++........+.+.+|+++|++++|||| ||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999995 5688999999987777777889999999999999994 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999876543 25899999999999999999999 7889999999999999999999999999997654321
Q ss_pred ceeeeeccccCCccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 437 SHVTTFAQGTLGYLDPEYYI-----NFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
. ......||+.|+|||++. +..|+.++|||||||++|||++|+.||...+..+. .. ...... .
T Consensus 165 ~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~---~i~~~~-~---- 232 (288)
T d2jfla1 165 Q-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LL---KIAKSE-P---- 232 (288)
T ss_dssp H-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HH---HHHHSC-C----
T ss_pred c-cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HH---HHHcCC-C----
Confidence 1 122345999999999984 45688999999999999999999999975543321 11 111110 0
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+.. ....+..+.+|+.+||+.||++|||++|+++
T Consensus 233 -~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 -PTLAQ-----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CCCSS-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCc-----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 1123467889999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=370.94 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=183.8
Q ss_pred hCCCCCCCccccCCccEEEEEEecCC-----cEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDE-----TITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
.+.|++.++||+|+||+||+|.+++. ..||||++..... ....+|.+|+++|++++||||
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999986543 4799999865433 334579999999999999995
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
|+||+.++++.+.+.... ..+++..++.++.|++.||+||| +++|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhh
Confidence 679999999998876543 35899999999999999999999 7889999999999999999999999999998
Q ss_pred eccCCCce--eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 431 LALNGASH--VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 431 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
........ ......||+.|||||++.+..++.++||||||+++|||++++.|+........ . ......+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~----~~~i~~~--- 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--V----MKAINDG--- 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H----HHHHHTT---
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--H----HHHHhcc---
Confidence 76543222 22234589999999999999999999999999999999997776653332211 1 1111111
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
..+.. +...+..+.+|+.+||+.||++||||.||+++|++|
T Consensus 230 --~~~~~-------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 230 --FRLPT-------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp --CCCCC-------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCCC-------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 00111 112336788999999999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=366.54 Aligned_cols=233 Identities=27% Similarity=0.349 Sum_probs=185.0
Q ss_pred CccccCCccEEEEEEecC---CcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce--------------EEeeCCCC
Q 047195 299 NLLGSGGFGEVFKAILDD---ETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL--------------FMSMSPNG 359 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~---~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni--------------v~~~~~~g 359 (559)
++||+|+||+||+|.+++ ++.||||+++.... ...++|.+|+++|++++|||| ||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 579999999999998643 46899999865332 234679999999999999994 78999999
Q ss_pred cHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCCcee
Q 047195 360 TLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGASHV 439 (559)
Q Consensus 360 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 439 (559)
+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 93 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred cHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999987532 5899999999999999999999 7889999999999999999999999999999776543332
Q ss_pred e--eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccccc
Q 047195 440 T--TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPMLK 516 (559)
Q Consensus 440 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 516 (559)
. ....||+.|||||++.+..++.++||||||+++|||+| |+.||......+ . ......+.. +.+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~----~~~i~~~~~-----~~~- 231 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKGER-----MGC- 231 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTCC-----CCC-
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---H----HHHHHcCCC-----CCC-
Confidence 2 33458999999999999999999999999999999998 899997543221 1 111111110 001
Q ss_pred cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 517 EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 517 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+...+.++.+|+.+||+.||++||||++|+++|+.+
T Consensus 232 ------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 112346788999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=369.71 Aligned_cols=240 Identities=25% Similarity=0.363 Sum_probs=191.1
Q ss_pred CCCCCCC-ccccCCccEEEEEEec---CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------EE
Q 047195 293 NNFSTGN-LLGSGGFGEVFKAILD---DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------FM 353 (559)
Q Consensus 293 ~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v~ 353 (559)
++|.+.+ +||+|+||+||+|.++ ++..||||+++.... ...++|.+|+++|++++|||| ||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 3455656 4999999999999753 456799999875433 345679999999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 88 E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp ECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999875432 35899999999999999999999 7889999999999999999999999999999876
Q ss_pred CCCceee--eeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 434 NGASHVT--TFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 434 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
....... ....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ .. .....+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~----~~i~~~~~--- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKR--- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTCC---
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCC---
Confidence 4433222 23458999999999998899999999999999999998 899997544321 11 11111110
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+.+ +...+.++.+|+.+||+.+|++||||.+|++.|+.+
T Consensus 231 --~~~-------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 231 --MEC-------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --CCC-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCC-------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011 112346788999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=358.96 Aligned_cols=229 Identities=23% Similarity=0.341 Sum_probs=180.6
Q ss_pred CCCCccccCCccEEEEEEec-CCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce-------------------EE
Q 047195 296 STGNLLGSGGFGEVFKAILD-DETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL-------------------FM 353 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni-------------------v~ 353 (559)
++.++||+|+||+||+|+.. +++.||+|.+.... ....+.+.+|+++|++++|||| ||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55578999999999999964 57899999987543 2334578999999999999994 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCC--eEECCCCCCCeeec-CCCCEEEeecccce
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPP--IYHRDIKSSNILLD-EKLDAKISDFGLSR 430 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dikp~Nill~-~~~~~kl~DFG~a~ 430 (559)
||+++|+|.+++.... .+++..+..++.||+.||+||| +++ |+||||||+|||++ +++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999999997643 4899999999999999999999 776 99999999999996 57899999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
...... .....||+.|||||++.+ .++.++|||||||++|||++|+.||........ . ......+..
T Consensus 164 ~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~-~~~i~~~~~--- 230 (270)
T d1t4ha_ 164 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----I-YRRVTSGVK--- 230 (270)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----H-HHHHTTTCC---
T ss_pred eccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----H-HHHHHcCCC---
Confidence 644332 234469999999998865 699999999999999999999999964432221 1 111111110
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...+.. ....++.+|+.+||+.||++|||+.|+++
T Consensus 231 -~~~~~~-------~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 -PASFDK-------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -CGGGGG-------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CcccCc-------cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 011111 12245788999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=377.05 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=188.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.++|++.++||+|+||+||+|+. .+++.||+|+++.... ...+.+.+|+.+|++++|||| |||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46799999999999999999995 5689999999876533 334678999999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ .++|+||||||+|||+++++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999997643 48999999999999999999993 24799999999999999999999999999987643
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH-HHHHhh----------
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY-FGNILK---------- 503 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~---------- 503 (559)
.. .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.......... ......
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 22 2234699999999999999999999999999999999999999976543221100000 000000
Q ss_pred ------------cchhhhccccccccCCChh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 504 ------------QERLVDAIDPMLKEGASEI-ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 504 ------------~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.....+.++.......... ......++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000000000000000 0012356888999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=372.59 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=194.1
Q ss_pred HHHhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCCC-ChhhHHHHHHHHHhcCCCce----------
Q 047195 289 TEATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNTK-GIDPILNEVRILCQLNHRSL---------- 351 (559)
Q Consensus 289 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni---------- 351 (559)
+...++|++.+.||+|+||+||+|+.+ +++.||||+++..... ..++|.+|+++|++++||||
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 334578999999999999999999864 4578999998754333 34579999999999999995
Q ss_pred -----EEeeCCCCcHhHhHhhccC-------------------CCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECC
Q 047195 352 -----FMSMSPNGTLFDRLHRVQS-------------------GNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRD 407 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~D 407 (559)
++||+++|+|.+++..... .....+++..++.++.|++.||+||| +++|+|||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeE
Confidence 6799999999999875321 11235889999999999999999999 78899999
Q ss_pred CCCCCeeecCCCCEEEeecccceeccCCC-ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCC-CCCC
Q 047195 408 IKSSNILLDEKLDAKISDFGLSRLALNGA-SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK-AVDF 485 (559)
Q Consensus 408 ikp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~-p~~~ 485 (559)
|||+|||++.++++||+|||+|+...... ........||+.|+|||.+.+..++.++||||||+++|||++|.. ||..
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999998654332 222334558999999999999999999999999999999999965 5654
Q ss_pred CCccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 486 NREEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
....+. . .....+.... + +...+..+.+|+.+||+.+|++||||.||+++|++|.
T Consensus 246 ~~~~e~---~----~~v~~~~~~~-----~-------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAHEEV---I----YYVRDGNILA-----C-------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCHHHH---H----HHHHTTCCCC-----C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHHHH---H----HHHHcCCCCC-----C-------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 432221 1 1111111110 1 1123357889999999999999999999999999984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=368.85 Aligned_cols=233 Identities=22% Similarity=0.316 Sum_probs=187.0
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++++|||| ||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4699999999999999999996 56899999998643 23445679999999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence 9999999999887653 4899999999999999999999 7889999999999999999999999999999775
Q ss_pred CCC-ceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 434 NGA-SHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 434 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. .... ....
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i-~~~~------ 226 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKI-IKLE------ 226 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-HTTC------
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH------HHHH-HcCC------
Confidence 432 2223345699999999999999999999999999999999999999975432211 1111 1111
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.. .....+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~p~-------~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 YDFPE-------KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCCT-------TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCc-------cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 01111 22356788999999999999999999743
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=370.81 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=190.8
Q ss_pred HhCCCCCCCccccCCccEEEEEEecCC------cEEEEEEeecC-CCCChhhHHHHHHHHHhc-CCCce-----------
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILDDE------TITAVKRAKLG-NTKGIDPILNEVRILCQL-NHRSL----------- 351 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~avk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni----------- 351 (559)
..++|++.++||+|+||+||+|++... ..||+|.+... .......+.+|+.+|.++ +||||
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 346799999999999999999986432 36899987653 334456799999999998 89994
Q ss_pred ----EEeeCCCCcHhHhHhhccCC------------------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCC
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSG------------------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIK 409 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dik 409 (559)
||||+++|+|.+++...... ....+++..++.++.||+.||+||| +++|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence 78999999999999764321 1235899999999999999999999 7889999999
Q ss_pred CCCeeecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCC
Q 047195 410 SSNILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNR 487 (559)
Q Consensus 410 p~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~ 487 (559)
|+|||++.++++||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 2334458999999999999999999999999999999998 899997554
Q ss_pred ccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 047195 488 EEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIER 557 (559)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~ 557 (559)
..... ......+. .... +...+.++.+|+.+||+.||++||||+||+++|.-
T Consensus 272 ~~~~~------~~~~~~~~-----~~~~-------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDANF------YKLIQNGF-----KMDQ-------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSHHH------HHHHHTTC-----CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH------HHHHhcCC-----CCCC-------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 32211 11111110 0001 11233678899999999999999999999999964
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=368.51 Aligned_cols=242 Identities=23% Similarity=0.330 Sum_probs=182.6
Q ss_pred hCCCCCCCccccCCccEEEEEEecC----CcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce--------------E
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD----ETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
.++|++.+.||+|+||+||+|++.. +..||||.++.... ...+.|.+|+++|++++|||| |
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence 4578999999999999999998542 35688888765433 234579999999999999994 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++|+|.+++.... ..+++..++.++.||++||+||| +++|+||||||+|||+++++.+||+|||+|+..
T Consensus 86 ~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheec
Confidence 89999999999876533 35899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
............||+.|+|||++.+..++.++|||||||++|||++ |..||......+. ... ...+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~----i~~~~~---- 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----IENGER---- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH----HHTTCC----
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHH----HHcCCC----
Confidence 6544444455568999999999999999999999999999999998 7888875543321 111 111110
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..+ +...+..+.+|+.+||+.||++|||+.||++.|+.|+
T Consensus 228 -~~~-------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 -LPM-------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCC-------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 001 1123467889999999999999999999999998873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.9e-46 Score=372.12 Aligned_cols=237 Identities=19% Similarity=0.255 Sum_probs=191.0
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
.++|++.+.||+|+||+||+|+. .+++.||||++........+.+.+|+++|++++|||| ||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34799999999999999999995 5689999999977665556779999999999999994 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec--CCCCEEEeecccceecc
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD--EKLDAKISDFGLSRLAL 433 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~--~~~~~kl~DFG~a~~~~ 433 (559)
+++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+++...
T Consensus 105 ~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999886432 25899999999999999999999 78899999999999996 46789999999998775
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.... .....||+.|||||++.+..++.++|||||||++|||++|+.||...+..+.. .... .... ....
T Consensus 178 ~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~-~~~~--~~~~ 246 (350)
T d1koaa2 178 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------RNVK-SCDW--NMDD 246 (350)
T ss_dssp TTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-HTCC--CSCC
T ss_pred cccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH------HHHH-hCCC--CCCc
Confidence 4433 23345999999999999999999999999999999999999999755432211 1110 0000 0000
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. .......+.+|+.+||+.||++|||++|+++
T Consensus 247 ~~-------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 247 SA-------FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GG-------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cc-------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0122356888999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-45 Score=361.94 Aligned_cols=237 Identities=26% Similarity=0.354 Sum_probs=173.8
Q ss_pred HhCCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
..+.|++.+.||+|+||+||+|+.+ +++.||||++..... ...+.+.+|+++|++++|||| ||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3456999999999999999999964 689999999875432 233568899999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec---CCCCEEEeecccce
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD---EKLDAKISDFGLSR 430 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~---~~~~~kl~DFG~a~ 430 (559)
||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||+. +++.+||+|||+|+
T Consensus 87 E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp CCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred eccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999753 25999999999999999999999 78899999999999994 57899999999998
Q ss_pred eccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
...... ......||+.|||||++.+..++.++|||||||++|||++|+.||......+ . ..... .....
T Consensus 159 ~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~---~~~i~-~~~~~-- 227 (307)
T d1a06a_ 159 MEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---L---FEQIL-KAEYE-- 227 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHH-TTCCC--
T ss_pred EccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---H---HHHHh-ccCCC--
Confidence 664332 2233459999999999999999999999999999999999999997543221 1 11111 11000
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ....+..+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPY-------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTT-------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCcc-------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00000 1123367889999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=366.90 Aligned_cols=240 Identities=23% Similarity=0.345 Sum_probs=186.8
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCc----EEEEEEeecC-CCCChhhHHHHHHHHHhcCCCce--------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DET----ITAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL--------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~~avk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni--------------v 352 (559)
.+|+++++||+|+||+||+|++. +++ .||+|+++.. +.+..++|.+|+++|++++|||| +
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 36999999999999999999854 333 6888887653 34456789999999999999995 5
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
++++.+|+|.+.+.... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++++||+|||+|+..
T Consensus 89 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 68899999999887643 35899999999999999999999 788999999999999999999999999999876
Q ss_pred cCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhc
Q 047195 433 LNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDA 510 (559)
Q Consensus 433 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (559)
....... .....||+.|+|||++.+..++.++||||||+++|||+| |+.||......+. .... ..+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~i----~~~~~--- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSIL----EKGER--- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHHH----HHTCC---
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----HcCCC---
Confidence 5443332 233458999999999999999999999999999999998 7888765443221 1111 11100
Q ss_pred cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 511 IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 511 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
... +...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 232 --~~~-------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 --LPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --CCC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCC-------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 000 112336688899999999999999999999998765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=365.25 Aligned_cols=255 Identities=25% Similarity=0.326 Sum_probs=187.3
Q ss_pred ChHHHHHHhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcC-CCc-----
Q 047195 284 SSREITEATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLN-HRS----- 350 (559)
Q Consensus 284 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~-h~n----- 350 (559)
...+++...++|++.++||+|+||+||+|... +++.||||+++.... ...+.+.+|+.++.++. |+|
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34455455578999999999999999999853 246899999875433 33456889999998875 555
Q ss_pred -----------eEEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCC
Q 047195 351 -----------LFMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDI 408 (559)
Q Consensus 351 -----------iv~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Di 408 (559)
+||||+++|+|.+++...... ....+++..++.++.||+.||+||| +++|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcC
Confidence 478999999999999764321 1235889999999999999999999 788999999
Q ss_pred CCCCeeecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCC-CCCCC
Q 047195 409 KSSNILLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK-AVDFN 486 (559)
Q Consensus 409 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~-p~~~~ 486 (559)
||+||||++++++||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||.. ||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 2234469999999999999999999999999999999999754 66543
Q ss_pred CccccccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 487 REEEDVNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
..... +......+.. +.+. ...+.++.+|+.+||+.||++||||.||++.|++|+
T Consensus 241 ~~~~~------~~~~~~~~~~-----~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 241 KIDEE------FCRRLKEGTR-----MRAP-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CCSHH------HHHHHHHTCC-----CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHH------HHHHHhcCCC-----CCCC-------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 32221 1111111110 1111 112356889999999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=357.22 Aligned_cols=235 Identities=24% Similarity=0.324 Sum_probs=183.6
Q ss_pred hCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce----------------EEee
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL----------------FMSM 355 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni----------------v~~~ 355 (559)
.++|++.+.||+|+||.||+|+++ +..||||+++.. ...+.|.+|++++++++|||| |+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356888899999999999999985 678999998643 344789999999999999994 7899
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
+++|+|.+++..... ..+++..+++++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999976432 24899999999999999999999 788999999999999999999999999999865432
Q ss_pred CceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
. ....+|+.|+|||++.+..++.++||||||+++|||+| |+.|+......+ ..... ..+ ..+.
T Consensus 157 ~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~-----~~~~ 220 (262)
T d1byga_ 157 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKG-----YKMD 220 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTT-----CCCC
T ss_pred C----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcC-----CCCC
Confidence 2 22348999999999999999999999999999999998 576765443222 11111 111 1111
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+. .....++.+|+.+||+.||++||||.||+++|++|
T Consensus 221 ~~-------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 221 AP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11 12236788999999999999999999999999876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-45 Score=369.10 Aligned_cols=236 Identities=21% Similarity=0.261 Sum_probs=190.5
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
++|++.+.||+|+||+||+|+. .+++.||||++........+.+.+|+++|++++|||| ||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4799999999999999999995 5689999999887655555678999999999999994 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec--CCCCEEEeecccceeccC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD--EKLDAKISDFGLSRLALN 434 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~--~~~~~kl~DFG~a~~~~~ 434 (559)
++|+|.+.+.... ..+++..+..++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+|+....
T Consensus 109 ~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 109 SGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999998775432 35899999999999999999999 78899999999999998 678999999999988765
Q ss_pred CCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccccc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDPM 514 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 514 (559)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+. .... .
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~----~~~~------~ 246 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVK----RCDW------E 246 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHH----HCCC------C
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCCC------C
Confidence 433 2334599999999999999999999999999999999999999975443221 11111 1000 0
Q ss_pred cccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 515 LKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 515 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDA---FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSST---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCccc---ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0123366789999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-45 Score=362.00 Aligned_cols=229 Identities=26% Similarity=0.344 Sum_probs=182.6
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK---GIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
.|+.++.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+++|++++|||| |||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999985 56889999998765432 23568999999999999995 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+.+|+|..++... ..+++..+..++.||+.||.||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999887665432 25899999999999999999999 78899999999999999999999999999986543
Q ss_pred CCceeeeeccccCCccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcc
Q 047195 435 GASHVTTFAQGTLGYLDPEYYIN---FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAI 511 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (559)
. ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||......+. ....... ..
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~~-~~---- 231 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-ES---- 231 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-CC----
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhC-CC----
Confidence 2 23459999999999864 3589999999999999999999999975432211 1111111 00
Q ss_pred ccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 DPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
+.+.. ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 232 -~~~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 -PALQS------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCCSC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCC------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11110 112367889999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=365.04 Aligned_cols=232 Identities=26% Similarity=0.346 Sum_probs=189.3
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++++.||+|+||+||+|+. .+++.||||++... .....+.+.+|+.+|++++|||| ||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999995 57899999998753 34456779999999999999994 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|.+++.... .+++..++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999988753 4899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
..... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+. .. .......
T Consensus 157 ~~~~~-~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~-~i~~~~~------ 222 (337)
T d1o6la_ 157 SDGAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FE-LILMEEI------ 222 (337)
T ss_dssp CTTCC-BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH-HHHHCCC------
T ss_pred cCCcc-cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH------HH-HHhcCCC------
Confidence 43322 2334599999999999999999999999999999999999999976543221 11 1111110
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
.+. ...+.++.+|+.+||+.||++||+ ++|+++
T Consensus 223 ~~p-------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCC-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCC-------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111 122356788999999999999995 777764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=356.99 Aligned_cols=236 Identities=25% Similarity=0.289 Sum_probs=188.8
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC------CChhhHHHHHHHHHhcCCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT------KGIDPILNEVRILCQLNHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~------~~~~~~~~E~~~l~~l~h~ni------------- 351 (559)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++++||||
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999996 5689999999865422 234679999999999999994
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC----CEEEee
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL----DAKISD 425 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~----~~kl~D 425 (559)
||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++ .+||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecc
Confidence 789999999999997643 4999999999999999999999 78899999999999998776 499999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE 505 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 505 (559)
||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.. .... ..
T Consensus 161 fG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~i~-~~ 231 (293)
T d1jksa_ 161 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANVS-AV 231 (293)
T ss_dssp CTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-TT
T ss_pred hhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH------HHHH-hc
Confidence 999987654332 23345899999999999989999999999999999999999999755432211 1110 10
Q ss_pred hhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 506 RLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 506 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ..... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~--~~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NY--EFEDE-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC--CCCHH-------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC--CCCch-------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 01123356788999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-44 Score=351.53 Aligned_cols=243 Identities=25% Similarity=0.341 Sum_probs=188.2
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC---ChhhHHHHHHHHHhcCCCce----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK---GIDPILNEVRILCQLNHRSL---------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni---------------- 351 (559)
.++|++.+.||+|+||+||+|+. .+++.||||+++..... ..+.+.+|+++|++++||||
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999995 57899999998764332 23568999999999999984
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
||||+++++|.+.+.... .+++..++.++.||+.||+||| +++|+||||||+|||++.++..+|+|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhh
Confidence 789999999999887643 4899999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCc--eeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 429 SRLALNGAS--HVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 429 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~ 231 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDP 231 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCC
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCC
Confidence 876543322 22334569999999999999899999999999999999999999997544322 1111111111
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhh
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRP-SIKEVADEIERI 558 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~i 558 (559)
.. +... ....+..+.+|+.+||+.||++|| |++++++.|.++
T Consensus 232 ~~----~~~~------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 IP----PSAR------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CC----GGGT------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CC----Cchh------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 10 0000 012336788999999999999999 899999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=353.79 Aligned_cols=241 Identities=25% Similarity=0.347 Sum_probs=183.0
Q ss_pred CCCCCCCccccCCccEEEEEEecC--C--cEEEEEEeecCC---CCChhhHHHHHHHHHhcCCCce--------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD--E--TITAVKRAKLGN---TKGIDPILNEVRILCQLNHRSL-------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~--~--~~~avk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni-------------- 351 (559)
++|++.+.||+|+||+||+|+.+. + ..||||+++... ....++|.+|+++|++++||||
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 468999999999999999998532 2 478999886542 2334679999999999999995
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
|+||+++|++.+.+..... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 88 v~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 6899999999988876432 5899999999999999999999 78899999999999999999999999999998
Q ss_pred ccCCCcee--eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhhcchhh
Q 047195 432 ALNGASHV--TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVNLVVYFGNILKQERLV 508 (559)
Q Consensus 432 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (559)
........ .....|+..|+|||++.+..++.++||||||+++|||+| |+.||...+..+. .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCCC-
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------HHHHHhCCCC-
Confidence 75443322 233458889999999999999999999999999999998 8999875433221 1111111100
Q ss_pred hccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 509 DAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 509 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
+.. ....+..+.+|+.+||+.||++||||+||+++|++.
T Consensus 234 ----~~~-------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 ----LPR-------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCC-------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 000 112235688999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=359.11 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=186.3
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHH--HHHHhcCCCce-------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEV--RILCQLNHRSL------------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~--~~l~~l~h~ni------------------- 351 (559)
.+|.+.++||+|+||.||+|++ +++.||||++.... ...+.+|. ..+.+++||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3567778999999999999986 57899999986432 23444444 45567899984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHc-----CCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLL-----ATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
||||+++|+|.++++.. .++|..+..++.|++.||+|||+. +.++|+||||||+||||++++++||+||
T Consensus 79 v~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 78999999999999762 489999999999999999999943 3479999999999999999999999999
Q ss_pred ccceeccCCCcee---eeeccccCCccCccccccC------CCCcccchhHHHHHHHHHHhCCCCCCCCCcccccc----
Q 047195 427 GLSRLALNGASHV---TTFAQGTLGYLDPEYYINF------QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVN---- 493 (559)
Q Consensus 427 G~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~---- 493 (559)
|+++......... .....||+.|+|||++.+. .++.++|||||||+||||+||..|+..........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9999876543322 2345699999999998754 26779999999999999999998875432221110
Q ss_pred ----HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 494 ----LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 494 ----~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
............ .+++.+.... ...+....+.+|+.+||+.||++||||.||+++|++|
T Consensus 233 ~~~~~~~~~~~~~~~~----~~~p~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQ----KLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CSSCCHHHHHHHHTTS----CCCCCCCGGG--GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcc----ccCCCCCccc--CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 011111111111 1122111111 1234567789999999999999999999999999886
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-44 Score=356.34 Aligned_cols=229 Identities=24% Similarity=0.312 Sum_probs=187.8
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++++.||+|+||+||+|+. .+++.||||++... .....+.+.+|+.+|++++|||| ||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4699999999999999999996 56899999998643 34456789999999999999995 78
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
||+++|+|..++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 9999999999887643 4788899999999999999999 8899999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
... ....||+.|||||++.+..++.++|||||||++|||++|+.||...+..+. ..... ... .
T Consensus 156 ~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~-~~~------~ 218 (316)
T d1fota_ 156 DVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKIL-NAE------L 218 (316)
T ss_dssp SCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH-HCC------C
T ss_pred ccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHH-cCC------C
Confidence 432 234699999999999999999999999999999999999999975443221 11111 110 0
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
.+. ......+.+++.+||+.||.+|| |++|+++
T Consensus 219 ~~p-------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 RFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCC-------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC-------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 011 12235678899999999999996 8888875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=357.81 Aligned_cols=237 Identities=26% Similarity=0.350 Sum_probs=185.4
Q ss_pred CCccccCCccEEEEEEecCC----cEEEEEEeecC-CCCChhhHHHHHHHHHhcCCCce----------------EEeeC
Q 047195 298 GNLLGSGGFGEVFKAILDDE----TITAVKRAKLG-NTKGIDPILNEVRILCQLNHRSL----------------FMSMS 356 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~----~~~avk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni----------------v~~~~ 356 (559)
.++||+|+||+||+|++.+. ..||||+++.. +....++|.+|+++|++++|||| ||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 36899998643 33445779999999999999994 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999887532 35788899999999999999999 7889999999999999999999999999998765432
Q ss_pred ce---eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 437 SH---VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 437 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.|+.......+ ..... ..+.. +
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i----~~g~~-----~ 253 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL----LQGRR-----L 253 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCC-----C
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCCC-----C
Confidence 22 12234589999999999999999999999999999999999888764432221 11111 11110 0
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
... ......+.+|+.+||+.||++||||.||++.|++|+
T Consensus 254 ~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 254 LQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCc-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 000 112356889999999999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=358.97 Aligned_cols=243 Identities=28% Similarity=0.389 Sum_probs=186.3
Q ss_pred CCCCCCCccccCCccEEEEEEecC-Cc--EEEEEEeecC-CCCChhhHHHHHHHHHhc-CCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDD-ET--ITAVKRAKLG-NTKGIDPILNEVRILCQL-NHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~--~~avk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni---------------v 352 (559)
++|++.++||+|+||+||+|++++ +. .||||++... .....+.|.+|+++|+++ +|||| |
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999999654 43 5778887543 334567899999999998 79995 6
Q ss_pred EeeCCCCcHhHhHhhcc-----------CCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCE
Q 047195 353 MSMSPNGTLFDRLHRVQ-----------SGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDA 421 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~ 421 (559)
+||+++|+|.++++... ......+++..+..++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 89999999999987531 122346899999999999999999999 7889999999999999999999
Q ss_pred EEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCC-CCCCCCccccccHHHHHHH
Q 047195 422 KISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKK-AVDFNREEEDVNLVVYFGN 500 (559)
Q Consensus 422 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~-p~~~~~~~~~~~~~~~~~~ 500 (559)
||+|||+++....... .....||..|+|||.+.+..++.++||||||+++|||++|.. ||...+..+ . ..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------~-~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------L-YE 237 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-HH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------H-HH
Confidence 9999999976542221 123348999999999999999999999999999999999765 554332211 1 11
Q ss_pred HhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 501 ILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 501 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
....+. .+.. +...+.++.+|+.+||+.||++||||+||++.|++|+
T Consensus 238 ~i~~~~-----~~~~-------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 238 KLPQGY-----RLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HGGGTC-----CCCC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcC-----CCCC-------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111110 0111 1123467889999999999999999999999998863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=358.77 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=195.9
Q ss_pred HHHHHHhCCCCCCCccccCCccEEEEEEec------CCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce-------
Q 047195 286 REITEATNNFSTGNLLGSGGFGEVFKAILD------DETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------- 351 (559)
Q Consensus 286 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------- 351 (559)
++++...++|++.++||+|+||+||+|.++ ++..||||+++.... .....|.+|++++++++||||
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 344455678999999999999999999863 357899999875432 333468999999999999994
Q ss_pred --------EEeeCCCCcHhHhHhhcc-----CCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCC
Q 047195 352 --------FMSMSPNGTLFDRLHRVQ-----SGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEK 418 (559)
Q Consensus 352 --------v~~~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~ 418 (559)
|+||+++|+|.+++.... ......+++..+..++.|+++||.||| +++|+||||||+|||++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCC
Confidence 789999999999886532 122345789999999999999999999 7789999999999999999
Q ss_pred CCEEEeecccceeccCCCcee-eeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCC-CCCCCCCccccccHHH
Q 047195 419 LDAKISDFGLSRLALNGASHV-TTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSK-KAVDFNREEEDVNLVV 496 (559)
Q Consensus 419 ~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~-~p~~~~~~~~~~~~~~ 496 (559)
+++||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||+ .|+...+..+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------ 243 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------ 243 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 999999999998765433322 22335899999999999999999999999999999999986 5554332211
Q ss_pred HHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 497 YFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 497 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
... ....+.... . +...+..+.+|+.+||+.+|++||||.+|+++|++.+
T Consensus 244 ~~~-~i~~~~~~~-----~-------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 244 VLR-FVMEGGLLD-----K-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHH-HHHTTCCCC-----C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHH-HHHhCCCCC-----C-------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111 111111110 0 1122367899999999999999999999999998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-44 Score=359.68 Aligned_cols=229 Identities=23% Similarity=0.323 Sum_probs=187.7
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHHhcCCCce---------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILCQLNHRSL---------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni---------------v~ 353 (559)
++|++++.||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++++|||| |+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4799999999999999999986 56899999998642 33455779999999999999995 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceecc
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLAL 433 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~ 433 (559)
+|+.+|+|.+.+.... .+++..+..++.||+.||.||| +++||||||||+|||++.++++||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 9999999999997643 4899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhcccc
Q 047195 434 NGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAIDP 513 (559)
Q Consensus 434 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 513 (559)
... ....||+.|||||++.+..++.++|||||||++|||+||+.||...+... ...... ....
T Consensus 193 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~-~~~~------ 255 (350)
T d1rdqe_ 193 GRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIV-SGKV------ 255 (350)
T ss_dssp SCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCC------
T ss_pred ccc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHHHh-cCCC------
Confidence 432 23459999999999999999999999999999999999999997543221 111111 1100
Q ss_pred ccccCCChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047195 514 MLKEGASEIELDSMKAFGLLGAACLDERRQNRP-----SIKEVAD 553 (559)
Q Consensus 514 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~ 553 (559)
... ......+.+|+.+||+.||.+|+ |++|+++
T Consensus 256 ~~p-------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFP-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCC-------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC-------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 001 12235688999999999999994 8999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=354.34 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=189.1
Q ss_pred hCCCCCCCccccCCccEEEEEEecC--------CcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce----------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAILDD--------ETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL---------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni---------- 351 (559)
.++|++++.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +||||
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578999999999999999998532 24799999876543 3346789999999998 79995
Q ss_pred -----EEeeCCCCcHhHhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeee
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSG-----------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILL 415 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill 415 (559)
||||+++|+|.+++...... ....+++..++.++.||+.||+||| +++|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 68999999999999754321 2246899999999999999999999 7889999999999999
Q ss_pred cCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCcccccc
Q 047195 416 DEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLT-SKKAVDFNREEEDVN 493 (559)
Q Consensus 416 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~t-g~~p~~~~~~~~~~~ 493 (559)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..|+.++||||||+++|||++ |+.||.......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 99999999999999877544322 2334458999999999999999999999999999999998 577775433211
Q ss_pred HHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 494 LVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
....+..+. .+.... ..+..+.+|+.+||+.||++||||.||+++|++|+
T Consensus 246 ----~~~~i~~~~-----~~~~p~-------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 ----LFKLLKEGH-----RMDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ----HHHHHHTTC-----CCCCCS-------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHcCC-----CCCCCc-------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111111111 111111 22356889999999999999999999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=352.81 Aligned_cols=244 Identities=23% Similarity=0.230 Sum_probs=178.6
Q ss_pred CCccccCCccEEEEEEe-cCCcEEEEEEeecCCCC-----ChhhHHHHHHHHHhcCCCce---------------EEeeC
Q 047195 298 GNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTK-----GIDPILNEVRILCQLNHRSL---------------FMSMS 356 (559)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~-----~~~~~~~E~~~l~~l~h~ni---------------v~~~~ 356 (559)
+++||+|+||+||+|+. .+++.||||+++..... ..+.+.+|+++|++++|||| ||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999995 56899999998654322 23568999999999999994 78999
Q ss_pred CCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCCC
Q 047195 357 PNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNGA 436 (559)
Q Consensus 357 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~~ 436 (559)
.++.+..+.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 887766555422 35888999999999999999999 7889999999999999999999999999998765443
Q ss_pred ceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc---hhhhcc-
Q 047195 437 SHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE---RLVDAI- 511 (559)
Q Consensus 437 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 511 (559)
... ....||+.|+|||++... .++.++|||||||++|||++|+.||......+.... +....... .+....
T Consensus 155 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 RAY-THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCC-CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSSSTTS
T ss_pred ccc-cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH---HHHhcCCCChhhccchhc
Confidence 322 234599999999998754 579999999999999999999999976554332211 11111110 000000
Q ss_pred --ccccccCCChh-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 512 --DPMLKEGASEI-----ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 512 --d~~l~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
........... .......+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000000 0122357889999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-43 Score=344.67 Aligned_cols=236 Identities=26% Similarity=0.292 Sum_probs=187.9
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCC---------hhhHHHHHHHHHhcC-CCce---------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKG---------IDPILNEVRILCQLN-HRSL--------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~---------~~~~~~E~~~l~~l~-h~ni--------- 351 (559)
.++|++.+.||+|+||+||+|+. .+++.+|||++....... .+.+.+|+.+|++++ ||||
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999995 578999999987654321 235889999999997 9994
Q ss_pred ------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 352 ------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 352 ------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
||||+++|+|.+++.... .+++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEcc
Confidence 789999999999997542 5899999999999999999999 78899999999999999999999999
Q ss_pred cccceeccCCCceeeeeccccCCccCcccccc------CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYIN------FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG 499 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 499 (559)
||+++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ..
T Consensus 154 FG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------~~ 225 (277)
T d1phka_ 154 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LR 225 (277)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred chheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH------HH
Confidence 999987754332 233569999999999863 3468899999999999999999999975543221 11
Q ss_pred HHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 500 NILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 500 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. ...+... ...+ .....+.++.+|+.+||+.||++|||+.||++
T Consensus 226 ~-i~~~~~~-~~~~--------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 M-IMSGNYQ-FGSP--------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp H-HHHTCCC-CCTT--------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H-HHhCCCC-CCCc--------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 1111100 0000 01123467889999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-44 Score=353.39 Aligned_cols=249 Identities=28% Similarity=0.390 Sum_probs=194.6
Q ss_pred HHhCCCCCCCccccCCccEEEEEEe------cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhc-CCCce----------
Q 047195 290 EATNNFSTGNLLGSGGFGEVFKAIL------DDETITAVKRAKLGNT-KGIDPILNEVRILCQL-NHRSL---------- 351 (559)
Q Consensus 290 ~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni---------- 351 (559)
...++|++.++||+|+||.||+|++ ..++.||||+++.... .....|.+|+.+++++ +||||
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 3356889999999999999999985 3457899999876433 3345689999999999 69995
Q ss_pred -----EEeeCCCCcHhHhHhhccCC-------------CCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCe
Q 047195 352 -----FMSMSPNGTLFDRLHRVQSG-------------NWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNI 413 (559)
Q Consensus 352 -----v~~~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Ni 413 (559)
||||+++|+|.++++..... ....+++..+..++.||+.||+||| +++++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence 78999999999999764321 2235899999999999999999999 78899999999999
Q ss_pred eecCCCCEEEeecccceeccCCCce-eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCC-CCCCCcccc
Q 047195 414 LLDEKLDAKISDFGLSRLALNGASH-VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKA-VDFNREEED 491 (559)
Q Consensus 414 ll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p-~~~~~~~~~ 491 (559)
|++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+|++.| +......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999977654333 33445699999999999999999999999999999999995555 443332221
Q ss_pred ccHHHHHHHHhhcchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 047195 492 VNLVVYFGNILKQERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERII 559 (559)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i~ 559 (559)
.......+ . .+... ...+..+.+|+.+||+.||++||||.+|+++|++++
T Consensus 257 ------~~~~i~~~-~----~~~~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 ------FYKMIKEG-F----RMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ------HHHHHHHT-C----CCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHhcC-C----CCCCc-------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11111111 0 01111 122367889999999999999999999999999763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=352.30 Aligned_cols=236 Identities=21% Similarity=0.239 Sum_probs=183.9
Q ss_pred hCCCCCCC-ccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHh-cCCCce-----------------
Q 047195 292 TNNFSTGN-LLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQ-LNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~-~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~-l~h~ni----------------- 351 (559)
.++|++.+ .||+|+||+||+|+. .+++.||||+++. ...+.+|++++.+ .+||||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788765 599999999999985 5689999999863 2568899999765 489984
Q ss_pred --EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC---CCCEEEeec
Q 047195 352 --FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE---KLDAKISDF 426 (559)
Q Consensus 352 --v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~---~~~~kl~DF 426 (559)
||||+++|+|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+|||+++ ++.+||+||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccc
Confidence 6799999999999975322 35899999999999999999999 788999999999999985 567999999
Q ss_pred ccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
|+|+....... .....||+.|||||++.+..|+.++|||||||++|||+||+.||...+....... ........
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~- 232 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMG- 232 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC-
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcC-
Confidence 99987654332 2344599999999999999999999999999999999999999975543221110 00000000
Q ss_pred hhhccccccccCCC-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 507 LVDAIDPMLKEGAS-EIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ... ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 233 -------~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 -------QY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -------SS--SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------CC--CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 000 111234567899999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-43 Score=358.45 Aligned_cols=233 Identities=23% Similarity=0.314 Sum_probs=181.3
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC---CCChhhHHHH---HHHHHhcCCCce--------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN---TKGIDPILNE---VRILCQLNHRSL-------------- 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~---~~~~~~~~~E---~~~l~~l~h~ni-------------- 351 (559)
++|++.+.||+|+||+||+|+. .+++.||||++.... ......+.+| +++++.++||||
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999996 468999999986421 2222334444 666777789984
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceee
Confidence 789999999999997643 4889999999999999999999 7889999999999999999999999999998
Q ss_pred eccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
....... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+.. .... .....
T Consensus 156 ~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~-~~~~~---- 224 (364)
T d1omwa3 156 DFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDR-MTLTM---- 224 (364)
T ss_dssp ECSSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHH-HSSSC----
T ss_pred ecCCCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH-hcccC----
Confidence 7654322 23459999999999874 56899999999999999999999999765433211 1111 00000
Q ss_pred ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 510 AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 510 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
...+.. ..+..+.+|+.+||+.||++||| ++|+++
T Consensus 225 --~~~~~~-------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 --AVELPD-------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCCCS-------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCCCC-------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 001111 22356889999999999999999 577764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=354.40 Aligned_cols=232 Identities=25% Similarity=0.386 Sum_probs=186.8
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecC---CCCChhhHHHHHHHHH-hcCCCce---------------E
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLG---NTKGIDPILNEVRILC-QLNHRSL---------------F 352 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~---~~~~~~~~~~E~~~l~-~l~h~ni---------------v 352 (559)
++|++.+.||+|+||+||+|+. .+++.||||+++.. .....+.+.+|+.++. .++|||| |
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999995 46899999998753 2344567788888876 6899994 7
Q ss_pred EeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 353 MSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 353 ~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 89999999999997643 4889999999999999999999 788999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . . ..... .
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~---~-~i~~~------~ 219 (320)
T d1xjda_ 154 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---F---H-SIRMD------N 219 (320)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---H-HHHHC------C
T ss_pred ccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---H---H-HHHcC------C
Confidence 54332 23344699999999999999999999999999999999999999975543221 1 1 11111 0
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIK-EVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl~ 553 (559)
+.+.. ..+..+.+|+.+||+.||++|||+. |+++
T Consensus 220 ~~~p~-------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 PFYPR-------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCT-------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCc-------cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111 1236688999999999999999995 6753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=352.44 Aligned_cols=237 Identities=20% Similarity=0.267 Sum_probs=188.1
Q ss_pred HhCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 291 ATNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 291 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
..++|++.+.||+|+||+||+|.. .+++.||||.++.... ....+.+|+++|++++|||| |||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 346799999999999999999996 4688999999876432 23568899999999999994 789
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC--CCCEEEeecccceec
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE--KLDAKISDFGLSRLA 432 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~--~~~~kl~DFG~a~~~ 432 (559)
|+++|+|.+.+.... ..+++..+..++.||+.||+||| +++|+||||||+|||++. ...+||+|||+++..
T Consensus 82 ~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999999999986532 25899999999999999999999 788999999999999985 458999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhccc
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDAID 512 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 512 (559)
..... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...... ... ..+
T Consensus 155 ~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------~~~i~~-~~~--~~~ 223 (321)
T d1tkia_ 155 KPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMN-AEY--TFD 223 (321)
T ss_dssp CTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-TCC--CCC
T ss_pred ccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CCC--CCC
Confidence 54332 2234489999999999999999999999999999999999999975543221 111111 000 000
Q ss_pred cccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 513 PMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 513 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ......++.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~-------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 EEA-------FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHH-------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhh-------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0112356789999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=348.94 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=182.9
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
++|++.++||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+++|++++|||| |||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4799999999999999999995 5689999999865432 335789999999999999995 678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
|+.+ .+.+.+..... ..+++..+..++.|++.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~-~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence 8765 44444443222 35999999999999999999999 78899999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh---c
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQ-LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD---A 510 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 510 (559)
.... .....||+.|+|||.+.... ++.++|||||||++|||++|+.||...+..+.............+..... .
T Consensus 155 ~~~~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 155 PVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CSBC-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred Cccc-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 3322 23345999999999887665 57899999999999999999999976543322111110000000000000 0
Q ss_pred ------cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 ------IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
...................+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000000000011123367888999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=347.14 Aligned_cols=253 Identities=20% Similarity=0.235 Sum_probs=183.5
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cC-CcEEEEEEeecCC--CCChhhHHHHHHHHHhc---CCCce-------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DD-ETITAVKRAKLGN--TKGIDPILNEVRILCQL---NHRSL------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~-~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l---~h~ni------------- 351 (559)
.++|+++++||+|+||+||+|+. ++ ++.||||+++... ......+.+|+.+|+.| +||||
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999986 33 6789999986542 23345688899888776 79995
Q ss_pred -------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEe
Q 047195 352 -------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKIS 424 (559)
Q Consensus 352 -------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~ 424 (559)
++|++.++.+....... ...+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence 45677776655443322 235899999999999999999999 7889999999999999999999999
Q ss_pred ecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 047195 425 DFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 425 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
|||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+..............
T Consensus 159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred chhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 999998654322 223445999999999999999999999999999999999999999866543322221111100000
Q ss_pred chhhh-------ccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ERLVD-------AIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~~~~~-------~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
..+.. ....................+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 00000000000111123356788999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-42 Score=340.39 Aligned_cols=244 Identities=18% Similarity=0.239 Sum_probs=186.0
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc----------------eEEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS----------------LFMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n----------------iv~~~ 355 (559)
++|++.+.||+|+||+||+|+. .+++.||||++..... .+++.+|++++++++|+| +||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999985 5689999998776433 356899999999998876 36777
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeec---CCCCEEEeecccceec
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLD---EKLDAKISDFGLSRLA 432 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~---~~~~~kl~DFG~a~~~ 432 (559)
+ ++++.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++ .+..+||+|||+|+..
T Consensus 85 ~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp C-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred c-CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 6 566666655432 25899999999999999999999 78899999999999986 3557999999999987
Q ss_pred cCCCce------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 433 LNGASH------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 433 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
...... ......||+.|||||++.+..++.++||||||+++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 543321 12334599999999999999999999999999999999999999976554333222211111110000
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.. .+. ...+.++.+++.+||+.+|++||+++++.+.|+.+
T Consensus 237 ~~-----~~~-------~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 IE-----VLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HH-----HHT-------TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hh-----Hhc-------cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00 011 12236788899999999999999999999998865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.9e-43 Score=345.01 Aligned_cols=249 Identities=20% Similarity=0.203 Sum_probs=182.3
Q ss_pred CCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce---------------EEee
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL---------------FMSM 355 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni---------------v~~~ 355 (559)
++|++.++||+|+||+||+|+.++++.||||++.... ....+.+.+|+.+|++++|||| ++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5789999999999999999999999999999986643 3335689999999999999996 4566
Q ss_pred CCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccCC
Q 047195 356 SPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALNG 435 (559)
Q Consensus 356 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~~ 435 (559)
..++.+..+.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 6665555554322 35999999999999999999999 788999999999999999999999999999876543
Q ss_pred CceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhhc----
Q 047195 436 ASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVDA---- 510 (559)
Q Consensus 436 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 510 (559)
.. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+.... .............
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGG
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH---HHHhhCCCChhhccchh
Confidence 22 22333589999999998764 568999999999999999999999975543322111 1111111000000
Q ss_pred ----cccccc----cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 511 ----IDPMLK----EGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 511 ----~d~~l~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.+.... .............+.+|+++||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000111123357889999999999999999999984
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=348.80 Aligned_cols=253 Identities=23% Similarity=0.278 Sum_probs=185.2
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC-CChhhHHHHHHHHHhcCCCce------------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT-KGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
.++|+++++||+|+||+||+|+. .+++.||||++..... ...+.+++|+.+|++++|||+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999985 5789999999875432 334578999999999999985
Q ss_pred -EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccce
Q 047195 352 -FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSR 430 (559)
Q Consensus 352 -v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~ 430 (559)
+++++.+|+|.+++... .+++..++.++.|++.||+||| +++||||||||+|||+++++.+||+|||+++
T Consensus 87 ~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 45778899999999642 4899999999999999999999 7889999999999999999999999999998
Q ss_pred eccCCCce--eeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchh
Q 047195 431 LALNGASH--VTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERL 507 (559)
Q Consensus 431 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (559)
........ ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.................
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 76433222 2234559999999999854 46788999999999999999999999765433322221111100000000
Q ss_pred hhc-----------cccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDA-----------IDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~-----------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
... ..................++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000000000112346789999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=337.29 Aligned_cols=225 Identities=25% Similarity=0.392 Sum_probs=178.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC------CChhhHHHHHHHHHhcC--CCce-----------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT------KGIDPILNEVRILCQLN--HRSL----------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~------~~~~~~~~E~~~l~~l~--h~ni----------- 351 (559)
.++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+|+.+|++++ ||||
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999995 5789999999875322 12345789999999997 8885
Q ss_pred ----EEeeCCC-CcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-CCCEEEee
Q 047195 352 ----FMSMSPN-GTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-KLDAKISD 425 (559)
Q Consensus 352 ----v~~~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-~~~~kl~D 425 (559)
||||+.+ +++.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECc
Confidence 6788765 57777776532 4899999999999999999999 788999999999999985 57999999
Q ss_pred cccceeccCCCceeeeeccccCCccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc
Q 047195 426 FGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQL-TDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ 504 (559)
Q Consensus 426 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 504 (559)
||+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . . .
T Consensus 155 FG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i---~-~ 218 (273)
T d1xwsa_ 155 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------I---I-R 218 (273)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H---H-H
T ss_pred cccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------H---h-h
Confidence 99998754332 233459999999999987765 5678999999999999999999963210 0 0 0
Q ss_pred chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.. ..+.. ..+.++.+|+.+||+.||++|||++|+++
T Consensus 219 ~~------~~~~~-------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 GQ------VFFRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC------CCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc------cCCCC-------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 01111 12356888999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=342.20 Aligned_cols=254 Identities=20% Similarity=0.220 Sum_probs=180.5
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCC--CCChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGN--TKGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.+.||+|+||+||+|+. ++++.||||++.... ....+.+.+|+++|++++|+|+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 35799999999999999999996 578999999986542 3345678999999999999985
Q ss_pred ------EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEee
Q 047195 352 ------FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISD 425 (559)
Q Consensus 352 ------v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~D 425 (559)
|+|++.++.+...... ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeee
Confidence 4566665554433322 235889999999999999999999 78899999999999999999999999
Q ss_pred cccceeccCCCce---eeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 047195 426 FGLSRLALNGASH---VTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNI 501 (559)
Q Consensus 426 FG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 501 (559)
||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..................
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999876533222 12224599999999998765 6899999999999999999999999765433322222111111
Q ss_pred hhcchhhhcccccc-------ccCCChh-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 502 LKQERLVDAIDPML-------KEGASEI-----ELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 502 ~~~~~~~~~~d~~l-------~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.............. ....... .......+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11110000000000 0000000 0112345678999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.6e-41 Score=330.80 Aligned_cols=245 Identities=16% Similarity=0.190 Sum_probs=189.6
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC-Cc---------------eEEe
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNH-RS---------------LFMS 354 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h-~n---------------iv~~ 354 (559)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+|+++++.|+| +| +|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 36799999999999999999995 468999999876543 23568899999999977 44 4678
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecC-----CCCEEEeecccc
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDE-----KLDAKISDFGLS 429 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~-----~~~~kl~DFG~a 429 (559)
|+ +++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEccccee
Confidence 87 789988886543 25899999999999999999999 889999999999999974 568999999999
Q ss_pred eeccCCCce------eeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh
Q 047195 430 RLALNGASH------VTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK 503 (559)
Q Consensus 430 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 503 (559)
+........ ......||+.|||||++.+..++.++||||||+++|||+||+.||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 986543221 12234599999999999999999999999999999999999999986554432222111111111
Q ss_pred cchhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 047195 504 QERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVADEIERI 558 (559)
Q Consensus 504 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~i 558 (559)
.....+ +. ...+.++.+++..|++.+|++||+++.+.+.|+++
T Consensus 234 ~~~~~~-----l~-------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 234 STPLRE-----LC-------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HSCHHH-----HT-------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCChHH-----hc-------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111111 11 12235688899999999999999999999988875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-42 Score=344.81 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=179.7
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCce---------------------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRSL--------------------- 351 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~ni--------------------- 351 (559)
+|+..++||+|+||+||+|+. .+++.||||++..... .+.+|+++|++++|+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588889999999999999996 4689999999875432 23479999999999984
Q ss_pred EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeecccce
Q 047195 352 FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDFGLSR 430 (559)
Q Consensus 352 v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DFG~a~ 430 (559)
||||++++.+..+...... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++
T Consensus 97 v~Ey~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEeccCCccHHHHHhhhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 5688876544444333222 236999999999999999999999 89999999999999999775 89999999998
Q ss_pred eccCCCceeeeeccccCCccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcchhhh
Q 047195 431 LALNGASHVTTFAQGTLGYLDPEYYIN-FQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQERLVD 509 (559)
Q Consensus 431 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (559)
........ ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+................+..
T Consensus 172 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 172 QLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp ECCTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hccCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 76543322 23459999999998875 4689999999999999999999999976654332221111000000000000
Q ss_pred c----cccc---ccc-CC-ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 510 A----IDPM---LKE-GA-SEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 510 ~----~d~~---l~~-~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
. .+.. +.. .. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 000 00 0000123356888999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=339.71 Aligned_cols=248 Identities=21% Similarity=0.272 Sum_probs=177.3
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|++.++||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+++|++++||||
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 56899999999999999999995 5689999999875432 234578999999999999985
Q ss_pred ----EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecc
Q 047195 352 ----FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFG 427 (559)
Q Consensus 352 ----v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG 427 (559)
||||+ +.+|..++.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccc
Confidence 45666 4566665543 24999999999999999999999 7889999999999999999999999999
Q ss_pred cceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHH-------
Q 047195 428 LSRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFG------- 499 (559)
Q Consensus 428 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~------- 499 (559)
+|+...... +...||+.|+|||++.+. .++.++|||||||++|||++|+.||...+............
T Consensus 167 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 167 LARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp TCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 998764432 334599999999998764 56899999999999999999999997654332221111110
Q ss_pred -HHhhcch---hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 500 -NILKQER---LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 500 -~~~~~~~---~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....... ....+...-..............+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 00000000000111111122356778999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-41 Score=329.18 Aligned_cols=250 Identities=19% Similarity=0.218 Sum_probs=186.2
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce---------------EEe
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL---------------FMS 354 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni---------------v~~ 354 (559)
++|+++++||+|+||+||+|+. .+++.||||+++.... .....+.+|+.+|+.++|||| |++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 5789999999876543 334678999999999999995 568
Q ss_pred eCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeecccceeccC
Q 047195 355 MSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGLSRLALN 434 (559)
Q Consensus 355 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~~~ 434 (559)
++.++.+..++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||.++....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 88888887776543 25889999999999999999999 78899999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcc---hh---
Q 047195 435 GASHVTTFAQGTLGYLDPEYYINFQ-LTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQE---RL--- 507 (559)
Q Consensus 435 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~--- 507 (559)
.... .....+++.|+|||.+.... ++.++|||||||++|||++|+.||........ ............ ..
T Consensus 154 ~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 154 PVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTG
T ss_pred CCcc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhh
Confidence 4332 22334788999999987665 68999999999999999999999754332221 111111111110 00
Q ss_pred hhcccc------ccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 508 VDAIDP------MLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 508 ~~~~d~------~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
....+. ................+.+|+.+||+.||.+|||++||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0001111111233456788999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-41 Score=332.23 Aligned_cols=237 Identities=25% Similarity=0.315 Sum_probs=186.1
Q ss_pred CCCCCCCccccCCccEEEEEEe----cCCcEEEEEEeecC----CCCChhhHHHHHHHHHhcCC-Cce------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL----DDETITAVKRAKLG----NTKGIDPILNEVRILCQLNH-RSL------------ 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~avk~~~~~----~~~~~~~~~~E~~~l~~l~h-~ni------------ 351 (559)
++|++.+.||+|+||+||+|+. .+++.||||.+... +....+.+.+|+++|++++| |||
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999984 24789999998543 23345678999999999987 674
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
++||+.+|+|.+.+.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccc
Confidence 679999999999998754 3778899999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCceeeeeccccCCccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhcch
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYINF--QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQER 506 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 506 (559)
++..............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+........ .. ...
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~-~~~ 252 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--IL-KSE 252 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HH-HCC
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cc-cCC
Confidence 987655444444455699999999998754 4678999999999999999999999866544322221111 10 000
Q ss_pred hhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047195 507 LVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPS-----IKEVAD 553 (559)
Q Consensus 507 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~ 553 (559)
+.+. .....++.+|+.+||+.||++||| ++|+++
T Consensus 253 ------~~~~-------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ------PPYP-------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCC-------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCCc-------ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0011 123367888999999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.7e-40 Score=328.81 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=181.9
Q ss_pred CCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC-CCce-----------------EE
Q 047195 293 NNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLN-HRSL-----------------FM 353 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni-----------------v~ 353 (559)
++|+++++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|++++ |||| ||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4799999999999999999995 57899999998643 3467899999999995 9984 67
Q ss_pred eeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC-CEEEeecccceec
Q 047195 354 SMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL-DAKISDFGLSRLA 432 (559)
Q Consensus 354 ~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~-~~kl~DFG~a~~~ 432 (559)
||+.+++|..... .+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+..
T Consensus 112 e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred eecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceec
Confidence 8999998866532 4899999999999999999999 88899999999999998655 6999999999876
Q ss_pred cCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhhc-------
Q 047195 433 LNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILKQ------- 504 (559)
Q Consensus 433 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 504 (559)
..... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... .........
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~--~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHHHCHHHHHHHH
T ss_pred cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH--HHHHHHHCCchhhhhh
Confidence 54332 2334589999999998765 47999999999999999999999997554322111 111110000
Q ss_pred --------chhhhccccccccC-----CChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 505 --------ERLVDAIDPMLKEG-----ASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 505 --------~~~~~~~d~~l~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.............. ..........++.+|+.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000 00001223456889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=332.36 Aligned_cols=248 Identities=21% Similarity=0.201 Sum_probs=177.2
Q ss_pred CCCCCCCccccCCccEEEEEEec-CCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce------------------
Q 047195 293 NNFSTGNLLGSGGFGEVFKAILD-DETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL------------------ 351 (559)
Q Consensus 293 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni------------------ 351 (559)
++|++.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+|++++||||
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999954 689999999875432 334568999999999999984
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
||||+.++ +.+.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~iv~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence 67887654 444443 24899999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHH--------
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGN-------- 500 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-------- 500 (559)
++...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+.............
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 87654322 23344589999999999999999999999999999999999999976543322211110000
Q ss_pred --------Hhhc------chhhhccccccccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 501 --------ILKQ------ERLVDAIDPMLKEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 501 --------~~~~------~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
.... .........................+.+|+++||+.||++|||++||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0000111111111122223456678899999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=333.89 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=182.5
Q ss_pred hCCCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCC--CChhhHHHHHHHHHhcCCCce-----------------
Q 047195 292 TNNFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNT--KGIDPILNEVRILCQLNHRSL----------------- 351 (559)
Q Consensus 292 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni----------------- 351 (559)
.++|+++++||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++++|+|+
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999995 5789999999875432 234568999999999999985
Q ss_pred ---EEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeeccc
Q 047195 352 ---FMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDFGL 428 (559)
Q Consensus 352 ---v~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DFG~ 428 (559)
+++++.+|+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccch
Confidence 4677889999998854 24999999999999999999999 78899999999999999999999999999
Q ss_pred ceeccCCCceeeeeccccCCccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhh----
Q 047195 429 SRLALNGASHVTTFAQGTLGYLDPEYYINF-QLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVYFGNILK---- 503 (559)
Q Consensus 429 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 503 (559)
+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+................
T Consensus 168 a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 168 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp --CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 8754322 1233489999999987765 468899999999999999999999976543322221111100000
Q ss_pred ----cchhhhcccccc---ccCCChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047195 504 ----QERLVDAIDPML---KEGASEIELDSMKAFGLLGAACLDERRQNRPSIKEVAD 553 (559)
Q Consensus 504 ----~~~~~~~~d~~l---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~ 553 (559)
............ ..............+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000000 00000000122356788999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.8e-37 Score=309.63 Aligned_cols=250 Identities=19% Similarity=0.207 Sum_probs=172.8
Q ss_pred CCCCCCccccCCccEEEEEEe-cCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc-----------eE---------
Q 047195 294 NFSTGNLLGSGGFGEVFKAIL-DDETITAVKRAKLGNTKGIDPILNEVRILCQLNHRS-----------LF--------- 352 (559)
Q Consensus 294 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n-----------iv--------- 352 (559)
+|+++++||+|+||+||+|+. .+++.||||+++.... ..+.+.+|++++++++|++ ||
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 499999999999999999995 5789999999875322 2367889999999987654 32
Q ss_pred --------EeeCCCCc-HhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCC----
Q 047195 353 --------MSMSPNGT-LFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKL---- 419 (559)
Q Consensus 353 --------~~~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~---- 419 (559)
+++...+. ....... .....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cccceeeeeeeccccccccccccc---ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 22322222 2222222 122468889999999999999999994 37899999999999998654
Q ss_pred --CEEEeecccceeccCCCceeeeeccccCCccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 047195 420 --DAKISDFGLSRLALNGASHVTTFAQGTLGYLDPEYYINFQLTDKSDVYSFGVVLVELLTSKKAVDFNREEEDVNLVVY 497 (559)
Q Consensus 420 --~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~el~tg~~p~~~~~~~~~~~~~~~ 497 (559)
.+|++|||.+....... ....||+.|+|||++....++.++||||+|++++||++|+.||..............
T Consensus 168 ~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 39999999998654322 234599999999999999999999999999999999999999975433221111111
Q ss_pred HH---HHhhc--------c----------hhhhccccccc-------cCCChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047195 498 FG---NILKQ--------E----------RLVDAIDPMLK-------EGASEIELDSMKAFGLLGAACLDERRQNRPSIK 549 (559)
Q Consensus 498 ~~---~~~~~--------~----------~~~~~~d~~l~-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ 549 (559)
.. ..+.. . .....+..... .............+.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 10 00000 0 00000000000 001111245677899999999999999999999
Q ss_pred HHHH
Q 047195 550 EVAD 553 (559)
Q Consensus 550 evl~ 553 (559)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.2e-22 Score=183.81 Aligned_cols=154 Identities=22% Similarity=0.252 Sum_probs=110.5
Q ss_pred CCCCccccCCccEEEEEEecCCcEEEEEEeecCCCC------------------ChhhHHHHHHHHHhcCCCc-------
Q 047195 296 STGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTK------------------GIDPILNEVRILCQLNHRS------- 350 (559)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~------------------~~~~~~~E~~~l~~l~h~n------- 350 (559)
.+.++||+|+||+||+|+..+++.||||+++..... ....+.+|...+.++.|.+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999889999999986542110 0123457888999998876
Q ss_pred ----eEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcCCCCeEECCCCCCCeeecCCCCEEEeec
Q 047195 351 ----LFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLATPPIYHRDIKSSNILLDEKLDAKISDF 426 (559)
Q Consensus 351 ----iv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dikp~Nill~~~~~~kl~DF 426 (559)
++|+|+++..+. .++......++.|++++|+||| +++|+||||||+|||+++++ ++|+||
T Consensus 83 ~~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 83 EGNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp ETTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred cCCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEEC
Confidence 456776654432 2455566789999999999999 78899999999999999754 899999
Q ss_pred ccceeccCCCceeeeeccccCCccCc--c---ccccCCCCcccchhHHHHHHH
Q 047195 427 GLSRLALNGASHVTTFAQGTLGYLDP--E---YYINFQLTDKSDVYSFGVVLV 474 (559)
Q Consensus 427 G~a~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~Dv~SlG~il~ 474 (559)
|+|......... .|... + .+....|+.++|+||+.--++
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 999765433211 11111 0 012356788999999864443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.04 E-value=1.1e-05 Score=75.00 Aligned_cols=136 Identities=16% Similarity=0.123 Sum_probs=88.7
Q ss_pred hHHHHHHhCCCCCCCccccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC----C-----------
Q 047195 285 SREITEATNNFSTGNLLGSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH----R----------- 349 (559)
Q Consensus 285 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h----~----------- 349 (559)
..++......|+..+..+.++.+.||+...+ +..+.+|+...........+.+|+..+..+.- |
T Consensus 6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp CHHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred CHHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 3566777777877666665666799998654 44566787766555555678899999887631 2
Q ss_pred -ceEEeeCCCCcHhHhHhhccCCCCCCCChHHHHHHHHHHHHHHHHHHHcC-----------------------------
Q 047195 350 -SLFMSMSPNGTLFDRLHRVQSGNWPPLKWHHRLHIARQTAQAIAYLHLLA----------------------------- 399 (559)
Q Consensus 350 -niv~~~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------- 399 (559)
.+||++.++..+.+.... ......++.++++.+..||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred eEEEEEecccccccccccc----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 267888887776543321 0112223444444444454321
Q ss_pred ---------------------------CCCeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 400 ---------------------------TPPIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 400 ---------------------------~~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877678999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.09 E-value=0.00069 Score=61.85 Aligned_cols=30 Identities=20% Similarity=0.204 Sum_probs=25.9
Q ss_pred CeEECCCCCCCeeecCCCCEEEeeccccee
Q 047195 402 PIYHRDIKSSNILLDEKLDAKISDFGLSRL 431 (559)
Q Consensus 402 ~iiH~Dikp~Nill~~~~~~kl~DFG~a~~ 431 (559)
.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 389999999999999877778999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.92 E-value=0.0022 Score=62.67 Aligned_cols=31 Identities=19% Similarity=0.323 Sum_probs=26.7
Q ss_pred CCeEECCCCCCCeeecCCCCEEEeecccceec
Q 047195 401 PPIYHRDIKSSNILLDEKLDAKISDFGLSRLA 432 (559)
Q Consensus 401 ~~iiH~Dikp~Nill~~~~~~kl~DFG~a~~~ 432 (559)
..++|+|+.|.|||++++. ++|+||..+...
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 4699999999999998765 899999888653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.43 E-value=0.0026 Score=59.99 Aligned_cols=63 Identities=10% Similarity=0.092 Sum_probs=40.7
Q ss_pred cChHHHHHHhCCCCCCCcc-----ccCCccEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcCC
Q 047195 283 FSSREITEATNNFSTGNLL-----GSGGFGEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLNH 348 (559)
Q Consensus 283 ~~~~~~~~~~~~y~~~~~l-----G~G~~g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h 348 (559)
.+.+|++....+|.+.+.. ..|---+.|+.+.++++ +++|+.... ...+++..|++++..|..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAA 70 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhh
Confidence 4678888888889876544 35555678998877765 678876543 233556678888877754
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.09 E-value=0.0014 Score=40.54 Aligned_cols=28 Identities=18% Similarity=0.256 Sum_probs=22.9
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccCCC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWDPI 217 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gnpy 217 (559)
.|.. |+.|.+.. ++|.|.|++||.||.+
T Consensus 8 ~C~~--~A~C~Nt~---Gsy~C~C~~Gy~GdG~ 35 (40)
T d1gl4a2 8 QCSV--HAECRDYA---TGFCCRCVANYTGNGR 35 (40)
T ss_dssp GSCT--TEEEEECS---SCEEEEECTTEEECSS
T ss_pred CCCC--CCEeecCC---CCeEeECCCCCcCCCC
Confidence 5654 99998864 6799999999999854
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.91 E-value=0.012 Score=55.62 Aligned_cols=40 Identities=25% Similarity=0.170 Sum_probs=31.6
Q ss_pred cEEEEEEecCCcEEEEEEeecCCCCChhhHHHHHHHHHhcC
Q 047195 307 GEVFKAILDDETITAVKRAKLGNTKGIDPILNEVRILCQLN 347 (559)
Q Consensus 307 g~Vy~~~~~~~~~~avk~~~~~~~~~~~~~~~E~~~l~~l~ 347 (559)
-.||++..++|..+++|..... ....+++..|...+..|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLV 75 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHH
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHH
Confidence 4899999999999999987643 234467889999988874
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.73 E-value=0.0081 Score=37.30 Aligned_cols=27 Identities=22% Similarity=0.391 Sum_probs=22.5
Q ss_pred cCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 186 CQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 186 C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
|.. ++.|.+.... .+|+|.|+.||.|.
T Consensus 6 C~n--gG~C~~~~~~-~~y~C~C~~g~~G~ 32 (41)
T d1tpga1 6 CFN--GGTCQQALYF-SDFVCQCPEGFAGK 32 (41)
T ss_dssp SCT--TCEEEEESSS-SCEEEECCTTCBSS
T ss_pred CCC--CCEEecCCCC-CCeEECCCCCCCCC
Confidence 665 8999887655 78999999999884
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.55 E-value=0.0091 Score=37.33 Aligned_cols=27 Identities=19% Similarity=0.509 Sum_probs=22.0
Q ss_pred cccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 184 VDCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 184 ~~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
.-|.. +++|.+.. ++|.|.|+.||.|.
T Consensus 11 ~pC~n--~g~C~n~~---g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 11 NPCEH--AGKCINTL---GSFECQCLQGYTGP 37 (42)
T ss_dssp CSSST--TCEEEECS---SSEEEECCTTEEST
T ss_pred CCCCC--CcEeECCC---CCEEeECCCCCcCC
Confidence 35765 99998854 67999999999885
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.54 E-value=0.01 Score=37.24 Aligned_cols=29 Identities=21% Similarity=0.478 Sum_probs=22.7
Q ss_pred CCeeecCCCCCCcceeEecCCCccCCCCCccc
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDPISGICK 222 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnpy~~~c~ 222 (559)
++.|.+.. ++|+|.|+.||+.++-...|.
T Consensus 14 ~~~C~Nt~---G~y~C~C~~Gy~l~~d~~~C~ 42 (43)
T d1uzka1 14 SGNCVNTP---GSYICDCPPDFELNPTRVGCV 42 (43)
T ss_dssp TSEEEEET---TEEEEECCTTCEECTTSSBEE
T ss_pred CCEeECCC---CCEEEecCCCCEECCCCCccc
Confidence 77898865 689999999999876544443
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.14 E-value=0.014 Score=36.67 Aligned_cols=23 Identities=17% Similarity=0.499 Sum_probs=19.8
Q ss_pred CCeeecCCCCCCcceeEecCCCccCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDP 216 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnp 216 (559)
++.|.+.. ++|.|.|++||+++.
T Consensus 15 ~~~C~Nt~---Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 15 RGQCVNTP---GDFECKCDEGYESGF 37 (44)
T ss_dssp TSCEEEET---TEEEECCCSSEEECT
T ss_pred CCEeEcCC---CCeEEeCCCCCccCC
Confidence 77898865 789999999999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.12 E-value=0.051 Score=52.51 Aligned_cols=60 Identities=15% Similarity=0.150 Sum_probs=38.2
Q ss_pred CccccCCccEEEEEEecCC--------cEEEEEEeecCCCCChhhHHHHHHHHHhcCCCc------------eEEeeCCC
Q 047195 299 NLLGSGGFGEVFKAILDDE--------TITAVKRAKLGNTKGIDPILNEVRILCQLNHRS------------LFMSMSPN 358 (559)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~--------~~~avk~~~~~~~~~~~~~~~E~~~l~~l~h~n------------iv~~~~~~ 358 (559)
+.|+.|-.=.+|+....++ ..+.+++.- .........+|..+++.+.-.+ +|++|.++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g--~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~g~I~efi~g 125 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF--NPETESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEYIPS 125 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC--SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECCCCE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC--CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCCceEEEEecc
Confidence 5688888889999886543 345555433 2333456778999998874322 36777765
Q ss_pred Cc
Q 047195 359 GT 360 (559)
Q Consensus 359 g~ 360 (559)
..
T Consensus 126 ~~ 127 (395)
T d1nw1a_ 126 RP 127 (395)
T ss_dssp EE
T ss_pred cc
Confidence 43
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.01 E-value=0.013 Score=35.78 Aligned_cols=26 Identities=27% Similarity=0.777 Sum_probs=21.4
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|.+.. .+|+|.|+.||.|-
T Consensus 8 PC~n--~g~C~~~~---~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 8 PCQN--DATCLDQI---GEFQCICMPGYEGV 33 (39)
T ss_dssp CCCS--SCEEEECS---SCEEEECCTTEESS
T ss_pred CCCC--CCEEECCC---CCEEEeCCCCCccC
Confidence 4776 89998754 57999999999883
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.76 E-value=0.024 Score=35.48 Aligned_cols=24 Identities=17% Similarity=0.461 Sum_probs=19.9
Q ss_pred CCeeecCCCCCCcceeEecCCCccCCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDPI 217 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnpy 217 (559)
++.|.+.. ++|+|.|+.||..++-
T Consensus 15 ~~~C~Nt~---Gsy~C~C~~Gy~l~~~ 38 (43)
T d1uzka2 15 GGKCINTF---GSFQCRCPTGYYLNED 38 (43)
T ss_dssp TSEEEECS---SCEEEECCTTCCBCTT
T ss_pred CCEEECCC---CCeEeECCCCCeECcC
Confidence 67898876 7899999999987653
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.72 E-value=0.017 Score=34.40 Aligned_cols=26 Identities=27% Similarity=0.599 Sum_probs=21.2
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. +++|.+.. .+|.|.|+.||.|.
T Consensus 7 PC~n--gg~C~~~~---~~y~C~C~~g~~G~ 32 (35)
T d2vj3a3 7 PCLH--NGRCLDKI---NEFQCECPTGFTGH 32 (35)
T ss_dssp CSTT--TCEEEECS---SCEEEECCTTEESS
T ss_pred CCCC--CcEEECCC---CCeEEECCCCCCCC
Confidence 4776 89998754 57999999999874
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.70 E-value=0.015 Score=35.50 Aligned_cols=26 Identities=27% Similarity=0.641 Sum_probs=21.2
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|.+.. .+|.|.|+.||.|.
T Consensus 7 PC~n--gg~C~~~~---~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 7 PCQN--QGKCKDGL---GEYTCTCLEGFEGK 32 (39)
T ss_dssp CCCS--SCEECCCS---SSCCEECCTTEETT
T ss_pred CCCC--CcEEECCC---CCEEEECCCCCCcC
Confidence 4776 89998754 57999999999884
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=93.35 E-value=0.017 Score=34.88 Aligned_cols=26 Identities=19% Similarity=0.461 Sum_probs=21.1
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. +++|.+.. .+|.|.|+.||.|.
T Consensus 9 PC~n--gg~C~~~~---~~y~C~C~~g~~G~ 34 (37)
T d2c4fl1 9 PCQN--GGSCKDQL---QSYICFCLPAFEGR 34 (37)
T ss_dssp CCCT--TCEEEEET---TEEEEECCTTEEST
T ss_pred CCCC--CCEEECCC---CCeEEECCCCCcCC
Confidence 4776 89998754 67999999999874
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.29 E-value=0.02 Score=35.00 Aligned_cols=31 Identities=23% Similarity=0.554 Sum_probs=23.5
Q ss_pred CCCCCcccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 179 TCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 179 ~C~~~~~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
.|.. .-|.. +++|.+.. .+|.|.|+.||.|.
T Consensus 5 ~C~~-~PC~n--gg~C~~~~---~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 5 QCES-NPCLN--GGSCKDDI---NSYECWCPFGFEGK 35 (39)
T ss_dssp TTTT-CCCCT--TCEEEEET---TEEEEECCTTCCST
T ss_pred cCCC-CCCCC--CcEEEcCC---CCEEEECCCCCCCC
Confidence 3543 35776 89998754 68999999999874
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.15 E-value=0.031 Score=34.51 Aligned_cols=29 Identities=34% Similarity=0.812 Sum_probs=20.4
Q ss_pred CCeeecCCCCCCcceeEecCCCccCCCCCccc
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDPISGICK 222 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnpy~~~c~ 222 (559)
...|.+.. ++|+|.|++||.-++-...|+
T Consensus 11 ~~~C~n~~---Gsy~C~C~~Gy~L~~d~~~C~ 39 (41)
T d1i0ua2 11 SQLCVNLE---GGYKCQCEEGFQLDPHTKACK 39 (41)
T ss_dssp SSCEECSS---SCCEECCCTTEEECTTTCCEE
T ss_pred CCEeECCC---CCEEeECCCCCeECCCCCccc
Confidence 44677654 689999999998765333344
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.80 E-value=0.03 Score=34.81 Aligned_cols=23 Identities=30% Similarity=0.676 Sum_probs=19.6
Q ss_pred CCeeecCCCCCCcceeEecCCCccCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDP 216 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnp 216 (559)
++.|.+.. ++|+|.|+.||..++
T Consensus 14 ~~~C~Nt~---Gsy~C~C~~Gy~l~~ 36 (42)
T d1lmja2 14 GGVCHNTE---GSYRCECPPGHQLSP 36 (42)
T ss_dssp TSEEEEET---TEEEEESCTTSCCCS
T ss_pred CCEeECCC---CCeEEeCCCCCeECc
Confidence 78898876 789999999998664
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.65 E-value=0.022 Score=34.97 Aligned_cols=26 Identities=27% Similarity=0.609 Sum_probs=21.3
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|.+.. .+|+|.|+.||.|.
T Consensus 8 pC~n--gg~C~~~~---~~y~C~C~~g~~G~ 33 (40)
T d1g1sa2 8 SCSK--QGECLETI---GNYTCSCYPGFYGP 33 (40)
T ss_dssp GGGG--SEEEEECS---SSEEEEECTTEEST
T ss_pred cCCC--CcEEECCC---CCeEEeCCCCccCC
Confidence 4776 89998754 57999999999884
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.59 E-value=0.019 Score=35.12 Aligned_cols=26 Identities=19% Similarity=0.519 Sum_probs=21.4
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|.+.. .+|.|.|+.||.|.
T Consensus 8 pC~n--gg~C~~~~---~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 8 SCSG--HGECVETI---NNYTCKCDPGFSGL 33 (39)
T ss_dssp GGGG--SEEEEEET---TEEEEEECTTEEST
T ss_pred cCCC--CcEEECCC---CCEEEeCCCCCcCc
Confidence 4776 89998754 68999999999884
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.10 E-value=0.04 Score=36.16 Aligned_cols=28 Identities=18% Similarity=0.449 Sum_probs=22.7
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. +++|...... .+|.|.|+.||.|.
T Consensus 13 ~C~N--gG~C~~~~~~-~~~~C~C~~gy~G~ 40 (53)
T d3egfa_ 13 YCLN--GGVCMHIESL-DSYTCNCVIGYSGD 40 (53)
T ss_dssp CSCS--SCEEEEESSS-SCEEEECCTTCCSS
T ss_pred CCCC--CcEeeccCCC-CCeEeECCCCCcCC
Confidence 4875 7999875555 78999999999885
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.86 E-value=0.032 Score=35.71 Aligned_cols=30 Identities=20% Similarity=0.616 Sum_probs=21.9
Q ss_pred CCCCCcccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 179 TCKLPVDCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 179 ~C~~~~~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
.|.+ .-|. |+.|.+.. ++|+|.|+.||.|.
T Consensus 10 ~C~~-~PC~---nG~C~~~~---~~y~C~C~~G~~G~ 39 (48)
T d1autl1 10 PCAS-LCCG---HGTCIDGI---GSFSCDCRSGWEGR 39 (48)
T ss_dssp SSSS-TTTT---SEEECCCS---SCCCEEECTTEEST
T ss_pred cccC-CCCC---CCEEECCC---CCCeEeCCCCCcCC
Confidence 3444 3464 78998754 57999999999874
|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.55 E-value=0.041 Score=35.25 Aligned_cols=28 Identities=14% Similarity=0.385 Sum_probs=22.6
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|...... .+|.|.|..||.|.
T Consensus 11 ~C~n--gG~C~~~~~~-~~~~C~C~~gy~G~ 38 (48)
T d1nqlb_ 11 YCLH--DGVCMYIEAL-DKYACNCVVGYIGE 38 (48)
T ss_dssp EECT--TCEEEEETTT-TEEEEEECTTEEST
T ss_pred CCCC--CcEEeeeCCC-CCeEEeCCCCcccC
Confidence 4775 7999876555 68999999999884
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.51 E-value=0.041 Score=34.34 Aligned_cols=23 Identities=22% Similarity=0.540 Sum_probs=18.8
Q ss_pred CCeeecCCCCCCcceeEecCCCccCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDP 216 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnp 216 (559)
++.|.+.. ++|.|.|+.||.++.
T Consensus 16 ~~~C~Nt~---Gsy~C~C~~Gy~~~g 38 (43)
T d1emoa1 16 HGQCINTD---GSYRCECPFGYILAG 38 (43)
T ss_dssp SSCCCCCS---SCCCCCCCTTEEESS
T ss_pred CCEeECCC---CCeEeECCCCcccCC
Confidence 67787765 689999999998764
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.07 E-value=0.07 Score=30.82 Aligned_cols=24 Identities=29% Similarity=0.613 Sum_probs=20.0
Q ss_pred CCeeecCCCCCCcceeEecCCCccCCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDPI 217 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnpy 217 (559)
|++|.+.. +||.|.|.+||+.-|-
T Consensus 12 nGTCtNvi---GgFec~C~~GFepgpm 35 (39)
T d1emoa2 12 NGTCKNVI---GGFECTCEEGFEPGPM 35 (39)
T ss_dssp SSCEEECS---SSEEECCSSSSCCCSS
T ss_pred Cceeeecc---cceEEeecCCcCCCcc
Confidence 88888765 7899999999987664
|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epiregulin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.82 E-value=0.058 Score=34.08 Aligned_cols=27 Identities=19% Similarity=0.429 Sum_probs=21.9
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|. ||.|.+..+. .+|.|.|+.||.|.
T Consensus 13 yC~---nG~C~~~~~~-~~~~C~C~~gY~G~ 39 (46)
T d1k36a_ 13 YCL---HGQCIYLVDM-SQNYCRCEVGYTGV 39 (46)
T ss_dssp SCS---SEEEEEETTT-TEEEEEECTTCSST
T ss_pred cCc---CCEEEEeCCC-CccEeECCCCceec
Confidence 465 8889876655 78999999999885
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.75 E-value=0.12 Score=33.80 Aligned_cols=23 Identities=17% Similarity=0.525 Sum_probs=18.8
Q ss_pred CCeeecCCCCCCcceeEecCCCccCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDP 216 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnp 216 (559)
...|.+.. ++|+|.|+.||..++
T Consensus 23 ~~~C~Nt~---GsY~C~C~~Gy~l~~ 45 (53)
T d1apqa_ 23 QHLCHNYV---GGYFCSCRPGYELQE 45 (53)
T ss_dssp SSEEEEET---TEEEEECSTTCEECT
T ss_pred cCEeEcCC---CCeEeECCCCCeECC
Confidence 45788866 789999999998654
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.26 E-value=0.064 Score=32.69 Aligned_cols=23 Identities=13% Similarity=0.302 Sum_probs=18.4
Q ss_pred CCeeecCCCCCCcceeEecCCCccCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDP 216 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnp 216 (559)
...|.+.. ++|+|.|+.||..++
T Consensus 12 ~~~C~N~~---Gsy~C~C~~Gy~l~g 34 (40)
T d1dx5i3 12 SGVCHNLP---GTFECICGPDSALAG 34 (40)
T ss_dssp SSEEEECS---SSEEEEECSSSSCEE
T ss_pred cCEeeCCC---CCeEeECCCCCeeCC
Confidence 45787765 789999999998764
|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Sheep (Ovis aries) [TaxId: 9940]
Probab=89.23 E-value=0.082 Score=32.68 Aligned_cols=27 Identities=19% Similarity=0.497 Sum_probs=20.5
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecC-CCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKA-GFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~-Gy~gn 215 (559)
-|+. +++|.+... .+|.|.|+. ||.|.
T Consensus 9 PC~n--gG~C~~~~~--~~y~C~C~~~G~~G~ 36 (42)
T d1q4ga2 9 PCQH--QGICVRFGL--DRYQCDCTRTGYSGP 36 (42)
T ss_dssp CCCT--TCEEEEETT--TEEEEECTTSSEETT
T ss_pred CCCC--CCEeeeCCC--CCEEEECCCCCcCCc
Confidence 4776 899986433 589999975 89874
|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.63 E-value=0.08 Score=32.53 Aligned_cols=27 Identities=26% Similarity=0.583 Sum_probs=20.4
Q ss_pred ccCCCCCCeeecCCCCCCcceeEec-CCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYK-AGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~-~Gy~gn 215 (559)
-|.. ++.|.+... .+|+|.|+ .||.|.
T Consensus 8 PC~n--gG~C~~~~~--~~y~C~C~~~gy~G~ 35 (41)
T d1cvua2 8 PCQN--RGECMSTGF--DQYKCDCTRTGFYGE 35 (41)
T ss_dssp CCCT--TCEEEEEET--TEEEEECTTSSEETT
T ss_pred CCCC--CCEEEECCC--CCEEEeCcCCCcCCc
Confidence 4776 899986433 57999997 599874
|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=87.66 E-value=0.13 Score=32.36 Aligned_cols=23 Identities=17% Similarity=0.447 Sum_probs=18.4
Q ss_pred CCeeecCCCCCCcceeEecCCCccCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDP 216 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnp 216 (559)
...|.+.. ++|+|.|++||..++
T Consensus 15 ~~~C~Nt~---gsy~C~C~~Gy~L~~ 37 (45)
T d1nt0a3 15 DHYCHNYL---GGYYCSCRVGYILHQ 37 (45)
T ss_dssp SSEEEEET---TEEEEECCTTEEECT
T ss_pred CCEeecCC---CCEEEeCCCCCEECC
Confidence 56788765 689999999998654
|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.06 E-value=0.18 Score=31.66 Aligned_cols=23 Identities=22% Similarity=0.489 Sum_probs=18.1
Q ss_pred CCeeecCCCCCCcceeEecCCCccCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDP 216 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnp 216 (559)
+..|.+.. ++|+|.|++||+-++
T Consensus 15 ~~~C~Nt~---Gsy~C~C~~Gy~l~~ 37 (45)
T d1szba2 15 DHHCHNHL---GGFYCSCRAGYVLHR 37 (45)
T ss_dssp SSEEEEET---TEEEEECCTTEEECT
T ss_pred CCCCccCC---CCeEEECCCCCeECC
Confidence 55788754 789999999998543
|
| >d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (urokinase-type) species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.53 E-value=0.3 Score=28.35 Aligned_cols=29 Identities=17% Similarity=0.394 Sum_probs=20.4
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
.|.. ++.|+...-=..-.+|.|+.+|.|-
T Consensus 3 ~ClN--GG~Cvsyk~FS~I~rC~CPk~f~G~ 31 (40)
T d2i9aa1 3 DCLN--GGTCVSNKYFSNIHWCNCPKKFGGQ 31 (40)
T ss_dssp CCCT--TCEEEECSSSTTCEEEECCTTEEST
T ss_pred cccc--CCEEEEEehhcCCEEecCCcccCce
Confidence 4665 8899764332245789999999874
|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heregulin-alpha, EGF-like domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.11 E-value=0.23 Score=33.68 Aligned_cols=29 Identities=17% Similarity=0.391 Sum_probs=20.7
Q ss_pred ccCCCCCCeeecC--CCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQD--AESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~--~~~~~gy~C~C~~Gy~gn 215 (559)
-|.. ++.|... .++..+|.|.|+.||.|.
T Consensus 13 ~C~N--gG~C~~~~~~~~~~~y~C~C~~gy~G~ 43 (63)
T d1haea_ 13 FCVN--GGECFMVKDLSNPSRYLCKCQPGFTGA 43 (63)
T ss_dssp TSCT--TCEEEEEESSSSSCCEEEECCTTEEST
T ss_pred cCCC--CCEEeecccccCCCCEEeECCCCCCCC
Confidence 3765 7999642 122268999999999884
|
| >d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Betacellulin-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.28 E-value=0.24 Score=31.69 Aligned_cols=26 Identities=15% Similarity=0.388 Sum_probs=18.0
Q ss_pred cCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 186 CQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 186 C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
|. |+.|-+.... ..+.|.|+.||.|.
T Consensus 16 C~---nGgcc~~~~~-~~~~C~C~~gy~G~ 41 (50)
T d1ioxa_ 16 CI---KGRCRFVVAE-QTPSCVCDEGYIGA 41 (50)
T ss_dssp CT---TCCEEEETTT-TEEEECCCTTEETT
T ss_pred cc---CCeEEEeCCC-CCcEeECCCCCeeC
Confidence 76 4444433333 67999999999885
|
| >d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heparin-binding epidermal growth factor, HBEGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.64 E-value=0.21 Score=30.46 Aligned_cols=24 Identities=17% Similarity=0.415 Sum_probs=20.4
Q ss_pred CCeeecCCCCCCcceeEecCCCccC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
||.|.+-.+. ..+.|+|..||.|.
T Consensus 12 hG~C~~i~~l-~~~~C~C~~gY~G~ 35 (41)
T d1xdtr_ 12 HGECKYVKEL-RAPSCICHPGYHGE 35 (41)
T ss_dssp SEEECCBGGG-TBCCEEECTTEEST
T ss_pred CcEEeecCcC-CCceeECCCCCeec
Confidence 8999886665 67899999999885
|
| >d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Transforming growth factor alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.22 E-value=0.29 Score=31.13 Aligned_cols=27 Identities=15% Similarity=0.383 Sum_probs=19.7
Q ss_pred ccCCCCCCeeecCCCCCCcceeEecCCCccC
Q 047195 185 DCQDLLNSMCLQDAESAGQKRCLYKAGFQWD 215 (559)
Q Consensus 185 ~C~~~~~s~C~~~~~~~~gy~C~C~~Gy~gn 215 (559)
-|. |+.|-+.... ..+.|.|+.||.|.
T Consensus 14 yCl---nGgcc~~~~~-~~~~C~C~~gy~G~ 40 (49)
T d1moxc_ 14 FCF---HGTCRFLVQE-DKPACVCHSGYVGA 40 (49)
T ss_dssp SST---TEEEEEETTT-TEEEEEECTTEEST
T ss_pred Eee---CCeEEecCCC-CCcEeECCCCCEec
Confidence 476 5556554444 68999999999985
|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement C1S component species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.52 E-value=0.53 Score=28.79 Aligned_cols=23 Identities=13% Similarity=0.231 Sum_probs=18.0
Q ss_pred CCeeecCCCCCCcceeEecCCCccCC
Q 047195 191 NSMCLQDAESAGQKRCLYKAGFQWDP 216 (559)
Q Consensus 191 ~s~C~~~~~~~~gy~C~C~~Gy~gnp 216 (559)
...|.+.. ++|+|.|++||.-++
T Consensus 12 ~~~C~n~~---Gsy~C~C~~Gy~L~~ 34 (42)
T d1nzia2 12 SHFCNNFI---GGYFCSCPPEYFLHD 34 (42)
T ss_dssp SSEEEEET---TEEEEECCTTCEECT
T ss_pred CCEeecCC---CCEEEeCCCCCEECC
Confidence 44687765 789999999998654
|